Citrus Sinensis ID: 011158
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 492 | 2.2.26 [Sep-21-2011] | |||||||
| Q55GU0 | 916 | Probable serine/threonine | yes | no | 0.308 | 0.165 | 0.416 | 6e-30 | |
| Q54H46 | 642 | Probable serine/threonine | no | no | 0.288 | 0.221 | 0.442 | 1e-29 | |
| Q7T6Y2 | 1624 | Putative serine/threonine | N/A | no | 0.278 | 0.084 | 0.442 | 4e-29 | |
| Q7T6X2 | 1657 | Putative serine/threonine | N/A | no | 0.302 | 0.089 | 0.424 | 4e-29 | |
| Q05609 | 821 | Serine/threonine-protein | no | no | 0.363 | 0.218 | 0.386 | 2e-28 | |
| Q2MHE4 | 390 | Serine/threonine-protein | no | no | 0.282 | 0.356 | 0.402 | 2e-28 | |
| Q54H45 | 690 | Probable serine/threonine | no | no | 0.288 | 0.205 | 0.421 | 5e-28 | |
| Q5UQG7 | 1651 | Putative serine/threonine | N/A | no | 0.282 | 0.084 | 0.422 | 8e-27 | |
| P09560 | 638 | RAF proto-oncogene serine | N/A | no | 0.398 | 0.307 | 0.333 | 1e-26 | |
| Q6VAB6 | 950 | Kinase suppressor of Ras | yes | no | 0.392 | 0.203 | 0.338 | 4e-26 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function desciption |
|---|
Score = 132 bits (332), Expect = 6e-30, Method: Compositional matrix adjust.
Identities = 65/156 (41%), Positives = 103/156 (66%), Gaps = 4/156 (2%)
Query: 288 EIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLK-PERINSDMQKEFAQEVFIMRKV 346
EI LK SK+ G++G +Y+G + VAIK +K E +N+ + +EF +E+ I+ ++
Sbjct: 656 EISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKINEDVNNQVLEEFRKELTILSRL 715
Query: 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 406
RH N+V + ACT PP+LC +TE++ GGS+YD LH K + K+AI +++GMNYL
Sbjct: 716 RHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKKIKMNMQLYKKLAIQIAQGMNYL 775
Query: 407 HQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL 442
H + +IHRD+K+ NLL+DE+ + + +C F +S L
Sbjct: 776 HLSGVIHRDIKSLNLLLDEH---MNVKICDFGLSKL 808
|
Dictyostelium discoideum (taxid: 44689) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 131 bits (330), Expect = 1e-29, Method: Compositional matrix adjust.
Identities = 65/147 (44%), Positives = 95/147 (64%), Gaps = 5/147 (3%)
Query: 282 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVF 341
DG D ID +K G ++ G+YG++Y GT+ VA+K L IN ++ KEF +E+
Sbjct: 365 DGKD---IDIHQIKIGVRIGKGNYGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREIN 421
Query: 342 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 401
+M+ +RH NV+QF+G+C PP +CI TE+M GS+Y LH + L+K+ ID +K
Sbjct: 422 LMKNLRHPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHDQALQLQWSLLIKMMIDAAK 481
Query: 402 GMNYLHQNN--IIHRDLKAANLLMDEN 426
G+ YLH + I+HRDLK+ NLL+DEN
Sbjct: 482 GVIYLHNSTPVILHRDLKSHNLLVDEN 508
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 129 bits (325), Expect = 4e-29, Method: Compositional matrix adjust.
Identities = 62/140 (44%), Positives = 95/140 (67%), Gaps = 3/140 (2%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 346
WEID L+ G + +G YG++Y+ + +VA+K++ + ++ DM++ F +EV IM +
Sbjct: 779 WEIDFSELEIGETLGTGGYGEVYKSIWKGTEVAVKLISSKHVSKDMERSFFEEVKIMTSL 838
Query: 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKV--AIDVSKGMN 404
RH NVV F+ A TK P++CIV EFMS GS+YD L + + ++P LK+ A SKGM+
Sbjct: 839 RHPNVVLFMAASTKSPNMCIVMEFMSLGSLYDLLGN-ELIPEIPYALKIKMAYQASKGMH 897
Query: 405 YLHQNNIIHRDLKAANLLMD 424
+LH + I+HRDLK+ NLL+D
Sbjct: 898 FLHSSGIVHRDLKSLNLLLD 917
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 129 bits (325), Expect = 4e-29, Method: Compositional matrix adjust.
Identities = 65/153 (42%), Positives = 103/153 (67%), Gaps = 4/153 (2%)
Query: 275 YHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPER-INSDMQ 333
+ L+ +D WEID L+ G ++ +G++G++++GT+ +VA+K++ P++ I D++
Sbjct: 767 FSLRFRKGISDDWEIDFHELELGEQLGTGAFGEVHKGTWRGTEVAVKMISPDKTITKDIE 826
Query: 334 KEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLL 393
+ F EV +M +RH NVV F+ A TKPP +CIV EFM+ GS++D L K + + +P L
Sbjct: 827 RNFKDEVRVMTTLRHPNVVLFMAASTKPPKMCIVMEFMALGSLHDLL-KNELIPDIPFAL 885
Query: 394 KVAI--DVSKGMNYLHQNNIIHRDLKAANLLMD 424
KV I SKGM++LH + I HRDLK+ NLL+D
Sbjct: 886 KVKIAYQASKGMHFLHSSGITHRDLKSLNLLLD 918
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 127 bits (319), Expect = 2e-28, Method: Compositional matrix adjust.
Identities = 78/202 (38%), Positives = 114/202 (56%), Gaps = 23/202 (11%)
Query: 266 EDTGMKSHPYHLKIPN--------DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD 317
E M + P +PN DG D+ +I L K+ +GS+G ++R + D
Sbjct: 516 EAAPMNAPPISQPVPNRANRELGLDGDDM-DIPWCDLNIKEKIGAGSFGTVHRAEWHGSD 574
Query: 318 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
VA+K+L + +++ EF +EV IM+++RH N+V F+GA T+PP+L IVTE++S GS+Y
Sbjct: 575 VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY 634
Query: 378 DYLHKLKGVFKLPS--LLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEVSLLLS 433
LHK +L L +A DV+KGMNYLH N I+HRDLK+ NLL+D+
Sbjct: 635 RLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKK------- 687
Query: 434 LCLFTVSILFCGKGRELISLFL 455
+TV + G R S FL
Sbjct: 688 ---YTVKVCDFGLSRLKASTFL 706
|
Acts as a negative regulator in the ethylene response pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 127 bits (318), Expect = 2e-28, Method: Compositional matrix adjust.
Identities = 58/144 (40%), Positives = 96/144 (66%), Gaps = 5/144 (3%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLK----PERINSDMQKEFAQEVFI 342
W D L G+K ASG++ +YRG Y + VA+K+++ E + ++++F EV +
Sbjct: 79 WTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPTHKEETRAKLEQQFKSEVAL 138
Query: 343 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSK 401
+ ++ H N+VQFI AC KPP CI+TE+MS G++ YL+K + + ++L++A+D+S+
Sbjct: 139 LSRLFHPNIVQFIAACKKPPVYCIITEYMSQGNLRMYLNKKEPYSLSIETVLRLALDISR 198
Query: 402 GMNYLHQNNIIHRDLKAANLLMDE 425
GM YLH +IHRDLK+ NLL+++
Sbjct: 199 GMEYLHSQGVIHRDLKSNNLLLND 222
|
Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 125 bits (315), Expect = 5e-28, Method: Compositional matrix adjust.
Identities = 62/147 (42%), Positives = 94/147 (63%), Gaps = 5/147 (3%)
Query: 282 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVF 341
DG D ID + +K G ++ G++G++Y GT+ VA+K L IN ++ KEF +E+
Sbjct: 382 DGKD---IDTQQIKIGVRIGKGNFGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREIN 438
Query: 342 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 401
+M+ +RH NV+QF+G+C P +CI TE+M GS+Y LH K + ++ ID +K
Sbjct: 439 LMKNLRHPNVIQFLGSCLISPDICICTEYMPRGSLYSILHNEKIKISWSLVKRMMIDAAK 498
Query: 402 GMNYLHQNN--IIHRDLKAANLLMDEN 426
G+ YLH + I+HRDLK+ NLL+DEN
Sbjct: 499 GIIYLHGSTPVILHRDLKSHNLLVDEN 525
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5UQG7|YR818_MIMIV Putative serine/threonine-protein kinase/receptor R818 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R818 PE=4 SV=1 | Back alignment and function description |
|---|
Score = 122 bits (305), Expect = 8e-27, Method: Compositional matrix adjust.
Identities = 60/142 (42%), Positives = 92/142 (64%), Gaps = 3/142 (2%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMR 344
D WE+D L F + SG G++++ + +VA+K L I D ++ F QE+ M
Sbjct: 784 DEWEVDFHELDFMESLGSGGSGEVFKAMWKGTEVAVKKLVNSNITKDAERNFKQEIHRMT 843
Query: 345 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLL--KVAIDVSKG 402
+RH NVV F+ A T+PP++CIV EFMS GS+YD L + V ++P +L ++A +KG
Sbjct: 844 SLRHPNVVLFMAASTRPPNMCIVMEFMSLGSLYDLLGN-ELVTEIPPVLRIRIAYQAAKG 902
Query: 403 MNYLHQNNIIHRDLKAANLLMD 424
M++LH ++I+HRDLK+ NLL+D
Sbjct: 903 MHFLHSSDIVHRDLKSLNLLLD 924
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P09560|RAF1_XENLA RAF proto-oncogene serine/threonine-protein kinase OS=Xenopus laevis GN=raf1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 121 bits (304), Expect = 1e-26, Method: Compositional matrix adjust.
Identities = 67/201 (33%), Positives = 109/201 (54%), Gaps = 5/201 (2%)
Query: 248 LERQGWPSHRSSSPT---SEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGS 304
L GW + ++ +PT TG + + + D + WEI + S++ SGS
Sbjct: 291 LSPTGWSNAKAPAPTHREKAASSTGQEKNKIRARGQRDSSYYWEIIASEVMLSSRIGSGS 350
Query: 305 YGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364
+G +Y+G + DVA+K+LK + + F EV ++RK RH N++ F+G TK +L
Sbjct: 351 FGTVYKGKW-HGDVAVKILKVTDPTPEQLQAFRNEVAVLRKTRHVNILLFMGYMTKD-NL 408
Query: 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD 424
IVT++ G S+Y +LH L F++ L+ +A ++GM+YLH NIIHRD+K+ N+ +
Sbjct: 409 AIVTQWCEGSSLYYHLHVLDTKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLH 468
Query: 425 ENEVSLLLSLCLFTVSILFCG 445
E + L TV + G
Sbjct: 469 EGLTVKIGDFGLATVKTRWSG 489
|
Serine/threonine-protein kinase that acts as a regulatory link between the membrane-associated Ras GTPases and the MAPK/ERK cascade, and this critical regulatory link functions as a switch determining cell fate decisions. RAF1 activation initiates a mitogen-activated protein kinase (MAPK) cascade that comprises a sequential phosphorylation of the dual-specific MAPK kinases (MAP2K1/MEK1 and MAP2K2/MEK2) and the extracellular signal-regulated kinases (MAPK3/ERK1 and MAPK1/ERK2). Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6VAB6|KSR2_HUMAN Kinase suppressor of Ras 2 OS=Homo sapiens GN=KSR2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 119 bits (299), Expect = 4e-26, Method: Compositional matrix adjust.
Identities = 67/198 (33%), Positives = 104/198 (52%), Gaps = 5/198 (2%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 346
W+I + L+ G + G +G +Y G + +VAI+++ ER N D K F +EV R+
Sbjct: 659 WDIPFEQLEIGELIGKGRFGQVYHGRW-HGEVAIRLIDIERDNEDQLKAFKREVMAYRQT 717
Query: 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 406
RH+NVV F+GAC PP L I+T G ++Y + K V + ++A ++ KGM YL
Sbjct: 718 RHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL 777
Query: 407 HQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSILFCGKGRELISLFLGNDVLLQFGTY 466
H I+H+DLK+ N+ D +V ++ LF++S + GR L + N L
Sbjct: 778 HAKGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVL-QAGRREDKLRIQNGWLCHLAPE 835
Query: 467 WIIFRRSSCDKKNSDAPF 484
I R+ S D + PF
Sbjct: 836 --IIRQLSPDTEEDKLPF 851
|
Location-regulated scaffold connecting MEK to RAF. Blocks MAP3K8 kinase activity and MAP3K8-mediated signaling. Acts as a negative regulator of MAP3K3-mediated activation of ERK, JNK and NF-kappa-B pathways, inhibiting MAP3K3-mediated interleukin-8 production. Homo sapiens (taxid: 9606) |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 492 | ||||||
| 297744550 | 580 | unnamed protein product [Vitis vinifera] | 0.853 | 0.724 | 0.764 | 0.0 | |
| 449454245 | 573 | PREDICTED: protein-tyrosine kinase 2-bet | 0.845 | 0.726 | 0.769 | 0.0 | |
| 359474826 | 1515 | PREDICTED: uncharacterized mscS family p | 0.847 | 0.275 | 0.713 | 0.0 | |
| 283132359 | 578 | ACT-domain-containing protein kinase [Lo | 0.855 | 0.728 | 0.718 | 1e-178 | |
| 255560441 | 558 | protein kinase, putative [Ricinus commun | 0.825 | 0.727 | 0.745 | 1e-175 | |
| 357444821 | 771 | Protein kinase like protein [Medicago tr | 0.851 | 0.543 | 0.716 | 1e-175 | |
| 356574129 | 581 | PREDICTED: uncharacterized protein LOC10 | 0.855 | 0.724 | 0.707 | 1e-172 | |
| 18420244 | 575 | ACT-like protein tyrosine kinase family | 0.843 | 0.721 | 0.704 | 1e-166 | |
| 297797832 | 565 | kinase family protein [Arabidopsis lyrat | 0.829 | 0.722 | 0.710 | 1e-164 | |
| 217074650 | 538 | unknown [Medicago truncatula] | 0.845 | 0.773 | 0.663 | 1e-161 |
| >gi|297744550|emb|CBI37812.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 675 bits (1741), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 338/442 (76%), Positives = 375/442 (84%), Gaps = 22/442 (4%)
Query: 1 MVMEENNNESCGSRASDTSSTSSPPPQHQSRQHRQKLGVYNEVLGRLKESNNDEAIQPRF 60
MVME +NESC SR D+SS + QSRQ RQKL VYNEVL RLK+S+N+EA +P F
Sbjct: 1 MVME--DNESCSSRVHDSSSPA------QSRQQRQKLEVYNEVLRRLKDSDNEEAFEPGF 52
Query: 61 DDELWTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDR- 119
D+ELW HF RLPTRYALDVNVERAEDVL HKRLLHLAHDP NRPAIEVRLVQVHP+SD
Sbjct: 53 DEELWAHFVRLPTRYALDVNVERAEDVLTHKRLLHLAHDPTNRPAIEVRLVQVHPISDGI 112
Query: 120 NSAVSSLLDSEVP-----------AQRQSIHPPPAFGSSPNLEALAIEANNSH--NLDGD 166
+ ++ + S P + +QSI PPPAFGSSPNLEALAIEANNSH + DGD
Sbjct: 113 HGNIADSIHSNSPTIGPAHGSPKYSSKQSILPPPAFGSSPNLEALAIEANNSHVQDGDGD 172
Query: 167 NSVHANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV 226
+SVHA+ Q+SRPMHEITFS+DDKPKLLSQLT LL+++ LNIQEAHAFSTVDGYSLDVFVV
Sbjct: 173 DSVHASSQYSRPMHEITFSSDDKPKLLSQLTCLLSELELNIQEAHAFSTVDGYSLDVFVV 232
Query: 227 DGWPYEETEQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDV 286
DGWPYEETEQLR ALEKEV K+E+Q WP+H S SPT E E+TG+K + IPNDGTDV
Sbjct: 233 DGWPYEETEQLRTALEKEVFKIEKQSWPNHHSLSPTGEQEETGIKCESDFVTIPNDGTDV 292
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 346
WEID + LKF +KVASGSYGDLY+GTYCSQ+VAIKVLKPER+NSDMQKEFAQEVFIMRKV
Sbjct: 293 WEIDVRQLKFENKVASGSYGDLYKGTYCSQEVAIKVLKPERLNSDMQKEFAQEVFIMRKV 352
Query: 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 406
RHKNVVQFIGACT+PPSL IVTEFMSGGSVYDYLHK KGVFKLP+LLKV+IDVSKGMNYL
Sbjct: 353 RHKNVVQFIGACTRPPSLYIVTEFMSGGSVYDYLHKQKGVFKLPALLKVSIDVSKGMNYL 412
Query: 407 HQNNIIHRDLKAANLLMDENEV 428
HQNNIIHRDLKAANLLMDENEV
Sbjct: 413 HQNNIIHRDLKAANLLMDENEV 434
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449454245|ref|XP_004144866.1| PREDICTED: protein-tyrosine kinase 2-beta-like [Cucumis sativus] gi|449528766|ref|XP_004171374.1| PREDICTED: protein-tyrosine kinase 2-beta-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 672 bits (1733), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 338/439 (76%), Positives = 368/439 (83%), Gaps = 23/439 (5%)
Query: 1 MVMEENNNESCGSRASDTSSTSSPPPQHQSRQHRQKLGVYNEVLGRLKESNNDEAIQPRF 60
MVME +NESCGSRA D S + QSRQ RQK VYNEVL RLK+SNN+EAIQP F
Sbjct: 1 MVME--DNESCGSRAYDLLSPA------QSRQQRQKFEVYNEVLRRLKDSNNEEAIQPGF 52
Query: 61 DDELWTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDRN 120
DDELW HFNRLPTRYALDVNVERAEDVLMHKRLL AHDP NRPAIEVRLVQV VSD +
Sbjct: 53 DDELWVHFNRLPTRYALDVNVERAEDVLMHKRLLQFAHDPANRPAIEVRLVQVQAVSDEH 112
Query: 121 SAVSSLLDSEVPAQ-----------RQSIHPPPAFGSSPNLEALAIEANNSHNLDGDNSV 169
SA DS P + RQS+HPPPAFGSSPNLEALA+EANN+ +L+ D SV
Sbjct: 113 SA--DFADS-CPVKDTDHNSSNCLSRQSMHPPPAFGSSPNLEALALEANNTQDLEVDQSV 169
Query: 170 HANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGW 229
HA QF RPMHEITFSTDDKPKLLSQLT+LLA+IGLNIQEAHAFSTVDGYSLDVFVVDGW
Sbjct: 170 HARTQFFRPMHEITFSTDDKPKLLSQLTSLLAEIGLNIQEAHAFSTVDGYSLDVFVVDGW 229
Query: 230 PYEETEQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEI 289
PYEETE+L+ ALE EVL +ER+GWP+ +SSSP E + T K ++IP DGTDVWEI
Sbjct: 230 PYEETERLKTALESEVLLVERRGWPNQKSSSPVGELDITA-KCESDRVEIPTDGTDVWEI 288
Query: 290 DPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 349
+P+HLKF KVASGSYGDLY+GTYCSQ+VAIKVLK ER+N+DMQ EFAQEV+IMRKVRHK
Sbjct: 289 NPRHLKFEHKVASGSYGDLYKGTYCSQEVAIKVLKTERVNTDMQSEFAQEVYIMRKVRHK 348
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 409
NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHK KG F+LPSLLKVAIDVSKGMNYLHQN
Sbjct: 349 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKQKGTFRLPSLLKVAIDVSKGMNYLHQN 408
Query: 410 NIIHRDLKAANLLMDENEV 428
NIIHRDLKAANLLMDENEV
Sbjct: 409 NIIHRDLKAANLLMDENEV 427
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359474826|ref|XP_002280985.2| PREDICTED: uncharacterized mscS family protein At1g78610-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 650 bits (1677), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 336/471 (71%), Positives = 373/471 (79%), Gaps = 54/471 (11%)
Query: 1 MVMEENNNESCGSRASDTSSTSSPPPQHQSRQHRQKLGVYNEVLGRLKESNNDEAIQPRF 60
MVME +NESC SR D+SS + QSRQ RQKL VYNEVL RLK+S+N+EA +P F
Sbjct: 1 MVME--DNESCSSRVHDSSSPA------QSRQQRQKLEVYNEVLRRLKDSDNEEAFEPGF 52
Query: 61 DDELWTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQ-------- 112
D+ELW HF RLPTRYALDVNVERAEDVL HKRLLHLAHDP NRPAIEVRLVQ
Sbjct: 53 DEELWAHFVRLPTRYALDVNVERAEDVLTHKRLLHLAHDPTNRPAIEVRLVQFGKFDVSH 112
Query: 113 ---------------------VHPVSDR-NSAVSSLLDSEVP-----------AQRQSIH 139
VHP+SD + ++ + S P + +QSI
Sbjct: 113 KRYVRCGWALRQGKRNIISLTVHPISDGIHGNIADSIHSNSPTIGPAHGSPKYSSKQSIL 172
Query: 140 PPPAFGSSPNLEALAIEANNSH--NLDGDNSVHANVQFSRPMHEITFSTDDKPKLLSQLT 197
PPPAFGSSPNLEALAIEANNSH + DGD+SVHA+ S+PMHEITFS+DDKPKLLSQLT
Sbjct: 173 PPPAFGSSPNLEALAIEANNSHVQDGDGDDSVHAS---SQPMHEITFSSDDKPKLLSQLT 229
Query: 198 ALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEVLKLERQGWPSHR 257
LL+++ LNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLR ALEKEV K+E+Q WP+H
Sbjct: 230 CLLSELELNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRTALEKEVFKIEKQSWPNHH 289
Query: 258 SSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD 317
S SPT E E+TG+K + IPNDGTDVWEID + LKF +KVASGSYGDLY+GTYCSQ+
Sbjct: 290 SLSPTGEQEETGIKCESDFVTIPNDGTDVWEIDVRQLKFENKVASGSYGDLYKGTYCSQE 349
Query: 318 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
VAIKVLKPER+NSDMQKEFAQEVFIMRKVRHKNVVQFIGACT+PPSL IVTEFMSGGSVY
Sbjct: 350 VAIKVLKPERLNSDMQKEFAQEVFIMRKVRHKNVVQFIGACTRPPSLYIVTEFMSGGSVY 409
Query: 378 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428
DYLHK KGVFKLP+LLKV+IDVSKGMNYLHQNNIIHRDLKAANLLMDENEV
Sbjct: 410 DYLHKQKGVFKLPALLKVSIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 460
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|283132359|dbj|BAI63585.1| ACT-domain-containing protein kinase [Lotus japonicus] | Back alignment and taxonomy information |
|---|
Score = 630 bits (1626), Expect = e-178, Method: Compositional matrix adjust.
Identities = 314/437 (71%), Positives = 358/437 (81%), Gaps = 16/437 (3%)
Query: 1 MVMEENNNESCGSRASDTSSTSSPPPQHQSRQHRQKLGVYNEVLGRLKESNNDEAIQPRF 60
MV+ ++N+ S TS+ + P Q+RQHR K+ VYNE+L RL +S N EA+QP F
Sbjct: 3 MVVVDDND------TSGTSNHRATPSPSQTRQHRHKVEVYNEILRRLNDSGNPEALQPGF 56
Query: 61 DDELWTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDRN 120
D+LW HFNRLP RYALDVNVERA DVLMHKRLLHLAHDP NRP+IEVRLVQVHP SD N
Sbjct: 57 HDQLWAHFNRLPARYALDVNVERAADVLMHKRLLHLAHDPANRPSIEVRLVQVHPTSDGN 116
Query: 121 SAVSSLLDS---------EVPAQRQSIHPPPAFGSSPNLEALAIEANNSHNLDGDNSVHA 171
SA S DS + RQSIHPPPAFGSSPNLEALA+E NNS ++D + SVHA
Sbjct: 117 SADSFHSDSPGTESGQSSSKYSSRQSIHPPPAFGSSPNLEALALEENNSEDID-ERSVHA 175
Query: 172 NVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPY 231
+VQ+SRPMHEITFST+DKPKLLSQLTALLA+IGLNIQEAHAFST DGYSLDVFVVDGWPY
Sbjct: 176 SVQYSRPMHEITFSTEDKPKLLSQLTALLAEIGLNIQEAHAFSTSDGYSLDVFVVDGWPY 235
Query: 232 EETEQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDP 291
EETE+L+ ALEKE+LK+ERQ + +S S EP+ MK HL IPNDGTDVWEID
Sbjct: 236 EETEKLKVALEKEILKIERQARSNQQSVSSADEPDQARMKHEQDHLTIPNDGTDVWEIDA 295
Query: 292 KHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV 351
KHL +G+++ASGSYG+L++GTYCSQ+VAIKVLK E +N++MQ+EF QEV+IMRKVRHKNV
Sbjct: 296 KHLTYGNQIASGSYGELFKGTYCSQEVAIKVLKGEHVNAEMQREFVQEVYIMRKVRHKNV 355
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
VQFIGACTKPP LCI+TEFMSGGSVYDYLHK KG FK PSLLKVAIDVSKGMNYLHQ+NI
Sbjct: 356 VQFIGACTKPPRLCIITEFMSGGSVYDYLHKQKGFFKFPSLLKVAIDVSKGMNYLHQHNI 415
Query: 412 IHRDLKAANLLMDENEV 428
IHRDLK ANLLMDEN V
Sbjct: 416 IHRDLKGANLLMDENGV 432
|
Source: Lotus japonicus Species: Lotus japonicus Genus: Lotus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255560441|ref|XP_002521235.1| protein kinase, putative [Ricinus communis] gi|223539503|gb|EEF41091.1| protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 621 bits (1601), Expect = e-175, Method: Compositional matrix adjust.
Identities = 323/433 (74%), Positives = 356/433 (82%), Gaps = 27/433 (6%)
Query: 1 MVMEENNNESCGSRASDTSSTSSPPPQHQSRQHRQKLGVYNEVLGRLKESNNDEAIQPRF 60
MV+ NESCGSR D++++S P H R RQKL VYNEVL RLKESNN+EA QP F
Sbjct: 1 MVVMMEENESCGSRVQDSTTSSPSP-SHAGRNQRQKLEVYNEVLRRLKESNNEEANQPGF 59
Query: 61 DDELWTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDRN 120
DDELW+HF+RLPTRYALDVNVERAEDVLMHKRLL LAHDP NRPAIE+RLVQV PVSD N
Sbjct: 60 DDELWSHFHRLPTRYALDVNVERAEDVLMHKRLLQLAHDPDNRPAIEIRLVQVPPVSDGN 119
Query: 121 SAVSSLLDS----EVPAQRQSIHPPPAFGSSPNLEALAIEANNSHNLD-GDNSVHANVQF 175
SA S L S + + R+SIHPPPAFGSSPNLEALA+EA N G++ + ++Q
Sbjct: 120 SADSDLSGSPRKGDTQSNRKSIHPPPAFGSSPNLEALALEAINPKMXXLGNSDLLYHLQ- 178
Query: 176 SRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETE 235
PMHEITFSTDDKPKLLSQLT+LLA+IGLNIQEAHAFSTVDGYSLDVFVVDGWPYE
Sbjct: 179 --PMHEITFSTDDKPKLLSQLTSLLAEIGLNIQEAHAFSTVDGYSLDVFVVDGWPYE--- 233
Query: 236 QLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLK 295
+ WP+ S SP+SE + T +K P H+ IPNDGTDVWEIDPK+LK
Sbjct: 234 --------------KHTWPT-LSLSPSSEHKQTKIKCDPDHVTIPNDGTDVWEIDPKNLK 278
Query: 296 FGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI 355
F +KVASGSYGDLY+GTYCSQ+VAIK+LKPERINSD++KEFAQEVFIMRKVRHKNVVQFI
Sbjct: 279 FENKVASGSYGDLYKGTYCSQEVAIKILKPERINSDLEKEFAQEVFIMRKVRHKNVVQFI 338
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
GACTKPPSLCIVTEFMSGGSVYDYLHK KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD
Sbjct: 339 GACTKPPSLCIVTEFMSGGSVYDYLHKQKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 398
Query: 416 LKAANLLMDENEV 428
LKAANLLMDENEV
Sbjct: 399 LKAANLLMDENEV 411
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357444821|ref|XP_003592688.1| Protein kinase like protein [Medicago truncatula] gi|355481736|gb|AES62939.1| Protein kinase like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 619 bits (1597), Expect = e-175, Method: Compositional matrix adjust.
Identities = 309/431 (71%), Positives = 357/431 (82%), Gaps = 12/431 (2%)
Query: 7 NNESCGSRASDTSSTSSPPPQHQSRQHRQKLGVYNEVLGRLKESNNDEAIQPRFDDELWT 66
+NESCGS +S+S P QSRQ RQK+ VYNE+L RLK+S N+EA+QP FDD+LW
Sbjct: 8 DNESCGSGIHHRTSSSIPA---QSRQQRQKVEVYNEILRRLKDSGNEEAMQPGFDDQLWN 64
Query: 67 HFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDRNSA---- 122
HFNRLP+RYALDVNVERAEDVLMHKRLLHLAHDP NRP+IEV LVQ+HP SD NSA
Sbjct: 65 HFNRLPSRYALDVNVERAEDVLMHKRLLHLAHDPANRPSIEVHLVQLHPSSDGNSADSFQ 124
Query: 123 -----VSSLLDSEVPAQRQSIHPPPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSR 177
V S S + +Q I PPPAFGSSPNLEALA+E N+S +L+ + SVHA+VQ+SR
Sbjct: 125 SCAPGVDSGQSSSKYSSKQGILPPPAFGSSPNLEALALEENDSEDLEEEQSVHASVQYSR 184
Query: 178 PMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQL 237
PMHEIT STDDKPKLLSQLTALLA++GLNIQEAHAFST DG+SLDVFVV+GWPYEETE+L
Sbjct: 185 PMHEITVSTDDKPKLLSQLTALLAEVGLNIQEAHAFSTTDGFSLDVFVVEGWPYEETEKL 244
Query: 238 RAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFG 297
+ LEKEVLK+ER S +S S E + + MK+ IPNDGTDVWEIDPKHLK+G
Sbjct: 245 KETLEKEVLKIERGERSSQQSVSSVDECDQSRMKNELDRFTIPNDGTDVWEIDPKHLKYG 304
Query: 298 SKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 357
+++AS SYG+LY+G YCSQ+VAIKVLK E ++S+MQKEFAQEV+IMRKVRHKNVVQF+GA
Sbjct: 305 TQIASASYGELYKGIYCSQEVAIKVLKAEHVSSEMQKEFAQEVYIMRKVRHKNVVQFMGA 364
Query: 358 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 417
CT+PP LCIVTEFMSGGSVYDYLHK KG FK P++LKVAIDVSKGMNYLHQ+NIIHRDLK
Sbjct: 365 CTQPPRLCIVTEFMSGGSVYDYLHKQKGFFKFPTVLKVAIDVSKGMNYLHQHNIIHRDLK 424
Query: 418 AANLLMDENEV 428
AANLLMDEN V
Sbjct: 425 AANLLMDENGV 435
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356574129|ref|XP_003555204.1| PREDICTED: uncharacterized protein LOC100804170 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 612 bits (1577), Expect = e-172, Method: Compositional matrix adjust.
Identities = 310/438 (70%), Positives = 359/438 (81%), Gaps = 17/438 (3%)
Query: 2 VMEENNNESCGSRAS-DTSSTSSPPPQHQSRQHRQKLGVYNEVLGRLKESNNDEAIQPRF 60
++ E NN SCGS + +TSS QSR RQKL VYNE+L RLK+S N+EA+QP F
Sbjct: 1 MLTEGNNSSCGSGSGVQHHTTSSSSSPAQSRLQRQKLEVYNEILRRLKDSGNEEAMQPGF 60
Query: 61 DDELWTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDRN 120
D+LW HFNRLPT YALDVNVERA DVLMHKRLLHLAHDP NRP+IEVRLVQVHP S+ N
Sbjct: 61 HDQLWAHFNRLPTWYALDVNVERAADVLMHKRLLHLAHDPANRPSIEVRLVQVHPTSNGN 120
Query: 121 SAVSSLLDSEVPA-----------QRQSIHPPPAFGSSPNLEALAIEANNSHNLDGDNSV 169
SA +S+ P RQSIHPPPAFGSSPNLEALA+EANNS +++ + S
Sbjct: 121 SA--DTFESDDPGIESGQSSSKYSSRQSIHPPPAFGSSPNLEALALEANNSEDIEEEQSA 178
Query: 170 HANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGW 229
HANVQ+SR MHEIT STDDKPKLLSQLTALL++IGLNIQEAHAFST DG+SLDVFVV+GW
Sbjct: 179 HANVQYSRHMHEITISTDDKPKLLSQLTALLSEIGLNIQEAHAFSTTDGFSLDVFVVEGW 238
Query: 230 PYEETEQLRAALEKEVL-KLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWE 288
P+EETE+L+AALE+ VL K+E + P +S S +P+ MKS +L IP DGTDVWE
Sbjct: 239 PHEETEKLKAALERGVLKKIEVKSSP--QSVSSVDKPDQAKMKSELDYLTIPTDGTDVWE 296
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH 348
IDPKHLK+G+++ASGSYG+L++G YCSQ+VAIKVLK + +NS++Q+EFAQEV+IMRKVRH
Sbjct: 297 IDPKHLKYGTQIASGSYGELFKGVYCSQEVAIKVLKADHVNSELQREFAQEVYIMRKVRH 356
Query: 349 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
KNVVQFIGACTKPP LCIVTEFMSGGSVYDYLHK KG FK P+LLKVAIDVSKGMNYLHQ
Sbjct: 357 KNVVQFIGACTKPPGLCIVTEFMSGGSVYDYLHKQKGFFKFPTLLKVAIDVSKGMNYLHQ 416
Query: 409 NNIIHRDLKAANLLMDEN 426
+NIIHRDLKAANLLMDEN
Sbjct: 417 HNIIHRDLKAANLLMDEN 434
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18420244|ref|NP_568041.1| ACT-like protein tyrosine kinase family protein [Arabidopsis thaliana] gi|332661531|gb|AEE86931.1| ACT-like protein tyrosine kinase family protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 592 bits (1526), Expect = e-166, Method: Compositional matrix adjust.
Identities = 308/437 (70%), Positives = 352/437 (80%), Gaps = 22/437 (5%)
Query: 1 MVMEENNNESCGSRAS-DTSSTSSPPPQHQSRQHRQKLGVYNEVLGRLKESNNDEAIQPR 59
MVME +NESC SR D TS R+ R K+ V++EVL RL++S+ ++A P
Sbjct: 1 MVME--DNESCASRVIFDALPTSQAT---MDRRERIKMEVFDEVLRRLRQSDIEDAHLPG 55
Query: 60 FDDELWTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDR 119
F+D+LW HFNRLP RYALDVNVERAEDVLMHKRLLH A+DP+NRPAIEV LVQV P
Sbjct: 56 FEDDLWNHFNRLPARYALDVNVERAEDVLMHKRLLHSAYDPQNRPAIEVHLVQVQP---- 111
Query: 120 NSAVSSLLDS------EVPAQRQSIHPPPAFGSSPNLEALAIEANNSHNLDGDNSVHANV 173
+ +S+ LDS R+SIHPPPAFGSSPNLEALA+ A+ S + D DNSVH N
Sbjct: 112 -AGISADLDSTSNDAGHSSPTRKSIHPPPAFGSSPNLEALALAASLSQDEDADNSVHNNS 170
Query: 174 QFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEE 233
+SRP+HEITFST+DKPKLL QLTALLA++GLNIQEAHAFST DGYSLDVFVVDGWPYEE
Sbjct: 171 LYSRPLHEITFSTEDKPKLLFQLTALLAELGLNIQEAHAFSTTDGYSLDVFVVDGWPYEE 230
Query: 234 TEQLRAALEKEVLKLE--RQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDP 291
TE+LR +LEKE K+E Q WP +S SP E TG ++H + IPNDGTDVWEI+
Sbjct: 231 TERLRISLEKEAAKIELQSQSWPMQQSFSPEKENGQTGARTH---VPIPNDGTDVWEINL 287
Query: 292 KHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV 351
KHLKFG K+ASGSYGDLY+GTYCSQ+VAIKVLKPER++SD++KEFAQEVFIMRKVRHKNV
Sbjct: 288 KHLKFGHKIASGSYGDLYKGTYCSQEVAIKVLKPERLDSDLEKEFAQEVFIMRKVRHKNV 347
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
VQFIGACTKPP LCIVTEFM GGSVYDYLHK KGVFKLP+L KVAID+ KGM+YLHQNNI
Sbjct: 348 VQFIGACTKPPHLCIVTEFMPGGSVYDYLHKQKGVFKLPTLFKVAIDICKGMSYLHQNNI 407
Query: 412 IHRDLKAANLLMDENEV 428
IHRDLKAANLLMDENEV
Sbjct: 408 IHRDLKAANLLMDENEV 424
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297797832|ref|XP_002866800.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297312636|gb|EFH43059.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 583 bits (1503), Expect = e-164, Method: Compositional matrix adjust.
Identities = 302/425 (71%), Positives = 346/425 (81%), Gaps = 17/425 (4%)
Query: 8 NESCGSRASDTSSTSSPPPQHQSRQHRQKLGVYNEVLGRLKESNNDEAIQPRFDDELWTH 67
NESC SR +S S R+ R K+ V++EVL RL++S+ +A P F+DELWTH
Sbjct: 3 NESCASRLILDASQSKAT---MDRRERIKMEVFDEVLRRLRQSDIQDAHLPGFEDELWTH 59
Query: 68 FNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSD--RNSAVSS 125
FNRLP RYALDVNVERAEDVLMHKRLLH A+DP+NRPAI+V LVQV P ++A+SS
Sbjct: 60 FNRLPARYALDVNVERAEDVLMHKRLLHSAYDPQNRPAIDVHLVQVQPADSPTYDAALSS 119
Query: 126 LLDSEVPAQRQSIHPPPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRPMHEITFS 185
R+SIHPPPAFGSSPNLEALA+ A+ S + DGDNSVH N +SRP+HEITFS
Sbjct: 120 -------PTRKSIHPPPAFGSSPNLEALALAASISQDHDGDNSVHNNSLYSRPLHEITFS 172
Query: 186 TDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEV 245
T DKPKLL QLTALLA++GLNIQEAHAFST DGYSLDVFVVDGWPYEET++LR +LEKE
Sbjct: 173 TQDKPKLLLQLTALLAELGLNIQEAHAFSTTDGYSLDVFVVDGWPYEETDRLRISLEKEA 232
Query: 246 LKLE--RQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASG 303
K+E Q WP +S SP E TG ++H + IPNDGTDVWEI+ KHLKFG K+ASG
Sbjct: 233 AKIELQSQSWPMQQSFSPEKENGQTGARTH---VPIPNDGTDVWEINLKHLKFGHKIASG 289
Query: 304 SYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363
SYGDLY+GTYCSQ+VAIKVLKPER++S+++KEFAQEVFIMRKVRHKNVVQFIGACTKPP
Sbjct: 290 SYGDLYKGTYCSQEVAIKVLKPERLDSELEKEFAQEVFIMRKVRHKNVVQFIGACTKPPH 349
Query: 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 423
LCIVTEFM GGSVYDYLHK KGVFKLP+L KVAID+ KGM+YLHQNNIIHRDLKAANLLM
Sbjct: 350 LCIVTEFMPGGSVYDYLHKQKGVFKLPTLFKVAIDICKGMSYLHQNNIIHRDLKAANLLM 409
Query: 424 DENEV 428
DENEV
Sbjct: 410 DENEV 414
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|217074650|gb|ACJ85685.1| unknown [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 574 bits (1480), Expect = e-161, Method: Compositional matrix adjust.
Identities = 288/434 (66%), Positives = 344/434 (79%), Gaps = 18/434 (4%)
Query: 5 ENNNESCGSRASDTSSTSSPPPQHQSRQHRQKLGVYNEVLGRLKESNNDEAIQPRFDDEL 64
EN+ ESCGSRA S ++P R HRQKL VYNEVL R+++S+ ++A+ P FDD+L
Sbjct: 4 ENDIESCGSRA--VQSHANP------RHHRQKLEVYNEVLRRIQDSDCEDALVPGFDDQL 55
Query: 65 WTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDRN---S 121
W HFNRLP RYALDVNVERAEDVL HKRLL LA DP NRPA +VRLVQV+P + N S
Sbjct: 56 WLHFNRLPARYALDVNVERAEDVLAHKRLLELAEDPANRPAFQVRLVQVYPFAGANHNDS 115
Query: 122 AVSSLLDSEVPAQ-------RQSIHPPPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQ 174
+V S + AQ +Q IHPPP FGSS NLEALA+ N ++ DGDN++
Sbjct: 116 SVHSDPSEKDDAQSSLNYSLKQGIHPPPTFGSSSNLEALALHTNKNNIEDGDNTMGVTPN 175
Query: 175 FSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEET 234
F+RPMHEITFST DKPKLLSQLT++L +IGLNIQEAHAFST DG+SLDVFVV+GWP EET
Sbjct: 176 FNRPMHEITFSTIDKPKLLSQLTSILGEIGLNIQEAHAFSTSDGFSLDVFVVEGWPNEET 235
Query: 235 EQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHL 294
E+L+ LEKE+LK++ Q + + +++ T M+S P ++IP DG DVWEIDP L
Sbjct: 236 EELKGVLEKEILKVKDQYLSNQGTLYSSNDQYQTRMESSPDCIQIPFDGADVWEIDPSQL 295
Query: 295 KFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 354
K+ +KV SGS+GDL+RG+YCSQDVAIKVLKPERI++DM KEFAQEV+IMRK+RHKNVVQF
Sbjct: 296 KYENKVGSGSFGDLFRGSYCSQDVAIKVLKPERISTDMLKEFAQEVYIMRKIRHKNVVQF 355
Query: 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 414
IGACT+PP+LCIVTEFMS GS+YD+LH+ KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR
Sbjct: 356 IGACTRPPNLCIVTEFMSRGSLYDFLHRQKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 415
Query: 415 DLKAANLLMDENEV 428
DLK ANLLMDENE+
Sbjct: 416 DLKTANLLMDENEL 429
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 492 | ||||||
| TAIR|locus:2121154 | 575 | STY46 "serine/threonine/tyrosi | 0.853 | 0.730 | 0.699 | 4.9e-156 | |
| TAIR|locus:2128043 | 570 | STY17 "serine/threonine/tyrosi | 0.853 | 0.736 | 0.617 | 3.4e-132 | |
| TAIR|locus:2827943 | 546 | STY8 "serine/threonine/tyrosin | 0.839 | 0.756 | 0.610 | 6.1e-126 | |
| DICTYBASE|DDB_G0267514 | 916 | DDB_G0267514 "protein kinase, | 0.315 | 0.169 | 0.412 | 2.1e-29 | |
| TAIR|locus:2061092 | 411 | AT2G24360 [Arabidopsis thalian | 0.304 | 0.364 | 0.430 | 2.7e-29 | |
| TAIR|locus:2126311 | 412 | AT4G31170 [Arabidopsis thalian | 0.292 | 0.349 | 0.448 | 1.1e-28 | |
| DICTYBASE|DDB_G0289791 | 642 | drkA "DRK subfamily protein ki | 0.317 | 0.242 | 0.416 | 1.4e-28 | |
| TAIR|locus:2180992 | 333 | AT5G01850 [Arabidopsis thalian | 0.290 | 0.429 | 0.44 | 1.1e-26 | |
| DICTYBASE|DDB_G0289709 | 690 | drkB "DRK subfamily protein ki | 0.284 | 0.202 | 0.442 | 3.7e-26 | |
| TAIR|locus:2144613 | 821 | CTR1 "CONSTITUTIVE TRIPLE RESP | 0.376 | 0.225 | 0.378 | 5.5e-26 |
| TAIR|locus:2121154 STY46 "serine/threonine/tyrosine kinase 46" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1521 (540.5 bits), Expect = 4.9e-156, P = 4.9e-156
Identities = 302/432 (69%), Positives = 345/432 (79%)
Query: 1 MVMEENNNESCGSRASDXXXXXXXXXXXXXXXXXXKLGVYNEVLGRLKESNNDEAIQPRF 60
MVME+N ESC SR K+ V++EVL RL++S+ ++A P F
Sbjct: 1 MVMEDN--ESCASRV--IFDALPTSQATMDRRERIKMEVFDEVLRRLRQSDIEDAHLPGF 56
Query: 61 DDELWTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHP--VSD 118
+D+LW HFNRLP RYALDVNVERAEDVLMHKRLLH A+DP+NRPAIEV LVQV P +S
Sbjct: 57 EDDLWNHFNRLPARYALDVNVERAEDVLMHKRLLHSAYDPQNRPAIEVHLVQVQPAGISA 116
Query: 119 RNSAVSSLLDSEVPAQRQSIHPPPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRP 178
+ S+ P R+SIHPPPAFGSSPNLEALA+ A+ S + D DNSVH N +SRP
Sbjct: 117 DLDSTSNDAGHSSPT-RKSIHPPPAFGSSPNLEALALAASLSQDEDADNSVHNNSLYSRP 175
Query: 179 MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLR 238
+HEITFST+DKPKLL QLTALLA++GLNIQEAHAFST DGYSLDVFVVDGWPYEETE+LR
Sbjct: 176 LHEITFSTEDKPKLLFQLTALLAELGLNIQEAHAFSTTDGYSLDVFVVDGWPYEETERLR 235
Query: 239 AALEKEVLKLE--RQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKF 296
+LEKE K+E Q WP +S SP E TG ++H + IPNDGTDVWEI+ KHLKF
Sbjct: 236 ISLEKEAAKIELQSQSWPMQQSFSPEKENGQTGARTH---VPIPNDGTDVWEINLKHLKF 292
Query: 297 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
G K+ASGSYGDLY+GTYCSQ+VAIKVLKPER++SD++KEFAQEVFIMRKVRHKNVVQFIG
Sbjct: 293 GHKIASGSYGDLYKGTYCSQEVAIKVLKPERLDSDLEKEFAQEVFIMRKVRHKNVVQFIG 352
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
ACTKPP LCIVTEFM GGSVYDYLHK KGVFKLP+L KVAID+ KGM+YLHQNNIIHRDL
Sbjct: 353 ACTKPPHLCIVTEFMPGGSVYDYLHKQKGVFKLPTLFKVAIDICKGMSYLHQNNIIHRDL 412
Query: 417 KAANLLMDENEV 428
KAANLLMDENEV
Sbjct: 413 KAANLLMDENEV 424
|
|
| TAIR|locus:2128043 STY17 "serine/threonine/tyrosine kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1296 (461.3 bits), Expect = 3.4e-132, P = 3.4e-132
Identities = 268/434 (61%), Positives = 312/434 (71%)
Query: 1 MVMEENNNESCGSRASDXXXXXXXXXXXXXXXXXXKLGVYNEVLGRLKESNNDEAIQPRF 60
M ++E ESCGSRA KL VY EVL R++ESN +EA P F
Sbjct: 1 MAIKEETEESCGSRA-----VVASITKESPRQHRMKLEVYGEVLQRIQESNYEEANFPGF 55
Query: 61 DDELWTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDRN 120
DD LW HFNRLP RYALDVNVERAEDVL H+RLL LA DP RP EVR VQV P + N
Sbjct: 56 DDLLWLHFNRLPARYALDVNVERAEDVLTHQRLLKLAEDPATRPVFEVRCVQVSPTLNGN 115
Query: 121 SAVSSLLDSEVPAQRQSIH-----PPPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQF 175
S D V QS + PP FGSSPN EAL +A H D D++V+A +
Sbjct: 116 SGDVDPSDPAVNEDAQSSYNSRSLAPPTFGSSPNFEALT-QAYKDHAQDDDSAVNAQLPN 174
Query: 176 SRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETE 235
SRPMHEITFST D+PKLLSQLT++L ++GLNIQEAHAFST DG+SLDVFVVDGW EETE
Sbjct: 175 SRPMHEITFSTIDRPKLLSQLTSMLGELGLNIQEAHAFSTADGFSLDVFVVDGWSQEETE 234
Query: 236 QLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSH-PYHLKIPNDGTDVWEIDPKHL 294
L+ AL+KE+ K + Q P + S T D P ++IP DGTD WEID K L
Sbjct: 235 GLKDALKKEIRKFKDQ--PCSKQKSITFFEHDKSTNELLPACVEIPTDGTDEWEIDMKQL 292
Query: 295 KFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 354
K KVA GSYG+L+RGTYCSQ+VAIK+LKPER+N++M +EF+QEV+IMRKVRHKNVVQF
Sbjct: 293 KIEKKVACGSYGELFRGTYCSQEVAIKILKPERVNAEMLREFSQEVYIMRKVRHKNVVQF 352
Query: 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 414
IGACT+ P+LCIVTEFM+ GS+YD+LHK KGVFK+ SLLKVA+DVSKGMNYLHQNNIIHR
Sbjct: 353 IGACTRSPNLCIVTEFMTRGSIYDFLHKHKGVFKIQSLLKVALDVSKGMNYLHQNNIIHR 412
Query: 415 DLKAANLLMDENEV 428
DLK ANLLMDE+EV
Sbjct: 413 DLKTANLLMDEHEV 426
|
|
| TAIR|locus:2827943 STY8 "serine/threonine/tyrosine kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1237 (440.5 bits), Expect = 6.1e-126, P = 6.1e-126
Identities = 259/424 (61%), Positives = 308/424 (72%)
Query: 5 ENNNESCGSRASDXXXXXXXXXXXXXXXXXXKLGVYNEVLGRLKESNNDEAIQPRFDDEL 64
++ +ESCGSRA KL VY+EVL RL+ESN +EA P F+D+L
Sbjct: 4 KDESESCGSRA-----VVASPSQENPRHYRMKLDVYSEVLQRLQESNYEEATLPDFEDQL 58
Query: 65 WTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHP-VS-DRNSA 122
W HFNRLP RYALDV VERAEDVL H+RLL LA DP RP EVR VQV P +S D + A
Sbjct: 59 WLHFNRLPARYALDVKVERAEDVLTHQRLLKLAADPATRPVFEVRSVQVSPRISADSDPA 118
Query: 123 VSSLLDSEVPAQRQSIHPPPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRPMHEI 182
V S + PP FGSSPN EA I + D D+ V+A + +RPMHEI
Sbjct: 119 VEEDAQSSHQPSGPGVLAPPTFGSSPNFEA--ITQGSKIVEDVDSVVNATLS-TRPMHEI 175
Query: 183 TFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALE 242
TFST DKPKLLSQLT+LL ++GLNIQEAHAFSTVDG+SLDVFVVDGW EET+ LR AL
Sbjct: 176 TFSTIDKPKLLSQLTSLLGELGLNIQEAHAFSTVDGFSLDVFVVDGWSQEETDGLRDALS 235
Query: 243 KEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVAS 302
KE+LKL+ Q +S S E + + + P ++IP DGTD WEID LK KVAS
Sbjct: 236 KEILKLKDQPGSKQKSIS-FFEHDKSSNELIPACIEIPTDGTDEWEIDVTQLKIEKKVAS 294
Query: 303 GSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362
GSYGDL+RGTYCSQ+VAIK LKP+R+N++M +EF+QEVFIMRKVRHKNVVQF+GACT+ P
Sbjct: 295 GSYGDLHRGTYCSQEVAIKFLKPDRVNNEMLREFSQEVFIMRKVRHKNVVQFLGACTRSP 354
Query: 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 422
+LCIVTEFM+ GS+YD+LHK K FKL +LLKVA+DV+KGM+YLHQNNIIHRDLK ANLL
Sbjct: 355 TLCIVTEFMARGSIYDFLHKQKCAFKLQTLLKVALDVAKGMSYLHQNNIIHRDLKTANLL 414
Query: 423 MDEN 426
MDE+
Sbjct: 415 MDEH 418
|
|
| DICTYBASE|DDB_G0267514 DDB_G0267514 "protein kinase, TKL group" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 337 (123.7 bits), Expect = 2.1e-29, Sum P(2) = 2.1e-29
Identities = 66/160 (41%), Positives = 106/160 (66%)
Query: 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLK-PERINSDMQKEFAQEVFI 342
+D+ EI LK SK+ G++G +Y+G + VAIK +K E +N+ + +EF +E+ I
Sbjct: 653 SDI-EISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKINEDVNNQVLEEFRKELTI 711
Query: 343 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 402
+ ++RH N+V + ACT PP+LC +TE++ GGS+YD LH K + K+AI +++G
Sbjct: 712 LSRLRHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKKIKMNMQLYKKLAIQIAQG 771
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL 442
MNYLH + +IHRD+K+ NLL+DE+ + + +C F +S L
Sbjct: 772 MNYLHLSGVIHRDIKSLNLLLDEH---MNVKICDFGLSKL 808
|
|
| TAIR|locus:2061092 AT2G24360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 325 (119.5 bits), Expect = 2.7e-29, P = 2.7e-29
Identities = 68/158 (43%), Positives = 99/158 (62%)
Query: 278 KIPNDGT---DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVL-KPERINSD-- 331
+ P +G D W ID + L G A G++G LY+GTY +DVAIK+L +PE
Sbjct: 111 RYPTEGLTNYDEWTIDLRKLNMGPAFAQGAFGKLYKGTYNGEDVAIKILERPENSPEKAQ 170
Query: 332 -MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKL 389
M+++F QEV ++ ++H N+V+FIGAC KP CIVTE+ GGSV +L + + L
Sbjct: 171 FMEQQFQQEVSMLANLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTRRQNRAVPL 230
Query: 390 PSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 427
+K A+DV++GM Y+H N IHRDLK+ NLL+ ++
Sbjct: 231 KLAVKQALDVARGMAYVHGRNFIHRDLKSDNLLISADK 268
|
|
| TAIR|locus:2126311 AT4G31170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 320 (117.7 bits), Expect = 1.1e-28, P = 1.1e-28
Identities = 70/156 (44%), Positives = 101/156 (64%)
Query: 278 KIPNDGT---DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLK-----PERIN 329
K P +G + W ID + L G A G++G LYRGTY +DVAIK+L+ PE+
Sbjct: 112 KYPTEGLVNYEEWTIDLRKLHMGPAFAQGAFGKLYRGTYNGEDVAIKLLERSDSNPEKAQ 171
Query: 330 SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKL 389
+ ++++F QEV ++ ++H N+V+FIGAC KP CIVTE+ GGSV +L K + +
Sbjct: 172 A-LEQQFQQEVSMLAFLKHPNIVRFIGACIKPMVWCIVTEYAKGGSVRQFLTKRQNR-AV 229
Query: 390 PSLLKV--AIDVSKGMNYLHQNNIIHRDLKAANLLM 423
P L V A+DV++GM Y+H+ N IHRDLK+ NLL+
Sbjct: 230 PLKLAVMQALDVARGMAYVHERNFIHRDLKSDNLLI 265
|
|
| DICTYBASE|DDB_G0289791 drkA "DRK subfamily protein kinase" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 337 (123.7 bits), Expect = 1.4e-28, P = 1.4e-28
Identities = 67/161 (41%), Positives = 101/161 (62%)
Query: 271 KSHPYHLKIPNDGTDVWE---IDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPER 327
+S Y+ ND T + + ID +K G ++ G+YG++Y GT+ VA+K L
Sbjct: 348 RSSGYYKPDKNDYTQIKDGKDIDIHQIKIGVRIGKGNYGEVYLGTWRGSQVAVKKLPAHN 407
Query: 328 INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF 387
IN ++ KEF +E+ +M+ +RH NV+QF+G+C PP +CI TE+M GS+Y LH
Sbjct: 408 INENILKEFHREINLMKNLRHPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHDQALQL 467
Query: 388 KLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDEN 426
+ L+K+ ID +KG+ YLH + I+HRDLK+ NLL+DEN
Sbjct: 468 QWSLLIKMMIDAAKGVIYLHNSTPVILHRDLKSHNLLVDEN 508
|
|
| TAIR|locus:2180992 AT5G01850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 303 (111.7 bits), Expect = 1.1e-26, P = 1.1e-26
Identities = 66/150 (44%), Positives = 98/150 (65%)
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVL----KPERINSDMQKEFAQEVFIMR 344
+DPK L GSK+ G++G +Y+G Y Q VAIKV+ KP++ S ++ F +EV +M
Sbjct: 13 VDPKLLFIGSKIGEGAHGKVYQGRYGRQIVAIKVVNRGSKPDQ-QSSLESRFVREVNMMS 71
Query: 345 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGM 403
+V+H N+V+FIGAC K P + IVTE + G S+ YL ++ + LP L A+D+++ +
Sbjct: 72 RVQHHNLVKFIGAC-KDPLMVIVTELLPGMSLRKYLTSIRPQLLHLPLALSFALDIARAL 130
Query: 404 NYLHQNNIIHRDLKAANLLMDENEVSLLLS 433
+ LH N IIHRDLK NLL+ EN S+ L+
Sbjct: 131 HCLHANGIIHRDLKPDNLLLTENHKSVKLA 160
|
|
| DICTYBASE|DDB_G0289709 drkB "DRK subfamily protein kinase" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 319 (117.4 bits), Expect = 3.7e-26, P = 3.7e-26
Identities = 66/149 (44%), Positives = 98/149 (65%)
Query: 282 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVF 341
DG D ID + +K G ++ G++G++Y GT+ VA+K L IN ++ KEF +E+
Sbjct: 382 DGKD---IDTQQIKIGVRIGKGNFGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREIN 438
Query: 342 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP-SLLK-VAIDV 399
+M+ +RH NV+QF+G+C P +CI TE+M GS+Y LH K K+ SL+K + ID
Sbjct: 439 LMKNLRHPNVIQFLGSCLISPDICICTEYMPRGSLYSILHNEK--IKISWSLVKRMMIDA 496
Query: 400 SKGMNYLHQNN--IIHRDLKAANLLMDEN 426
+KG+ YLH + I+HRDLK+ NLL+DEN
Sbjct: 497 AKGIIYLHGSTPVILHRDLKSHNLLVDEN 525
|
|
| TAIR|locus:2144613 CTR1 "CONSTITUTIVE TRIPLE RESPONSE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 319 (117.4 bits), Expect = 5.5e-26, P = 5.5e-26
Identities = 76/201 (37%), Positives = 116/201 (57%)
Query: 254 PSHRSSSPTSEPEDTGMKSHPYHLKIPN--------DGTDVWEIDPKHLKFGSKVASGSY 305
P +++ E M + P +PN DG D+ +I L K+ +GS+
Sbjct: 504 PPQNMMRASNQIEAAPMNAPPISQPVPNRANRELGLDGDDM-DIPWCDLNIKEKIGAGSF 562
Query: 306 GDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365
G ++R + DVA+K+L + +++ EF +EV IM+++RH N+V F+GA T+PP+L
Sbjct: 563 GTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 622
Query: 366 IVTEFMSGGSVYDYLHKLKGVFKLPSL--LKVAIDVSKGMNYLHQNN--IIHRDLKAANL 421
IVTE++S GS+Y LHK +L L +A DV+KGMNYLH N I+HRDLK+ NL
Sbjct: 623 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNL 682
Query: 422 LMDENEVSLLLSLCLFTVSIL 442
L+D+ + +C F +S L
Sbjct: 683 LVDKKYT---VKVCDFGLSRL 700
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 492 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-45 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-45 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 9e-44 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-38 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-37 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-35 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-35 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-34 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-33 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-33 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-33 | |
| cd04928 | 68 | cd04928, ACT_TyrKc, Uncharacterized, N-terminal AC | 3e-32 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-32 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-29 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-28 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-28 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 9e-28 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-27 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-26 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-26 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-25 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-25 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-25 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-25 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-24 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-24 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-24 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-24 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-23 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-22 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-22 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-22 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-22 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-22 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-21 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-21 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-21 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-20 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-19 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-19 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-19 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-19 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-19 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-19 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-18 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-18 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-18 | |
| cd04900 | 73 | cd04900, ACT_UUR-like_1, ACT domain family, ACT_UU | 5e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-18 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-17 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-17 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-16 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-15 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-15 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-15 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-15 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 8e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-14 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-14 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-14 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-14 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-13 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-13 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-13 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-12 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-12 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-12 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-12 | |
| cd04873 | 70 | cd04873, ACT_UUR-ACR-like, ACT domains of the bact | 9e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-12 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 9e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-11 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-11 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-11 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-11 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 9e-11 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-10 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-10 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-10 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-10 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-10 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-09 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-09 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-09 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-09 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-09 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-08 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-08 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-08 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-08 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-08 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 5e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-08 | |
| PRK05092 | 931 | PRK05092, PRK05092, PII uridylyl-transferase; Prov | 5e-08 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-08 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-08 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-08 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-08 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-08 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-07 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-07 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-07 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-07 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-07 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-07 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-07 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-07 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-07 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-07 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-07 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 9e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-06 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-06 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-06 | |
| cd02116 | 60 | cd02116, ACT, ACT domains are commonly involved in | 1e-06 | |
| COG2844 | 867 | COG2844, GlnD, UTP:GlnB (protein PII) uridylyltran | 2e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-06 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-06 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-06 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-06 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-06 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-06 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-06 | |
| pfam01842 | 66 | pfam01842, ACT, ACT domain | 4e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-06 | |
| cd04899 | 70 | cd04899, ACT_ACR-UUR-like_2, C-terminal ACT domain | 5e-06 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 6e-06 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-06 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-05 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-05 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-05 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-05 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-05 | |
| TIGR01693 | 850 | TIGR01693, UTase_glnD, [Protein-PII] uridylyltrans | 2e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-05 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-05 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-05 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-05 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-05 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 8e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 9e-05 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-04 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-04 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-04 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-04 | |
| PRK05007 | 884 | PRK05007, PRK05007, PII uridylyl-transferase; Prov | 1e-04 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-04 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-04 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-04 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-04 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-04 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-04 | |
| PRK03381 | 774 | PRK03381, PRK03381, PII uridylyl-transferase; Prov | 6e-04 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-04 | |
| PRK03381 | 774 | PRK03381, PRK03381, PII uridylyl-transferase; Prov | 7e-04 | |
| PRK00275 | 895 | PRK00275, glnD, PII uridylyl-transferase; Provisio | 7e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-04 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.001 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 0.001 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 0.001 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 0.001 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 0.001 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 0.001 | |
| PRK05092 | 931 | PRK05092, PRK05092, PII uridylyl-transferase; Prov | 0.002 | |
| COG2844 | 867 | COG2844, GlnD, UTP:GlnB (protein PII) uridylyltran | 0.002 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.002 | |
| TIGR01693 | 850 | TIGR01693, UTase_glnD, [Protein-PII] uridylyltrans | 0.002 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.002 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 0.002 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 0.002 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 0.002 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 0.002 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 0.003 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 0.003 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.003 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 2e-45
Identities = 56/141 (39%), Positives = 80/141 (56%), Gaps = 7/141 (4%)
Query: 294 LKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR 347
L G K+ G++G++Y+G +VA+K LK + + +EF +E IMRK+
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA-SEQQIEEFLREARIMRKLD 59
Query: 348 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 407
H NVV+ +G CT+ L IV E+M GG + YL K + L LL A+ +++GM YL
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 408 QNNIIHRDLKAANLLMDENEV 428
N IHRDL A N L+ EN V
Sbjct: 120 SKNFIHRDLAARNCLVGENLV 140
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 4e-45
Identities = 56/141 (39%), Positives = 85/141 (60%), Gaps = 7/141 (4%)
Query: 294 LKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR 347
L+ G K+ G++G++Y+GT VA+K LK + + ++EF +E IM+K+
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEG-ASEEEREEFLEEASIMKKLS 59
Query: 348 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 407
H N+V+ +G CT+ L IVTE+M GG + D+L K L LL++A+ ++KGM YL
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 408 QNNIIHRDLKAANLLMDENEV 428
N +HRDL A N L+ EN V
Sbjct: 120 SKNFVHRDLAARNCLVTENLV 140
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 9e-44
Identities = 57/142 (40%), Positives = 82/142 (57%), Gaps = 8/142 (5%)
Query: 294 LKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR 347
L G K+ G++G++Y+GT +VA+K LK + + +EF +E IMRK+
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKED-ASEQQIEEFLREARIMRKLD 59
Query: 348 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYL 406
H N+V+ +G CT+ L IV E+M GG + DYL K + L LL A+ +++GM YL
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119
Query: 407 HQNNIIHRDLKAANLLMDENEV 428
N IHRDL A N L+ EN V
Sbjct: 120 ESKNFIHRDLAARNCLVGENLV 141
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 1e-38
Identities = 44/134 (32%), Positives = 76/134 (56%), Gaps = 3/134 (2%)
Query: 302 SGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359
G +G +Y + VAIK++K E +S ++ E +E+ I++K+ H N+V+ G
Sbjct: 3 EGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLE-ELLREIEILKKLNHPNIVKLYGVFE 61
Query: 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419
L +V E+ GGS+ D L + +G +L++ + + +G+ YLH N IIHRDLK
Sbjct: 62 DENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPE 121
Query: 420 NLLMDENEVSLLLS 433
N+L+D + + L+
Sbjct: 122 NILLDSDNGKVKLA 135
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 1e-37
Identities = 52/138 (37%), Positives = 80/138 (57%), Gaps = 14/138 (10%)
Query: 302 SGSYGDLYRGTY-----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
G++G++Y+G + +VA+K LK E + + +K+F +E +M+K+ H NVV+ +G
Sbjct: 5 EGAFGEVYKGKLKGKDGKTTEVAVKTLK-EDASEEERKDFLKEARVMKKLGHPNVVRLLG 63
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS--------LLKVAIDVSKGMNYLHQ 408
CT+ L +V E+M GG + DYL K + VF P LL AI ++KGM YL
Sbjct: 64 VCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS 123
Query: 409 NNIIHRDLKAANLLMDEN 426
+HRDL A N L+ E+
Sbjct: 124 KKFVHRDLAARNCLVGED 141
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-35
Identities = 49/137 (35%), Positives = 78/137 (56%), Gaps = 3/137 (2%)
Query: 294 LKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV 351
+ K+ SGS+G +Y+ + + VA+K+LK S + +E+ I+R++ H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
V+ I A L +V E+ GG ++DYL + G K+A+ + +G+ YLH N I
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSR-GGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 412 IHRDLKAANLLMDENEV 428
IHRDLK N+L+DEN V
Sbjct: 120 IHRDLKPENILLDENGV 136
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 3e-35
Identities = 41/134 (30%), Positives = 70/134 (52%), Gaps = 4/134 (2%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ K+ GS+G +Y + VAIKV+K ++I D ++ +E+ I++K++H N+V
Sbjct: 2 EILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKD-RERILREIKILKKLKHPNIV 60
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
+ L +V E+ GG ++D L K +G + + YLH I+
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKK-RGRLSEDEARFYLRQILSALEYLHSKGIV 119
Query: 413 HRDLKAANLLMDEN 426
HRDLK N+L+DE+
Sbjct: 120 HRDLKPENILLDED 133
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-34
Identities = 58/144 (40%), Positives = 84/144 (58%), Gaps = 4/144 (2%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 346
W I+ K LK G+ + G +GD+ G Y Q VA+K LK +S + F E +M +
Sbjct: 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKD---DSTAAQAFLAEASVMTTL 57
Query: 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMNY 405
RH N+VQ +G + L IVTE+M+ GS+ DYL + + V L L A+DV +GM Y
Sbjct: 58 RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEY 117
Query: 406 LHQNNIIHRDLKAANLLMDENEVS 429
L + N +HRDL A N+L+ E+ V+
Sbjct: 118 LEEKNFVHRDLAARNVLVSEDLVA 141
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 3e-33
Identities = 56/144 (38%), Positives = 83/144 (57%), Gaps = 5/144 (3%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 345
WEID ++ K+ +G +G+++ G + + VA+K LKP ++ K+F E IM+K
Sbjct: 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP---KDFLAEAQIMKK 57
Query: 346 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMN 404
+RH ++Q CT + IVTE M GS+ +YL G KLP L+ +A V+ GM
Sbjct: 58 LRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMA 117
Query: 405 YLHQNNIIHRDLKAANLLMDENEV 428
YL N IHRDL A N+L+ EN +
Sbjct: 118 YLEAQNYIHRDLAARNVLVGENNI 141
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 5e-33
Identities = 60/145 (41%), Positives = 88/145 (60%), Gaps = 7/145 (4%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKE-FAQEVFIMR 344
WEI + LK K+ +G +G+++ GT+ + VA+K LKP M E F QE IM+
Sbjct: 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKP----GTMSPEAFLQEAQIMK 56
Query: 345 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLLKVAIDVSKGM 403
K+RH +VQ C++ + IVTE+MS GS+ D+L +G +LP L+ +A +++GM
Sbjct: 57 KLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGM 116
Query: 404 NYLHQNNIIHRDLKAANLLMDENEV 428
YL N IHRDL A N+L+ EN V
Sbjct: 117 AYLESRNYIHRDLAARNILVGENLV 141
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 8e-33
Identities = 55/141 (39%), Positives = 82/141 (58%), Gaps = 4/141 (2%)
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRKVR 347
IDP L F ++ SG +G ++ G + + DVAIK+++ ++ D +F +E +M K+
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLS 57
Query: 348 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 407
H N+VQ G CTK + IVTE+M+ G + +YL + KG LL + DV + M YL
Sbjct: 58 HPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE 117
Query: 408 QNNIIHRDLKAANLLMDENEV 428
N IHRDL A N L+ E+ V
Sbjct: 118 SNGFIHRDLAARNCLVGEDNV 138
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|153200 cd04928, ACT_TyrKc, Uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 3e-32
Identities = 45/68 (66%), Positives = 53/68 (77%)
Query: 179 MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLR 238
MHEITF+ DKPKLLSQL++LL D+GLNI EAHAFST DG +LD+FVV GW ET L
Sbjct: 1 MHEITFAAGDKPKLLSQLSSLLGDLGLNIAEAHAFSTDDGLALDIFVVTGWKRGETAALG 60
Query: 239 AALEKEVL 246
AL+KE+
Sbjct: 61 HALQKEID 68
|
This CD includes a novel, yet uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains. Members of this CD belong to the superfamily of ACT regulatory domains. Length = 68 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 6e-32
Identities = 50/141 (35%), Positives = 82/141 (58%), Gaps = 5/141 (3%)
Query: 293 HLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN 350
+ K+ G +G++Y+ + ++VAIKV+K E + + +++ E+ I++K +H N
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLE--SKEKKEKIINEIQILKKCKHPN 58
Query: 351 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 410
+V++ G+ K L IV EF SGGS+ D L + V ++ KG+ YLH N
Sbjct: 59 IVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG 118
Query: 411 IIHRDLKAANLLM-DENEVSL 430
IIHRD+KAAN+L+ + EV L
Sbjct: 119 IIHRDIKAANILLTSDGEVKL 139
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 5e-29
Identities = 52/146 (35%), Positives = 85/146 (58%), Gaps = 8/146 (5%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQKEFAQEVFIMR 344
WE++ + K+ G YG++Y G + VA+K LK + + + EF +E +M+
Sbjct: 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMK 57
Query: 345 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS--LLKVAIDVSKG 402
+++H N+VQ +G CT+ P I+TEFM+ G++ DYL + ++ + LL +A +S
Sbjct: 58 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSA 116
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEV 428
M YL + N IHRDL A N L+ EN +
Sbjct: 117 MEYLEKKNFIHRDLAARNCLVGENHL 142
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 2e-28
Identities = 52/141 (36%), Positives = 83/141 (58%), Gaps = 4/141 (2%)
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTYCSQD-VAIKVLKPERINSDMQKEFAQEVFIMRKVR 347
I P L ++ SG +G ++ G + + VAIK ++ ++ +++F +E +M K+
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS---EEDFIEEAQVMMKLS 57
Query: 348 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 407
H +VQ G CT+ +C+V EFM G + DYL +G F +LL + +DV +GM YL
Sbjct: 58 HPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE 117
Query: 408 QNNIIHRDLKAANLLMDENEV 428
+N+IHRDL A N L+ EN+V
Sbjct: 118 SSNVIHRDLAARNCLVGENQV 138
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 39/134 (29%), Positives = 71/134 (52%), Gaps = 5/134 (3%)
Query: 297 GSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 354
G + GS+G +Y +A+K ++ + + + +E+ I+ ++H N+V++
Sbjct: 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRY 64
Query: 355 IGACTKPP--SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
G+ +L I E++SGGS+ L K G P + K + +G+ YLH N I+
Sbjct: 65 YGSERDEEKNTLNIFLEYVSGGSLSSLLKK-FGKLPEPVIRKYTRQILEGLAYLHSNGIV 123
Query: 413 HRDLKAANLLMDEN 426
HRD+K AN+L+D +
Sbjct: 124 HRDIKGANILVDSD 137
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 9e-28
Identities = 46/143 (32%), Positives = 74/143 (51%), Gaps = 9/143 (6%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRK 345
+HLKF ++ G +G + Y VA+K L +F +E+ I+R
Sbjct: 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHR-SDFEREIEILRT 62
Query: 346 VRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 403
+ H+N+V++ G C KP SL ++ E++ GS+ DYL + + L LL + + KGM
Sbjct: 63 LDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGM 122
Query: 404 NYLHQNNIIHRDLKAANLLMDEN 426
+YL IHRDL A N+L++
Sbjct: 123 DYLGSQRYIHRDLAARNILVESE 145
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 1e-27
Identities = 48/131 (36%), Positives = 74/131 (56%), Gaps = 2/131 (1%)
Query: 299 KVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 357
K+ G++GD+Y+G +VA+K + +K F QE I+++ H N+V+ IG
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRK-FLQEAEILKQYDHPNIVKLIGV 60
Query: 358 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 417
C + + IV E + GGS+ +L K K + LL++++D + GM YL N IHRDL
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLA 120
Query: 418 AANLLMDENEV 428
A N L+ EN V
Sbjct: 121 ARNCLVGENNV 131
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 56/139 (40%), Positives = 82/139 (58%), Gaps = 4/139 (2%)
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRKVR 347
IDPK L F ++ +G +G + G + Q DVAIK++K ++ D EF +E +M K+
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLS 57
Query: 348 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 407
H+ +VQ G CTK + IVTE+MS G + +YL + F+ LL++ DV +GM YL
Sbjct: 58 HEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE 117
Query: 408 QNNIIHRDLKAANLLMDEN 426
IHRDL A N L+D+
Sbjct: 118 SKQFIHRDLAARNCLVDDQ 136
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 49/144 (34%), Positives = 84/144 (58%), Gaps = 4/144 (2%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRK 345
WE + K+ SG +G+++ G + VAIK+LK + + Q++F +EV +++
Sbjct: 1 WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD--DLLKQQDFQKEVQALKR 58
Query: 346 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMN 404
+RHK+++ C+ + I+TE M GS+ +L +G V + SL+ +A V++GM
Sbjct: 59 LRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMA 118
Query: 405 YLHQNNIIHRDLKAANLLMDENEV 428
YL + N IHRDL A N+L+ E+ V
Sbjct: 119 YLEEQNSIHRDLAARNILVGEDLV 142
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 5e-26
Identities = 56/144 (38%), Positives = 91/144 (63%), Gaps = 6/144 (4%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 345
WEI + L+ K+ G +G+++ GT+ + VAIK LKP ++ + F QE +M+K
Sbjct: 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKK 57
Query: 346 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLLKVAIDVSKGMN 404
+RH+ +VQ ++ P + IVTE+MS GS+ D+L G + +LP L+ +A ++ GM
Sbjct: 58 LRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 116
Query: 405 YLHQNNIIHRDLKAANLLMDENEV 428
Y+ + N +HRDL+AAN+L+ EN V
Sbjct: 117 YVERMNYVHRDLRAANILVGENLV 140
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 54/145 (37%), Positives = 81/145 (55%), Gaps = 6/145 (4%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 346
W ++ K LK + G +GD+ G Y VA+K +K N + F E +M ++
Sbjct: 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQL 56
Query: 347 RHKNVVQFIGACTKPP-SLCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMN 404
RH N+VQ +G + L IVTE+M+ GS+ DYL + + V LLK ++DV + M
Sbjct: 57 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 116
Query: 405 YLHQNNIIHRDLKAANLLMDENEVS 429
YL NN +HRDL A N+L+ E+ V+
Sbjct: 117 YLEANNFVHRDLAARNVLVSEDNVA 141
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 3e-25
Identities = 58/144 (40%), Positives = 89/144 (61%), Gaps = 6/144 (4%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 345
WEI + L+ K+ G +G+++ GT+ + VAIK LKP + M + F QE IM+K
Sbjct: 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKP---GTMMPEAFLQEAQIMKK 57
Query: 346 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLLKVAIDVSKGMN 404
+RH +V ++ P + IVTEFM GS+ D+L + G + KLP L+ +A ++ GM
Sbjct: 58 LRHDKLVPLYAVVSEEP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMA 116
Query: 405 YLHQNNIIHRDLKAANLLMDENEV 428
Y+ + N IHRDL+AAN+L+ +N V
Sbjct: 117 YIERMNYIHRDLRAANILVGDNLV 140
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 5e-25
Identities = 55/144 (38%), Positives = 91/144 (63%), Gaps = 6/144 (4%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 345
WEI + L+ K+ +G +G+++ GT+ + VA+K LKP ++ + F +E IM+K
Sbjct: 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE---SFLEEAQIMKK 57
Query: 346 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMN 404
+RH +VQ ++ P + IVTE+MS GS+ D+L +G KLP+L+ +A V+ GM
Sbjct: 58 LRHDKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMA 116
Query: 405 YLHQNNIIHRDLKAANLLMDENEV 428
Y+ + N IHRDL++AN+L+ + V
Sbjct: 117 YIERMNYIHRDLRSANILVGDGLV 140
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 8e-25
Identities = 52/141 (36%), Positives = 79/141 (56%), Gaps = 4/141 (2%)
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRKVR 347
I+P L F ++ SG +G ++ G + +Q VAIK + ++ + +F +E +M K+
Sbjct: 1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE---DFIEEAKVMMKLS 57
Query: 348 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 407
H +VQ G CT+ L IVTEFM G + +YL + +G LL + DV +GM YL
Sbjct: 58 HPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE 117
Query: 408 QNNIIHRDLKAANLLMDENEV 428
+N+ IHRDL A N L+ V
Sbjct: 118 RNSFIHRDLAARNCLVSSTGV 138
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 46/141 (32%), Positives = 84/141 (59%), Gaps = 6/141 (4%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 345
WE+ + LK K+ +G +G+++ G Y VAIK LK ++ + F E +M++
Sbjct: 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE---AFLAEANLMKQ 57
Query: 346 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKGMN 404
++H +V+ T+ P + I+TE+M GS+ D+L +G+ + L+ +A +++GM
Sbjct: 58 LQHPRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMA 116
Query: 405 YLHQNNIIHRDLKAANLLMDE 425
++ + N IHRDL+AAN+L+ E
Sbjct: 117 FIERKNYIHRDLRAANILVSE 137
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 45/141 (31%), Positives = 78/141 (55%), Gaps = 9/141 (6%)
Query: 293 HLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN 350
+ + G + G++G +Y+G VAIK + E+I + K QE+ +++ ++H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 351 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS---KGMNYLH 407
+V++IG+ SL I+ E+ GS+ + K P L VA+ V +G+ YLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFG---PFPESL-VAVYVYQVLQGLAYLH 116
Query: 408 QNNIIHRDLKAANLLMDENEV 428
+ +IHRD+KAAN+L ++ V
Sbjct: 117 EQGVIHRDIKAANILTTKDGV 137
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 48/136 (35%), Positives = 76/136 (55%), Gaps = 5/136 (3%)
Query: 298 SKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI 355
++ SG+YGD+Y R + VAIKV+K E D + QE+ ++++ RH N+V +
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLE--PGDDFEIIQQEISMLKECRHPNIVAYF 66
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
G+ + L IV E+ GGS+ D +G + V + KG+ YLH+ IHRD
Sbjct: 67 GSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRD 126
Query: 416 LKAANLLMDEN-EVSL 430
+K AN+L+ E+ +V L
Sbjct: 127 IKGANILLTEDGDVKL 142
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 6e-24
Identities = 50/146 (34%), Positives = 79/146 (54%), Gaps = 8/146 (5%)
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQK-EFAQEVFI 342
IDP ++ + G +G++ RG DVAIK LK +SD Q+ +F E I
Sbjct: 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG--SSDKQRLDFLTEASI 58
Query: 343 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 402
M + H N+++ G TK + I+TE+M GS+ +L + G F + L+ + ++ G
Sbjct: 59 MGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASG 118
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEV 428
M YL + N +HRDL A N+L++ N V
Sbjct: 119 MKYLSEMNYVHRDLAARNILVNSNLV 144
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 2e-23
Identities = 46/144 (31%), Positives = 82/144 (56%), Gaps = 6/144 (4%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 346
W ++ + L G + G +G + +G Y Q VA+K +K + + F +E +M K+
Sbjct: 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----TAQAFLEETAVMTKL 56
Query: 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMNY 405
HKN+V+ +G L IV E MS G++ ++L + + + + LL+ ++DV++GM Y
Sbjct: 57 HHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEY 115
Query: 406 LHQNNIIHRDLKAANLLMDENEVS 429
L ++HRDL A N+L+ E+ V+
Sbjct: 116 LESKKLVHRDLAARNILVSEDGVA 139
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 1e-22
Identities = 48/130 (36%), Positives = 75/130 (57%), Gaps = 2/130 (1%)
Query: 300 VASGSYGDLYRGTYCSQD-VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 358
+ G++G++++GT + VA+K K E + +++ +F E I+++ H N+V+ IG C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCK-EDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 359 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 418
T+ + IV E + GG +L K K K L+K A+D + GM YL N IHRDL A
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAA 121
Query: 419 ANLLMDENEV 428
N L+ EN V
Sbjct: 122 RNCLVGENNV 131
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 1e-22
Identities = 46/131 (35%), Positives = 72/131 (54%), Gaps = 8/131 (6%)
Query: 299 KVASGSYGDLYRGTYCSQ-----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 353
K+ GS+G + RG + + VA+K LK +++ SD+ +F +E IM + H+N+++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL-SDIMDDFLKEAAIMHSLDHENLIR 60
Query: 354 FIGACTKPPSLCIVTEFMSGGSVYDYLHK-LKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
G P L +VTE GS+ D L K G F + +L A+ ++ GM YL I
Sbjct: 61 LYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFI 119
Query: 413 HRDLKAANLLM 423
HRDL A N+L+
Sbjct: 120 HRDLAARNILL 130
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 1e-22
Identities = 42/140 (30%), Positives = 77/140 (55%), Gaps = 6/140 (4%)
Query: 290 DP-KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV 346
DP + K K+ G+ G++Y+ T + ++VAIK + R+ ++ E+ IM+
Sbjct: 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM---RLRKQNKELIINEILIMKDC 72
Query: 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 406
+H N+V + + L +V E+M GGS+ D + + P + V +V +G+ YL
Sbjct: 73 KHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYL 132
Query: 407 HQNNIIHRDLKAANLLMDEN 426
H N+IHRD+K+ N+L+ ++
Sbjct: 133 HSQNVIHRDIKSDNILLSKD 152
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 3e-22
Identities = 49/141 (34%), Positives = 85/141 (60%), Gaps = 5/141 (3%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 345
WEI + +K K+ +G +G+++ G Y S VA+K LKP ++ + F +E +M+
Sbjct: 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSV---QAFLEEANLMKT 57
Query: 346 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKGMN 404
++H +V+ TK + I+TE+M+ GS+ D+L +G LP L+ + +++GM
Sbjct: 58 LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA 117
Query: 405 YLHQNNIIHRDLKAANLLMDE 425
Y+ + N IHRDL+AAN+L+ E
Sbjct: 118 YIERKNYIHRDLRAANVLVSE 138
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 6e-22
Identities = 43/135 (31%), Positives = 71/135 (52%), Gaps = 6/135 (4%)
Query: 299 KVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
+ GS+G++Y+ +Q VAIKV+ E +++ + QE+ + + R + ++ G
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIE-DIQQEIQFLSQCRSPYITKYYG 66
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
+ K L I+ E+ GGS D L G + + +V G+ YLH+ IHRD+
Sbjct: 67 SFLKGSKLWIIMEYCGGGSCLDLL--KPGKLDETYIAFILREVLLGLEYLHEEGKIHRDI 124
Query: 417 KAAN-LLMDENEVSL 430
KAAN LL +E +V L
Sbjct: 125 KAANILLSEEGDVKL 139
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 1e-21
Identities = 47/146 (32%), Positives = 73/146 (50%), Gaps = 7/146 (4%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQEVF 341
+EI + + G + G +GD+Y+G Y S + VA+K K S +K F QE +
Sbjct: 1 YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK-FLQEAY 59
Query: 342 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 401
IMR+ H ++V+ IG T+ P IV E G + YL K L SL+ + +S
Sbjct: 60 IMRQFDHPHIVKLIGVITENPVW-IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLST 118
Query: 402 GMNYLHQNNIIHRDLKAANLLMDENE 427
+ YL +HRD+ A N+L+ +
Sbjct: 119 ALAYLESKRFVHRDIAARNVLVSSPD 144
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 3e-21
Identities = 42/129 (32%), Positives = 66/129 (51%), Gaps = 6/129 (4%)
Query: 299 KVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
K+ GSYG +Y+ + Q VAIKV+ E ++ KE + I+++ +V++ G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKE----ISILKQCDSPYIVKYYG 65
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
+ K L IV E+ GSV D + + + KG+ YLH N IHRD+
Sbjct: 66 SYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDI 125
Query: 417 KAANLLMDE 425
KA N+L++E
Sbjct: 126 KAGNILLNE 134
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 4e-21
Identities = 43/135 (31%), Positives = 72/135 (53%), Gaps = 8/135 (5%)
Query: 294 LKFGSKVASGSYGDLYRGTYCSQ------DVAIKVLKPERINSDMQKEFAQEVFIMRKVR 347
L+ + SG++G +Y+G + + VAIKVL+ E + KE E ++M V
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR-EETSPKANKEILDEAYVMASVD 67
Query: 348 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 407
H +VV+ +G C + ++T+ M G + DY+ K LL + ++KGM+YL
Sbjct: 68 HPHVVRLLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE 126
Query: 408 QNNIIHRDLKAANLL 422
+ ++HRDL A N+L
Sbjct: 127 EKRLVHRDLAARNVL 141
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 6e-21
Identities = 49/139 (35%), Positives = 83/139 (59%), Gaps = 6/139 (4%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRK 345
WEI + LK K+ +G +G+++ TY VA+K +KP ++ + F E +M+
Sbjct: 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE---AFLAEANVMKT 57
Query: 346 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMN 404
++H +V+ TK P + I+TEFM+ GS+ D+L +G LP L+ + +++GM
Sbjct: 58 LQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA 116
Query: 405 YLHQNNIIHRDLKAANLLM 423
++ Q N IHRDL+AAN+L+
Sbjct: 117 FIEQRNYIHRDLRAANILV 135
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 8e-21
Identities = 47/160 (29%), Positives = 80/160 (50%), Gaps = 23/160 (14%)
Query: 288 EIDPKHLKFGSKVASGSYGDLYRG-------TYCSQDVAIKVLKPERINSDMQKEFAQEV 340
EI ++F ++ G++G +Y+G + VAIK LK E +Q+EF QE
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLK-ENAEPKVQQEFRQEA 59
Query: 341 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------------HKLKG 385
+M ++H N+V +G CTK C++ E+++ G ++++L +K
Sbjct: 60 ELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKS 119
Query: 386 VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE 425
L +AI ++ GM YL ++ +HRDL A N L+ E
Sbjct: 120 SLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE 159
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 1e-20
Identities = 42/144 (29%), Positives = 74/144 (51%), Gaps = 12/144 (8%)
Query: 291 PKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKE---FAQEVFI 342
P + + G + G++G +Y C +++A+K + + + + +KE E+ +
Sbjct: 1 PTNWRRGKLLGQGAFGRVY---LCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQL 57
Query: 343 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 402
++ ++H+ +VQ+ G +L I E+M GGSV D L K G K + +G
Sbjct: 58 LKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQL-KAYGALTETVTRKYTRQILEG 116
Query: 403 MNYLHQNNIIHRDLKAANLLMDEN 426
+ YLH N I+HRD+K AN+L D
Sbjct: 117 VEYLHSNMIVHRDIKGANILRDSA 140
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 2e-20
Identities = 44/133 (33%), Positives = 71/133 (53%), Gaps = 9/133 (6%)
Query: 302 SGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
G++G + +G Y + VA+K LK E I + +KEF +E +M ++ H +V+ IG
Sbjct: 5 HGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAG-KKEFLREASVMAQLDHPCIVRLIG 63
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
C K L +V E G + YL K + + L ++A V+ GM YL + +HRDL
Sbjct: 64 VC-KGEPLMLVMELAPLGPLLKYLKK-RREIPVSDLKELAHQVAMGMAYLESKHFVHRDL 121
Query: 417 KAAN-LLMDENEV 428
A N LL++ ++
Sbjct: 122 AARNVLLVNRHQA 134
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 9e-20
Identities = 50/153 (32%), Positives = 86/153 (56%), Gaps = 13/153 (8%)
Query: 294 LKFGSKVASGSYGD----LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 349
L++ ++ +G+ G L+R T + +A+K ++ E IN +QK+ +E+ I+ K
Sbjct: 3 LEYLGELGAGNSGVVSKVLHRPT--GKIMAVKTIRLE-INEAIQKQILRELDILHKCNSP 59
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH-Q 408
+V F GA + I E+M GGS+ L +++G L K+A+ V KG+ YLH +
Sbjct: 60 YIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119
Query: 409 NNIIHRDLKAANLLMDEN-EVSLLLSLCLFTVS 440
+ IIHRD+K +N+L++ ++ LC F VS
Sbjct: 120 HKIIHRDVKPSNILVNSRGQI----KLCDFGVS 148
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 1e-19
Identities = 44/135 (32%), Positives = 69/135 (51%), Gaps = 6/135 (4%)
Query: 297 GSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ---KEFAQEVFIMRKVRHKNV 351
G + SGS+G +Y G A+K + Q K+ QE+ ++ K++H N+
Sbjct: 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
VQ++G + +L I E + GGS+ L K G F P + + G+ YLH N
Sbjct: 65 VQYLGTEREEDNLYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNT 123
Query: 412 IHRDLKAANLLMDEN 426
+HRD+K AN+L+D N
Sbjct: 124 VHRDIKGANILVDTN 138
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 88.3 bits (220), Expect = 1e-19
Identities = 42/141 (29%), Positives = 69/141 (48%), Gaps = 12/141 (8%)
Query: 299 KVASGSYGDLYRGTYCSQDVAIKVLKPERIN-SDM---QKEFA-QEVFIMRKVRHKNVVQ 353
++ GS+G +Y D + VLK I+ S+M ++E A EV I++K+ H N+++
Sbjct: 7 QIGKGSFGKVYLVR-RKSDGKLYVLK--EIDLSNMSEKEREDALNEVKILKKLNHPNIIK 63
Query: 354 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS---LLKVAIDVSKGMNYLHQNN 410
+ + + LCIV E+ GG + + K K K +L + + + YLH
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK 123
Query: 411 IIHRDLKAAN-LLMDENEVSL 430
I+HRD+K N L V L
Sbjct: 124 ILHRDIKPQNIFLTSNGLVKL 144
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 2e-19
Identities = 41/140 (29%), Positives = 68/140 (48%), Gaps = 7/140 (5%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYC---SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH 348
+ + G+ +Y C ++ VAIK + E+ + + E +EV M + H
Sbjct: 1 DDYELIEVIGVGATAVVYAA-ICLPNNEKVAIKRIDLEKCQTSV-DELRKEVQAMSQCNH 58
Query: 349 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL-HKLK-GVFKLPSLLKVAIDVSKGMNYL 406
NVV++ + L +V ++SGGS+ D + G + V +V KG+ YL
Sbjct: 59 PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118
Query: 407 HQNNIIHRDLKAANLLMDEN 426
H N IHRD+KA N+L+ E+
Sbjct: 119 HSNGQIHRDIKAGNILLGED 138
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 3e-19
Identities = 51/164 (31%), Positives = 83/164 (50%), Gaps = 18/164 (10%)
Query: 274 PYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPE 326
PY LK WE +L FG + +G++G + T VA+K+LKP
Sbjct: 25 PYDLK--------WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKP- 75
Query: 327 RINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG 385
+S ++ E+ IM + H+N+V +GACT + ++TE+ G + ++L + +
Sbjct: 76 TAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRE 135
Query: 386 VF-KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428
F L LL + V+KGM +L N IHRDL A N+L+ ++
Sbjct: 136 SFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKI 179
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 4e-19
Identities = 56/175 (32%), Positives = 83/175 (47%), Gaps = 33/175 (18%)
Query: 282 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQE 339
D T ++E+ + G+YG +Y+ + Q VAIK++ I D ++E +E
Sbjct: 3 DPTGIFEL-------VEVIGEGTYGKVYKARHKKTGQLVAIKIMD---IIEDEEEEIKEE 52
Query: 340 VFIMRKV-RHKNVVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLPSL 392
I+RK H N+ F GA K +V E GGSV D + KG+ K
Sbjct: 53 YNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV---KGLRKKGKR 109
Query: 393 LKVAI------DVSKGMNYLHQNNIIHRDLKAANLLMDEN-EVSLLLSLCLFTVS 440
LK + +G+ YLH+N +IHRD+K N+L+ +N EV L F VS
Sbjct: 110 LKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEV----KLVDFGVS 160
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 5e-19
Identities = 46/140 (32%), Positives = 70/140 (50%), Gaps = 15/140 (10%)
Query: 300 VASGSYGDLYRGTYCSQD--------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV 351
+ SG++G++Y GT VA+K L+ + + +KEF +E +M H N+
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE-KKEFLKEAHLMSNFNHPNI 61
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK------GVFKLPSLLKVAIDVSKGMNY 405
V+ +G C I+ E M GG + YL + + L LL + +DV+KG Y
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 406 LHQNNIIHRDLKAANLLMDE 425
L Q + IHRDL A N L+ E
Sbjct: 122 LEQMHFIHRDLAARNCLVSE 141
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 5e-19
Identities = 43/134 (32%), Positives = 70/134 (52%), Gaps = 5/134 (3%)
Query: 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN 350
L+ + GS G +Y+ + + A+K + + + +K+ +E+ +R
Sbjct: 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIH-VDGDEEFRKQLLRELKTLRSCESPY 60
Query: 351 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN- 409
VV+ GA K + IV E+M GGS+ D L K G P L +A + KG++YLH
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLAD-LLKKVGKIPEPVLAYIARQILKGLDYLHTKR 119
Query: 410 NIIHRDLKAANLLM 423
+IIHRD+K +NLL+
Sbjct: 120 HIIHRDIKPSNLLI 133
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 5e-19
Identities = 48/149 (32%), Positives = 76/149 (51%), Gaps = 14/149 (9%)
Query: 288 EIDPKHLKFGSKVASGSYGDLYRGTYCSQD-------VAIKVLKPERINSDMQKEFAQEV 340
E+ + + G++G++Y G Y +D VA+K L PE + + +F E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTL-PESCSEQDESDFLMEA 60
Query: 341 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS------LLK 394
IM K H+N+V+ IG + I+ E M+GG + +L + + + PS LL
Sbjct: 61 LIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLF 120
Query: 395 VAIDVSKGMNYLHQNNIIHRDLKAANLLM 423
A DV+KG YL +N+ IHRD+ A N L+
Sbjct: 121 CARDVAKGCKYLEENHFIHRDIAARNCLL 149
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 1e-18
Identities = 47/149 (31%), Positives = 70/149 (46%), Gaps = 16/149 (10%)
Query: 294 LKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQEVFIMRKVRH 348
LK G + G +G + G D VA+K +K + +EF E M+ H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 349 KNVVQFIGAC------TKPPSLCIVTEFMSGGSVYDYLHKLK---GVFKLP--SLLKVAI 397
NV++ IG C K P ++ FM G ++ +L + KLP +LLK +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 398 DVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
D++ GM YL N IHRDL A N ++ E+
Sbjct: 121 DIALGMEYLSNRNFIHRDLAARNCMLRED 149
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 45/173 (26%), Positives = 80/173 (46%), Gaps = 26/173 (15%)
Query: 279 IPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-------VAIKVLKPERINSD 331
+P D WE+ L G + G++G + + D VA+K+LK + D
Sbjct: 1 LPLD--PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKD 58
Query: 332 MQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------- 380
+ + E+ +M+ + +HKN++ +G CT+ L +V E+ + G++ D+L
Sbjct: 59 L-SDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYA 117
Query: 381 -----HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428
+ L+ A V++GM +L IHRDL A N+L+ E+ V
Sbjct: 118 SPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHV 170
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 86.3 bits (212), Expect = 3e-18
Identities = 43/142 (30%), Positives = 72/142 (50%), Gaps = 5/142 (3%)
Query: 295 KFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRH-KNVV 352
+ K+ GS+G++Y + VA+KVL + + S + F +E+ I+ + H N+V
Sbjct: 3 RILRKLGEGSFGEVYLA-RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIV 61
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKL--KGVFKLPSLLKVAIDVSKGMNYLHQNN 410
+ SL +V E++ GGS+ D L K+ KG L + + + YLH
Sbjct: 62 KLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG 121
Query: 411 IIHRDLKAANLLMDENEVSLLL 432
IIHRD+K N+L+D + + L
Sbjct: 122 IIHRDIKPENILLDRDGRVVKL 143
|
Length = 384 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (209), Expect = 4e-18
Identities = 31/133 (23%), Positives = 65/133 (48%), Gaps = 9/133 (6%)
Query: 299 KVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
K+ G+YG +Y+ + VA+K ++ + + +E+ ++++++H N+V+ +
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLD 65
Query: 357 ACTKPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 413
L +V E+ D YL K G + + + +G+ Y H + I+H
Sbjct: 66 VIHTERKLYLVFEYCD----MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILH 121
Query: 414 RDLKAANLLMDEN 426
RDLK N+L++ +
Sbjct: 122 RDLKPQNILINRD 134
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 4e-18
Identities = 40/117 (34%), Positives = 61/117 (52%), Gaps = 8/117 (6%)
Query: 329 NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS--LCIVTEFMSGGS---VYDYLHKL 383
N D+QK+ +E+ I + + +V++ GA S + I E+ GGS +Y + K
Sbjct: 39 NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKR 98
Query: 384 KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440
G L K+A V KG++YLH IIHRD+K +N+L+ + LC F VS
Sbjct: 99 GGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQ---VKLCDFGVS 152
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|153172 cd04900, ACT_UUR-like_1, ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD and related domains | Back alignment and domain information |
|---|
Score = 77.9 bits (193), Expect = 5e-18
Identities = 29/72 (40%), Positives = 40/72 (55%), Gaps = 6/72 (8%)
Query: 179 MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV---DGWPY---E 232
E+ T D+P L +++ L +GLNI +A F+T DGY+LD FVV DG P E
Sbjct: 1 GTEVFIYTPDRPGLFARIAGALDQLGLNILDARIFTTRDGYALDTFVVLDPDGEPIGERE 60
Query: 233 ETEQLRAALEKE 244
++R ALE
Sbjct: 61 RLARIREALEDA 72
|
This ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD is the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted tyrosine kinase. Members of this CD belong to the superfamily of ACT regulatory domains. Length = 73 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 7e-18
Identities = 48/144 (33%), Positives = 72/144 (50%), Gaps = 6/144 (4%)
Query: 288 EIDPKHLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERINSDMQKEFAQEVFI 342
EI P H+ + +G +G+++RG VAIK LKP Q +F E I
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQ-DFLSEASI 59
Query: 343 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 402
M + H N+++ G TK I+TE+M G++ YL G F L+ + ++ G
Sbjct: 60 MGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAG 119
Query: 403 MNYLHQNNIIHRDLKAANLLMDEN 426
M YL N +HRDL A N+L++ N
Sbjct: 120 MKYLSDMNYVHRDLAARNILVNSN 143
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 43/171 (25%), Positives = 73/171 (42%), Gaps = 27/171 (15%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTY--CSQD-----VAIKVLKPERINSDMQKEFAQE 339
WE+ + + ++ GS+G +Y G + VAIK + E + + EF E
Sbjct: 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN-ENASMRERIEFLNE 59
Query: 340 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK------GVFKLPSLL 393
+M++ +VV+ +G + +V E M+ G + YL + P+L
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119
Query: 394 KV---AIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI 441
K A +++ GM YL +HRDL A N ++ E+ TV I
Sbjct: 120 KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAED----------LTVKI 160
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-17
Identities = 42/153 (27%), Positives = 79/153 (51%), Gaps = 14/153 (9%)
Query: 282 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQKE-FAQ 338
+ D+WEI ++ G++G +Y+ + + A K+++ I S+ + E F
Sbjct: 2 NPNDIWEII-------GELGDGAFGKVYKAQHKETGLFAAAKIIQ---IESEEELEDFMV 51
Query: 339 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 398
E+ I+ + +H N+V A L I+ EF GG++ + +L+ P + V
Sbjct: 52 EIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQ 111
Query: 399 VSKGMNYLHQNNIIHRDLKAANLLMD-ENEVSL 430
+ + +N+LH + +IHRDLKA N+L+ + +V L
Sbjct: 112 MLEALNFLHSHKVIHRDLKAGNILLTLDGDVKL 144
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 3e-17
Identities = 46/152 (30%), Positives = 81/152 (53%), Gaps = 17/152 (11%)
Query: 300 VASGSYGDLYRGTY--CSQDVAIKVLK---PERINSDMQKEFAQEVFIMRKVRH---KNV 351
+ G+YG +YRG + + VA+K++ P+ SD+Q+E A ++ ++R N+
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVA----LLSQLRQSQPPNI 64
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
++ G+ K P L I+ E+ GGSV + G + + +V + Y+H+ +
Sbjct: 65 TKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGV 122
Query: 412 IHRDLKAANLLMDENEVSLLLSLCLFTVSILF 443
IHRD+KAAN+L+ N ++ LC F V+ L
Sbjct: 123 IHRDIKAANILV-TNTGNVK--LCDFGVAALL 151
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 3e-17
Identities = 46/145 (31%), Positives = 74/145 (51%), Gaps = 6/145 (4%)
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIM 343
ID +K + +G +G++ RG VAIK LK +++F E IM
Sbjct: 1 IDVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIM 59
Query: 344 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 403
+ H N++ G TK + I+TEFM G++ +L + G F + L+ + ++ GM
Sbjct: 60 GQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGM 119
Query: 404 NYLHQNNIIHRDLKAANLLMDENEV 428
YL + N +HRDL A N+L++ N V
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLV 144
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 3e-17
Identities = 36/136 (26%), Positives = 72/136 (52%), Gaps = 7/136 (5%)
Query: 297 GSKVASGSYGDLYRGTYCSQD----VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
G+K+ G++G +Y + D +A+K ++ + + KE A E+ ++ ++H N+V
Sbjct: 5 GNKIGGGTFGKVYTAV--NLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
++ G + I E+ SGG++ + L + + + + +G+ YLH + I+
Sbjct: 63 KYYGVEVHREKVYIFMEYCSGGTLEELLE-HGRILDEHVIRVYTLQLLEGLAYLHSHGIV 121
Query: 413 HRDLKAANLLMDENEV 428
HRD+K AN+ +D N V
Sbjct: 122 HRDIKPANIFLDHNGV 137
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 4e-17
Identities = 42/120 (35%), Positives = 70/120 (58%), Gaps = 4/120 (3%)
Query: 310 RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP--SLCIV 367
G + VA+K LKPE + + + +E+ I+R + H+N+V++ G CT+ + ++
Sbjct: 28 EGDNTGEQVAVKSLKPESGGNHIA-DLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLI 86
Query: 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 427
EF+ GS+ +YL + K L LK A+ + KGM+YL +HRDL A N+L+ E+E
Sbjct: 87 MEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV-ESE 145
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 6e-17
Identities = 43/141 (30%), Positives = 78/141 (55%), Gaps = 6/141 (4%)
Query: 297 GSKVASGSYGDLYRG-TYCSQDVAIKVLKPERINSDM-QKEFA---QEVFIMRKVRHKNV 351
G + G+YG +Y G T Q +A+K ++ + N +KE+ +EV +++ ++H N+
Sbjct: 5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
VQ++G C ++ I EF+ GGS+ L++ G P K + G+ YLH N +
Sbjct: 65 VQYLGTCLDDNTISIFMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNCV 123
Query: 412 IHRDLKAANLLMDENEVSLLL 432
+HRD+K N+++ N + L+
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLI 144
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 7e-17
Identities = 41/132 (31%), Positives = 73/132 (55%), Gaps = 3/132 (2%)
Query: 299 KVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
++ G++G+++ G + + VA+K + E + D++ +F QE I+++ H N+V+ IG
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCR-ETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
CT+ + IV E + GG +L K+ L+++ + + GM YL + IHRDL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 417 KAANLLMDENEV 428
A N L+ E V
Sbjct: 121 AARNCLVTEKNV 132
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 52/193 (26%), Positives = 87/193 (45%), Gaps = 39/193 (20%)
Query: 288 EIDPKHLKFGSKVASGSYGDLY-RGTYCSQD-----------------VAIKVLKPERIN 329
E + L F K+ G +G+++ QD VA+KVL+P+ +
Sbjct: 1 EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPD-AS 59
Query: 330 SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHK------- 382
+ +++F +EV I+ ++ N+ + +G CT P LC++ E+M G + +L K
Sbjct: 60 DNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSG 119
Query: 383 -LKGVFKLP--SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTV 439
L +LL +A ++ GM YL N +HRDL N L+ +N +T+
Sbjct: 120 LACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKN----------YTI 169
Query: 440 SILFCGKGRELIS 452
I G R L S
Sbjct: 170 KIADFGMSRNLYS 182
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 2e-16
Identities = 41/145 (28%), Positives = 71/145 (48%), Gaps = 35/145 (24%)
Query: 299 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKE-----FAQEVFIMRKVRHKNV 351
++ G+YG +Y+ + VA+K +I + +KE +E+ +++K+RH N+
Sbjct: 6 QIGEGTYGQVYKARNKKTGELVALK-----KIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVY---DYL-HKLKGVFKLPSLLKVAIDVSK------ 401
V+ IVT GS+Y +Y+ H L G+ P + K K
Sbjct: 61 VRLK---------EIVTS-KGKGSIYMVFEYMDHDLTGLLDSPEV-KFTESQIKCYMKQL 109
Query: 402 --GMNYLHQNNIIHRDLKAANLLMD 424
G+ YLH N I+HRD+K +N+L++
Sbjct: 110 LEGLQYLHSNGILHRDIKGSNILIN 134
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 2e-16
Identities = 66/199 (33%), Positives = 104/199 (52%), Gaps = 29/199 (14%)
Query: 300 VASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIG 356
V +G+YG +Y+G + Q AIKV+ + D ++E QE+ +++K H+N+ + G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINMLKKYSHHRNIATYYG 70
Query: 357 ACTK--PP----SLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQN 409
A K PP L +V EF GSV D + KG K + + ++ +G+++LHQ+
Sbjct: 71 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 130
Query: 410 NIIHRDLKAANLLMDEN-EVSLLLSLCLFTVSI-LFCGKGRELISLFLGNDVLLQFGTYW 467
+IHRD+K N+L+ EN EV L+ F VS L GR + F+G YW
Sbjct: 131 KVIHRDIKGQNVLLTENAEVKLV----DFGVSAQLDRTVGRR--NTFIGT-------PYW 177
Query: 468 IIFRRSSCDKKNSDAPFLF 486
+ +CD +N DA + F
Sbjct: 178 MAPEVIACD-ENPDATYDF 195
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 46/144 (31%), Positives = 78/144 (54%), Gaps = 11/144 (7%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYCS-QD-----VAIKVLKPERINSDMQKEFAQEVFIMRK 345
+HLKF ++ G++G + Y QD VA+K L+ ++ ++F +E+ I++
Sbjct: 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKS 61
Query: 346 VRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 403
++H N+V++ G C +L +V E++ GS+ DYL K + LL A + KGM
Sbjct: 62 LQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGM 121
Query: 404 NYLHQNNIIHRDLKAANLLMDENE 427
YL +HRDL N+L+ E+E
Sbjct: 122 EYLGSKRYVHRDLATRNILV-ESE 144
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 2e-16
Identities = 41/126 (32%), Positives = 70/126 (55%), Gaps = 11/126 (8%)
Query: 309 YRGTYCSQDV------AIKVLKPERINSDMQKEFAQ----EVFIMRKVRHKNVVQFIGAC 358
+ Y ++DV A+K + R S Q+E + E+ +M ++ H ++++ +GA
Sbjct: 13 FSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT 72
Query: 359 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 418
+ + E+M+GGSV L K G FK ++ + +G++YLH+N IIHRD+K
Sbjct: 73 CEDSHFNLFVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKG 131
Query: 419 ANLLMD 424
ANLL+D
Sbjct: 132 ANLLID 137
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 5e-16
Identities = 40/146 (27%), Positives = 72/146 (49%), Gaps = 22/146 (15%)
Query: 318 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
VA+K+L+ + + + +F +E+ IM ++++ N+++ +G C LC++TE+M G +
Sbjct: 47 VAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 378 DYL------HKLKGVFKLPS-----LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
+L +PS LL +A+ ++ GM YL N +HRDL N L+ +
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNH 165
Query: 427 EVSLLLSLCLFTVSILFCGKGRELIS 452
+T+ I G R L S
Sbjct: 166 ----------YTIKIADFGMSRNLYS 181
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 45/138 (32%), Positives = 68/138 (49%), Gaps = 11/138 (7%)
Query: 297 GSKVASGSYGDLYRGTYCS--QDVAIK-VLKPERINS-------DMQKEFAQEVFIMRKV 346
G + G+YG +Y + + +A+K V P I DM K E+ ++ +
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 406
H N+VQ++G T L I E++ GGS+ L G F+ + V +G+ YL
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRT-YGRFEEQLVRFFTEQVLEGLAYL 124
Query: 407 HQNNIIHRDLKAANLLMD 424
H I+HRDLKA NLL+D
Sbjct: 125 HSKGILHRDLKADNLLVD 142
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-15
Identities = 31/131 (23%), Positives = 65/131 (49%), Gaps = 5/131 (3%)
Query: 299 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
K+ GS+G +++ + + A+K + ++N ++E E ++ K+ ++++
Sbjct: 7 KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS--LLKVAIDVSKGMNYLHQNNIIHR 414
+ L IV E+ G ++ L +G LP + + I + G+ +LH I+HR
Sbjct: 67 SFLDKGKLNIVMEYAENGDLHKLLKMQRGR-PLPEDQVWRFFIQILLGLAHLHSKKILHR 125
Query: 415 DLKAANLLMDE 425
D+K+ NL +D
Sbjct: 126 DIKSLNLFLDA 136
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 35/139 (25%), Positives = 62/139 (44%), Gaps = 11/139 (7%)
Query: 295 KFGSKVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-----R 347
KFG + GS+ + +++ AIK+L ++ +K + V I ++V
Sbjct: 4 KFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIK-EKKV--KYVKIEKEVLTRLNG 60
Query: 348 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 407
H +++ +L V E+ G + Y+ K G A ++ + YLH
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLH 119
Query: 408 QNNIIHRDLKAANLLMDEN 426
IIHRDLK N+L+D++
Sbjct: 120 SKGIIHRDLKPENILLDKD 138
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 45/145 (31%), Positives = 78/145 (53%), Gaps = 6/145 (4%)
Query: 285 DVWEIDPKH-LKFGSKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVF 341
D+ +P+H + +V SG+YGD+Y R + + A+K++K E D QE+F
Sbjct: 1 DILRRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIF 58
Query: 342 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 401
++++ +H N+V + G+ L I E+ GGS+ D H + G + V + +
Sbjct: 59 MVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYH-VTGPLSELQIAYVCRETLQ 117
Query: 402 GMNYLHQNNIIHRDLKAANLLMDEN 426
G+ YLH +HRD+K AN+L+ +N
Sbjct: 118 GLAYLHSKGKMHRDIKGANILLTDN 142
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 48/143 (33%), Positives = 79/143 (55%), Gaps = 14/143 (9%)
Query: 300 VASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIG 356
V +G+YG +Y+G + Q AIKV+ + D ++E E+ +++K H+N+ + G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMD---VTEDEEEEIKLEINMLKKYSHHRNIATYYG 80
Query: 357 ACTK--PP----SLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQN 409
A K PP L +V EF GSV D + KG K + + ++ +G+ +LH +
Sbjct: 81 AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH 140
Query: 410 NIIHRDLKAANLLMDEN-EVSLL 431
+IHRD+K N+L+ EN EV L+
Sbjct: 141 KVIHRDIKGQNVLLTENAEVKLV 163
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 2e-15
Identities = 45/133 (33%), Positives = 73/133 (54%), Gaps = 11/133 (8%)
Query: 299 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFA---QEVFIMRKVRHKNVVQ 353
++ SG+YGD+Y R + AIKV+K E ++FA QE+ +M+ +H N+V
Sbjct: 16 RIGSGTYGDVYKARNVNTGELAAIKVIKLEP-----GEDFAVVQQEIIMMKDCKHSNIVA 70
Query: 354 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 413
+ G+ + L I EF GGS+ D H + G + V+ + +G+ YLH +H
Sbjct: 71 YFGSYLRRDKLWICMEFCGGGSLQDIYH-VTGPLSESQIAYVSRETLQGLYYLHSKGKMH 129
Query: 414 RDLKAANLLMDEN 426
RD+K AN+L+ +N
Sbjct: 130 RDIKGANILLTDN 142
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 3e-15
Identities = 46/145 (31%), Positives = 71/145 (48%), Gaps = 6/145 (4%)
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQEVFIM 343
ID +K + +G +G++ G VAIK LK +++F E IM
Sbjct: 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQ-RRDFLSEASIM 59
Query: 344 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 403
+ H N++ G TK + IVTE+M GS+ +L K G F + L+ + ++ GM
Sbjct: 60 GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGM 119
Query: 404 NYLHQNNIIHRDLKAANLLMDENEV 428
YL +HRDL A N+L++ N V
Sbjct: 120 KYLSDMGYVHRDLAARNILVNSNLV 144
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 4e-15
Identities = 43/130 (33%), Positives = 71/130 (54%), Gaps = 8/130 (6%)
Query: 300 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 353
+ SG++G +Y+G + + VAIK+L E EF E IM + H ++V+
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 354 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 413
+G C P ++ +VT+ M G + DY+H+ K LL + ++KGM YL + ++H
Sbjct: 74 LLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVH 132
Query: 414 RDLKAANLLM 423
RDL A N+L+
Sbjct: 133 RDLAARNVLV 142
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 4e-15
Identities = 52/197 (26%), Positives = 84/197 (42%), Gaps = 53/197 (26%)
Query: 293 HLKFGSKVASGSYGDLYRGTYCSQD---------------------VAIKVLKPERINSD 331
HL F K+ G +G+++ C VA+K+L+P+ N +
Sbjct: 6 HLLFKEKLGEGQFGEVH---LCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD-ANKN 61
Query: 332 MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL--HKLKG---- 385
+ +F +EV I+ +++ N+++ +G C LC++TE+M G + +L H L
Sbjct: 62 ARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEEN 121
Query: 386 ------------VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLS 433
SLL VA+ ++ GM YL N +HRDL N L+ EN
Sbjct: 122 GNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGEN------- 174
Query: 434 LCLFTVSILFCGKGREL 450
T+ I G R L
Sbjct: 175 ---LTIKIADFGMSRNL 188
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 6e-15
Identities = 41/147 (27%), Positives = 72/147 (48%), Gaps = 21/147 (14%)
Query: 300 VASGSYGDLYRGTYCS----QD---VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ G++G ++ G D VA+K LK E ++D +K+F +E ++ +H+N+V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLK-ETASNDARKDFEREAELLTNFQHENIV 71
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHK-------------LKGVFKLPSLLKVAIDV 399
+F G CT+ +V E+M G + +L G L LL++A+ +
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 400 SKGMNYLHQNNIIHRDLKAANLLMDEN 426
+ GM YL + +HRDL N L+ +
Sbjct: 132 ASGMVYLASQHFVHRDLATRNCLVGYD 158
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 8e-15
Identities = 37/136 (27%), Positives = 70/136 (51%), Gaps = 5/136 (3%)
Query: 298 SKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI 355
K+ GSYG +Y+ S Q A+K + ++ +++ E+ I+ V H N++ +
Sbjct: 6 KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYK 65
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
A LCIV E+ G + + K + + + ++ I + +G+ LH+ I+
Sbjct: 66 EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKIL 125
Query: 413 HRDLKAANLLMDENEV 428
HRDLK+AN+L+ N++
Sbjct: 126 HRDLKSANILLVANDL 141
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 42/145 (28%), Positives = 73/145 (50%), Gaps = 12/145 (8%)
Query: 298 SKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
V G+YG + + C + VAIK K + D++K +EV ++R++RH+N+V
Sbjct: 7 GVVGEGAYGVVLK---CRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIV 63
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
A + L +V E++ ++ + L G ++ + + + Y H +NII
Sbjct: 64 NLKEAFRRKGRLYLVFEYV-ERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNII 122
Query: 413 HRDLKAANLLMDENEVSLLLSLCLF 437
HRD+K N+L+ E+ V L LC F
Sbjct: 123 HRDIKPENILVSESGV---LKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 44/137 (32%), Positives = 78/137 (56%), Gaps = 10/137 (7%)
Query: 297 GSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSD-------MQKEFAQEVFIMRKVR 347
G+ + SGS+G +Y G S +A+K ++ +++ M A+E+ ++++++
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 348 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 407
H+N+VQ++G+ L I E++ GGSV L+ G F+ + + KG+NYLH
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLH 123
Query: 408 QNNIIHRDLKAANLLMD 424
IIHRD+K AN+L+D
Sbjct: 124 NRGIIHRDIKGANILVD 140
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 41/132 (31%), Positives = 67/132 (50%), Gaps = 22/132 (16%)
Query: 318 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
VA+K+LK E ++DMQ +F +E +M + H N+V+ +G C +C++ E+M+ G +
Sbjct: 38 VAVKMLK-EEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 96
Query: 378 DYLH-----------------KLKGVFKLP----SLLKVAIDVSKGMNYLHQNNIIHRDL 416
++L + G+ LP L +A V+ GM YL + +HRDL
Sbjct: 97 EFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDL 156
Query: 417 KAANLLMDENEV 428
N L+ EN V
Sbjct: 157 ATRNCLVGENMV 168
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 48/161 (29%), Positives = 81/161 (50%), Gaps = 21/161 (13%)
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIMR 344
++ +KF + G++G + + D AIK +K E + D ++FA E+ ++
Sbjct: 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLC 62
Query: 345 KV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS------------ 391
K+ H N++ +GAC L + E+ G++ D+L K + + P+
Sbjct: 63 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 122
Query: 392 ---LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVS 429
LL A DV++GM+YL Q IHRDL A N+L+ EN V+
Sbjct: 123 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 163
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 36/144 (25%), Positives = 66/144 (45%), Gaps = 20/144 (13%)
Query: 295 KFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQ---KEFAQEVFIMRKVRHK 349
+ G K+ G+Y +Y+ + VAIK +K +E+ ++++++H
Sbjct: 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHP 62
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS-------KG 402
N++ + ++ +V EFM L+ V K S++ D+ +G
Sbjct: 63 NIIGLLDVFGHKSNINLVFEFMET--------DLEKVIKDKSIVLTPADIKSYMLMTLRG 114
Query: 403 MNYLHQNNIIHRDLKAANLLMDEN 426
+ YLH N I+HRDLK NLL+ +
Sbjct: 115 LEYLHSNWILHRDLKPNNLLIASD 138
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 38/153 (24%), Positives = 71/153 (46%), Gaps = 6/153 (3%)
Query: 298 SKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI 355
K+ G+YG +Y R + VAIK +K + + K +E+ +++++ H N+++ +
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
L +V EFM +Y + + + + +G+ + H + I+HRD
Sbjct: 65 DVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRD 123
Query: 416 LKAANLLMDENEVSLLLSLCLFTVSILFCGKGR 448
LK NLL++ V L L F ++ F R
Sbjct: 124 LKPENLLINTEGV---LKLADFGLARSFGSPVR 153
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 45/129 (34%), Positives = 73/129 (56%), Gaps = 6/129 (4%)
Query: 299 KVASGSYGDLYRGTYCSQ----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 354
++ SG++G + +G Y + DVAIKVLK E S + E +E IM ++ + +V+
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSV-RDEMMREAEIMHQLDNPYIVRM 60
Query: 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 414
IG C + +L +V E SGG + +L K + +++++ VS GM YL N +HR
Sbjct: 61 IGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHR 119
Query: 415 DLKAANLLM 423
DL A N+L+
Sbjct: 120 DLAARNVLL 128
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 40/130 (30%), Positives = 71/130 (54%), Gaps = 8/130 (6%)
Query: 300 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 353
+ SG++G +Y+G + + VAIK L+ E + KE E ++M V + +V +
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 73
Query: 354 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 413
+G C ++ ++T+ M G + DY+ + K LL + ++KGMNYL + ++H
Sbjct: 74 LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVH 132
Query: 414 RDLKAANLLM 423
RDL A N+L+
Sbjct: 133 RDLAARNVLV 142
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 42/122 (34%), Positives = 67/122 (54%), Gaps = 11/122 (9%)
Query: 316 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG------ACTKPPSLCIVTE 369
Q VA+K+LK + +S +EF +E M++ H NV++ IG A + P ++
Sbjct: 28 QKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILP 87
Query: 370 FMSGGSVYDYLHKLK---GVFKLP--SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD 424
FM G ++ +L + F LP +L++ ID++ GM YL N IHRDL A N +++
Sbjct: 88 FMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLN 147
Query: 425 EN 426
EN
Sbjct: 148 EN 149
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 43/167 (25%), Positives = 75/167 (44%), Gaps = 26/167 (15%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 337
WE L G + G +G + R D VA+K+LK + D+ +
Sbjct: 7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDL-ADLI 65
Query: 338 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK------------ 384
E+ +M+ + +HKN++ +G CT+ L ++ E+ + G++ ++L +
Sbjct: 66 SEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITK 125
Query: 385 ---GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428
L+ A V++GM YL IHRDL A N+L+ E+ V
Sbjct: 126 VPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNV 172
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 6e-14
Identities = 50/163 (30%), Positives = 80/163 (49%), Gaps = 25/163 (15%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFI 342
WE +KF + G++G + R + AIK+LK E + + ++FA E+ +
Sbjct: 1 WE----DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLK-EFASENDHRDFAGELEV 55
Query: 343 MRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS---------- 391
+ K+ H N++ +GAC L I E+ G++ D+L K + + P+
Sbjct: 56 LCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST 115
Query: 392 -----LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVS 429
LL+ A DV+ GM YL + IHRDL A N+L+ EN S
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLAS 158
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 7e-14
Identities = 32/110 (29%), Positives = 52/110 (47%), Gaps = 2/110 (1%)
Query: 318 VAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376
AIKV+ K + I + + E I+ + + VV+ + +L +V E++ GG +
Sbjct: 21 YAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80
Query: 377 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
L + G ++ + YLH N IIHRDLK N+L+D N
Sbjct: 81 ASLLENV-GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSN 129
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 7e-14
Identities = 41/131 (31%), Positives = 75/131 (57%), Gaps = 7/131 (5%)
Query: 299 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
++ GS+G++++G Q VAIK++ E +++ + QE+ ++ + V ++ G
Sbjct: 11 RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYVTKYYG 69
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
+ K L I+ E++ GGS D L F++ ++LK ++ KG++YLH IHRD
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---EILKGLDYLHSEKKIHRD 126
Query: 416 LKAANLLMDEN 426
+KAAN+L+ E
Sbjct: 127 IKAANVLLSEQ 137
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 8e-14
Identities = 38/129 (29%), Positives = 72/129 (55%), Gaps = 5/129 (3%)
Query: 299 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
++ GS+G++Y+G + VAIK++ E +++ + QE+ ++ + + ++ G
Sbjct: 11 RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYITRYYG 69
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
+ K L I+ E++ GGS D L G + + + ++ KG++YLH IHRD+
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDI 127
Query: 417 KAANLLMDE 425
KAAN+L+ E
Sbjct: 128 KAANVLLSE 136
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 45/167 (26%), Positives = 76/167 (45%), Gaps = 26/167 (15%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 337
WE+ L G + G +G + D VA+K+LK + D+ +
Sbjct: 13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLS-DLI 71
Query: 338 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------------H 381
E+ +M+ + +HKN++ +GACT+ L ++ E+ S G++ +YL
Sbjct: 72 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQ 131
Query: 382 KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428
+ L+ A V++GM YL IHRDL A N+L+ E+ V
Sbjct: 132 VPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV 178
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 39/129 (30%), Positives = 72/129 (55%), Gaps = 6/129 (4%)
Query: 299 KVASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 354
++ SG++G + +G Y + VA+K+LK + + ++ E +E +M+++ + +V+
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 414
IG C + S +V E G + +L K K V ++ ++ VS GM YL + N +HR
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFLQKNKHV-TEKNITELVHQVSMGMKYLEETNFVHR 119
Query: 415 DLKAANLLM 423
DL A N+L+
Sbjct: 120 DLAARNVLL 128
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 1e-13
Identities = 42/135 (31%), Positives = 75/135 (55%), Gaps = 6/135 (4%)
Query: 299 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
K+ GS+G++++G + VAIK++ E +++ + QE+ ++ + V ++ G
Sbjct: 11 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYVTKYYG 69
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
+ K L I+ E++ GGS D L G + + ++ KG++YLH IHRD+
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDI 127
Query: 417 KAANLLMDEN-EVSL 430
KAAN+L+ E+ EV L
Sbjct: 128 KAANVLLSEHGEVKL 142
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 48/176 (27%), Positives = 82/176 (46%), Gaps = 28/176 (15%)
Query: 278 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERI 328
++P D WE L G + G +G + D VA+K+LK +
Sbjct: 3 ELPED--PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT 60
Query: 329 NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK--- 384
D+ + E+ +M+ + +HKN++ +GACT+ L ++ E+ S G++ +YL +
Sbjct: 61 EKDLS-DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 119
Query: 385 -----GVFKLPS-------LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428
+ ++P L+ V++GM YL IHRDL A N+L+ EN V
Sbjct: 120 MEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNV 175
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 46/146 (31%), Positives = 76/146 (52%), Gaps = 13/146 (8%)
Query: 292 KHLKFGSKVASGSYGD--LYRGTYCSQD----VAIKVLKPERINSDMQKE-FAQEVFIMR 344
++LK + G +G LY + VA+K LK E + +E+ I++
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRE--CGQQNTSGWKKEINILK 61
Query: 345 KVRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 402
+ H+N+V++ G C++ L ++ E++ GS+ DYL K K L LL A + +G
Sbjct: 62 TLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEG 119
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEV 428
M YLH + IHRDL A N+L+D + +
Sbjct: 120 MAYLHSQHYIHRDLAARNVLLDNDRL 145
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 48/167 (28%), Positives = 80/167 (47%), Gaps = 26/167 (15%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 337
WE+ L G + G +G + D VA+K+LK + + D+ +
Sbjct: 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLS-DLV 65
Query: 338 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK--------GVFK 388
E+ +M+ + +HKN++ +GACT+ L ++ E+ S G++ +YL + K
Sbjct: 66 SEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCK 125
Query: 389 LPS-------LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428
LP L+ A V++GM YL IHRDL A N+L+ E+ V
Sbjct: 126 LPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNV 172
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 44/142 (30%), Positives = 73/142 (51%), Gaps = 8/142 (5%)
Query: 299 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFI 355
V GSYG + + Q VAIK E + M K+ A +E+ +++++RH+N+V I
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFL-ESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
+ L +V EF+ +V D L K + K + +G+ + H +NIIHRD
Sbjct: 67 EVFRRKKRLYLVFEFVDH-TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRD 125
Query: 416 LKAANLLMDENEVSLLLSLCLF 437
+K N+L+ ++ V + LC F
Sbjct: 126 IKPENILVSQSGV---VKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 44/148 (29%), Positives = 70/148 (47%), Gaps = 15/148 (10%)
Query: 294 LKFGSKVASGSYGDLYRGTYCSQD----VAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 349
L G + G +G + G D VA+K +K ++F E M++ H
Sbjct: 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60
Query: 350 NVVQFIGACTKP------PSLCIVTEFMSGGSVYDYL--HKLKGV-FKLPS--LLKVAID 398
NV++ IG C + PS ++ FM G ++ +L +L LP+ L+K D
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 399 VSKGMNYLHQNNIIHRDLKAANLLMDEN 426
++ GM YL + IHRDL A N +++EN
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNEN 148
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 41/130 (31%), Positives = 69/130 (53%), Gaps = 8/130 (6%)
Query: 300 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 353
+ SG++G +Y+G + VAIKVL+ E + KE E ++M V V +
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLR-ENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 354 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 413
+G C ++ +VT+ M G + DY+ + K LL + ++KGM+YL + ++H
Sbjct: 74 LLGICLTS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVH 132
Query: 414 RDLKAANLLM 423
RDL A N+L+
Sbjct: 133 RDLAARNVLV 142
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 5e-13
Identities = 39/135 (28%), Positives = 66/135 (48%), Gaps = 11/135 (8%)
Query: 300 VASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQK--EFAQEVFIMRKVRHKNVV 352
+ G +G +Y GT D A+K L RI +D+++ +F +E IM+ H NV+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLN--RI-TDLEEVEQFLKEGIIMKDFSHPNVL 59
Query: 353 QFIGACTKPPSL-CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
+G C +V +M G + +++ + L+ + V+KGM YL
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKF 119
Query: 412 IHRDLKAANLLMDEN 426
+HRDL A N ++DE+
Sbjct: 120 VHRDLAARNCMLDES 134
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 6e-13
Identities = 34/135 (25%), Positives = 62/135 (45%), Gaps = 4/135 (2%)
Query: 318 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
VA+K + R+ + + +E+ ++ +H VV+ + +V E+M +
Sbjct: 28 VALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLS 86
Query: 378 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLF 437
+ L + + + KG+ Y+H N I+HRDLK ANLL+ + V L + F
Sbjct: 87 EVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGV---LKIADF 143
Query: 438 TVSILFCGKGRELIS 452
++ LF + L S
Sbjct: 144 GLARLFSEEEPRLYS 158
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 7e-13
Identities = 31/137 (22%), Positives = 73/137 (53%), Gaps = 3/137 (2%)
Query: 300 VASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 357
V G++G ++ R + V IK + E++ D + E +++ + H N++++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 358 CTKPPSLCIVTEFMSGGSVYDYLHK-LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
+ +L IV E+ GG++ +Y+ K + ++L + + ++++H I+HRDL
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDL 127
Query: 417 KAANLLMDENEVSLLLS 433
K N+L+D++++ + +
Sbjct: 128 KTQNILLDKHKMVVKIG 144
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 7e-13
Identities = 49/193 (25%), Positives = 86/193 (44%), Gaps = 39/193 (20%)
Query: 288 EIDPKHLKFGSKVASGSYGDL----------YRGTYCSQD--------VAIKVLKPERIN 329
E K L F K+ G +G++ + S D VA+K+L+ E N
Sbjct: 1 EFPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLR-EDAN 59
Query: 330 SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL--HKLKG-- 385
+ + +F +E+ IM +++ N+++ + C LC++TE+M G + +L H+ +
Sbjct: 60 KNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAA 119
Query: 386 ------VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTV 439
+L+ +A ++ GM YL N +HRDL N L+ +N +T+
Sbjct: 120 EKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKN----------YTI 169
Query: 440 SILFCGKGRELIS 452
I G R L S
Sbjct: 170 KIADFGMSRNLYS 182
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 8e-13
Identities = 37/125 (29%), Positives = 68/125 (54%), Gaps = 4/125 (3%)
Query: 303 GSYGDLYRGTYCSQDVAIKVLK-PERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361
G+YG +Y S V I + + PER + +Q +E+ + ++H+N+VQ++G+ ++
Sbjct: 19 GTYGIVYAARDLSTQVRIAIKEIPERDSRYVQP-LHEEIALHSYLKHRNIVQYLGSDSEN 77
Query: 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKL--PSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419
I E + GGS+ L G K +++ + +G+ YLH N I+HRD+K
Sbjct: 78 GFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGD 137
Query: 420 NLLMD 424
N+L++
Sbjct: 138 NVLVN 142
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 30/127 (23%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 300 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 357
+ G++G+ LYR T V K + R++ +++ E+ I+ ++H N++ +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 358 CTKPPSLCIVTEFMSGGSVYDYL-HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
+L I E+ +GG++YD + + +F+ +L + ++Y+H+ I+HRD+
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDI 127
Query: 417 KAANLLM 423
K N+ +
Sbjct: 128 KTLNIFL 134
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 1e-12
Identities = 34/108 (31%), Positives = 55/108 (50%), Gaps = 2/108 (1%)
Query: 319 AIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A+KVLK ++I + E E I+ ++ H +V+ A L +V E+ GG ++
Sbjct: 22 AMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELF 81
Query: 378 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE 425
+L K +G F A ++ + YLH II+RDLK N+L+D
Sbjct: 82 SHLSK-EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDA 128
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 1e-12
Identities = 40/146 (27%), Positives = 74/146 (50%), Gaps = 10/146 (6%)
Query: 288 EIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQEV 340
E+D K +K + +G +G+L RG C + VAI L+ + ++ F E
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRG--CLKLPSKRELPVAIHTLR-AGCSDKQRRGFLAEA 57
Query: 341 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS 400
+ + H N+V+ G T+ ++ IVTE+MS G++ +L K +G L+ + ++
Sbjct: 58 LTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLA 117
Query: 401 KGMNYLHQNNIIHRDLKAANLLMDEN 426
GM YL + +H+ L A +L++ +
Sbjct: 118 SGMKYLSEMGYVHKGLAAHKVLVNSD 143
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 43/153 (28%), Positives = 76/153 (49%), Gaps = 35/153 (22%)
Query: 298 SKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKE-FA----QEVFIMRKVRHKN 350
+K+ G++G+++ R Q VA+K ++ + +KE F +E+ I++ ++H+N
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALK-----KVLMENEKEGFPITALREIKILQLLKHEN 72
Query: 351 VVQFIGACTKPP--------SLCIVTEFMSGGSVYDYLHKLKGV-------FKLPSLLKV 395
VV I C S +V EF H L G+ F L + KV
Sbjct: 73 VVNLIEICRTKATPYNRYKGSFYLVFEFCE--------HDLAGLLSNKNVKFTLSEIKKV 124
Query: 396 AIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428
+ G+ Y+H+N I+HRD+KAAN+L+ ++ +
Sbjct: 125 MKMLLNGLYYIHRNKILHRDMKAANILITKDGI 157
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 42/142 (29%), Positives = 75/142 (52%), Gaps = 10/142 (7%)
Query: 291 PKHLKFGSKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQ---EVFIMRK 345
P + + G + G++G++Y +++A+K + + + + KE E+ +++
Sbjct: 1 PVNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKN 60
Query: 346 VRHKNVVQFIGACTKPPS---LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 402
+RH +VQ+ G C + P L I E+M GGS+ D L K G + + +G
Sbjct: 61 LRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQL-KAYGALTENVTRRYTRQILQG 118
Query: 403 MNYLHQNNIIHRDLKAANLLMD 424
++YLH N I+HRD+K AN+L D
Sbjct: 119 VSYLHSNMIVHRDIKGANILRD 140
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 43/155 (27%), Positives = 78/155 (50%), Gaps = 25/155 (16%)
Query: 294 LKFGSKVASGSYGDLYRGTYC------SQDVAIKVLKPERINSDMQ-KEFAQEVFIMRKV 346
++F ++ ++G +Y+G +Q VAIK LK IN+ Q EF QE +M ++
Sbjct: 7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKD--INNPQQWGEFQQEASLMAEL 64
Query: 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL----------------HKLKGVFKLP 390
H N+V +G T+ +C++ E+++ G ++++L +K
Sbjct: 65 HHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHG 124
Query: 391 SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE 425
L +AI ++ GM YL + +H+DL A N+L+ E
Sbjct: 125 DFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE 159
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 46/150 (30%), Positives = 76/150 (50%), Gaps = 21/150 (14%)
Query: 300 VASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQF 354
+ G++G + + D AIK +K E + D ++FA E+ ++ K+ H N++
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS---------------LLKVAIDV 399
+GAC L + E+ G++ D+L K + + P+ LL A DV
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 400 SKGMNYLHQNNIIHRDLKAANLLMDENEVS 429
++GM+YL Q IHRDL A N+L+ EN V+
Sbjct: 122 ARGMDYLSQKQFIHRDLAARNILVGENYVA 151
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 3e-12
Identities = 38/122 (31%), Positives = 63/122 (51%), Gaps = 6/122 (4%)
Query: 306 GDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365
G+ +RG ++ V +K L+ D Q F QEV R++ H NV+Q +G C +
Sbjct: 14 GEAHRGMSKAR-VVVKELR-ASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYL 71
Query: 366 IVTEFMSGGSVYDYLHKLKGVFKLPS----LLKVAIDVSKGMNYLHQNNIIHRDLKAANL 421
+V EF G + +YL +G+ + L ++A +V+ G+ +LHQ + IH DL N
Sbjct: 72 LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNC 131
Query: 422 LM 423
+
Sbjct: 132 QL 133
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|153145 cd04873, ACT_UUR-ACR-like, ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 9e-12
Identities = 24/69 (34%), Positives = 35/69 (50%), Gaps = 2/69 (2%)
Query: 181 EITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV-DGWPYEETEQLRA 239
+ D+P LL+ +T +LAD+GLNI +A ST +LDVF V D + A
Sbjct: 2 VVEVYAPDRPGLLADITRVLADLGLNIHDAR-ISTTGERALDVFYVTDSDGRPLDPERIA 60
Query: 240 ALEKEVLKL 248
LE+ +
Sbjct: 61 RLEEALEDA 69
|
This ACT domain family, ACT_UUR_ACR-like, includes the two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD are the four ACT domains of a novel protein composed almost entirely of ACT domain repeats (the ACR protein) and like proteins. These ACR proteins, found in Arabidopsis and Oryza, are proposed to function as novel regulatory or sensor proteins in plants. This CD also includes the first of the two ACT domains that comprise the Glycine Cleavage System Transcriptional Repressor (GcvR) protein and related domains, as well as, the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted tyrosine kinase. Members of this CD belong to the superfamily of ACT regulatory domains. Length = 70 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 9e-12
Identities = 41/141 (29%), Positives = 73/141 (51%), Gaps = 8/141 (5%)
Query: 291 PKHLKFGSKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQ---EVFIMRK 345
P + + G + G++G +Y +++A+K ++ + + + KE E+ +++
Sbjct: 1 PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKN 60
Query: 346 VRHKNVVQFIGACTKPP--SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 403
+ H+ +VQ+ G P +L I E M GGS+ D L K G K + +G+
Sbjct: 61 LLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL-KSYGALTENVTRKYTRQILEGV 119
Query: 404 NYLHQNNIIHRDLKAANLLMD 424
+YLH N I+HRD+K AN+L D
Sbjct: 120 SYLHSNMIVHRDIKGANILRD 140
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 9e-12
Identities = 36/139 (25%), Positives = 70/139 (50%), Gaps = 8/139 (5%)
Query: 291 PKHLKFGSKVASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMR 344
L+ + SG +G +++G + + VAIK ++ +R +E + M
Sbjct: 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQ-DRSGRQTFQEITDHMLAMG 64
Query: 345 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 404
+ H +V+ +G C SL +VT+ GS+ D++ + + LL + ++KGM
Sbjct: 65 SLDHAYIVRLLGICPGA-SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMY 123
Query: 405 YLHQNNIIHRDLKAANLLM 423
YL ++ ++HR+L A N+L+
Sbjct: 124 YLEEHRMVHRNLAARNILL 142
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 43/142 (30%), Positives = 76/142 (53%), Gaps = 10/142 (7%)
Query: 291 PKHLKFGSKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQ---EVFIMRK 345
P + + G + G++G +Y +++A K ++ + + + KE + E+ +++
Sbjct: 1 PINWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKN 60
Query: 346 VRHKNVVQFIGACTK---PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 402
++H+ +VQ+ G C + +L I E+M GGSV D L K G K + +G
Sbjct: 61 LQHERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESVTRKYTRQILEG 118
Query: 403 MNYLHQNNIIHRDLKAANLLMD 424
M+YLH N I+HRD+K AN+L D
Sbjct: 119 MSYLHSNMIVHRDIKGANILRD 140
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 44/155 (28%), Positives = 76/155 (49%), Gaps = 12/155 (7%)
Query: 299 KVASGSYGDLY--RGTYCSQDVAIKVLKP---ERINSDMQKEFAQEVFIMRKVRHKNVVQ 353
++ GS+G +Y + + +KVLK +N + + QE ++ K+ H +V+
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 354 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQNN 410
F + + + CI+TE+ G + L +LK + + I + G++Y+HQ
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR 126
Query: 411 IIHRDLKAANLLMDENEVSLLLSLCLFTVSILFCG 445
I+HRDLKA N+ + N LL + F VS L G
Sbjct: 127 ILHRDLKAKNIFLKNN----LLKIGDFGVSRLLMG 157
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 45/159 (28%), Positives = 78/159 (49%), Gaps = 41/159 (25%)
Query: 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFA-----QEVFIMRK 345
+ K+ G++G++Y+ + VA+K +I +K+ +E+ I++K
Sbjct: 9 DYEILGKLGEGTFGEVYKARQIKTGRVVALK-----KILMHNEKDGFPITALREIKILKK 63
Query: 346 VRHKNVVQFI--------GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 397
++H NVV I + K S+ +VT +M H L G+ + PS V +
Sbjct: 64 LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD--------HDLSGLLENPS---VKL 112
Query: 398 DVSK----------GMNYLHQNNIIHRDLKAANLLMDEN 426
S+ G+NYLH+N+I+HRD+KAAN+L+D
Sbjct: 113 TESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQ 151
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 35/131 (26%), Positives = 71/131 (54%), Gaps = 3/131 (2%)
Query: 299 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
K+ GS+G +Y + S+ IK + ++ ++ +EV ++ K++H N+V F
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
+ + L IV E+ GG + +++ +GV F +L + +S G+ ++H I+HRD
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRD 126
Query: 416 LKAANLLMDEN 426
+K+ N+ + +N
Sbjct: 127 IKSQNIFLSKN 137
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 41/150 (27%), Positives = 72/150 (48%), Gaps = 11/150 (7%)
Query: 276 HLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQ 333
H++ D +VWEI ++ G++G +Y+ A KV+ E + +
Sbjct: 3 HVRRDLDPNEVWEII-------GELGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEEL 53
Query: 334 KEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLL 393
+++ E+ I+ H +V+ +GA L I+ EF GG+V + +L P +
Sbjct: 54 EDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ 113
Query: 394 KVAIDVSKGMNYLHQNNIIHRDLKAANLLM 423
+ + + + YLH IIHRDLKA N+L+
Sbjct: 114 VICRQMLEALQYLHSMKIIHRDLKAGNVLL 143
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 40/143 (27%), Positives = 73/143 (51%), Gaps = 15/143 (10%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERI----NSDMQKEFAQEV 340
+ WEI ++ G++G +Y+ +Q+ VL ++ + + +++ E+
Sbjct: 5 EFWEII-------GELGDGAFGKVYK----AQNKETGVLAAAKVIDTKSEEELEDYMVEI 53
Query: 341 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS 400
I+ H N+V+ + A +L I+ EF +GG+V + +L+ P + V
Sbjct: 54 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTL 113
Query: 401 KGMNYLHQNNIIHRDLKAANLLM 423
+ +NYLH+N IIHRDLKA N+L
Sbjct: 114 EALNYLHENKIIHRDLKAGNILF 136
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 34/158 (21%), Positives = 75/158 (47%), Gaps = 23/158 (14%)
Query: 288 EIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEV 340
EI+ ++F ++ +G +Y+G +Q VAIK LK ++ +++EF E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK-DKAEGPLREEFKHEA 59
Query: 341 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------------HKLKG 385
+ +++H N+V +G TK L ++ + S ++++L +K
Sbjct: 60 MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119
Query: 386 VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 423
+ + + ++ GM +L ++++H+DL N+L+
Sbjct: 120 TLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV 157
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 6e-11
Identities = 38/120 (31%), Positives = 57/120 (47%), Gaps = 8/120 (6%)
Query: 309 YRGTYCSQDVAIKVLKPERINSDMQKE---FAQEVF-IMRKVRHKNVVQFIGACTKPPSL 364
Y+ T + AIK LK I + + E + +F RH +V +
Sbjct: 20 YKKT--GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHV 77
Query: 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD 424
C V E+ +GG + ++H VF P + A V G+ YLH+N I++RDLK NLL+D
Sbjct: 78 CFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLD 135
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 8e-11
Identities = 42/150 (28%), Positives = 75/150 (50%), Gaps = 18/150 (12%)
Query: 303 GSYGDLY----RGTYCSQD---VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI 355
G +G+++ +G V +K L+ + + ++Q EF +E+ + RK+ HKNVV+ +
Sbjct: 16 GEFGEVFLAKAKGIEEEGGETLVLVKALQ-KTKDENLQSEFRRELDMFRKLSHKNVVRLL 74
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKG---VFKLPSL-----LKVAIDVSKGMNYLH 407
G C + ++ E+ G + +L K K P L + + ++ GM++L
Sbjct: 75 GLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS 134
Query: 408 QNNIIHRDLKAAN-LLMDENEVSL-LLSLC 435
+HRDL A N L+ + EV + LLSL
Sbjct: 135 NARFVHRDLAARNCLVSSQREVKVSLLSLS 164
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 9e-11
Identities = 51/157 (32%), Positives = 75/157 (47%), Gaps = 29/157 (18%)
Query: 282 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---VAIKVLKPERINSDMQKEFAQ 338
D TD WEI + G+YG +Y+ T +D A+K+L P SD+ +E
Sbjct: 19 DPTDTWEII-------ETIGKGTYGKVYKVTN-KKDGSLAAVKILDPI---SDVDEEIEA 67
Query: 339 EVFIMRKV-RHKNVVQFIGACTKPP-----SLCIVTEFMSGGSVYDYLHKLKGVFKLPSL 392
E I++ + H NVV+F G K L +V E +GGSV + + KG+
Sbjct: 68 EYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV---KGLLICGQR 124
Query: 393 LKVAI------DVSKGMNYLHQNNIIHRDLKAANLLM 423
L A+ G+ +LH N IIHRD+K N+L+
Sbjct: 125 LDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILL 161
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 38/112 (33%), Positives = 65/112 (58%), Gaps = 5/112 (4%)
Query: 330 SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKL 389
S ++K+ +E+ IM + R +V F GA ++C+ EFM GS+ D ++K G +
Sbjct: 44 SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPV 102
Query: 390 PSLLKVAIDVSKGMNYLH-QNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440
L K+A+ V +G+ YL+ + I+HRD+K +N+L++ + LC F VS
Sbjct: 103 EILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG---QIKLCDFGVS 151
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 48/180 (26%), Positives = 84/180 (46%), Gaps = 27/180 (15%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQE 339
WE+ + + ++ GS+G +Y G VAIK + E + + EF E
Sbjct: 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVN-EAASMRERIEFLNE 59
Query: 340 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG------VFKLPSL- 392
+M++ +VV+ +G ++ ++ E M+ G + YL L+ V PSL
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLK 119
Query: 393 --LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSILFCGKGREL 450
+++A +++ GM YL+ N +HRDL A N ++ E+ FTV I G R++
Sbjct: 120 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED----------FTVKIGDFGMTRDI 169
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 35/125 (28%), Positives = 62/125 (49%), Gaps = 16/125 (12%)
Query: 318 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
VA+K LK + +++F +E ++ ++H+++V+F G CT+ L +V E+M G +
Sbjct: 38 VAVKALK--EASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLN 95
Query: 378 DYL-------HKLK-------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 423
+L L G L +L +A ++ GM YL + +HRDL N L+
Sbjct: 96 RFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV 155
Query: 424 DENEV 428
+ V
Sbjct: 156 GQGLV 160
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 40/162 (24%), Positives = 74/162 (45%), Gaps = 31/162 (19%)
Query: 294 LKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV 346
L G + G +G + + T VA+K+LK E +S ++ E ++++V
Sbjct: 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLK-ENASSSELRDLLSEFNLLKQV 60
Query: 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-------------------- 386
H +V++ GAC++ L ++ E+ GS+ +L + + V
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 387 ---FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE 425
+ L+ A +S+GM YL + ++HRDL A N+L+ E
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAE 162
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 39/139 (28%), Positives = 74/139 (53%), Gaps = 11/139 (7%)
Query: 290 DP--KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFA-QEVFIMR 344
DP K+ +F K+ G+ G +Y + Q+VAIK + + +KE E+ +MR
Sbjct: 16 DPKKKYTRF-EKIGQGASGTVYTAIDVATGQEVAIKQMN---LQQQPKKELIINEILVMR 71
Query: 345 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 404
+ +H N+V ++ + L +V E+++GGS+ D + + + V + + +
Sbjct: 72 ENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALE 129
Query: 405 YLHQNNIIHRDLKAANLLM 423
+LH N +IHRD+K+ N+L+
Sbjct: 130 FLHSNQVIHRDIKSDNILL 148
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 3e-10
Identities = 41/123 (33%), Positives = 64/123 (52%), Gaps = 9/123 (7%)
Query: 318 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
+A+KV+ P I ++QK+ E+ I+ K ++ F GA + I TEFM GGS+
Sbjct: 29 LAVKVI-PLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLD 87
Query: 378 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLF 437
Y L ++A+ V KG+ YL I+HRD+K +N+L++ + LC F
Sbjct: 88 VY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRG---QVKLCDF 139
Query: 438 TVS 440
VS
Sbjct: 140 GVS 142
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (149), Expect = 3e-10
Identities = 41/138 (29%), Positives = 70/138 (50%), Gaps = 8/138 (5%)
Query: 294 LKFGSKVASGSYGD----LYRGTYCSQDVAIKVLKPERINSDMQKE-FAQEVFIMRKVRH 348
+F + +GS+G ++G+ + A+K+L +I Q E E I++ +RH
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSG--KYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 349 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
+V G+ +L +V E++ GG ++ +L K G F P A V + YLH
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK-SGRFPEPVARFYAAQVVLALEYLHS 119
Query: 409 NNIIHRDLKAANLLMDEN 426
+I++RDLK NLL+D +
Sbjct: 120 LDIVYRDLKPENLLLDSD 137
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-10
Identities = 38/135 (28%), Positives = 58/135 (42%), Gaps = 13/135 (9%)
Query: 300 VASGSYGDLY------RGTYCSQDVAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHK-NV 351
++ G++G +Y G Y AIKVLK + + Q E IM V
Sbjct: 4 ISKGAFGSVYLAKKRSTGDY----FAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYV 59
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
+ + L +V E+++GG + L G + +V G+ LHQ I
Sbjct: 60 AKLYYSFQSKDYLYLVMEYLNGGDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRGI 118
Query: 412 IHRDLKAANLLMDEN 426
IHRD+K NLL+D+
Sbjct: 119 IHRDIKPENLLIDQT 133
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 34/136 (25%), Positives = 62/136 (45%), Gaps = 7/136 (5%)
Query: 295 KFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 354
G L + + VA+K + + + + K QE+ R+++H N++ +
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LPSLLKVAI--DVSKGMNYLHQNN 410
+ + L +V+ M+ GS D LK F LP L I DV ++Y+H
Sbjct: 65 VTSFIVDSELYVVSPLMAYGSCEDL---LKTHFPEGLPELAIAFILKDVLNALDYIHSKG 121
Query: 411 IIHRDLKAANLLMDEN 426
IHR +KA+++L+ +
Sbjct: 122 FIHRSVKASHILLSGD 137
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 4e-10
Identities = 31/129 (24%), Positives = 68/129 (52%), Gaps = 3/129 (2%)
Query: 298 SKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI 355
K+ GS+G L + + IK + +++ ++E +EV ++ ++H N+VQ+
Sbjct: 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKGMNYLHQNNIIHR 414
+ + +L IV ++ GG +Y ++ +GV F +L + + + ++H I+HR
Sbjct: 66 ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHR 125
Query: 415 DLKAANLLM 423
D+K+ N+ +
Sbjct: 126 DIKSQNIFL 134
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 41/137 (29%), Positives = 72/137 (52%), Gaps = 16/137 (11%)
Query: 294 LKFGSKVASGSYGDLY----RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 349
L+ +++ SG+ G +Y R T + A+KV+ ++++ +E+ I+R V H
Sbjct: 76 LERVNRIGSGAGGTVYKVIHRPT--GRLYALKVIYGNH-EDTVRRQICREIEILRDVNHP 132
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG--VFKLPSLLKVAIDVSKGMNYLH 407
NVV+ + ++ EFM GGS L+G + L VA + G+ YLH
Sbjct: 133 NVVKCHDMFDHNGEIQVLLEFMDGGS-------LEGTHIADEQFLADVARQILSGIAYLH 185
Query: 408 QNNIIHRDLKAANLLMD 424
+ +I+HRD+K +NLL++
Sbjct: 186 RRHIVHRDIKPSNLLIN 202
|
Length = 353 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 9e-10
Identities = 35/124 (28%), Positives = 61/124 (49%), Gaps = 17/124 (13%)
Query: 318 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
VA+K LK + + +K+F +E ++ ++H+++V+F G C L +V E+M G +
Sbjct: 38 VAVKALKDPTLAA--RKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLN 95
Query: 378 DYLH---------------KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 422
+L + KG L +L +A ++ GM YL + +HRDL N L
Sbjct: 96 KFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCL 155
Query: 423 MDEN 426
+ N
Sbjct: 156 VGAN 159
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 33/140 (23%), Positives = 70/140 (50%), Gaps = 21/140 (15%)
Query: 303 GSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKE-FAQEVFIMRKVRHKNVVQFI 355
G++G ++ G ++V +K +K S++Q QE ++ + H+N++ +
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPIL 74
Query: 356 GACTK---PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS-------LLKVAIDVSKGMNY 405
C + PP + +M+ G++ +L + + L+ +AI ++ GM+Y
Sbjct: 75 HVCIEDGEPPFVLY--PYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSY 132
Query: 406 LHQNNIIHRDLKAANLLMDE 425
LH+ +IH+D+ A N ++DE
Sbjct: 133 LHKRGVIHKDIAARNCVIDE 152
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 46/156 (29%), Positives = 71/156 (45%), Gaps = 27/156 (17%)
Query: 282 DGTDVWEIDPKHLKFGSKVASGSYGDLYR--GTYCSQDVAIKVLKPERINSDMQKEFAQE 339
D +D WEI + G+YG +++ A+K+L P D+ +E E
Sbjct: 15 DPSDTWEII-------ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAE 64
Query: 340 VFIMRKVR-HKNVVQFIGACTKPP-----SLCIVTEFMSGGSVYDYLHKLKGVFKL---- 389
I++ + H NVV+F G K L +V E +GGSV D + KG K
Sbjct: 65 YNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV---KGFLKRGERM 121
Query: 390 --PSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 423
P + + + G+ +LH N IHRD+K N+L+
Sbjct: 122 EEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILL 157
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 40/122 (32%), Positives = 60/122 (49%), Gaps = 13/122 (10%)
Query: 274 PYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGT-------YCSQDVAIKVLKPE 326
P L P D WE+ +L G + SG++G + T + VA+K+LK
Sbjct: 23 PMQL--PYDSA--WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKST 78
Query: 327 RINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG 385
+S+ Q E+ IM + H N+V +GACTK + I+TE+ G + DYLH+ K
Sbjct: 79 ARSSEKQA-LMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKH 137
Query: 386 VF 387
F
Sbjct: 138 TF 139
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 37/132 (28%), Positives = 69/132 (52%), Gaps = 5/132 (3%)
Query: 299 KVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
K+ G+YG +Y+G Q VA+K ++ E + +E+ ++++++H N+V
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAI-DVSKGMNYLHQNNIIHR 414
+ L ++ EF+S + YL L KG + L+K + + +G+ + H ++HR
Sbjct: 67 VLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHR 125
Query: 415 DLKAANLLMDEN 426
DLK NLL+D
Sbjct: 126 DLKPQNLLIDNK 137
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 42/154 (27%), Positives = 81/154 (52%), Gaps = 7/154 (4%)
Query: 277 LKIPNDGTDVWEIDPKHLKFG-SKVASGSYGDLYRGT--YCSQDVAIKVLK--PERINSD 331
+K P ++ DP+ + G ++ GS+G +Y T + ++ VA+K + ++ N
Sbjct: 5 VKDPEIADLFYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEK 64
Query: 332 MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS 391
Q + +EV +++++H N +++ G K + +V E+ G S D L K +
Sbjct: 65 WQ-DIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLG-SASDLLEVHKKPLQEVE 122
Query: 392 LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE 425
+ + +G+ YLH +N+IHRD+KA N+L+ E
Sbjct: 123 IAAITHGALQGLAYLHSHNMIHRDIKAGNILLTE 156
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 27/106 (25%), Positives = 56/106 (52%), Gaps = 4/106 (3%)
Query: 318 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
V +KVL + +S F + +M ++ HK++V+ G C + ++ +V E++ G +
Sbjct: 33 VVLKVLGSDHRDSL---AFFETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPLD 88
Query: 378 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 423
+LH+ K L L VA ++ ++YL ++H ++ N+L+
Sbjct: 89 VFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILV 134
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 34/148 (22%), Positives = 69/148 (46%), Gaps = 30/148 (20%)
Query: 295 KFGSKVASGSYGDLYRG----TYCSQDVAIKVLKPERINSD-MQKEFAQEVFIMRKVRHK 349
+ + G+YG +Y+ ++ AIK K ++ + + +E+ ++R+++H+
Sbjct: 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHE 62
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDY----------LHKLKGVFKLP-----SLLK 394
NVV + + + ++ ++DY H+ +P SLL
Sbjct: 63 NVVSLVEVFLEHADKSV---YL----LFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW 115
Query: 395 VAIDVSKGMNYLHQNNIIHRDLKAANLL 422
++ G++YLH N ++HRDLK AN+L
Sbjct: 116 QILN---GVHYLHSNWVLHRDLKPANIL 140
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 41/130 (31%), Positives = 70/130 (53%), Gaps = 4/130 (3%)
Query: 299 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHKNVVQFI 355
++ GS+G +Y R S+ VAIK + S+ + ++ +EV ++K+RH N +Q+
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
G + + +V E+ G S D L K + + V +G+ YLH +N+IHRD
Sbjct: 82 GCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140
Query: 416 LKAANLLMDE 425
+KA N+L+ E
Sbjct: 141 VKAGNILLSE 150
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 37/128 (28%), Positives = 62/128 (48%), Gaps = 9/128 (7%)
Query: 303 GSYGDL----YRGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKV-RHKNVVQFIG 356
GS+G + +GT + A+KVLK + I D E E ++ +H + Q
Sbjct: 6 GSFGKVLLAELKGT--DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHS 63
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
L V E+++GG + ++ + G F P A ++ G+ +LH+ II+RDL
Sbjct: 64 CFQTKDRLFFVMEYVNGGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERGIIYRDL 122
Query: 417 KAANLLMD 424
K N+L+D
Sbjct: 123 KLDNVLLD 130
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (141), Expect = 3e-09
Identities = 49/163 (30%), Positives = 75/163 (46%), Gaps = 34/163 (20%)
Query: 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQ----EVFIMRKV 346
+ + SG+YG + + VAIK K + D A+ E+ ++R +
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIK--KISNVFDD--LIDAKRILREIKLLRHL 56
Query: 347 RHKNVVQFIGACTKPPS------LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI--- 397
RH+N++ + +PPS + IVTE M D LHK V K P L
Sbjct: 57 RHENIIGLLDI-LRPPSPEDFNDVYIVTELMET----D-LHK---VIKSPQPLTDDHIQY 107
Query: 398 ---DVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLF 437
+ +G+ YLH N+IHRDLK +N+L++ N L +C F
Sbjct: 108 FLYQILRGLKYLHSANVIHRDLKPSNILVNSNCD---LKICDF 147
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 3e-09
Identities = 36/121 (29%), Positives = 61/121 (50%), Gaps = 14/121 (11%)
Query: 318 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
VA+K LK N+ +K+F +E ++ ++H+++V+F G C + L +V E+M G +
Sbjct: 38 VAVKTLKDASDNA--RKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLN 95
Query: 378 DYL--HKLKGV----------FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE 425
+L H V +L +A ++ GM YL + +HRDL N L+ E
Sbjct: 96 KFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE 155
Query: 426 N 426
N
Sbjct: 156 N 156
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 39/141 (27%), Positives = 72/141 (51%), Gaps = 5/141 (3%)
Query: 290 DPKHLKFG-SKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQ-KEFAQEVFIMRK 345
DP+ L ++ GS+G +Y R ++ VAIK + S+ + ++ +EV +++
Sbjct: 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQ 71
Query: 346 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 405
+RH N +++ G + + +V E+ G S D L K + + + +G+ Y
Sbjct: 72 LRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAY 130
Query: 406 LHQNNIIHRDLKAANLLMDEN 426
LH + IHRD+KA N+L+ E
Sbjct: 131 LHSHERIHRDIKAGNILLTEP 151
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 47/187 (25%), Positives = 83/187 (44%), Gaps = 41/187 (21%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKP-----ERINSDM 332
WE+ + + ++ GS+G +Y G ++D VA+K + ERI
Sbjct: 1 WEVSREKITLLRELGQGSFGMVYEGN--ARDIIKGEAETRVAVKTVNESASLRERI---- 54
Query: 333 QKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK---- 388
EF E +M+ +VV+ +G +K +V E M+ G + YL L+ +
Sbjct: 55 --EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 112
Query: 389 -----LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSILF 443
L ++++A +++ GM YL+ +HRDL A N ++ + FTV I
Sbjct: 113 RPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD----------FTVKIGD 162
Query: 444 CGKGREL 450
G R++
Sbjct: 163 FGMTRDI 169
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 5e-09
Identities = 34/145 (23%), Positives = 68/145 (46%), Gaps = 15/145 (10%)
Query: 295 KFGSKVASGSYGDLYR------GTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR- 347
K K+ G++ ++ + G Y AIK +K + S Q +E+ +R++
Sbjct: 2 KILGKIGEGTFSEVLKAQSRKTGKY----YAIKCMK-KHFKSLEQVNNLREIQALRRLSP 56
Query: 348 HKNVVQFIGAC--TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 405
H N+++ I K L +V E M ++Y+ + K + + K +++
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDH 115
Query: 406 LHQNNIIHRDLKAANLLMDENEVSL 430
+H+N I HRD+K N+L+ ++ + L
Sbjct: 116 MHRNGIFHRDIKPENILIKDDILKL 140
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 5e-09
Identities = 33/128 (25%), Positives = 69/128 (53%), Gaps = 8/128 (6%)
Query: 299 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFI 355
K+ G+ G ++ + Q+VAIK + + +KE E+ +M+++++ N+V F+
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQIN---LQKQPKKELIINEILVMKELKNPNIVNFL 82
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
+ L +V E+++GGS+ D + + + V + + + +LH N +IHRD
Sbjct: 83 DSFLVGDELFVVMEYLAGGSLTDVV--TETCMDEAQIAAVCRECLQALEFLHANQVIHRD 140
Query: 416 LKAANLLM 423
+K+ N+L+
Sbjct: 141 IKSDNVLL 148
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 6e-09
Identities = 38/139 (27%), Positives = 74/139 (53%), Gaps = 11/139 (7%)
Query: 290 DPK--HLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMR 344
DPK + +F K+ G+ G +Y Q+VAIK + + +KE E+ +MR
Sbjct: 16 DPKKKYTRF-EKIGQGASGTVYTAIDIATGQEVAIKQMN---LQQQPKKELIINEILVMR 71
Query: 345 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 404
+ ++ N+V ++ + L +V E+++GGS+ D + + + V + + ++
Sbjct: 72 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALD 129
Query: 405 YLHQNNIIHRDLKAANLLM 423
+LH N +IHRD+K+ N+L+
Sbjct: 130 FLHSNQVIHRDIKSDNILL 148
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 41/142 (28%), Positives = 72/142 (50%), Gaps = 29/142 (20%)
Query: 298 SKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQKE-FA----QEVFIMRKVRHKN 350
+++ G+YG +YR VA+K LK E+ +KE F +E+ I+ K++H N
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEK-----EKEGFPITSLREINILLKLQHPN 65
Query: 351 VVQF--IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK------LPSLLK-VAIDVSK 401
+V + + + +V E++ H LK + + L S +K + + +
Sbjct: 66 IVTVKEVVVGSNLDKIYMVMEYVE--------HDLKSLMETMKQPFLQSEVKCLMLQLLS 117
Query: 402 GMNYLHQNNIIHRDLKAANLLM 423
G+ +LH N I+HRDLK +NLL+
Sbjct: 118 GVAHLHDNWILHRDLKTSNLLL 139
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 1e-08
Identities = 36/136 (26%), Positives = 67/136 (49%), Gaps = 9/136 (6%)
Query: 299 KVASGSYGDLYRGT----YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 354
++ +G +G + G Y V +K L+ + Q +F +E R ++H N++Q
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQE-QMKFLEEAQPYRSLQHSNLLQC 60
Query: 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP----SLLKVAIDVSKGMNYLHQNN 410
+G CT+ +V EF G + YL + + +L ++A +++ G+ +LH+NN
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 411 IIHRDLKAANLLMDEN 426
IH DL N L+ +
Sbjct: 121 FIHSDLALRNCLLTAD 136
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 37/133 (27%), Positives = 65/133 (48%), Gaps = 7/133 (5%)
Query: 300 VASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 357
+ G +G++Y R + A+K L +RI + A IM + FI
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 358 CT----KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 413
T P LC + + M+GG ++ +L + GVF + A ++ G+ ++H +++
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNRFVVY 120
Query: 414 RDLKAANLLMDEN 426
RDLK AN+L+DE+
Sbjct: 121 RDLKPANILLDEH 133
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 35/131 (26%), Positives = 67/131 (51%), Gaps = 9/131 (6%)
Query: 299 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF-- 354
++ G+YG +YR T + VA+K ++ + + +E+ ++ +RH N+V+
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKE 73
Query: 355 IGACTKPPSLCIVTEFMSG--GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
+ S+ +V E+ S+ D + F + + + + +G+ YLH+N II
Sbjct: 74 VVVGKHLDSIFLVMEYCEQDLASLLD---NMPTPFSESQVKCLMLQLLRGLQYLHENFII 130
Query: 413 HRDLKAANLLM 423
HRDLK +NLL+
Sbjct: 131 HRDLKVSNLLL 141
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 1e-08
Identities = 42/154 (27%), Positives = 81/154 (52%), Gaps = 7/154 (4%)
Query: 277 LKIPNDGTDVWEIDPKHLKFGS--KVASGSYGDLY--RGTYCSQDVAIKVLK-PERINSD 331
LK P ++ DP+ L F ++ GS+G +Y R ++ VAIK + + +++
Sbjct: 9 LKDPEIAELFFKEDPEKL-FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNE 67
Query: 332 MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS 391
++ +EV +++++H N +++ G + + +V E+ G S D L K +
Sbjct: 68 KWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVE 126
Query: 392 LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE 425
+ + +G+ YLH +N+IHRD+KA N+L+ E
Sbjct: 127 IAAITHGALQGLAYLHSHNMIHRDIKAGNILLTE 160
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 41/122 (33%), Positives = 62/122 (50%), Gaps = 11/122 (9%)
Query: 277 LKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC----SQ---DVAIKVLKPERIN 329
+++P D WE L G + SG++G + GT SQ VA+K+LKP +
Sbjct: 24 MQLPYDSR--WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARS 81
Query: 330 SDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK 388
S+ Q E+ IM + H N+V +GACTK + I+TE+ G + +YLHK + F
Sbjct: 82 SEKQA-LMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFL 140
Query: 389 LP 390
Sbjct: 141 SR 142
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 1e-08
Identities = 37/139 (26%), Positives = 73/139 (52%), Gaps = 11/139 (7%)
Query: 290 DPK--HLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMR 344
DPK + +F K+ G+ G +Y Q+VAI+ + + +KE E+ +MR
Sbjct: 17 DPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMR 72
Query: 345 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 404
+ ++ N+V ++ + L +V E+++GGS+ D + + + V + + +
Sbjct: 73 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALE 130
Query: 405 YLHQNNIIHRDLKAANLLM 423
+LH N +IHRD+K+ N+L+
Sbjct: 131 FLHSNQVIHRDIKSDNILL 149
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (132), Expect = 3e-08
Identities = 35/131 (26%), Positives = 60/131 (45%), Gaps = 6/131 (4%)
Query: 300 VASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 356
+ G +G + S++ A+K +K I Q+E E I+ + H +V+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
+ ++ E+ GG ++ L +G+F + + +A V YLH II+RD
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRD-RGLFDEYTARFYIACVVL-AFEYLHNRGIIYRD 118
Query: 416 LKAANLLMDEN 426
LK NLL+D N
Sbjct: 119 LKPENLLLDSN 129
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 3e-08
Identities = 31/109 (28%), Positives = 55/109 (50%), Gaps = 2/109 (1%)
Query: 319 AIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A K L +R+ ++ A E I+ KV + +V A LC+V M+GG +
Sbjct: 22 ACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLK 81
Query: 378 DYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE 425
+++ + + F + A + G+ +LHQ I++RDLK N+L+D+
Sbjct: 82 YHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDD 130
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-08
Identities = 36/133 (27%), Positives = 64/133 (48%), Gaps = 4/133 (3%)
Query: 300 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 357
V GSYG+ L R + IK L + +K QE ++ +++H N+V + +
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 358 CTKPPS-LCIVTEFMSGGSVYDYLHKLKGVFKLPS-LLKVAIDVSKGMNYLHQNNIIHRD 415
L IV F GG +Y L + KG + +++ + ++ + YLH+ +I+HRD
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRD 127
Query: 416 LKAANLLMDENEV 428
LK N+ + +
Sbjct: 128 LKTQNVFLTRTNI 140
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 36/132 (27%), Positives = 67/132 (50%), Gaps = 16/132 (12%)
Query: 299 KVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKE-----FAQEVFIMRKVRHKNV 351
K+ GS G + R + + VA+K++ D++K+ EV IMR +H+NV
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMM-------DLRKQQRRELLFNEVVIMRDYQHQNV 80
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
V+ + L ++ EF+ GG++ D + + + + V V + + YLH +
Sbjct: 81 VEMYKSYLVGEELWVLMEFLQGGALTDIVSQTR--LNEEQIATVCESVLQALCYLHSQGV 138
Query: 412 IHRDLKAANLLM 423
IHRD+K+ ++L+
Sbjct: 139 IHRDIKSDSILL 150
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 35/133 (26%), Positives = 64/133 (48%), Gaps = 7/133 (5%)
Query: 300 VASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 357
+ G +G++Y R + A+K L +RI + A IM + FI
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 358 CT----KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 413
+ P L + + M+GG ++ +L + GVF + A ++ G+ ++H +++
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120
Query: 414 RDLKAANLLMDEN 426
RDLK AN+L+DE+
Sbjct: 121 RDLKPANILLDEH 133
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 5e-08
Identities = 30/106 (28%), Positives = 56/106 (52%), Gaps = 2/106 (1%)
Query: 318 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
V +KVL P + D+ F + +MR+V HK++V G C + +V EF+ G +
Sbjct: 35 VILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD 92
Query: 378 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 423
++H+ V P KVA ++ ++YL +++H ++ N+L+
Sbjct: 93 LFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILL 138
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 5e-08
Identities = 42/144 (29%), Positives = 69/144 (47%), Gaps = 24/144 (16%)
Query: 294 LKFGSKVASGSYGDL----YRGTYCSQDVAIKVLKPERINSDMQKE-FAQEVFIMRKVRH 348
+ G + +GS+G + ++GT + AIK LK I Q + AQE I+ ++ H
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGT--GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSH 77
Query: 349 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK------- 401
+V + + + + EF+ GG ++ +L K + P+ DV+K
Sbjct: 78 PFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAG---RFPN------DVAKFYHAELV 128
Query: 402 -GMNYLHQNNIIHRDLKAANLLMD 424
YLH +II+RDLK NLL+D
Sbjct: 129 LAFEYLHSKDIIYRDLKPENLLLD 152
|
Length = 329 |
| >gnl|CDD|235342 PRK05092, PRK05092, PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 5e-08
Identities = 24/73 (32%), Positives = 34/73 (46%), Gaps = 7/73 (9%)
Query: 181 EITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV---DGWPYEETEQL 237
E+T D P L S++ A G NI +A F+T DG +LD F + G +E +L
Sbjct: 734 EVTVLAADHPGLFSRIAGACAAAGANIVDARIFTTTDGRALDTFWIQDAFGRDEDEPRRL 793
Query: 238 ---RAALEKEVLK 247
A+E L
Sbjct: 794 ARLAKAIED-ALS 805
|
Length = 931 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 5e-08
Identities = 26/85 (30%), Positives = 47/85 (55%), Gaps = 2/85 (2%)
Query: 339 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 398
EV IMR +H N+V+ + L +V EF+ GG++ D + + + V +
Sbjct: 66 EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLA 123
Query: 399 VSKGMNYLHQNNIIHRDLKAANLLM 423
V K +++LH +IHRD+K+ ++L+
Sbjct: 124 VLKALSFLHAQGVIHRDIKSDSILL 148
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 6e-08
Identities = 23/87 (26%), Positives = 41/87 (47%), Gaps = 1/87 (1%)
Query: 339 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 398
E +++ V H +V++ C+V S +Y YL K + L +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQ 165
Query: 399 VSKGMNYLHQNNIIHRDLKAANLLMDE 425
+ +G+ YLH IIHRD+K N+ +++
Sbjct: 166 ILEGLRYLHAQRIIHRDVKTENIFIND 192
|
Length = 357 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 7e-08
Identities = 44/145 (30%), Positives = 68/145 (46%), Gaps = 11/145 (7%)
Query: 303 GSYGDLYRGTYCSQDVAIKVLKPERINSDM--QKEFAQEV-FIMRKVRHKNVVQFIGACT 359
G++G + + + + V K R D QK ++ +MR +V+F GA
Sbjct: 15 GAFGTVNKMLHKPSGTIMAV-KRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALF 73
Query: 360 KPPSLCIVTEFM--SGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRD 415
+ I E M S Y Y++ LK V L K+A+ K +NYL + IIHRD
Sbjct: 74 REGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRD 133
Query: 416 LKAANLLMDENEVSLLLSLCLFTVS 440
+K +N+L+D N + LC F +S
Sbjct: 134 VKPSNILLDRNGN---IKLCDFGIS 155
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 7e-08
Identities = 27/132 (20%), Positives = 68/132 (51%), Gaps = 6/132 (4%)
Query: 298 SKVASGSYGDLYRG--TYCSQDVAIKVLKP-ERINSDMQKEFAQEVFIMRKVRHKNVVQF 354
K+ G + +Y+ + VA+K ++ E +++ +++ +E+ +++++ H NV+++
Sbjct: 8 KKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKY 67
Query: 355 IGACTKPPSLCIVTEFMSGGSV---YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
+ + + L IV E G + + K K + ++ K + + + ++H I
Sbjct: 68 LASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRI 127
Query: 412 IHRDLKAANLLM 423
+HRD+K AN+ +
Sbjct: 128 MHRDIKPANVFI 139
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 7e-08
Identities = 38/158 (24%), Positives = 73/158 (46%), Gaps = 9/158 (5%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRK 345
+ D L+ ++ SG+ G +Y+ + + V + R N + K ++ ++ K
Sbjct: 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLK 69
Query: 346 VRH-KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHK-LKGVFKLPSLLKVAIDVSKGM 403
+V+ G + I E MS + D L K ++G L K+ + + K +
Sbjct: 70 SHDCPYIVKCYGYFITDSDVFICMELMS--TCLDKLLKRIQGPIPEDILGKMTVAIVKAL 127
Query: 404 NYLHQN-NIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440
+YL + +IHRD+K +N+L+D + + LC F +S
Sbjct: 128 HYLKEKHGVIHRDVKPSNILLDASGN---VKLCDFGIS 162
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 7e-08
Identities = 36/128 (28%), Positives = 64/128 (50%), Gaps = 8/128 (6%)
Query: 299 KVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFI 355
K+ GS G + T + + VA+K + + ++E EV IMR H+NVV
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMD---LRKQQRRELLFNEVVIMRDYHHENVVDMY 85
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
+ L +V EF+ GG++ D + + + V + V + ++YLH +IHRD
Sbjct: 86 NSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRALSYLHNQGVIHRD 143
Query: 416 LKAANLLM 423
+K+ ++L+
Sbjct: 144 IKSDSILL 151
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 8e-08
Identities = 38/135 (28%), Positives = 66/135 (48%), Gaps = 3/135 (2%)
Query: 290 DPK-HLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH 348
DP+ +L K+ GS G + T S + V K + ++ EV IMR +H
Sbjct: 17 DPRTYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH 76
Query: 349 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
+NVV+ + L +V EF+ GG++ D + + + V + V K ++ LH
Sbjct: 77 ENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLKALSVLHA 134
Query: 409 NNIIHRDLKAANLLM 423
+IHRD+K+ ++L+
Sbjct: 135 QGVIHRDIKSDSILL 149
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 8e-08
Identities = 41/144 (28%), Positives = 67/144 (46%), Gaps = 10/144 (6%)
Query: 303 GSYGDLYRGTYCSQDVAIKVLK-PERINSDMQKEFAQEVFI-MRKVRHKNVVQFIGACTK 360
G+YG + + + + V + +NS QK ++ I MR V V F GA +
Sbjct: 12 GAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR 71
Query: 361 PPSLCIVTEFMSGGSVYD-YLHKLKGVFKLPS--LLKVAIDVSKGMNYLHQN-NIIHRDL 416
+ I E M S+ Y +P L K+A+ + K + YLH ++IHRD+
Sbjct: 72 EGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDV 130
Query: 417 KAANLLMDENEVSLLLSLCLFTVS 440
K +N+L++ N + LC F +S
Sbjct: 131 KPSNVLINRNGQ---VKLCDFGIS 151
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 45/155 (29%), Positives = 77/155 (49%), Gaps = 15/155 (9%)
Query: 294 LKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQ---EVFIMRKVRHKN 350
++ ++ G+YG +Y+ + V +K R+ D K F Q E+ I+ K
Sbjct: 3 IEVLDELGKGNYGSVYKVLHRPTGV-TMAMKEIRLELDESK-FNQIIMELDILHKAVSPY 60
Query: 351 VVQFIGACTKPPSLCIVTEFMSGGSV---YDYLHKLKGVFKLPSLLKVAIDVSKGMNYL- 406
+V F GA ++ + E+M GS+ Y +G+ + L ++ V KG+ +L
Sbjct: 61 IVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPE-DVLRRITYAVVKGLKFLK 119
Query: 407 HQNNIIHRDLKAANLLMDEN-EVSLLLSLCLFTVS 440
++NIIHRD+K N+L++ N +V LC F VS
Sbjct: 120 EEHNIIHRDVKPTNVLVNGNGQV----KLCDFGVS 150
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 1e-07
Identities = 30/141 (21%), Positives = 62/141 (43%), Gaps = 12/141 (8%)
Query: 299 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
+ GS+G + + S + + K + + +++ EV I+R+++H N+V++
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 357 ACTKPPS--LCIVTEFMSGG---SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH---- 407
+ L IV E+ GG + K + + + ++ + + H
Sbjct: 67 RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSD 126
Query: 408 -QNNIIHRDLKAANLLMDENE 427
N ++HRDLK AN+ +D N
Sbjct: 127 PGNTVLHRDLKPANIFLDANN 147
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 33/131 (25%), Positives = 65/131 (49%), Gaps = 5/131 (3%)
Query: 299 KVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQ--KEFA-QEVFIMRKVRHKNVVQFI 355
K+ G+YG +++ + I LK R++ D + A +E+ ++++++HKN+V+
Sbjct: 7 KIGEGTYGTVFKAKN-RETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLY 65
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
L +V E+ + Y G + + KG+ + H +N++HRD
Sbjct: 66 DVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRD 124
Query: 416 LKAANLLMDEN 426
LK NLL+++N
Sbjct: 125 LKPQNLLINKN 135
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 41/142 (28%), Positives = 78/142 (54%), Gaps = 10/142 (7%)
Query: 300 VASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 357
V G+YG + R + VAIK K N ++++ +E+ ++R ++ +N+V+ A
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 358 CTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAI-DVSKGMNYLHQNNIIHRD 415
+ L +V E++ ++ + L ++ GV P ++ I + K +++ H+N+I+HRD
Sbjct: 69 FRRRGKLYLVFEYVEK-NMLELLEEMPNGV--PPEKVRSYIYQLIKAIHWCHKNDIVHRD 125
Query: 416 LKAANLLMDENEVSLLLSLCLF 437
+K NLL+ N+V L LC F
Sbjct: 126 IKPENLLISHNDV---LKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 30/106 (28%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGT---YCSQD----VAIKVLKPERINSDMQKEFA 337
+ WE +L+FG + +G++G + T +D VA+K+LK ++D ++
Sbjct: 31 EKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKA-SAHTDEREALM 89
Query: 338 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHK 382
E+ I+ + +HKN+V +GACT + ++TE+ G + ++L K
Sbjct: 90 SELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRK 135
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 34/110 (30%), Positives = 56/110 (50%), Gaps = 2/110 (1%)
Query: 319 AIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV- 376
A K L+ +RI + A E I+ KV + VV A +LC+V M+GG +
Sbjct: 29 ACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK 88
Query: 377 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
+ H + F+ + A ++ G+ LHQ I++RDLK N+L+D++
Sbjct: 89 FHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDH 138
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 35/157 (22%), Positives = 73/157 (46%), Gaps = 28/157 (17%)
Query: 288 EIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFA-------- 337
I ++++ G+ + G+YG + + T + VAIK +K I++D+ K+
Sbjct: 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIH 64
Query: 338 ----QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLL 393
+E+ IM +++H+N++ + + + +V + M+ LK V L
Sbjct: 65 FTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS--------DLKKVVDRKIRL 116
Query: 394 KVA------IDVSKGMNYLHQNNIIHRDLKAANLLMD 424
+ + + G+N LH+ +HRDL AN+ ++
Sbjct: 117 TESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFIN 153
|
Length = 335 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 33/109 (30%), Positives = 56/109 (51%), Gaps = 2/109 (1%)
Query: 319 AIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A K L+ +RI + A E I+ KV + VV A +LC+V M+GG +
Sbjct: 29 ACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLK 88
Query: 378 DYLHKLKGV-FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE 425
+++ + F+ L A ++ G+ LH+ N ++RDLK N+L+D+
Sbjct: 89 FHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDD 137
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 37/127 (29%), Positives = 67/127 (52%), Gaps = 4/127 (3%)
Query: 300 VASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
++ G++G +Y R S+ A+KV+ K + IN +M + E + + +V
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
+ ++ +V E++ GG V LH + G F +K +V+ ++YLH++ IIHRDL
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLH-IYGYFDEEMAVKYISEVALALDYLHRHGIIHRDL 130
Query: 417 KAANLLM 423
K N+L+
Sbjct: 131 KPDNMLI 137
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 40/145 (27%), Positives = 73/145 (50%), Gaps = 12/145 (8%)
Query: 298 SKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI 355
SK+ GSYG ++ R Q VAIK + ++K +E+ ++++++H N+V I
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLL--KVAIDVSKGMNYLHQNNII 412
+ L +V E+ + L++L K +P L K+ + +N+ H++N I
Sbjct: 67 EVFRRKRKLHLVFEYCD----HTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCI 122
Query: 413 HRDLKAANLLMDENEVSLLLSLCLF 437
HRD+K N+L+ + + LC F
Sbjct: 123 HRDVKPENILITKQGQ---IKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 3e-07
Identities = 32/130 (24%), Positives = 69/130 (53%), Gaps = 4/130 (3%)
Query: 300 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 357
V GS+G L + Q A+K ++ + +S ++ +E ++ K++H N+V F +
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDS-RKEAVLLAKMKHPNIVAFKES 66
Query: 358 CTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
L IV E+ GG + + +G +F ++L+ + + G+ ++H+ ++HRD+
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDI 126
Query: 417 KAANLLMDEN 426
K+ N+ + +N
Sbjct: 127 KSKNIFLTQN 136
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 30/132 (22%), Positives = 71/132 (53%), Gaps = 8/132 (6%)
Query: 299 KVASGSYGDLYRGTYC---SQDVAIKVLKP-ERINSDMQKEFAQEVFIMRKVRHKNVVQF 354
K+ G + ++YR T C + VA+K ++ E +++ +++ +E+ +++++ H NV+++
Sbjct: 9 KIGRGQFSEVYRAT-CLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKY 67
Query: 355 IGACTKPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
+ + + L IV E G + Y K K + ++ K + + + ++H +
Sbjct: 68 LDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRV 127
Query: 412 IHRDLKAANLLM 423
+HRD+K AN+ +
Sbjct: 128 MHRDIKPANVFI 139
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 34/129 (26%), Positives = 65/129 (50%), Gaps = 5/129 (3%)
Query: 300 VASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQKE--FAQEVFIMRKVRHKNVVQFI 355
+ GS+G + S A+KVL+ + I ++ A+ +++ ++H +V
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
+ L V ++++GG ++ +L + + F P A +V+ + YLH NII+RD
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRER-CFLEPRARFYAAEVASAIGYLHSLNIIYRD 121
Query: 416 LKAANLLMD 424
LK N+L+D
Sbjct: 122 LKPENILLD 130
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 34/129 (26%), Positives = 66/129 (51%), Gaps = 4/129 (3%)
Query: 299 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
K+ G+YG +Y R + VA+K ++ E + + +E+ +++++ H N+V+ +
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI-DVSKGMNYLHQNNIIHRD 415
L +V EF+ + Y+ P L+K + + +G+ Y H + ++HRD
Sbjct: 66 VVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRD 124
Query: 416 LKAANLLMD 424
LK NLL+D
Sbjct: 125 LKPQNLLID 133
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 50/158 (31%), Positives = 79/158 (50%), Gaps = 17/158 (10%)
Query: 303 GSYGDLYR-----GTYCSQDVAIKVLKPERINSDMQKEFAQ---EVFIMRKVRHKNVVQF 354
G YG +++ G + A+KVLK I + QK+ A E I+ V+H +V
Sbjct: 7 GGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRN-QKDTAHTKAERNILEAVKHPFIVDL 65
Query: 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 414
I A L ++ E++SGG ++ +L + +G+F + ++S + +LHQ II+R
Sbjct: 66 IYAFQTGGKLYLILEYLSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQGIIYR 124
Query: 415 DLKAANLLMDEN-EVSLL-LSLC-----LFTVSILFCG 445
DLK N+L+D V L LC TV+ FCG
Sbjct: 125 DLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCG 162
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 5e-07
Identities = 33/138 (23%), Positives = 73/138 (52%), Gaps = 4/138 (2%)
Query: 299 KVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
K+ G+YG +Y+ ++ +A+K ++ E+ + + +E+ ++++++H N+V+
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI-DVSKGMNYLHQNNIIHRD 415
L +V E++ + ++ K P L+K + + +G+ Y H + ++HRD
Sbjct: 69 VVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRD 127
Query: 416 LKAANLLMDENEVSLLLS 433
LK NLL+D +L L+
Sbjct: 128 LKPQNLLIDRRTNALKLA 145
|
Length = 294 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 5e-07
Identities = 32/109 (29%), Positives = 56/109 (51%), Gaps = 2/109 (1%)
Query: 319 AIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A K L+ +RI + A E I+ KV + VV A +LC+V M+GG +
Sbjct: 29 ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK 88
Query: 378 DYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE 425
+++ + F + A +++ G+ LH+ I++RDLK N+L+D+
Sbjct: 89 FHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDD 137
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.0 bits (123), Expect = 5e-07
Identities = 40/146 (27%), Positives = 69/146 (47%), Gaps = 22/146 (15%)
Query: 295 KFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFA--------QEVFIMR 344
K ++ G++G +Y + VAIK +K K+F +EV +R
Sbjct: 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMK---------KKFYSWEECMNLREVKSLR 52
Query: 345 KV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI-DVSKG 402
K+ H N+V+ + L V E+M G ++Y + KG S+++ I + +G
Sbjct: 53 KLNEHPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQG 111
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEV 428
+ ++H++ HRDLK NLL+ EV
Sbjct: 112 LAHIHKHGFFHRDLKPENLLVSGPEV 137
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 34/130 (26%), Positives = 63/130 (48%), Gaps = 4/130 (3%)
Query: 300 VASGSYGD--LYRGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
+ G++G L R + A+K+LK E I D E +++ RH +
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
+ LC V E+++GG ++ +L + + VF ++ ++YLH I++RDL
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLSRER-VFSEDRTRFYGAEIVSALDYLHSGKIVYRDL 121
Query: 417 KAANLLMDEN 426
K NL++D++
Sbjct: 122 KLENLMLDKD 131
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 6e-07
Identities = 30/111 (27%), Positives = 57/111 (51%), Gaps = 6/111 (5%)
Query: 319 AIKVLKPERINSDMQKEFAQ---EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 375
A+K+LK E I + + E A E +++ RH + + LC V E+ +GG
Sbjct: 24 AMKILKKEVIIA--KDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81
Query: 376 VYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
++ +L + + VF ++ + YLH ++++RDLK NL++D++
Sbjct: 82 LFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKD 131
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 7e-07
Identities = 32/131 (24%), Positives = 67/131 (51%), Gaps = 8/131 (6%)
Query: 299 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSD--MQKEFAQEVFIMRKVRHKNVVQF 354
K+ G+Y +Y+G + VA+K + ++++ +E+ +M++++H+N+V+
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEI---HLDAEEGTPSTAIREISLMKELKHENIVRL 63
Query: 355 IGACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 413
L +V E+M Y H ++G ++ + KG+ + H+N ++H
Sbjct: 64 HDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLH 123
Query: 414 RDLKAANLLMD 424
RDLK NLL++
Sbjct: 124 RDLKPQNLLIN 134
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 8e-07
Identities = 35/129 (27%), Positives = 66/129 (51%), Gaps = 5/129 (3%)
Query: 300 VASGSYGDLYRGTYCSQDV--AIKVLKPERI-NSDMQKE-FAQEVFIMRKVRHKNVVQFI 355
+ GS+G + + + A+KVL+ + I QK A+ +++ V+H +V
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
+ L V ++++GG ++ +L + + F P A +++ + YLH NII+RD
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERS-FPEPRARFYAAEIASALGYLHSLNIIYRD 121
Query: 416 LKAANLLMD 424
LK N+L+D
Sbjct: 122 LKPENILLD 130
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 9e-07
Identities = 36/117 (30%), Positives = 62/117 (52%), Gaps = 11/117 (9%)
Query: 328 INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF 387
I ++ + +E+ ++ + +V F GA + I E M GGS+ D + LK
Sbjct: 38 IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQV--LKKAG 94
Query: 388 KLPS--LLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDEN-EVSLLLSLCLFTVS 440
++P L K++I V +G+ YL + I+HRD+K +N+L++ E+ LC F VS
Sbjct: 95 RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEI----KLCDFGVS 147
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 32/109 (29%), Positives = 53/109 (48%), Gaps = 8/109 (7%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRG-------TYCSQDVAIKVLKPERINSDMQKEFAQE 339
WE LK G + G++G + T + VA+K+LK +S+ + ++
Sbjct: 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSEL 61
Query: 340 VFIMRKVRHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVF 387
++ H NVV +GACTKP L ++ EF G++ +YL +G F
Sbjct: 62 KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEF 110
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 35/126 (27%), Positives = 59/126 (46%), Gaps = 13/126 (10%)
Query: 308 LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367
L R T V +++ E + K EV + RH N++ T L ++
Sbjct: 18 LARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVI 77
Query: 368 TEFMSGGSVYDYLHKLKGVFK-------LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 420
+ FM+ GS LK F + ++L A+ +G+NYLHQN IHR++KA++
Sbjct: 78 SPFMAYGSAN---SLLKTYFPEGMSEALIGNILFGAL---RGLNYLHQNGYIHRNIKASH 131
Query: 421 LLMDEN 426
+L+ +
Sbjct: 132 ILISGD 137
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 30/144 (20%), Positives = 69/144 (47%), Gaps = 6/144 (4%)
Query: 299 KVASGSYGDLYRGTYCSQDVAIKVLKPE---RINSDMQKEFAQEVFIMRKVRHKNVVQFI 355
K+ G + ++YR T V + + K + +++ + + +E+ +++++ H NV+++
Sbjct: 9 KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 68
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKL---PSLLKVAIDVSKGMNYLHQNNII 412
+ + L IV E G + + K +L ++ K + + + ++H ++
Sbjct: 69 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVM 128
Query: 413 HRDLKAANLLMDENEVSLLLSLCL 436
HRD+K AN+ + V L L L
Sbjct: 129 HRDIKPANVFITATGVVKLGDLGL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 38/136 (27%), Positives = 68/136 (50%), Gaps = 10/136 (7%)
Query: 319 AIKVLKPERI-NSDMQKE-FAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376
A+KVL+ + + N QK A+ +++ V+H +V + L V +F++GG +
Sbjct: 24 AVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGEL 83
Query: 377 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLL--LSL 434
+ +L + + F P A +++ + YLH NI++RDLK N+L+D +L L
Sbjct: 84 FFHLQRER-SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGL 142
Query: 435 CLFTVSI-----LFCG 445
C ++ FCG
Sbjct: 143 CKEGIAQSDTTTTFCG 158
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 32/128 (25%), Positives = 64/128 (50%), Gaps = 4/128 (3%)
Query: 300 VASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIG 356
V +G++G ++ R A+KV+ + Q++ E ++++V H +++
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
L ++ E++ GG ++ YL + G F + L A ++ + YLH I++RDL
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYL-RNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDL 127
Query: 417 KAANLLMD 424
K N+L+D
Sbjct: 128 KPENILLD 135
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|153139 cd02116, ACT, ACT domains are commonly involved in specifically binding an amino acid or other small ligand leading to regulation of the enzyme | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 1e-06
Identities = 24/62 (38%), Positives = 38/62 (61%), Gaps = 3/62 (4%)
Query: 182 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVF-VVDGWPYEETEQLRAA 240
+T S D+P LL+++ ++LA+ G+NI ++ DG D+F VVDG + E+L A
Sbjct: 1 LTVSGPDRPGLLAKVLSVLAEAGINITSIEQRTSGDGGEADIFIVVDGD--GDLEKLLEA 58
Query: 241 LE 242
LE
Sbjct: 59 LE 60
|
Members of this CD belong to the superfamily of ACT regulatory domains. Pairs of ACT domains are commonly involved in specifically binding an amino acid or other small ligand leading to regulation of the enzyme. The ACT domain has been detected in a number of diverse proteins; some of these proteins are involved in amino acid and purine biosynthesis, phenylalanine hydroxylation, regulation of bacterial metabolism and transcription, and many remain to be characterized. ACT domain-containing enzymes involved in amino acid and purine synthesis are in many cases allosteric enzymes with complex regulation enforced by the binding of ligands. The ACT domain is commonly involved in the binding of a small regulatory molecule, such as the amino acids L-Ser and L-Phe in the case of D-3-phosphoglycerate dehydrogenase and the bifunctional chorismate mutase-prephenate dehydratase enzyme (P-protein), respectively. Aspartokinases typically consist of two C-terminal ACT domains in a tandem repeat, but the second ACT domain is inserted within the first, resulting in, what is normally the terminal beta strand of ACT2, formed from a region N-terminal of ACT1. ACT domain repeats have been shown to have nonequivalent ligand-binding sites with complex regulatory patterns such as those seen in the bifunctional enzyme, aspartokinase-homoserine dehydrogenase (ThrA). In other enzymes, such as phenylalanine hydroxylases, the ACT domain appears to function as a flexible small module providing allosteric regulation via transmission of conformational changes, these conformational changes are not necessarily initiated by regulatory ligand binding at the ACT domain itself. ACT domains are present either singularly, N- or C-terminal, or in pairs present C-terminal or between two catalytic domains. Unique to cyanobacteria are four ACT domains C-terminal to an aspartokinase domain. A few proteins are composed almost entirely of ACT domain repeats as seen in the four ACT domain protein, the ACR protein, found in higher plants; and the two ACT domain protein, the glycine cleavage system transcriptional repressor (GcvR) protein, found in some bacteria. Also seen are single ACT domain proteins similar to the Streptococcus pneumoniae ACT domain protein (uncharacterized pdb structure 1ZPV) found in both bacteria and archaea. Purportedly, the ACT domain is an evolutionarily mobile ligand binding regulatory module that has been fused to different enzymes at various times. Length = 60 |
| >gnl|CDD|225400 COG2844, GlnD, UTP:GlnB (protein PII) uridylyltransferase [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 30/107 (28%), Positives = 48/107 (44%), Gaps = 9/107 (8%)
Query: 169 VHANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV-- 226
V +V+ E+ D+P+L + + A L+ GL+I +A F+T DGY+LD F+V
Sbjct: 674 VLISVRPHSGGTEVFVYAPDRPRLFAVVCAALSRRGLSIVDAQIFTTRDGYALDTFIVLE 733
Query: 227 -DGWPYEETEQLR------AALEKEVLKLERQGWPSHRSSSPTSEPE 266
DG+P EE + AL + R+ + P
Sbjct: 734 PDGFPVEEDRRAALRGELIEALLSGKAQPPRRRRIPRKLRHFPIPPR 780
|
Length = 867 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 32/118 (27%), Positives = 62/118 (52%), Gaps = 5/118 (4%)
Query: 306 GDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365
++Y T ++ V +K LK +S Q EF Q+ R ++H N++Q +G C +
Sbjct: 14 SEIYTDTGVAR-VVVKELKAN-ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYL 71
Query: 366 IVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 420
+V E+ G + YL + + +L L ++A +++ G+ ++H++N +H DL N
Sbjct: 72 LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRN 129
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 38/151 (25%), Positives = 74/151 (49%), Gaps = 27/151 (17%)
Query: 293 HLKFGSKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKE-----FAQEVFIMRK 345
++ G+YG +Y R + VA+K ++ D +KE +E+ I+R+
Sbjct: 8 KFDIIGQIGEGTYGQVYKARDKDTGELVALK-----KVRLDNEKEGFPITAIREIKILRQ 62
Query: 346 VRHKNVVQFIGACT-KPPSLCIVTEFMSGGSVYDYL-HKLKGVFK----------LPSLL 393
+ H+N+V T K +L + + V++Y+ H L G+ + + S +
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFM 122
Query: 394 KVAIDVSKGMNYLHQNNIIHRDLKAANLLMD 424
K ++ G+NY H+ N +HRD+K +N+L++
Sbjct: 123 KQLLE---GLNYCHKKNFLHRDIKCSNILLN 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 31/129 (24%), Positives = 69/129 (53%), Gaps = 5/129 (3%)
Query: 300 VASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQKE--FAQEVFIMRKVRHKNVVQFI 355
+ GS+G + + +++ A+KVL+ + I +++ ++ +++ V+H +V
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
+ L V ++++GG ++ +L + + F P A +++ + YLH NI++RD
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLHSLNIVYRD 121
Query: 416 LKAANLLMD 424
LK N+L+D
Sbjct: 122 LKPENILLD 130
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 33/131 (25%), Positives = 67/131 (51%), Gaps = 7/131 (5%)
Query: 297 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
G + G YG+L++ +V +KVL ++ + + + F + +M ++ HK++V G
Sbjct: 14 GIRREVGDYGELHK-----TEVLLKVL--DKSHRNYSESFFEAASMMSQLSHKHLVLNYG 66
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
C +V E++ GS+ YL K K + + L+VA ++ +++L + H ++
Sbjct: 67 VCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNV 126
Query: 417 KAANLLMDENE 427
A N+L+ E
Sbjct: 127 CAKNVLLIREE 137
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 28/102 (27%), Positives = 49/102 (48%), Gaps = 10/102 (9%)
Query: 334 KEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLL 393
K +E+ I++ + H+ ++ I A ++C+V D + LP L
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK----CDLFTYVDRSGPLP--L 184
Query: 394 KVAIDVSKGM----NYLHQNNIIHRDLKAANLLMDENEVSLL 431
+ AI + + + YLH IIHRD+K N+ +DE E ++L
Sbjct: 185 EQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVL 226
|
Length = 392 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 22/91 (24%), Positives = 46/91 (50%), Gaps = 4/91 (4%)
Query: 341 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK---GVFKLPSLLKVAI 397
I ++RH N+V++ + L IV + + G + ++ + LK F + + +
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 398 DVSKGMNYLH-QNNIIHRDLKAANLLMDENE 427
+ + YLH + I+HRDL N+++ E++
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDD 151
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 33/112 (29%), Positives = 52/112 (46%), Gaps = 4/112 (3%)
Query: 319 AIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A K L +R+ E A E I+ KV + +V A LC+V M+GG +
Sbjct: 22 ACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLR 81
Query: 378 DYLHKLKGV---FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
+++ + F P + G+ +LHQ II+RDLK N+L+D +
Sbjct: 82 YHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDND 133
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 38/131 (29%), Positives = 68/131 (51%), Gaps = 9/131 (6%)
Query: 300 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIG 356
+ GSY L R + A+KV+K E +N D ++ Q E + + + + +
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 357 ACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--VAIDVSKGMNYLHQNNIIH 413
+C + S L V E+++GG + ++ + + KLP + ++S +NYLH+ II+
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERGIIY 119
Query: 414 RDLKAANLLMD 424
RDLK N+L+D
Sbjct: 120 RDLKLDNVLLD 130
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 36/134 (26%), Positives = 66/134 (49%), Gaps = 14/134 (10%)
Query: 299 KVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQKEFA-----QEVFIMRKVRHKNV 351
K+ G+Y +Y+G D VA+K ++ E +E A +EV +++ ++H N+
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLE------HEEGAPCTAIREVSLLKDLKHANI 66
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
V SL +V E++ + YL + ++ + +G+NY H+ +
Sbjct: 67 VTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKV 125
Query: 412 IHRDLKAANLLMDE 425
+HRDLK NLL++E
Sbjct: 126 LHRDLKPQNLLINE 139
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 43/153 (28%), Positives = 69/153 (45%), Gaps = 21/153 (13%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQ 338
VWE+ P+ +V SG+YG + CS + VAIK L + K +
Sbjct: 10 VWEL-PERYTSLKQVGSGAYGSV-----CSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR 63
Query: 339 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDY----LHKLKGV-FKLPSLL 393
E+ +++ ++H+NV+ + T S EF V Y L K+ G +
Sbjct: 64 ELTLLKHMQHENVIGLLDVFTSAVSG---DEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQ 120
Query: 394 KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
+ + G+ Y+H IIHRDLK NL ++E+
Sbjct: 121 YLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNED 153
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 38/137 (27%), Positives = 69/137 (50%), Gaps = 9/137 (6%)
Query: 299 KVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFA--QEVFIMRKVRHKNVVQF 354
K+ GSY +Y+G + VA+KV+ R+ + F +E +++ ++H N+V
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVI---RLQEEEGTPFTAIREASLLKGLKHANIVLL 68
Query: 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 414
+L +V E++ + Y+ K G ++ + +G++Y+HQ I+HR
Sbjct: 69 HDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHR 127
Query: 415 DLKAANLLM-DENEVSL 430
DLK NLL+ D E+ L
Sbjct: 128 DLKPQNLLISDTGELKL 144
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 35/112 (31%), Positives = 54/112 (48%), Gaps = 14/112 (12%)
Query: 287 WEIDPKHLKFGSKVASGSYG--------DLYRGTYCSQDVAIKVLKPERINSDMQKEFAQ 338
WE LK G + G++G + + C + VA+K+LK E + K
Sbjct: 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASC-RTVAVKMLK-EGATASEYKALMT 59
Query: 339 EVFIMRKV-RHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVF 387
E+ I+ + H NVV +GACTKP P + IV E+ G++ +YL + F
Sbjct: 60 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIV-EYCKFGNLSNYLRSKRECF 110
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 40/139 (28%), Positives = 66/139 (47%), Gaps = 9/139 (6%)
Query: 294 LKFGSKVASGSYGDLYRGTYCSQD---VAIKVLKPERINSDMQKEFA-QEVFIMRKVRHK 349
F + +GS+G + TY ++D VAIK + +I Q + E I+ + H
Sbjct: 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHP 91
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKV--AIDVSKGMNYLH 407
V G+ L +V EF+ GG + +L + K + P+ + A + YL
Sbjct: 92 FCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQ 148
Query: 408 QNNIIHRDLKAANLLMDEN 426
NI++RDLK NLL+D++
Sbjct: 149 SLNIVYRDLKPENLLLDKD 167
|
Length = 340 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 3e-06
Identities = 29/131 (22%), Positives = 63/131 (48%), Gaps = 4/131 (3%)
Query: 299 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
K+ G+YG +Y R + VA+K ++ + + +E+ +++++ H N+V+ +
Sbjct: 7 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
L +V EF+ + ++ LP + + +G+ + H + ++HRD
Sbjct: 67 VIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 125
Query: 416 LKAANLLMDEN 426
LK NLL++
Sbjct: 126 LKPQNLLINTE 136
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 24/105 (22%), Positives = 50/105 (47%), Gaps = 6/105 (5%)
Query: 321 KVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL 380
K ++ + + + E I++++ H +V + ++ +V + + GG + +L
Sbjct: 37 KCVEKGSVRNVLN-----ERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHL 91
Query: 381 HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE 425
+ K F + ++ + YLH IIHRD+K N+L+DE
Sbjct: 92 SQ-KVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDE 135
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|190133 pfam01842, ACT, ACT domain | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 4e-06
Identities = 18/64 (28%), Positives = 30/64 (46%), Gaps = 1/64 (1%)
Query: 180 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRA 239
+ D+P LL+++ LAD G+NI+ ++ D + VV E+ E
Sbjct: 1 TVLEVGVPDRPGLLAEVFGALADRGINIESISQSTSGDKAGIVFIVVVV-DEEDLEAALE 59
Query: 240 ALEK 243
AL+K
Sbjct: 60 ALKK 63
|
This family of domains generally have a regulatory role. ACT domains are linked to a wide range of metabolic enzymes that are regulated by amino acid concentration. Pairs of ACT domains bind specifically to a particular amino acid leading to regulation of the linked enzyme. The ACT domain is found in: D-3-phosphoglycerate dehydrogenase EC:1.1.1.95, which is inhibited by serine. Aspartokinase EC:2.7.2.4, which is regulated by lysine. Acetolactate synthase small regulatory subunit, which is inhibited by valine. Phenylalanine-4-hydroxylase EC:1.14.16.1, which is regulated by phenylalanine. Prephenate dehydrogenase EC:4.2.1.51. formyltetrahydrofolate deformylase EC:3.5.1.10, which is activated by methionine and inhibited by glycine. GTP pyrophosphokinase EC:2.7.6.5. Length = 66 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 4e-06
Identities = 45/159 (28%), Positives = 74/159 (46%), Gaps = 32/159 (20%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQ 338
VWE+ P + S V SG+YG CS + VAIK L ++ K +
Sbjct: 10 VWEV-PDRYQNLSPVGSGAYG-----QVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR 63
Query: 339 EVFIMRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYL--HKLKG---VF 387
E+ +++ + H+NV+ + T SL +VT M G + + + KL F
Sbjct: 64 ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQF 122
Query: 388 KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
+ +L+ G+ Y+H IIHRDLK +N+ ++E+
Sbjct: 123 LVYQILR-------GLKYIHSAGIIHRDLKPSNIAVNED 154
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|153171 cd04899, ACT_ACR-UUR-like_2, C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD and related domains | Back alignment and domain information |
|---|
Score = 43.6 bits (104), Expect = 5e-06
Identities = 27/63 (42%), Positives = 38/63 (60%), Gaps = 6/63 (9%)
Query: 188 DKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV---DGWPY--EETEQLRAALE 242
D+P LL+ +T +LA++GLNI A +T+ + DVF V DG P E E LRAAL
Sbjct: 9 DRPGLLADVTRVLAELGLNIHSAKI-ATLGERAEDVFYVTDADGQPLDPERQEALRAALG 67
Query: 243 KEV 245
+ +
Sbjct: 68 EAL 70
|
This ACT domain family, ACT_ACR-UUR-like_2, includes the second of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD are the second and fourth ACT domains of a novel protein composed almost entirely of ACT domain repeats, the ACR protein. These ACR proteins, found in Arabidopsis and Oryza, are proposed to function as novel regulatory or sensor proteins in plants. Members of this CD belong to the superfamily of ACT regulatory domains. Length = 70 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 5e-06
Identities = 36/134 (26%), Positives = 68/134 (50%), Gaps = 18/134 (13%)
Query: 303 GSYGDLY-----RGTYCSQDVAIKVLKP------ERINSDMQKEFAQEVFIMRKVRHKNV 351
GS+G ++ G Q A+KVLK +R+ + M+++ I+ +V H +
Sbjct: 7 GSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERD------ILAEVNHPFI 60
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
V+ A L ++ +F+ GG ++ L K + +F + +++ +++LH I
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGI 119
Query: 412 IHRDLKAANLLMDE 425
I+RDLK N+L+DE
Sbjct: 120 IYRDLKPENILLDE 133
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 49/160 (30%), Positives = 78/160 (48%), Gaps = 24/160 (15%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYC---SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH 348
K K G+ + +GS+G +Y C S+ VAIK ++ D Q + +E+ IM+ + H
Sbjct: 66 KSYKLGNIIGNGSFGVVYEAI-CIDTSEKVAIK-----KVLQDPQYK-NRELLIMKNLNH 118
Query: 349 KNVV----QFIGACTKPPS----LCIVTEFMSGGSVYDYL-HKLKGVFKLPSLLK--VAI 397
N++ + C K L +V EF+ +V+ Y+ H + LP L +
Sbjct: 119 INIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSY 177
Query: 398 DVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLF 437
+ + + Y+H I HRDLK NLL+D N + L LC F
Sbjct: 178 QLCRALAYIHSKFICHRDLKPQNLLIDPN--THTLKLCDF 215
|
Length = 440 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 6e-06
Identities = 30/126 (23%), Positives = 64/126 (50%), Gaps = 9/126 (7%)
Query: 308 LYRGTYCSQDVAIKVLKPERINSDMQKE-FAQEVFIMRKVRHKNVVQ----FIGACTKPP 362
+Y+G + +++V I+ K + + E+ +R++ N+++ I P
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 363 SLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAAN 420
L ++ E+ + G + + L K K + FK + L +AID KG+ L++ N +++L + +
Sbjct: 96 RLSLILEYCTRGYLREVLDKEKDLSFK--TKLDMAIDCCKGLYNLYKYTNKPYKNLTSVS 153
Query: 421 LLMDEN 426
L+ EN
Sbjct: 154 FLVTEN 159
|
Length = 283 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 7e-06
Identities = 31/116 (26%), Positives = 61/116 (52%), Gaps = 10/116 (8%)
Query: 315 SQDVAIK-VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-PSLCIVTEFMS 372
Q+VAIK ++KP ++ + +E+ +++ +RH+N++ P + VTE +
Sbjct: 35 GQNVAIKKIMKPFSTPVLAKRTY-RELKLLKHLRHENIISLSDIFISPLEDIYFVTELLG 93
Query: 373 GGSVYDYLHKLKGVFKL-PSLLK-VAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
LH+L L ++ + +G+ Y+H ++HRDLK +N+L++EN
Sbjct: 94 TD-----LHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINEN 144
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 8e-06
Identities = 39/131 (29%), Positives = 65/131 (49%), Gaps = 9/131 (6%)
Query: 300 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIG 356
+ GSY L + A+KV+K E +N D ++ Q E + + + +
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 357 ACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--VAIDVSKGMNYLHQNNIIH 413
+C + S L V EF+SGG D + ++ KLP + ++S +N+LH+ II+
Sbjct: 63 SCFQTESRLFFVIEFVSGG---DLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIY 119
Query: 414 RDLKAANLLMD 424
RDLK N+L+D
Sbjct: 120 RDLKLDNVLLD 130
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 8e-06
Identities = 36/114 (31%), Positives = 59/114 (51%), Gaps = 5/114 (4%)
Query: 328 INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF 387
I ++ + +E+ ++ + +V F GA + I E M GGS+ D + K G
Sbjct: 42 IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRI 100
Query: 388 KLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440
L KV+I V KG+ YL + + I+HRD+K +N+L++ + LC F VS
Sbjct: 101 PEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVS 151
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 8e-06
Identities = 32/130 (24%), Positives = 62/130 (47%), Gaps = 4/130 (3%)
Query: 300 VASGSYGD--LYRGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
+ G++G L R + A+K+L+ E I D E +++ RH +
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
A LC V E+ +GG ++ +L + + VF ++ + YLH ++++RD+
Sbjct: 63 AFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDI 121
Query: 417 KAANLLMDEN 426
K NL++D++
Sbjct: 122 KLENLMLDKD 131
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 9e-06
Identities = 32/111 (28%), Positives = 53/111 (47%), Gaps = 12/111 (10%)
Query: 287 WEIDPKHLKFGSKVASGSYGDL--------YRGTYCSQDVAIKVLKPERINSDMQKEFAQ 338
WE L+ G + G++G + + + C VA+K+LK E + K
Sbjct: 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSC-NTVAVKMLK-EGATASEHKALMS 59
Query: 339 EVFIMRKV-RHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVF 387
E+ I+ + H NVV +GACTKP L ++ EF G++ ++L + F
Sbjct: 60 ELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFF 110
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 43/152 (28%), Positives = 72/152 (47%), Gaps = 18/152 (11%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 343
+WE+ P+ + S V SG+YG + T VA+K L + K +E+ ++
Sbjct: 12 IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 70
Query: 344 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 394
+ ++H+NV+ + T SL EF VY H L + K L
Sbjct: 71 KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 124
Query: 395 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
+ + +G+ Y+H +IIHRDLK +NL ++E+
Sbjct: 125 LIYQILRGLKYIHSADIIHRDLKPSNLAVNED 156
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 44/147 (29%), Positives = 69/147 (46%), Gaps = 33/147 (22%)
Query: 298 SKVASGSYGDLYRGTYC--SQDVAIKVLKP-ERINSDMQKEFAQ----EVFIMRKVRHKN 350
S + G+YG + T+ VAIK + P E + F Q E+ I+R+ +H+N
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH------QTFCQRTLREIKILRRFKHEN 64
Query: 351 VVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI-----DV 399
++ I +PPS IV E M L+K + K L I +
Sbjct: 65 IIG-ILDIIRPPSFESFNDVYIVQELMETD-----LYK---LIKTQHLSNDHIQYFLYQI 115
Query: 400 SKGMNYLHQNNIIHRDLKAANLLMDEN 426
+G+ Y+H N++HRDLK +NLL++ N
Sbjct: 116 LRGLKYIHSANVLHRDLKPSNLLLNTN 142
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 28/111 (25%), Positives = 53/111 (47%), Gaps = 3/111 (2%)
Query: 315 SQDVAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI-VTEFMS 372
+VAIK+L+ + + Q F +E + ++ H N+V + + PP L V E++
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 373 GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 423
G ++ + L G ++ + V + H I+HRDLK N+++
Sbjct: 63 GRTLREVLAA-DGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMV 112
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 39/154 (25%), Positives = 71/154 (46%), Gaps = 22/154 (14%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 343
VWE+ P+ + + V SG+YG + T Q VA+K L + + +E+ ++
Sbjct: 10 VWEV-PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLL 68
Query: 344 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 397
+ ++H+NV+ + T S+ +VT M L + K L +
Sbjct: 69 KHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGA--------DLNNIVKCQKLSDEHV 120
Query: 398 D-----VSKGMNYLHQNNIIHRDLKAANLLMDEN 426
+ +G+ Y+H IIHRDLK +N+ ++E+
Sbjct: 121 QFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNED 154
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 30/111 (27%), Positives = 58/111 (52%), Gaps = 9/111 (8%)
Query: 319 AIKVLKPERINSDMQKEFAQEVFIMRKV-----RHKNVVQFIGACTKPPSLCIVTEFMSG 373
AIK+LK + I +Q + + + ++V + + Q L V E+++G
Sbjct: 29 AIKILKKDVI---IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNG 85
Query: 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD 424
G + ++ ++ G FK P + A +++ G+ +LH II+RDLK N+++D
Sbjct: 86 GDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD 135
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 26/88 (29%), Positives = 46/88 (52%), Gaps = 2/88 (2%)
Query: 337 AQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVA 396
A E I+R + H +++Q G T C++ +Y YL + + + +L +
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNI-AICDILAIE 188
Query: 397 IDVSKGMNYLHQNNIIHRDLKAANLLMD 424
V + + YLH+N IIHRD+KA N+ ++
Sbjct: 189 RSVLRAIQYLHENRIIHRDIKAENIFIN 216
|
Length = 391 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 34/131 (25%), Positives = 63/131 (48%), Gaps = 8/131 (6%)
Query: 299 KVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFA--QEVFIMRKVRHKNVVQF 354
K+ GSY +Y+G Q VA+K + R+ + F +E +++ ++H N+V
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEI---RLEHEEGAPFTAIREASLLKDLKHANIVTL 68
Query: 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 414
+L +V E++ + Y+ G + ++ + +G+ Y HQ ++HR
Sbjct: 69 HDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHR 127
Query: 415 DLKAANLLMDE 425
DLK NLL+ E
Sbjct: 128 DLKPQNLLISE 138
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 29/106 (27%), Positives = 53/106 (50%), Gaps = 2/106 (1%)
Query: 318 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
V +KVL P + D+ F + +M +V H ++ G C + +V EF+ G +
Sbjct: 47 VVLKVLDPS--HRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD 104
Query: 378 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 423
L K KG + + VA ++ ++YL N++H ++ A N+L+
Sbjct: 105 VCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILL 150
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 37/133 (27%), Positives = 68/133 (51%), Gaps = 9/133 (6%)
Query: 300 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIG 356
+ GSY L R Q A+KV+K E ++ D ++ Q E + + + +
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 357 ACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--VAIDVSKGMNYLHQNNIIH 413
+C + S L +V E+++GG + ++ + + KLP A ++ +N+LH+ II+
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHERGIIY 119
Query: 414 RDLKAANLLMDEN 426
RDLK N+L+D +
Sbjct: 120 RDLKLDNVLLDAD 132
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|233534 TIGR01693, UTase_glnD, [Protein-PII] uridylyltransferase | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 23/85 (27%), Positives = 37/85 (43%), Gaps = 4/85 (4%)
Query: 181 EITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV---DGWPYEETEQL 237
E+ D+P L +++ LA + L++ +A +T DG +LD FVV G P
Sbjct: 670 EVFIYAPDQPGLFAKVAGALAMLSLSVHDAQVNTTKDGVALDTFVVQDLFGSPPAAERVF 729
Query: 238 RAALEKEVLKLE-RQGWPSHRSSSP 261
+ L+ V L P S+
Sbjct: 730 QELLQGLVDVLAGLAKDPDTISARR 754
|
This model describes GlnD, the uridylyltransferase/uridylyl-removing enzyme for the nitrogen regulatory protein PII. Not all homologs of PII share the property of uridylyltransferase modification on the characteristic Tyr residue (see Prosite pattern PS00496 and document PDOC00439), but the modification site is preserved in the PII homolog of all species with a member of this family [Central intermediary metabolism, Nitrogen metabolism, Regulatory functions, Protein interactions]. Length = 850 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 34/133 (25%), Positives = 67/133 (50%), Gaps = 5/133 (3%)
Query: 296 FGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNV 351
F + GS+G + D AIK+LK + + + D++ ++ + + + +
Sbjct: 4 FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFL 63
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
Q L V E+++GG + ++ ++ G FK P + A ++S G+ +LH+ I
Sbjct: 64 TQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRGI 122
Query: 412 IHRDLKAANLLMD 424
I+RDLK N+++D
Sbjct: 123 IYRDLKLDNVMLD 135
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 30/129 (23%), Positives = 63/129 (48%), Gaps = 4/129 (3%)
Query: 299 KVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
K+ G+Y +++G + VA+K ++ E +EV +++ ++H N+V
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
SL +V E++ + Y+ + + ++ + +G+ Y H+ ++HRDL
Sbjct: 72 IVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDL 130
Query: 417 KAANLLMDE 425
K NLL++E
Sbjct: 131 KPQNLLINE 139
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 25/80 (31%), Positives = 45/80 (56%), Gaps = 4/80 (5%)
Query: 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 420
L +VT++MSGG ++ +L K +G F ++ + +LH+ +I++RDLK N
Sbjct: 68 DSDLYLVTDYMSGGELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPEN 126
Query: 421 LLMDENEVSLLLSLCLFTVS 440
+L+D ++LC F +S
Sbjct: 127 ILLDATG---HIALCDFGLS 143
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 37/137 (27%), Positives = 65/137 (47%), Gaps = 20/137 (14%)
Query: 299 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFA-----QEVFIMRKVRHKNV 351
K+ G+Y +++G VA+K ++ E +E A +EV +++ ++H N+
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLE------HEEGAPCTAIREVSLLKNLKHANI 65
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI---DVSKGMNYLHQ 408
V L +V E++ D L L S+ V I + +G++Y H+
Sbjct: 66 VTLHDIIHTERCLTLVFEYLDS----DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK 121
Query: 409 NNIIHRDLKAANLLMDE 425
I+HRDLK NLL++E
Sbjct: 122 RKILHRDLKPQNLLINE 138
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 35/116 (30%), Positives = 61/116 (52%), Gaps = 9/116 (7%)
Query: 328 INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF 387
I ++ + +E+ ++ + +V F GA + I E M GGS+ L + K
Sbjct: 42 IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK--- 98
Query: 388 KLPS--LLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440
++P L KV+I V +G+ YL + + I+HRD+K +N+L++ + LC F VS
Sbjct: 99 RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE---IKLCDFGVS 151
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 48/158 (30%), Positives = 75/158 (47%), Gaps = 30/158 (18%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVL-KPERINSDM-QKEF 336
+WE+ P + +V SG+YG T CS VAIK L +P S++ K
Sbjct: 10 IWEV-PDRYRDLKQVGSGAYG-----TVCSALDRRTGAKVAIKKLYRP--FQSELFAKRA 61
Query: 337 AQEVFIMRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLP 390
+E+ +++ ++H+NV+ + T SL +V FM L KL KL
Sbjct: 62 YRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTD-----LGKLMKHEKLS 116
Query: 391 S--LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
+ + + KG+ Y+H IIHRDLK NL ++E+
Sbjct: 117 EDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNED 154
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 3e-05
Identities = 34/129 (26%), Positives = 63/129 (48%), Gaps = 8/129 (6%)
Query: 299 KVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFA--QEVFIMRKVRHKNVVQF 354
K+ GSY +Y+G Q VA+KV+ + ++ F +E +++ ++H N+V
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVIS---MKTEEGVPFTAIREASLLKGLKHANIVLL 68
Query: 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 414
+L V E+M + Y+ + G ++ + +G+ Y+H +I+HR
Sbjct: 69 HDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHR 127
Query: 415 DLKAANLLM 423
DLK NLL+
Sbjct: 128 DLKPQNLLI 136
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 4e-05
Identities = 32/129 (24%), Positives = 56/129 (43%), Gaps = 8/129 (6%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQE 339
WE L FG + +G++G + T + VA+K+LKP ++ + ++
Sbjct: 30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSEL 89
Query: 340 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 399
+ H N+V +GACT ++TE+ G + ++L + + F P A
Sbjct: 90 KVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAA 149
Query: 400 SKGMNYLHQ 408
N LHQ
Sbjct: 150 LY-KNLLHQ 157
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 4e-05
Identities = 35/138 (25%), Positives = 65/138 (47%), Gaps = 33/138 (23%)
Query: 314 CSQDVAIKVLKPERINSDMQ--KEFAQEVFIMRKVRHKNVVQF--------------IGA 357
C + VA+K + + +D Q K +E+ I+R++ H N+V+ +G+
Sbjct: 29 CDKRVAVKKI----VLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84
Query: 358 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK-----VAIDVSKGMNYLHQNNII 412
T+ S+ IV E+M L V + L + + +G+ Y+H N++
Sbjct: 85 LTELNSVYIVQEYMET--------DLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVL 136
Query: 413 HRDLKAANLLMDENEVSL 430
HRDLK AN+ ++ ++ L
Sbjct: 137 HRDLKPANVFINTEDLVL 154
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 5e-05
Identities = 35/126 (27%), Positives = 60/126 (47%), Gaps = 5/126 (3%)
Query: 303 GSYGD--LYRGTYCSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 358
GS+G L R + A+KVLK + I + D++ ++ + H + Q
Sbjct: 6 GSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF 65
Query: 359 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 418
P L V EF++GG + ++ K + F A +++ + +LH II+RDLK
Sbjct: 66 QTPDRLFFVMEFVNGGDLMFHIQKSRR-FDEARARFYAAEITSALMFLHDKGIIYRDLKL 124
Query: 419 ANLLMD 424
N+L+D
Sbjct: 125 DNVLLD 130
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 8e-05
Identities = 33/138 (23%), Positives = 66/138 (47%), Gaps = 13/138 (9%)
Query: 298 SKVASGSYGDLYRGTYCSQD---VAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNV 351
+++ G+YG +++ VA+K ++ + M +EV ++R + H NV
Sbjct: 7 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 66
Query: 352 VQFIGACT-----KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK-VAIDVSKGMNY 405
V+ CT + L +V E + + YL K+ +K + + +G+++
Sbjct: 67 VRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 406 LHQNNIIHRDLKAANLLM 423
LH + ++HRDLK N+L+
Sbjct: 126 LHSHRVVHRDLKPQNILV 143
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 9e-05
Identities = 27/108 (25%), Positives = 55/108 (50%), Gaps = 3/108 (2%)
Query: 318 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
V ++ + E ++M E+ + + H N+V + L +VT FM+ GS
Sbjct: 28 VTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAK 87
Query: 378 DYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 423
D + H + G+ +L ++ + V K ++Y+H +HR +KA+++L+
Sbjct: 88 DLICTHFMDGMSEL-AIAYILQGVLKALDYIHHMGYVHRSVKASHILI 134
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 32/126 (25%), Positives = 59/126 (46%), Gaps = 5/126 (3%)
Query: 303 GSYGDLYRGTYCSQD--VAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 358
GS+G + D AIKVLK + I + D+ ++ + +H +
Sbjct: 6 GSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF 65
Query: 359 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 418
L V E+++GG + + + + F P A +V+ + +LH++ +I+RDLK
Sbjct: 66 QTKDRLFFVMEYVNGGDLMFQIQRSRK-FDEPRSRFYAAEVTLALMFLHRHGVIYRDLKL 124
Query: 419 ANLLMD 424
N+L+D
Sbjct: 125 DNILLD 130
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 34/138 (24%), Positives = 64/138 (46%), Gaps = 20/138 (14%)
Query: 300 VASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNVVQF 354
+ G+YG +Y+ + VA+K ++ + +E+ +++++ H N+V+
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 355 IGACTKPP-----SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI-DVSK----GMN 404
+ C P L +V E + + YL K P L I D+ + G++
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPK----PGLPPETIKDLMRQLLRGVD 121
Query: 405 YLHQNNIIHRDLKAANLL 422
+LH + I+HRDLK N+L
Sbjct: 122 FLHSHRIVHRDLKPQNIL 139
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 31/109 (28%), Positives = 54/109 (49%), Gaps = 2/109 (1%)
Query: 319 AIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A K L+ +RI + A E I+ KV + VV A +LC+V M+GG +
Sbjct: 29 ACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLK 88
Query: 378 DYLHKLKGV-FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE 425
+++ + F + A ++ G+ L + I++RDLK N+L+D+
Sbjct: 89 FHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDD 137
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 42/150 (28%), Positives = 65/150 (43%), Gaps = 34/150 (22%)
Query: 310 RGTY---CS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359
RG Y CS + VAIK + N K +E+ ++R + H+NV+ I
Sbjct: 15 RGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIA-IKDIM 73
Query: 360 KPPS------LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK------VAIDVSKGMNYLH 407
PP + IV E M LH+ + + L + +G+ Y+H
Sbjct: 74 PPPHREAFNDVYIVYELMDTD-----LHQ---IIRSSQTLSDDHCQYFLYQLLRGLKYIH 125
Query: 408 QNNIIHRDLKAANLLMDENEVSLLLSLCLF 437
N++HRDLK +NLL++ N L +C F
Sbjct: 126 SANVLHRDLKPSNLLLNAN---CDLKICDF 152
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|235329 PRK05007, PRK05007, PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 24/75 (32%), Positives = 41/75 (54%), Gaps = 5/75 (6%)
Query: 174 QFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV---DGWP 230
Q +R EI + D+P L + + A L L++ +A F++ DG ++D F+V DG P
Sbjct: 696 QATRGGTEIFIWSPDRPYLFAAVCAELDRRNLSVHDAQIFTSRDGMAMDTFIVLEPDGSP 755
Query: 231 YEET--EQLRAALEK 243
+ + +R ALE+
Sbjct: 756 LSQDRHQVIRKALEQ 770
|
Length = 884 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 27/110 (24%), Positives = 56/110 (50%), Gaps = 2/110 (1%)
Query: 319 AIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A K L +R+ ++ A E I+ KV +V A LC+V M+GG +
Sbjct: 22 ACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLK 81
Query: 378 DYLHKLKGV-FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
+++ + ++ ++ + ++ G+ +LH +I++RD+K N+L+D+
Sbjct: 82 YHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQ 131
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 41/135 (30%), Positives = 64/135 (47%), Gaps = 20/135 (14%)
Query: 300 VASGSYGDLY--RGTYCSQDVAIKVLKPERINSD--MQKEFAQEVFIMRKV----RHKNV 351
+++G+YG +Y R Q A+K +IN + + Q+VF+ R + + V
Sbjct: 9 ISNGAYGAVYLVRHKETRQRFAMK-----KINKQNLILRNQIQQVFVERDILTFAENPFV 63
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP---SLLKVAIDVSKGMNYLHQ 408
V + LC+V E++ GG D LK + LP + + A V + YLH
Sbjct: 64 VSMFCSFETKRHLCMVMEYVEGG---DCATLLKNIGALPVDMARMYFAETVL-ALEYLHN 119
Query: 409 NNIIHRDLKAANLLM 423
I+HRDLK NLL+
Sbjct: 120 YGIVHRDLKPDNLLI 134
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 33/146 (22%), Positives = 68/146 (46%), Gaps = 27/146 (18%)
Query: 299 KVASGSYGDLYRGTYCSQDVA---IKVLKPERINSD-------------MQKEFAQEVFI 342
K+ G+YG +Y+ ++D + LK R+ D + + ++ ++I
Sbjct: 8 KIGEGTYGKVYK----ARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYI 63
Query: 343 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLP--SLLKVAIDV 399
+R + ++V + G PSL +V E++ + + LP ++ +
Sbjct: 64 VRLLDVEHVEEKNGK----PSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119
Query: 400 SKGMNYLHQNNIIHRDLKAANLLMDE 425
KG+ + H++ ++HRDLK NLL+D+
Sbjct: 120 LKGVAHCHKHGVMHRDLKPQNLLVDK 145
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 34/139 (24%), Positives = 65/139 (46%), Gaps = 12/139 (8%)
Query: 300 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359
++ G G Y+G + V + +NS E A M K++H N+V+ IG C
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLIGLCR 753
Query: 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN---NIIHRDL 416
++ E++ G ++ + L L + K+AI ++K + +LH ++ +L
Sbjct: 754 SEKGAYLIHEYIEGKNLSEVLRNLSWERR----RKIAIGIAKALRFLHCRCSPAVVVGNL 809
Query: 417 KAANLLMD-ENEVSLLLSL 434
+++D ++E L LSL
Sbjct: 810 SPEKIIIDGKDEPHLRLSL 828
|
Length = 968 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 31/110 (28%), Positives = 50/110 (45%), Gaps = 2/110 (1%)
Query: 319 AIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A+KVL K E I + K E I+ + H + + LC+V ++ GG ++
Sbjct: 30 ALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELF 89
Query: 378 DYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
L + G A +V + YLH I++RDLK N+L+ E+
Sbjct: 90 RLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHES 139
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 14/26 (53%), Positives = 22/26 (84%)
Query: 401 KGMNYLHQNNIIHRDLKAANLLMDEN 426
+G+ Y+H N+IHRDLK +NLL++E+
Sbjct: 118 RGLKYIHSANVIHRDLKPSNLLVNED 143
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 30/110 (27%), Positives = 56/110 (50%), Gaps = 3/110 (2%)
Query: 319 AIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A+K+LK E I D E +++ RH + + LC V E+ +GG ++
Sbjct: 24 AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELF 83
Query: 378 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLH-QNNIIHRDLKAANLLMDEN 426
+L + + VF ++ ++YLH + N+++RDLK NL++D++
Sbjct: 84 FHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD 132
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (101), Expect = 2e-04
Identities = 29/136 (21%), Positives = 62/136 (45%), Gaps = 19/136 (13%)
Query: 299 KVASGSYGDLY----RGTYCSQDVAIKVLKPERINSDMQKEFAQEVF---IMRKVRHKNV 351
K+ G +G + + T + K++K + N+ E +M+ + N
Sbjct: 23 KLIDGKFGKVSVLKHKPT--QKLFVQKIIKAKNFNAI-------EPMVHQLMKD--NPNF 71
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
++ + T ++ +++ G ++D L K +G + K+ + + +N LH++NI
Sbjct: 72 IKLYYSVTTLKGHVLIMDYIKDGDLFDLLKK-EGKLSEAEVKKIIRQLVEALNDLHKHNI 130
Query: 412 IHRDLKAANLLMDENE 427
IH D+K N+L D +
Sbjct: 131 IHNDIKLENVLYDRAK 146
|
Length = 267 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 21/61 (34%), Positives = 38/61 (62%), Gaps = 1/61 (1%)
Query: 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 423
L V E+++GG + + ++ G FK P + A +++ G+ +LH II+RDLK N+++
Sbjct: 76 LYFVMEYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134
Query: 424 D 424
D
Sbjct: 135 D 135
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 35/136 (25%), Positives = 66/136 (48%), Gaps = 15/136 (11%)
Query: 300 VASGSYGDLY----RGTYCSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNVVQ 353
+ GS+G ++ +GT +Q AIK LK + + + D++ ++ + H +
Sbjct: 3 LGKGSFGKVFLAELKGT--NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 354 FIGACTKPPSLCIVTEFMSGGSVYDYL---HKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 410
+L V E+++GG + ++ HK F LP A ++ G+ +LH
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK----FDLPRATFYAAEIICGLQFLHSKG 116
Query: 411 IIHRDLKAANLLMDEN 426
I++RDLK N+L+D +
Sbjct: 117 IVYRDLKLDNILLDTD 132
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|235123 PRK03381, PRK03381, PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 6e-04
Identities = 36/135 (26%), Positives = 54/135 (40%), Gaps = 26/135 (19%)
Query: 123 VSSLLDSEVPAQRQSIHPPPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRP-MHE 181
++L E P P P ALA D VH + + P M E
Sbjct: 560 CRAVLAGEPLP-----EPEPL---DPAQLALA----------ADGGVHVEIAPADPHMVE 601
Query: 182 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVD---GWPYEET---E 235
+T D+ LLS+ +LA L ++ A + DG ++ FVV G P + +
Sbjct: 602 VTVVAPDRRGLLSKAAGVLALHRLRVRSASV-RSHDGVAVLEFVVSPRFGSPPDAALLRQ 660
Query: 236 QLRAALEKEVLKLER 250
LR AL+ ++ L R
Sbjct: 661 DLRRALDGDLDVLAR 675
|
Length = 774 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 6e-04
Identities = 22/63 (34%), Positives = 36/63 (57%), Gaps = 1/63 (1%)
Query: 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 423
L V EF++GG + ++ KG F L A ++ G+ +LH II+RDLK N+++
Sbjct: 71 LFFVMEFLNGGDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML 129
Query: 424 DEN 426
D +
Sbjct: 130 DRD 132
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|235123 PRK03381, PRK03381, PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 7e-04
Identities = 19/62 (30%), Positives = 32/62 (51%), Gaps = 3/62 (4%)
Query: 186 TDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVF-VVDGWPYEETEQLRAALEKE 244
D+P LL++L L G++++ A +T+ +DVF V + RAA+E+
Sbjct: 714 AADRPGLLARLARALERAGVDVRWARV-ATLGADVVDVFYVTGAAGGPLADA-RAAVEQA 771
Query: 245 VL 246
VL
Sbjct: 772 VL 773
|
Length = 774 |
| >gnl|CDD|234709 PRK00275, glnD, PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 7e-04
Identities = 16/72 (22%), Positives = 31/72 (43%), Gaps = 7/72 (9%)
Query: 186 TDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV---DGWPY----EETEQLR 238
D+ + A + + LNI +A ++ ++LD ++V DG P EQ+R
Sbjct: 711 APDQHDFFAATVAAMDQLNLNIHDARIITSSSQFTLDTYIVLDDDGEPIGDNPARIEQIR 770
Query: 239 AALEKEVLKLER 250
L + + +
Sbjct: 771 EGLTEALRNPDD 782
|
Length = 895 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 8e-04
Identities = 33/112 (29%), Positives = 52/112 (46%), Gaps = 10/112 (8%)
Query: 316 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL------CIVTE 369
Q+VAIK L N K +E+ +M+ V HKN++ + T SL +V E
Sbjct: 42 QNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVME 101
Query: 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANL 421
M ++ + ++ LL + G+ +LH IIHRDLK +N+
Sbjct: 102 LMDA-NLCQVIQMDLDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNI 149
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 8e-04
Identities = 33/138 (23%), Positives = 62/138 (44%), Gaps = 8/138 (5%)
Query: 292 KHLKFGSKVASGSYGDLY----RGTYCSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKV 346
K + ++V G YG ++ + T + VA+K +K + + + E I+
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDT--GEIVALKRMKKSLLFKLNEVRHVLTERDILTTT 58
Query: 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 406
+ + +V+ + A L + E++ GG L+ L GV ++ + ++ L
Sbjct: 59 KSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDAL 117
Query: 407 HQNNIIHRDLKAANLLMD 424
H+ IHRDLK N L+D
Sbjct: 118 HELGYIHRDLKPENFLID 135
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 8e-04
Identities = 41/155 (26%), Positives = 68/155 (43%), Gaps = 47/155 (30%)
Query: 297 GSKVASGSYGDLYRGTYCS----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
G KV G+YG +Y+ +D A+K ++ I+ +E A ++R+++H NV+
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIA----LLRELKHPNVI 61
Query: 353 QFIGACTKPPSLCIVTEFMSGGS-----VYDY----------LHKLKGVFKLP------- 390
+ F+S ++DY H+ K P
Sbjct: 62 S------------LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGM 109
Query: 391 --SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 423
SLL +D G++YLH N ++HRDLK AN+L+
Sbjct: 110 VKSLLYQILD---GIHYLHANWVLHRDLKPANILV 141
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 22/54 (40%), Positives = 30/54 (55%), Gaps = 3/54 (5%)
Query: 384 KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLF 437
K V L L+ + V+KGM +L IHRDL A N+L+ EN V + +C F
Sbjct: 173 KKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNV---VKICDF 223
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 36/141 (25%), Positives = 60/141 (42%), Gaps = 35/141 (24%)
Query: 303 GSYGDLY----RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 358
GS+G + +GT ++ AIK LK + + D E + R+V +
Sbjct: 6 GSFGKVMLAELKGT--NEFFAIKALKKDVVLEDDDVECT---MVERRV--------LALA 52
Query: 359 TKPPSLC-------------IVTEFMSGGSVYDYLHKL--KGVFKLPSLLKVAIDVSKGM 403
+ P L V E+++GG D + + G F A ++ G+
Sbjct: 53 WEHPFLTHLFCTFQTKEHLFFVMEYLNGG---DLMFHIQSSGRFDEARARFYAAEIICGL 109
Query: 404 NYLHQNNIIHRDLKAANLLMD 424
+LH+ II+RDLK N+L+D
Sbjct: 110 QFLHKKGIIYRDLKLDNVLLD 130
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 41/146 (28%), Positives = 64/146 (43%), Gaps = 33/146 (22%)
Query: 300 VASGSYGDLYRG--TYCSQDVAIKVLKPERIN------SDMQKEFAQEVFIMRKVRHKNV 351
+ GSYG + T+ + VAIK +IN SD + +E+ ++R +RH ++
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIK-----KINDVFEHVSDATR-ILREIKLLRLLRHPDI 61
Query: 352 VQFIGACTKPPS------LCIVTEFMSGG-----SVYDYLHKLKGVFKLPSLLKVAIDVS 400
V+ I PPS + +V E M D L F L LL+
Sbjct: 62 VE-IKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLR------ 114
Query: 401 KGMNYLHQNNIIHRDLKAANLLMDEN 426
+ Y+H N+ HRDLK N+L + +
Sbjct: 115 -ALKYIHTANVFHRDLKPKNILANAD 139
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 16/37 (43%), Positives = 24/37 (64%), Gaps = 3/37 (8%)
Query: 401 KGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLF 437
+G+ YLH I+HRD+K NLL++ N +L +C F
Sbjct: 114 RGLKYLHSAGILHRDIKPGNLLVNSN---CVLKICDF 147
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 16/63 (25%), Positives = 38/63 (60%), Gaps = 1/63 (1%)
Query: 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 423
L ++ ++++GG ++ +L++ + F + ++ +++LHQ II+RD+K N+L+
Sbjct: 80 LHLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL 138
Query: 424 DEN 426
D
Sbjct: 139 DSE 141
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 31/141 (21%), Positives = 60/141 (42%), Gaps = 19/141 (13%)
Query: 299 KVASGSYGDLYRG--TYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFI 355
+ G G++Y CS+ VA+K ++ + N ++K F +E I + H +V
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK-------------LPSLLKVAIDVSKG 402
C+ + ++ G Y LK V++ + + L + +
Sbjct: 69 SICSDGDPVYYTMPYIEG---YTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125
Query: 403 MNYLHQNNIIHRDLKAANLLM 423
+ Y+H ++HRDLK N+L+
Sbjct: 126 IEYVHSKGVLHRDLKPDNILL 146
|
Length = 932 |
| >gnl|CDD|235342 PRK05092, PRK05092, PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 0.002
Identities = 28/85 (32%), Positives = 44/85 (51%), Gaps = 9/85 (10%)
Query: 182 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGY---SLDVF-VVDGWPYEETEQL 237
I + D+P LL LT L+D+ LNI AH + Y ++DVF V D + + T +
Sbjct: 846 IEVNGRDRPGLLYDLTRALSDLNLNIASAH----IATYGERAVDVFYVTDLFGLKITNEA 901
Query: 238 R-AALEKEVLKLERQGWPSHRSSSP 261
R AA+ + +L +G R++ P
Sbjct: 902 RQAAIRRALLAALAEGEAEARAARP 926
|
Length = 931 |
| >gnl|CDD|225400 COG2844, GlnD, UTP:GlnB (protein PII) uridylyltransferase [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.002
Identities = 25/114 (21%), Positives = 39/114 (34%), Gaps = 14/114 (12%)
Query: 134 QRQSIHPPPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRPMHEITFSTDDKPKLL 193
PP L I V S + D+P LL
Sbjct: 756 LSGKAQPPRRRRIPRKLRHFPIPP----------RVTILPTASNDKTVLEVRALDRPGLL 805
Query: 194 SQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEVLK 247
+ L + AD+GL++ A +T DVF+V + + L A L + +L+
Sbjct: 806 AALAGVFADLGLSLHSAKI-TTFGERVEDVFIVTD---ADGQALNAELRQSLLQ 855
|
Length = 867 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 17/40 (42%), Positives = 24/40 (60%)
Query: 389 LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428
L L+ + V++GM +L IHRDL A N+L+ EN V
Sbjct: 172 LEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNV 211
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|233534 TIGR01693, UTase_glnD, [Protein-PII] uridylyltransferase | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.002
Identities = 17/51 (33%), Positives = 27/51 (52%), Gaps = 1/51 (1%)
Query: 176 SRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV 226
SR + D+P LL+++ L ++GL+IQ A +T + DVF V
Sbjct: 776 SRKATIMEVRALDRPGLLARVGRTLEELGLSIQSAK-ITTFGEKAEDVFYV 825
|
This model describes GlnD, the uridylyltransferase/uridylyl-removing enzyme for the nitrogen regulatory protein PII. Not all homologs of PII share the property of uridylyltransferase modification on the characteristic Tyr residue (see Prosite pattern PS00496 and document PDOC00439), but the modification site is preserved in the PII homolog of all species with a member of this family [Central intermediary metabolism, Nitrogen metabolism, Regulatory functions, Protein interactions]. Length = 850 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 16/38 (42%), Positives = 24/38 (63%)
Query: 392 LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVS 429
LL + V+KGM++L N IHRDL A N+L+ ++
Sbjct: 216 LLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRIT 253
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.002
Identities = 12/24 (50%), Positives = 19/24 (79%)
Query: 401 KGMNYLHQNNIIHRDLKAANLLMD 424
K + Y+H N+IHRDLK +N+L++
Sbjct: 118 KALKYIHSGNVIHRDLKPSNILLN 141
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 32/140 (22%), Positives = 69/140 (49%), Gaps = 18/140 (12%)
Query: 298 SKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNVV 352
+++ G+YG +Y R + VA+K ++ + + +EV +++++ H N+V
Sbjct: 6 AEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIV 65
Query: 353 QFIGACT-----KPPSLCIVTEFMSGGSVYDYLHKLKG----VFKLPSLLKVAIDVSKGM 403
+ + C + + +V E + + YL K+ + L++ + +G+
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFL---RGL 121
Query: 404 NYLHQNNIIHRDLKAANLLM 423
++LH N I+HRDLK N+L+
Sbjct: 122 DFLHANCIVHRDLKPENILV 141
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.002
Identities = 33/121 (27%), Positives = 57/121 (47%), Gaps = 18/121 (14%)
Query: 316 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 375
++VAIK L N K +E+ +M+ V HKN++ + T SL EF
Sbjct: 43 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL---EEFQD--- 96
Query: 376 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 425
VY + + L ++++ +D + G+ +LH IIHRDLK +N+++
Sbjct: 97 VYLVMELMDA--NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 154
Query: 426 N 426
+
Sbjct: 155 D 155
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 35/129 (27%), Positives = 57/129 (44%), Gaps = 5/129 (3%)
Query: 300 VASGSYGD--LYRGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
+ G++G+ L R + A+K+L K E I F +E IM VVQ
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 110
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
A L +V E+M GG + + + K +V ++ +H +IHRD+
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTA--EVVLALDAIHSMGLIHRDV 168
Query: 417 KAANLLMDE 425
K N+L+D+
Sbjct: 169 KPDNMLLDK 177
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 33/121 (27%), Positives = 57/121 (47%), Gaps = 18/121 (14%)
Query: 316 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 375
++VAIK L N K +E+ +M+ V HKN++ + T SL EF
Sbjct: 50 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL---EEFQD--- 103
Query: 376 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 425
VY + + L ++++ +D + G+ +LH IIHRDLK +N+++
Sbjct: 104 VYIVMELMDA--NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 426 N 426
+
Sbjct: 162 D 162
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 32/129 (24%), Positives = 63/129 (48%), Gaps = 6/129 (4%)
Query: 300 VASGSYGDLY--RGTYCSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNVVQFI 355
+ GS+G + R + A+K ++ I S++ A+ ++ +V +V
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERT-VLAQVNCPFIVPLK 59
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
+ P L +V F++GG ++ +L + +G F L ++ + LH+ N+I+RD
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRD 118
Query: 416 LKAANLLMD 424
LK N+L+D
Sbjct: 119 LKPENILLD 127
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.003
Identities = 37/144 (25%), Positives = 72/144 (50%), Gaps = 25/144 (17%)
Query: 297 GSKVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
G KV G+YG +Y+ ++ A+K ++ I+ +E A ++R+++H NV+
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIA----LLRELKHPNVI 61
Query: 353 --QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK---------GVFKLP-SLLKVAI-DV 399
Q + + ++ ++ +D H +K +LP S++K + +
Sbjct: 62 ALQKVFLSHSDRKVWLLFDYAE----HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQI 117
Query: 400 SKGMNYLHQNNIIHRDLKAANLLM 423
G++YLH N ++HRDLK AN+L+
Sbjct: 118 LDGIHYLHANWVLHRDLKPANILV 141
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 35/130 (26%), Positives = 57/130 (43%), Gaps = 5/130 (3%)
Query: 300 VASGSYGD--LYRGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
+ G++G+ L R + A+K+L K E I F +E IM VVQ
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 110
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
A L +V E+M GG + + + K +V ++ +H IHRD+
Sbjct: 111 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA--EVVLALDAIHSMGFIHRDV 168
Query: 417 KAANLLMDEN 426
K N+L+D++
Sbjct: 169 KPDNMLLDKS 178
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 492 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.98 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.97 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.97 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.97 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.97 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.97 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.97 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.97 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.97 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.97 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.97 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.97 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.97 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.96 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.96 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.96 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.96 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.96 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.96 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.96 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.96 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.96 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.96 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.96 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.96 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.96 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.96 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.96 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.96 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.96 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.96 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.96 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.96 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.96 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.96 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.96 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.95 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.95 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.95 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.95 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.95 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.95 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.95 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.95 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.95 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.95 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.95 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.95 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.95 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.95 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.95 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.95 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.95 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.95 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.95 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.95 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.95 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.95 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.95 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.95 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.95 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.95 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.95 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.95 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.95 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.95 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.95 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.95 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.94 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.94 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.94 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.94 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.94 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.94 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.94 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.94 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.94 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.94 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.94 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.94 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.94 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.94 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.94 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.94 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.94 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.94 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.94 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.94 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.94 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.94 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.94 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.94 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.94 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.94 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.94 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.94 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.94 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.94 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.94 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.94 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.94 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.94 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.94 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.94 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.94 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.94 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.94 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.94 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.94 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.94 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.94 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.94 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.94 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.94 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.93 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.93 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.93 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.93 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.93 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.93 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.93 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.93 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.93 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.93 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.93 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.93 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.93 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.93 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.93 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.93 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.93 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.93 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.93 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.93 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.93 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.93 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.93 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.93 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.93 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.93 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.93 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.93 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.93 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.93 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.93 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.93 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.93 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.93 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.93 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.93 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.93 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.93 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.93 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.93 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.93 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.93 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.93 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.93 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.93 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.93 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.93 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.92 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.92 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.92 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.92 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.92 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.92 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.92 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.92 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.92 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.92 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.92 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.92 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.92 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.92 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.92 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.92 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.92 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.92 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.92 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.92 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.92 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.92 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.92 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.92 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.92 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.92 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.92 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.92 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.92 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.92 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.92 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.92 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.92 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.92 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.92 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.92 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.92 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.92 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.92 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.91 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.91 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.91 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.91 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.91 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.91 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.91 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.91 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.91 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.91 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.91 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.91 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.91 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.91 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.91 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.91 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.91 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.91 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.91 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.91 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.91 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.91 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.91 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.91 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.91 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.91 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.91 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.91 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.9 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.9 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.9 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.9 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.9 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.9 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.9 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.9 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.9 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.9 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.9 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.9 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.9 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.9 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.9 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.9 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.89 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.89 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.89 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.89 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.89 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.89 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.89 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.88 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.87 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.87 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.87 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.87 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.86 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.86 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.85 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.84 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.83 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.83 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.83 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.83 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.81 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.81 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.8 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.8 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.78 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.78 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.77 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.77 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.77 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.77 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.76 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.76 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.75 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.75 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.7 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.7 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.69 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.68 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.62 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.59 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.58 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.52 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.5 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.49 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.49 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.42 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.37 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.32 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.27 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.23 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.21 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.19 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.16 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.16 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.15 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.15 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.1 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 98.84 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.83 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.78 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.75 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.7 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.64 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.61 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.6 | |
| cd04928 | 68 | ACT_TyrKc Uncharacterized, N-terminal ACT domain o | 98.5 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 98.45 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.45 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.43 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.4 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.36 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.35 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.24 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.16 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.14 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.11 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.05 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.02 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.97 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 97.87 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.84 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.83 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.76 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.49 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.43 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.4 | |
| cd04900 | 73 | ACT_UUR-like_1 ACT domain family, ACT_UUR-like_1, | 97.35 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.27 | |
| PRK05092 | 931 | PII uridylyl-transferase; Provisional | 97.24 | |
| PRK00275 | 895 | glnD PII uridylyl-transferase; Provisional | 97.24 | |
| PRK04374 | 869 | PII uridylyl-transferase; Provisional | 97.23 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.17 | |
| PRK03059 | 856 | PII uridylyl-transferase; Provisional | 97.05 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 96.98 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.96 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.94 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.78 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.76 | |
| PRK05007 | 884 | PII uridylyl-transferase; Provisional | 96.69 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.59 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.53 | |
| cd04927 | 76 | ACT_ACR-like_2 Second ACT domain, of a novel type | 96.48 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.45 | |
| TIGR01693 | 850 | UTase_glnD [Protein-PII] uridylyltransferase. This | 96.35 | |
| PRK01759 | 854 | glnD PII uridylyl-transferase; Provisional | 96.16 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.16 | |
| PLN02236 | 344 | choline kinase | 95.81 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.71 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 95.59 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.56 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.35 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.34 | |
| cd04925 | 74 | ACT_ACR_2 ACT domain-containing protein which is c | 95.29 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.04 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.77 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.64 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 94.58 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=312.75 Aligned_cols=190 Identities=23% Similarity=0.447 Sum_probs=171.8
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
.+|.+.++||+|+||.||+|++ ++..||||.+.....++...+-+..|++||+.++|||||++++++..++.+|||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 3577778899999999999987 46889999999887788888889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccC------CCeEEEEEeeccee---
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN------EVSLLLSLCLFTVS--- 440 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~------~~~kl~DFGla~~~--- 440 (492)
||.||+|.+||++ ++.+++..++.++.||+.||++||+++||||||||+||||+.. -.+||+|||+|+..
T Consensus 90 yC~gGDLs~yi~~-~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~ 168 (429)
T KOG0595|consen 90 YCNGGDLSDYIRR-RGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG 168 (429)
T ss_pred eCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch
Confidence 9999999999988 5689999999999999999999999999999999999999875 35899999999875
Q ss_pred ---eeeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 441 ---ILFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 441 ---~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
...+|++-|||||+.....|....|.|++ .....+|.++|.+
T Consensus 169 ~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 169 SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 35799999999999999999999999995 3345677777775
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=297.76 Aligned_cols=196 Identities=23% Similarity=0.354 Sum_probs=177.2
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeE
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 364 (492)
.+..++|++.++||+|+||+||.++. +++-+|+|++++.... ....+....|..||.+++||.||+++..|++..++
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 35567899999999999999999975 6788999999877543 34567788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee----
Q 011158 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS---- 440 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~---- 440 (492)
|||+||+.||.|+..|++ .+.+++..+..++..|+.||.|||++|||||||||+|||+|++|.++|+|||+++..
T Consensus 101 ylVld~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQR-EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred EEEEeccCCccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence 999999999999999987 578999999999999999999999999999999999999999999999999999854
Q ss_pred ---eeeeCCCceeecceeccccccCccceeee---ecccccCCCCCCCcc
Q 011158 441 ---ILFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDAPF 484 (492)
Q Consensus 441 ---~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~aPE 484 (492)
..++||..|||||++....|....|||++ +..+.+|-++|.++-
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~ 229 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED 229 (357)
T ss_pred CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc
Confidence 35799999999999999999999999995 556778888888763
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=293.60 Aligned_cols=191 Identities=20% Similarity=0.322 Sum_probs=164.0
Q ss_pred CCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCh-----HHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 011158 290 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS-----DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (492)
Q Consensus 290 ~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 362 (492)
..+.|.+.+.||+|+||.|-+|.. +++.||||+++...... .......+|++||++|+|||||+++++|..++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 345678889999999999999976 67999999998764322 12234579999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccC---CCeEEEEEeecce
Q 011158 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN---EVSLLLSLCLFTV 439 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~---~~~kl~DFGla~~ 439 (492)
..|||||||.||+|.+++-. .+.+.+..-+.+++|++.|+.|||++||+||||||+|||+..+ ..+||.|||+|++
T Consensus 250 s~YmVlE~v~GGeLfd~vv~-nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA-NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred ceEEEEEEecCccHHHHHHh-ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 99999999999999999987 4667888889999999999999999999999999999999866 7899999999987
Q ss_pred e------eeeeCCCceeecceeccccccCcc---ceeee---ecccccCCCCCC
Q 011158 440 S------ILFCGKGRELISLFLGNDVLLQFG---TYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 440 ~------~~~~g~~~~~ape~~~~e~~~~~~---d~W~l---~~~~~~gt~~Y~ 481 (492)
. ...|||+.|.|||++....+.... |.|++ .....+|+|+|.
T Consensus 329 ~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS 382 (475)
T KOG0615|consen 329 SGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFS 382 (475)
T ss_pred cccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcc
Confidence 6 468999999999999886665555 99994 344567888765
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=300.93 Aligned_cols=186 Identities=37% Similarity=0.636 Sum_probs=167.1
Q ss_pred CCCceeeCCCCceeeeeeeecCceEEEEEEECCce-EEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 011158 283 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (492)
Q Consensus 283 ~~~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g~~-vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 361 (492)
....|+|+...+.+.+.||+|+||+||+|.|.|+. ||||++.....+....+.|.+|+.+|.+++|||||+++|+|..+
T Consensus 32 ~~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~ 111 (362)
T KOG0192|consen 32 ELPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP 111 (362)
T ss_pred cccceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 34668999999999999999999999999999988 99999987765555578999999999999999999999999998
Q ss_pred C-eEEEEEeccCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCCCCEEEccCC-CeEEEEEeec
Q 011158 362 P-SLCIVTEFMSGGSVYDYLHK-LKGVFKLPSLLKVAIDVSKGMNYLHQNN-IIHRDLKAANLLMDENE-VSLLLSLCLF 437 (492)
Q Consensus 362 ~-~~~lV~Ey~~ggsL~~~L~~-~~~~l~~~~~~~i~~qI~~gL~yLH~~~-IiHrDLKp~NILld~~~-~~kl~DFGla 437 (492)
. .++||||||++|+|.+++++ .+..+++..++.++.||++||+|||+++ ||||||||+|||++.++ .+||+|||++
T Consensus 112 ~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGls 191 (362)
T KOG0192|consen 112 PGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLS 191 (362)
T ss_pred CCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccc
Confidence 8 79999999999999999988 4678999999999999999999999999 99999999999999997 9999999999
Q ss_pred ceeee-------eeCCCceeecceecc--ccccCccceee
Q 011158 438 TVSIL-------FCGKGRELISLFLGN--DVLLQFGTYWI 468 (492)
Q Consensus 438 ~~~~~-------~~g~~~~~ape~~~~--e~~~~~~d~W~ 468 (492)
+.... ..||..|||||.+.. ..|...+|.|+
T Consensus 192 r~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvyS 231 (362)
T KOG0192|consen 192 REKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYS 231 (362)
T ss_pred eeeccccccccCCCCCccccChhhhcCCCCcCCccchhhh
Confidence 76543 567888999999984 47777776533
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=290.15 Aligned_cols=180 Identities=27% Similarity=0.417 Sum_probs=165.0
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCe-E
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-L 364 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~-~ 364 (492)
.+...+++.++.||+|..|+||++.++ ++-+|+|++.. ..+....+++.+|++|+++++|||||.+||+|..+.. +
T Consensus 75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL-NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 355567888899999999999999884 78899999954 4567788999999999999999999999999999995 9
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEccCCCeEEEEEeeccee---
Q 011158 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVSLLLSLCLFTVS--- 440 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~-~~IiHrDLKp~NILld~~~~~kl~DFGla~~~--- 440 (492)
+|+||||.+|||.+++... +.+++..+.+|+.+|++||.|||. ++||||||||+|||++..|.+||+|||.++..
T Consensus 154 sI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred EeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 9999999999999999874 779999999999999999999996 89999999999999999999999999999754
Q ss_pred --eeeeCCCceeecceeccccccCccceeee
Q 011158 441 --ILFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 441 --~~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
..+.||..||+||-+..+.|+..+|+|++
T Consensus 233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSL 263 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISGESYSVKSDIWSL 263 (364)
T ss_pred hcccccccccccChhhhcCCcCCcccceecc
Confidence 56889999999999999999999999996
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=297.96 Aligned_cols=192 Identities=23% Similarity=0.345 Sum_probs=174.2
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 367 (492)
...|+.++.||+|+|..||++++ +|+.||+|++.+..+ .....+.+.+||+|.++|+|||||+++++|++.+++|||
T Consensus 17 ~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 17 SKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred cceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEE
Confidence 36799999999999999999987 689999999987543 345678899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee------
Q 011158 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------ 441 (492)
Q Consensus 368 ~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------ 441 (492)
+|+|..++|..++++ ++.+++++++.+++||+.||.|||+++|||||||..||+++++..+||+|||+|....
T Consensus 97 LELC~~~sL~el~Kr-rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk 175 (592)
T KOG0575|consen 97 LELCHRGSLMELLKR-RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERK 175 (592)
T ss_pred EEecCCccHHHHHHh-cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccccc
Confidence 999999999999985 6789999999999999999999999999999999999999999999999999997653
Q ss_pred -eeeCCCceeecceeccccccCccceeee---ecccccCCCCCCCc
Q 011158 442 -LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDAP 483 (492)
Q Consensus 442 -~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~aP 483 (492)
..+||+.|.|||++.....+...|+|++ +...-+|.|+|+.-
T Consensus 176 ~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk 221 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK 221 (592)
T ss_pred ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc
Confidence 5799999999999998888888999994 55667888888764
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=293.15 Aligned_cols=182 Identities=34% Similarity=0.592 Sum_probs=163.0
Q ss_pred CCceeeCCCCceeeeeeeecCceEEEEEEECCc-eEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 011158 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (492)
Q Consensus 284 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g~-~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 362 (492)
.+.|+|+++.+++++.||+|-||.||.|.|+++ +||+|.++...+.. +.|.+|+.||++|+|+|||+++++|..+.
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~---~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~ 274 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSP---EAFLREAQIMKKLRHEKLVKLYGVCTKQE 274 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccCh---hHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence 678999999999999999999999999999886 89999999865443 67889999999999999999999999988
Q ss_pred eEEEEEeccCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee
Q 011158 363 SLCIVTEFMSGGSVYDYLHK-LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI 441 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~-~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~ 441 (492)
.+|||||||+.|+|.+||+. ....+...+++.++.|||+||+||+++++|||||.++||||+++..+||+|||+|+...
T Consensus 275 piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 275 PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIG 354 (468)
T ss_pred ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccC
Confidence 99999999999999999987 45689999999999999999999999999999999999999999999999999999532
Q ss_pred --eee---C---CCceeecceeccccccCccceee
Q 011158 442 --LFC---G---KGRELISLFLGNDVLLQFGTYWI 468 (492)
Q Consensus 442 --~~~---g---~~~~~ape~~~~e~~~~~~d~W~ 468 (492)
.+. + ...|.|||.+.-..++..+|.|+
T Consensus 355 d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWS 389 (468)
T KOG0197|consen 355 DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWS 389 (468)
T ss_pred CCceeecCCCCCCceecCHHHHhhCCcccccceee
Confidence 111 1 13578888887777888888887
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=268.19 Aligned_cols=191 Identities=22% Similarity=0.350 Sum_probs=170.5
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 367 (492)
.++|++++.||.|+||.|.+++. ++..+|+|+++.+.. .-...+...+|..+|+.+.||+++++++.|.+..++|||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 45788889999999999999977 568899999987643 234456678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee----eee
Q 011158 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS----ILF 443 (492)
Q Consensus 368 ~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~----~~~ 443 (492)
|||.+||.|+.++++ .++++++.++.++.||+.||+|||+++||+|||||+|||||.+|.+||.|||.|+.. ...
T Consensus 123 meyv~GGElFS~Lrk-~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~rT~Tl 201 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRK-SGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGRTWTL 201 (355)
T ss_pred EeccCCccHHHHHHh-cCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCcEEEe
Confidence 999999999999988 578999999999999999999999999999999999999999999999999999654 468
Q ss_pred eCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 444 CGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 444 ~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
||++.|++||.+....+....|||++ ...+.+|.++|-+
T Consensus 202 CGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~ 243 (355)
T KOG0616|consen 202 CGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYD 243 (355)
T ss_pred cCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcC
Confidence 99999999999999999999999994 4456677776654
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=286.10 Aligned_cols=198 Identities=30% Similarity=0.569 Sum_probs=169.0
Q ss_pred CCCCceeeCCCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 011158 282 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (492)
Q Consensus 282 ~~~~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 361 (492)
+..++|+|..+.+.+++.||+|+||+||+|.|.| +||||+++.+..+++..+.|++|+.++++-+|.||+-|.|+|..+
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 3457899999999999999999999999999976 689999999988888999999999999999999999999999998
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee
Q 011158 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI 441 (492)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~ 441 (492)
+. .||+-+|+|-+|+.+|+..+..|.....+.|+.||++||.|||.++|||||||..||++.+++.+||.|||+|....
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence 76 99999999999999999877889999999999999999999999999999999999999999999999999998765
Q ss_pred ee---------eCCCceeecceeccc---cccCccceee---eecccccCCCCCC
Q 011158 442 LF---------CGKGRELISLFLGND---VLLQFGTYWI---IFRRSSCDKKNSD 481 (492)
Q Consensus 442 ~~---------~g~~~~~ape~~~~e---~~~~~~d~W~---l~~~~~~gt~~Y~ 481 (492)
.. .+...|||||++.-. .|+..+|.|+ ++.+..+|..+|.
T Consensus 540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys 594 (678)
T KOG0193|consen 540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS 594 (678)
T ss_pred eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC
Confidence 43 344567888865432 2333334333 1223446666665
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=279.46 Aligned_cols=191 Identities=21% Similarity=0.303 Sum_probs=155.9
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--CeEEE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLCI 366 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~l 366 (492)
.+.|+.+++||+|+||.||+|++ +|+.||+|.+..+...........+||.||++|+||||+++.+..... ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 35688889999999999999987 578899999998876666677788999999999999999999999877 68999
Q ss_pred EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeeeee--
Q 011158 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSILFC-- 444 (492)
Q Consensus 367 V~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~~~-- 444 (492)
|+||| .-+|.-++....-.|++.+++.++.|++.||+|||.+||+|||||.+|||||.+|.+||+|||+|++-....
T Consensus 196 VFeYM-dhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~ 274 (560)
T KOG0600|consen 196 VFEYM-DHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSA 274 (560)
T ss_pred EEecc-cchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCc
Confidence 99999 559999987756689999999999999999999999999999999999999999999999999999643211
Q ss_pred -CCCc-----eeecce-eccccccCccceee---eecccccCCCCCCC
Q 011158 445 -GKGR-----ELISLF-LGNDVLLQFGTYWI---IFRRSSCDKKNSDA 482 (492)
Q Consensus 445 -g~~~-----~~ape~-~~~e~~~~~~d~W~---l~~~~~~gt~~Y~a 482 (492)
-|.+ |.+||. ++...|+...|.|+ ++.....|.|-+..
T Consensus 275 ~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G 322 (560)
T KOG0600|consen 275 PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQG 322 (560)
T ss_pred ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCC
Confidence 2222 334442 23344555667787 45555555555443
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-33 Score=270.83 Aligned_cols=180 Identities=18% Similarity=0.314 Sum_probs=162.5
Q ss_pred CCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEE-EEecCCe-EE
Q 011158 290 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG-ACTKPPS-LC 365 (492)
Q Consensus 290 ~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g-~~~~~~~-~~ 365 (492)
...+|++.++||.|+||.||++.. .|..||.|.++-+.++....+....|+.+|++|+|||||++++ .+..... ++
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 345789999999999999999976 6889999999988888888899999999999999999999998 4544444 89
Q ss_pred EEEeccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH--CC--ceecCCCCCCEEEccCCCeEEEEEeecc
Q 011158 366 IVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQ--NN--IIHRDLKAANLLMDENEVSLLLSLCLFT 438 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~---~~~~l~~~~~~~i~~qI~~gL~yLH~--~~--IiHrDLKp~NILld~~~~~kl~DFGla~ 438 (492)
||||||.+|+|.+.|+. .+..++++.+++++.|++.||.+||. .+ |+||||||+||+++.+|.+|++|||+++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 99999999999999964 35679999999999999999999999 45 9999999999999999999999999998
Q ss_pred ee-------eeeeCCCceeecceeccccccCccceeee
Q 011158 439 VS-------ILFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 439 ~~-------~~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
.. ..+.||+.||+||.+....|...+|+|++
T Consensus 177 ~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWsl 214 (375)
T KOG0591|consen 177 FLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSL 214 (375)
T ss_pred HhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHH
Confidence 64 35789999999999999999999999994
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-32 Score=278.37 Aligned_cols=175 Identities=29% Similarity=0.486 Sum_probs=154.4
Q ss_pred CCceeeeeeeecCceEEEEEEECC-ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC-eEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP-SLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~g-~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-~~~lV~E 369 (492)
++|.-...||+|+||.||+|...+ +.||||++....... ..+|.+|+.++.+++|||+|+++|||.+.+ ..+||+|
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYE 152 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYE 152 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEE
Confidence 566666899999999999999865 889999887653322 456999999999999999999999999988 4999999
Q ss_pred ccCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCCCCEEEccCCCeEEEEEeecceeee---
Q 011158 370 FMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNN---IIHRDLKAANLLMDENEVSLLLSLCLFTVSIL--- 442 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~---IiHrDLKp~NILld~~~~~kl~DFGla~~~~~--- 442 (492)
||++|+|.++|+.... .++|..+++|+.++|+||+|||... ||||||||+|||+|+++.+||+|||+++....
T Consensus 153 ym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~ 232 (361)
T KOG1187|consen 153 YMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDT 232 (361)
T ss_pred ccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcccc
Confidence 9999999999988666 8999999999999999999999963 99999999999999999999999999976532
Q ss_pred ----e-eCCCceeecceeccccccCccceee
Q 011158 443 ----F-CGKGRELISLFLGNDVLLQFGTYWI 468 (492)
Q Consensus 443 ----~-~g~~~~~ape~~~~e~~~~~~d~W~ 468 (492)
. .|+..|++|||.....+....|.|+
T Consensus 233 ~~~~~~~gt~gY~~PEy~~~g~lt~KsDVyS 263 (361)
T KOG1187|consen 233 SVSTTVMGTFGYLAPEYASTGKLTEKSDVYS 263 (361)
T ss_pred ceeeecCCCCccCChhhhccCCcCccccccc
Confidence 1 6778899999998888888888777
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=276.27 Aligned_cols=194 Identities=26% Similarity=0.479 Sum_probs=168.6
Q ss_pred eCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC---hHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCC
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN---SDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPP 362 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~---~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~ 362 (492)
.....|.+++.||+|+||.|+.|.. ++..||+|++..+... ....+.+.+|+.++++++ ||||++++.++..+.
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3446788999999999999999977 5789999988765222 134556778999999999 999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccC-CCeEEEEEeeccee-
Q 011158 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-EVSLLLSLCLFTVS- 440 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~-~~~kl~DFGla~~~- 440 (492)
.+||||||+.||+|++++.+ .+++.+..+..++.|++.|++|||++||+||||||+|||++.+ +.+||+|||++...
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 99999999999999999998 7899999999999999999999999999999999999999999 99999999999865
Q ss_pred ------eeeeCCCceeecceecccc-cc-Cccceeee---ecccccCCCCCCCc
Q 011158 441 ------ILFCGKGRELISLFLGNDV-LL-QFGTYWII---FRRSSCDKKNSDAP 483 (492)
Q Consensus 441 ------~~~~g~~~~~ape~~~~e~-~~-~~~d~W~l---~~~~~~gt~~Y~aP 483 (492)
...+|++.|++||.+.... |. ...|+|++ .....||..+|..+
T Consensus 173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~ 226 (370)
T KOG0583|consen 173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS 226 (370)
T ss_pred CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc
Confidence 2578999999999888866 75 55699994 44566787777753
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-32 Score=264.80 Aligned_cols=188 Identities=22% Similarity=0.268 Sum_probs=158.6
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
+.|+.+.++|+|+||.||+|++ +|+.||||++.....++...+-.++|+++|++++|+|+|.++++|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 4577788999999999999976 68999999998766666677778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------e
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-------L 442 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-------~ 442 (492)
||. -++.+-|.+....++...+..++.|++.|+.|+|+++||||||||+||||+.++.+|+||||.|+... .
T Consensus 82 ~~d-hTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTD 160 (396)
T KOG0593|consen 82 YCD-HTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTD 160 (396)
T ss_pred ecc-hHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhh
Confidence 994 46667777777789999999999999999999999999999999999999999999999999998764 2
Q ss_pred eeCCCceeecceecc-ccccCccceeee---ecccccCCCCC
Q 011158 443 FCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNS 480 (492)
Q Consensus 443 ~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y 480 (492)
+..|.-|.+||.+-+ -.|+...|+|++ +....-|.|-|
T Consensus 161 YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~ 202 (396)
T KOG0593|consen 161 YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLW 202 (396)
T ss_pred hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCC
Confidence 344455666765433 567777889985 55555555543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=276.87 Aligned_cols=194 Identities=24% Similarity=0.359 Sum_probs=170.4
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChH-HHHHHHHHHHHHHhc-CCCceeeEEEEEecCCe
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSD-MQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPS 363 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~-~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~ 363 (492)
....++|++++.||.|+|++||+|+. +++.||||++.+..+..+ ..+-+.+|-.+|.+| .||.|++|+-.|.+...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 44567999999999999999999987 578999999986543222 234567799999999 79999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee---
Q 011158 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS--- 440 (492)
Q Consensus 364 ~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~--- 440 (492)
+|+|+||+++|+|.++|++ -+.|++...+.++.||+.||+|||++|||||||||+|||+|.++.+||.|||.|++.
T Consensus 149 LYFvLe~A~nGdll~~i~K-~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKK-YGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred eEEEEEecCCCcHHHHHHH-hCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 9999999999999999988 478999999999999999999999999999999999999999999999999998652
Q ss_pred -----------------eeeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 441 -----------------ILFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 441 -----------------~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
..+.||..|.+||.+.........|+|++ ..-+..|.|+|-+
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra 289 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRA 289 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcc
Confidence 23788999999999999999999999984 3345678888876
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=271.85 Aligned_cols=190 Identities=22% Similarity=0.385 Sum_probs=166.6
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 367 (492)
..+|++.+.||+|+||.|-++.. .|+.||||.++++.+. ....-.+.+||+||..|+||||+++|.+|++.+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 35788899999999999999976 5899999999887653 44566789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee------e
Q 011158 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS------I 441 (492)
Q Consensus 368 ~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~------~ 441 (492)
|||..+|.|+||+.+ .+.|++.....|++||..|+.|||+++++|||||.+|||+|.|+.+||+|||++.+- .
T Consensus 132 MEYaS~GeLYDYiSe-r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLq 210 (668)
T KOG0611|consen 132 MEYASGGELYDYISE-RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQ 210 (668)
T ss_pred EEecCCccHHHHHHH-hccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHHH
Confidence 999999999999987 578999999999999999999999999999999999999999999999999998653 4
Q ss_pred eeeCCCceeecceeccccc-cCccceeee---ecccccCCCCCC
Q 011158 442 LFCGKGRELISLFLGNDVL-LQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 ~~~g~~~~~ape~~~~e~~-~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
.+||++-|.+||+..+..| +...|-|++ .....+||.+|+
T Consensus 211 TFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFD 254 (668)
T KOG0611|consen 211 TFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFD 254 (668)
T ss_pred HhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccC
Confidence 6899999999997766555 445688984 334567777665
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=281.15 Aligned_cols=190 Identities=24% Similarity=0.389 Sum_probs=171.2
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
++|.+.+.||+|+||.||||+. +.+.||+|.+.+..-..+..+.+.+|++|+++++|||||.++++|+...++|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 4677889999999999999975 56889999998776667778889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee-------ee
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS-------IL 442 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~-------~~ 442 (492)
|+.| +|..+|.. .+.+++.++..|+.|++.||.|||+++|+|||+||.|||++..+.+|++|||+|+.. ..
T Consensus 82 ~a~g-~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlts 159 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTS 159 (808)
T ss_pred hhhh-hHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeee
Confidence 9955 99999977 688999999999999999999999999999999999999999999999999999864 35
Q ss_pred eeCCCceeecceeccccccCccceeee---ecccccCCCCCCCc
Q 011158 443 FCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDAP 483 (492)
Q Consensus 443 ~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~aP 483 (492)
..|++-||+||......|....|.|++ ......|.|+|-|-
T Consensus 160 ikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~ 203 (808)
T KOG0597|consen 160 IKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR 203 (808)
T ss_pred ccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH
Confidence 679999999999999999999999994 44566777776554
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=273.92 Aligned_cols=149 Identities=21% Similarity=0.300 Sum_probs=136.4
Q ss_pred eCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEE
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 365 (492)
+..++|++++.||+|+||.||+|+. +|..+|+|++++..+ .....+.++.|-.||....+++||+++..|++..++|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 4556888999999999999999965 789999999987644 3345567888999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecc
Q 011158 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFT 438 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~ 438 (492)
|||||++||++..+|.+ .+.|++..+..++.+++.|++-||+.|+|||||||+|+|||..|.+||+|||++.
T Consensus 218 LiMEylPGGD~mTLL~~-~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMR-KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred EEEEecCCccHHHHHHh-cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccc
Confidence 99999999999999987 6789999999999999999999999999999999999999999999999999983
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=272.74 Aligned_cols=185 Identities=29% Similarity=0.493 Sum_probs=162.1
Q ss_pred CCceeeCCCCceeeeeeeecCceEEEEEEEC--C---ce-EEEEEecCC-CCChHHHHHHHHHHHHHHhcCCCceeeEEE
Q 011158 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--S---QD-VAIKVLKPE-RINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356 (492)
Q Consensus 284 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~--g---~~-vAvK~l~~~-~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g 356 (492)
...|++..++..+.++||+|+||.||+|++. + .. ||||..+.+ ........+|.+|.++|++++|||||++||
T Consensus 149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG 228 (474)
T KOG0194|consen 149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG 228 (474)
T ss_pred ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 4559999999999999999999999999872 1 23 899999863 366778899999999999999999999999
Q ss_pred EEecCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEee
Q 011158 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCL 436 (492)
Q Consensus 357 ~~~~~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGl 436 (492)
++.....++||||+|+||+|.++|++.++.++..+...++.+.+.||+|||++++|||||.++|+|++.++.+||+|||+
T Consensus 229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGL 308 (474)
T KOG0194|consen 229 VAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGL 308 (474)
T ss_pred EEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCcccc
Confidence 99999999999999999999999999777899999999999999999999999999999999999999999999999999
Q ss_pred cceeeeee-------CCCceeecceeccccccCccceee
Q 011158 437 FTVSILFC-------GKGRELISLFLGNDVLLQFGTYWI 468 (492)
Q Consensus 437 a~~~~~~~-------g~~~~~ape~~~~e~~~~~~d~W~ 468 (492)
++....+. -..+|+|||.+....++...|.|+
T Consensus 309 s~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~s 347 (474)
T KOG0194|consen 309 SRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWS 347 (474)
T ss_pred ccCCcceeeccccccCcceecChhhhccCccccccchhh
Confidence 98774221 225788898777766666666543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=260.93 Aligned_cols=189 Identities=24% Similarity=0.379 Sum_probs=157.0
Q ss_pred CCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC--eEEE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP--SLCI 366 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~--~~~l 366 (492)
..++..++.||+|+||.||++++. |...|||.+.... ....+.+.+|+.+|++++|||||+++|...... .++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~--~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED--SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc--chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 345777899999999999999885 6899999987652 222577899999999999999999999855444 6999
Q ss_pred EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcc-CCCeEEEEEeecceee----
Q 011158 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEVSLLLSLCLFTVSI---- 441 (492)
Q Consensus 367 V~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~-~~~~kl~DFGla~~~~---- 441 (492)
.|||+++|+|.+++.+..+.+++..++.+++||++||.|||++|||||||||+|||++. ++.+||+|||.++...
T Consensus 94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 99999999999999986668999999999999999999999999999999999999999 7999999999886432
Q ss_pred ------eeeCCCceeecceeccc-cccCccceeee---ecccccCCCCCC
Q 011158 442 ------LFCGKGRELISLFLGND-VLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 ------~~~g~~~~~ape~~~~e-~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...|+..||+||+..+. ......|.|++ +-.+.-|.++|.
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~ 223 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWS 223 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcch
Confidence 36788889999988852 23337899985 333444455544
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=250.79 Aligned_cols=185 Identities=19% Similarity=0.281 Sum_probs=157.6
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
.+|...++||+|+||.||+|++ +|+.||||.++.............+||..|+.++|+||+.++++|.....+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 3577788999999999999988 57899999999876665556778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeeee------
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSILF------ 443 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~~------ 443 (492)
|| ..+|...|+.....++..++..++.++++||+|||++.|+||||||.|+||+++|.+|++|||+++.-...
T Consensus 82 fm-~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~ 160 (318)
T KOG0659|consen 82 FM-PTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTH 160 (318)
T ss_pred ec-cccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccccc
Confidence 99 56999999987789999999999999999999999999999999999999999999999999999875321
Q ss_pred -eCCCceeecc-eeccccccCccceeee---ecccccCC
Q 011158 444 -CGKGRELISL-FLGNDVLLQFGTYWII---FRRSSCDK 477 (492)
Q Consensus 444 -~g~~~~~ape-~~~~e~~~~~~d~W~l---~~~~~~gt 477 (492)
.-+.=|.+|| .++...|....|+|++ +.+...+.
T Consensus 161 ~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~ 199 (318)
T KOG0659|consen 161 QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRV 199 (318)
T ss_pred ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccC
Confidence 2333355666 3466677888889983 44444444
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=273.35 Aligned_cols=176 Identities=20% Similarity=0.298 Sum_probs=146.8
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCC-eEEE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPP-SLCI 366 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~-~~~l 366 (492)
.++|.++++||.|+||.||+|+. .+..||||.++.....-+ .-.=++|+..|++++ |||||++.+++.+.+ .+|+
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~e-e~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHH-HHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 46899999999999999999976 578899999987654322 233468999999999 999999999999888 8999
Q ss_pred EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeeee---
Q 011158 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSILF--- 443 (492)
Q Consensus 367 V~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~~--- 443 (492)
||||| ..+|+++++..+..|++..+..|+.||++||+|+|++|+.|||+||+|||+..+..+||+|||+||.....
T Consensus 88 VfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPY 166 (538)
T KOG0661|consen 88 VFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPY 166 (538)
T ss_pred eHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCCc
Confidence 99999 78999999988889999999999999999999999999999999999999998889999999999987533
Q ss_pred ---eCCCceeeccee-ccccccCccceee
Q 011158 444 ---CGKGRELISLFL-GNDVLLQFGTYWI 468 (492)
Q Consensus 444 ---~g~~~~~ape~~-~~e~~~~~~d~W~ 468 (492)
..|.=|.|||.+ ....|....|+|+
T Consensus 167 TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA 195 (538)
T KOG0661|consen 167 TEYVSTRWYRAPEVLLRSGYYSSPVDMWA 195 (538)
T ss_pred chhhhcccccchHHhhhccccCCchHHHH
Confidence 333334444433 2233444455666
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-30 Score=264.75 Aligned_cols=190 Identities=18% Similarity=0.239 Sum_probs=161.6
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
.|+++++||+|+||.||+|++ +++.||||++..... .......+.+|+.++++++|+||+++++++...+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 578889999999999999987 467899999975432 33445678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee---------
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS--------- 440 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~--------- 440 (492)
|+++|+|.+++.+ ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 82 ~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 82 YIPGGDMMSLLIR-MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred cCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 9999999999976 456899999999999999999999999999999999999999999999999986421
Q ss_pred ---------------------------------------------eeeeCCCceeecceeccccccCccceeee---ecc
Q 011158 441 ---------------------------------------------ILFCGKGRELISLFLGNDVLLQFGTYWII---FRR 472 (492)
Q Consensus 441 ---------------------------------------------~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~ 472 (492)
....|+..|++||.+....+....|+|++ +..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~e 240 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHH
Confidence 12357778888988877777888899984 334
Q ss_pred cccCCCCCCCc
Q 011158 473 SSCDKKNSDAP 483 (492)
Q Consensus 473 ~~~gt~~Y~aP 483 (492)
...|.++|..+
T Consensus 241 lltG~~Pf~~~ 251 (381)
T cd05626 241 MLVGQPPFLAP 251 (381)
T ss_pred HHhCCCCCcCC
Confidence 55677777654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-30 Score=258.35 Aligned_cols=184 Identities=25% Similarity=0.379 Sum_probs=162.8
Q ss_pred CceeeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 011158 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (492)
Q Consensus 285 ~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 362 (492)
..|-++.++|++.++||.|..+.||+|.. ++..||||++..++.+.. ...+.+|+..|+.++||||++++..|....
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~ 97 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDS 97 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecc
Confidence 34778889999999999999999999987 578999999998877665 788999999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee-
Q 011158 363 SLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS- 440 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~- 440 (492)
.+|+||.||.+||+.++++.. +..+++..+..|++++++||.|||++|.||||||+.||||+.+|.+||+|||.....
T Consensus 98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 999999999999999999764 446999999999999999999999999999999999999999999999999885321
Q ss_pred ----------eeeeCCCceeecceecc--ccccCccceeee
Q 011158 441 ----------ILFCGKGRELISLFLGN--DVLLQFGTYWII 469 (492)
Q Consensus 441 ----------~~~~g~~~~~ape~~~~--e~~~~~~d~W~l 469 (492)
..+.++..||+||++.. ..|....|+|++
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSf 218 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSF 218 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhh
Confidence 34578888999998433 456777889983
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=275.45 Aligned_cols=193 Identities=24% Similarity=0.363 Sum_probs=170.2
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCe
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPS 363 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~ 363 (492)
.+..++|.++++||+|+||+|+++..+ ++.+|||+++++.+ ..+..+....|.+|+...+ ||.+++++..|+++++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 566789999999999999999999885 57899999998754 4456677888999988875 9999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee---
Q 011158 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS--- 440 (492)
Q Consensus 364 ~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~--- 440 (492)
+|+||||+.||++..+++ .+.+++..+..|+..|+.||.|||++|||+||||.+|||+|.+|.+||+|||+++..
T Consensus 444 l~fvmey~~Ggdm~~~~~--~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIH--TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred EEEEEEecCCCcEEEEEe--cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence 999999999999554443 378999999999999999999999999999999999999999999999999999764
Q ss_pred ----eeeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 441 ----ILFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 441 ----~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
..++||+.||+||++....|+...|||++ +..+.+|-++|-+
T Consensus 522 g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g 570 (694)
T KOG0694|consen 522 GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG 570 (694)
T ss_pred CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC
Confidence 36899999999999999999999999994 4456677777763
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-30 Score=263.98 Aligned_cols=189 Identities=17% Similarity=0.216 Sum_probs=159.7
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
++|++.+.||+|+||.||+|.. +++.||||+++.... .......+.+|+.++.+++|+||+++++.+.....+||||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 3688899999999999999987 468899999975422 2334467888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------- 441 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------- 441 (492)
|||+||+|.+++.+ .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~ 159 (363)
T cd05628 81 EFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF 159 (363)
T ss_pred cCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc
Confidence 99999999999977 4678999999999999999999999999999999999999999999999999986321
Q ss_pred -----------------------------------eeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 442 -----------------------------------LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 -----------------------------------~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...|+..|++||++....+....|+|++ +.....|.++|.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 2356777888888877777778888884 333445666664
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=262.08 Aligned_cols=189 Identities=17% Similarity=0.195 Sum_probs=160.1
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
++|++.+.||+|+||.||+|++ +++.||||+++.... .......+.+|+.+|+.++|+||+++++++.....+||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 3688899999999999999988 468899999975422 2334566888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------- 441 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------- 441 (492)
|||++|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 E~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 159 (364)
T cd05599 81 EYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF 159 (364)
T ss_pred CCCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence 99999999999976 4578999999999999999999999999999999999999999999999999975421
Q ss_pred --------------------------------------eeeCCCceeecceeccccccCccceeee---ecccccCCCCC
Q 011158 442 --------------------------------------LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNS 480 (492)
Q Consensus 442 --------------------------------------~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y 480 (492)
...|+..|++||+.....+....|+|++ +.....|.++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCC
Confidence 1246778888888877777888899984 33344566665
Q ss_pred C
Q 011158 481 D 481 (492)
Q Consensus 481 ~ 481 (492)
.
T Consensus 240 ~ 240 (364)
T cd05599 240 C 240 (364)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=264.36 Aligned_cols=193 Identities=21% Similarity=0.247 Sum_probs=155.1
Q ss_pred eCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChH------------HHHHHHHHHHHHHhcCCCceeeE
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSD------------MQKEFAQEVFIMRKVRHKNVVQF 354 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~------------~~~~~~~Ei~il~~l~HpnIv~l 354 (492)
...+.|++++.||+|.||.|-+|.+ .++.||||++.+...... ..+...+||.||+++.|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 3457899999999999999999988 468899999976532211 13578999999999999999999
Q ss_pred EEEEecC--CeEEEEEeccCCCCHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEE
Q 011158 355 IGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLL 431 (492)
Q Consensus 355 ~g~~~~~--~~~~lV~Ey~~ggsL~~~L~~~~~~-l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl 431 (492)
+.+..++ +++|||+|||..|.+...=. ... +++.++++|+++++.||+|||.+|||||||||+|+||+++|.+||
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~--d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKI 251 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPP--DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKI 251 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCC--CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEe
Confidence 9998765 56999999999888754321 234 899999999999999999999999999999999999999999999
Q ss_pred EEEeeccee------------eeeeCCCceeecceecc---ccccC-ccceeee---ecccccCCCCCCCc
Q 011158 432 LSLCLFTVS------------ILFCGKGRELISLFLGN---DVLLQ-FGTYWII---FRRSSCDKKNSDAP 483 (492)
Q Consensus 432 ~DFGla~~~------------~~~~g~~~~~ape~~~~---e~~~~-~~d~W~l---~~~~~~gt~~Y~aP 483 (492)
+|||.+-.. ....||+.++|||.+.. ..+.+ .-|+|++ ..+..+|..+|.+-
T Consensus 252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~ 322 (576)
T KOG0585|consen 252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD 322 (576)
T ss_pred eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence 999998643 13568888888887755 22333 3378985 33556677777664
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=262.64 Aligned_cols=189 Identities=17% Similarity=0.173 Sum_probs=159.4
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
++|++.++||+|+||.||++.. +++.||||++..... .......+.+|+.++++++||||+++++++.....+||||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3688899999999999999987 568899999865322 2344567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------- 441 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------- 441 (492)
||+++|+|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+|++|||+++...
T Consensus 81 E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 159 (377)
T cd05629 81 EFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY 159 (377)
T ss_pred eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 99999999999976 4578999999999999999999999999999999999999999999999999885210
Q ss_pred -----------------------------------------------eeeCCCceeecceeccccccCccceeee---ec
Q 011158 442 -----------------------------------------------LFCGKGRELISLFLGNDVLLQFGTYWII---FR 471 (492)
Q Consensus 442 -----------------------------------------------~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~ 471 (492)
...|+..|++||+.....+....|+|++ +.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ 239 (377)
T cd05629 160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF 239 (377)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhh
Confidence 1246777888888877778888899984 33
Q ss_pred ccccCCCCCC
Q 011158 472 RSSCDKKNSD 481 (492)
Q Consensus 472 ~~~~gt~~Y~ 481 (492)
....|.++|.
T Consensus 240 elltG~~Pf~ 249 (377)
T cd05629 240 ECLIGWPPFC 249 (377)
T ss_pred hhhcCCCCCC
Confidence 4455666664
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-30 Score=260.40 Aligned_cols=194 Identities=25% Similarity=0.427 Sum_probs=158.7
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeEEEEE
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGAC 358 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~~-------g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~ 358 (492)
|.++.++|++.++||+|+||.||+|.+. ++.||||+++... .......+.+|+.+++++ +||||++++++|
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 7888999999999999999999999752 3569999997532 334456789999999999 899999999998
Q ss_pred ecCC-eEEEEEeccCCCCHHHHHHhcC-----------------------------------------------------
Q 011158 359 TKPP-SLCIVTEFMSGGSVYDYLHKLK----------------------------------------------------- 384 (492)
Q Consensus 359 ~~~~-~~~lV~Ey~~ggsL~~~L~~~~----------------------------------------------------- 384 (492)
...+ .+++||||+++|+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 7644 5899999999999999997532
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee---------eeCCC
Q 011158 385 --------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL---------FCGKG 447 (492)
Q Consensus 385 --------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~---------~~g~~ 447 (492)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ..++.
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 2477888999999999999999999999999999999999999999999999875321 12234
Q ss_pred ceeecceeccccccCccceeee----ecccccCCCCCC
Q 011158 448 RELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSD 481 (492)
Q Consensus 448 ~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~ 481 (492)
.|++||+.....+...+|+|++ +.....|.++|.
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~ 278 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP 278 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCC
Confidence 6899998888788888899984 222334655554
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=260.50 Aligned_cols=189 Identities=17% Similarity=0.236 Sum_probs=159.3
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
+|++.++||+|+||.||++.. +++.||||++..... .......+.+|+.+|++++|+||+++++.+...+.+|||||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 688899999999999999987 468899999865322 12234668899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee---------
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS--------- 440 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~--------- 440 (492)
||++|+|.+++.+ .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 82 ~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 82 YIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 9999999999977 457899999999999999999999999999999999999999999999999986311
Q ss_pred -----------------------------------------eeeeCCCceeecceeccccccCccceeee---ecccccC
Q 011158 441 -----------------------------------------ILFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCD 476 (492)
Q Consensus 441 -----------------------------------------~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~g 476 (492)
....|+..|++||++....+....|+|++ +....+|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G 240 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhC
Confidence 01357778899998888778888899984 3344556
Q ss_pred CCCCCC
Q 011158 477 KKNSDA 482 (492)
Q Consensus 477 t~~Y~a 482 (492)
.++|..
T Consensus 241 ~~Pf~~ 246 (376)
T cd05598 241 QPPFLA 246 (376)
T ss_pred CCCCCC
Confidence 666654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=261.75 Aligned_cols=188 Identities=17% Similarity=0.231 Sum_probs=158.5
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
.|.++++||+|+||.||+|.. +++.||+|++..... .......+.+|+.++++++|+||+++++.+...+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 578899999999999999987 467899999875322 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee---------
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS--------- 440 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~--------- 440 (492)
||++|+|.+++.+ .+.+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++...
T Consensus 82 ~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 82 YIPGGDMMSLLIR-MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 9999999999976 356899999999999999999999999999999999999999999999999986421
Q ss_pred ---------------------------------------------eeeeCCCceeecceeccccccCccceeee---ecc
Q 011158 441 ---------------------------------------------ILFCGKGRELISLFLGNDVLLQFGTYWII---FRR 472 (492)
Q Consensus 441 ---------------------------------------------~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~ 472 (492)
....|+..|++||+.....+....|+|++ +..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHH
Confidence 11246777888888877778888899985 333
Q ss_pred cccCCCCCC
Q 011158 473 SSCDKKNSD 481 (492)
Q Consensus 473 ~~~gt~~Y~ 481 (492)
...|.++|.
T Consensus 241 lltG~~Pf~ 249 (382)
T cd05625 241 MLVGQPPFL 249 (382)
T ss_pred HHhCCCCCC
Confidence 445666664
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=255.80 Aligned_cols=188 Identities=20% Similarity=0.267 Sum_probs=162.5
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
+|++.++||+|+||.||+|++ +++.||||+++..... ......+.+|+.+++.++||||+++++++...+..|||||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 688899999999999999988 4688999999754321 2345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee----eeeC
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI----LFCG 445 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~----~~~g 445 (492)
|+++|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... ...+
T Consensus 82 ~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~~~~g 160 (333)
T cd05600 82 YVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVG 160 (333)
T ss_pred CCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCcccccccCCccc
Confidence 9999999999976 4578999999999999999999999999999999999999999999999999987542 3467
Q ss_pred CCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 446 KGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 446 ~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
+..|++||+.....+....|+|++ +....+|.++|.
T Consensus 161 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~ 199 (333)
T cd05600 161 SPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFS 199 (333)
T ss_pred CccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCC
Confidence 788999999888888888999984 334456666664
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=256.51 Aligned_cols=191 Identities=21% Similarity=0.312 Sum_probs=163.5
Q ss_pred CCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEE
Q 011158 290 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (492)
Q Consensus 290 ~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 366 (492)
...+|++.+.||+|+||.||+|++ +++.||+|+++.... .......+.+|+.++++++||||+++++++...+.+|+
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 346899999999999999999988 468899999975422 22345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee----e
Q 011158 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI----L 442 (492)
Q Consensus 367 V~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~----~ 442 (492)
||||+++|+|.+++.+ .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... .
T Consensus 96 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 174 (329)
T PTZ00263 96 LLEFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT 174 (329)
T ss_pred EEcCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCcce
Confidence 9999999999999977 4578999999999999999999999999999999999999999999999999987542 3
Q ss_pred eeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 443 FCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 443 ~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
..|+..|++||+.....+....|+|++ +.....|.++|.
T Consensus 175 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 216 (329)
T PTZ00263 175 LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFF 216 (329)
T ss_pred ecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCC
Confidence 467788999999888888888999984 223445666554
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-30 Score=269.07 Aligned_cols=174 Identities=25% Similarity=0.402 Sum_probs=158.8
Q ss_pred ceeeeeeeecCceEEEEEEE--CCceEEEEEecCC-CCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEec
Q 011158 294 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPE-RINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (492)
Q Consensus 294 ~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~-~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 370 (492)
|++++.||+|+.|.|-+|++ +|+.+|||++... .........+.+||.||+-+.||||+++|+++++..++|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 56679999999999999988 6899999999766 44555567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee------eeee
Q 011158 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS------ILFC 444 (492)
Q Consensus 371 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~------~~~~ 444 (492)
++||.|+++|.+ ++++++....++++||+.|+.|||..+|+||||||+|+|+|.++.+||+|||.|.+. ...|
T Consensus 94 v~gGELFdylv~-kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeTSC 172 (786)
T KOG0588|consen 94 VPGGELFDYLVR-KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLETSC 172 (786)
T ss_pred cCCchhHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCccccccC
Confidence 999999999987 688999999999999999999999999999999999999999999999999999764 4679
Q ss_pred CCCceeecceeccccccCc-cceee
Q 011158 445 GKGRELISLFLGNDVLLQF-GTYWI 468 (492)
Q Consensus 445 g~~~~~ape~~~~e~~~~~-~d~W~ 468 (492)
|++.|.+||++.++.|.++ +|.|+
T Consensus 173 GSPHYA~PEIV~G~pYdG~~sDVWS 197 (786)
T KOG0588|consen 173 GSPHYAAPEIVSGRPYDGRPSDVWS 197 (786)
T ss_pred CCcccCCchhhcCCCCCCCccccch
Confidence 9999999999988888765 48888
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=257.39 Aligned_cols=196 Identities=22% Similarity=0.315 Sum_probs=165.4
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEECC---ceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCS---QDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g---~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 362 (492)
+.+..++|++.+.||+|+||.||+|++.+ ..||+|++..... .......+.+|+.+++.++||||+++++++...+
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 45667789999999999999999998642 5799999865322 2334567889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee--
Q 011158 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS-- 440 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~-- 440 (492)
.+|+||||+++|+|.+++.+ ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999999999999977 457899999999999999999999999999999999999999999999999998653
Q ss_pred --eeeeCCCceeecceeccccccCccceeee---ecccccCCCCCCCc
Q 011158 441 --ILFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDAP 483 (492)
Q Consensus 441 --~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~aP 483 (492)
....|+..|++||+.....+....|+|++ +.....|.++|...
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 231 (340)
T PTZ00426 184 RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN 231 (340)
T ss_pred CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCC
Confidence 23467788999998877777788899994 33344566666543
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=255.96 Aligned_cols=189 Identities=17% Similarity=0.219 Sum_probs=160.1
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
++|++.+.||+|+||.||++.. +++.||||+++... ........+.+|+.++.+++|+||+++++.+...+.+||||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 3678889999999999999987 46889999997532 12334567888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------- 441 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------- 441 (492)
|||+||+|.+++.+ .+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~ 159 (360)
T cd05627 81 EFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF 159 (360)
T ss_pred eCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence 99999999999976 4578999999999999999999999999999999999999999999999999875321
Q ss_pred -----------------------------------eeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 442 -----------------------------------LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 -----------------------------------~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...|+..|++||+.....+....|+|++ +....+|.++|.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 1347778899998877778888899984 334455666653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=252.83 Aligned_cols=183 Identities=21% Similarity=0.346 Sum_probs=156.3
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEeccCCC
Q 011158 298 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG 374 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~gg 374 (492)
+.||+|+||.||++.. .++.||||+++.... .......+.+|+.++++++||||+++++++...+.+||||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4689999999999987 468899999975432 2334567889999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee-------eeeeCCC
Q 011158 375 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS-------ILFCGKG 447 (492)
Q Consensus 375 sL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~-------~~~~g~~ 447 (492)
+|.+++.+ .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.. ....|+.
T Consensus 81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~ 159 (323)
T cd05571 81 ELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 159 (323)
T ss_pred cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCc
Confidence 99999976 457899999999999999999999999999999999999999999999999998643 2345788
Q ss_pred ceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 448 RELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 448 ~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
.|++||+.....+....|+|++ +.....|..+|.
T Consensus 160 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 196 (323)
T cd05571 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 196 (323)
T ss_pred cccChhhhcCCCCCccccCcccchhhhhhhcCCCCCC
Confidence 8999998888778888999984 334445665554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-30 Score=267.49 Aligned_cols=179 Identities=26% Similarity=0.480 Sum_probs=162.8
Q ss_pred CCCCCCceeeCCCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Q 011158 280 PNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359 (492)
Q Consensus 280 ~~~~~~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~ 359 (492)
.....+.|+|+.+.+.-++-||+|+-|.||+|+..++.||||.++. .-..+|+-|++|+|+||+.|.|+|+
T Consensus 112 k~qq~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~e---------lkETdIKHLRkLkH~NII~FkGVCt 182 (904)
T KOG4721|consen 112 KQQQEELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVRE---------LKETDIKHLRKLKHPNIITFKGVCT 182 (904)
T ss_pred hhhhhhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhh---------hhhhhHHHHHhccCcceeeEeeeec
Confidence 3344677999999999999999999999999999999999998752 1234788899999999999999999
Q ss_pred cCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecce
Q 011158 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTV 439 (492)
Q Consensus 360 ~~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~ 439 (492)
..+.+|||||||+.|-|+..|+. ...++...+..+..+|+.||+|||.+.|||||||.-||||..+..+||+|||-++.
T Consensus 183 qsPcyCIiMEfCa~GqL~~VLka-~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e 261 (904)
T KOG4721|consen 183 QSPCYCIIMEFCAQGQLYEVLKA-GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKE 261 (904)
T ss_pred CCceeEEeeeccccccHHHHHhc-cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHh
Confidence 99999999999999999999987 56789999999999999999999999999999999999999999999999999875
Q ss_pred e------eeeeCCCceeecceeccccccCccceee
Q 011158 440 S------ILFCGKGRELISLFLGNDVLLQFGTYWI 468 (492)
Q Consensus 440 ~------~~~~g~~~~~ape~~~~e~~~~~~d~W~ 468 (492)
. ..+.|+..||+||++.++......|+|+
T Consensus 262 ~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwS 296 (904)
T KOG4721|consen 262 LSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWS 296 (904)
T ss_pred hhhhhhhhhhhhhHhhhCHHHhhcCCcccccceeh
Confidence 4 2578999999999999999999999888
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=258.15 Aligned_cols=193 Identities=18% Similarity=0.184 Sum_probs=160.3
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeE
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 364 (492)
.+..++|++.++||+|+||.||++.+. ++.||+|++..... .......+.+|+.+++.++||||+++++++.....+
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 345568899999999999999999884 67899999865322 223345678899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee---
Q 011158 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI--- 441 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~--- 441 (492)
|+|||||++|+|.+++.. ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~ 196 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 196 (370)
T ss_pred EEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence 999999999999999976 458999999999999999999999999999999999999999999999999986531
Q ss_pred -----eeeCCCceeecceeccc----cccCccceeee---ecccccCCCCCCC
Q 011158 442 -----LFCGKGRELISLFLGND----VLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 442 -----~~~g~~~~~ape~~~~e----~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
...|+..|++||.+... .+....|+|++ +....+|.++|..
T Consensus 197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~ 249 (370)
T cd05621 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA 249 (370)
T ss_pred ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC
Confidence 23477788888877543 25667899995 3345567766654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=254.95 Aligned_cols=190 Identities=17% Similarity=0.219 Sum_probs=163.0
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
++|++.+.||+|+||.||+|.+. ++.||||+++..... ......+.+|+.++..++|+||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888999999999999999985 789999999754322 244567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------- 441 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------- 441 (492)
||+++|+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY 159 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence 999999999999874 678999999999999999999999999999999999999999999999999986432
Q ss_pred -----------------------------eeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 442 -----------------------------LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 442 -----------------------------~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
...|+..|++||+.....+....|+|++ +....+|..+|..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~ 232 (350)
T cd05573 160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS 232 (350)
T ss_pred cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC
Confidence 2346778899998888888888999994 3344556666654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=257.60 Aligned_cols=195 Identities=17% Similarity=0.178 Sum_probs=161.8
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCe
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 363 (492)
..+..++|++.+.||+|+||.||++.+ +++.||+|++..... .......+.+|+.+++.++||||+++++++.....
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 355668899999999999999999988 467899999864322 22334567889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee--
Q 011158 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-- 441 (492)
Q Consensus 364 ~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-- 441 (492)
+|+|||||++|+|.+++.. ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred EEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence 9999999999999999976 458999999999999999999999999999999999999999999999999986432
Q ss_pred ------eeeCCCceeecceeccc----cccCccceeee---ecccccCCCCCCCc
Q 011158 442 ------LFCGKGRELISLFLGND----VLLQFGTYWII---FRRSSCDKKNSDAP 483 (492)
Q Consensus 442 ------~~~g~~~~~ape~~~~e----~~~~~~d~W~l---~~~~~~gt~~Y~aP 483 (492)
...|+..|++||.+... .+....|+|++ +.....|.++|.+.
T Consensus 196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 250 (371)
T cd05622 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (371)
T ss_pred CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC
Confidence 23477788899877543 26677899995 33445577666543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=250.95 Aligned_cols=190 Identities=15% Similarity=0.169 Sum_probs=158.3
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
++|++.++||+|+||.||++++. ++.||+|++.... ........+.+|+.++..++|+||+++++++...+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999874 5789999987532 12333456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------- 441 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------- 441 (492)
||++||+|.+++.+....+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||++....
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 160 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS 160 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence 9999999999998766788999999999999999999999999999999999999999999999999986432
Q ss_pred -eeeCCCceeecceecc-----ccccCccceeee---ecccccCCCCCC
Q 011158 442 -LFCGKGRELISLFLGN-----DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 -~~~g~~~~~ape~~~~-----e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...|+..|++||+... ..+....|+|++ +....+|..+|.
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~ 209 (331)
T cd05624 161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCcc
Confidence 2347778888887654 345667799994 333455666654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=252.26 Aligned_cols=189 Identities=19% Similarity=0.300 Sum_probs=160.4
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
++|++.+.||+|+||.||+|.+. ++.||+|++..... .......+.+|+.++++++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36788899999999999999884 78899999975432 2234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee----eee
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI----LFC 444 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~----~~~ 444 (492)
||+++|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... ...
T Consensus 81 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~ 159 (291)
T cd05612 81 EYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC 159 (291)
T ss_pred eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCccccc
Confidence 99999999999976 4578999999999999999999999999999999999999999999999999987542 245
Q ss_pred CCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 445 GKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 445 g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
|+..|++||......+....|+|++ +.....|..+|.
T Consensus 160 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~ 199 (291)
T cd05612 160 GTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFF 199 (291)
T ss_pred CChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 7788999998888778888899984 223344555553
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=250.41 Aligned_cols=190 Identities=18% Similarity=0.214 Sum_probs=160.1
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
++|++.+.||+|+||.||++.+ +++.||+|+++.... .......+.+|+.+++.++|+||+++++++...+.+||||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 3688899999999999999987 468899999986432 2334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------- 441 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------- 441 (492)
||+++|+|.+++.+....+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++....
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 160 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS 160 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence 9999999999998866789999999999999999999999999999999999999999999999999986432
Q ss_pred -eeeCCCceeecceec------cccccCccceeee---ecccccCCCCCC
Q 011158 442 -LFCGKGRELISLFLG------NDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 -~~~g~~~~~ape~~~------~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||+.. ...+....|+|++ +.....|..+|.
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 210 (330)
T cd05601 161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH 210 (330)
T ss_pred ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCC
Confidence 234677888888765 3455667788883 334455666664
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=249.25 Aligned_cols=178 Identities=20% Similarity=0.276 Sum_probs=148.5
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCc-eeeEEEEEecCC-----
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN-VVQFIGACTKPP----- 362 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~g~~~~~~----- 362 (492)
...|...++||+|+||.||+|+. +|+.||+|.++.+..++..-....+|+.+|++++|+| |+.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 45677788999999999999977 6789999999876544334456789999999999999 999999998877
Q ss_pred -eEEEEEeccCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecc
Q 011158 363 -SLCIVTEFMSGGSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFT 438 (492)
Q Consensus 363 -~~~lV~Ey~~ggsL~~~L~~~~---~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~ 438 (492)
.+++|+||+ .-+|.+++.... ..++...++.++.||+.||+|||+++|+||||||+||||+++|.+||+|||+|+
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence 899999999 779999998765 357888999999999999999999999999999999999999999999999998
Q ss_pred eee-------eeeCCCceeecceecc-ccccCccceeee
Q 011158 439 VSI-------LFCGKGRELISLFLGN-DVLLQFGTYWII 469 (492)
Q Consensus 439 ~~~-------~~~g~~~~~ape~~~~-e~~~~~~d~W~l 469 (492)
... ....+.-|.+||.+-+ ..|....|+|++
T Consensus 169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~ 207 (323)
T KOG0594|consen 169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSL 207 (323)
T ss_pred HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhH
Confidence 542 1233344666665533 356666788873
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=244.14 Aligned_cols=189 Identities=20% Similarity=0.237 Sum_probs=159.5
Q ss_pred ceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEec
Q 011158 294 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (492)
Q Consensus 294 ~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 370 (492)
|+..+.||+|+||.||+|.+ +++.||+|++...... ......+.+|+.++++++|+||+++++++...+.+|+||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 67789999999999999987 5789999998754332 22335678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee------eee
Q 011158 371 MSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS------ILF 443 (492)
Q Consensus 371 ~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~------~~~ 443 (492)
|++|+|.+++.... ..+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||++... ...
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 161 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR 161 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecCC
Confidence 99999998886533 46899999999999999999999999999999999999999999999999998653 123
Q ss_pred eCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 444 CGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 444 ~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
.++..|++||+.....+....|+|++ +.....|.++|..
T Consensus 162 ~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 203 (285)
T cd05631 162 VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRK 203 (285)
T ss_pred CCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCC
Confidence 56788999999988888888899984 2334457666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=250.52 Aligned_cols=183 Identities=22% Similarity=0.372 Sum_probs=155.8
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEeccCCC
Q 011158 298 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG 374 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~gg 374 (492)
+.||+|+||.||++.. +++.||+|+++.... .......+.+|+.+++.++||||+++++++...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999987 468899999976432 2344567889999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------eeeCCC
Q 011158 375 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-------LFCGKG 447 (492)
Q Consensus 375 sL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-------~~~g~~ 447 (492)
+|.+++.. ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++... ...|+.
T Consensus 81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 159 (328)
T cd05593 81 ELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTP 159 (328)
T ss_pred CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCc
Confidence 99999976 4578999999999999999999999999999999999999999999999999986531 245778
Q ss_pred ceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 448 RELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 448 ~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
.|++||+.....+....|+|++ +.....|..+|.
T Consensus 160 ~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~ 196 (328)
T cd05593 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 196 (328)
T ss_pred CccChhhhcCCCCCccCCccccchHHHHHhhCCCCCC
Confidence 8999998887778888899984 233445655553
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=246.81 Aligned_cols=180 Identities=26% Similarity=0.462 Sum_probs=151.7
Q ss_pred eCCCCceeeeeeeecCceEEEEEEEC------------------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCc
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTYC------------------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN 350 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~~------------------g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~Hpn 350 (492)
+...+|.+.++||+|+||.||+|.+. +..||+|++.... .......|.+|+.++++++|||
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCC
Confidence 34567889999999999999999752 2359999987642 3445678999999999999999
Q ss_pred eeeEEEEEecCCeEEEEEeccCCCCHHHHHHhcC------------------CCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 011158 351 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK------------------GVFKLPSLLKVAIDVSKGMNYLHQNNII 412 (492)
Q Consensus 351 Iv~l~g~~~~~~~~~lV~Ey~~ggsL~~~L~~~~------------------~~l~~~~~~~i~~qI~~gL~yLH~~~Ii 412 (492)
|+++++++...+..|+||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 9999999999999999999999999999996531 2467888999999999999999999999
Q ss_pred ecCCCCCCEEEccCCCeEEEEEeecceeee---------eeCCCceeecceeccccccCccceeee
Q 011158 413 HRDLKAANLLMDENEVSLLLSLCLFTVSIL---------FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 413 HrDLKp~NILld~~~~~kl~DFGla~~~~~---------~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
||||||+|||++.++.+||+|||+++.... ..++..|++||+.....+...+|+|++
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 226 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAF 226 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHH
Confidence 999999999999999999999999864311 122456889998777777888899884
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=248.39 Aligned_cols=181 Identities=20% Similarity=0.328 Sum_probs=154.5
Q ss_pred eeecCceEEEEEEEC--CceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEeccCCCCH
Q 011158 300 VASGSYGDLYRGTYC--SQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376 (492)
Q Consensus 300 LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ggsL 376 (492)
||+|+||.||+|.+. ++.||+|+++... ........+.+|+.++++++||||+++++++...+.+|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999884 6789999997532 2334456788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------eeeCCCce
Q 011158 377 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-------LFCGKGRE 449 (492)
Q Consensus 377 ~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-------~~~g~~~~ 449 (492)
.+++.. .+.+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++... ...|+..|
T Consensus 81 ~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y 159 (312)
T cd05585 81 FHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEY 159 (312)
T ss_pred HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCccc
Confidence 999976 4678999999999999999999999999999999999999999999999999987531 24577889
Q ss_pred eecceeccccccCccceeee---ecccccCCCCCC
Q 011158 450 LISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 450 ~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
++||......+....|+|++ +.....|.++|.
T Consensus 160 ~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~ 194 (312)
T cd05585 160 LAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFY 194 (312)
T ss_pred CCHHHHcCCCCCCccceechhHHHHHHHhCCCCcC
Confidence 99998888778888899994 223445666654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=250.32 Aligned_cols=184 Identities=21% Similarity=0.350 Sum_probs=155.8
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEeccCCC
Q 011158 298 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG 374 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~gg 374 (492)
+.||+|+||.||++.. .++.||+|+++.... .......+.+|+.++++++||||+++++++...+.+||||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4689999999999987 468899999976422 2334567788999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee-------eeeeCCC
Q 011158 375 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS-------ILFCGKG 447 (492)
Q Consensus 375 sL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~-------~~~~g~~ 447 (492)
+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++... ....++.
T Consensus 81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 159 (323)
T cd05595 81 ELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 159 (323)
T ss_pred cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCc
Confidence 99999876 457899999999999999999999999999999999999999999999999988642 1245778
Q ss_pred ceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 448 RELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 448 ~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
.|++||+.....+....|+|++ +....+|..+|..
T Consensus 160 ~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 197 (323)
T cd05595 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197 (323)
T ss_pred CcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCC
Confidence 8999999888778888899984 3334456655543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=249.25 Aligned_cols=190 Identities=15% Similarity=0.197 Sum_probs=156.9
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
++|++.+.||+|+||.||+++. .++.||+|++.... ........+.+|+.+++.++|+||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4688899999999999999987 46889999997432 22334466889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------- 441 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------- 441 (492)
||+++|+|.+++.+....+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++....
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS 160 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence 9999999999998766679999999999999999999999999999999999999999999999999975421
Q ss_pred -eeeCCCceeecceecc-----ccccCccceeee---ecccccCCCCCC
Q 011158 442 -LFCGKGRELISLFLGN-----DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 -~~~g~~~~~ape~~~~-----e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||.+.. ..+....|+|++ +.....|..+|.
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 209 (331)
T cd05597 161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCC
Confidence 1346778888887642 345556789984 223334555554
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=253.74 Aligned_cols=193 Identities=17% Similarity=0.185 Sum_probs=159.4
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCe
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 363 (492)
+.+..++|++.++||+|+||.||+++. +++.||+|+++.... .......+.+|+.+++.++||||+++++++.....
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~ 117 (370)
T cd05596 38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY 117 (370)
T ss_pred CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 355667899999999999999999987 467899999975322 22234557889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee--
Q 011158 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-- 441 (492)
Q Consensus 364 ~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-- 441 (492)
+|+|||||++|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||.+....
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999999999976 458899999999999999999999999999999999999999999999999986432
Q ss_pred ------eeeCCCceeecceeccc----cccCccceeee---ecccccCCCCCC
Q 011158 442 ------LFCGKGRELISLFLGND----VLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 ------~~~g~~~~~ape~~~~e----~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...|+..|++||++... .+...+|+|++ +.....|.++|.
T Consensus 196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~ 248 (370)
T cd05596 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248 (370)
T ss_pred CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcC
Confidence 23467788888876543 35667899994 233445666554
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-28 Score=247.02 Aligned_cols=184 Identities=22% Similarity=0.362 Sum_probs=155.5
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEeccCCC
Q 011158 298 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG 374 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~gg 374 (492)
+.||+|+||.||++.+ +++.||+|+++.... .......+..|+.+++.++||||+++++++...+.+||||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4689999999999987 568899999986432 2334567788999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEccCCCeEEEEEeecceee-------eeeCC
Q 011158 375 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-------LFCGK 446 (492)
Q Consensus 375 sL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~-~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-------~~~g~ 446 (492)
+|.+++.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++... ...++
T Consensus 81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 159 (325)
T cd05594 81 ELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGT 159 (325)
T ss_pred cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCC
Confidence 99999876 4578999999999999999999997 799999999999999999999999999876431 24577
Q ss_pred CceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 447 GRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 447 ~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
..|++||+.....+....|+|++ +.....|..+|..
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~ 198 (325)
T cd05594 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 198 (325)
T ss_pred cccCCHHHHccCCCCCccccccccceeeeeccCCCCCCC
Confidence 88999998887778888899984 3344556666543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=247.19 Aligned_cols=184 Identities=23% Similarity=0.316 Sum_probs=155.5
Q ss_pred eeeeecCceEEEEEEE-----CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEeccC
Q 011158 298 SKVASGSYGDLYRGTY-----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS 372 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~-----~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 372 (492)
+.||+|+||.||++.. .++.||+|+++...........+.+|+.++++++||||+++++++...+.+|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999865 46789999998644333344567889999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------eeeC
Q 011158 373 GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-------LFCG 445 (492)
Q Consensus 373 ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-------~~~g 445 (492)
+|+|.+++.+ ...+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++.... ...|
T Consensus 82 ~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 160 (318)
T cd05582 82 GGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG 160 (318)
T ss_pred CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccC
Confidence 9999999976 4578999999999999999999999999999999999999999999999999986532 2356
Q ss_pred CCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 446 KGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 446 ~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
+..|++||......+....|+|++ +.....|..+|..
T Consensus 161 ~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 200 (318)
T cd05582 161 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG 200 (318)
T ss_pred ChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCC
Confidence 778999998877777778899984 3344456666654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-28 Score=247.81 Aligned_cols=191 Identities=16% Similarity=0.198 Sum_probs=158.8
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
++|++.++||+|+||.||++.+. ++.+|+|++.... ........+.+|+.++..++|+||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36888999999999999999884 5779999986422 12233455888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------- 441 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------- 441 (492)
||+++|+|.+++.+....+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++....
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~ 160 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 160 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence 9999999999998766789999999999999999999999999999999999999999999999999875421
Q ss_pred -eeeCCCceeecceec-----cccccCccceeee---ecccccCCCCCCC
Q 011158 442 -LFCGKGRELISLFLG-----NDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 442 -~~~g~~~~~ape~~~-----~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
...|+..|++||+.. ...+...+|+|++ +.....|..+|..
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~ 210 (332)
T cd05623 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (332)
T ss_pred cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence 235777888998764 3456677899995 3334556666654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-30 Score=241.53 Aligned_cols=191 Identities=19% Similarity=0.318 Sum_probs=166.3
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
++|.+++.||+|.||.||.|+.. +-.||+|++.+..+. .....++.+|++|-..|+||||+++|++|.+...+|+++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 57888999999999999999874 456999999765432 234567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee-----ee
Q 011158 369 EFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS-----IL 442 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~-----~~ 442 (492)
||.++|+|+..|+..+ ..+++.....++.|++.||.|+|.++||||||||+|+|++..+..|++|||-+-.. ..
T Consensus 102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~kR~t 181 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSNKRKT 181 (281)
T ss_pred EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCCCCcee
Confidence 9999999999998543 46899999999999999999999999999999999999999999999999997554 46
Q ss_pred eeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 443 FCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 443 ~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
.+|+-.|.+||+..+.......|.|++ -.....|.|+|.+
T Consensus 182 lcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes 224 (281)
T KOG0580|consen 182 LCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFES 224 (281)
T ss_pred eecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhh
Confidence 899999999999999999999999995 1233456655543
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=259.85 Aligned_cols=186 Identities=21% Similarity=0.331 Sum_probs=163.1
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
..|...++||+|+.|.||.+.. +++.||||.+..... ...+-+.+|+.+|+..+|+|||.+++.|...+.+|+|||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q--~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ--PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC--CchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 4677778999999999999977 467899999976542 234668899999999999999999999998899999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee-------ee
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS-------IL 442 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~-------~~ 442 (492)
||+||+|.|.+.. ..+++.++..|++++++||+|||.+||||||||.+|||++.+|.+||.|||++... ..
T Consensus 351 ym~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~T 428 (550)
T KOG0578|consen 351 YMEGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRST 428 (550)
T ss_pred ecCCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcccc
Confidence 9999999999976 45999999999999999999999999999999999999999999999999998654 24
Q ss_pred eeCCCceeecceeccccccCccceeee--ec-ccccCCCCCC
Q 011158 443 FCGKGRELISLFLGNDVLLQFGTYWII--FR-RSSCDKKNSD 481 (492)
Q Consensus 443 ~~g~~~~~ape~~~~e~~~~~~d~W~l--~~-~~~~gt~~Y~ 481 (492)
..|++.||+||+.....|+...|+|++ +. .+.-|-|+|.
T Consensus 429 mVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYl 470 (550)
T KOG0578|consen 429 MVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYL 470 (550)
T ss_pred ccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCcc
Confidence 679999999999999999999999995 11 3445666654
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=257.22 Aligned_cols=190 Identities=24% Similarity=0.383 Sum_probs=162.1
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
..|.+.++||+|.|+.|.+++. ++..||||++.+...+......+.+|+++|+.++|||||+++.+...+..+|+|||
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e 135 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME 135 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence 4577889999999999999987 68899999999888888777789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee------eee
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS------ILF 443 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~------~~~ 443 (492)
|+.+|.+++|+.+ .+.+.+..+..++.|+.+|++|||+++|+|||||++|||++.+..+||+|||++..- ..+
T Consensus 136 ya~~ge~~~yl~~-~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lqt~ 214 (596)
T KOG0586|consen 136 YASGGELFDYLVK-HGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQTF 214 (596)
T ss_pred eccCchhHHHHHh-cccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccccccccc
Confidence 9999999999988 456677999999999999999999999999999999999999999999999998653 356
Q ss_pred eCCCceeecceeccccccC-ccceeee---ecccccCCCCCCC
Q 011158 444 CGKGRELISLFLGNDVLLQ-FGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 444 ~g~~~~~ape~~~~e~~~~-~~d~W~l---~~~~~~gt~~Y~a 482 (492)
+|+..|.+||...+..|.. ..|.|++ +....||..+|+-
T Consensus 215 cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG 257 (596)
T KOG0586|consen 215 CGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG 257 (596)
T ss_pred CCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC
Confidence 7777777777665544433 3467774 2234566666553
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=241.76 Aligned_cols=192 Identities=21% Similarity=0.335 Sum_probs=160.2
Q ss_pred eCCCCceeeeeeeecCceEEEEEEEC-----CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCe
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~~-----g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 363 (492)
|+.++|++.+.||+|+||.||+|.+. +..||+|+++... .......|.+|+.++++++||||+++++++...+.
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 56778999999999999999999763 3579999998643 33445679999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee-
Q 011158 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL- 442 (492)
Q Consensus 364 ~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~- 442 (492)
.++||||+++|+|.+++......+++..++.++.||+.||+|||+++++||||||+|||++.++.++++|||.+.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 9999999999999999987666899999999999999999999999999999999999999999999999998654311
Q ss_pred -------eeCCCceeecceeccccccCccceeee----ecccccCCCCCC
Q 011158 443 -------FCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSD 481 (492)
Q Consensus 443 -------~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~ 481 (492)
..++..|++||......+...+|+|++ +....+|.++|.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~ 210 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYW 210 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcC
Confidence 112346888888877777778888883 222334666553
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=247.67 Aligned_cols=184 Identities=26% Similarity=0.363 Sum_probs=155.0
Q ss_pred eeeeecCceEEEEEEE-----CCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEec
Q 011158 298 SKVASGSYGDLYRGTY-----CSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~-----~g~~vAvK~l~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 370 (492)
++||+|+||.||+++. .++.||||+++.... +......+.+|+.+|++++||||+++++++...+.+|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6899999999999975 357899999975422 223345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------ee
Q 011158 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-------LF 443 (492)
Q Consensus 371 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-------~~ 443 (492)
+++|+|.+++.+ .+.+.+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... ..
T Consensus 82 ~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (323)
T cd05584 82 LSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF 160 (323)
T ss_pred CCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence 999999999976 4568899999999999999999999999999999999999999999999999986431 23
Q ss_pred eCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 444 CGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 444 ~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
.++..|++||+.....+....|+|++ +....+|.++|..
T Consensus 161 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~ 202 (323)
T cd05584 161 CGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA 202 (323)
T ss_pred CCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCC
Confidence 57778999998887777788899984 3344567666654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=244.79 Aligned_cols=177 Identities=23% Similarity=0.325 Sum_probs=146.4
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEec--CCeEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--PPSLCIV 367 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~~~lV 367 (492)
++|+.+++|++|+||.||+|++ +++.||+|.++.+......--.-++||.+|.+++|||||.+-.+... -+.+|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 4678889999999999999988 46789999998765333333456899999999999999999988764 4569999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee-----
Q 011158 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL----- 442 (492)
Q Consensus 368 ~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~----- 442 (492)
|||| ..+|..+|...+.++...+++.++.|+++|++|||.+.|+||||||+|+|++..|.+||+|||+||.-..
T Consensus 156 Me~~-EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~ 234 (419)
T KOG0663|consen 156 MEYV-EHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPY 234 (419)
T ss_pred HHHH-HhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcccC
Confidence 9999 5599999998888999999999999999999999999999999999999999999999999999986421
Q ss_pred --eeCCCceeecce-eccccccCccceeee
Q 011158 443 --FCGKGRELISLF-LGNDVLLQFGTYWII 469 (492)
Q Consensus 443 --~~g~~~~~ape~-~~~e~~~~~~d~W~l 469 (492)
..-|-=|.+||. ++...|+...|+|++
T Consensus 235 T~lVVTLWYRaPELLLG~~tyst~iDMWSv 264 (419)
T KOG0663|consen 235 TPLVVTLWYRAPELLLGAKTYSTAVDMWSV 264 (419)
T ss_pred cceEEEeeecCHHHhcCCcccCcchhhhhH
Confidence 222233455553 355666667778883
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-28 Score=245.71 Aligned_cols=188 Identities=21% Similarity=0.310 Sum_probs=157.8
Q ss_pred CceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCC-CceeeEEEEEecCCeEEEEE
Q 011158 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRH-KNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~H-pnIv~l~g~~~~~~~~~lV~ 368 (492)
+|++.+.||+|+||.||+|.+. ++.||||+++.... .....+.+..|+.++..++| ++|+++++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999884 56899999976432 23345678889999999976 46889999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee-------e
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS-------I 441 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~-------~ 441 (492)
||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++... .
T Consensus 81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (324)
T cd05587 81 EYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR 159 (324)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCcee
Confidence 99999999999976 457899999999999999999999999999999999999999999999999987642 2
Q ss_pred eeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 442 LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 ~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...|+..|++||+.....+....|+|++ +.....|.++|.
T Consensus 160 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~ 202 (324)
T cd05587 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202 (324)
T ss_pred eecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCC
Confidence 3457888999998887777788899984 233445666664
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-28 Score=241.95 Aligned_cols=190 Identities=18% Similarity=0.241 Sum_probs=159.8
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
++|++.+.||+|+||.||+|++. ++.||+|+++.........+.+.+|+.++++++|+||+++++++...+.+|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888999999999999999984 5789999998654444556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee--------
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-------- 441 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-------- 441 (492)
|++++.+..+. .....+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (287)
T cd07848 81 YVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT 159 (287)
T ss_pred cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence 99887665544 435678999999999999999999999999999999999999999999999999986532
Q ss_pred eeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 442 LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 442 ~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
...++..|++||+.....+....|+|++ +....+|.++|..
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~ 203 (287)
T cd07848 160 EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPG 203 (287)
T ss_pred ccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCC
Confidence 2346677899998877778888899984 3345567776643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-28 Score=246.14 Aligned_cols=193 Identities=21% Similarity=0.298 Sum_probs=164.9
Q ss_pred eCCCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEE
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 366 (492)
+..++|++.++||+|+||.||++++. +..+|+|++... ........+.+|+.+|++++||||+++++++...+.+++
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 45678999999999999999999884 678999999764 234456789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEEccCCCeEEEEEeecceee----
Q 011158 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVSLLLSLCLFTVSI---- 441 (492)
Q Consensus 367 V~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~-~IiHrDLKp~NILld~~~~~kl~DFGla~~~~---- 441 (492)
||||+++|+|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 159 (331)
T cd06649 81 CMEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 159 (331)
T ss_pred EeecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccccc
Confidence 9999999999999976 35689999999999999999999986 69999999999999999999999999986432
Q ss_pred -eeeCCCceeecceeccccccCccceeee---ecccccCCCCCCCc
Q 011158 442 -LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDAP 483 (492)
Q Consensus 442 -~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~aP 483 (492)
...++..|++||+.....+...+|+|++ +.....|..+|..|
T Consensus 160 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 2457778999998887778888899984 33345566666554
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-28 Score=247.08 Aligned_cols=188 Identities=25% Similarity=0.392 Sum_probs=156.3
Q ss_pred ceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHH---HhcCCCceeeEEEEEecCCeEEEE
Q 011158 294 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIM---RKVRHKNVVQFIGACTKPPSLCIV 367 (492)
Q Consensus 294 ~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il---~~l~HpnIv~l~g~~~~~~~~~lV 367 (492)
|++.+.||+|+||.||+|.+ +++.||||+++.... .....+.+.+|+.++ ++++||||+++++++...+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 56789999999999999987 468899999975432 223345677777665 466799999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee------
Q 011158 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------ 441 (492)
Q Consensus 368 ~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------ 441 (492)
|||+++|+|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (324)
T cd05589 81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT 158 (324)
T ss_pred EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcc
Confidence 999999999998865 578999999999999999999999999999999999999999999999999876431
Q ss_pred -eeeCCCceeecceeccccccCccceeee---ecccccCCCCCCCc
Q 011158 442 -LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDAP 483 (492)
Q Consensus 442 -~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~aP 483 (492)
...|+..|++||+.....+....|+|++ +.....|..+|...
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~ 204 (324)
T cd05589 159 STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD 204 (324)
T ss_pred cccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC
Confidence 2457788999998888888888899984 33344577666543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-28 Score=244.96 Aligned_cols=188 Identities=18% Similarity=0.270 Sum_probs=155.4
Q ss_pred CceeeeeeeecCceEEEEEEE-----CCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCeE
Q 011158 293 HLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSL 364 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~-----~g~~vAvK~l~~~~~--~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~ 364 (492)
+|++.++||+|+||.||++.. .++.||+|+++.... .....+.+..|+.++++++ |+||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999876 457899999975322 1233456888999999995 89999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee----
Q 011158 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS---- 440 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~---- 440 (492)
|+||||+++|+|.+++.+ ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~ 159 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE 159 (332)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence 999999999999999976 456899999999999999999999999999999999999999999999999998642
Q ss_pred ----eeeeCCCceeecceeccc-cccCccceeee---ecccccCCCCCC
Q 011158 441 ----ILFCGKGRELISLFLGND-VLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 441 ----~~~~g~~~~~ape~~~~e-~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
....|+..|++||..... .+....|+|++ +.....|..+|.
T Consensus 160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~ 208 (332)
T cd05614 160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFT 208 (332)
T ss_pred CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCC
Confidence 124577889999987654 35667889984 333445665553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-28 Score=242.42 Aligned_cols=189 Identities=19% Similarity=0.253 Sum_probs=155.1
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
.++|++.++||+|+||.||+|.. +++.||+|+++.... ......+.+|+.++++++||||+++++++......++||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 45688899999999999999987 468899999975432 222356788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------- 441 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------- 441 (492)
||+. |+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||.++...
T Consensus 83 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~ 161 (288)
T cd07871 83 EYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYS 161 (288)
T ss_pred eCCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcccc
Confidence 9996 59999998766678999999999999999999999999999999999999999999999999986532
Q ss_pred eeeCCCceeecceecc-ccccCccceeee---ecccccCCCCCC
Q 011158 442 LFCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 ~~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||.... ..+...+|+|++ +....+|.++|.
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~ 205 (288)
T cd07871 162 NEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFP 205 (288)
T ss_pred CceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 2345667888886643 456667888884 223445665553
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-28 Score=253.13 Aligned_cols=184 Identities=25% Similarity=0.422 Sum_probs=155.6
Q ss_pred CceeeCCCCceeeeeeeecCceEEEEEEE-------CCceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeEEE
Q 011158 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIG 356 (492)
Q Consensus 285 ~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~-------~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g 356 (492)
..|+++.++|++.++||+|+||.||+|++ .+..||||+++... .....+.+.+|+.+++.+ +||||+++++
T Consensus 28 ~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~ 106 (375)
T cd05104 28 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLG 106 (375)
T ss_pred cccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeee
Confidence 45788889999999999999999999974 23579999997543 233456788999999999 8999999999
Q ss_pred EEecCCeEEEEEeccCCCCHHHHHHhcC----------------------------------------------------
Q 011158 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------------------------------------------- 384 (492)
Q Consensus 357 ~~~~~~~~~lV~Ey~~ggsL~~~L~~~~---------------------------------------------------- 384 (492)
+|...+..++|||||++|+|.++++...
T Consensus 107 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 186 (375)
T cd05104 107 ACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKR 186 (375)
T ss_pred eeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccc
Confidence 9999999999999999999999996532
Q ss_pred ----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee
Q 011158 385 ----------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL 442 (492)
Q Consensus 385 ----------------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~ 442 (492)
..+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 187 RSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred cccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 1467888999999999999999999999999999999999999999999999864321
Q ss_pred -----ee----CCCceeecceeccccccCccceeee
Q 011158 443 -----FC----GKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 443 -----~~----g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
.. ++..|++||+.....+...+|+|++
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~sl 302 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSY 302 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHH
Confidence 11 2235889998877778888899884
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-28 Score=246.52 Aligned_cols=182 Identities=21% Similarity=0.294 Sum_probs=154.8
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCeEEEEEeccCC
Q 011158 298 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSG 373 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~Ey~~g 373 (492)
+.||+|+||.||++.+ +++.||+|+++..... ......+..|..++.++ +||||+++++++.....+|||||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3689999999999987 4678999999865332 23446688899999998 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee-------eeeeCC
Q 011158 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS-------ILFCGK 446 (492)
Q Consensus 374 gsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~-------~~~~g~ 446 (492)
|+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.. ....|+
T Consensus 81 g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 159 (329)
T cd05588 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGT 159 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCC
Confidence 999999876 467999999999999999999999999999999999999999999999999998642 234677
Q ss_pred CceeecceeccccccCccceeee---ecccccCCCCC
Q 011158 447 GRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNS 480 (492)
Q Consensus 447 ~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y 480 (492)
..|++||+.....+....|+|++ +.....|..+|
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf 196 (329)
T cd05588 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196 (329)
T ss_pred ccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCc
Confidence 88999999888888888899994 22334565555
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-28 Score=250.53 Aligned_cols=191 Identities=22% Similarity=0.355 Sum_probs=167.4
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCh-HHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCeEEE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCI 366 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~-~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~l 366 (492)
...|++.+.||+|.||.||+++. +|+.+|+|++.+..... .....+.+|+.||+++. |||||+++++|+....+++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 45788889999999999999987 47889999998765432 24568899999999998 9999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccC----CCeEEEEEeeccee--
Q 011158 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN----EVSLLLSLCLFTVS-- 440 (492)
Q Consensus 367 V~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~----~~~kl~DFGla~~~-- 440 (492)
|||+|.||.|++.|.+. .+++..+..++.||+.++.|||+.||+||||||+|+|+... +.+|++|||++...
T Consensus 114 vmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~ 191 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP 191 (382)
T ss_pred EEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence 99999999999999875 49999999999999999999999999999999999999643 47999999999654
Q ss_pred ----eeeeCCCceeecceeccccccCccceeee---ecccccCCCCCCCc
Q 011158 441 ----ILFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDAP 483 (492)
Q Consensus 441 ----~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~aP 483 (492)
...+|+..|++||......|....|.|++ .....||.++|.+.
T Consensus 192 ~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~ 241 (382)
T KOG0032|consen 192 GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGE 241 (382)
T ss_pred CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCC
Confidence 35689999999999999999999999995 33457888777654
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-28 Score=244.83 Aligned_cols=183 Identities=21% Similarity=0.306 Sum_probs=153.8
Q ss_pred eeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCeEEEEEeccCC
Q 011158 298 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSG 373 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~Ey~~g 373 (492)
++||+|+||.||+|++. ++.||||+++.... .......+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36899999999999884 57899999976432 233446677899999876 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee-------eeeeCC
Q 011158 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS-------ILFCGK 446 (492)
Q Consensus 374 gsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~-------~~~~g~ 446 (492)
|+|.+++.+ ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++... ....|+
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 159 (321)
T cd05591 81 GDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGT 159 (321)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccC
Confidence 999999976 457899999999999999999999999999999999999999999999999988642 124577
Q ss_pred CceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 447 GRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 447 ~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
..|++||+.....+....|+|++ +.....|.++|.
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~ 197 (321)
T cd05591 160 PDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFE 197 (321)
T ss_pred ccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCC
Confidence 88999998888778888899984 223445666664
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-28 Score=252.27 Aligned_cols=185 Identities=26% Similarity=0.464 Sum_probs=157.0
Q ss_pred CCceeeCCCCceeeeeeeecCceEEEEEEEC--C-----ceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeEE
Q 011158 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--S-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFI 355 (492)
Q Consensus 284 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~--g-----~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~ 355 (492)
.+.|.++.++|++.+.||+|+||.||+|++. + ..||||+++... .......+.+|+.+++++ +|+||++++
T Consensus 30 ~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~ 108 (374)
T cd05106 30 NEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLL 108 (374)
T ss_pred cccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEe
Confidence 4568889999999999999999999999752 2 469999997643 234456788999999999 899999999
Q ss_pred EEEecCCeEEEEEeccCCCCHHHHHHhcC---------------------------------------------------
Q 011158 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLK--------------------------------------------------- 384 (492)
Q Consensus 356 g~~~~~~~~~lV~Ey~~ggsL~~~L~~~~--------------------------------------------------- 384 (492)
++|...+.+|+|||||++|+|.+++.+..
T Consensus 109 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (374)
T cd05106 109 GACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS 188 (374)
T ss_pred eEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence 99999999999999999999999996421
Q ss_pred ------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee----
Q 011158 385 ------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL---- 442 (492)
Q Consensus 385 ------------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~---- 442 (492)
..+++..++.++.||+.||.|||++||+||||||+|||+++++.+||+|||+++....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 2478888999999999999999999999999999999999999999999999864321
Q ss_pred -ee----CCCceeecceeccccccCccceeee
Q 011158 443 -FC----GKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 443 -~~----g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
.. ++..|++||+.....+...+|+|++
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSl 300 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSY 300 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHH
Confidence 11 2235899998887778888899984
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-28 Score=244.26 Aligned_cols=189 Identities=20% Similarity=0.319 Sum_probs=158.2
Q ss_pred CceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCeEEEEE
Q 011158 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
+|.+.+.||+|+||.||+|.+. ++.||||+++.... .......+..|..++..+ +|++|+++++++...+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999884 57899999986432 223345677788888887 5899999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------- 441 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------- 441 (492)
||+++|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~ 159 (323)
T cd05616 81 EYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK 159 (323)
T ss_pred cCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccc
Confidence 99999999999976 4568999999999999999999999999999999999999999999999999986432
Q ss_pred eeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 442 LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 442 ~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
...|+..|++||+.....+....|+|++ +.....|.++|..
T Consensus 160 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~ 203 (323)
T cd05616 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 203 (323)
T ss_pred cCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCC
Confidence 3457788999999888888888999994 2234456666654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.5e-28 Score=244.86 Aligned_cols=182 Identities=20% Similarity=0.292 Sum_probs=153.7
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCeEEEEEeccCC
Q 011158 298 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSG 373 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~Ey~~g 373 (492)
+.||+|+||.||++.+ +++.||+|+++.... .......+.+|+.++.++ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 3689999999999987 457899999986532 233455678899988877 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee-------eeeeCC
Q 011158 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS-------ILFCGK 446 (492)
Q Consensus 374 gsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~-------~~~~g~ 446 (492)
|+|.+++.. ...+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.. ....|+
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 159 (329)
T cd05618 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGT 159 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCC
Confidence 999999876 457899999999999999999999999999999999999999999999999998643 134577
Q ss_pred CceeecceeccccccCccceeee---ecccccCCCCC
Q 011158 447 GRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNS 480 (492)
Q Consensus 447 ~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y 480 (492)
..|++||+.....+....|+|++ +.....|..+|
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf 196 (329)
T cd05618 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196 (329)
T ss_pred ccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCC
Confidence 88999999888888888999995 22334455555
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=262.77 Aligned_cols=193 Identities=28% Similarity=0.430 Sum_probs=170.0
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEEC--C---ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC--S---QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~~--g---~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 361 (492)
.||+...+++.++||.|.||.||+|..+ + ..||||.+|.. .....+.+|+.|..||.+..||||++|.|+.+..
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks 702 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS 702 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence 4899999999999999999999999873 3 45999999975 4566788999999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee
Q 011158 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI 441 (492)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~ 441 (492)
..+.||+|||++|+|+.||+++.+.|+..++..++++|+.||+||-..++|||||.+.|||++.+-++|++|||++|+..
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998763
Q ss_pred ee--------eCC--CceeecceeccccccCccceee----eecccccCCCCC
Q 011158 442 LF--------CGK--GRELISLFLGNDVLLQFGTYWI----IFRRSSCDKKNS 480 (492)
Q Consensus 442 ~~--------~g~--~~~~ape~~~~e~~~~~~d~W~----l~~~~~~gt~~Y 480 (492)
.. .|+ .+|.+||.++-..+...+|.|+ +...+.+|-.+|
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPY 835 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 835 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcc
Confidence 21 111 4678899888888888888877 344556776665
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-28 Score=243.10 Aligned_cols=189 Identities=20% Similarity=0.258 Sum_probs=154.7
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
.++|++.++||+|+||.||+|++ +++.||||+++.... ......+.+|+.++++++||||+++++++......|+||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 35788999999999999999988 468899999975432 222346778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------- 441 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------- 441 (492)
||+ .++|.+++.+..+.+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||.+....
T Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 161 (303)
T cd07869 83 EYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYS 161 (303)
T ss_pred ECC-CcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCC
Confidence 999 578999988766779999999999999999999999999999999999999999999999999986432
Q ss_pred eeeCCCceeecceec-cccccCccceeee---ecccccCCCCCC
Q 011158 442 LFCGKGRELISLFLG-NDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 ~~~g~~~~~ape~~~-~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||... ...+....|+|++ +.....|.++|.
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 205 (303)
T cd07869 162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFP 205 (303)
T ss_pred CCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 133456688888653 3445666788884 223345655553
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-28 Score=245.55 Aligned_cols=187 Identities=19% Similarity=0.265 Sum_probs=152.7
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-----CeEE
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-----PSLC 365 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-----~~~~ 365 (492)
+|++.++||+|+||.||+|.+ +++.||||+++...........+.+|+.++++++||||+++++++... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 478889999999999999987 468899999875433333446788999999999999999999988643 2489
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee----
Q 011158 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI---- 441 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~---- 441 (492)
+||||| +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~-~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 81 VVFELM-ESDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEecC-CCCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 999999 5799999976 4568999999999999999999999999999999999999999999999999987532
Q ss_pred ------eeeCCCceeecceecc--ccccCccceeee---ecccccCCCCCC
Q 011158 442 ------LFCGKGRELISLFLGN--DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 ------~~~g~~~~~ape~~~~--e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||+... ..+....|+|++ +.....|.++|.
T Consensus 159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~ 209 (338)
T cd07859 159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 209 (338)
T ss_pred ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCC
Confidence 1246677888887755 556677888984 223345665553
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=241.06 Aligned_cols=195 Identities=23% Similarity=0.344 Sum_probs=172.0
Q ss_pred ceeeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 011158 286 VWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (492)
Q Consensus 286 ~~ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 362 (492)
.-.+..++|.++++||+|+||+|.+++- +++.+|||+++++-+ ..+....-+.|-++|+..+||.+..+...|+..+
T Consensus 162 ~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d 241 (516)
T KOG0690|consen 162 KNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD 241 (516)
T ss_pred cceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc
Confidence 3456678899999999999999999976 578899999998643 3444455677999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee--
Q 011158 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS-- 440 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~-- 440 (492)
.+|+||||..||.|+-+|.+ ...+++.....+...|+.||.|||+++||.||||.+|+|+|.+|.+||.|||+++..
T Consensus 242 rlCFVMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred eEEEEEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccc
Confidence 99999999999999999977 467899999999999999999999999999999999999999999999999999754
Q ss_pred -----eeeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 441 -----ILFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 441 -----~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
..++|++.|++||++....|....|||.+ +..+.||-.+|-
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFy 369 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFY 369 (516)
T ss_pred ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccc
Confidence 46899999999999999999999999994 556678766554
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.9e-29 Score=245.51 Aligned_cols=169 Identities=24% Similarity=0.354 Sum_probs=133.6
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC-----eEE
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP-----SLC 365 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-----~~~ 365 (492)
.|.-.+++|+|+||.||+|.. .++.||||.+-.+. +--.+|+.||+++.|||||++.-+|.... .+.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~------r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK------RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC------CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 456678999999999999987 45789999887653 12236999999999999999998885322 356
Q ss_pred EEEeccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccC-CCeEEEEEeecceee
Q 011158 366 IVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-EVSLLLSLCLFTVSI 441 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~-~~~kl~DFGla~~~~ 441 (492)
+|||||+ .+|+++++.. +..++...++-++.||.+||.|||+.||+||||||+|||+|.+ |.+||+|||.|+...
T Consensus 99 lVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 99 LVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 8999995 5999999742 5678888999999999999999999999999999999999976 899999999999876
Q ss_pred eeeCCCceeecc-eeccc------cccCccceee
Q 011158 442 LFCGKGRELISL-FLGND------VLLQFGTYWI 468 (492)
Q Consensus 442 ~~~g~~~~~ape-~~~~e------~~~~~~d~W~ 468 (492)
.......|.... |.+|| .|...-|.|+
T Consensus 178 ~~epniSYicSRyYRaPELifga~~Yt~~IDiWS 211 (364)
T KOG0658|consen 178 KGEPNISYICSRYYRAPELIFGATEYTTSIDIWS 211 (364)
T ss_pred cCCCceeEEEeccccCHHHHcCccccCceeEEhh
Confidence 544444444433 33333 4444445566
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=243.54 Aligned_cols=184 Identities=23% Similarity=0.361 Sum_probs=152.6
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHH-HHHhcCCCceeeEEEEEecCCeEEEEEeccCC
Q 011158 298 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVF-IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG 373 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~-il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~g 373 (492)
+.||+|+||.||+|.+ .++.||+|++..... .......+..|.. +++.++||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4689999999999987 478899999975422 2233345566655 56779999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee-------eeeeCC
Q 011158 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS-------ILFCGK 446 (492)
Q Consensus 374 gsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~-------~~~~g~ 446 (492)
|+|..++.+ ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.. ....|+
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 159 (325)
T cd05604 81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGT 159 (325)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCC
Confidence 999999876 467899999999999999999999999999999999999999999999999998643 124577
Q ss_pred CceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 447 GRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 447 ~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
..|++||+.....+....|+|++ +.....|.++|..
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~ 198 (325)
T cd05604 160 PEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYC 198 (325)
T ss_pred hhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCC
Confidence 88999998888778888899984 3344566666543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.3e-28 Score=244.09 Aligned_cols=184 Identities=22% Similarity=0.349 Sum_probs=151.4
Q ss_pred eeeeecCceEEEEEEEC--CceEEEEEecCCCCC-hHHHHHHHHHHH-HHHhcCCCceeeEEEEEecCCeEEEEEeccCC
Q 011158 298 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVF-IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG 373 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~-~~~~~~~~~Ei~-il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~g 373 (492)
+.||+|+||.||+|.+. ++.||+|++...... ......+..|.. +++.++|+||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46899999999999884 577999999754221 122234444544 56789999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee-------eeeeCC
Q 011158 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS-------ILFCGK 446 (492)
Q Consensus 374 gsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~-------~~~~g~ 446 (492)
|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.. ....|+
T Consensus 81 ~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt 159 (325)
T cd05602 81 GELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGT 159 (325)
T ss_pred CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCC
Confidence 999999976 456889999999999999999999999999999999999999999999999998642 234577
Q ss_pred CceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 447 GRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 447 ~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
..|++||+.....+....|+|++ +....+|.++|..
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 198 (325)
T cd05602 160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (325)
T ss_pred ccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCC
Confidence 88999998888888888999995 3345567766653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.8e-28 Score=243.37 Aligned_cols=184 Identities=23% Similarity=0.353 Sum_probs=152.0
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHH-HHHhcCCCceeeEEEEEecCCeEEEEEeccCC
Q 011158 298 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVF-IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG 373 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~-il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~g 373 (492)
++||+|+||.||+|++ .++.||+|++..... .......+..|+. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4689999999999988 467899999975432 2223345555654 67889999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee-------eeeeCC
Q 011158 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS-------ILFCGK 446 (492)
Q Consensus 374 gsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~-------~~~~g~ 446 (492)
|+|.+++.+ ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.. ....++
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (321)
T cd05603 81 GELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGT 159 (321)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCC
Confidence 999998876 457899999999999999999999999999999999999999999999999998643 124567
Q ss_pred CceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 447 GRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 447 ~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
..|++||......+....|+|++ +.....|.++|..
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 198 (321)
T cd05603 160 PEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (321)
T ss_pred cccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCC
Confidence 78999998877778888899984 3345567766644
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=244.73 Aligned_cols=194 Identities=23% Similarity=0.328 Sum_probs=163.5
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEE
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 365 (492)
++..++|++.++||+|+||.||++.+. +..+|+|+++... .......+.+|+.++++++|+||++++++|...+.+|
T Consensus 1 ~l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred CcchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 356678999999999999999999884 6789999987642 3445577999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEEccCCCeEEEEEeecceee---
Q 011158 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVSLLLSLCLFTVSI--- 441 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~-~IiHrDLKp~NILld~~~~~kl~DFGla~~~~--- 441 (492)
+||||+++|+|.+++.+ .+.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 80 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 80 ICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred EEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 99999999999999976 45689999999999999999999985 79999999999999999999999999986432
Q ss_pred --eeeCCCceeecceeccccccCccceeee---ecccccCCCCCCCc
Q 011158 442 --LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDAP 483 (492)
Q Consensus 442 --~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~aP 483 (492)
...++..|++||+.....+...+|+|++ +....+|..+|..|
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 2356778999998877777777899984 23344565555544
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-28 Score=243.99 Aligned_cols=184 Identities=23% Similarity=0.341 Sum_probs=154.5
Q ss_pred eeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCeEEEEEeccCC
Q 011158 298 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSG 373 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~Ey~~g 373 (492)
+.||+|+||.||+|.+. ++.||||+++.... .......+..|+.++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999874 67899999975422 223456678899998877 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee-------eeeeCC
Q 011158 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS-------ILFCGK 446 (492)
Q Consensus 374 gsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~-------~~~~g~ 446 (492)
|+|.+++.+ ...+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++.. ....|+
T Consensus 81 g~L~~~i~~-~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 159 (320)
T cd05590 81 GDLMFHIQK-SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGT 159 (320)
T ss_pred chHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccC
Confidence 999999976 457899999999999999999999999999999999999999999999999997643 124577
Q ss_pred CceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 447 GRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 447 ~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
..|++||+.....+....|+|++ +....+|.++|..
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (320)
T cd05590 160 PDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA 198 (320)
T ss_pred ccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCC
Confidence 88999998888888888899984 2334456666643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=242.33 Aligned_cols=184 Identities=24% Similarity=0.368 Sum_probs=151.6
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHH-HHHhcCCCceeeEEEEEecCCeEEEEEeccCC
Q 011158 298 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVF-IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG 373 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~-il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~g 373 (492)
+.||+|+||.||+|.+ +++.||||++..... .......+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4689999999999988 478899999975422 1223344555554 56789999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------eeeCC
Q 011158 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-------LFCGK 446 (492)
Q Consensus 374 gsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-------~~~g~ 446 (492)
|+|.+++.+ ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... ...|+
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (323)
T cd05575 81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGT 159 (323)
T ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCC
Confidence 999999976 4578999999999999999999999999999999999999999999999999986431 24577
Q ss_pred CceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 447 GRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 447 ~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
..|++||+.....+....|+|++ +.....|.++|..
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~ 198 (323)
T cd05575 160 PEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (323)
T ss_pred hhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCC
Confidence 78999998888778888899984 3334456666543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=250.33 Aligned_cols=184 Identities=28% Similarity=0.475 Sum_probs=156.3
Q ss_pred CceeeCCCCceeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCceeeEEE
Q 011158 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIG 356 (492)
Q Consensus 285 ~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g-------~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g 356 (492)
..|+++.++|.++++||+|+||.||+|++.+ ..||||+++... .....+.+.+|+.+++++. ||||+++++
T Consensus 30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 5689999999999999999999999998632 359999997542 3344567999999999996 999999999
Q ss_pred EEecCCeEEEEEeccCCCCHHHHHHhcC----------------------------------------------------
Q 011158 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------------------------------------------- 384 (492)
Q Consensus 357 ~~~~~~~~~lV~Ey~~ggsL~~~L~~~~---------------------------------------------------- 384 (492)
+|...+.+|||||||++|+|.++|.+..
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 9999999999999999999999987531
Q ss_pred -------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCE
Q 011158 385 -------------------------------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANL 421 (492)
Q Consensus 385 -------------------------------------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NI 421 (492)
..+++..++.++.||+.||.|||+++|+||||||+||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni 268 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV 268 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence 2377888899999999999999999999999999999
Q ss_pred EEccCCCeEEEEEeecceeee---------eeCCCceeecceeccccccCccceeee
Q 011158 422 LMDENEVSLLLSLCLFTVSIL---------FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 422 Lld~~~~~kl~DFGla~~~~~---------~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
|++.++.+|++|||+++.... ..++..|++||......+....|+|++
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSl 325 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSY 325 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHH
Confidence 999999999999999875321 123346888888877777777888884
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=242.25 Aligned_cols=183 Identities=20% Similarity=0.291 Sum_probs=155.1
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCeEEEEEeccCC
Q 011158 298 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSG 373 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~Ey~~g 373 (492)
+.||+|+||.||+|.. .++.||+|+++.... .......+.+|+.++.++ +|+||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999987 457899999986532 233456688999999988 599999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee-------eeeeCC
Q 011158 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS-------ILFCGK 446 (492)
Q Consensus 374 gsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~-------~~~~g~ 446 (492)
|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++... ....|+
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (327)
T cd05617 81 GDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGT 159 (327)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCC
Confidence 999999876 457999999999999999999999999999999999999999999999999998642 234578
Q ss_pred CceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 447 GRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 447 ~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
..|++||+.....+...+|+|++ +.....|.++|.
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~ 197 (327)
T cd05617 160 PNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197 (327)
T ss_pred cccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCC
Confidence 88999999888888888999994 223345666653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=252.25 Aligned_cols=178 Identities=22% Similarity=0.373 Sum_probs=164.2
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCe-EEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-LCIVT 368 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~-~~lV~ 368 (492)
++|..++++|+|+||.++.++.+ ++.+++|.+..........+...+|+.++++++|||||.+.+.|..++. +||||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56788899999999999988664 5789999999888777777788999999999999999999999998888 99999
Q ss_pred eccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee-------
Q 011158 369 EFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS------- 440 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~------- 440 (492)
+||+||+|.+.|.+.+ ..+++..+..++.|++.|+.|||+++|+|||||++||+++.++.+|+.|||+++..
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a 163 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLA 163 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhhh
Confidence 9999999999998876 57999999999999999999999999999999999999999999999999999754
Q ss_pred eeeeCCCceeecceeccccccCccceeee
Q 011158 441 ILFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 441 ~~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
....|++.||.||.+.+..|....|.|++
T Consensus 164 ~tvvGTp~YmcPEil~d~pYn~KSDiWsL 192 (426)
T KOG0589|consen 164 STVVGTPYYMCPEILSDIPYNEKSDIWSL 192 (426)
T ss_pred heecCCCcccCHHHhCCCCCCccCcchhh
Confidence 45789999999999999999999999996
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=242.80 Aligned_cols=183 Identities=20% Similarity=0.313 Sum_probs=151.5
Q ss_pred eeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCeEEEEEeccCC
Q 011158 298 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSG 373 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~Ey~~g 373 (492)
+.||+|+||.||+|++. ++.||||+++.... .....+.+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999884 57799999986432 223344566677777654 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------eeeCC
Q 011158 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-------LFCGK 446 (492)
Q Consensus 374 gsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-------~~~g~ 446 (492)
|+|.+++.. ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++... ...|+
T Consensus 81 g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt 159 (316)
T cd05592 81 GDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGT 159 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCC
Confidence 999999976 4578999999999999999999999999999999999999999999999999986431 24577
Q ss_pred CceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 447 GRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 447 ~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
..|++||+.....+....|+|++ +.....|..+|.
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~ 197 (316)
T cd05592 160 PDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFH 197 (316)
T ss_pred ccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCC
Confidence 88999998887778888899994 223445665554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=243.04 Aligned_cols=189 Identities=21% Similarity=0.312 Sum_probs=157.2
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCeEEEEE
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~ 368 (492)
+|++.+.||+|+||.||+|.+ +++.||+|+++.... .....+.+..|..+++.+. |++|+++++++...+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 367789999999999999987 467899999975422 2233456788999998886 577889999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee-------e
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS-------I 441 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~-------~ 441 (492)
||+++|+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.. .
T Consensus 81 Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~ 159 (323)
T cd05615 81 EYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTR 159 (323)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcccc
Confidence 99999999999976 457999999999999999999999999999999999999999999999999998643 1
Q ss_pred eeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 442 LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 442 ~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
...|+..|++||+.....+....|+|++ +.....|.++|..
T Consensus 160 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~ 203 (323)
T cd05615 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG 203 (323)
T ss_pred CccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCC
Confidence 2347788999998887778888899984 2233456666654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=263.86 Aligned_cols=187 Identities=24% Similarity=0.410 Sum_probs=158.9
Q ss_pred CCCCCceeeCCCCceeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceee
Q 011158 281 NDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 353 (492)
Q Consensus 281 ~~~~~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g-------~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 353 (492)
+......+|.+.++++.++||+|+||+||+|...+ +.||||.++.. .+.+.+.+|.+|+++|..++|||||+
T Consensus 475 ~~~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-a~~~~~~dF~REaeLla~l~H~nIVr 553 (774)
T KOG1026|consen 475 NPDLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-AENQARQDFRREAELLAELQHPNIVR 553 (774)
T ss_pred CCccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-ccHHHHHHHHHHHHHHHhccCCCeEE
Confidence 34456789999999999999999999999997642 45999999864 34557899999999999999999999
Q ss_pred EEEEEecCCeEEEEEeccCCCCHHHHHHhc-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCC
Q 011158 354 FIGACTKPPSLCIVTEFMSGGSVYDYLHKL-------------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 420 (492)
Q Consensus 354 l~g~~~~~~~~~lV~Ey~~ggsL~~~L~~~-------------~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~N 420 (492)
|+|+|...+.+|||+|||..|+|.+||... +.+|+..+.+.|+.|||.||.||-++.+|||||.++|
T Consensus 554 LlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRN 633 (774)
T KOG1026|consen 554 LLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRN 633 (774)
T ss_pred EEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhh
Confidence 999999999999999999999999999742 1238899999999999999999999999999999999
Q ss_pred EEEccCCCeEEEEEeecceee--e-------eeCCCceeecceeccccccCccceee
Q 011158 421 LLMDENEVSLLLSLCLFTVSI--L-------FCGKGRELISLFLGNDVLLQFGTYWI 468 (492)
Q Consensus 421 ILld~~~~~kl~DFGla~~~~--~-------~~g~~~~~ape~~~~e~~~~~~d~W~ 468 (492)
+||.++..+||+|||++|..- . ..-..+||+||-+.-..++..+|.|+
T Consensus 634 CLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs 690 (774)
T KOG1026|consen 634 CLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWS 690 (774)
T ss_pred ceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhh
Confidence 999999999999999998642 1 11124788888666666666666554
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=240.74 Aligned_cols=192 Identities=23% Similarity=0.384 Sum_probs=158.0
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEE--CCc----eEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQ----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~----~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 361 (492)
.+...+|+..+.||+|+||.||+|++ .++ .||+|+++.. ......+++.+|+.+++.++||||++++++|...
T Consensus 3 ~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~ 81 (316)
T cd05108 3 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 81 (316)
T ss_pred ccchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence 34567889999999999999999986 333 3899998753 2344567899999999999999999999999864
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee
Q 011158 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI 441 (492)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~ 441 (492)
..++|+||+++|+|.+++.+....+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence 5789999999999999998866678999999999999999999999999999999999999999999999999997542
Q ss_pred e------e---eCCCceeecceeccccccCccceeee----ecccccCCCCCC
Q 011158 442 L------F---CGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSD 481 (492)
Q Consensus 442 ~------~---~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~ 481 (492)
. . ..+..|++||+.....+...+|+|++ +....+|.++|.
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~ 213 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 1 1 11235888888877777778899984 222345666664
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=235.93 Aligned_cols=189 Identities=21% Similarity=0.248 Sum_probs=157.7
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCh-HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
.|+..++||+|+||.||++.+ +++.||+|++....... .....+.+|+.++++++|+||+++++.+...+.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 367789999999999999987 46889999997543322 223557889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee------e
Q 011158 370 FMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------L 442 (492)
Q Consensus 370 y~~ggsL~~~L~~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------~ 442 (492)
|+++|+|.+++... ...+++..+..++.|++.||.|||+++|+||||||+||++++++.++|+|||++.... .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG 160 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcccc
Confidence 99999999988654 3468999999999999999999999999999999999999999999999999986532 2
Q ss_pred eeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 443 FCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 443 ~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
..++..|++||+.....+....|+|++ +.....|..+|.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~ 202 (285)
T cd05605 161 RVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFR 202 (285)
T ss_pred ccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCC
Confidence 346678899998877777778899984 222334666554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=237.64 Aligned_cols=194 Identities=16% Similarity=0.204 Sum_probs=158.7
Q ss_pred eeeCCCCceee--eeeeecCceEEEEEEECCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCceeeEEEEEec---
Q 011158 287 WEIDPKHLKFG--SKVASGSYGDLYRGTYCSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--- 360 (492)
Q Consensus 287 ~ei~~~~~~~~--~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--- 360 (492)
+.|+.++++.. ..||+|++|.||+|.++|+.||||+++..... ....+.|.+|+.+|++++||||+++++++..
T Consensus 13 ~~i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~ 92 (283)
T PHA02988 13 KCIESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD 92 (283)
T ss_pred eecCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEeccc
Confidence 44555555555 67999999999999999999999999765332 2335778899999999999999999999876
Q ss_pred -CCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEEccCCCeEEEEEeecc
Q 011158 361 -PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVSLLLSLCLFT 438 (492)
Q Consensus 361 -~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~-~IiHrDLKp~NILld~~~~~kl~DFGla~ 438 (492)
...+++||||+++|+|.+++.+ ...+++...+.++.|++.||.|||+. +++||||||+|||++.++.+|++|||+++
T Consensus 93 ~~~~~~lv~Ey~~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~ 171 (283)
T PHA02988 93 DLPRLSLILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEK 171 (283)
T ss_pred CCCceEEEEEeCCCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHh
Confidence 4578999999999999999977 45789999999999999999999985 99999999999999999999999999987
Q ss_pred eee----eeeCCCceeecceecc--ccccCccceeee---ecccccCCCCCC
Q 011158 439 VSI----LFCGKGRELISLFLGN--DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 439 ~~~----~~~g~~~~~ape~~~~--e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
... ...++..|++||+... ..+...+|+|++ +....+|..+|.
T Consensus 172 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~ 223 (283)
T PHA02988 172 ILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE 223 (283)
T ss_pred hhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCC
Confidence 532 2346677899998865 567778888884 223334555554
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=241.03 Aligned_cols=183 Identities=20% Similarity=0.288 Sum_probs=152.0
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCeEEEEEeccCC
Q 011158 298 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSG 373 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~Ey~~g 373 (492)
++||+|+||.||+|.+ +++.||+|+++.... .......+..|..++... +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999988 467899999976422 122345567788888765 899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee-------eeeeCC
Q 011158 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS-------ILFCGK 446 (492)
Q Consensus 374 gsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~-------~~~~g~ 446 (492)
|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.. ....|+
T Consensus 81 g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (316)
T cd05620 81 GDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGT 159 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCC
Confidence 999999976 467899999999999999999999999999999999999999999999999988642 234578
Q ss_pred CceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 447 GRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 447 ~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
..|++||+.....+....|+|++ +....+|..+|.
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~ 197 (316)
T cd05620 160 PDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFH 197 (316)
T ss_pred cCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCC
Confidence 88999998888788888899984 223334555543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=248.09 Aligned_cols=171 Identities=22% Similarity=0.316 Sum_probs=150.4
Q ss_pred eCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEE
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 366 (492)
+....|++.++||+|+||.||+|.+ +++.||+|.... ..+.+|+.++++++||||+++++++......|+
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence 4556799999999999999999988 468899997542 346789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-----
Q 011158 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI----- 441 (492)
Q Consensus 367 V~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~----- 441 (492)
|+|++ +++|..++.. ...+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||++....
T Consensus 161 v~e~~-~~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 161 ILPRY-KTDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred EEecC-CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 99999 5799999876 4568999999999999999999999999999999999999999999999999986421
Q ss_pred ---eeeCCCceeecceeccccccCccceeee
Q 011158 442 ---LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 442 ---~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
...|+..|++||+.....+....|+|++
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 269 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSA 269 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHH
Confidence 2357788899998888778888899984
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=249.43 Aligned_cols=184 Identities=20% Similarity=0.263 Sum_probs=159.0
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-C-----CceeeEEEEEecCCeE
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-H-----KNVVQFIGACTKPPSL 364 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~-H-----pnIv~l~g~~~~~~~~ 364 (492)
+|.+.+.||+|+||+|.+|.+ +++.||||+++.. .....+-..|+.||..|+ | -|+|+++++|...+++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 788899999999999999988 5688999999864 455566778999999997 4 3899999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccC--CCeEEEEEeecceee
Q 011158 365 CIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN--EVSLLLSLCLFTVSI 441 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~--~~~kl~DFGla~~~~ 441 (492)
|||+|.+ ..+|+++|+.++ ..++...++.|+.||+.||.+||+.+|||+||||+||||.+- ..+||+|||.+....
T Consensus 264 ciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~ 342 (586)
T KOG0667|consen 264 CIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFES 342 (586)
T ss_pred eeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccC
Confidence 9999999 789999998764 368999999999999999999999999999999999999754 379999999997653
Q ss_pred ----eeeCCCceeecceeccccccCccceeee---ecccccCCCCC
Q 011158 442 ----LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNS 480 (492)
Q Consensus 442 ----~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y 480 (492)
.+..+..|.+||++-+-.|...-|+|++ ..+...|.|-|
T Consensus 343 q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLf 388 (586)
T KOG0667|consen 343 QRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLF 388 (586)
T ss_pred CcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCcccc
Confidence 4667778888998888888888999994 44556666654
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=231.01 Aligned_cols=178 Identities=29% Similarity=0.463 Sum_probs=152.3
Q ss_pred eCCCCceeeeeeeecCceEEEEEEECC-ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEE
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~~g-~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 367 (492)
++.++|++.+.||+|+||.||++.+.. ..+|+|.++..... ...+.+|+.++++++||||+++++++......|+|
T Consensus 1 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred CCHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence 355678899999999999999998854 57999988754332 35788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee-----
Q 011158 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL----- 442 (492)
Q Consensus 368 ~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~----- 442 (492)
|||+++|+|.+++....+.+++..++.++.|++.||.|||+++|+||||||+||+++.++.+|++|||.++....
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 999999999999987556789999999999999999999999999999999999999999999999998864311
Q ss_pred ---eeCCCceeecceeccccccCccceeee
Q 011158 443 ---FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 443 ---~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
..+...|++||+.....+...+|+|++
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~ 187 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSF 187 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHH
Confidence 112235888888877677777888884
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.1e-28 Score=241.34 Aligned_cols=152 Identities=22% Similarity=0.304 Sum_probs=138.0
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEECC--ceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCe
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g--~~vAvK~l~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 363 (492)
..+..++|++++.||.|.-|.||++...+ ..+|+|++.++.+. .....+...|-+||+.++||.++.+|..++....
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~ 151 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY 151 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence 35677889999999999999999999865 78999999876443 3445667789999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecc
Q 011158 364 LCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFT 438 (492)
Q Consensus 364 ~~lV~Ey~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~ 438 (492)
.|++||||+||+|..+++++. +.+++..++.++..|+.||+|||-.|||.|||||+||||-++|.+.++||.++.
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~ 227 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSL 227 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccc
Confidence 999999999999999998875 479999999999999999999999999999999999999999999999998863
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=243.22 Aligned_cols=189 Identities=22% Similarity=0.285 Sum_probs=164.4
Q ss_pred eeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEeccCCC
Q 011158 297 GSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG 374 (492)
Q Consensus 297 ~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~gg 374 (492)
.++||+|.||+||-|+. +|+.||||++.+.+........+.+|+.||++++||.||.+.-.|+.++.++.|||-+.|-
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 37899999999999976 6899999999888776666688999999999999999999999999999999999999444
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCC---CeEEEEEeeccee------eeeeC
Q 011158 375 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE---VSLLLSLCLFTVS------ILFCG 445 (492)
Q Consensus 375 sL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~---~~kl~DFGla~~~------~~~~g 445 (492)
=|.-.|...++.+++..-+.++.||+.||.|||.++|+|+||||+|||+.... .+|++|||.||+. +...|
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVG 728 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVG 728 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcC
Confidence 44555566678999999999999999999999999999999999999997543 7899999999976 35789
Q ss_pred CCceeecceeccccccCccceeee---ecccccCCCCCCCccc
Q 011158 446 KGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDAPFL 485 (492)
Q Consensus 446 ~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~aPE~ 485 (492)
++.|++||++.+..|...-|+|++ +....-||.+|.--|.
T Consensus 729 TPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd 771 (888)
T KOG4236|consen 729 TPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED 771 (888)
T ss_pred CccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc
Confidence 999999999999999999999994 4455678877765543
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-27 Score=234.31 Aligned_cols=188 Identities=20% Similarity=0.320 Sum_probs=151.6
Q ss_pred CceeeeeeeecCceEEEEEEEC---CceEEEEEecCCCCChHHHHHHHHHHHHHHhc---CCCceeeEEEEEe-----cC
Q 011158 293 HLKFGSKVASGSYGDLYRGTYC---SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV---RHKNVVQFIGACT-----KP 361 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~~---g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~g~~~-----~~ 361 (492)
+|++.+.||+|+||.||+|.+. ++.||+|+++...........+.+|+.+++.+ +||||+++++++. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 6788899999999999999872 46799999976544343445667788887766 6999999999985 24
Q ss_pred CeEEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 362 PSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
..+++||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 160 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence 56899999995 79999997643 45899999999999999999999999999999999999999999999999998653
Q ss_pred e------eeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 441 I------LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 441 ~------~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
. ...++..|++||......+....|+|++ +.....|.+.|.
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~ 210 (290)
T cd07862 161 SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 210 (290)
T ss_pred cCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcC
Confidence 2 2346677899998877777778899984 223334555554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=239.82 Aligned_cols=183 Identities=20% Similarity=0.308 Sum_probs=152.2
Q ss_pred eeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCeEEEEEeccCC
Q 011158 298 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSG 373 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~Ey~~g 373 (492)
+.||+|+||.||+|.+. ++.||||+++.... .......+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46899999999999884 57899999976422 122345567788888764 899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee-------eeeeCC
Q 011158 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS-------ILFCGK 446 (492)
Q Consensus 374 gsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~-------~~~~g~ 446 (492)
|+|.+++.. ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.. ....++
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (316)
T cd05619 81 GDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGT 159 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCC
Confidence 999999976 356899999999999999999999999999999999999999999999999998642 234577
Q ss_pred CceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 447 GRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 447 ~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
..|++||+.....+....|+|++ +.....|..+|.
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~ 197 (316)
T cd05619 160 PDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFH 197 (316)
T ss_pred ccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCC
Confidence 88999999888788888899984 223345665554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-27 Score=230.76 Aligned_cols=180 Identities=28% Similarity=0.415 Sum_probs=155.1
Q ss_pred eCCCCceeeeeeeecCceEEEEEEEC-----CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCe
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~~-----g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 363 (492)
|++++|++.+.||+|+||.||+|.+. ...||||+++... .......|.+|+.++++++|+||+++++++...+.
T Consensus 1 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (266)
T cd05033 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP 79 (266)
T ss_pred CChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence 34677899999999999999999873 2469999987543 34455778999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee-
Q 011158 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL- 442 (492)
Q Consensus 364 ~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~- 442 (492)
.++||||+++++|.+++....+.+++..++.++.|++.||.|||+++|+|+||||+|||+++++.++++|||.+.....
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 9999999999999999987667899999999999999999999999999999999999999999999999999875421
Q ss_pred --------eeCCCceeecceeccccccCccceeee
Q 011158 443 --------FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 443 --------~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
..++..|++||+.....+...+|+|++
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~sl 194 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSF 194 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHH
Confidence 112245888888877777888899984
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-27 Score=251.64 Aligned_cols=189 Identities=14% Similarity=0.189 Sum_probs=157.7
Q ss_pred CCceeeeeeeecCceEEEEEEEC---CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC---SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~---g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
..|.+.+.||+|+||.||+|... ++.||+|.+... .......+.+|+.+|+.++||||+++++++...+.+||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~ 144 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence 34888999999999999999763 467899977543 3344466788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee----
Q 011158 369 EFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI---- 441 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~---- 441 (492)
||+++|+|.++|... ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999999988642 3468999999999999999999999999999999999999999999999999986531
Q ss_pred -----eeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 442 -----LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 442 -----~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
...|+..|++||+.....+....|+|++ +.....|.++|..
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~ 273 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG 273 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence 2347778999998888778888888884 2233445555554
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=234.97 Aligned_cols=182 Identities=21% Similarity=0.263 Sum_probs=151.4
Q ss_pred eeecCceEEEEEEE--CCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEeccCCCCH
Q 011158 300 VASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376 (492)
Q Consensus 300 LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ggsL 376 (492)
||+|+||.||++.+ +++.||+|++...... ....+.+..|+.++++++|+||+++++++......|+|||||++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999987 4688999998754322 22345678899999999999999999999999999999999999999
Q ss_pred HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------eeeCC
Q 011158 377 YDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-------LFCGK 446 (492)
Q Consensus 377 ~~~L~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-------~~~g~ 446 (492)
.+++... ...+++..++.++.||+.||.|||+++|+||||||+|||++.++.++|+|||.+.... ...++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~ 160 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT 160 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence 9888542 3468999999999999999999999999999999999999999999999999986432 23566
Q ss_pred CceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 447 GRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 447 ~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
..|++||+.....+....|+|++ +.....|..+|.
T Consensus 161 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~ 198 (280)
T cd05608 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFR 198 (280)
T ss_pred cCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 78999998887777888899984 223334555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=230.79 Aligned_cols=192 Identities=28% Similarity=0.457 Sum_probs=160.4
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEE
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 365 (492)
|.|+.++|++.++||+|+||.||+|.+. ++.||+|.+.... ...+.+.+|+.++++++|+||+++++.+...+..+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 6788899999999999999999999874 5679999987543 23467899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee--
Q 011158 366 IVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL-- 442 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~-- 442 (492)
++|||+++|+|.+++.+. ...+++..++.++.|++.||.|||+++++||||||+||+++.++.++++|||++.....
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 999999999999999764 34688999999999999999999999999999999999999999999999999875421
Q ss_pred ------eeCCCceeecceeccccccCccceeee----ecccccCCCCCC
Q 011158 443 ------FCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSD 481 (492)
Q Consensus 443 ------~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~ 481 (492)
..++..|++||+.....+....|+|++ +.....|..+|.
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~ 206 (261)
T cd05072 158 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYP 206 (261)
T ss_pred eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCC
Confidence 112235888888777667777899984 222223555553
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=266.01 Aligned_cols=180 Identities=30% Similarity=0.517 Sum_probs=157.1
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 360 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~~g-------~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 360 (492)
++.+...++...||+|.||.||+|.+.+ ..||||.++.. .+.....+|.+|..+|++++|||||+++|+|..
T Consensus 688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 4668889999999999999999998843 23899988754 345667899999999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEE
Q 011158 361 PPSLCIVTEFMSGGSVYDYLHKL------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSL 434 (492)
Q Consensus 361 ~~~~~lV~Ey~~ggsL~~~L~~~------~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DF 434 (492)
....+|++|||+||+|..||++. ...++...++.++.|||+||+||+++++|||||.++|+|+++...+||+||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence 99999999999999999999986 567999999999999999999999999999999999999999999999999
Q ss_pred eecceee-----eeeCC----CceeecceeccccccCccceee
Q 011158 435 CLFTVSI-----LFCGK----GRELISLFLGNDVLLQFGTYWI 468 (492)
Q Consensus 435 Gla~~~~-----~~~g~----~~~~ape~~~~e~~~~~~d~W~ 468 (492)
|+|+... ...+. .+||+||.+....++..+|.|+
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWs 889 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWS 889 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhh
Confidence 9998431 11122 4789999998877877788766
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-28 Score=252.41 Aligned_cols=183 Identities=31% Similarity=0.545 Sum_probs=161.1
Q ss_pred CCceeeCCCCceeeeeeeecCceEEEEEEECC--ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 011158 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (492)
Q Consensus 284 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g--~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 361 (492)
.|.||+++.++....+||-|.||.||.|.|+. -.||||.++.+.+ ..++|+.|..+|+.++|||+|+++|+|+.+
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM---eveEFLkEAAvMKeikHpNLVqLLGVCT~E 335 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTHE 335 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch---hHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence 48899999999999999999999999999964 5799999986543 458999999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 362 PSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~L~~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
..+|||+|||..|+|.+||+++.. .++.-.++.++.||..||+||..+++|||||.+.|+|+.++..+|++|||++++.
T Consensus 336 pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 336 PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 999999999999999999998754 5777788899999999999999999999999999999999999999999999986
Q ss_pred eee--e---CC---CceeecceeccccccCccceeee
Q 011158 441 ILF--C---GK---GRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 441 ~~~--~---g~---~~~~ape~~~~e~~~~~~d~W~l 469 (492)
.-. . |. ..|.+||-++=..+...+|.|++
T Consensus 416 tgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAF 452 (1157)
T KOG4278|consen 416 TGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAF 452 (1157)
T ss_pred cCCceecccCccCcccccCcccccccccccchhhHHH
Confidence 421 1 11 35678887777777777887773
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=248.11 Aligned_cols=188 Identities=23% Similarity=0.357 Sum_probs=166.0
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
..|...+.||+|+||.||+|.+ +++.||+|++..+.. ....+++.+|+.+|.+++++||.++|+.+.....+||+||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhc-chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 4566668999999999999988 468899999988653 4456889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee-------ee
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS-------IL 442 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~-------~~ 442 (492)
||.||++.+.|+. ...+.+..+..++++++.||.|||.++.||||||++|||+..+|.+|++|||.+... ..
T Consensus 92 y~~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~t 170 (467)
T KOG0201|consen 92 YCGGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKT 170 (467)
T ss_pred HhcCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcccc
Confidence 9999999999976 344588889999999999999999999999999999999999999999999999754 35
Q ss_pred eeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 443 FCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 443 ~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
+.||+.|||||++....|....|+|++ .-...-|.|+|.
T Consensus 171 fvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s 212 (467)
T KOG0201|consen 171 FVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHS 212 (467)
T ss_pred ccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCc
Confidence 789999999999999999999999996 223456777765
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-27 Score=238.55 Aligned_cols=183 Identities=21% Similarity=0.337 Sum_probs=153.8
Q ss_pred eeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCeEEEEEeccCC
Q 011158 298 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSG 373 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~Ey~~g 373 (492)
+.||+|+||.||+|.+. ++.||||+++.... .......+.+|+.++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999884 57899999975422 223446678899999888 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee-------eeeeCC
Q 011158 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS-------ILFCGK 446 (492)
Q Consensus 374 gsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~-------~~~~g~ 446 (492)
|+|.+++.+ ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.. ....++
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~ 159 (318)
T cd05570 81 GDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGT 159 (318)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecC
Confidence 999999976 457999999999999999999999999999999999999999999999999988642 124577
Q ss_pred CceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 447 GRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 447 ~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
..|++||+.....+....|+|++ +....+|..+|.
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~ 197 (318)
T cd05570 160 PDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197 (318)
T ss_pred ccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCC
Confidence 88999998888778888899984 223345666654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.8e-27 Score=227.80 Aligned_cols=180 Identities=33% Similarity=0.527 Sum_probs=156.5
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEE
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 366 (492)
|.++.++|++.+.||+|+||.||+|...++.||+|.++.... ..+++.+|+.++++++|+||+++++++......|+
T Consensus 1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 77 (256)
T cd05039 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI 77 (256)
T ss_pred CccChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence 456778899999999999999999999999999999975432 45789999999999999999999999998889999
Q ss_pred EEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeeee--
Q 011158 367 VTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSILF-- 443 (492)
Q Consensus 367 V~Ey~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~~-- 443 (492)
||||+++++|.+++.... ..+++..++.++.|++.||.|||+++|+||||||+||+++.++.++++|||.++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence 999999999999997643 26899999999999999999999999999999999999999999999999998765321
Q ss_pred --eCCCceeecceeccccccCccceeee
Q 011158 444 --CGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 444 --~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
.....|++||+.....+...+|+|++
T Consensus 158 ~~~~~~~~~ape~~~~~~~~~~~Di~sl 185 (256)
T cd05039 158 SGKLPVKWTAPEALREKKFSTKSDVWSF 185 (256)
T ss_pred cCCCcccccCchhhcCCcCCcHHHHHHH
Confidence 22335788887766666777888884
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-27 Score=237.59 Aligned_cols=182 Identities=23% Similarity=0.332 Sum_probs=148.3
Q ss_pred eeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhc---CCCceeeEEEEEecCCeEEEEEeccCC
Q 011158 300 VASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV---RHKNVVQFIGACTKPPSLCIVTEFMSG 373 (492)
Q Consensus 300 LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l---~HpnIv~l~g~~~~~~~~~lV~Ey~~g 373 (492)
||+|+||.||+|.+ .++.||||++..... .......+..|..++.++ +||||+++++++.....+|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999987 468899999864322 122334456677777766 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee-------eeeeCC
Q 011158 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS-------ILFCGK 446 (492)
Q Consensus 374 gsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~-------~~~~g~ 446 (492)
|+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.. ....|+
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt 159 (330)
T cd05586 81 GELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGT 159 (330)
T ss_pred ChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCC
Confidence 999999976 467899999999999999999999999999999999999999999999999998642 134577
Q ss_pred Cceeecceecc-ccccCccceeee---ecccccCCCCCCC
Q 011158 447 GRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 447 ~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
..|++||.... ..+....|+|++ +....+|..+|..
T Consensus 160 ~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~ 199 (330)
T cd05586 160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA 199 (330)
T ss_pred ccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC
Confidence 78999997754 346677899984 3344556666544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.2e-29 Score=239.57 Aligned_cols=187 Identities=22% Similarity=0.318 Sum_probs=165.6
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
+-|.+.++||+|+||.||++.+ .|+.+|||.+..+ ...+++..|+.||++++.|++|++||.+.....+|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 3567789999999999999976 6899999998764 235788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------e
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-------L 442 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-------~ 442 (492)
||-.|++.+.++..+..+++..+..+++..++||+|||...-||||||+.|||++.+|.+|++|||.++... .
T Consensus 109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNT 188 (502)
T KOG0574|consen 109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNT 188 (502)
T ss_pred hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCc
Confidence 999999999999888899999999999999999999999999999999999999999999999999998652 4
Q ss_pred eeCCCceeecceeccccccCccceeeee---cccccCCCCCCC
Q 011158 443 FCGKGRELISLFLGNDVLLQFGTYWIIF---RRSSCDKKNSDA 482 (492)
Q Consensus 443 ~~g~~~~~ape~~~~e~~~~~~d~W~l~---~~~~~gt~~Y~a 482 (492)
..|++.||+||++..-.|....|+|++- -.+.-|-|+|..
T Consensus 189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsD 231 (502)
T KOG0574|consen 189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSD 231 (502)
T ss_pred cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccc
Confidence 6799999999999888888888999851 134456666653
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-28 Score=250.65 Aligned_cols=176 Identities=23% Similarity=0.349 Sum_probs=157.8
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCC-CCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPE-RINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~-~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
.|.-++.||.|+||.||-+++ +.+.||||.+.-. +.+...+.+++.|+..|++++|||++.+.|+|......|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 466678999999999999987 4678999998754 2344567899999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee---eeeeCC
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS---ILFCGK 446 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~---~~~~g~ 446 (492)
|| -||-.|++.-.+.++.+-.+..|+.+.+.||.|||+.+.||||||+.|||+++.|.+|++|||.|.+. ..+.|+
T Consensus 107 YC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAnsFvGT 185 (948)
T KOG0577|consen 107 YC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPANSFVGT 185 (948)
T ss_pred HH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCchhcccCC
Confidence 99 78999999877789999999999999999999999999999999999999999999999999999765 468999
Q ss_pred Cceeeccee---ccccccCccceeee
Q 011158 447 GRELISLFL---GNDVLLQFGTYWII 469 (492)
Q Consensus 447 ~~~~ape~~---~~e~~~~~~d~W~l 469 (492)
+.||+||++ ....|.+..|+|++
T Consensus 186 PywMAPEVILAMDEGqYdgkvDvWSL 211 (948)
T KOG0577|consen 186 PYWMAPEVILAMDEGQYDGKVDVWSL 211 (948)
T ss_pred ccccchhHheeccccccCCccceeec
Confidence 999999965 44678888899995
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.6e-27 Score=240.23 Aligned_cols=188 Identities=18% Similarity=0.217 Sum_probs=155.9
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC------
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP------ 362 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~------ 362 (492)
.++|++.+.||+|+||.||++.+ .++.||+|+++...........+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 36789999999999999999987 4688999999765444555677889999999999999999999986543
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-
Q 011158 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI- 441 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~- 441 (492)
.+|+||||+. ++|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 100 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 100 DVYLVMELMD-ANLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred eeEEEEeCCC-cCHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 4799999995 577777643 47889999999999999999999999999999999999999999999999986532
Q ss_pred -----eeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 442 -----LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 442 -----~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
...++..|++||......+....|+|++ +.....|..+|..
T Consensus 176 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 224 (359)
T cd07876 176 NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG 224 (359)
T ss_pred CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 2355677899998887778888899984 3344456666653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.6e-27 Score=228.38 Aligned_cols=180 Identities=33% Similarity=0.528 Sum_probs=155.2
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEE
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 365 (492)
|+++.++|++.+.||+|+||.||+|.+. ++.||+|.++.... ..+.+.+|+.++++++|+||+++++++...+..|
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM---DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc---cHHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 6788889999999999999999999874 46799999876432 2467889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee--
Q 011158 366 IVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL-- 442 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~-- 442 (492)
+||||+++++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||++++++.+|++|||.+.....
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 9999999999999997644 4689999999999999999999999999999999999999999999999999865421
Q ss_pred ---eeC---CCceeecceeccccccCccceeee
Q 011158 443 ---FCG---KGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 443 ---~~g---~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
..+ ...|++||+.....+...+|+|++
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 190 (261)
T cd05068 158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSF 190 (261)
T ss_pred ccccCCCcCceeccCccccccCCCCchhhHHHH
Confidence 111 125788888877777777888884
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.6e-27 Score=251.47 Aligned_cols=194 Identities=17% Similarity=0.222 Sum_probs=161.9
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC---
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP--- 362 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~--- 362 (492)
+...++|.+.+.||+|+||.||+|.+ +++.||||++.....+......+.+|+.++..++|+||++++..+....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 34457899999999999999999987 5789999999877666666778899999999999999999988775432
Q ss_pred -----eEEEEEeccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEE
Q 011158 363 -----SLCIVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSL 434 (492)
Q Consensus 363 -----~~~lV~Ey~~ggsL~~~L~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DF 434 (492)
.+++||||+++|+|.++|... ...+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence 368999999999999999753 246899999999999999999999999999999999999999999999999
Q ss_pred eecceee---------eeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 435 CLFTVSI---------LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 435 Gla~~~~---------~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
|+++... ...|+..|++||+.....+....|+|++ +.....|..+|.
T Consensus 188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~ 246 (496)
T PTZ00283 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246 (496)
T ss_pred ccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 9986431 2457788999998888778888898884 223334555553
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-27 Score=229.28 Aligned_cols=177 Identities=32% Similarity=0.505 Sum_probs=151.7
Q ss_pred CCCCceeeeeeeecCceEEEEEEECC-ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 290 DPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 290 ~~~~~~~~~~LG~G~fG~Vy~~~~~g-~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
+..+|++.+.||+|+||.||++.+.+ ..+|+|++...... ...+.+|+.++++++|+||+++++++......|+||
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 45678889999999999999998854 57999998754332 256888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee-----e
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL-----F 443 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~-----~ 443 (492)
||+++++|.+++......+++..++.++.||+.||.|||+++|+||||||+||+++.++.+|++|||.++.... .
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 99999999999987666789999999999999999999999999999999999999999999999999875421 1
Q ss_pred eC---CCceeecceeccccccCccceeee
Q 011158 444 CG---KGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 444 ~g---~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
.+ ...|++||+.....+...+|+|++
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~sl 187 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSF 187 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHH
Confidence 11 125888988877777777888883
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-27 Score=229.69 Aligned_cols=178 Identities=33% Similarity=0.493 Sum_probs=152.2
Q ss_pred eCCCCceeeeeeeecCceEEEEEEECC-ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEE
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~~g-~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 367 (492)
++.++|++.+.||+|+||.||+|.+.+ ..+|+|.++..... ...+.+|+.++++++||||+++++++.....+|+|
T Consensus 1 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred CChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 356678999999999999999998865 45999998754332 35789999999999999999999999988889999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee-----
Q 011158 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL----- 442 (492)
Q Consensus 368 ~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~----- 442 (492)
|||+++|+|.+++......+++..++.++.||+.||.|||+++|+|+||||+|||++.++.+|++|||.++....
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 999999999999987556789999999999999999999999999999999999999999999999998864321
Q ss_pred ---eeCCCceeecceeccccccCccceeee
Q 011158 443 ---FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 443 ---~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
..++..|++||+.....+...+|+|++
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~sl 187 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAF 187 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHH
Confidence 112245788888876667777888883
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=236.34 Aligned_cols=181 Identities=19% Similarity=0.276 Sum_probs=147.6
Q ss_pred CceeeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEec--
Q 011158 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK-- 360 (492)
Q Consensus 285 ~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-- 360 (492)
..|++.. .|...+.||+|+||.|..+++ +|+.||||.+.....+.-..++..+|+.+|+.++|+||+.+++++..
T Consensus 16 ~~~~i~~-~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~ 94 (359)
T KOG0660|consen 16 ELFEIPR-YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPS 94 (359)
T ss_pred eEEeccc-eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccc
Confidence 3455553 344478999999999999988 57899999987555566677889999999999999999999999876
Q ss_pred ---CCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeec
Q 011158 361 ---PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLF 437 (492)
Q Consensus 361 ---~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla 437 (492)
-..+|+|+|+| +.+|.+.|+. ...++...+..+++||++||+|+|+.+|+||||||.|+|++.++..||+|||+|
T Consensus 95 ~~~f~DvYiV~elM-etDL~~iik~-~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 95 RDKFNDVYLVFELM-ETDLHQIIKS-QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred ccccceeEEehhHH-hhHHHHHHHc-CccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccce
Confidence 24589999999 8899999977 345999999999999999999999999999999999999999999999999999
Q ss_pred ceeee---------eeCCCceeeccee-ccccccCccceee
Q 011158 438 TVSIL---------FCGKGRELISLFL-GNDVLLQFGTYWI 468 (492)
Q Consensus 438 ~~~~~---------~~g~~~~~ape~~-~~e~~~~~~d~W~ 468 (492)
|.... +..|.-|.+||.+ ....|+...|+|+
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWS 213 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWS 213 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhh
Confidence 98742 2223334444433 2244566667787
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.4e-27 Score=227.46 Aligned_cols=179 Identities=31% Similarity=0.497 Sum_probs=154.3
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEe-cCCeEE
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT-KPPSLC 365 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~-~~~~~~ 365 (492)
|-++.++|++.+.||+|+||.||++...+..||+|.++... ..+.+.+|+.++++++|+||+++++++. .....+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05082 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 76 (256)
T ss_pred CCccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence 56777899999999999999999999999999999986432 2467889999999999999999999764 456789
Q ss_pred EEEeccCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeeee-
Q 011158 366 IVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSILF- 443 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~~- 443 (492)
+||||+++++|.+++.+... .+++..++.++.||+.||.|||++||+||||||+||+++.++.+|++|||.+......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 99999999999999976443 4889999999999999999999999999999999999999999999999998754321
Q ss_pred ---eCCCceeecceeccccccCccceeee
Q 011158 444 ---CGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 444 ---~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
.....|++||+.....+...+|+|++
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 185 (256)
T cd05082 157 DTGKLPVKWTAPEALREKKFSTKSDVWSF 185 (256)
T ss_pred CCCccceeecCHHHHccCCCCchhhhHHH
Confidence 22346888998887778888899984
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-27 Score=253.16 Aligned_cols=171 Identities=22% Similarity=0.376 Sum_probs=146.3
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC------eEEEEEe
Q 011158 298 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP------SLCIVTE 369 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~------~~~lV~E 369 (492)
+.||+|+||.||+|+. +|+.||||.++... .....+..-+|+++|++++|+|||+++++-.... ...+|||
T Consensus 19 e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 19 ERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 7899999999999986 68999999998643 3344567789999999999999999999865443 4689999
Q ss_pred ccCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc--cCC--CeEEEEEeeccee---
Q 011158 370 FMSGGSVYDYLHKLK--GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD--ENE--VSLLLSLCLFTVS--- 440 (492)
Q Consensus 370 y~~ggsL~~~L~~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld--~~~--~~kl~DFGla~~~--- 440 (492)
||+||||+..|.+.. ..|++.+++.++.+++.||.|||++||+||||||.||++- ++| .-||+|||.|+..
T Consensus 98 yC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~ 177 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDN 177 (732)
T ss_pred ecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCC
Confidence 999999999998643 3699999999999999999999999999999999999984 333 5799999999864
Q ss_pred ---eeeeCCCceeecceec-cccccCccceeee
Q 011158 441 ---ILFCGKGRELISLFLG-NDVLLQFGTYWII 469 (492)
Q Consensus 441 ---~~~~g~~~~~ape~~~-~e~~~~~~d~W~l 469 (492)
....||..|++|+... ...|....|+|++
T Consensus 178 s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~ 210 (732)
T KOG4250|consen 178 SLFTSLVGTEEYLHPELYERQKKYTATVDLWSF 210 (732)
T ss_pred CeeeeecCchhhcChHHHhhccCcCceeehhhh
Confidence 3567888899998877 4778888999995
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=244.07 Aligned_cols=190 Identities=19% Similarity=0.286 Sum_probs=170.0
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEec
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 370 (492)
-|.+.+.||+|.|..|-++++ +|..||||++.+.+++......+.+|++.|+-++|||||++|.+......+|||+|+
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 466678999999999998864 899999999998888887778899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc-cCCCeEEEEEeeccee------eee
Q 011158 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD-ENEVSLLLSLCLFTVS------ILF 443 (492)
Q Consensus 371 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld-~~~~~kl~DFGla~~~------~~~ 443 (492)
-.+|+|+|||-++...+.+....+++.||+.|+.|||+..+|||||||+|+++- .-|.+|+.|||++..- ...
T Consensus 99 GD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~Ts 178 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTTS 178 (864)
T ss_pred cCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchhhcc
Confidence 999999999998888899999999999999999999999999999999999876 4589999999997432 467
Q ss_pred eCCCceeecceeccccccC-ccceeee---ecccccCCCCCCC
Q 011158 444 CGKGRELISLFLGNDVLLQ-FGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 444 ~g~~~~~ape~~~~e~~~~-~~d~W~l---~~~~~~gt~~Y~a 482 (492)
+|+-.|-+||++-++.|.. ..|+|++ ..+..||.++|+-
T Consensus 179 CGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqe 221 (864)
T KOG4717|consen 179 CGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQE 221 (864)
T ss_pred cchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccc
Confidence 8999999999988877754 5589994 6678899998873
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=230.55 Aligned_cols=191 Identities=24% Similarity=0.360 Sum_probs=156.1
Q ss_pred eCCCCceeeeeeeecCceEEEEEEE------CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 362 (492)
++.++|++.++||+|+||.||+|.+ .+..|++|.++... .......+.+|+.++++++||||+++++++....
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 4456788999999999999999975 23679999987532 3444577899999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhcC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccC
Q 011158 363 SLCIVTEFMSGGSVYDYLHKLK----------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~~----------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~ 426 (492)
..|+||||+++++|.+++.... ..+++.+++.++.|++.||.|||+++|+||||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 9999999999999999996421 247888999999999999999999999999999999999999
Q ss_pred CCeEEEEEeecceee---------eeeCCCceeecceeccccccCccceeee----ecccccCCCCC
Q 011158 427 EVSLLLSLCLFTVSI---------LFCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNS 480 (492)
Q Consensus 427 ~~~kl~DFGla~~~~---------~~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y 480 (492)
+.+|++|||+++... ...++..|++||+.....+...+|+|++ +.....|.++|
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~ 227 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPY 227 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCC
Confidence 999999999986531 1122345888998876677778899984 23333466554
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=224.01 Aligned_cols=189 Identities=18% Similarity=0.287 Sum_probs=161.7
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEec
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 370 (492)
+|.+.+.||+|+||.||+|++ +++.|++|.+............+.+|+.++++++||||+++++++...+..|+||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 467789999999999999987 468899999986655566678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------e
Q 011158 371 MSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-------L 442 (492)
Q Consensus 371 ~~ggsL~~~L~~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-------~ 442 (492)
+++++|.+++... ...+++..++.++.|++.||.|||++||+|+||||+||+++.++.++++|||++.... .
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 160 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT 160 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhc
Confidence 9999999999875 4578999999999999999999999999999999999999999999999999876532 1
Q ss_pred eeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 443 FCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 443 ~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
..++..|++||+.....+...+|+|++ +.....|..+|.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 202 (256)
T cd08529 161 IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFD 202 (256)
T ss_pred cccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 245667889998887777788899984 223444655554
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=230.15 Aligned_cols=189 Identities=22% Similarity=0.244 Sum_probs=157.5
Q ss_pred ceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCh-HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEec
Q 011158 294 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (492)
Q Consensus 294 ~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 370 (492)
|+..+.||+|+||.||++.+ +++.||+|++....... .....+.+|+.++++++|+||+.+++.+...+..|+||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 56678999999999999988 46889999997653322 2345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee------ee
Q 011158 371 MSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------LF 443 (492)
Q Consensus 371 ~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------~~ 443 (492)
+++++|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.++++|||.+.... ..
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 161 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR 161 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccCC
Confidence 99999999987543 469999999999999999999999999999999999999999999999999885431 23
Q ss_pred eCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 444 CGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 444 ~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
.++..|++||+.....+....|+|++ +.....|..+|.+
T Consensus 162 ~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~ 203 (285)
T cd05632 162 VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRG 203 (285)
T ss_pred CCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence 56778899998877777777899984 2233346666643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.4e-27 Score=229.08 Aligned_cols=190 Identities=26% Similarity=0.380 Sum_probs=157.1
Q ss_pred CCCCceeeeeeeecCceEEEEEEEC--C---ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeE
Q 011158 290 DPKHLKFGSKVASGSYGDLYRGTYC--S---QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (492)
Q Consensus 290 ~~~~~~~~~~LG~G~fG~Vy~~~~~--g---~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 364 (492)
+..+|++.+.||+|+||.||+|.+. + ..+|+|.++... .......+.+|+.++++++||||+++++++...+..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 4567888999999999999999762 2 369999987543 334457889999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeeee-
Q 011158 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSILF- 443 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~~- 443 (492)
|+||||+++++|.+++.+....+++.+++.++.|++.||.|||+++|+||||||+|||++.++.++++|||.+......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999999876667899999999999999999999999999999999999999999999999988653211
Q ss_pred ---------eCCCceeecceeccccccCccceeee----ecccccCCCCC
Q 011158 444 ---------CGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNS 480 (492)
Q Consensus 444 ---------~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y 480 (492)
..+..|++||+.....+....|+|++ +.....|..+|
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~ 210 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 210 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCc
Confidence 11235788888877777778888884 22233466555
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=225.90 Aligned_cols=193 Identities=21% Similarity=0.307 Sum_probs=161.3
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCh---HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS---DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 366 (492)
+.|++.+.||+|+||.||+|.. +++.||+|.+....... .....+.+|+.++++++||||+++++++.....+++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4577889999999999999986 56899999987543322 234578899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-----
Q 011158 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI----- 441 (492)
Q Consensus 367 V~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~----- 441 (492)
|+||+++++|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||.+....
T Consensus 82 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~ 160 (263)
T cd06625 82 FMEYMPGGSVKDQLKA-YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS 160 (263)
T ss_pred EEEECCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence 9999999999999976 4568999999999999999999999999999999999999999999999999986431
Q ss_pred -----eeeCCCceeecceeccccccCccceeee---ecccccCCCCCCCccc
Q 011158 442 -----LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDAPFL 485 (492)
Q Consensus 442 -----~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~aPE~ 485 (492)
...++..|++||+.....+....|+|++ +.....|.++|.+++.
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 212 (263)
T cd06625 161 GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA 212 (263)
T ss_pred cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch
Confidence 1234557889998888778888899983 3345567777665543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=243.49 Aligned_cols=184 Identities=28% Similarity=0.466 Sum_probs=155.0
Q ss_pred CceeeCCCCceeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCceeeEEE
Q 011158 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIG 356 (492)
Q Consensus 285 ~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g-------~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g 356 (492)
..|+++.++|.+.++||+|+||.||+|++.+ ..||+|+++... .....+.+.+|+.+|.++. ||||+++++
T Consensus 30 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~ 108 (401)
T cd05107 30 SAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLG 108 (401)
T ss_pred CcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence 4599999999999999999999999998643 469999997643 2333457889999999997 999999999
Q ss_pred EEecCCeEEEEEeccCCCCHHHHHHhcC----------------------------------------------------
Q 011158 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------------------------------------------- 384 (492)
Q Consensus 357 ~~~~~~~~~lV~Ey~~ggsL~~~L~~~~---------------------------------------------------- 384 (492)
+|...+.++||||||++|+|.+++++.+
T Consensus 109 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (401)
T cd05107 109 ACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD 188 (401)
T ss_pred EEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence 9999999999999999999999997532
Q ss_pred ---------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q 011158 385 ---------------------------------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419 (492)
Q Consensus 385 ---------------------------------------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~ 419 (492)
..+++..++.++.||+.||.|||+++|+||||||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~ 268 (401)
T cd05107 189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAAR 268 (401)
T ss_pred ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcc
Confidence 13567788999999999999999999999999999
Q ss_pred CEEEccCCCeEEEEEeecceeee---------eeCCCceeecceeccccccCccceeee
Q 011158 420 NLLMDENEVSLLLSLCLFTVSIL---------FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 420 NILld~~~~~kl~DFGla~~~~~---------~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
|||++.++.+|++|||+++.... ..++..|++||+.....+....|+|++
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 327 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSF 327 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHH
Confidence 99999999999999999875321 123345888887776667777888883
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-29 Score=235.12 Aligned_cols=177 Identities=19% Similarity=0.336 Sum_probs=157.7
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
.+.|++.+.||+|.|+.||++.. +|+.+|+|++..........+++.+|+.|.+.++||||+++.+.+......|||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 45688889999999999999976 6899999999888777777889999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcc---CCCeEEEEEeeccee-----
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVSLLLSLCLFTVS----- 440 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~---~~~~kl~DFGla~~~----- 440 (492)
|+|.|++|..-|-+ +..+++..+-.++.||+.+|.|+|.++|||||+||+|+|+.. ...+|++|||++...
T Consensus 90 e~m~G~dl~~eIV~-R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~ 168 (355)
T KOG0033|consen 90 DLVTGGELFEDIVA-REFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEA 168 (355)
T ss_pred ecccchHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccc
Confidence 99999999877755 256789999999999999999999999999999999999964 347899999998543
Q ss_pred -eeeeCCCceeecceeccccccCccceee
Q 011158 441 -ILFCGKGRELISLFLGNDVLLQFGTYWI 468 (492)
Q Consensus 441 -~~~~g~~~~~ape~~~~e~~~~~~d~W~ 468 (492)
.-..|++.||+||+...+.|+...|+|+
T Consensus 169 ~~G~~GtP~fmaPEvvrkdpy~kpvDiW~ 197 (355)
T KOG0033|consen 169 WHGFAGTPGYLSPEVLKKDPYSKPVDIWA 197 (355)
T ss_pred cccccCCCcccCHHHhhcCCCCCcchhhh
Confidence 2356889999999999999999999998
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-27 Score=239.74 Aligned_cols=194 Identities=26% Similarity=0.433 Sum_probs=158.5
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeEEEEE
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGAC 358 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~~-------g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~ 358 (492)
|+++.++|++.+.||+|+||.||+|.+. ++.||+|+++... .....+.+.+|+.+++++ +|+||++++++|
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 8889999999999999999999999642 3579999987543 334456788999999999 799999999988
Q ss_pred ecC-CeEEEEEeccCCCCHHHHHHhcC-----------------------------------------------------
Q 011158 359 TKP-PSLCIVTEFMSGGSVYDYLHKLK----------------------------------------------------- 384 (492)
Q Consensus 359 ~~~-~~~~lV~Ey~~ggsL~~~L~~~~----------------------------------------------------- 384 (492)
... ..++++|||+++++|.+++....
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 654 56899999999999999996422
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee---------eeCCCc
Q 011158 385 -------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL---------FCGKGR 448 (492)
Q Consensus 385 -------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~---------~~g~~~ 448 (492)
..+++..+..++.||+.||.|||+++|+||||||+|||++.++.++|+|||++..... ..++..
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 2578999999999999999999999999999999999999999999999999875311 122346
Q ss_pred eeecceeccccccCccceeee----ecccccCCCCCC
Q 011158 449 ELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSD 481 (492)
Q Consensus 449 ~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~ 481 (492)
|++||+.....+...+|+|++ +.....|.++|.
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~ 277 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP 277 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCC
Confidence 889998877778888899984 222223666664
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=229.34 Aligned_cols=178 Identities=26% Similarity=0.421 Sum_probs=149.5
Q ss_pred CCCCceeeeeeeecCceEEEEEEE------CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEec--C
Q 011158 290 DPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--P 361 (492)
Q Consensus 290 ~~~~~~~~~~LG~G~fG~Vy~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~ 361 (492)
+.++|++.+.||+|+||.||++.+ .+..||+|.++.. .....+.+.+|+.++++++||||+++++++.. .
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 2 EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred ccccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 345788999999999999999974 3578999998753 34456788999999999999999999998754 3
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee
Q 011158 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI 441 (492)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~ 441 (492)
..+++||||+++|+|.+++.+....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 46899999999999999998766678999999999999999999999999999999999999999999999999987542
Q ss_pred ee----------eCCCceeecceeccccccCccceeee
Q 011158 442 LF----------CGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 442 ~~----------~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
.. .+...|++||+.....+....|+|++
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 197 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSF 197 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHH
Confidence 11 11224788888776667777888884
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=226.96 Aligned_cols=190 Identities=26% Similarity=0.389 Sum_probs=157.6
Q ss_pred CCCCceeeeeeeecCceEEEEEEEC--C---ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeE
Q 011158 290 DPKHLKFGSKVASGSYGDLYRGTYC--S---QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (492)
Q Consensus 290 ~~~~~~~~~~LG~G~fG~Vy~~~~~--g---~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 364 (492)
+..+|++.+.||+|+||.||+|.+. + ..||||+++.. ........|..|+.++++++||||+++++++......
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 3456888999999999999999874 2 35999998754 2455567899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeeee-
Q 011158 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSILF- 443 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~~- 443 (492)
++||||+++|+|.+++....+.+++.+++.++.|++.||.|||++|++||||||+||+++.++.+|++|||.+......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999999999876677899999999999999999999999999999999999999999999999988653211
Q ss_pred -----eC------CCceeecceeccccccCccceeee----ecccccCCCCC
Q 011158 444 -----CG------KGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNS 480 (492)
Q Consensus 444 -----~g------~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y 480 (492)
.. +..|++||+.....+....|+|++ +.....|.++|
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~ 212 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 212 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCC
Confidence 10 125788888877777778899984 22233466555
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=239.00 Aligned_cols=186 Identities=22% Similarity=0.319 Sum_probs=149.7
Q ss_pred CCCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEE
Q 011158 290 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (492)
Q Consensus 290 ~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 367 (492)
...+|+..++||+|+||.||+|++. ++.||||++.... .......+.+|+.++++++|+||+++++++...+.+|+|
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 150 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL 150 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence 3456788899999999999999884 6889999997543 344557789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee------
Q 011158 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------ 441 (492)
Q Consensus 368 ~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------ 441 (492)
||||++|+|.+. ....+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 151 ~e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~ 225 (353)
T PLN00034 151 LEFMDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC 225 (353)
T ss_pred EecCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccccc
Confidence 999999998653 235678888999999999999999999999999999999999999999999987542
Q ss_pred -eeeCCCceeecceecccc-----ccCccceeee---ecccccCCCCCC
Q 011158 442 -LFCGKGRELISLFLGNDV-----LLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 -~~~g~~~~~ape~~~~e~-----~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...|+..|++||++.... .....|+|++ +....+|...|.
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~ 274 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFG 274 (353)
T ss_pred cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence 234667788888764322 2235688873 223344555443
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.4e-27 Score=239.12 Aligned_cols=182 Identities=29% Similarity=0.472 Sum_probs=151.3
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEE-------CCceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeEEEEE
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGAC 358 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~-------~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~ 358 (492)
|+++.++|++.+.||+|+||.||+|.+ .++.||||+++... .......+.+|+.++.++ +|+||+++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 788889999999999999999999974 24679999997643 233456788999999999 689999999988
Q ss_pred ecC-CeEEEEEeccCCCCHHHHHHhcC-----------------------------------------------------
Q 011158 359 TKP-PSLCIVTEFMSGGSVYDYLHKLK----------------------------------------------------- 384 (492)
Q Consensus 359 ~~~-~~~~lV~Ey~~ggsL~~~L~~~~----------------------------------------------------- 384 (492)
... ..+++|||||++|+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 654 46899999999999999997532
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee---------
Q 011158 385 -------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL--------- 442 (492)
Q Consensus 385 -------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~--------- 442 (492)
..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+|++|||++.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 2367888899999999999999999999999999999999999999999999865321
Q ss_pred eeCCCceeecceeccccccCccceeee
Q 011158 443 FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 443 ~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
..++..|++||+.....+...+|+|++
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~sl 267 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSF 267 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHH
Confidence 112345888888777777777888884
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=233.75 Aligned_cols=189 Identities=19% Similarity=0.257 Sum_probs=154.1
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
.++|.+.++||+|+||.||+|++ +++.||+|+++.... ......+.+|+.++++++|+||+++++++...+..|+||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 35788999999999999999987 467899999975432 222346778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------- 441 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------- 441 (492)
||++ ++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||.+....
T Consensus 84 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 162 (309)
T cd07872 84 EYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYS 162 (309)
T ss_pred eCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccccc
Confidence 9995 58999988766678999999999999999999999999999999999999999999999999986432
Q ss_pred eeeCCCceeecceecc-ccccCccceeee---ecccccCCCCCC
Q 011158 442 LFCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 ~~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||.... ..+....|+|++ +....+|.++|.
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~ 206 (309)
T cd07872 163 NEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFP 206 (309)
T ss_pred cccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 1234566777876533 445666788884 333445666664
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=227.98 Aligned_cols=180 Identities=31% Similarity=0.522 Sum_probs=155.4
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeE
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 364 (492)
|+++..+|.+.++||+|+||.||+|.+. ++.||+|+++.+ ......+.+|+.++++++|+||+++++++...+.+
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 77 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCc
Confidence 6788888999999999999999999874 678999998753 22346789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeeee
Q 011158 365 CIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSILF 443 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~~ 443 (492)
++||||+++++|.+++.... ..+++..++.++.|++.||.|||+++|+||||||+|||+++++.+|++|||.+......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 99999999999999997643 46899999999999999999999999999999999999999999999999998654211
Q ss_pred --------eCCCceeecceeccccccCccceeee
Q 011158 444 --------CGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 444 --------~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
..+..|++||+.....+...+|+|++
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 191 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF 191 (263)
T ss_pred eeeccCCCCCccccCCHHHhccCCCCchhHHHHH
Confidence 11235888888777777777899983
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.7e-27 Score=241.47 Aligned_cols=187 Identities=19% Similarity=0.225 Sum_probs=153.0
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC-----eEE
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP-----SLC 365 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-----~~~ 365 (492)
+|++.++||+|+||.||++.+ .++.||||++.....+....+.+.+|+.+++.++|+||+++++++.... .+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 367789999999999999987 5788999998754334445577899999999999999999999998776 789
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee----
Q 011158 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI---- 441 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~---- 441 (492)
+||||+. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158 (372)
T ss_pred EEeeccc-cCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence 9999994 689888865 4578999999999999999999999999999999999999999999999999987542
Q ss_pred ----eeeCCCceeecceecc-ccccCccceeee---ecccccCCCCCC
Q 011158 442 ----LFCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 ----~~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||+... ..+....|+|++ +.....|.+.|.
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 206 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQ 206 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCC
Confidence 1234556788886654 345666789984 334455666654
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=229.63 Aligned_cols=182 Identities=23% Similarity=0.413 Sum_probs=152.3
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g-------~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~ 359 (492)
|++..++|++.++||+|+||.||+|.+.+ ..||||+++... ......++.+|+.+++.++|+||+++++++.
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 66778889999999999999999997643 469999986432 2334567899999999999999999999999
Q ss_pred cCCeEEEEEeccCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeE
Q 011158 360 KPPSLCIVTEFMSGGSVYDYLHKLK---------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSL 430 (492)
Q Consensus 360 ~~~~~~lV~Ey~~ggsL~~~L~~~~---------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~k 430 (492)
.....++||||+++|+|.+++.+.. ..+++..+..++.|++.||.|||+++++||||||+|||+++++.++
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEE
Confidence 9899999999999999999997632 2357788999999999999999999999999999999999999999
Q ss_pred EEEEeecceee---------eeeCCCceeecceeccccccCccceeee
Q 011158 431 LLSLCLFTVSI---------LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 431 l~DFGla~~~~---------~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
++|||+++... ...++..|++||+.....+...+|+|++
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 207 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 207 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHH
Confidence 99999886421 0122345888888777667777888884
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=230.67 Aligned_cols=182 Identities=23% Similarity=0.383 Sum_probs=151.7
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~~-------g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~ 359 (492)
|+++.++|++.++||+|+||.||+|... +..||+|.++... .......+.+|+.++++++|+||+++++++.
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 7888999999999999999999999653 2469999886442 2333456889999999999999999999999
Q ss_pred cCCeEEEEEeccCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeE
Q 011158 360 KPPSLCIVTEFMSGGSVYDYLHKLK---------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSL 430 (492)
Q Consensus 360 ~~~~~~lV~Ey~~ggsL~~~L~~~~---------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~k 430 (492)
.....|+||||+++|+|.+++.+.. ..++...+..++.|++.||.|||+++|+||||||+|||++.++.++
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence 9999999999999999999997532 2346778899999999999999999999999999999999999999
Q ss_pred EEEEeecceeee---------eeCCCceeecceeccccccCccceeee
Q 011158 431 LLSLCLFTVSIL---------FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 431 l~DFGla~~~~~---------~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
++|||+++.... ..++..|++||+.....+...+|+|++
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dvwsl 207 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSF 207 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHH
Confidence 999999864311 112345888888776667777888884
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.1e-27 Score=242.85 Aligned_cols=182 Identities=22% Similarity=0.409 Sum_probs=154.6
Q ss_pred ceeeCCCCceeeeeeeecCceEEEEEEECC-ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeE
Q 011158 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (492)
Q Consensus 286 ~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g-~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 364 (492)
.-++++..+.+.++||+|.||.|.+|...+ ..||||+++.+. +.....+|.+|+++|.+++||||++++|+|..++.+
T Consensus 532 l~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi 610 (807)
T KOG1094|consen 532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL 610 (807)
T ss_pred hhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence 457888999999999999999999998876 899999999753 455578999999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee--
Q 011158 365 CIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-- 441 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~~~-l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-- 441 (492)
|||+|||++|+|.+|+.++..+ +.-....+|+.||+.||+||.+.++|||||.+.|+|+|.++.+||+|||.+|-.-
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccC
Confidence 9999999999999999886433 3555667899999999999999999999999999999999999999999998321
Q ss_pred ---e----eeCCCceeecceeccccccCccceee
Q 011158 442 ---L----FCGKGRELISLFLGNDVLLQFGTYWI 468 (492)
Q Consensus 442 ---~----~~g~~~~~ape~~~~e~~~~~~d~W~ 468 (492)
. ..-..+||++|-+--..++..+|.|.
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWa 724 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWA 724 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccccchhhhhh
Confidence 1 11225788888665555555666655
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=258.19 Aligned_cols=178 Identities=17% Similarity=0.295 Sum_probs=151.7
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
.+|++.++||+|+||.||+|.+ +++.||||+++.... .....+++.+|+.++++++||||+++++++...+..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 4688899999999999999987 468899999976432 2345577999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecc
Q 011158 369 EFMSGGSVYDYLHKL----------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFT 438 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~----------~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~ 438 (492)
||++||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+++
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 999999999999642 1235667889999999999999999999999999999999999999999999987
Q ss_pred eee-------------------------eeeCCCceeecceeccccccCccceeee
Q 011158 439 VSI-------------------------LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 439 ~~~-------------------------~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
... ...|+..|++||+.....+...+|+|++
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSL 217 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYAL 217 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHH
Confidence 541 1246777888888777777777788883
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-26 Score=228.39 Aligned_cols=189 Identities=21% Similarity=0.262 Sum_probs=157.3
Q ss_pred ceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEec
Q 011158 294 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (492)
Q Consensus 294 ~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 370 (492)
|+..+.||+|+||.||++.+ +++.||+|.+...... ......+.+|+.++++++|+||+.+++.+...+.+|+||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 56778999999999999988 4678999998764332 22345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee------ee
Q 011158 371 MSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------LF 443 (492)
Q Consensus 371 ~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------~~ 443 (492)
+++++|.+++.... ..+++..++.++.|++.||.|||+++|+||||||+||+++.++.++++|||++.... ..
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 161 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR 161 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccCC
Confidence 99999999996533 368999999999999999999999999999999999999999999999999986432 13
Q ss_pred eCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 444 CGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 444 ~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
.++..|++||+.....+....|+|++ +.....|.++|..
T Consensus 162 ~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~ 203 (285)
T cd05630 162 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 203 (285)
T ss_pred CCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence 46678899998877777777899984 2233456666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=225.82 Aligned_cols=191 Identities=24% Similarity=0.417 Sum_probs=158.1
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEE-CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEE
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 365 (492)
|+|..+.|++.++||+|+||.||+|.. .++.||+|.+...... ...+.+|+.++++++|+||+++++++. ....|
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 678889999999999999999999987 4578999998765433 367889999999999999999999875 45689
Q ss_pred EEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee--
Q 011158 366 IVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL-- 442 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~-- 442 (492)
++|||+++++|.+++.... ..+++.++..++.|++.||.|||++|++||||||+||+++.++.++++|||.+.....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 9999999999999997643 4689999999999999999999999999999999999999999999999999865431
Q ss_pred ------eeCCCceeecceeccccccCccceeee---ecccc-cCCCCCC
Q 011158 443 ------FCGKGRELISLFLGNDVLLQFGTYWII---FRRSS-CDKKNSD 481 (492)
Q Consensus 443 ------~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~-~gt~~Y~ 481 (492)
..+...|++||+.....+....|+|++ +.... .|.++|.
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 205 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYP 205 (260)
T ss_pred cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCC
Confidence 112345888888877777777899984 11222 2666664
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=224.81 Aligned_cols=183 Identities=23% Similarity=0.384 Sum_probs=150.4
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEeccCCCC
Q 011158 298 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 375 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ggs 375 (492)
++||+|+||.||+|++ .++.||+|.+... ........+.+|+.++++++||||+++++++......|+||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 4689999999999987 5788999988643 334555789999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeeee---------eCC
Q 011158 376 VYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSILF---------CGK 446 (492)
Q Consensus 376 L~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~~---------~g~ 446 (492)
|.+++......+++..++.++.|++.||.|||+++|+||||||+|||++.++.+|++|||.+...... ...
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 159 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP 159 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCc
Confidence 99999775567899999999999999999999999999999999999999999999999998643211 111
Q ss_pred CceeecceeccccccCccceeee----ecccccCCCCCC
Q 011158 447 GRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSD 481 (492)
Q Consensus 447 ~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~ 481 (492)
..|++||+.....+...+|+|++ +.....|.++|.
T Consensus 160 ~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~ 198 (252)
T cd05084 160 VKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYA 198 (252)
T ss_pred eeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 24777887766666677888883 222223665553
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=224.75 Aligned_cols=180 Identities=33% Similarity=0.539 Sum_probs=155.4
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEE
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 365 (492)
|+++.++|.+.++||+|+||.||++.+. ++.||||.+...... ..++.+|+.++++++|+||+++++++......+
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 6788999999999999999999999874 467999999865432 367889999999999999999999999888999
Q ss_pred EEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee--
Q 011158 366 IVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL-- 442 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~-- 442 (492)
+||||+++++|.+++.... ..+++..+..++.|++.||.|||+++|+|+||||+||+++.++.+|++|||.+.....
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 9999999999999997744 4689999999999999999999999999999999999999999999999999865321
Q ss_pred ------eeCCCceeecceeccccccCccceeee
Q 011158 443 ------FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 443 ------~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
......|++||+.....+...+|+|++
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl 190 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSF 190 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHH
Confidence 112245788887776667777888884
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=231.76 Aligned_cols=184 Identities=25% Similarity=0.449 Sum_probs=155.8
Q ss_pred CceeeCCCCceeeeeeeecCceEEEEEEECC---------ceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeE
Q 011158 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS---------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQF 354 (492)
Q Consensus 285 ~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g---------~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l 354 (492)
..|++..++|.+.+.||+|+||.||++.+.+ ..+|+|.++... ......++.+|+.+++++ +|+||+++
T Consensus 11 ~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~ 89 (307)
T cd05098 11 PRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINL 89 (307)
T ss_pred CcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 3588888999999999999999999997632 359999998643 234456788999999999 79999999
Q ss_pred EEEEecCCeEEEEEeccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q 011158 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419 (492)
Q Consensus 355 ~g~~~~~~~~~lV~Ey~~ggsL~~~L~~~~---------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~ 419 (492)
++++...+..|+||||+++|+|.+++.... ..+++.+++.++.|++.||+|||++|++||||||+
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~ 169 (307)
T cd05098 90 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAAR 169 (307)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHH
Confidence 999999999999999999999999997642 24788999999999999999999999999999999
Q ss_pred CEEEccCCCeEEEEEeecceeee---------eeCCCceeecceeccccccCccceeee
Q 011158 420 NLLMDENEVSLLLSLCLFTVSIL---------FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 420 NILld~~~~~kl~DFGla~~~~~---------~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
|||++.++.+|++|||.++.... ...+..|++||+.....+...+|+|++
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 228 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 228 (307)
T ss_pred heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHH
Confidence 99999999999999999864321 112246888988877777777899884
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-26 Score=227.32 Aligned_cols=182 Identities=19% Similarity=0.257 Sum_probs=150.7
Q ss_pred eeecCceEEEEEEE--CCceEEEEEecCCCCCh-HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEeccCCCCH
Q 011158 300 VASGSYGDLYRGTY--CSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376 (492)
Q Consensus 300 LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ggsL 376 (492)
||+|+||.||++.. +++.||+|++....... .....+..|+.++++++||||+++++++.....+|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999987 47899999987543322 2234556799999999999999999999999999999999999999
Q ss_pred HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee------eeeCCCce
Q 011158 377 YDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------LFCGKGRE 449 (492)
Q Consensus 377 ~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------~~~g~~~~ 449 (492)
.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.... ...++..|
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y 160 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGY 160 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCc
Confidence 99886533 368999999999999999999999999999999999999999999999999976432 23567789
Q ss_pred eecceeccccccCccceeee---ecccccCCCCCC
Q 011158 450 LISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 450 ~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
++||+.....+...+|+|++ +.....|.++|.
T Consensus 161 ~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~ 195 (277)
T cd05607 161 MAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFK 195 (277)
T ss_pred cCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCC
Confidence 99998877778888899984 233344665554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-26 Score=227.58 Aligned_cols=184 Identities=24% Similarity=0.444 Sum_probs=156.5
Q ss_pred CceeeCCCCceeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeEEE
Q 011158 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIG 356 (492)
Q Consensus 285 ~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g-------~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g 356 (492)
..|+++.++|++.+.||+|+||.||++.+.+ ..+|+|+++... .......+.+|+.+++++ +|+||+++++
T Consensus 5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (293)
T cd05053 5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLG 83 (293)
T ss_pred cccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 3588899999999999999999999998632 569999987643 333456788999999999 7999999999
Q ss_pred EEecCCeEEEEEeccCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCE
Q 011158 357 ACTKPPSLCIVTEFMSGGSVYDYLHKL---------------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANL 421 (492)
Q Consensus 357 ~~~~~~~~~lV~Ey~~ggsL~~~L~~~---------------~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NI 421 (492)
++...+.++++|||+++|+|.+++... ...+++..++.++.|++.||.|||+++|+||||||+||
T Consensus 84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Ni 163 (293)
T cd05053 84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV 163 (293)
T ss_pred EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeE
Confidence 999999999999999999999999642 24688999999999999999999999999999999999
Q ss_pred EEccCCCeEEEEEeecceeee---------eeCCCceeecceeccccccCccceeee
Q 011158 422 LMDENEVSLLLSLCLFTVSIL---------FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 422 Lld~~~~~kl~DFGla~~~~~---------~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
|++.++.+|++|||.++.... ..+...|++||+.....+...+|+|++
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 220 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 220 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeeh
Confidence 999999999999999875321 112235888888777777778899994
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.4e-27 Score=229.78 Aligned_cols=173 Identities=32% Similarity=0.513 Sum_probs=146.1
Q ss_pred eeeeeeeecCceEEEEEEEC------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 295 KFGSKVASGSYGDLYRGTYC------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 295 ~~~~~LG~G~fG~Vy~~~~~------g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
++.+.||.|+||.||+|++. +..|+||+++.. ......+.|.+|+.++++++||||++++|++...+..++||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeecccccccccccccccccccccccccccccc
Confidence 56789999999999999987 467999999653 34455788999999999999999999999999888899999
Q ss_pred eccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee------
Q 011158 369 EFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------ 441 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------ 441 (492)
|||++|+|.++|... ...+++..+..++.||+.||.|||+++|+|+||+++|||++.++.+||+|||++....
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~ 160 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK 160 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999886 5689999999999999999999999999999999999999999999999999987651
Q ss_pred ---eeeCCCceeecceeccccccCccceee
Q 011158 442 ---LFCGKGRELISLFLGNDVLLQFGTYWI 468 (492)
Q Consensus 442 ---~~~g~~~~~ape~~~~e~~~~~~d~W~ 468 (492)
.......|++||......+...+|.|+
T Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVys 190 (259)
T PF07714_consen 161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYS 190 (259)
T ss_dssp ESTTSESGGGGS-HHHHHHSEESHHHHHHH
T ss_pred cccccccccccccccccccccccccccccc
Confidence 123445678888877777777777776
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=239.47 Aligned_cols=171 Identities=19% Similarity=0.320 Sum_probs=150.0
Q ss_pred CCCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEE
Q 011158 290 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (492)
Q Consensus 290 ~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 367 (492)
....|++.+.||+|+||.||+|++. ++.||+|+.... ....|+.++++++|+||+++++++......|+|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 3457999999999999999999984 467999985432 235699999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee------
Q 011158 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------ 441 (492)
Q Consensus 368 ~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------ 441 (492)
|||+ .++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.++...
T Consensus 136 ~e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 214 (357)
T PHA03209 136 LPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL 214 (357)
T ss_pred EEcc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCcccc
Confidence 9999 679999998766789999999999999999999999999999999999999999999999999987532
Q ss_pred eeeCCCceeecceeccccccCccceeee
Q 011158 442 LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 442 ~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
...++..|++||+.....+....|+|++
T Consensus 215 ~~~gt~~y~aPE~~~~~~~~~~~DiwSl 242 (357)
T PHA03209 215 GLAGTVETNAPEVLARDKYNSKADIWSA 242 (357)
T ss_pred cccccccccCCeecCCCCCCchhhHHHH
Confidence 2457778999999888888888899984
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=237.88 Aligned_cols=192 Identities=21% Similarity=0.303 Sum_probs=155.9
Q ss_pred ceeeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--
Q 011158 286 VWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-- 361 (492)
Q Consensus 286 ~~ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-- 361 (492)
.|++ .++|++.+.||+|+||.||+|.+ +++.||||+++...........+.+|+.++++++|+||+++++++...
T Consensus 10 ~~~~-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07878 10 VWEV-PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS 88 (343)
T ss_pred Hhhh-hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence 3555 36789999999999999999987 467899999976543334456788999999999999999999987543
Q ss_pred ----CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeec
Q 011158 362 ----PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLF 437 (492)
Q Consensus 362 ----~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla 437 (492)
...|+++|++ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 89 ~~~~~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 89 IENFNEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred ccccCcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccc
Confidence 3479999998 8899988864 56899999999999999999999999999999999999999999999999998
Q ss_pred ceee----eeeCCCceeecceecc-ccccCccceeee---ecccccCCCCCC
Q 011158 438 TVSI----LFCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 438 ~~~~----~~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
+... ...++..|++||+... ..+....|+|++ +....+|.+.|.
T Consensus 166 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 217 (343)
T cd07878 166 RQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFP 217 (343)
T ss_pred eecCCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 7542 2346677888887655 456667899984 333445666554
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=229.01 Aligned_cols=180 Identities=26% Similarity=0.455 Sum_probs=152.3
Q ss_pred eCCCCceeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~~g-------~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 361 (492)
++..+|++.+.||+|+||.||+|.+.+ ..||+|.++... .......|.+|+.++++++||||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 345678899999999999999998633 469999987543 344567799999999999999999999999998
Q ss_pred CeEEEEEeccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccC
Q 011158 362 PSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426 (492)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~L~~~~---------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~ 426 (492)
...|++|||+++|+|.+++.... ..+++..++.++.|++.||.|||+++|+||||||+|||++++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 89999999999999999997632 457889999999999999999999999999999999999999
Q ss_pred CCeEEEEEeecceee---------eeeCCCceeecceeccccccCccceeee
Q 011158 427 EVSLLLSLCLFTVSI---------LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 427 ~~~kl~DFGla~~~~---------~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
+.++|+|||+++... ...++..|++||+.....+...+|+|++
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~sl 212 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSF 212 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHH
Confidence 999999999986431 1123456888988777777778899884
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=226.08 Aligned_cols=182 Identities=23% Similarity=0.386 Sum_probs=154.4
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g-------~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~ 359 (492)
|+++.++|++.+.||+|+||.||+|.+.+ ..||+|.+.... .......+.+|+.+++.++|+||+++++++.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence 67888999999999999999999998742 569999987542 3344567889999999999999999999999
Q ss_pred cCCeEEEEEeccCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeE
Q 011158 360 KPPSLCIVTEFMSGGSVYDYLHKLK---------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSL 430 (492)
Q Consensus 360 ~~~~~~lV~Ey~~ggsL~~~L~~~~---------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~k 430 (492)
.....|+||||+++|+|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.+|
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence 9999999999999999999997532 2468889999999999999999999999999999999999999999
Q ss_pred EEEEeecceee---------eeeCCCceeecceeccccccCccceeee
Q 011158 431 LLSLCLFTVSI---------LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 431 l~DFGla~~~~---------~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
++|||.++... ...++..|++||......+...+|+|++
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 207 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSF 207 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHH
Confidence 99999986431 1123346888888777777777898884
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=227.18 Aligned_cols=191 Identities=24% Similarity=0.389 Sum_probs=156.0
Q ss_pred eCCCCceeeeeeeecCceEEEEEEE--CCc----eEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQ----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~--~g~----~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 362 (492)
+..++|++.++||+|+||.||+|++ +++ .||+|+++.. ........+.+|+.+++.++|+||+++++++...
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~- 81 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN-TSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS- 81 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC-CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-
Confidence 4567888999999999999999986 333 4899998754 2344567889999999999999999999999764
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee
Q 011158 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL 442 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~ 442 (492)
..++++||+++|+|.+++....+.+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 57899999999999999987667799999999999999999999999999999999999999999999999999875421
Q ss_pred ---------eeCCCceeecceeccccccCccceeee----ecccccCCCCCC
Q 011158 443 ---------FCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSD 481 (492)
Q Consensus 443 ---------~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~ 481 (492)
..++..|++||......+....|+|++ +....+|.++|.
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 213 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 112345788888776667777888884 222334666654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-26 Score=229.98 Aligned_cols=187 Identities=21% Similarity=0.309 Sum_probs=156.5
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
++|++.++||+|+||.||++.+ ++..+|+|.++.+ .......++.+|+.++++++||||+++++++...+.+|+|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE-IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 3588899999999999999987 4677999988754 234455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEccCCCeEEEEEeecceee-----ee
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-----LF 443 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~-~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-----~~ 443 (492)
|+++++|.+++.+. +.+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+|++|||.++... ..
T Consensus 80 y~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (308)
T cd06615 80 HMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 158 (308)
T ss_pred ccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccccccC
Confidence 99999999999773 678999999999999999999997 599999999999999999999999999987542 23
Q ss_pred eCCCceeecceeccccccCccceeee---ecccccCCCCC
Q 011158 444 CGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNS 480 (492)
Q Consensus 444 ~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y 480 (492)
.++..|++||......+....|+|++ +....+|..+|
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~ 198 (308)
T cd06615 159 VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198 (308)
T ss_pred CCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCC
Confidence 45667888887766666777888884 22333455444
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-26 Score=227.31 Aligned_cols=179 Identities=26% Similarity=0.433 Sum_probs=151.2
Q ss_pred CCCCceeeeeeeecCceEEEEEEE------CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--
Q 011158 290 DPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-- 361 (492)
Q Consensus 290 ~~~~~~~~~~LG~G~fG~Vy~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-- 361 (492)
+.+.|++.++||+|+||.||++.+ .+..||+|.++... .......+.+|+.++++++|+||+++++++...
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (284)
T cd05079 2 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 80 (284)
T ss_pred chhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 345678899999999999999975 35679999987543 344456799999999999999999999998775
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee
Q 011158 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI 441 (492)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~ 441 (492)
...++||||+++++|.+++.+....+++..++.++.||+.||.|||++||+||||||+|||++.++.++++|||+++...
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 56899999999999999997755578999999999999999999999999999999999999999999999999986432
Q ss_pred ----------eeeCCCceeecceeccccccCccceeee
Q 011158 442 ----------LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 442 ----------~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
...+...|++||+.....+...+|+|++
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~sl 198 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSF 198 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhh
Confidence 1223345788888776667777888884
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=236.97 Aligned_cols=187 Identities=19% Similarity=0.218 Sum_probs=155.1
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC------C
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP------P 362 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------~ 362 (492)
.++|++.+.||+|+||.||++.+ .++.||||++............+.+|+.+++.++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 46889999999999999999987 468899999986554555567888999999999999999999988643 3
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-
Q 011158 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI- 441 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~- 441 (492)
..|+||||+. ++|.+++.. .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 96 ~~~lv~e~~~-~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 96 DVYLVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_pred eeEEEhhhhc-ccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence 4799999995 578777754 47899999999999999999999999999999999999999999999999987542
Q ss_pred -----eeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 442 -----LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 -----~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||......+....|+|++ +.....|..+|.
T Consensus 172 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 219 (355)
T cd07874 172 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 219 (355)
T ss_pred ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 2456778999998877778888899984 233344555543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=225.63 Aligned_cols=179 Identities=31% Similarity=0.502 Sum_probs=151.5
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEECC-ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEE
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g-~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 365 (492)
|+++..+|++.++||+|+||.||+|++.+ ..||+|+++..... ...+.+|+.++++++|+||+++++.+.. ...|
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (262)
T cd05071 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 76 (262)
T ss_pred CCCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcE
Confidence 67788899999999999999999998754 57999999864332 3578899999999999999999998754 5689
Q ss_pred EEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee--
Q 011158 366 IVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL-- 442 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~-- 442 (492)
+||||+++|+|.+++.+.. ..+++..++.++.|++.||.|||+++|+||||||+||+++.++.++|+|||.++....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 9999999999999997643 4579999999999999999999999999999999999999999999999999864321
Q ss_pred ------eeCCCceeecceeccccccCccceeee
Q 011158 443 ------FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 443 ------~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
..++..|++||+.....+...+|+|++
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dvwsl 189 (262)
T cd05071 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 189 (262)
T ss_pred cccccCCcccceecCHhHhccCCCCchhhHHHH
Confidence 112335888888877777778899884
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-26 Score=230.47 Aligned_cols=185 Identities=24% Similarity=0.440 Sum_probs=156.3
Q ss_pred CCceeeCCCCceeeeeeeecCceEEEEEEEC---------CceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceee
Q 011158 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC---------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQ 353 (492)
Q Consensus 284 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~---------g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~ 353 (492)
...|.++..+|++.++||+|+||.||+++.. ...+|+|+++... .......+.+|+.+++++ +||||++
T Consensus 4 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~ 82 (314)
T cd05099 4 DPKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIIN 82 (314)
T ss_pred cccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeee
Confidence 3458888899999999999999999999752 2459999987543 344456788999999999 6999999
Q ss_pred EEEEEecCCeEEEEEeccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 011158 354 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 418 (492)
Q Consensus 354 l~g~~~~~~~~~lV~Ey~~ggsL~~~L~~~~---------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp 418 (492)
+++++.....+|+||||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||
T Consensus 83 ~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp 162 (314)
T cd05099 83 LLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAA 162 (314)
T ss_pred EEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence 9999999889999999999999999997632 3488899999999999999999999999999999
Q ss_pred CCEEEccCCCeEEEEEeecceeee-------ee--CCCceeecceeccccccCccceeee
Q 011158 419 ANLLMDENEVSLLLSLCLFTVSIL-------FC--GKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 419 ~NILld~~~~~kl~DFGla~~~~~-------~~--g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
+|||++.++.+|++|||.++.... .. +...|++||+.....+...+|+|++
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl 222 (314)
T cd05099 163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSF 222 (314)
T ss_pred eeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHH
Confidence 999999999999999999875421 11 2235889998877777788899984
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.7e-26 Score=220.50 Aligned_cols=177 Identities=17% Similarity=0.287 Sum_probs=153.9
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEec
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 370 (492)
+|+..+.||.|+||.||.++. .++.+++|.+.....+.....++.+|+.++++++|+||+++++++...+.++++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 478899999999999988876 568899999887665666677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------e
Q 011158 371 MSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-------L 442 (492)
Q Consensus 371 ~~ggsL~~~L~~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-------~ 442 (492)
+++++|.+++.+. ...+++..+..++.|++.||.|||+++++|+||||+||+++.++.+|++|||.+.... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET 160 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccccc
Confidence 9999999999875 3468999999999999999999999999999999999999999999999999986542 2
Q ss_pred eeCCCceeecceeccccccCccceeee
Q 011158 443 FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 443 ~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
..++..|.+||+.........+|+|++
T Consensus 161 ~~~~~~y~ape~~~~~~~~~~~Dv~sl 187 (256)
T cd08221 161 VVGTPYYMSPELCQGVKYNFKSDIWAL 187 (256)
T ss_pred cCCCccccCHhhcCCCCCCCcchhHHH
Confidence 345667788887766666666788883
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=224.09 Aligned_cols=179 Identities=31% Similarity=0.500 Sum_probs=152.1
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEE
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 365 (492)
|++..++|++.++||+|+||.||+|.+. +..+|+|.++..... ...+.+|+.++++++|+||+++++++.. ...|
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIY 76 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEECC-CCcE
Confidence 6788889999999999999999999874 467999999865433 3568999999999999999999998854 5689
Q ss_pred EEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee--
Q 011158 366 IVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL-- 442 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~-- 442 (492)
++|||+++++|.+++.... ..+++..++.++.|++.||.|||+++|+||||||+||++++++.++++|||.+.....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 9999999999999997643 4589999999999999999999999999999999999999999999999999865321
Q ss_pred ------eeCCCceeecceeccccccCccceeee
Q 011158 443 ------FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 443 ------~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
..+...|++||+.....+...+|+|++
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 189 (260)
T cd05070 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 189 (260)
T ss_pred cccccCCCCCccccChHHHhcCCCcchhhhHHH
Confidence 112235888888776667777889984
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-26 Score=223.68 Aligned_cols=176 Identities=27% Similarity=0.411 Sum_probs=149.0
Q ss_pred ceeeeeeeecCceEEEEEEEC-----CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCe-----
Q 011158 294 LKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS----- 363 (492)
Q Consensus 294 ~~~~~~LG~G~fG~Vy~~~~~-----g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~----- 363 (492)
|++.+.||+|+||.||+|+.. +..||+|+++.+.........+.+|+.+++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 467789999999999999863 2569999998765555566789999999999999999999998866554
Q ss_pred -EEEEEeccCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeec
Q 011158 364 -LCIVTEFMSGGSVYDYLHKL-----KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLF 437 (492)
Q Consensus 364 -~~lV~Ey~~ggsL~~~L~~~-----~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla 437 (492)
.++||||+++|+|..++... ...+++..++.++.|++.||.|||+++|+||||||+||++++++.+|++|||.+
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 79999999999999998543 236899999999999999999999999999999999999999999999999998
Q ss_pred ceeee---------eeCCCceeecceeccccccCccceeee
Q 011158 438 TVSIL---------FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 438 ~~~~~---------~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
+.... ...+..|++||+.....+...+|+|++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~Sl 201 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAF 201 (273)
T ss_pred eeccccccccccccccCCccccCHhhcccCCCCcccchHHH
Confidence 75321 122346788888877778888999994
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=229.25 Aligned_cols=180 Identities=21% Similarity=0.410 Sum_probs=150.6
Q ss_pred eCCCCceeeeeeeecCceEEEEEEECC----------------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcee
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTYCS----------------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~~g----------------~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv 352 (492)
++.++|++.++||+|+||.||++...+ ..||+|+++.. ........|.+|+.++++++|+||+
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCcC
Confidence 456788999999999999999987532 24899998754 3344556799999999999999999
Q ss_pred eEEEEEecCCeEEEEEeccCCCCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCE
Q 011158 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK-----------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANL 421 (492)
Q Consensus 353 ~l~g~~~~~~~~~lV~Ey~~ggsL~~~L~~~~-----------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NI 421 (492)
++++++......|+||||+++++|.+++.... ..+++..++.++.|++.||.|||+++++||||||+||
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 99999999999999999999999999996532 1368889999999999999999999999999999999
Q ss_pred EEccCCCeEEEEEeecceeee---------eeCCCceeecceeccccccCccceeee
Q 011158 422 LMDENEVSLLLSLCLFTVSIL---------FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 422 Lld~~~~~kl~DFGla~~~~~---------~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
|++.++.+|++|||++..... ..++..|++||+.....+...+|+|++
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSl 217 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAF 217 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHH
Confidence 999999999999999864311 112346788887766667778899984
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-26 Score=226.56 Aligned_cols=190 Identities=22% Similarity=0.343 Sum_probs=159.3
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
++|++.+.||+|+||.||++.+ .++.||+|+++.... .......+.+|+.++++++||||+++++++.....+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 3688899999999999999988 468899999875432 2334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee----eee
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI----LFC 444 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~----~~~ 444 (492)
||+++++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.... ...
T Consensus 81 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 159 (290)
T cd05580 81 EYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC 159 (290)
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCCCCCCC
Confidence 999999999999773 678999999999999999999999999999999999999999999999999987542 234
Q ss_pred CCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 445 GKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 445 g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
++..|++||+..........|.|++ +....+|..+|..
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 200 (290)
T cd05580 160 GTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFD 200 (290)
T ss_pred CCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 5667888887766666667788884 2234456655543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-27 Score=212.76 Aligned_cols=146 Identities=23% Similarity=0.438 Sum_probs=134.8
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEec
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 370 (492)
+|.-.++||+|+||+||+|+. +++.||+|.++.+..++......++||.+++.++|+|||++++.......+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 455668999999999999986 457899999998776666667789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecce
Q 011158 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTV 439 (492)
Q Consensus 371 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~ 439 (492)
| ..+|..|....++.++...+..++.|+++||.|+|+++++||||||.|+||+.+|..|++|||+++.
T Consensus 83 c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglara 150 (292)
T KOG0662|consen 83 C-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARA 150 (292)
T ss_pred h-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhh
Confidence 9 7799999998889999999999999999999999999999999999999999999999999999874
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-26 Score=223.10 Aligned_cols=190 Identities=22% Similarity=0.342 Sum_probs=156.6
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--CeE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI---NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSL 364 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~ 364 (492)
++|++.+.||+|+||.||+|.+ ++..||||.+..... .....+.+.+|+.++++++|+||+++++++... ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 5788899999999999999987 468899998864322 123456788999999999999999999988763 468
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee---
Q 011158 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI--- 441 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~--- 441 (492)
++||||+++++|.+++.+. ..+++..++.++.|++.||.|||+++|+|+||||+||+++.++.++|+|||.+....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~ 160 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC 160 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence 8999999999999999763 568899999999999999999999999999999999999999999999999886432
Q ss_pred -------eeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 442 -------LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 442 -------~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
...++..|++||......+...+|+|++ +.....|.++|..
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 211 (265)
T cd06652 161 LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE 211 (265)
T ss_pred ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCc
Confidence 1335567888998877777777899984 3344456666654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-26 Score=229.25 Aligned_cols=180 Identities=28% Similarity=0.456 Sum_probs=150.2
Q ss_pred eCCCCceeeeeeeecCceEEEEEEEC--Cc--eEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCe
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTYC--SQ--DVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPS 363 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~~--g~--~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~ 363 (492)
+..++|++.+.||+|+||.||+|.+. +. .+++|.++.. ........+.+|+.++.++ +|+||+++++++...+.
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 45568899999999999999999873 43 4677776532 2344557889999999999 89999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCC
Q 011158 364 LCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428 (492)
Q Consensus 364 ~~lV~Ey~~ggsL~~~L~~~~---------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~ 428 (492)
.|+||||+++|+|.+++.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc
Confidence 999999999999999997532 25789999999999999999999999999999999999999999
Q ss_pred eEEEEEeecceeee------eeCCCceeecceeccccccCccceeee
Q 011158 429 SLLLSLCLFTVSIL------FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 429 ~kl~DFGla~~~~~------~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
+||+|||++..... ...+..|++||+.....+...+|+|++
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 209 (303)
T cd05088 163 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSY 209 (303)
T ss_pred EEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhh
Confidence 99999999864321 112345888988877777788899994
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=225.82 Aligned_cols=189 Identities=28% Similarity=0.468 Sum_probs=157.2
Q ss_pred ceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEecc
Q 011158 294 LKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 371 (492)
Q Consensus 294 ~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 371 (492)
|++.+.||+|+||.||++... ++.||+|++..............+|+.++++++|+||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 678899999999999999985 457999999876544444445567999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee-------eeee
Q 011158 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS-------ILFC 444 (492)
Q Consensus 372 ~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~-------~~~~ 444 (492)
.+++|.+++.. ...+++..++.++.||+.||.|||+++|+|+||||+||++++++.++|+|||.+... ....
T Consensus 81 ~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 159 (260)
T PF00069_consen 81 PGGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFV 159 (260)
T ss_dssp TTEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSS
T ss_pred ccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999984 467899999999999999999999999999999999999999999999999998631 1345
Q ss_pred CCCceeecceec-cccccCccceeee---ecccccCCCCCCCc
Q 011158 445 GKGRELISLFLG-NDVLLQFGTYWII---FRRSSCDKKNSDAP 483 (492)
Q Consensus 445 g~~~~~ape~~~-~e~~~~~~d~W~l---~~~~~~gt~~Y~aP 483 (492)
++..|++||... ........|.|++ +-...+|..+|...
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 160 GTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp SSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccc
Confidence 667788888877 6667777788874 22333455555543
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=229.86 Aligned_cols=183 Identities=26% Similarity=0.448 Sum_probs=154.0
Q ss_pred ceeeCCCCceeeeeeeecCceEEEEEEEC---------CceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeEE
Q 011158 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYC---------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFI 355 (492)
Q Consensus 286 ~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~---------g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~ 355 (492)
.|++...+|.+.+.||+|+||.||+|++. +..||+|.++... .......+.+|+.+++.+ +||||++++
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchhee
Confidence 37788889999999999999999999752 2369999887532 334457789999999999 799999999
Q ss_pred EEEecCCeEEEEEeccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCC
Q 011158 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 420 (492)
Q Consensus 356 g~~~~~~~~~lV~Ey~~ggsL~~~L~~~~---------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~N 420 (492)
+++......|+||||+++|+|.+++.+.. ..+++..+..++.||+.||.|||++||+||||||+|
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 167 (304)
T cd05101 88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN 167 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence 99999999999999999999999997632 247888899999999999999999999999999999
Q ss_pred EEEccCCCeEEEEEeecceeee---------eeCCCceeecceeccccccCccceeee
Q 011158 421 LLMDENEVSLLLSLCLFTVSIL---------FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 421 ILld~~~~~kl~DFGla~~~~~---------~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
||++.++.+|++|||.++.... ..++..|++||......+...+|+|++
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 225 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 225 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHH
Confidence 9999999999999999864321 112345888887777677777888884
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.4e-26 Score=224.22 Aligned_cols=187 Identities=25% Similarity=0.367 Sum_probs=151.7
Q ss_pred CceeeeeeeecCceEEEEEEE------CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--CeE
Q 011158 293 HLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSL 364 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~ 364 (492)
.|++.+.||+|+||.||++.+ .++.||+|+++... .......+.+|+.++++++||||+++++++... ..+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred hceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 348889999999999988764 34679999997642 233456788999999999999999999988653 458
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee--
Q 011158 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL-- 442 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~-- 442 (492)
++||||+++++|.+++.. ..+++.+++.++.|++.||.|||+++|+||||||+|||++.++.++++|||++.....
T Consensus 84 ~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 161 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 161 (283)
T ss_pred EEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence 999999999999999976 4589999999999999999999999999999999999999999999999999865321
Q ss_pred --------eeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 443 --------FCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 443 --------~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
..+...|++||......+...+|+|++ +.....|..+|..
T Consensus 162 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~ 212 (283)
T cd05080 162 EYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQS 212 (283)
T ss_pred hhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCC
Confidence 123345788888877777788899984 2233345544443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-26 Score=226.89 Aligned_cols=179 Identities=20% Similarity=0.354 Sum_probs=148.6
Q ss_pred eCCCCceeeeeeeecCceEEEEEEE--CCc----eEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQ----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~--~g~----~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 362 (492)
+...+|++.+.||+|+||.||+|.+ .++ .+++|.+... .......++..|+.++++++||||+++++++.. .
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~ 81 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-A 81 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-C
Confidence 3446788889999999999999988 343 4788877532 223445678889999999999999999998864 4
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee
Q 011158 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL 442 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~ 442 (492)
..++++||+++|+|.+++......+++..++.++.||+.||.|||+++++||||||+|||++.++.+|++|||.++....
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 57899999999999999987667899999999999999999999999999999999999999999999999999865321
Q ss_pred ---------eeCCCceeecceeccccccCccceeee
Q 011158 443 ---------FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 443 ---------~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
..++..|++||+.....+...+|+|++
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~sl 197 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSY 197 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHH
Confidence 123346888888776667777888883
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=249.40 Aligned_cols=184 Identities=20% Similarity=0.353 Sum_probs=150.5
Q ss_pred CCceeeCCCCceeeeeeeecCceEEEEEEEC-C-ceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCceeeEEEE-Ee
Q 011158 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC-S-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGA-CT 359 (492)
Q Consensus 284 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~-g-~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~-~~ 359 (492)
...++|...++++.+.|.+|||+.||+|.+. + ..||+|++-.. +....+.+.+||.+|++|+ |+|||.+++. ..
T Consensus 29 G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~ 106 (738)
T KOG1989|consen 29 GQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAI 106 (738)
T ss_pred ceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Confidence 3567899999999999999999999999984 3 78999998754 6777889999999999997 9999999993 22
Q ss_pred c------CCeEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCCEEEccCCCeE
Q 011158 360 K------PPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEVSL 430 (492)
Q Consensus 360 ~------~~~~~lV~Ey~~ggsL~~~L~~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~--IiHrDLKp~NILld~~~~~k 430 (492)
. .-+++|.||||+||+|-|+|... ...|++.++++|+.|+++|+.+||... |||||||.+||||+.++..|
T Consensus 107 ~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~K 186 (738)
T KOG1989|consen 107 NRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYK 186 (738)
T ss_pred cccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEE
Confidence 1 12478999999999999999753 346999999999999999999999997 99999999999999999999
Q ss_pred EEEEeecceeeee-----------eCCCceeecceecccc--------ccCccceeee
Q 011158 431 LLSLCLFTVSILF-----------CGKGRELISLFLGNDV--------LLQFGTYWII 469 (492)
Q Consensus 431 l~DFGla~~~~~~-----------~g~~~~~ape~~~~e~--------~~~~~d~W~l 469 (492)
|||||.+.-.... ..-..|.+|.|.+||+ +....|+|++
T Consensus 187 LCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWAL 244 (738)
T KOG1989|consen 187 LCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWAL 244 (738)
T ss_pred eCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHH
Confidence 9999998543211 1112344555555554 4556788995
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-26 Score=226.44 Aligned_cols=179 Identities=25% Similarity=0.416 Sum_probs=152.0
Q ss_pred CCCCceeeeeeeecCceEEEEEEECC------------------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCce
Q 011158 290 DPKHLKFGSKVASGSYGDLYRGTYCS------------------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV 351 (492)
Q Consensus 290 ~~~~~~~~~~LG~G~fG~Vy~~~~~g------------------~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnI 351 (492)
...+|++.++||+|+||.||++++.. ..||+|++.... .......+.+|+.++++++|+||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCE
Confidence 45678889999999999999987632 358999987543 34556789999999999999999
Q ss_pred eeEEEEEecCCeEEEEEeccCCCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCE
Q 011158 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK----------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANL 421 (492)
Q Consensus 352 v~l~g~~~~~~~~~lV~Ey~~ggsL~~~L~~~~----------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NI 421 (492)
+++++++...+..++||||+++++|.+++.+.. ..+++..++.++.|++.||.|||+++|+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 999999999999999999999999999997643 2689999999999999999999999999999999999
Q ss_pred EEccCCCeEEEEEeecceeee---------eeCCCceeecceeccccccCccceeee
Q 011158 422 LMDENEVSLLLSLCLFTVSIL---------FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 422 Lld~~~~~kl~DFGla~~~~~---------~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
+++.++.++++|||.++.... ..++..|++||+.....+...+|+|++
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 218 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAF 218 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhh
Confidence 999999999999999874311 122346888888776677778898884
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-26 Score=236.06 Aligned_cols=187 Identities=19% Similarity=0.207 Sum_probs=155.3
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC------C
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP------P 362 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------~ 362 (492)
.++|++.+.||+|+||.||++.+ .++.||||++............+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 46799999999999999999987 468899999986544455567788999999999999999999987643 3
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-
Q 011158 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI- 441 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~- 441 (492)
.+|+||||+. ++|.+++.. .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 103 DVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred eEEEEEeCCC-CCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 5799999994 578887754 47889999999999999999999999999999999999999999999999987542
Q ss_pred -----eeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 442 -----LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 -----~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||+.....+....|+|++ +.....|..+|.
T Consensus 179 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 226 (364)
T cd07875 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFP 226 (364)
T ss_pred CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCC
Confidence 2356778999998888778888899984 223345555553
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-25 Score=218.06 Aligned_cols=176 Identities=19% Similarity=0.324 Sum_probs=151.5
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEec
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 370 (492)
+|++.++||+|+||.||++.+ +++.+|+|.++... .....+.+.+|+.++++++|+||+++++.+...+.+|+||||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 467889999999999999987 46889999987543 233456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------e
Q 011158 371 MSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-------L 442 (492)
Q Consensus 371 ~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-------~ 442 (492)
+++|+|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++++|||.+.... .
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT 159 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccccccc
Confidence 99999999987643 468999999999999999999999999999999999999999999999999986542 2
Q ss_pred eeCCCceeecceeccccccCccceeee
Q 011158 443 FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 443 ~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
..++..|++||+.....+....|+|++
T Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~Dv~sl 186 (255)
T cd08219 160 YVGTPYYVPPEIWENMPYNNKSDIWSL 186 (255)
T ss_pred ccCCccccCHHHHccCCcCchhhhhhh
Confidence 345667888988877667777888874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.2e-26 Score=223.60 Aligned_cols=178 Identities=28% Similarity=0.461 Sum_probs=151.3
Q ss_pred CCCceeeeeeeecCceEEEEEEEC------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEec--CC
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTYC------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--PP 362 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~~------g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~ 362 (492)
.++|++.+.||+|+||.||++++. +..||||+++..... .....|.+|+.++++++|+||+++++++.. ..
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 356788899999999999999863 467999999865433 356789999999999999999999999887 55
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee
Q 011158 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL 442 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~ 442 (492)
..++||||+++++|.+++......+++..+..++.|++.||.|||++||+|+||||+||+++.++.++++|||.+.....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 79999999999999999987666799999999999999999999999999999999999999999999999999876531
Q ss_pred ----------eeCCCceeecceeccccccCccceeee
Q 011158 443 ----------FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 443 ----------~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
..+...|++||+.....+...+|+|++
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~sl 198 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSF 198 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCCCcccchHHH
Confidence 112234778887776667777788873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-26 Score=241.98 Aligned_cols=187 Identities=21% Similarity=0.275 Sum_probs=148.8
Q ss_pred eCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-----
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP----- 361 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~----- 361 (492)
....+|++.++||+|+||.||+|.+ +++.||||++.... ....+|+.+|++++|+||+++++++...
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN 136 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence 3456799999999999999999987 56889999886432 2345799999999999999999876432
Q ss_pred ---CeEEEEEeccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCC-CeEEEEE
Q 011158 362 ---PSLCIVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-VSLLLSL 434 (492)
Q Consensus 362 ---~~~~lV~Ey~~ggsL~~~L~~---~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~-~~kl~DF 434 (492)
..+++||||++ ++|.+++.. ....+++..++.++.||+.||.|||+++|+||||||+|||++.++ .+||+||
T Consensus 137 ~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 137 EKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred CCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence 24779999995 578887753 245789999999999999999999999999999999999999665 7999999
Q ss_pred eecceee------eeeCCCceeecceec-cccccCccceeee---ecccccCCCCCCC
Q 011158 435 CLFTVSI------LFCGKGRELISLFLG-NDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 435 Gla~~~~------~~~g~~~~~ape~~~-~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
|+++... ...++..|++||.+. ...+....|+|++ +....+|.++|..
T Consensus 216 Gla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 273 (440)
T PTZ00036 216 GSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSG 273 (440)
T ss_pred ccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9996432 345677788998754 3457777889984 3345567777653
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.1e-26 Score=224.29 Aligned_cols=182 Identities=23% Similarity=0.375 Sum_probs=153.1
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEec
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 370 (492)
+|++.++||+|+||.||+|.+ +++.||+|++..+. .......+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 577889999999999999987 56889999987542 344557799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-----eeeC
Q 011158 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-----LFCG 445 (492)
Q Consensus 371 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-----~~~g 445 (492)
+++++|..+ ..+++..+..++.|++.||.|||+++|+|+||||+|||++.++.++|+|||++.... ...+
T Consensus 81 ~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~ 155 (279)
T cd06619 81 MDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVG 155 (279)
T ss_pred CCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccccccCCCC
Confidence 999999654 246888999999999999999999999999999999999999999999999986432 2456
Q ss_pred CCceeecceeccccccCccceeee---ecccccCCCCC
Q 011158 446 KGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNS 480 (492)
Q Consensus 446 ~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y 480 (492)
+..|++||+.....+...+|+|++ +.....|..+|
T Consensus 156 ~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf 193 (279)
T cd06619 156 TNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPY 193 (279)
T ss_pred ChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCc
Confidence 678889998877777777888884 22233455554
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-26 Score=225.24 Aligned_cols=176 Identities=19% Similarity=0.337 Sum_probs=145.1
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhc---CCCceeeEEEEEec-----CC
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV---RHKNVVQFIGACTK-----PP 362 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~g~~~~-----~~ 362 (492)
+|++.+.||+|+||.||+|.+ +++.||+|.++...........+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 477889999999999999987 468899999976533333334566777777765 69999999998864 24
Q ss_pred eEEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee
Q 011158 363 SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI 441 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~ 441 (492)
.+++||||+. ++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||.++...
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~ 159 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS 159 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence 5899999996 58999987643 358999999999999999999999999999999999999999999999999987542
Q ss_pred ------eeeCCCceeecceeccccccCccceeee
Q 011158 442 ------LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 442 ------~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
...++..|++||+.....+...+|+|++
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl 193 (288)
T cd07863 160 CQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSV 193 (288)
T ss_pred CcccCCCccccccccCchHhhCCCCCCcchhhhH
Confidence 1245667899998877778888899994
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.1e-26 Score=221.38 Aligned_cols=178 Identities=18% Similarity=0.343 Sum_probs=151.5
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
.+|++.++||+|+||.||+|+. +++.||||.++... .+......+.+|+.+++.++||||+++++++...+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4678889999999999999987 57899999886532 34455567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee----
Q 011158 369 EFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI---- 441 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~---- 441 (492)
||+++|+|.+++... ...+++..++.++.||+.||.|||+++|+|+||||+|||++.++.++++|||.+....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 999999999988642 3458899999999999999999999999999999999999999999999999876542
Q ss_pred ---eeeCCCceeecceeccccccCccceeee
Q 011158 442 ---LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 442 ---~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
...++..|++||+.....+...+|+|++
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~sl 192 (267)
T cd08228 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSL 192 (267)
T ss_pred HHhcCCCCccccChhhhccCCCCchhhHHHH
Confidence 2345567888887766666667788873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-26 Score=243.70 Aligned_cols=170 Identities=20% Similarity=0.251 Sum_probs=148.7
Q ss_pred CCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
...|.+.+.||+|+||.||+|.+. ++.||||.... ..+.+|+.+|++++|+||+++++++...+..|+||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 346888899999999999999884 57899996432 34568999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------- 441 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------- 441 (492)
|++ .++|.+++......+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++...
T Consensus 240 e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 318 (461)
T PHA03211 240 PKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318 (461)
T ss_pred Ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence 999 579999997766679999999999999999999999999999999999999999999999999986531
Q ss_pred --eeeCCCceeecceeccccccCccceeee
Q 011158 442 --LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 442 --~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
...|+..|++||+.....+....|+|++
T Consensus 319 ~~~~~GT~~Y~APE~~~~~~~~~~sDvwSl 348 (461)
T PHA03211 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSA 348 (461)
T ss_pred ccccCCCcCCcCHHHHcCCCCCchHHHHHH
Confidence 2347788999998888778888888884
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=263.07 Aligned_cols=193 Identities=17% Similarity=0.204 Sum_probs=163.2
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeE
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 364 (492)
.+..++|.++++||+|+||.|..++. +++.||+|++++-.+ ......-|..|-.||..-+.+.|++++-+|.++.++
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L 150 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL 150 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence 45567899999999999999999987 467899999976322 233446788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecce-----
Q 011158 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTV----- 439 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~----- 439 (492)
|+|||||+||+|..+|.+.. ++++..++.++..|+.||.-||+.|+|||||||+|||||..|.+|++|||.+-.
T Consensus 151 YlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG 229 (1317)
T KOG0612|consen 151 YLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG 229 (1317)
T ss_pred EEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCC
Confidence 99999999999999998866 899999999999999999999999999999999999999999999999998732
Q ss_pred ---eeeeeCCCceeecceecc-----ccccCccceeee---ecccccC-CCCCC
Q 011158 440 ---SILFCGKGRELISLFLGN-----DVLLQFGTYWII---FRRSSCD-KKNSD 481 (492)
Q Consensus 440 ---~~~~~g~~~~~ape~~~~-----e~~~~~~d~W~l---~~~~~~g-t~~Y~ 481 (492)
+..-.||+.|.+||++.. ..|+...|||++ +..+.|| ||.|.
T Consensus 230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 234579999999997633 456777899995 3344555 45554
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-26 Score=223.97 Aligned_cols=175 Identities=25% Similarity=0.398 Sum_probs=144.2
Q ss_pred eeeeeeeecCceEEEEEEECC--c--eEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC------CeE
Q 011158 295 KFGSKVASGSYGDLYRGTYCS--Q--DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP------PSL 364 (492)
Q Consensus 295 ~~~~~LG~G~fG~Vy~~~~~g--~--~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------~~~ 364 (492)
.+.++||+|+||.||+|.+.. . .+|+|.++.........+.+.+|+.++++++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456899999999999998743 2 599999887655566678899999999999999999999987532 246
Q ss_pred EEEEeccCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecce
Q 011158 365 CIVTEFMSGGSVYDYLHKL-----KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTV 439 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~-----~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~ 439 (492)
+++|||+++|+|.+++... ...+++..+..++.||+.||.|||+++|+||||||+|||+++++.+||+|||.++.
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 161 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKK 161 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccc
Confidence 8999999999999988532 23588999999999999999999999999999999999999999999999999875
Q ss_pred eee---------eeCCCceeecceeccccccCccceeee
Q 011158 440 SIL---------FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 440 ~~~---------~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
... ...+..|++||+.....+...+|+|++
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~sl 200 (272)
T cd05075 162 IYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSF 200 (272)
T ss_pred cCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHH
Confidence 321 123345777777777777777888884
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7e-26 Score=222.57 Aligned_cols=192 Identities=27% Similarity=0.397 Sum_probs=157.2
Q ss_pred eCCCCceeeeeeeecCceEEEEEEEC--Cc---eEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCe
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTYC--SQ---DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~~--g~---~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 363 (492)
|..++|+..+.||+|+||.||+|+.. ++ .+|+|.++... .......+.+|+.++++++|+||+++++++...+.
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 45567888899999999999999873 32 69999887542 34445778999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeeee
Q 011158 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSILF 443 (492)
Q Consensus 364 ~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~~ 443 (492)
.|+||||+++++|.+++....+.+++.++..++.|++.||.|||+++|+||||||+||+++.++.+|++|||.+......
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999999999876678999999999999999999999999999999999999999999999999998654211
Q ss_pred -----e-----CCCceeecceeccccccCccceeee----ecccccCCCCCC
Q 011158 444 -----C-----GKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSD 481 (492)
Q Consensus 444 -----~-----g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~ 481 (492)
. ....|++||+.....+...+|+|++ +.....|..+|.
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~ 212 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYW 212 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCC
Confidence 1 1124778887766666677888873 222334666653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.5e-26 Score=224.09 Aligned_cols=179 Identities=25% Similarity=0.432 Sum_probs=151.7
Q ss_pred eCCCCceeeeeeeecCceEEEEEEEC--C----ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTYC--S----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~~--g----~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 362 (492)
+...+|++.+.||+|+||.||+|.+. + ..+|+|.++... .......+.+|+.++++++|+||+++++++.. .
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS-S 81 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 45578899999999999999999863 3 258999887543 24455778999999999999999999999987 7
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee
Q 011158 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL 442 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~ 442 (492)
..++||||+++|+|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++.++.+|++|||.++....
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 89999999999999999988667799999999999999999999999999999999999999999999999999865421
Q ss_pred ee---------CCCceeecceeccccccCccceeee
Q 011158 443 FC---------GKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 443 ~~---------g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
.. .+..|++||+.....+...+|+|++
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl 197 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSY 197 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHH
Confidence 10 1235788887776677777888884
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.7e-26 Score=222.02 Aligned_cols=192 Identities=25% Similarity=0.379 Sum_probs=156.2
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEECC-----ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~~g-----~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 362 (492)
++..++|.+.++||+|+||.||+|.+.. ..||||...... .....+.+.+|+.++++++|+||+++++++.. .
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~ 79 (270)
T cd05056 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N 79 (270)
T ss_pred eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence 4667788999999999999999998732 358999886542 24456789999999999999999999999876 4
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee
Q 011158 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL 442 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~ 442 (492)
..|+||||+++|+|.+++.+....+++..++.++.|++.||.|||+++++||||||+|||++.++.++++|||.++....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 57899999999999999987555789999999999999999999999999999999999999999999999999865321
Q ss_pred e--------eCCCceeecceeccccccCccceeee----ecccccCCCCCC
Q 011158 443 F--------CGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSD 481 (492)
Q Consensus 443 ~--------~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~ 481 (492)
. .+...|++||+.....+....|+|++ +....+|.++|.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~ 210 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQ 210 (270)
T ss_pred ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCC
Confidence 1 11235778887766667777899984 222334666653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.2e-26 Score=226.43 Aligned_cols=189 Identities=28% Similarity=0.438 Sum_probs=153.6
Q ss_pred CCceeeeeeeecCceEEEEEEEC--C--ceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCeEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC--S--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCI 366 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~--g--~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~l 366 (492)
++|++.+.||+|+||.||+|.+. + ..+++|.++.. ......+.+.+|+.++.++ +||||+++++++...+.+|+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 57888999999999999999874 3 24788888742 2344456789999999999 79999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEE
Q 011158 367 VTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLL 431 (492)
Q Consensus 367 V~Ey~~ggsL~~~L~~~~---------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl 431 (492)
||||+++|+|.+++.+.. ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEE
Confidence 999999999999997532 24889999999999999999999999999999999999999999999
Q ss_pred EEEeecceeee----eeC--CCceeecceeccccccCccceeee----ecccccCCCCCC
Q 011158 432 LSLCLFTVSIL----FCG--KGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSD 481 (492)
Q Consensus 432 ~DFGla~~~~~----~~g--~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~ 481 (492)
+|||++..... ..+ ...|++||+.....+...+|+|++ +.....|.++|.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~ 220 (297)
T cd05089 161 ADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYC 220 (297)
T ss_pred CCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 99999864321 111 235888988877777788899984 222234666553
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.6e-26 Score=221.95 Aligned_cols=189 Identities=24% Similarity=0.402 Sum_probs=155.5
Q ss_pred ceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCh-------HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeE
Q 011158 294 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS-------DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (492)
Q Consensus 294 ~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~-------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 364 (492)
|.+...||+|+||.||+|.+ .++.+|+|.+....... ...+.+.+|+.++++++||||+++++++......
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 56678999999999999987 46889999887543221 2345688999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee---
Q 011158 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI--- 441 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~--- 441 (492)
++||||+++++|.+++.. .+.+++..+..++.|++.||.|||+++++||||||+||+++.++.++++|||.++...
T Consensus 82 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 82 NIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred EEEEEecCCCCHHHHHHh-ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 999999999999999976 3678999999999999999999999999999999999999999999999999886543
Q ss_pred ----------eeeCCCceeecceeccccccCccceeee---ecccccCCCCCCCc
Q 011158 442 ----------LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDAP 483 (492)
Q Consensus 442 ----------~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~aP 483 (492)
...++..|++||+.....+....|+|++ +.....|..+|..+
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 215 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCc
Confidence 1234556788887766666667788883 22334566666543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.6e-26 Score=221.82 Aligned_cols=182 Identities=23% Similarity=0.367 Sum_probs=149.2
Q ss_pred eeeecCceEEEEEEE----CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEeccCCC
Q 011158 299 KVASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG 374 (492)
Q Consensus 299 ~LG~G~fG~Vy~~~~----~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~gg 374 (492)
+||+|+||.||+|.+ ++..+|+|+++....+....+.+.+|+.++++++|+||+++++++.. ...++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 689999999999975 35779999998665555667789999999999999999999998864 4679999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeeee----------e
Q 011158 375 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSILF----------C 444 (492)
Q Consensus 375 sL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~~----------~ 444 (492)
+|.+++.. ...+++..+..++.|++.||.|||++||+||||||.|||++.++.+|++|||.++..... .
T Consensus 81 ~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05116 81 PLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK 159 (257)
T ss_pred cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence 99999976 457899999999999999999999999999999999999999999999999998643210 1
Q ss_pred CCCceeecceeccccccCccceeee----ecccccCCCCCCC
Q 011158 445 GKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSDA 482 (492)
Q Consensus 445 g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~a 482 (492)
++..|++||......+...+|+|++ +....+|.++|.+
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 201 (257)
T cd05116 160 WPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG 201 (257)
T ss_pred CCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 1246778887766666677888884 2223346666653
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.1e-26 Score=224.28 Aligned_cols=188 Identities=22% Similarity=0.282 Sum_probs=153.1
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEec
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 370 (492)
+|++.+.||+|+||.||+|+. +++.||||+++....+......+.+|+.++++++||||+++++++..++.+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 477889999999999999987 468899999976544444456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------
Q 011158 371 MSGGSVYDYLHKLK--GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------- 441 (492)
Q Consensus 371 ~~ggsL~~~L~~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------- 441 (492)
++ ++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.++|+|||++....
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYT 159 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCccccc
Confidence 96 68999987543 568999999999999999999999999999999999999999999999999986432
Q ss_pred eeeCCCceeecceecc-ccccCccceeee---ecccccCCCCCC
Q 011158 442 LFCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 ~~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||+... ..+...+|+|++ +....+|.+.|.
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~ 203 (285)
T cd07861 160 HEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFH 203 (285)
T ss_pred CCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 1233556788886543 335566788884 223345655554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.93 E-value=7e-26 Score=225.76 Aligned_cols=191 Identities=20% Similarity=0.349 Sum_probs=157.0
Q ss_pred eCCCCceeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~~-------g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 361 (492)
|+.++|.+.+.||+|+||.||++... +..+|+|.+... .......+.+|+.++++++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 45678899999999999999999751 245899988643 344567799999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCe
Q 011158 362 PSLCIVTEFMSGGSVYDYLHKLK------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVS 429 (492)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~L~~~~------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~ 429 (492)
+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 99999999999999999997532 248999999999999999999999999999999999999999999
Q ss_pred EEEEEeecceeee---------eeCCCceeecceeccccccCccceeee----ecccccCCCCCC
Q 011158 430 LLLSLCLFTVSIL---------FCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSD 481 (492)
Q Consensus 430 kl~DFGla~~~~~---------~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~ 481 (492)
|++|||.++.... ..++..|++||+.....+...+|+|++ +.....|.++|.
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~ 224 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWY 224 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999864311 112346888998877777888899994 222233555543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.9e-26 Score=224.91 Aligned_cols=191 Identities=21% Similarity=0.334 Sum_probs=157.6
Q ss_pred eCCCCceeeeeeeecCceEEEEEEE-------CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~-------~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 361 (492)
|+.+++++.++||+|+||.||++.. .+..+|+|.++.. .......+.+|+.++++++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 4567888899999999999999964 2356899987643 345567899999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCC
Q 011158 362 PSLCIVTEFMSGGSVYDYLHKLK--------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 427 (492)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~L~~~~--------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~ 427 (492)
...+++|||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 99999999999999999997643 2478999999999999999999999999999999999999999
Q ss_pred CeEEEEEeecceee---------eeeCCCceeecceeccccccCccceeee----ecccccCCCCCC
Q 011158 428 VSLLLSLCLFTVSI---------LFCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSD 481 (492)
Q Consensus 428 ~~kl~DFGla~~~~---------~~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~ 481 (492)
.+||+|||+++... ...++..|++||+.....+...+|+|++ +....+|.++|.
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 226 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWY 226 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCc
Confidence 99999999986431 1112345788887777777777899983 334445777663
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=8e-26 Score=223.77 Aligned_cols=188 Identities=19% Similarity=0.239 Sum_probs=153.7
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
++|++.+.||+|+||.||+|++. ++.||+|++..........+.+.+|+.++++++|+||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36788899999999999999884 6889999987544333344668899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee-------
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL------- 442 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~------- 442 (492)
|+++++|..++.. ...+++..++.++.||+.||.|||+++|+||||||+||+++.++.++|+|||.+.....
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (286)
T cd07847 81 YCDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD 159 (286)
T ss_pred ccCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccC
Confidence 9998888877754 45689999999999999999999999999999999999999999999999999875421
Q ss_pred eeCCCceeecceecc-ccccCccceeee---ecccccCCCCC
Q 011158 443 FCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNS 480 (492)
Q Consensus 443 ~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y 480 (492)
..++..|++||+... ..+....|+|++ +.....|.++|
T Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~ 201 (286)
T cd07847 160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLW 201 (286)
T ss_pred cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCC
Confidence 234556788887644 445566788873 22334455554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=235.15 Aligned_cols=172 Identities=21% Similarity=0.343 Sum_probs=148.9
Q ss_pred eCCCCceeeeeeeecCceEEEEEEEC----CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeE
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~~----g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 364 (492)
+-..+|.+.++||+|+||.||++... +..||+|.+... ..+.+|+.+|++++||||+++++++......
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 33457999999999999999999763 357999988643 2356899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee---
Q 011158 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI--- 441 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~--- 441 (492)
|+|||++ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 162 ~lv~e~~-~~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 162 CMVMPKY-KCDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred EEEehhc-CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 9999999 5799999954 5679999999999999999999999999999999999999999999999999985431
Q ss_pred ------eeeCCCceeecceeccccccCccceeee
Q 011158 442 ------LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 442 ------~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
...|+..|++||+.....+....|+|++
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 273 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSA 273 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHH
Confidence 2357788899998887778888899884
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.3e-26 Score=221.35 Aligned_cols=181 Identities=27% Similarity=0.399 Sum_probs=147.6
Q ss_pred eeeecCceEEEEEEEC----CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEeccCCC
Q 011158 299 KVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG 374 (492)
Q Consensus 299 ~LG~G~fG~Vy~~~~~----g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~gg 374 (492)
.||+|+||.||+|.+. +..||+|++.... .....+.+.+|+.++++++|+||+++++++.. +..++||||+++|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence 4899999999999763 3469999987542 34455779999999999999999999998864 5689999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee-------e---e
Q 011158 375 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL-------F---C 444 (492)
Q Consensus 375 sL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~-------~---~ 444 (492)
+|.+++......+++..++.++.|++.||.|||++|++||||||+|||++.++.+|++|||.+..... . .
T Consensus 80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05115 80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGK 159 (257)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCC
Confidence 99999987667899999999999999999999999999999999999999999999999999864211 0 1
Q ss_pred CCCceeecceeccccccCccceeee----ecccccCCCCCC
Q 011158 445 GKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSD 481 (492)
Q Consensus 445 g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~ 481 (492)
++..|++||+.....+...+|+|++ +....+|.++|.
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 200 (257)
T cd05115 160 WPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYK 200 (257)
T ss_pred CCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcC
Confidence 1245888887766667777899984 222334666653
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.9e-26 Score=230.64 Aligned_cols=184 Identities=26% Similarity=0.453 Sum_probs=154.9
Q ss_pred CceeeCCCCceeeeeeeecCceEEEEEEECC---------ceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeE
Q 011158 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS---------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQF 354 (492)
Q Consensus 285 ~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g---------~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l 354 (492)
..|++...+|++.+.||+|+||.||++.+.+ ..||+|+++.. ........+.+|+.+++++ +|+||+++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINL 83 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence 4589999999999999999999999997521 25899988753 2344567899999999999 79999999
Q ss_pred EEEEecCCeEEEEEeccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q 011158 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419 (492)
Q Consensus 355 ~g~~~~~~~~~lV~Ey~~ggsL~~~L~~~~---------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~ 419 (492)
++++...+.++++|||+++|+|.+++.+.. ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 163 (334)
T cd05100 84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR 163 (334)
T ss_pred eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence 999999999999999999999999997532 24788899999999999999999999999999999
Q ss_pred CEEEccCCCeEEEEEeecceeee-------e--eCCCceeecceeccccccCccceeee
Q 011158 420 NLLMDENEVSLLLSLCLFTVSIL-------F--CGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 420 NILld~~~~~kl~DFGla~~~~~-------~--~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
|||++.++.+||+|||.++.... . .++..|++||+.....+...+|+|++
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 222 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 222 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHH
Confidence 99999999999999999864321 1 11235888888877777777888884
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.5e-27 Score=238.29 Aligned_cols=188 Identities=26% Similarity=0.388 Sum_probs=155.4
Q ss_pred CCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHh--cCCCceeeEEEEEecCC----eE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK--VRHKNVVQFIGACTKPP----SL 364 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~g~~~~~~----~~ 364 (492)
...+++.+.||+|.||.||+|.+.++.||||++.. ...+.|..|-.|.+. ++|+||++|+++-.... .+
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey 283 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY 283 (534)
T ss_pred CCchhhHHHhhcCccceeehhhccCceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence 45677889999999999999999999999999964 334667777777664 58999999999876555 79
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---------CceecCCCCCCEEEccCCCeEEEEEe
Q 011158 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN---------NIIHRDLKAANLLMDENEVSLLLSLC 435 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~---------~IiHrDLKp~NILld~~~~~kl~DFG 435 (492)
+||+||.+.|+|.+||.. ..++|....+++..+++||+|||.. .|+|||||..||||.+++.+.|+|||
T Consensus 284 wLVt~fh~kGsL~dyL~~--ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKA--NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred eEEeeeccCCcHHHHHHh--ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 999999999999999987 5689999999999999999999973 59999999999999999999999999
Q ss_pred eccee---------eeeeCCCceeecceecccc-------------ccCccceeeeeccc----ccCCCCCCCccc
Q 011158 436 LFTVS---------ILFCGKGRELISLFLGNDV-------------LLQFGTYWIIFRRS----SCDKKNSDAPFL 485 (492)
Q Consensus 436 la~~~---------~~~~g~~~~~ape~~~~e~-------------~~~~~d~W~l~~~~----~~gt~~Y~aPE~ 485 (492)
+|... ....||.+||+||++.... |..+-.+|++..+- .-..++|+.|+.
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe 437 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE 437 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence 98543 2367899999999776533 22223358876641 245678999975
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=217.30 Aligned_cols=177 Identities=22% Similarity=0.347 Sum_probs=152.3
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEec-CCeEEEEEe
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK-PPSLCIVTE 369 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~~~lV~E 369 (492)
.|++.+.||+|+||.||++++ .++.||+|.+..........+.+.+|+.++++++|+||+++++.+.. ...+|++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 378889999999999999987 45789999997665555566778999999999999999999998764 446899999
Q ss_pred ccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------
Q 011158 370 FMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------- 441 (492)
Q Consensus 370 y~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------- 441 (492)
|+++++|.+++.... ..+++.+++.++.|++.||.|||++||+||||||+||+++.++.++++|||++....
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS 160 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCccc
Confidence 999999999997643 458999999999999999999999999999999999999999999999999986542
Q ss_pred eeeCCCceeecceeccccccCccceeee
Q 011158 442 LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 442 ~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
...++..|++||+.....+....|+|++
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 188 (257)
T cd08223 161 TLIGTPYYMSPELFSNKPYNYKSDVWAL 188 (257)
T ss_pred cccCCcCccChhHhcCCCCCchhhhHHH
Confidence 2345667888998877777777888884
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.9e-26 Score=218.84 Aligned_cols=171 Identities=33% Similarity=0.546 Sum_probs=149.5
Q ss_pred eeeeecCceEEEEEEEC-----CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEeccC
Q 011158 298 SKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS 372 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~-----g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 372 (492)
+.||+|+||.||+|.+. +..|++|+++...... ....+.+|+.+++.++|+||+++++++......++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 46899999999999885 6789999998654333 46789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee--
Q 011158 373 GGSVYDYLHKL--------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL-- 442 (492)
Q Consensus 373 ggsL~~~L~~~--------~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~-- 442 (492)
+++|.+++... ...+++..++.++.|++.||.|||+++|+||||||+||+++.++.++++|||.+.....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 159 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD 159 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccccc
Confidence 99999999875 36789999999999999999999999999999999999999999999999999976532
Q ss_pred -------eeCCCceeecceeccccccCccceeee
Q 011158 443 -------FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 443 -------~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
..++..|++||......+...+|+|++
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 193 (262)
T cd00192 160 YYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSF 193 (262)
T ss_pred ccccccCCCcCccccCHHHhccCCcchhhccHHH
Confidence 234456788887777677777889884
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5e-27 Score=224.84 Aligned_cols=175 Identities=21% Similarity=0.335 Sum_probs=149.5
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC------ChHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCe
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI------NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPS 363 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~------~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~ 363 (492)
.|.-.+.||.|..+.|-++.. +++.+|+|++..... .....+.-.+|+.||+++ .||+|+++.++++.+..
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF 97 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAF 97 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcch
Confidence 455567899999999999866 578899999865321 123455667899999998 59999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee---
Q 011158 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS--- 440 (492)
Q Consensus 364 ~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~--- 440 (492)
+++|+|.|+.|.|+|+|.. .-.++++...+|++|+..|+.|||.++|+||||||+|||+|++..+||+|||.+...
T Consensus 98 ~FlVFdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~G 176 (411)
T KOG0599|consen 98 VFLVFDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPG 176 (411)
T ss_pred hhhhhhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCc
Confidence 9999999999999999977 567999999999999999999999999999999999999999999999999998654
Q ss_pred ---eeeeCCCceeecceec------cccccCccceee
Q 011158 441 ---ILFCGKGRELISLFLG------NDVLLQFGTYWI 468 (492)
Q Consensus 441 ---~~~~g~~~~~ape~~~------~e~~~~~~d~W~ 468 (492)
+..+|++.|++||.+. .+.|+...|.|+
T Consensus 177 ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa 213 (411)
T KOG0599|consen 177 EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWA 213 (411)
T ss_pred hhHHHhcCCCcccChhheeeecccCCCCccchhhHHH
Confidence 3578999999999553 355666667777
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=219.34 Aligned_cols=177 Identities=29% Similarity=0.514 Sum_probs=151.8
Q ss_pred CCCCceeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 290 DPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 290 ~~~~~~~~~~LG~G~fG~Vy~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
+..+|++.+.||+|+||.||++.+. +..+|+|+++..... ...|.+|+.++++++||||+++++++......|+||
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF 78 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence 4567889999999999999999875 678999998765433 256889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee------
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL------ 442 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~------ 442 (492)
||+++++|.+++....+.+++..++.++.|++.||.|||+++++||||||+||+++.++.++++|||.+.....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 99999999999987667789999999999999999999999999999999999999999999999998864321
Q ss_pred --eeCCCceeecceeccccccCccceeee
Q 011158 443 --FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 443 --~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
...+..|++||+.....+....|+|++
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~sl 187 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSF 187 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHH
Confidence 112235788887776667777888884
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.8e-26 Score=225.38 Aligned_cols=190 Identities=21% Similarity=0.342 Sum_probs=156.6
Q ss_pred CCCCceeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 011158 290 DPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (492)
Q Consensus 290 ~~~~~~~~~~LG~G~fG~Vy~~~~~-------g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 362 (492)
...+|.+.+.||+|+||.||+|.+. +..+++|.++.. .....+.+.+|+.++++++|+||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc--cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 4456888899999999999999752 245888888643 2334467899999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCC
Q 011158 363 SLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 427 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~~---------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~ 427 (492)
..++||||+++++|.+++.... +.+++..++.++.||+.||.|||+++|+||||||+|||++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 9999999999999999997532 3478999999999999999999999999999999999999999
Q ss_pred CeEEEEEeecceee---------eeeCCCceeecceeccccccCccceeee----ecccccCCCCCC
Q 011158 428 VSLLLSLCLFTVSI---------LFCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSD 481 (492)
Q Consensus 428 ~~kl~DFGla~~~~---------~~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~ 481 (492)
.++++|||++.... ...++..|++||+.....+...+|+|++ +....+|.++|.
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 227 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 227 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999986431 1223456889998877777788899984 333345777663
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-26 Score=239.93 Aligned_cols=183 Identities=23% Similarity=0.447 Sum_probs=156.2
Q ss_pred CCceeeCCCCceeeeeeeecCceEEEEEEECC----c--eEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEE
Q 011158 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS----Q--DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 357 (492)
Q Consensus 284 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g----~--~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~ 357 (492)
...++|.++.+.+.++||.|.||.||+|+++. . .||||+-+.+. +.+..+.|++|..+|++++||||++++|+
T Consensus 381 ~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv 459 (974)
T KOG4257|consen 381 VRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGV 459 (974)
T ss_pred CCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeee
Confidence 34678899999999999999999999999843 2 49999888643 45557899999999999999999999999
Q ss_pred EecCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeec
Q 011158 358 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLF 437 (492)
Q Consensus 358 ~~~~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla 437 (492)
|...+ .|||||+++-|.|..||+.++..++...+..++.||+.||.|||++++|||||...|||+.....+|++|||++
T Consensus 460 ~~e~P-~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 460 CVEQP-MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred eeccc-eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchh
Confidence 98865 99999999999999999998889999999999999999999999999999999999999999999999999999
Q ss_pred ceeee---eeC-----CCceeecceeccccccCccceee
Q 011158 438 TVSIL---FCG-----KGRELISLFLGNDVLLQFGTYWI 468 (492)
Q Consensus 438 ~~~~~---~~g-----~~~~~ape~~~~e~~~~~~d~W~ 468 (492)
|.... +.. ...||+||-+.=..+...+|.|-
T Consensus 539 R~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWM 577 (974)
T KOG4257|consen 539 RYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWM 577 (974)
T ss_pred hhccccchhhccccccceeecCccccchhcccchhhHHH
Confidence 86531 111 23578888665555555566543
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.6e-26 Score=227.72 Aligned_cols=183 Identities=27% Similarity=0.464 Sum_probs=154.1
Q ss_pred ceeeCCCCceeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeEEEE
Q 011158 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGA 357 (492)
Q Consensus 286 ~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~-------g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~ 357 (492)
.|.+..++|.+.+.||+|+||.||++++. +..||+|+++... .....+.+.+|+.+++++ +|+||++++++
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 47788889999999999999999999752 2469999987542 234456789999999999 79999999999
Q ss_pred EecCCeEEEEEeccCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEee
Q 011158 358 CTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCL 436 (492)
Q Consensus 358 ~~~~~~~~lV~Ey~~ggsL~~~L~~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGl 436 (492)
+...+..|+||||+++|+|.++++.... .+++.++..++.||+.||.|||+++|+|+||||+|||++.++.++++|||.
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 9999999999999999999999976433 489999999999999999999999999999999999999999999999999
Q ss_pred cceeee---------eeCCCceeecceeccccccCccceeee
Q 011158 437 FTVSIL---------FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 437 a~~~~~---------~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
++.... ..++..|++||+.....+...+|+|++
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl 229 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSY 229 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHH
Confidence 864321 112345788887766666777888884
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=217.50 Aligned_cols=177 Identities=28% Similarity=0.435 Sum_probs=153.7
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
.++|++.+.||+|+||.||+|.. .++.+++|++.... ....+.+.+|+.++++++||||+++++++.....+|++|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP--GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc--hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 46788899999999999999987 45789999998653 224578899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------- 441 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------- 441 (492)
||+++++|.+++......+++..+..++.|++.||.|||+++|+|+||||+||+++.++.+|++|||.+....
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 159 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK 159 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhccc
Confidence 9999999999998765789999999999999999999999999999999999999999999999999876432
Q ss_pred eeeCCCceeecceeccc---cccCccceeee
Q 011158 442 LFCGKGRELISLFLGND---VLLQFGTYWII 469 (492)
Q Consensus 442 ~~~g~~~~~ape~~~~e---~~~~~~d~W~l 469 (492)
...++..|++||+.... .+...+|+|++
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~sl 190 (262)
T cd06613 160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWAL 190 (262)
T ss_pred cccCCccccCchhhcccccCCcCchhhhHHH
Confidence 22455668888887665 66667888884
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.8e-26 Score=222.09 Aligned_cols=176 Identities=27% Similarity=0.460 Sum_probs=150.5
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
.++|++.++||+|+||.||+|.+ +++.||+|+++... ......+.+|+.+++.++||||+++++.+...+..|+||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 45788889999999999999987 46889999987543 233456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------- 441 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------- 441 (492)
||+++++|.+++.. .+.+++.+++.++.|++.||.|||++||+|+||||+||+++.++.++++|||++....
T Consensus 86 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06645 86 EFCGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRK 164 (267)
T ss_pred eccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccc
Confidence 99999999999976 4578999999999999999999999999999999999999999999999999985432
Q ss_pred eeeCCCceeecceec---cccccCccceeee
Q 011158 442 LFCGKGRELISLFLG---NDVLLQFGTYWII 469 (492)
Q Consensus 442 ~~~g~~~~~ape~~~---~e~~~~~~d~W~l 469 (492)
...++..|++||+.. ...+...+|+|++
T Consensus 165 ~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSl 195 (267)
T cd06645 165 SFIGTPYWMAPEVAAVERKGGYNQLCDIWAV 195 (267)
T ss_pred cccCcccccChhhhccccCCCCCchhhhHHH
Confidence 234666788888764 3335667788884
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.4e-26 Score=224.57 Aligned_cols=180 Identities=23% Similarity=0.412 Sum_probs=151.9
Q ss_pred eCCCCceeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~~-------g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 361 (492)
+...+|.+.+.||+|+||.||+|+.. ++.||||+++... .......+.+|+.++++++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred CChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 34567888899999999999999763 3579999987543 233457899999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCC
Q 011158 362 PSLCIVTEFMSGGSVYDYLHKLK-------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428 (492)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~L~~~~-------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~ 428 (492)
...|+||||+++++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 99999999999999999997532 34788899999999999999999999999999999999999999
Q ss_pred eEEEEEeecceeee---------eeCCCceeecceeccccccCccceeee
Q 011158 429 SLLLSLCLFTVSIL---------FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 429 ~kl~DFGla~~~~~---------~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
+|++|||.+..... ..++..|++||+.....+...+|+|++
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 210 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSF 210 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHH
Confidence 99999999864311 112345888888777777778899984
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.7e-26 Score=220.74 Aligned_cols=190 Identities=27% Similarity=0.467 Sum_probs=155.9
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEE
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 366 (492)
|-+..++|++.+.||+|+||.||++...++.||+|.++... ....+.+|+.++++++||||+++++++... ..++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred CcccHHHceeeeeeccCCCCceEecccCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 34455778999999999999999999999999999987532 236788999999999999999999998764 4799
Q ss_pred EEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee---
Q 011158 367 VTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL--- 442 (492)
Q Consensus 367 V~Ey~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~--- 442 (492)
||||+++++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+|++|||.+.....
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~ 155 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD 155 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccCC
Confidence 999999999999997643 3589999999999999999999999999999999999999999999999999865432
Q ss_pred -eeCCCceeecceeccccccCccceeee----ecccccCCCCCC
Q 011158 443 -FCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSD 481 (492)
Q Consensus 443 -~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~ 481 (492)
......|++||+.....+....|+|++ +.....|.++|.
T Consensus 156 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~ 199 (254)
T cd05083 156 NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYP 199 (254)
T ss_pred CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCc
Confidence 122345788888776667777888884 222223666554
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.1e-26 Score=229.52 Aligned_cols=186 Identities=17% Similarity=0.182 Sum_probs=150.3
Q ss_pred eeeeeeec--CceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEecc
Q 011158 296 FGSKVASG--SYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 371 (492)
Q Consensus 296 ~~~~LG~G--~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 371 (492)
++++||+| +||+||++.. +++.||+|+++...........+.+|+.+++.++||||+++++++..++..|+||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 7889999987 4688999999876544555567788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee---------
Q 011158 372 SGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI--------- 441 (492)
Q Consensus 372 ~ggsL~~~L~~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~--------- 441 (492)
++|+|.+++... ...+++..++.++.|++.||.|||+++|+||||||+|||++.++.+++.||+......
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 161 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVV 161 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccccc
Confidence 999999999754 3458999999999999999999999999999999999999999999999987532211
Q ss_pred -----eeeCCCceeecceecc--ccccCccceeee---ecccccCCCCCC
Q 011158 442 -----LFCGKGRELISLFLGN--DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 -----~~~g~~~~~ape~~~~--e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||+... ..+...+|+|++ +.....|..+|.
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 211 (327)
T cd08227 162 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 211 (327)
T ss_pred ccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 1123345788887754 346667788884 223344665553
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=225.23 Aligned_cols=180 Identities=22% Similarity=0.399 Sum_probs=148.6
Q ss_pred eCCCCceeeeeeeecCceEEEEEEEC------------------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCc
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTYC------------------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN 350 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~~------------------g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~Hpn 350 (492)
++.++|++.++||+|+||.||++.+. +..||+|+++... .......+.+|+.++++++|+|
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~ 80 (296)
T cd05095 2 FPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPN 80 (296)
T ss_pred CChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCC
Confidence 34567899999999999999998542 2358999987542 3445578999999999999999
Q ss_pred eeeEEEEEecCCeEEEEEeccCCCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCC
Q 011158 351 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK----------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 420 (492)
Q Consensus 351 Iv~l~g~~~~~~~~~lV~Ey~~ggsL~~~L~~~~----------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~N 420 (492)
|+++++++...+..|+||||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N 160 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN 160 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence 9999999999999999999999999999997632 236778999999999999999999999999999999
Q ss_pred EEEccCCCeEEEEEeecceeee---------eeCCCceeecceeccccccCccceeee
Q 011158 421 LLMDENEVSLLLSLCLFTVSIL---------FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 421 ILld~~~~~kl~DFGla~~~~~---------~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
||++.++.++++|||.++.... ......|++||......+...+|+|++
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSl 218 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAF 218 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHH
Confidence 9999999999999999864311 111245677776655667777899984
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=220.46 Aligned_cols=176 Identities=26% Similarity=0.432 Sum_probs=148.7
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
..+|++.++||+|+||.||+|++ .++.||+|++..... .....+.+|+.++++++||||+++++++...+.+|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 45788899999999999999987 467899999975432 23356788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------- 441 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------- 441 (492)
||+++++|.+++.+ .+.+++..+..++.|++.||.|||+++|+||||||+||+++.++.++++|||.+....
T Consensus 86 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06646 86 EYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK 164 (267)
T ss_pred eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccC
Confidence 99999999999976 4578999999999999999999999999999999999999999999999999986432
Q ss_pred eeeCCCceeecceecc---ccccCccceeee
Q 011158 442 LFCGKGRELISLFLGN---DVLLQFGTYWII 469 (492)
Q Consensus 442 ~~~g~~~~~ape~~~~---e~~~~~~d~W~l 469 (492)
...++..|++||+... ..+....|+|++
T Consensus 165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~ 195 (267)
T cd06646 165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAV 195 (267)
T ss_pred ccccCccccCHhHcccccCCCCcchhhHHHH
Confidence 1235567888887642 234456788873
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-26 Score=225.84 Aligned_cols=180 Identities=21% Similarity=0.385 Sum_probs=150.4
Q ss_pred eCCCCceeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~~-------g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 361 (492)
++..+|++.++||+|+||.||+|.+. ++.||+|+++... .......+.+|+.++++++||||+++++++...
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 44556888899999999999999863 3579999997543 334456788999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccC
Q 011158 362 PSLCIVTEFMSGGSVYDYLHKL---------------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426 (492)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~L~~~---------------~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~ 426 (492)
...++++||+.+++|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 9999999999999999999531 1347888899999999999999999999999999999999999
Q ss_pred CCeEEEEEeecceeee---------eeCCCceeecceeccccccCccceeee
Q 011158 427 EVSLLLSLCLFTVSIL---------FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 427 ~~~kl~DFGla~~~~~---------~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
+.+|++|||+++.... ..++..|++||+.....+....|+|++
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 212 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSY 212 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHH
Confidence 9999999998764311 112346888888766667777888884
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=222.35 Aligned_cols=180 Identities=21% Similarity=0.330 Sum_probs=152.5
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEE
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 365 (492)
-...+.|++.++||+|+||.||+|.. .++.+++|++... +....+.+.+|+.++++++|+||+++++.+.....+|
T Consensus 8 ~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (292)
T cd06644 8 LDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLW 85 (292)
T ss_pred cCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEE
Confidence 34456788999999999999999987 4678999998754 3455678899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee----
Q 011158 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI---- 441 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~---- 441 (492)
+||||+++++|..++.+....+++..++.++.|++.||.|||+++|+||||||+||+++.++.++|+|||.+....
T Consensus 86 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 86 IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred EEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 9999999999999887766779999999999999999999999999999999999999999999999999875421
Q ss_pred ---eeeCCCceeecceecc-----ccccCccceeee
Q 011158 442 ---LFCGKGRELISLFLGN-----DVLLQFGTYWII 469 (492)
Q Consensus 442 ---~~~g~~~~~ape~~~~-----e~~~~~~d~W~l 469 (492)
...++..|++||+... ..+...+|+|++
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~sl 201 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSL 201 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhH
Confidence 2345567888887742 234455788873
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.6e-26 Score=221.35 Aligned_cols=168 Identities=20% Similarity=0.347 Sum_probs=141.3
Q ss_pred eeeeecCceEEEEEEECCc------------eEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEE
Q 011158 298 SKVASGSYGDLYRGTYCSQ------------DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~g~------------~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 365 (492)
+.||+|+||.||+|.+... .+++|+++.... ....|.+|+.++++++|+||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 4689999999999988532 378887765421 15788999999999999999999999988 7789
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCC-------CeEEEEEeecc
Q 011158 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-------VSLLLSLCLFT 438 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~-------~~kl~DFGla~ 438 (492)
+||||+++|+|.+++......+++..+..++.||+.||.|||+++|+||||||+|||++.++ .+|++|||.+.
T Consensus 77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~ 156 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156 (259)
T ss_pred EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence 99999999999999987555789999999999999999999999999999999999999887 79999999987
Q ss_pred eee---eeeCCCceeecceeccc--cccCccceeee
Q 011158 439 VSI---LFCGKGRELISLFLGND--VLLQFGTYWII 469 (492)
Q Consensus 439 ~~~---~~~g~~~~~ape~~~~e--~~~~~~d~W~l 469 (492)
... ...+...|++||+.... .+...+|+|++
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~sl 192 (259)
T cd05037 157 TVLSREERVERIPWIAPECIRNGQASLTIAADKWSF 192 (259)
T ss_pred ccccccccccCCCccChhhhcCCCCCcchhhHHHHH
Confidence 532 23345668888887655 56666788873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=221.30 Aligned_cols=187 Identities=19% Similarity=0.263 Sum_probs=156.6
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEec
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 370 (492)
+|++.+.||+|+||.||+|++ .++.||+|++............+.+|+.++++++|+||+++++++......|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 478889999999999999987 468899999987654455567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee--------
Q 011158 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL-------- 442 (492)
Q Consensus 371 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~-------- 442 (492)
+ +++|.+++......+++..++.++.||+.||.|||+++|+|+||||+||+++.++.++++|||.+.....
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH 159 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcccc
Confidence 9 9999999987667799999999999999999999999999999999999999999999999999865422
Q ss_pred eeCCCceeecceecc-ccccCccceeee---ecccccCCCCC
Q 011158 443 FCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNS 480 (492)
Q Consensus 443 ~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y 480 (492)
..++..|++||+... ..+....|+|++ +.....|.+.|
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~ 201 (286)
T cd07832 160 QVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLF 201 (286)
T ss_pred ccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCc
Confidence 234556788887643 334666788884 22333455544
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.8e-26 Score=254.26 Aligned_cols=195 Identities=17% Similarity=0.276 Sum_probs=158.6
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEec--CC
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--PP 362 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~ 362 (492)
.+....+|.++++||+|+||.||+|.+. +..||+|++............|..|+.+|++++|||||+++++|.. ..
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 3455678999999999999999999884 5779999998766666667889999999999999999999998854 35
Q ss_pred eEEEEEeccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-------CceecCCCCCCEEEccC------
Q 011158 363 SLCIVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQN-------NIIHRDLKAANLLMDEN------ 426 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~-------~IiHrDLKp~NILld~~------ 426 (492)
.+||||||+++|+|.++|... ...+++..++.|+.||+.||.|||+. +||||||||+||||+..
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 689999999999999999753 25799999999999999999999984 49999999999999642
Q ss_pred -----------CCeEEEEEeecceee------eeeCCCceeecceecc--ccccCccceeee---ecccccCCCCCC
Q 011158 427 -----------EVSLLLSLCLFTVSI------LFCGKGRELISLFLGN--DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 427 -----------~~~kl~DFGla~~~~------~~~g~~~~~ape~~~~--e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
..+||+|||++.... ...++..|++||++.. ..+...+|+|++ +....+|.++|.
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 348999999986542 2357778889987743 346667899984 333445666654
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-26 Score=223.29 Aligned_cols=181 Identities=28% Similarity=0.468 Sum_probs=153.5
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEE
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 365 (492)
|+....+|++.++||.|+||.||+|.+. ++.+|+|+++... ......+..|+.+++.++|+||+++++++......+
T Consensus 1 ~~~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 78 (261)
T cd05148 1 WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVY 78 (261)
T ss_pred CcCcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeE
Confidence 3445567889999999999999999885 5789999987543 333567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee--
Q 011158 366 IVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL-- 442 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~-- 442 (492)
+||||+++++|.+++.+.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+|++|||.+.....
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 79 IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred EEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 9999999999999997643 4689999999999999999999999999999999999999999999999999865421
Q ss_pred -----eeCCCceeecceeccccccCccceeee
Q 011158 443 -----FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 443 -----~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
..++..|++||+.....+...+|+|++
T Consensus 159 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Diwsl 190 (261)
T cd05148 159 YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSF 190 (261)
T ss_pred ccccCCCCceEecCHHHHccCCCCchhhHHHH
Confidence 112335778887766667777889984
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=218.76 Aligned_cols=179 Identities=29% Similarity=0.473 Sum_probs=152.1
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEE
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 365 (492)
|++..++|++.++||+|+||.||++.+. +..+|+|.++.. ......+.+|+.++++++|+||+++++.+.. ...+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 7888999999999999999999999874 467999988753 2234678899999999999999999999887 6789
Q ss_pred EEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee--
Q 011158 366 IVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL-- 442 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~-- 442 (492)
++|||+++++|.+++.+.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+|++|||.+.....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 9999999999999997643 4578889999999999999999999999999999999999999999999998854321
Q ss_pred ------eeCCCceeecceeccccccCccceeee
Q 011158 443 ------FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 443 ------~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
..+...|++||+.....+....|+|++
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl 189 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSF 189 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCccccchHH
Confidence 112234788888777667777899994
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=220.14 Aligned_cols=191 Identities=23% Similarity=0.322 Sum_probs=156.6
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC---hHHHHHHHHHHHHHHhcCCCceeeEEEEEec--CCeE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN---SDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--PPSL 364 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~~ 364 (492)
.+|+..+.||+|+||.||++.. ++..||+|++...... ......+.+|+.++++++||||+++++++.. ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4677889999999999999987 4688999998754322 2345678899999999999999999998875 3568
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee--
Q 011158 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL-- 442 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~-- 442 (492)
++++||+++++|.+++.. ...+++..++.++.|++.||.|||+++|+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~l~~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA-YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 160 (266)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence 999999999999999976 34689999999999999999999999999999999999999999999999999864321
Q ss_pred --------eeCCCceeecceeccccccCccceeee---ecccccCCCCCCCc
Q 011158 443 --------FCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDAP 483 (492)
Q Consensus 443 --------~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~aP 483 (492)
..++..|++||+.....++..+|+|++ +.....|.++|.+.
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~ 212 (266)
T cd06651 161 MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY 212 (266)
T ss_pred ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence 235566888888877767777888884 33444566666544
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.7e-26 Score=220.65 Aligned_cols=189 Identities=17% Similarity=0.246 Sum_probs=161.0
Q ss_pred CceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
+|++.+.||.|+||.||+|.+. ++.||+|++...... ....+.+.+|+.++++++||||+++++.+......|+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999884 788999999765332 2456789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee------ee
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------LF 443 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------~~ 443 (492)
|+.+++|.+++... ..+++..+..++.||+.||.|||+++|+|+||||+||++++++.++++|||.+.... ..
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 159 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST 159 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcccccc
Confidence 99999999999774 578999999999999999999999999999999999999999999999999986532 23
Q ss_pred eCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 444 CGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 444 ~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
.+...|++||+.....+...+|+|++ +.....|..+|..
T Consensus 160 ~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 201 (258)
T cd05578 160 SGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG 201 (258)
T ss_pred CCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCC
Confidence 45667889998887778888899994 2234456655553
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.9e-26 Score=223.47 Aligned_cols=176 Identities=22% Similarity=0.355 Sum_probs=150.7
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
++|++.++||.|+||.||++.+ +++.+|+|+++.. .......+.+|+.++++++|+||+++++++..+...|+|||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 4688889999999999999987 4678999998754 34455789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------e
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-------L 442 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-------~ 442 (492)
|+++++|.+++.+....+++..++.++.|++.||.|||+++|+|+||||+||+++.++.++++|||.+.... .
T Consensus 83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 162 (280)
T cd06611 83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT 162 (280)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccce
Confidence 999999999998766679999999999999999999999999999999999999999999999999875432 2
Q ss_pred eeCCCceeecceecc-----ccccCccceeee
Q 011158 443 FCGKGRELISLFLGN-----DVLLQFGTYWII 469 (492)
Q Consensus 443 ~~g~~~~~ape~~~~-----e~~~~~~d~W~l 469 (492)
..++..|++||+... ..+...+|+|++
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~sl 194 (280)
T cd06611 163 FIGTPYWMAPEVVACETFKDNPYDYKADIWSL 194 (280)
T ss_pred eecchhhcCHHHHhhcccCCCCCCccccHHHH
Confidence 345667888887642 224445777873
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=221.65 Aligned_cols=171 Identities=25% Similarity=0.349 Sum_probs=137.0
Q ss_pred eeeeecCceEEEEEEEC----CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEeccCC
Q 011158 298 SKVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG 373 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~----g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~g 373 (492)
++||+|+||.||+|... ...+++|.+... ........+.+|+.+++.++|+||+++++.+......|+||||+++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCcc-CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 36899999999999752 246888877643 2344456788999999999999999999999999999999999999
Q ss_pred CCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee-------
Q 011158 374 GSVYDYLHKLKG----VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL------- 442 (492)
Q Consensus 374 gsL~~~L~~~~~----~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~------- 442 (492)
|+|.+++..... ..++..++.++.||+.||.|||+++|+||||||+|||++.++.+|++|||++.....
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK 159 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheecc
Confidence 999999976432 346778899999999999999999999999999999999999999999999864211
Q ss_pred --eeCCCceeecceecc-------ccccCccceeee
Q 011158 443 --FCGKGRELISLFLGN-------DVLLQFGTYWII 469 (492)
Q Consensus 443 --~~g~~~~~ape~~~~-------e~~~~~~d~W~l 469 (492)
..++..|++||+... ..+...+|+|++
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diwsl 195 (269)
T cd05042 160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSL 195 (269)
T ss_pred CCCCCcccccCHHHHhhccccccccccchhhHHHHH
Confidence 112234777776432 234556788873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=223.19 Aligned_cols=190 Identities=21% Similarity=0.280 Sum_probs=154.5
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
+.|++.+.||+|+||.||+|.. .++.||||.+...... .....+.+|+.++++++|+||+++++++......|+|||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 5788899999999999999987 4688999998754322 222456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee-------
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL------- 442 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~------- 442 (492)
|+. ++|.+++.+....+++..++.++.|++.||.|||+++|+||||||+|||++.++.+|++|||.++....
T Consensus 84 ~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 162 (291)
T cd07844 84 YLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSN 162 (291)
T ss_pred cCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccccc
Confidence 996 599999987666889999999999999999999999999999999999999999999999999864321
Q ss_pred eeCCCceeecceecc-ccccCccceeee---ecccccCCCCCCCc
Q 011158 443 FCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSDAP 483 (492)
Q Consensus 443 ~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~aP 483 (492)
..++..|++||+... ..+....|+|++ +....+|.+.|...
T Consensus 163 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 207 (291)
T cd07844 163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGS 207 (291)
T ss_pred cccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 123455677776533 345566788884 33455677776543
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=225.68 Aligned_cols=189 Identities=21% Similarity=0.267 Sum_probs=152.3
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
.++|.+.++||+|+||.||+|.+ +++.||+|.++.... ......+.+|+.++++++|+||+++++++......|+||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 35788899999999999999987 467899999875432 222356778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------- 441 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------- 441 (492)
||++ ++|.+++......+++..+..++.||+.||.|||+++|+||||||+|||++.++.++++|||.+....
T Consensus 84 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (301)
T cd07873 84 EYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYS 162 (301)
T ss_pred eccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCccc
Confidence 9995 69999998766678999999999999999999999999999999999999999999999999986432
Q ss_pred eeeCCCceeecceecc-ccccCccceeee---ecccccCCCCCC
Q 011158 442 LFCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 ~~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||.... ..+...+|+|++ +.....|.+.|.
T Consensus 163 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~ 206 (301)
T cd07873 163 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFP 206 (301)
T ss_pred ccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCC
Confidence 1223455677775533 334555688884 223344666554
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-25 Score=220.26 Aligned_cols=187 Identities=22% Similarity=0.335 Sum_probs=153.6
Q ss_pred CceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEec
Q 011158 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 370 (492)
.|++.++||+|+||.||+|.+. +..+++|.+... .......+.+|+.+++.++|+||+++++++...+..|+||||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 3567789999999999999884 567899988643 344567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------ee
Q 011158 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-------LF 443 (492)
Q Consensus 371 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-------~~ 443 (492)
+++++|..++.+....+++..+..++.|++.||.|||+.||+||||||+|||++.++.+|++|||++.... ..
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 163 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF 163 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccccc
Confidence 99999999887656679999999999999999999999999999999999999999999999999985432 23
Q ss_pred eCCCceeecceec-----cccccCccceeee---ecccccCCCCCC
Q 011158 444 CGKGRELISLFLG-----NDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 444 ~g~~~~~ape~~~-----~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
.++..|++||+.. ...+...+|+|++ +.....|.++|.
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~ 209 (282)
T cd06643 164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHH 209 (282)
T ss_pred cccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcc
Confidence 4566788888763 2334456788884 333344555543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=219.89 Aligned_cols=179 Identities=32% Similarity=0.517 Sum_probs=149.9
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEECC-ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEE
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g-~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 365 (492)
|++...+|.+.++||+|+||.||++.+.+ ..+|+|++..... ..+.+.+|+.++++++|+||+++++++.. +..+
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (260)
T cd05069 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIY 76 (260)
T ss_pred CcCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcE
Confidence 66777889999999999999999998854 5799998875432 23678899999999999999999998754 5689
Q ss_pred EEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee--
Q 011158 366 IVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL-- 442 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~-- 442 (492)
+||||+++|+|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||++++++.++|+|||.++....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 9999999999999997643 3589999999999999999999999999999999999999999999999999865321
Q ss_pred ------eeCCCceeecceeccccccCccceeee
Q 011158 443 ------FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 443 ------~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
..++..|++||+.....+....|+|++
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~sl 189 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 189 (260)
T ss_pred ccccCCCccchhhCCHHHhccCCcChHHHHHHH
Confidence 112235788887776667777788884
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=217.45 Aligned_cols=178 Identities=18% Similarity=0.329 Sum_probs=152.5
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
++|++.+.||+|+||.||+|.. +++.||+|.++.... +......+.+|+.++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 4688899999999999999988 478899999875332 3344678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee----
Q 011158 369 EFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI---- 441 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~---- 441 (492)
||+++|+|.+++... ...+++.+++.++.|++.||.|||+.||+||||||+||+++.++.++++|||.+....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 999999999999653 3468999999999999999999999999999999999999999999999999976432
Q ss_pred ---eeeCCCceeecceeccccccCccceeee
Q 011158 442 ---LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 442 ---~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
...++..|++||+.....+...+|+|++
T Consensus 162 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~sl 192 (267)
T cd08224 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSL 192 (267)
T ss_pred ccceecCCccccCHHHhccCCCCchhcHHHH
Confidence 2345566788887766667777788874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=219.24 Aligned_cols=191 Identities=22% Similarity=0.350 Sum_probs=157.5
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCC---CChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--CeE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPER---INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSL 364 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~---~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~ 364 (492)
.+|.+.+.||+|+||.||+|.+ +++.||+|++.... ........+.+|+.++++++|+||+++++++... ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 5688899999999999999987 46889999885432 1234456789999999999999999999998754 458
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee---
Q 011158 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI--- 441 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~--- 441 (492)
+++|||+++++|.+++.. .+.+++..++.++.||+.||.|||+++|+|+||||+||+++.++.++++|||.++...
T Consensus 82 ~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 160 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA-YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC 160 (264)
T ss_pred EEEEEeCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence 999999999999999976 3458999999999999999999999999999999999999999999999999986432
Q ss_pred -------eeeCCCceeecceeccccccCccceeee---ecccccCCCCCCCc
Q 011158 442 -------LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDAP 483 (492)
Q Consensus 442 -------~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~aP 483 (492)
...++..|++||+.........+|+|++ +....+|.++|...
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 212 (264)
T cd06653 161 MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212 (264)
T ss_pred ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence 1235567888888877777777899983 33445577776543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=218.62 Aligned_cols=189 Identities=23% Similarity=0.413 Sum_probs=156.7
Q ss_pred CceeeeeeeecCceEEEEEEE-CCceEEEEEecCCCCC----hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEE
Q 011158 293 HLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERIN----SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~-~g~~vAvK~l~~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 367 (492)
+|+..+.||+|+||.||+|.. .++.+|+|.++..... ......+.+|+.++++++|+||+++++++......|+|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 366778999999999999987 5778999998754321 23345688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee------
Q 011158 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------ 441 (492)
Q Consensus 368 ~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------ 441 (492)
|||+++++|.+++.+ ...+++..+..++.|++.||.|||+.+|+|+||||+||+++.++.++++|||.+....
T Consensus 81 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 81 MEFVPGGSISSILNR-FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 999999999999976 3568999999999999999999999999999999999999999999999999875421
Q ss_pred -------eeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 442 -------LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 442 -------~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
...++..|++||+.....+...+|+|++ +.....|..+|..
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~ 210 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS 210 (265)
T ss_pred cccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCcccc
Confidence 2335566888888877777778899884 3334445555543
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=223.95 Aligned_cols=176 Identities=23% Similarity=0.407 Sum_probs=147.7
Q ss_pred CceeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEE
Q 011158 293 HLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~~g-------~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 365 (492)
+|++.+.||+|+||.||+|+... ..+++|.+.... .......+.+|+.+++.++||||+++++.+...+..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 36778999999999999998632 458999887543 2344567899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEE
Q 011158 366 IVTEFMSGGSVYDYLHKLK-----------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 422 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~-----------------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NIL 422 (492)
++|||+.+|+|.+++.... ..+++..++.++.|++.||.|||+++|+||||||+|||
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil 159 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL 159 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence 9999999999999986421 24788999999999999999999999999999999999
Q ss_pred EccCCCeEEEEEeecceee---------eeeCCCceeecceeccccccCccceeee
Q 011158 423 MDENEVSLLLSLCLFTVSI---------LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 423 ld~~~~~kl~DFGla~~~~---------~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
+++++.+||+|||.++... ...++..|++||+.....+...+|+|++
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~sl 215 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSF 215 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHH
Confidence 9999999999999986431 1123346788888777777778888884
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-25 Score=223.21 Aligned_cols=177 Identities=20% Similarity=0.321 Sum_probs=150.7
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
++|++.+.||+|+||.||++... ++.|++|.+..... .......+.+|+.+++.++||||+++++.+...+.+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36788899999999999999874 57899999876532 2234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------- 441 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------- 441 (492)
||++|++|.+++.. .+.+++..+..++.|++.||.|||+++|+||||||+||+++.++.++++|||.++...
T Consensus 81 e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (305)
T cd05609 81 EYVEGGDCATLLKN-IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 159 (305)
T ss_pred ecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence 99999999999976 3578999999999999999999999999999999999999999999999999886421
Q ss_pred ---------------eeeCCCceeecceeccccccCccceeee
Q 011158 442 ---------------LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 442 ---------------~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
...++..|++||+.....+....|+|++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 202 (305)
T cd05609 160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAM 202 (305)
T ss_pred cccccccchhhccccCCccCccccCchhccCCCCCchhhHHHH
Confidence 1134456788888776667777888873
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=223.26 Aligned_cols=187 Identities=19% Similarity=0.307 Sum_probs=157.3
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
.+|++.+.||+|+||.||+|.+ .++.|++|.+...... ....+.+|+.+++.+.|+||+++++.+......|+|||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 5788889999999999999987 4688999998764432 34678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------e
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-------L 442 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-------~ 442 (492)
|+++++|.+++.+ ..+++.++..++.|++.||.|||++||+||||||+|||++.++.++|+|||.+.... .
T Consensus 98 ~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 175 (296)
T cd06654 98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (296)
T ss_pred ccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCc
Confidence 9999999999965 458999999999999999999999999999999999999999999999999876432 2
Q ss_pred eeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 443 FCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 443 ~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
..++..|++||+..........|+|++ +.....|.++|..
T Consensus 176 ~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~ 218 (296)
T cd06654 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218 (296)
T ss_pred ccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 356667889998877777777888883 2233445555543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-26 Score=224.26 Aligned_cols=139 Identities=22% Similarity=0.388 Sum_probs=125.1
Q ss_pred eeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCeEEEEEeccCC
Q 011158 297 GSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFMSG 373 (492)
Q Consensus 297 ~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~Ey~~g 373 (492)
.+.||+|+|+.|--++. ++..+|||++.+. ....+.++.+|++++.+++ |+||++++++|++...+|||||-|.|
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 36799999999998865 7899999999865 3455688999999999996 99999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCC---CeEEEEEeecc
Q 011158 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE---VSLLLSLCLFT 438 (492)
Q Consensus 374 gsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~---~~kl~DFGla~ 438 (492)
|+|...|++ +..+++..+.+++.+|+.||.|||.+||.||||||+|||-.... .+||+||.+..
T Consensus 161 GplLshI~~-~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgS 227 (463)
T KOG0607|consen 161 GPLLSHIQK-RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGS 227 (463)
T ss_pred chHHHHHHH-hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccc
Confidence 999999988 56799999999999999999999999999999999999986543 58999998863
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=218.80 Aligned_cols=181 Identities=26% Similarity=0.431 Sum_probs=151.8
Q ss_pred eeeeecCceEEEEEEECC-----ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEeccC
Q 011158 298 SKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS 372 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~g-----~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 372 (492)
++||+|+||.||+|.+.. ..||||.++..... ...+.+.+|+.++++++|+||+++++.+.. ...++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 468999999999998732 25999999876543 566789999999999999999999999988 88999999999
Q ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee---------
Q 011158 373 GGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL--------- 442 (492)
Q Consensus 373 ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~--------- 442 (492)
+|+|.+++.+.. ..+++..++.++.|++.||.|||+++++||||||+||+++.++.+|++|||.+.....
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 158 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEE 158 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceeccc
Confidence 999999998754 5789999999999999999999999999999999999999999999999999865422
Q ss_pred -eeCCCceeecceeccccccCccceeee----ecccccCCCCC
Q 011158 443 -FCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNS 480 (492)
Q Consensus 443 -~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y 480 (492)
..++..|++||+.....+...+|+|++ +....+|.++|
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~ 201 (257)
T cd05040 159 HLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPW 201 (257)
T ss_pred CCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCC
Confidence 223446888888877777778899884 22333466665
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=225.83 Aligned_cols=180 Identities=19% Similarity=0.286 Sum_probs=142.5
Q ss_pred eeeeeecCceEEEEEEEC----CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEec--CCeEEEEEec
Q 011158 297 GSKVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--PPSLCIVTEF 370 (492)
Q Consensus 297 ~~~LG~G~fG~Vy~~~~~----g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~~~lV~Ey 370 (492)
+.+||+|+||.||+|++. ++.||+|.++.... ...+.+|+.+|++++||||+++++++.. ...+|+||||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 368999999999999863 46799999875432 2456789999999999999999998854 4568999999
Q ss_pred cCCCCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE----ccCCCeEEEEEeecc
Q 011158 371 MSGGSVYDYLHKL--------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM----DENEVSLLLSLCLFT 438 (492)
Q Consensus 371 ~~ggsL~~~L~~~--------~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILl----d~~~~~kl~DFGla~ 438 (492)
+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 82 ~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 82 A-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred c-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 9 56999988632 1258899999999999999999999999999999999999 456789999999986
Q ss_pred eee----------eeeCCCceeecceecc-ccccCccceeee---ecccccCCCCCC
Q 011158 439 VSI----------LFCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 439 ~~~----------~~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
... ...++..|++||+... ..+....|+|++ +....+|.+.|.
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~ 217 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCcc
Confidence 531 2345667888887644 456777899984 333445666554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=220.29 Aligned_cols=170 Identities=21% Similarity=0.375 Sum_probs=141.5
Q ss_pred eeeeecCceEEEEEEECC--------------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCe
Q 011158 298 SKVASGSYGDLYRGTYCS--------------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~g--------------~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 363 (492)
+.||+|+||.||+|+... ..|++|++.... ......|.+|+.+++.++||||+++++++.....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 368999999999997521 248889876532 3445678899999999999999999999999989
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCC-------eEEEEEee
Q 011158 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV-------SLLLSLCL 436 (492)
Q Consensus 364 ~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~-------~kl~DFGl 436 (492)
.++||||+++|+|..++.+....+++..++.++.||+.||.|||+++|+||||||+|||++.++. ++++|||.
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~ 158 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence 99999999999999999876677999999999999999999999999999999999999987664 79999998
Q ss_pred cceee---eeeCCCceeecceec-cccccCccceeee
Q 011158 437 FTVSI---LFCGKGRELISLFLG-NDVLLQFGTYWII 469 (492)
Q Consensus 437 a~~~~---~~~g~~~~~ape~~~-~e~~~~~~d~W~l 469 (492)
+.... ...++..|++||+.. ...+...+|.|++
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl 195 (262)
T cd05077 159 PITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSF 195 (262)
T ss_pred CccccCcccccccccccChhhhcCCCCCCchhHHHHH
Confidence 76432 233556788999775 4556666788873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=223.34 Aligned_cols=187 Identities=19% Similarity=0.312 Sum_probs=156.4
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
.+|++.+.||+|+||.||++.. .++.||+|.+..... ...+.+.+|+.+++.++|+||+++++++......|+|||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 5788889999999999999986 578899999975432 234668899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------e
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-------L 442 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-------~ 442 (492)
|+++++|.+++.+ ..+++.++..++.|++.||.|||+.+|+||||||+|||++.++.++++|||.+.... .
T Consensus 97 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 174 (297)
T cd06656 97 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 174 (297)
T ss_pred ccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCc
Confidence 9999999999965 468999999999999999999999999999999999999999999999999886432 2
Q ss_pred eeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 443 FCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 443 ~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
..++..|++||+.....+....|.|++ +.....|.++|..
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~ 217 (297)
T cd06656 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217 (297)
T ss_pred ccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 345567888888777667777888883 2233345555543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=223.19 Aligned_cols=169 Identities=21% Similarity=0.327 Sum_probs=139.1
Q ss_pred eeeecCceEEEEEEEC--------------------------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcee
Q 011158 299 KVASGSYGDLYRGTYC--------------------------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352 (492)
Q Consensus 299 ~LG~G~fG~Vy~~~~~--------------------------g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv 352 (492)
.||+|+||.||+|... ...|++|++.... ......|.+|+.++++++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 6899999999999641 1248899886432 33456788999999999999999
Q ss_pred eEEEEEecCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCC-----
Q 011158 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE----- 427 (492)
Q Consensus 353 ~l~g~~~~~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~----- 427 (492)
++++++......++||||+++|+|..++.+..+.+++..+..++.||+.||.|||+++|+||||||+|||++..+
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~ 159 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGT 159 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCc
Confidence 999999999999999999999999999987667889999999999999999999999999999999999998654
Q ss_pred --CeEEEEEeecceee---eeeCCCceeecceecc-ccccCccceeee
Q 011158 428 --VSLLLSLCLFTVSI---LFCGKGRELISLFLGN-DVLLQFGTYWII 469 (492)
Q Consensus 428 --~~kl~DFGla~~~~---~~~g~~~~~ape~~~~-e~~~~~~d~W~l 469 (492)
.+|++|||.+.... ...++..|++||+... ..+....|+|++
T Consensus 160 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~sl 207 (274)
T cd05076 160 SPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSF 207 (274)
T ss_pred cceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHH
Confidence 37999999875332 2235567888886644 445666788873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=238.77 Aligned_cols=190 Identities=17% Similarity=0.277 Sum_probs=153.1
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCC------ceeeEEEEEe
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK------NVVQFIGACT 359 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~Hp------nIv~l~g~~~ 359 (492)
++...+|++.++||+|+||.||+|.+ .++.||||+++.. ......+..|+.++++++|. +|+++++++.
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV---PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc---hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 44567899999999999999999987 4678999999642 22334566788888877654 5888999887
Q ss_pred cC-CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEccCC----------
Q 011158 360 KP-PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENE---------- 427 (492)
Q Consensus 360 ~~-~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~-~~IiHrDLKp~NILld~~~---------- 427 (492)
.. ..+|||||++ +++|.+++.+ .+.+++..+..|+.||+.||.|||+ .|||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence 54 5689999999 8899999976 4679999999999999999999998 5999999999999998765
Q ss_pred ------CeEEEEEeeccee----eeeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 428 ------VSLLLSLCLFTVS----ILFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 428 ------~~kl~DFGla~~~----~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
.+||+|||.+... ....++..|++||++....+....|+|++ +....+|.++|..
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 347 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT 347 (467)
T ss_pred cCCCCceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 4899999987543 23567788999998887778888899994 3345567777653
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.9e-26 Score=236.93 Aligned_cols=195 Identities=17% Similarity=0.248 Sum_probs=164.6
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeE
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 364 (492)
.++...|..++.||-|+||.|.++.. +...+|+|.+++.. +..........|-.||..-..+.||+||-.|.+++++
T Consensus 625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL 704 (1034)
T KOG0608|consen 625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL 704 (1034)
T ss_pred hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce
Confidence 46667788899999999999999864 55679999997642 2333445577899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee----
Q 011158 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS---- 440 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~---- 440 (492)
|+||+|++||++..+|-+ .+.|.+..++.++..+..|+++.|..|+|||||||+|||||.+|.+||.|||++.--
T Consensus 705 YFVMdYIPGGDmMSLLIr-mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLIR-MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred EEEEeccCCccHHHHHHH-hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecc
Confidence 999999999999999977 578999999999999999999999999999999999999999999999999997310
Q ss_pred ---------------------------------------------eeeeCCCceeecceeccccccCccceeee---ecc
Q 011158 441 ---------------------------------------------ILFCGKGRELISLFLGNDVLLQFGTYWII---FRR 472 (492)
Q Consensus 441 ---------------------------------------------~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~ 472 (492)
....|++.|++||++....+.+..|||++ +..
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 12567788888888888888888888883 445
Q ss_pred cccCCCCCCCc
Q 011158 473 SSCDKKNSDAP 483 (492)
Q Consensus 473 ~~~gt~~Y~aP 483 (492)
+.+|.++|.++
T Consensus 864 m~~g~~pf~~~ 874 (1034)
T KOG0608|consen 864 MLVGQPPFLAD 874 (1034)
T ss_pred HhhCCCCccCC
Confidence 66777777664
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=216.34 Aligned_cols=171 Identities=29% Similarity=0.440 Sum_probs=145.5
Q ss_pred eeeeecCceEEEEEEE-CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEeccCCCCH
Q 011158 298 SKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ggsL 376 (492)
++||+|+||.||+|.. .++.+|+|+++... .......+.+|+.++++++||||+++++++......++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 3689999999999986 45779999987543 344456789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee--------eeCCCc
Q 011158 377 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL--------FCGKGR 448 (492)
Q Consensus 377 ~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~--------~~g~~~ 448 (492)
.+++......+++..++.++.|++.||.|||++|++||||||+||+++.++.+|++|||.+..... ......
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 159 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK 159 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCccc
Confidence 999977566789999999999999999999999999999999999999999999999999864321 112234
Q ss_pred eeecceeccccccCccceeee
Q 011158 449 ELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 449 ~~ape~~~~e~~~~~~d~W~l 469 (492)
|++||+.....+...+|+|++
T Consensus 160 y~aPE~~~~~~~~~~~Di~sl 180 (250)
T cd05085 160 WTAPEALNYGRYSSESDVWSY 180 (250)
T ss_pred ccCHHHhccCCCCchhHHHHH
Confidence 788888776667777888884
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.2e-26 Score=224.35 Aligned_cols=176 Identities=19% Similarity=0.295 Sum_probs=148.6
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEec
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 370 (492)
+|++.++||+|+||.||+|++ +|+.||+|+++...........+.+|+.++++++|+||+++++++.....+|+|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 477889999999999999988 578899999976543334446678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------ee
Q 011158 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-------LF 443 (492)
Q Consensus 371 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-------~~ 443 (492)
+. ++|.+++....+.+++..++.++.||++||.|||+++|+||||||+||+++.++.+||+|||.+.... ..
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAE 159 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCC
Confidence 95 68999887766779999999999999999999999999999999999999999999999999986432 12
Q ss_pred eCCCceeecceecc-ccccCccceeee
Q 011158 444 CGKGRELISLFLGN-DVLLQFGTYWII 469 (492)
Q Consensus 444 ~g~~~~~ape~~~~-e~~~~~~d~W~l 469 (492)
.++..|++||+... ..+...+|+|++
T Consensus 160 ~~~~~y~aPE~~~~~~~~~~~~Diwsl 186 (284)
T cd07839 160 VVTLWYRPPDVLFGAKLYSTSIDMWSA 186 (284)
T ss_pred ccccCCcChHHHhCCcccCcHHHHHHH
Confidence 34556788886644 335666788884
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-26 Score=241.50 Aligned_cols=225 Identities=24% Similarity=0.380 Sum_probs=170.0
Q ss_pred cceeeeeccccCCCceEEEEEEcCCCcchHHHHHHHHHHHHHhhhhcCCCCCCCCCCCCCCCCCCCCCCCCccccCCCCC
Q 011158 205 LNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGT 284 (492)
Q Consensus 205 l~i~~A~~fst~dg~sl~v~vv~~w~~e~~~~l~~~l~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~ 284 (492)
||++.+..|+-+....|+-+ |...-.+..|++++.+-.......+|.+..-.-..+. +......... .+..
T Consensus 32 lnvrr~~hf~yVk~eDLl~I---GMgRp~qRRLrea~kkm~~~~k~kswvkKvf~ga~p~-----h~~~t~~~~~-p~~~ 102 (1039)
T KOG0199|consen 32 LNVRRFDHFSYVKDEDLLEI---GMGRPQQRRLREAIKKMSREMKNKSWVKKVFIGADPS-----HPAQTNSVAN-PSID 102 (1039)
T ss_pred hccCchhhhhhcchhhhhhh---ccCcHHHHHHHHHHHHhhhhccccchHHHHhccCCcc-----ccccccCCCC-cCCC
Confidence 78888888888776655543 3444445555555443333333344433221111110 0000111111 1223
Q ss_pred CceeeCCCCceeeeeeeecCceEEEEEEEC---C--ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Q 011158 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC---S--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359 (492)
Q Consensus 285 ~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~---g--~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~ 359 (492)
+..-|..+.+++.++||+|+||.|++|.|+ | -.||||+++.+.... ...+|++|+.+|.+|+|+|++++||+..
T Consensus 103 lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl 181 (1039)
T KOG0199|consen 103 LKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVL 181 (1039)
T ss_pred cceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeec
Confidence 446788889999999999999999999995 3 359999999876654 5689999999999999999999999998
Q ss_pred cCCeEEEEEeccCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecc
Q 011158 360 KPPSLCIVTEFMSGGSVYDYLHK-LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFT 438 (492)
Q Consensus 360 ~~~~~~lV~Ey~~ggsL~~~L~~-~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~ 438 (492)
+ ..+.||||+++.|+|.+.|++ .+..|....+..++.||+.||.||..+++|||||.+.|||+.....+||+|||+.|
T Consensus 182 ~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmR 260 (1039)
T KOG0199|consen 182 D-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMR 260 (1039)
T ss_pred c-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeeccccee
Confidence 8 568999999999999999988 45678899999999999999999999999999999999999999999999999987
Q ss_pred ee
Q 011158 439 VS 440 (492)
Q Consensus 439 ~~ 440 (492)
-.
T Consensus 261 aL 262 (1039)
T KOG0199|consen 261 AL 262 (1039)
T ss_pred cc
Confidence 54
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-25 Score=215.67 Aligned_cols=191 Identities=18% Similarity=0.280 Sum_probs=158.8
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEec--CCeEEEEE
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--PPSLCIVT 368 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~~~lV~ 368 (492)
+|++.+.||+|+||.||++.+ .++.||+|++..........+.+..|+.++++++|+||+++++++.. ....|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 467889999999999999987 46789999998766666667789999999999999999999998764 45689999
Q ss_pred eccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH-----HCCceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 369 EFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLH-----QNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~---~~~l~~~~~~~i~~qI~~gL~yLH-----~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
||+++++|.+++... ...+++..++.++.||+.||.||| +.+|+|+||||+||+++.++.+|++|||.+...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999764 457899999999999999999999 889999999999999999999999999998754
Q ss_pred e-------eeeCCCceeecceeccccccCccceeee---ecccccCCCCCCCc
Q 011158 441 I-------LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDAP 483 (492)
Q Consensus 441 ~-------~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~aP 483 (492)
. ...++..|++||+.....+....|+|++ +.....|..+|...
T Consensus 161 ~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 213 (265)
T cd08217 161 GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR 213 (265)
T ss_pred cCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc
Confidence 2 2345667888888877777777888884 22334566665543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=223.04 Aligned_cols=180 Identities=24% Similarity=0.392 Sum_probs=150.9
Q ss_pred eCCCCceeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~~-------g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 361 (492)
++.++|++.+.||+|+||.||++.+. +..||+|++.... .......+.+|+.++++++||||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 45678899999999999999999863 4679999987542 344557799999999999999999999999998
Q ss_pred CeEEEEEeccCCCCHHHHHHhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCC
Q 011158 362 PSLCIVTEFMSGGSVYDYLHKLK---------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 420 (492)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~L~~~~---------------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~N 420 (492)
...|+||||+++|+|.+++.... ..+++..++.++.|++.||.|||+++++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 99999999999999999997532 246788899999999999999999999999999999
Q ss_pred EEEccCCCeEEEEEeecceeee---------eeCCCceeecceeccccccCccceeee
Q 011158 421 LLMDENEVSLLLSLCLFTVSIL---------FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 421 ILld~~~~~kl~DFGla~~~~~---------~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
||++.++.++++|||.+..... ...+..|++||+.....+....|+|++
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 218 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAY 218 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHH
Confidence 9999999999999998764311 112334788887776677777888883
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-25 Score=220.11 Aligned_cols=188 Identities=20% Similarity=0.220 Sum_probs=152.1
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
.+|++.+.||+|+||.||+|.. +++.||+|++..... ......+.+|+.++++++|+||+++++++......|+|||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 5688899999999999999987 478899999875432 2223467789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee-------
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL------- 442 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~------- 442 (492)
|+ .++|.+++......+++..+..++.||+.||.|||+++|+||||||+|||++.++.++|+|||.++....
T Consensus 84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 162 (291)
T cd07870 84 YM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSS 162 (291)
T ss_pred cc-cCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCC
Confidence 99 5788888876556788899999999999999999999999999999999999999999999998865321
Q ss_pred eeCCCceeecceecc-ccccCccceeee---ecccccCCCCCC
Q 011158 443 FCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 443 ~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
..++..|++||+... ..+...+|+|++ +.....|.+.|.
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~ 205 (291)
T cd07870 163 EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFP 205 (291)
T ss_pred ccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 224556777776643 334555788884 334455666654
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.4e-25 Score=216.48 Aligned_cols=179 Identities=21% Similarity=0.340 Sum_probs=148.2
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEE
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 365 (492)
+++.+.+.....||+|+||.||+|++. +..||+|.+... .....+.+.+|+.++++++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC--CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 445555555678999999999999874 567999988754 2344578899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcc-CCCeEEEEEeecceee-
Q 011158 366 IVTEFMSGGSVYDYLHKLKGVF--KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEVSLLLSLCLFTVSI- 441 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~~~l--~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~-~~~~kl~DFGla~~~~- 441 (492)
+|+||+++++|.+++......+ ++..+..++.||+.||.|||+++|+||||||+||+++. ++.++|+|||.+....
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 9999999999999998754555 88889999999999999999999999999999999986 6789999999986432
Q ss_pred ------eeeCCCceeecceeccc--cccCccceee
Q 011158 442 ------LFCGKGRELISLFLGND--VLLQFGTYWI 468 (492)
Q Consensus 442 ------~~~g~~~~~ape~~~~e--~~~~~~d~W~ 468 (492)
...++..|++||+.... .+...+|+|+
T Consensus 162 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~s 196 (268)
T cd06624 162 INPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWS 196 (268)
T ss_pred CCCccccCCCCccccChhhhccccccCCchhhhHH
Confidence 23456678888876442 3566678887
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=220.86 Aligned_cols=180 Identities=24% Similarity=0.403 Sum_probs=149.0
Q ss_pred eCCCCceeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~~g-------~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 361 (492)
+..+.|++.+.||+|+||.||+|.+.+ ..||+|.+.... .......|.+|+.++++++|+||+++++++...
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 344678899999999999999998843 568999876432 233456789999999999999999999999998
Q ss_pred CeEEEEEeccCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCC---CeEEE
Q 011158 362 PSLCIVTEFMSGGSVYDYLHKLK------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE---VSLLL 432 (492)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~L~~~~------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~---~~kl~ 432 (492)
...++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++++||||||+|||++.++ .+|++
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 89999999999999999997643 2589999999999999999999999999999999999998765 58999
Q ss_pred EEeecceeee----e-----eCCCceeecceeccccccCccceeee
Q 011158 433 SLCLFTVSIL----F-----CGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 433 DFGla~~~~~----~-----~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
|||.++.... . .....|++||+.....++..+|+|++
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl 207 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSF 207 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHH
Confidence 9999865311 0 11235788888776677788899984
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-25 Score=223.04 Aligned_cols=190 Identities=21% Similarity=0.290 Sum_probs=156.1
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCh-HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
++|++.+.||+|+||.||+|... ++.||+|.+....... ...+.+..|+.++++++|+||+++++.+......|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999884 6889999998654432 35567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee-----
Q 011158 369 EFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL----- 442 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~----- 442 (492)
||+.+++|.+++.+.. ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++++|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 9999999999997643 5789999999999999999999999999999999999999999999999998764311
Q ss_pred -------------------------------eeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 443 -------------------------------FCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 443 -------------------------------~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
..++..|++||+.....+....|+|++ +....+|..+|.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~ 233 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFK 233 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence 134455777777766666666777773 223334555543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-25 Score=219.17 Aligned_cols=180 Identities=22% Similarity=0.336 Sum_probs=149.2
Q ss_pred eCCCCceeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~~-------g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 361 (492)
+..++|+..+.||+|+||.||+|+.. .+.|++|.+.... .......+.+|+.++++++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 80 (275)
T cd05046 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA 80 (275)
T ss_pred CChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence 34567888999999999999999863 2569999886532 233567899999999999999999999999998
Q ss_pred CeEEEEEeccCCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEE
Q 011158 362 PSLCIVTEFMSGGSVYDYLHKLK--------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLS 433 (492)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~L~~~~--------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~D 433 (492)
...|+||||+++|+|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.++++|
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcc
Confidence 89999999999999999997643 1589999999999999999999999999999999999999999999999
Q ss_pred Eeecceee--------eeeCCCceeecceeccccccCccceeee
Q 011158 434 LCLFTVSI--------LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 434 FGla~~~~--------~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
||.+.... ...++..|++||+.........+|+|++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl 204 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSF 204 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHH
Confidence 99875431 1122334777887655556666788884
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.1e-25 Score=219.55 Aligned_cols=180 Identities=19% Similarity=0.329 Sum_probs=152.6
Q ss_pred eCCCCceeeeeeeecCceEEEEEEEC------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEec-C
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTYC------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK-P 361 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~~------g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~ 361 (492)
++.++|++.+.||+|+||.||+|.+. +..|++|+++.. ........+.+|+.++++++|+||+++++++.. .
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 56778999999999999999999874 367999988743 344556778999999999999999999998776 4
Q ss_pred CeEEEEEeccCCCCHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEE
Q 011158 362 PSLCIVTEFMSGGSVYDYLHKLK-------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSL 434 (492)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~L~~~~-------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DF 434 (492)
...++++||+++|+|.+++.... ..+++..++.++.||+.||.|||+++++||||||+|||++.++.+|++||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCC
Confidence 67899999999999999997642 35899999999999999999999999999999999999999999999999
Q ss_pred eecceee---------eeeCCCceeecceeccccccCccceeee
Q 011158 435 CLFTVSI---------LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 435 Gla~~~~---------~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
|+++... ...++..|++||+.....+...+|+|++
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~sl 205 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSF 205 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHh
Confidence 9986431 1223445889998877777888899984
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-25 Score=217.67 Aligned_cols=188 Identities=22% Similarity=0.383 Sum_probs=154.8
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC----hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEE
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN----SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 366 (492)
+|+..+.||+|+||.||++.. +++.||+|+++..... ....+.+.+|+.++++++|+||+++++++...+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 366778999999999999987 5788999999754321 2245778999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCC-CeEEEEEeecceeee---
Q 011158 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-VSLLLSLCLFTVSIL--- 442 (492)
Q Consensus 367 V~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~-~~kl~DFGla~~~~~--- 442 (492)
||||+++++|.+++.+ .+.+++..++.++.||+.||.|||++|++|+||||+||+++.++ .+|++|||.+.....
T Consensus 81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 81 FVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159 (268)
T ss_pred EEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence 9999999999999976 45789999999999999999999999999999999999998775 589999999865321
Q ss_pred --------eeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 443 --------FCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 443 --------~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
..++..|++||+.....+....|+|++ +.....|..+|.
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 209 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN 209 (268)
T ss_pred cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCC
Confidence 234557888988877777777888884 222334554443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.4e-25 Score=215.01 Aligned_cols=188 Identities=21% Similarity=0.376 Sum_probs=156.9
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEec
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 370 (492)
+|+..+.||+|+||.||+|.+ .++.|++|+++.........+.+.+|+.++++++|+||+++++.+...+.+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 477889999999999999987 468899999987655555678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee--------
Q 011158 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL-------- 442 (492)
Q Consensus 371 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~-------- 442 (492)
+++++|.+++.. ...+++..+..++.|++.||.|||+++|+|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 81 CSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred CCCCcHHHHHhh-cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence 999999999976 34588999999999999999999999999999999999999999999999999865421
Q ss_pred ---eeCCCceeecceecccc---ccCccceeee---ecccccCCCCCC
Q 011158 443 ---FCGKGRELISLFLGNDV---LLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 443 ---~~g~~~~~ape~~~~e~---~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
..++..|++||+..... .....|+|++ +.....|..+|.
T Consensus 160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~ 207 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWS 207 (264)
T ss_pred ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCcc
Confidence 23455678888776544 5666788873 222334555553
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.6e-25 Score=213.49 Aligned_cols=177 Identities=19% Similarity=0.326 Sum_probs=153.8
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEec
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 370 (492)
+|++.++||+|+||.||+++. .++.||+|.+...........++.+|+.++++++|+||+++++++...+..|+||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 478889999999999999987 568899999976544555567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------e
Q 011158 371 MSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-------L 442 (492)
Q Consensus 371 ~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-------~ 442 (492)
+++++|.+++.... ..+++.+++.++.|++.||.|||+++++|+||+|+|||++.++.++++|||.+.... .
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART 160 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhh
Confidence 99999999997643 368899999999999999999999999999999999999999999999999986542 1
Q ss_pred eeCCCceeecceeccccccCccceeee
Q 011158 443 FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 443 ~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
..++..|++||+.........+|.|++
T Consensus 161 ~~~~~~~~~pe~~~~~~~~~~~Dv~sl 187 (256)
T cd08218 161 CIGTPYYLSPEICENRPYNNKSDIWAL 187 (256)
T ss_pred ccCCccccCHHHhCCCCCCCccchhHH
Confidence 235567888998877667777888883
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=221.46 Aligned_cols=189 Identities=20% Similarity=0.259 Sum_probs=154.5
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
++|++.++||+|+||.||+|.+ .++.||+|++..........+.+.+|+.+++.++|+||+++++++......|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 3678889999999999999998 46889999987654334445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------e
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-------L 442 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-------~ 442 (492)
|+++++|..+... ...+++..++.++.||+.||.|||+++|+|+||||+||++++++.++++|||++.... .
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (286)
T cd07846 81 FVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD 159 (286)
T ss_pred cCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCc
Confidence 9999988887755 4458999999999999999999999999999999999999999999999999986532 1
Q ss_pred eeCCCceeecceecc-ccccCccceeee---ecccccCCCCCC
Q 011158 443 FCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 443 ~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
..++..|++||+... ..+...+|+|++ +....+|.+.|.
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~ 202 (286)
T cd07846 160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFP 202 (286)
T ss_pred ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCC
Confidence 234456777876643 334555788883 334556666553
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-25 Score=217.57 Aligned_cols=183 Identities=21% Similarity=0.295 Sum_probs=143.1
Q ss_pred eeeeecCceEEEEEEEC----CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEeccCC
Q 011158 298 SKVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG 373 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~----g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~g 373 (492)
+.||+|+||.||+|.+. +..+|+|.++.... ......+.+|+.++++++||||+++++++......++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 36899999999999863 24699998876432 33345788999999999999999999999998999999999999
Q ss_pred CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee--------
Q 011158 374 GSVYDYLHKLK----GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-------- 441 (492)
Q Consensus 374 gsL~~~L~~~~----~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-------- 441 (492)
|+|.+++.... ...++..++.++.|++.||.|||+++++||||||+||+++.++.+|++|||.+....
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP 159 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecC
Confidence 99999997532 245677888999999999999999999999999999999999999999999986431
Q ss_pred -eeeCCCceeecceeccc-------cccCccceeee----ecccccCCCCCC
Q 011158 442 -LFCGKGRELISLFLGND-------VLLQFGTYWII----FRRSSCDKKNSD 481 (492)
Q Consensus 442 -~~~g~~~~~ape~~~~e-------~~~~~~d~W~l----~~~~~~gt~~Y~ 481 (492)
...++..|++||+.... .+....|+|++ +.....|.++|.
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~ 211 (269)
T cd05087 160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYR 211 (269)
T ss_pred CCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCC
Confidence 11233457777766431 13446788884 222223665553
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.1e-25 Score=218.82 Aligned_cols=182 Identities=27% Similarity=0.422 Sum_probs=147.4
Q ss_pred eeeeecCceEEEEEEEC--Cc--eEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCeEEEEEeccC
Q 011158 298 SKVASGSYGDLYRGTYC--SQ--DVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMS 372 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~--g~--~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~Ey~~ 372 (492)
+.||+|+||.||+|++. +. .+++|.++.. ........+.+|+.++.++ +||||+++++++......|+||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 36899999999999874 33 4788888742 2344556889999999999 79999999999999999999999999
Q ss_pred CCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeec
Q 011158 373 GGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLF 437 (492)
Q Consensus 373 ggsL~~~L~~~~---------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla 437 (492)
+|+|.+++.+.. ..+++.+++.++.|++.||+|||+++++||||||+|||++.++.+|++|||++
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~ 159 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 159 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence 999999997532 24789999999999999999999999999999999999999999999999998
Q ss_pred ceeee------eeCCCceeecceeccccccCccceeee----ecccccCCCCC
Q 011158 438 TVSIL------FCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNS 480 (492)
Q Consensus 438 ~~~~~------~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y 480 (492)
..... ...+..|++||+.....+...+|+|++ +....+|..+|
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf 212 (270)
T cd05047 160 RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 212 (270)
T ss_pred cccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCc
Confidence 53321 112234888888877777778899984 22333466555
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.7e-25 Score=213.90 Aligned_cols=177 Identities=19% Similarity=0.317 Sum_probs=152.6
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEec
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 370 (492)
+|++.+.||+|+||.||++.. +++.+|+|++.....+......+.+|+.++++++|+||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 477889999999999999987 568899999987655566678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCC-CeEEEEEeecceee------e
Q 011158 371 MSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-VSLLLSLCLFTVSI------L 442 (492)
Q Consensus 371 ~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~-~~kl~DFGla~~~~------~ 442 (492)
+++++|.+++.... ..+++..+..++.|++.||.|||+++|+|+||||+||+++.++ .+|++|||.+.... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT 160 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccccc
Confidence 99999999997743 3589999999999999999999999999999999999998654 67999999986542 2
Q ss_pred eeCCCceeecceeccccccCccceeee
Q 011158 443 FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 443 ~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
..++..|++||+.....+....|+|++
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Dv~sl 187 (256)
T cd08220 161 VVGTPCYISPELCEGKPYNQKSDIWAL 187 (256)
T ss_pred cccCCcccCchhccCCCCCcccchHHH
Confidence 345667888888877666777888874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.5e-27 Score=243.75 Aligned_cols=175 Identities=23% Similarity=0.353 Sum_probs=153.2
Q ss_pred CceeeeeeeecCceEEEEEEECC--ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEec
Q 011158 293 HLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~~g--~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 370 (492)
.|.++..||.|+||.||++.... -..|.|++... +....++|+-||.||..+.||+||++++.|...+.+||+.||
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 45667899999999999998754 34677887643 456678999999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee-------eee
Q 011158 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS-------ILF 443 (492)
Q Consensus 371 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~-------~~~ 443 (492)
|.||-....+-.....|++.++..+++|++.||+|||+++|||||||+.|||++-+|.++++|||.+... ..+
T Consensus 111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsF 190 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSF 190 (1187)
T ss_pred cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhccc
Confidence 9999999999887889999999999999999999999999999999999999999999999999997543 258
Q ss_pred eCCCceeecceeccc-----cccCccceeee
Q 011158 444 CGKGRELISLFLGND-----VLLQFGTYWII 469 (492)
Q Consensus 444 ~g~~~~~ape~~~~e-----~~~~~~d~W~l 469 (492)
.|++.||+||++.-+ .|...+|+|++
T Consensus 191 IGTPYWMAPEVvmCET~KD~PYDykaDiWSl 221 (1187)
T KOG0579|consen 191 IGTPYWMAPEVVMCETFKDQPYDYKADIWSL 221 (1187)
T ss_pred cCCcccccchheeeccccCCCchhhhhHHhh
Confidence 899999999977554 35556678884
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=218.85 Aligned_cols=178 Identities=18% Similarity=0.334 Sum_probs=151.5
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
.+|++.+.||+|+||.||++.+ .++.+|||.+.... .+.....++.+|+.+++.++|+||+++++++...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 3577789999999999999986 57889999886532 23345568899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee----
Q 011158 369 EFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI---- 441 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~---- 441 (492)
||+++++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+||+++.++.++++|||.+....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 999999999998642 3468999999999999999999999999999999999999999999999999876432
Q ss_pred ---eeeCCCceeecceeccccccCccceeee
Q 011158 442 ---LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 442 ---~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
...++..|++||+.....+...+|+|++
T Consensus 162 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~sl 192 (267)
T cd08229 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSL 192 (267)
T ss_pred ccccccCCcCccCHHHhcCCCccchhhHHHH
Confidence 2345667888888766666667888883
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-25 Score=220.33 Aligned_cols=188 Identities=19% Similarity=0.285 Sum_probs=152.8
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
++|++.+.||+|+||.||++.+. ++.||+|.++.. .+......+.+|+.++++++|+||+++++.+...+.+|+|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 35788899999999999999884 788999998754 234445789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEccCCCeEEEEEeecceee-----
Q 011158 370 FMSGGSVYDYLHKL--KGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI----- 441 (492)
Q Consensus 370 y~~ggsL~~~L~~~--~~~l~~~~~~~i~~qI~~gL~yLH~-~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~----- 441 (492)
|+++++|.+++... ...+++..+..++.|++.||.|||. .+|+||||||+||+++.++.+|++|||.+....
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAK 159 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCccc
Confidence 99999999998763 2378999999999999999999997 599999999999999999999999999886431
Q ss_pred eeeCCCceeecceeccc------cccCccceeee---ecccccCCCCC
Q 011158 442 LFCGKGRELISLFLGND------VLLQFGTYWII---FRRSSCDKKNS 480 (492)
Q Consensus 442 ~~~g~~~~~ape~~~~e------~~~~~~d~W~l---~~~~~~gt~~Y 480 (492)
...++..|++||..... .+...+|+|++ +.....|..+|
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf 207 (286)
T cd06622 160 TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPY 207 (286)
T ss_pred cCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCC
Confidence 22345567778766332 23556788883 22333455554
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-25 Score=220.42 Aligned_cols=176 Identities=21% Similarity=0.278 Sum_probs=146.7
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC---hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEE
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN---SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 367 (492)
+|++.+.||+|+||.||+|.+ .++.||||.++..... ......+..|+.++++++|+||+++++++...+.+++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 367788999999999999987 4688999999865433 33445678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee-----
Q 011158 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL----- 442 (492)
Q Consensus 368 ~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~----- 442 (492)
|||+ +|+|.+++......+++..++.++.||++||.|||++||+|+||||+|||++.++.++|+|||.+.....
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM 159 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence 9999 9999999977444799999999999999999999999999999999999999999999999999865422
Q ss_pred --eeCCCceeecceec-cccccCccceeee
Q 011158 443 --FCGKGRELISLFLG-NDVLLQFGTYWII 469 (492)
Q Consensus 443 --~~g~~~~~ape~~~-~e~~~~~~d~W~l 469 (492)
..++..|++||+.. ...+....|+|++
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 189 (298)
T cd07841 160 THQVVTRWYRAPELLFGARHYGVGVDMWSV 189 (298)
T ss_pred cccccceeeeCHHHHhCCCCCCcHHHHHHH
Confidence 12234467777553 2344556788874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=221.14 Aligned_cols=191 Identities=24% Similarity=0.339 Sum_probs=160.0
Q ss_pred eCCCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEE
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 366 (492)
+..++|++.++||+|+||.||++.+. ++.||+|++.... .....+.+.+|+.+++.++||||+++++++...+.+|+
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 34567889999999999999999884 7889999987542 24456789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEccCCCeEEEEEeecceee----
Q 011158 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI---- 441 (492)
Q Consensus 367 V~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~-~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~---- 441 (492)
||||+++++|.+++.+ .+.+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++++|||+++...
T Consensus 81 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~ 159 (284)
T cd06620 81 CMEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA 159 (284)
T ss_pred EEecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhcc
Confidence 9999999999999876 4578999999999999999999997 589999999999999999999999999876431
Q ss_pred -eeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 442 -LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 -~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||+.....+....|+|++ +.....|..+|.
T Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~ 203 (284)
T cd06620 160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFA 203 (284)
T ss_pred CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCc
Confidence 2356778889998877677777888884 223334555554
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.3e-25 Score=216.00 Aligned_cols=171 Identities=23% Similarity=0.353 Sum_probs=141.4
Q ss_pred eeeeecCceEEEEEEEC-----CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEe-cCCeEEEEEecc
Q 011158 298 SKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT-KPPSLCIVTEFM 371 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~-----g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~-~~~~~~lV~Ey~ 371 (492)
+.||+|+||.||+|.+. +..||+|.+... ........+.+|+.+++.++||||+++++++. .++..++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 36899999999999863 246999988542 23344578889999999999999999999876 455689999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee----------
Q 011158 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI---------- 441 (492)
Q Consensus 372 ~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~---------- 441 (492)
.+|+|.+++.+....+++..++.++.||+.||.|||+++|+||||||+|||++.++.+|++|||.++...
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 159 (262)
T cd05058 80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH 159 (262)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeeccc
Confidence 9999999998765667888889999999999999999999999999999999999999999999986431
Q ss_pred -eeeCCCceeecceeccccccCccceeee
Q 011158 442 -LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 442 -~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
...++..|++||+.....+...+|+|++
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 188 (262)
T cd05058 160 TGAKLPVKWMALESLQTQKFTTKSDVWSF 188 (262)
T ss_pred ccCcCCccccChhHhccCccchHHHHHHH
Confidence 1122345888887776667777888884
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.4e-25 Score=213.90 Aligned_cols=171 Identities=29% Similarity=0.482 Sum_probs=146.2
Q ss_pred eeeeecCceEEEEEEEC-CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEeccCCCCH
Q 011158 298 SKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ggsL 376 (492)
++||+|+||.||++.+. ++.||+|+++..... .....+.+|+.++++++|+||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 46899999999999875 788999998765432 4557899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee---e------eCCC
Q 011158 377 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL---F------CGKG 447 (492)
Q Consensus 377 ~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~---~------~g~~ 447 (492)
.+++.+....+++..++.++.|++.||.|||+++|+||||||+|||++.++.++++|||.+..... . ....
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 159 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPI 159 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCccee
Confidence 999977566789999999999999999999999999999999999999999999999999864321 1 1123
Q ss_pred ceeecceeccccccCccceeee
Q 011158 448 RELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 448 ~~~ape~~~~e~~~~~~d~W~l 469 (492)
.|++||+.....+...+|+|++
T Consensus 160 ~y~~PE~~~~~~~~~~~Di~sl 181 (251)
T cd05041 160 KWTAPEALNYGRYTSESDVWSY 181 (251)
T ss_pred ccCChHhhccCCCCcchhHHHH
Confidence 4778887766666777888884
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.6e-25 Score=218.52 Aligned_cols=188 Identities=22% Similarity=0.258 Sum_probs=155.7
Q ss_pred CceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEec
Q 011158 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 370 (492)
+|++.++||+|+||.||+|.+. ++.||+|+++...........+.+|+.++++++|+||+++++++...+..++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 5888999999999999999884 67899999876544455567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee--------
Q 011158 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL-------- 442 (492)
Q Consensus 371 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~-------- 442 (492)
++++.+..++.+ ...+++..+..++.||+.||.|||+++|+||||||+||+++.++.+|++|||.+.....
T Consensus 82 ~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (288)
T cd07833 82 VERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD 160 (288)
T ss_pred CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccC
Confidence 987666655544 45689999999999999999999999999999999999999999999999999865432
Q ss_pred eeCCCceeecceeccc-cccCccceeee---ecccccCCCCCC
Q 011158 443 FCGKGRELISLFLGND-VLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 443 ~~g~~~~~ape~~~~e-~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
..++..|++||+.... .+...+|+|++ +.....|.+.|.
T Consensus 161 ~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~ 203 (288)
T cd07833 161 YVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFP 203 (288)
T ss_pred cccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 2345567888877666 66777888884 223345655553
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.9e-25 Score=214.40 Aligned_cols=182 Identities=25% Similarity=0.388 Sum_probs=149.1
Q ss_pred eeeeecCceEEEEEEEC--C---ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEeccC
Q 011158 298 SKVASGSYGDLYRGTYC--S---QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS 372 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~--g---~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 372 (492)
++||+|+||.||+|++. + ..+|+|.+...... ...+++.+|+.+++++.|+||+++++++.. ...++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCC
Confidence 47899999999999873 2 56999999865433 455789999999999999999999998764 46899999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeeeee--------
Q 011158 373 GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSILFC-------- 444 (492)
Q Consensus 373 ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~~~-------- 444 (492)
+|+|.+++.+. ..+++..++.++.|++.||.|||.++|+|+||||+|||++.++.+|++|||.++......
T Consensus 79 ~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 79 LGPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 99999999874 478999999999999999999999999999999999999999999999999986542110
Q ss_pred --CCCceeecceeccccccCccceeee----ecccccCCCCCCC
Q 011158 445 --GKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSDA 482 (492)
Q Consensus 445 --g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~a 482 (492)
++..|++||......+...+|+|++ +.....|.++|..
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~ 201 (257)
T cd05060 158 GRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGE 201 (257)
T ss_pred ccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCccc
Confidence 1135788888777777778899984 2233346776643
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=215.56 Aligned_cols=187 Identities=21% Similarity=0.282 Sum_probs=148.0
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHH-HHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI-MRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~i-l~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
++|++.+.||+|+||.||++.+ +++.||+|+++....... ..++..|+.+ ++.++||||+++++++...+..|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 3688889999999999999988 478899999976533332 3456666665 66678999999999999999999999
Q ss_pred eccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEEccCCCeEEEEEeecceee---
Q 011158 369 EFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVSLLLSLCLFTVSI--- 441 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~-~IiHrDLKp~NILld~~~~~kl~DFGla~~~~--- 441 (492)
||++ |+|.+++... ...+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||.++...
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 158 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV 158 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9995 7898888652 34689999999999999999999997 99999999999999999999999999987542
Q ss_pred ---eeeCCCceeecceecc----ccccCccceeee---ecccccCCCCC
Q 011158 442 ---LFCGKGRELISLFLGN----DVLLQFGTYWII---FRRSSCDKKNS 480 (492)
Q Consensus 442 ---~~~g~~~~~ape~~~~----e~~~~~~d~W~l---~~~~~~gt~~Y 480 (492)
...++..|++||+..+ ..+...+|+|++ +.....|..+|
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 207 (283)
T cd06617 159 AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPY 207 (283)
T ss_pred ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCC
Confidence 1345566888887654 234556788884 22333455444
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.9e-25 Score=220.65 Aligned_cols=188 Identities=19% Similarity=0.314 Sum_probs=157.6
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
.+|++.+.||.|+||.||+|.+ .++.|++|.+..... .....+.+|+.+++.++|+||+++++++...+.+|+|+|
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 5688999999999999999986 578899999875432 234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------e
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-------L 442 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-------~ 442 (492)
|+++++|.+++.. ..+++.++..++.|++.||.|||++||+|+||||+||+++.++.+|++|||++.... .
T Consensus 97 ~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 174 (296)
T cd06655 97 YLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST 174 (296)
T ss_pred ecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCC
Confidence 9999999999965 468999999999999999999999999999999999999999999999999876432 2
Q ss_pred eeCCCceeecceeccccccCccceeee---ecccccCCCCCCCc
Q 011158 443 FCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDAP 483 (492)
Q Consensus 443 ~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~aP 483 (492)
..++..|++||+.....+....|+|++ +.....|.++|...
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~ 218 (296)
T cd06655 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (296)
T ss_pred cCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 345567888998877777777888883 22333455555443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-25 Score=214.73 Aligned_cols=174 Identities=26% Similarity=0.376 Sum_probs=153.2
Q ss_pred CCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
.++|++.++||+|+||.||+|... ++.+++|.++... ....+.+|+.++++++|+||+++++++.....+|+++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 457888899999999999999884 5789999987532 1578999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------- 441 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------- 441 (492)
||+++++|.+++......+++..+..++.|++.||.|||+.+|+|+||+|+||+++.++.++++|||++....
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRN 157 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccccc
Confidence 9999999999998766789999999999999999999999999999999999999999999999999986532
Q ss_pred eeeCCCceeecceeccccccCccceee
Q 011158 442 LFCGKGRELISLFLGNDVLLQFGTYWI 468 (492)
Q Consensus 442 ~~~g~~~~~ape~~~~e~~~~~~d~W~ 468 (492)
...++..|++||+.....+...+|+|+
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Di~s 184 (256)
T cd06612 158 TVIGTPFWMAPEVIQEIGYNNKADIWS 184 (256)
T ss_pred cccCCccccCHHHHhcCCCCchhhHHH
Confidence 223556788898877777777788887
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=240.99 Aligned_cols=148 Identities=27% Similarity=0.423 Sum_probs=134.6
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
++|.+.++||+|+||.||+|.+. ++.||||+++... ........+..|+.+++.++|+||+++++++.....+||||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57889999999999999999985 7889999997543 23445577889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
||+.+++|.+++.. .+.+++..++.|+.||+.||.|||.++||||||||+||||+.++.+||+|||+++..
T Consensus 84 Ey~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~ 154 (669)
T cd05610 84 EYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154 (669)
T ss_pred eCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCccc
Confidence 99999999999976 356899999999999999999999999999999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.1e-25 Score=212.80 Aligned_cols=175 Identities=27% Similarity=0.456 Sum_probs=149.2
Q ss_pred ceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 294 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI---NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 294 ~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
|+..+.||+|+||.||+|.. .++.|++|.+..... .....+.+.+|+.++++++|+||+++++++.....+|++|
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 56678999999999999987 468899999865432 2345678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee------e
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------L 442 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------~ 442 (492)
||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+|+|+||||+||+++.++.+||+|||.+.... .
T Consensus 82 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~ 160 (258)
T cd06632 82 ELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS 160 (258)
T ss_pred EecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccccccc
Confidence 999999999999773 468999999999999999999999999999999999999999999999999986542 2
Q ss_pred eeCCCceeecceecccc-ccCccceeee
Q 011158 443 FCGKGRELISLFLGNDV-LLQFGTYWII 469 (492)
Q Consensus 443 ~~g~~~~~ape~~~~e~-~~~~~d~W~l 469 (492)
..++..|++||+..... +....|+|++
T Consensus 161 ~~~~~~y~~pe~~~~~~~~~~~~D~~sl 188 (258)
T cd06632 161 FKGSPYWMAPEVIAQQGGYGLAADIWSL 188 (258)
T ss_pred cCCCcceeCHHHhcCCCCCCchhhhHHH
Confidence 33556678888766555 6666788873
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.2e-25 Score=216.83 Aligned_cols=188 Identities=24% Similarity=0.346 Sum_probs=152.4
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC--------hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN--------SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~--------~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 362 (492)
+|...+.||+|+||.||+|.. +++.||+|.++..... ....+.+.+|+.++++++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 366778999999999999976 5788999988643211 112356888999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee
Q 011158 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL 442 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~ 442 (492)
..++||||+++++|.+++.+. +.+++..+..++.||+.||.|||+++++||||||+||+++.++.++++|||+++....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 160 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDD 160 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence 999999999999999999874 6789999999999999999999999999999999999999999999999999875421
Q ss_pred ---------eeCCCceeecceecccc--ccCccceeee---ecccccCCCCCC
Q 011158 443 ---------FCGKGRELISLFLGNDV--LLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 443 ---------~~g~~~~~ape~~~~e~--~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
..++..|++||...... +....|.|++ +.....|..+|.
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 213 (272)
T cd06629 161 IYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS 213 (272)
T ss_pred cccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCc
Confidence 23455678888765543 5666788883 222334555554
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-25 Score=225.40 Aligned_cols=140 Identities=31% Similarity=0.620 Sum_probs=123.1
Q ss_pred CCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHh--cCCCceeeEEEEEecCC----eEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK--VRHKNVVQFIGACTKPP----SLC 365 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~g~~~~~~----~~~ 365 (492)
..+.+.+.||+|.||.||+|.|.|+.||||++.... .+.+.+|.+|.+. |+|+||+.|++.-.... .+|
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd-----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD-----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred heeEEEEEecCccccceeeccccCCceEEEEecccc-----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 567888999999999999999999999999997531 2456677777665 59999999998865443 589
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CceecCCCCCCEEEccCCCeEEEEEeec
Q 011158 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN--------NIIHRDLKAANLLMDENEVSLLLSLCLF 437 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~--------~IiHrDLKp~NILld~~~~~kl~DFGla 437 (492)
||++|-+.|||+|||.+ ..++....++++..++.||.|||.. .|.|||||+.|||+..++.+.|+|+|+|
T Consensus 286 LvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA 363 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 363 (513)
T ss_pred EeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence 99999999999999987 6789999999999999999999963 4999999999999999999999999998
Q ss_pred c
Q 011158 438 T 438 (492)
Q Consensus 438 ~ 438 (492)
-
T Consensus 364 v 364 (513)
T KOG2052|consen 364 V 364 (513)
T ss_pred E
Confidence 4
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-25 Score=221.99 Aligned_cols=179 Identities=26% Similarity=0.438 Sum_probs=148.3
Q ss_pred eCCCCceeeeeeeecCceEEEEEEE--CCc----eEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQ----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~--~g~----~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 362 (492)
+...+|+..+.||+|+||.||+|.+ .+. .||+|++.... ......++.+|+.++++++||||+++++++...
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~- 81 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP- 81 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence 3456788889999999999999987 343 47899887543 233445788999999999999999999998764
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee
Q 011158 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL 442 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~ 442 (492)
..++++||+++|+|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||.++....
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence 47899999999999999987666789999999999999999999999999999999999999999999999999875321
Q ss_pred ---------eeCCCceeecceeccccccCccceeee
Q 011158 443 ---------FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 443 ---------~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
..++..|++||+.....+...+|+|++
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Diwsl 197 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSY 197 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHH
Confidence 112335778887766666777888884
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=210.64 Aligned_cols=191 Identities=20% Similarity=0.345 Sum_probs=162.3
Q ss_pred CceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEec
Q 011158 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 370 (492)
+|++.+.||.|+||.||++.+. ++.|++|++............+.+|+.++++++|+|++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999985 78899999987665556677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee------
Q 011158 371 MSGGSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------ 441 (492)
Q Consensus 371 ~~ggsL~~~L~~~~---~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------ 441 (492)
+++++|.+++.+.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++++|||.+....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA 160 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCccee
Confidence 99999999998753 679999999999999999999999999999999999999999999999999986532
Q ss_pred -eeeCCCceeecceeccccccCccceeee---ecccccCCCCCCCc
Q 011158 442 -LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDAP 483 (492)
Q Consensus 442 -~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~aP 483 (492)
...++..|++||......+....|+|++ +.....|..+|...
T Consensus 161 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 206 (258)
T cd08215 161 KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE 206 (258)
T ss_pred cceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Confidence 2345566888888777777777888883 22334566555443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6e-25 Score=221.23 Aligned_cols=192 Identities=20% Similarity=0.282 Sum_probs=154.6
Q ss_pred CCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--CeEE
Q 011158 290 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLC 365 (492)
Q Consensus 290 ~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~ 365 (492)
..++|++.+.||+|+||.||+|.+ +++.||+|+++...........+.+|+.++++++|+||+++++++... +.++
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 346788999999999999999988 478899999976543333334567899999999999999999998754 5689
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeeee--
Q 011158 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSILF-- 443 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~~-- 443 (492)
+||||+. ++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||.+......
T Consensus 85 lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 163 (309)
T cd07845 85 LVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK 163 (309)
T ss_pred EEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccC
Confidence 9999995 6899999876677999999999999999999999999999999999999999999999999998754321
Q ss_pred -----eCCCceeecceec-cccccCccceeee---ecccccCCCCCCC
Q 011158 444 -----CGKGRELISLFLG-NDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 444 -----~g~~~~~ape~~~-~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
.++..|++||... ...+....|+|++ +.....|.+.|.+
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~ 211 (309)
T cd07845 164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPG 211 (309)
T ss_pred CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 2234577888654 3445667788884 3344456666643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.9e-25 Score=219.84 Aligned_cols=189 Identities=21% Similarity=0.262 Sum_probs=152.8
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--CeEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLCIV 367 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~lV 367 (492)
++|++.+.||+|+||.||+|++. ++.+|+|.++...........+.+|+.++++++||||+++++++... ...|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999984 67899999986544444445678899999999999999999998877 889999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee-----
Q 011158 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL----- 442 (492)
Q Consensus 368 ~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~----- 442 (492)
|||+. ++|.+++......+++..++.++.||+.||.|||+++|+|+||||+|||++.++.++++|||.+.....
T Consensus 85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 163 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY 163 (293)
T ss_pred ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcccc
Confidence 99996 599999987556799999999999999999999999999999999999999999999999998865422
Q ss_pred --eeCCCceeecceecc-ccccCccceeee---ecccccCCCCCC
Q 011158 443 --FCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 443 --~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
..++..|++||+... .......|+|++ +.....|.+.|.
T Consensus 164 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~ 208 (293)
T cd07843 164 TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFP 208 (293)
T ss_pred ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCC
Confidence 223455777876543 334566788884 223344555554
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.2e-25 Score=216.30 Aligned_cols=187 Identities=24% Similarity=0.364 Sum_probs=158.4
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEec
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 370 (492)
+|++.+.||.|+||.||+|.+ +++.||+|++.... .......+.+|+.++++++|+||+++++++.....+|+|+||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 577788999999999999987 46889999987643 233456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------ee
Q 011158 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-------LF 443 (492)
Q Consensus 371 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-------~~ 443 (492)
+++++|.+++.. ..+++..++.++.|++.||.|||+++|+|+||||+||++++++.++++|||.++... ..
T Consensus 81 ~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (274)
T cd06609 81 CGGGSCLDLLKP--GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF 158 (274)
T ss_pred eCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccccccc
Confidence 999999999976 378999999999999999999999999999999999999999999999999986543 23
Q ss_pred eCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 444 CGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 444 ~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
.++..|++||+.....+...+|+|++ +....+|.++|..
T Consensus 159 ~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~ 200 (274)
T cd06609 159 VGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSD 200 (274)
T ss_pred cCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 44556888998877777788899884 2233456666654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.8e-25 Score=213.04 Aligned_cols=174 Identities=34% Similarity=0.544 Sum_probs=148.7
Q ss_pred eeeeeeeecCceEEEEEEECC------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 295 KFGSKVASGSYGDLYRGTYCS------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 295 ~~~~~LG~G~fG~Vy~~~~~g------~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
++.+.||.|+||.||++.+.. ..||+|+++.... ......+.+|+.+++.++|+||+++++++...+..|++|
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 567899999999999998854 7799999976432 225678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeeee----
Q 011158 369 EFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSILF---- 443 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~-l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~~---- 443 (492)
||+++++|.+++...... +++..+..++.|++.||.|||+++++|+||||+||+++.++.++++|||.+......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK 160 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccccc
Confidence 999999999999875444 899999999999999999999999999999999999999999999999998654321
Q ss_pred ----eCCCceeecceeccccccCccceeee
Q 011158 444 ----CGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 444 ----~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
.++..|++||......+...+|+|++
T Consensus 161 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~sl 190 (258)
T smart00219 161 KKGGKLPIRWMAPESLKDGKFTSKSDVWSF 190 (258)
T ss_pred cccCCCcccccChHHhccCCCCcchhHHHH
Confidence 13356777887766667777888884
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=213.39 Aligned_cols=182 Identities=21% Similarity=0.309 Sum_probs=152.5
Q ss_pred eeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEeccCCCCH
Q 011158 300 VASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376 (492)
Q Consensus 300 LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ggsL 376 (492)
||.|+||.||++++. ++.||+|++..... .....+.+.+|+.++++++|+||+++++.+.....+|+||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999986 78999999976433 234557799999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee------eeCCCcee
Q 011158 377 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL------FCGKGREL 450 (492)
Q Consensus 377 ~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~------~~g~~~~~ 450 (492)
.+++.+. ..+++..+..++.||+.||.|||+++++|+||||+||+++.++.++++|||.+..... ..++..|+
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
T cd05572 81 WTILRDR-GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYV 159 (262)
T ss_pred HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCcc
Confidence 9999773 4689999999999999999999999999999999999999999999999999875432 34566788
Q ss_pred ecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 451 ISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 451 ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
+||+.....+....|+|++ +.....|..+|..
T Consensus 160 ~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 194 (262)
T cd05572 160 APEIILNKGYDFSVDYWSLGILLYELLTGRPPFGE 194 (262)
T ss_pred ChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCC
Confidence 8887766666677788884 2233346666543
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=214.84 Aligned_cols=170 Identities=22% Similarity=0.328 Sum_probs=136.2
Q ss_pred eeeecCceEEEEEEEC-C---ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEeccCCC
Q 011158 299 KVASGSYGDLYRGTYC-S---QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG 374 (492)
Q Consensus 299 ~LG~G~fG~Vy~~~~~-g---~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~gg 374 (492)
+||+|+||.||+|... + ..+++|.++... .....+.+.+|+.+++.++||||+++++.+......|+||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 6899999999999753 2 245677665432 2344578999999999999999999999999999999999999999
Q ss_pred CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee---------e
Q 011158 375 SVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI---------L 442 (492)
Q Consensus 375 sL~~~L~~~~---~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~---------~ 442 (492)
+|.+++.+.. ..++...++.++.||+.||.|||+++|+||||||+|||++.++.++++|||++.... .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 160 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDD 160 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccC
Confidence 9999997642 345677888999999999999999999999999999999999999999999875321 1
Q ss_pred eeCCCceeecceeccc-------cccCccceeee
Q 011158 443 FCGKGRELISLFLGND-------VLLQFGTYWII 469 (492)
Q Consensus 443 ~~g~~~~~ape~~~~e-------~~~~~~d~W~l 469 (492)
..++..|++||+.... .+....|+|++
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diwsl 194 (268)
T cd05086 161 KCVPLRWLAPELVGEFHGGLITAEQTKPSNVWAL 194 (268)
T ss_pred CcCcccccCchhcccccCccccCCCCCcchhHHH
Confidence 2345567888876421 22345688873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.8e-25 Score=220.20 Aligned_cols=180 Identities=18% Similarity=0.284 Sum_probs=141.2
Q ss_pred eeeeeecCceEEEEEEEC----CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEec--CCeEEEEEec
Q 011158 297 GSKVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--PPSLCIVTEF 370 (492)
Q Consensus 297 ~~~LG~G~fG~Vy~~~~~----g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~~~lV~Ey 370 (492)
+.+||+|+||.||+|+.. +..||+|.++.... ...+.+|+.++++++||||+++++++.. ...+|+||||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 368999999999999863 36799999875432 2457789999999999999999998853 5678999999
Q ss_pred cCCCCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE----ccCCCeEEEEEeecc
Q 011158 371 MSGGSVYDYLHKL--------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM----DENEVSLLLSLCLFT 438 (492)
Q Consensus 371 ~~ggsL~~~L~~~--------~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILl----d~~~~~kl~DFGla~ 438 (492)
+ +++|.+++... ...+++..++.++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||+++
T Consensus 82 ~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 82 A-EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred e-CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 9 56888888532 1257899999999999999999999999999999999999 566789999999987
Q ss_pred eee----------eeeCCCceeecceecc-ccccCccceeee---ecccccCCCCCC
Q 011158 439 VSI----------LFCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 439 ~~~----------~~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
... ...++..|++||+... ..+...+|+|++ +.....|.+.|.
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~ 217 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcc
Confidence 532 1234566888886644 445666788884 333445666654
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-25 Score=233.65 Aligned_cols=170 Identities=23% Similarity=0.389 Sum_probs=149.3
Q ss_pred eeeeecCceEEEEEEECC--ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEeccCCCC
Q 011158 298 SKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 375 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~g--~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ggs 375 (492)
-+||+|+||+||-|++.. ..+|||-+... +....+-+..||.+.++++|+|||+++|.+..++.+-|.||-++||+
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 479999999999999854 45788887643 33444668889999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc-cCCCeEEEEEeeccee-------eeeeC
Q 011158 376 VYDYLHKLKGVF--KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD-ENEVSLLLSLCLFTVS-------ILFCG 445 (492)
Q Consensus 376 L~~~L~~~~~~l--~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld-~~~~~kl~DFGla~~~-------~~~~g 445 (492)
|.++|+..-+++ ++..+-.+.+||++||.|||.+.|||||||-+|+||+ ..|.+||+|||-++-. ..+.|
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTG 738 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTG 738 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccccc
Confidence 999998866777 8889999999999999999999999999999999997 5789999999987432 35789
Q ss_pred CCceeeccee--ccccccCccceeee
Q 011158 446 KGRELISLFL--GNDVLLQFGTYWII 469 (492)
Q Consensus 446 ~~~~~ape~~--~~e~~~~~~d~W~l 469 (492)
+-.||+||++ ++..|+...|+|++
T Consensus 739 TLQYMAPEvIDqG~RGYG~aADIWS~ 764 (1226)
T KOG4279|consen 739 TLQYMAPEVIDQGPRGYGKAADIWSF 764 (1226)
T ss_pred chhhhChHhhccCCcCCCchhhhhhc
Confidence 9999999976 77889999999994
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.6e-25 Score=215.44 Aligned_cols=187 Identities=26% Similarity=0.395 Sum_probs=150.5
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeEEEEEecC------C
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKP------P 362 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~------~ 362 (492)
..|.+.+.||+|+||.||+|.+ .++.||+|++.... .....+.+|+.+++++ +|+||+++++++... .
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 3567778999999999999987 46789999987542 2235788999999998 699999999998753 4
Q ss_pred eEEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee
Q 011158 363 SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI 441 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~ 441 (492)
.+|+||||+++++|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+||++++++.++++|||++....
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~ 162 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 162 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecc
Confidence 5899999999999999998643 468999999999999999999999999999999999999999999999999986532
Q ss_pred -------eeeCCCceeecceec-----cccccCccceeee---ecccccCCCCCC
Q 011158 442 -------LFCGKGRELISLFLG-----NDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 -------~~~g~~~~~ape~~~-----~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||+.. ...+...+|+|++ +.....|.++|.
T Consensus 163 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~ 217 (272)
T cd06637 163 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 217 (272)
T ss_pred cccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 234566788888764 2345566788884 223344555543
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.8e-25 Score=237.22 Aligned_cols=178 Identities=14% Similarity=0.243 Sum_probs=141.9
Q ss_pred CCCceeeeeeeecCceEEEEEEECC---ceEEEEEe---------------cCCCCChHHHHHHHHHHHHHHhcCCCcee
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTYCS---QDVAIKVL---------------KPERINSDMQKEFAQEVFIMRKVRHKNVV 352 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~~g---~~vAvK~l---------------~~~~~~~~~~~~~~~Ei~il~~l~HpnIv 352 (492)
..+|+++++||+|+||.||+|.... ...++|.+ +...........+.+|+.+|++++|+||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 3679999999999999999987532 22222211 10011223456788999999999999999
Q ss_pred eEEEEEecCCeEEEEEeccCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCC
Q 011158 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK----GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428 (492)
Q Consensus 353 ~l~g~~~~~~~~~lV~Ey~~ggsL~~~L~~~~----~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~ 428 (492)
++++++...+..|+|+|++ +++|.+++.... .......++.++.||+.||.|||++|||||||||+|||++.++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 9999999999999999999 678888885432 22346678889999999999999999999999999999999999
Q ss_pred eEEEEEeecceee--------eeeCCCceeecceeccccccCccceeee
Q 011158 429 SLLLSLCLFTVSI--------LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 429 ~kl~DFGla~~~~--------~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
+||+|||+++... ...|+..|++||++....+....|+|++
T Consensus 306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 354 (501)
T PHA03210 306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSC 354 (501)
T ss_pred EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHH
Confidence 9999999986432 2457788899998888778888898884
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-25 Score=218.50 Aligned_cols=170 Identities=20% Similarity=0.333 Sum_probs=141.7
Q ss_pred eeeeecCceEEEEEEECC---------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 298 SKVASGSYGDLYRGTYCS---------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~g---------~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
+.||+|+||.||+|.... ..+++|.+... .....+.+.+|+.+++.++||||+++++++......++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 468999999999997632 34888887543 2344567889999999999999999999999988999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCC--------eEEEEEeeccee
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV--------SLLLSLCLFTVS 440 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~--------~kl~DFGla~~~ 440 (492)
||+++|+|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++.++. ++++|||.+...
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~ 158 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV 158 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence 999999999999876667899999999999999999999999999999999999987765 588999887543
Q ss_pred e---eeeCCCceeecceecc-ccccCccceeee
Q 011158 441 I---LFCGKGRELISLFLGN-DVLLQFGTYWII 469 (492)
Q Consensus 441 ~---~~~g~~~~~ape~~~~-e~~~~~~d~W~l 469 (492)
. ...++..|++||+... ..+...+|+|++
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl 191 (258)
T cd05078 159 LPKEILLERIPWVPPECIENPQNLSLAADKWSF 191 (258)
T ss_pred CCchhccccCCccCchhccCCCCCCchhhHHHH
Confidence 2 2456667888987765 446667888884
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.5e-26 Score=229.73 Aligned_cols=182 Identities=21% Similarity=0.242 Sum_probs=159.2
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChH-HHHHHHHHHHHHHhcCCCceeeEEEEEecCCeE
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSD-MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 364 (492)
-+..+.|..-++||+|+||.||-+.. +|+-+|+|.+.+.++... .....++|-.||.+++.+.||.+-.+|++++.+
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L 260 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL 260 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence 44556777789999999999998865 788899998876654332 234567899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee---
Q 011158 365 CIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS--- 440 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~--- 440 (492)
|+|+..|+||+|.-+|.+.. ..+++..++.++.+|+.||++||+.+||.|||||+|||+|+.|.++|+|+|+|-..
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 99999999999999887643 37999999999999999999999999999999999999999999999999999543
Q ss_pred ---eeeeCCCceeecceeccccccCccceeee
Q 011158 441 ---ILFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 441 ---~~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
....||..|||||++.++.|+...|||++
T Consensus 341 ~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~l 372 (591)
T KOG0986|consen 341 KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSL 372 (591)
T ss_pred CccccccCcccccCHHHHcCCcccCCccHHHH
Confidence 22378999999999999999999999984
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=210.93 Aligned_cols=189 Identities=26% Similarity=0.375 Sum_probs=160.2
Q ss_pred CceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEec
Q 011158 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 370 (492)
+|++.+.||+|++|.||++++. ++.|++|++...... .....+.+|+.++.+++|+||+++++++.....+++||||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 5778899999999999999884 788999999765332 4567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEccCCCeEEEEEeecceee-------e
Q 011158 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-------L 442 (492)
Q Consensus 371 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~-~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-------~ 442 (492)
+++++|.+++... ..+++..++.++.|++.||.|||+ ++++||||+|+||+++.++.++++|||.+.... .
T Consensus 81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~ 159 (264)
T cd06623 81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT 159 (264)
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccc
Confidence 9999999999763 678999999999999999999999 999999999999999999999999999887542 2
Q ss_pred eeCCCceeecceeccccccCccceeee---ecccccCCCCCCCc
Q 011158 443 FCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDAP 483 (492)
Q Consensus 443 ~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~aP 483 (492)
..++..|++||+.....+...+|+|++ +.....|.++|...
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~ 203 (264)
T cd06623 160 FVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPP 203 (264)
T ss_pred eeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 345567888998887777777888884 22233455555443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-24 Score=210.64 Aligned_cols=177 Identities=24% Similarity=0.360 Sum_probs=150.9
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
++|++.+.||.|+||.||+|.. .+..+++|++....... ....+.+|+.+++.++|+||+++++.+...+..|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 3688899999999999999987 46789999997654433 56789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee-----
Q 011158 370 FMSGGSVYDYLHKL--KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL----- 442 (492)
Q Consensus 370 y~~ggsL~~~L~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~----- 442 (492)
|+++++|.+++... ...+++..+..++.|++.||.|||++||+||||||+||++++++.++++|||++.....
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence 99999999999764 24689999999999999999999999999999999999999999999999999754321
Q ss_pred ------eeCCCceeecceeccc-cccCccceeee
Q 011158 443 ------FCGKGRELISLFLGND-VLLQFGTYWII 469 (492)
Q Consensus 443 ------~~g~~~~~ape~~~~e-~~~~~~d~W~l 469 (492)
..++..|++||+.... .....+|+|++
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~sl 193 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSF 193 (267)
T ss_pred ccccccccCChhhcChHHHccccCcCcccchHhH
Confidence 2355567788876554 55666788883
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.2e-26 Score=226.06 Aligned_cols=194 Identities=21% Similarity=0.320 Sum_probs=165.8
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEECC--ceEEEEEecCCCC-ChHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCe
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPS 363 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~~g--~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~ 363 (492)
.|...+|.++.+||+|+||.|.++..+| +.+|||+++++-. ..+..+--..|-++|.-. +-|.+++++.+|+.-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 5667789999999999999999998866 5699999998743 222223344566676665 46899999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee---
Q 011158 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS--- 440 (492)
Q Consensus 364 ~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~--- 440 (492)
+|+||||+.||+|.-.|++ -+.+.++.+..++..|+-||-|||++|||.||||.+|||+|.+|.+||+|||+++..
T Consensus 425 LyFVMEyvnGGDLMyhiQQ-~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQ-VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred eeeEEEEecCchhhhHHHH-hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccC
Confidence 9999999999999999977 578999999999999999999999999999999999999999999999999999754
Q ss_pred ----eeeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 441 ----ILFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 441 ----~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
+.++|++.|++||++.-..|....|||+. ...+..|.|+|.-
T Consensus 504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG 552 (683)
T KOG0696|consen 504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG 552 (683)
T ss_pred CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC
Confidence 57899999999999999999999999993 4455667766653
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=214.64 Aligned_cols=179 Identities=22% Similarity=0.349 Sum_probs=146.2
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeEEEEEe-----
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACT----- 359 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~----- 359 (492)
....++|++.+.||+|+||.||++.+ .++.+|+|+++... .....+.+|+.+++++ +|+||+++++++.
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 34457888999999999999999987 46789999886432 2235678899999999 6999999999874
Q ss_pred cCCeEEEEEeccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEee
Q 011158 360 KPPSLCIVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCL 436 (492)
Q Consensus 360 ~~~~~~lV~Ey~~ggsL~~~L~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGl 436 (492)
..+..++||||+++++|.+++... ...+++..+..++.|++.||.|||+++|+||||||+||+++.++.+|++|||.
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~ 170 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGV 170 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCc
Confidence 345689999999999999988642 34688999999999999999999999999999999999999999999999999
Q ss_pred cceee-------eeeCCCceeecceecc-----ccccCccceeee
Q 011158 437 FTVSI-------LFCGKGRELISLFLGN-----DVLLQFGTYWII 469 (492)
Q Consensus 437 a~~~~-------~~~g~~~~~ape~~~~-----e~~~~~~d~W~l 469 (492)
+.... ...++..|++||+... ..+...+|+|++
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~sl 215 (286)
T cd06638 171 SAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSL 215 (286)
T ss_pred eeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhH
Confidence 86432 1235667888887643 234556788873
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-24 Score=216.00 Aligned_cols=189 Identities=21% Similarity=0.284 Sum_probs=154.3
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
+.|++.++||+|+||.||+|+. .++.||+|++.... ........+.+|+.+++.++||||+++++++...+..|+||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 5588889999999999999987 47889999986442 23344567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee---eeeC
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI---LFCG 445 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~---~~~g 445 (492)
||+. |+|.+++......+++..+..++.|++.||.|||+++|+||||+|+||+++.++.++++|||.+.... ...+
T Consensus 95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~~~~~ 173 (307)
T cd06607 95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVG 173 (307)
T ss_pred HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCCCCccC
Confidence 9995 68888887656679999999999999999999999999999999999999999999999999986542 2345
Q ss_pred CCceeecceec---cccccCccceeee---ecccccCCCCCC
Q 011158 446 KGRELISLFLG---NDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 446 ~~~~~ape~~~---~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
+..|++||+.. ...+....|+|++ +.....|.++|.
T Consensus 174 ~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~ 215 (307)
T cd06607 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215 (307)
T ss_pred CccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCC
Confidence 66788888763 3445566788873 223334555443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-26 Score=237.73 Aligned_cols=196 Identities=22% Similarity=0.287 Sum_probs=174.0
Q ss_pred eCCCCceeeeeeeecCceEEEEEEECCce--EEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEE
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~~g~~--vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 365 (492)
+...+++.+..||-|+||.|-++..+++. +|+|++++... +....+.+..|-.||..++.|.||++|..|.+..++|
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY 496 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence 44567788889999999999999887765 89999987643 4556677889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee-----
Q 011158 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS----- 440 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~----- 440 (492)
|+||-|-||.|...|++ ++.+.......++..++.|++|||++|||.|||||+|+|+|.+|.+|++|||.|+..
T Consensus 497 mLmEaClGGElWTiLrd-Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRD-RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK 575 (732)
T ss_pred hhHHhhcCchhhhhhhh-cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence 99999999999999987 688999999999999999999999999999999999999999999999999999754
Q ss_pred -eeeeCCCceeecceeccccccCccceeee---ecccccCCCCCCCccc
Q 011158 441 -ILFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDAPFL 485 (492)
Q Consensus 441 -~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~aPE~ 485 (492)
..++|++.|.+||.+-+..-....|||++ +.....|+|+|.+|..
T Consensus 576 TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp 624 (732)
T KOG0614|consen 576 TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP 624 (732)
T ss_pred eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch
Confidence 36889888888888888888888899995 5566789999998754
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=217.64 Aligned_cols=178 Identities=24% Similarity=0.319 Sum_probs=145.2
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC------
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP------ 362 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~------ 362 (492)
.++|++.++||+|+||.||+|.. +++.||||++............+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 35788999999999999999987 4688999998754333333455678999999999999999999987654
Q ss_pred --eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 363 --SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 363 --~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
..++||||+ +++|.+++......+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||.+...
T Consensus 91 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 169 (310)
T cd07865 91 KGSFYLVFEFC-EHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF 169 (310)
T ss_pred CceEEEEEcCC-CcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence 359999999 56899988775557899999999999999999999999999999999999999999999999998654
Q ss_pred ee-----------eeCCCceeecceeccc-cccCccceeee
Q 011158 441 IL-----------FCGKGRELISLFLGND-VLLQFGTYWII 469 (492)
Q Consensus 441 ~~-----------~~g~~~~~ape~~~~e-~~~~~~d~W~l 469 (492)
.. ..++..|++||+.... .+....|+|++
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 210 (310)
T cd07865 170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGA 210 (310)
T ss_pred cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHH
Confidence 21 1234457888865433 34556788883
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=215.65 Aligned_cols=176 Identities=20% Similarity=0.324 Sum_probs=146.8
Q ss_pred CceeeeeeeecCceEEEEEEE-----CCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCeE
Q 011158 293 HLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSL 364 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~-----~g~~vAvK~l~~~~~--~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~ 364 (492)
+|++.+.||+|+||.||++.. +++.||+|+++.... .....+.+.+|+.+++++ +|+||+++++++.....+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 367889999999999999976 467899999975422 123346788899999999 589999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee--
Q 011158 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL-- 442 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~-- 442 (492)
|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+++++||||||+|||++.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 159 (290)
T cd05613 81 HLILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE 159 (290)
T ss_pred EEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence 999999999999999976 45689999999999999999999999999999999999999999999999999865421
Q ss_pred ------eeCCCceeecceecc--ccccCccceeee
Q 011158 443 ------FCGKGRELISLFLGN--DVLLQFGTYWII 469 (492)
Q Consensus 443 ------~~g~~~~~ape~~~~--e~~~~~~d~W~l 469 (492)
..++..|++||+... ..+....|+|++
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~sl 194 (290)
T cd05613 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSM 194 (290)
T ss_pred ccccccccCCcccCChhhccCCCCCCCccccHHHH
Confidence 235567788887754 234556788873
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=215.32 Aligned_cols=184 Identities=20% Similarity=0.246 Sum_probs=151.0
Q ss_pred eeecCceEEEEEEE--CCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEeccCCCCH
Q 011158 300 VASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376 (492)
Q Consensus 300 LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ggsL 376 (492)
||+|+||.||++.+ +++.||+|++...... ......+..|+.++++++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999976 4788999998754322 22345677899999999999999999999999999999999999999
Q ss_pred HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee------eeeCCCce
Q 011158 377 YDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------LFCGKGRE 449 (492)
Q Consensus 377 ~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------~~~g~~~~ 449 (492)
.+++.+.. ..+++..++.++.|++.||.|||++||+||||||+||++++++.++++|||.+.... ...++..|
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y 160 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGY 160 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCc
Confidence 99997643 368999999999999999999999999999999999999999999999999886542 12345568
Q ss_pred eecceeccccccCccceeee---ecccccCCCCCCCc
Q 011158 450 LISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDAP 483 (492)
Q Consensus 450 ~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~aP 483 (492)
++||+.....+....|+|++ +.....|..+|...
T Consensus 161 ~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 197 (277)
T cd05577 161 MAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQR 197 (277)
T ss_pred CCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCC
Confidence 88888766666777888884 22334566666443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.1e-25 Score=214.54 Aligned_cols=176 Identities=25% Similarity=0.392 Sum_probs=155.1
Q ss_pred CceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEec
Q 011158 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 370 (492)
+|++.+.||+|+||.||++.+. ++.+|+|++..... .....++.+|+.++++++||||+++++.+.....+++++||
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 5677789999999999999885 68899999876532 34567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEccCCCeEEEEEeecceee-----eee
Q 011158 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-----LFC 444 (492)
Q Consensus 371 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~-~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-----~~~ 444 (492)
+++++|.+++......+++..+..++.|++.||.|||+ .+++|+||||+||++++++.++++|||.+.... ...
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~ 160 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV 160 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhccc
Confidence 99999999998755788999999999999999999999 999999999999999999999999999986432 245
Q ss_pred CCCceeecceeccccccCccceeee
Q 011158 445 GKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 445 g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
++..|++||+.....+...+|+|++
T Consensus 161 ~~~~y~~PE~~~~~~~~~~~Dv~sl 185 (265)
T cd06605 161 GTSSYMAPERIQGNDYSVKSDIWSL 185 (265)
T ss_pred CChhccCHHHHcCCCCCchhhHHHH
Confidence 6677899998877777888898884
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.5e-25 Score=203.20 Aligned_cols=197 Identities=20% Similarity=0.284 Sum_probs=163.4
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEE--ECCceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCe
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPS 363 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~--~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~ 363 (492)
++++.+.+.-+..||+|+||.|-+.+ .+|+..|+|.++.. .+.+.+++.++|+.+..+. .+|.+|.++|.......
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~t-vn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRAT-VNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhh-cChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 78888889999999999999876554 47899999999864 4566778889999876655 69999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEEccCCCeEEEEEeecce
Q 011158 364 LCIVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVSLLLSLCLFTV 439 (492)
Q Consensus 364 ~~lV~Ey~~ggsL~~~L~~---~~~~l~~~~~~~i~~qI~~gL~yLH~~-~IiHrDLKp~NILld~~~~~kl~DFGla~~ 439 (492)
+||.||.| ..||..+..+ ..+.+++..+-+|+..|..||.|||++ .|||||+||+||||+.+|.+|+||||.++.
T Consensus 120 vwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 120 VWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGY 198 (282)
T ss_pred EEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccccccee
Confidence 99999999 6788887753 356899999999999999999999987 899999999999999999999999999987
Q ss_pred eee------eeCCCceeecceeccc----cccCccceeee------ecccccCCCCCCCccc
Q 011158 440 SIL------FCGKGRELISLFLGND----VLLQFGTYWII------FRRSSCDKKNSDAPFL 485 (492)
Q Consensus 440 ~~~------~~g~~~~~ape~~~~e----~~~~~~d~W~l------~~~~~~gt~~Y~aPE~ 485 (492)
... ..|-..||+||...++ .|.-.+|.|++ +...+++++.|-.|+.
T Consensus 199 L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~ 260 (282)
T KOG0984|consen 199 LVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQ 260 (282)
T ss_pred ehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHH
Confidence 632 4455689999977664 45556789995 3345566666666754
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=214.54 Aligned_cols=186 Identities=24% Similarity=0.395 Sum_probs=155.2
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEec
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 370 (492)
.|+..++||+|+||.||+|++ .++.||+|+++.... ......+.+|+.++++++|+||+++++++......|+||||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 466778999999999999987 468899999875432 34457889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee-------e
Q 011158 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL-------F 443 (492)
Q Consensus 371 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~-------~ 443 (492)
+++|+|.+++.. +.+++.++..++.|++.||.|||+++++|+||+|+||+++.++.++++|||.+..... .
T Consensus 84 ~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (277)
T cd06640 84 LGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF 161 (277)
T ss_pred CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccccc
Confidence 999999999965 5689999999999999999999999999999999999999999999999999865421 2
Q ss_pred eCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 444 CGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 444 ~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
.++..|++||+.........+|+|++ +.....|.++|.
T Consensus 162 ~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~ 202 (277)
T cd06640 162 VGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNS 202 (277)
T ss_pred cCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCC
Confidence 34556788887766666667888873 333445666553
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=217.82 Aligned_cols=191 Identities=19% Similarity=0.256 Sum_probs=152.8
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC------
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP------ 362 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~------ 362 (492)
.++|++.+.||+|+||.||+|++ .++.||+|+++...........+.+|+.++++++||||+++++++....
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 45788889999999999999998 4688999999765433334456788999999999999999999987654
Q ss_pred ----eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecc
Q 011158 363 ----SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFT 438 (492)
Q Consensus 363 ----~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~ 438 (492)
.+|+|+||+++ +|.+++......+++..++.++.||+.||.|||+++|+|+||||+||++++++.+||+|||.+.
T Consensus 86 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~ 164 (302)
T cd07864 86 KDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR 164 (302)
T ss_pred ccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccc
Confidence 79999999965 8888887655678999999999999999999999999999999999999999999999999987
Q ss_pred eeeee--------eCCCceeecceec-cccccCccceeee---ecccccCCCCCCC
Q 011158 439 VSILF--------CGKGRELISLFLG-NDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 439 ~~~~~--------~g~~~~~ape~~~-~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
..... .++..|++||... ...+....|+|++ +.....|.+.|..
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~ 220 (302)
T cd07864 165 LYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQA 220 (302)
T ss_pred cccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 54221 2244577888654 3445666788873 2233345666654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-24 Score=213.56 Aligned_cols=189 Identities=23% Similarity=0.326 Sum_probs=154.7
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--CeEEEEE
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLCIVT 368 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~lV~ 368 (492)
+|...++||.|++|.||++.+ +++.+|+|++.... ......++.+|+.++++++||||+++++++... ..+|+||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC-chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 577889999999999999988 46889999987543 234567899999999999999999999988643 4689999
Q ss_pred eccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee----
Q 011158 369 EFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI---- 441 (492)
Q Consensus 369 Ey~~ggsL~~~L~~---~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~---- 441 (492)
||+++++|.+++.. ....+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++++|||++....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA 160 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccccc
Confidence 99999999998754 23568999999999999999999999999999999999999999999999999986532
Q ss_pred -eeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 442 -LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 442 -~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
...++..|++||......+...+|+|++ +.....|..+|.+
T Consensus 161 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 205 (287)
T cd06621 161 GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPP 205 (287)
T ss_pred ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCc
Confidence 2345667888888777777777888873 2233345555543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=213.86 Aligned_cols=188 Identities=19% Similarity=0.277 Sum_probs=152.3
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEec
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 370 (492)
+|++.++||.|++|.||+|++ +++.||||+++.... ......+.+|+.++++++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 477889999999999999998 478899999976432 22335677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------
Q 011158 371 MSGGSVYDYLHKLK--GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------- 441 (492)
Q Consensus 371 ~~ggsL~~~L~~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------- 441 (492)
++ ++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||++++++.++++|||.+....
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (284)
T cd07836 80 MD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS 158 (284)
T ss_pred CC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccc
Confidence 96 58999987643 468999999999999999999999999999999999999999999999999986432
Q ss_pred eeeCCCceeecceecc-ccccCccceeee---ecccccCCCCCCC
Q 011158 442 LFCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 442 ~~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
...++..|++||.... ..+...+|+|++ +.....|.++|..
T Consensus 159 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~ 203 (284)
T cd07836 159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPG 203 (284)
T ss_pred cccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 1233456788886533 345566788884 2334456666654
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.3e-25 Score=253.17 Aligned_cols=166 Identities=18% Similarity=0.296 Sum_probs=140.3
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEec
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 370 (492)
.++..+.||+|+||.||+|++ .+..||||+++.... ....|+.++++++|||||+++++|...+..|+||||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 355567899999999999986 568899999864321 123468899999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCCCCEEEccCCCeEEEEEeecceee---eee
Q 011158 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH---QNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI---LFC 444 (492)
Q Consensus 371 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH---~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~---~~~ 444 (492)
|++|+|.++++. +++..+..++.||++||.||| +.+|+||||||+||+++.++..++. |+.++... ...
T Consensus 765 ~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~~~~ 839 (968)
T PLN00113 765 IEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCF 839 (968)
T ss_pred CCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccCCCcc
Confidence 999999999964 799999999999999999999 6699999999999999998887765 77765432 234
Q ss_pred CCCceeecceeccccccCccceeee
Q 011158 445 GKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 445 g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
++..|++||+.....+...+|+|++
T Consensus 840 ~t~~y~aPE~~~~~~~~~~sDv~S~ 864 (968)
T PLN00113 840 ISSAYVAPETRETKDITEKSDIYGF 864 (968)
T ss_pred ccccccCcccccCCCCCcccchhhH
Confidence 5678999999988888888999883
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.5e-25 Score=217.69 Aligned_cols=174 Identities=25% Similarity=0.428 Sum_probs=150.2
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEec
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 370 (492)
.|+..+.||+|+||.||+|.+ .++.||+|.++.... ......+.+|+.++++++|+||+++++++...+..|+||||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 466678899999999999987 467899999875432 34457889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee-------e
Q 011158 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL-------F 443 (492)
Q Consensus 371 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~-------~ 443 (492)
+++++|.+++.. ..+++..+..++.|++.||.|||+++|+|+||||+||++++++.++++|||+++.... .
T Consensus 84 ~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (277)
T cd06642 84 LGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF 161 (277)
T ss_pred cCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcc
Confidence 999999999865 5689999999999999999999999999999999999999999999999999865321 2
Q ss_pred eCCCceeecceeccccccCccceeee
Q 011158 444 CGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 444 ~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
.++..|++||+.....+...+|.|++
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~Dv~sl 187 (277)
T cd06642 162 VGTPFWMAPEVIKQSAYDFKADIWSL 187 (277)
T ss_pred cCcccccCHHHhCcCCCchhhhHHHH
Confidence 35567889998877777777888873
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=223.95 Aligned_cols=154 Identities=18% Similarity=0.217 Sum_probs=138.6
Q ss_pred CceeeCCCCceeeeeeeecCceEEEEEEECC-ceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCC
Q 011158 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPP 362 (492)
Q Consensus 285 ~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g-~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~ 362 (492)
..+.+....|+++++||+||.+.||++...+ +.+|+|.+.....+......|.+|+..|.+++ |.+||++++|-..++
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~ 433 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG 433 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence 4567888999999999999999999998854 67888888777778888899999999999996 899999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
.+||||||- ..+|.++|++....++...++.++.||+.++.++|++||||.||||+|+|+- .|.+||+|||.|...
T Consensus 434 ~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 434 YLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAI 509 (677)
T ss_pred eEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhccc
Confidence 999999987 7899999998666666568899999999999999999999999999999997 578999999999754
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-25 Score=216.13 Aligned_cols=176 Identities=22% Similarity=0.289 Sum_probs=151.2
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeEEEEEec----CCeEEEEEec
Q 011158 298 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTK----PPSLCIVTEF 370 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~----~~~~~lV~Ey 370 (492)
++||-|-.|.|..+.. +++.+|+|++.-. ....+|+++.-.. .|||||+++++|.+ ...+.||||+
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~ 140 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMEC 140 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeec
Confidence 6899999999999976 5789999998632 4567888876655 59999999998864 4568899999
Q ss_pred cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcc---CCCeEEEEEeecceee-----
Q 011158 371 MSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVSLLLSLCLFTVSI----- 441 (492)
Q Consensus 371 ~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~---~~~~kl~DFGla~~~~----- 441 (492)
|+||.|+..++.+. ..+++.++..|+.||+.|+.|||+.+|.||||||+|+|... |..+|++|||.|+...
T Consensus 141 meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L 220 (400)
T KOG0604|consen 141 MEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDL 220 (400)
T ss_pred ccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCCccc
Confidence 99999999998753 46999999999999999999999999999999999999974 5589999999997653
Q ss_pred -eeeCCCceeecceeccccccCccceeee---ecccccCCCCC
Q 011158 442 -LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNS 480 (492)
Q Consensus 442 -~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y 480 (492)
..+-++.|.+||+++++.|....|.|++ +....||+|+|
T Consensus 221 ~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPF 263 (400)
T KOG0604|consen 221 MTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 263 (400)
T ss_pred cCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcc
Confidence 4567788999999999999999999995 55677999875
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-24 Score=214.66 Aligned_cols=189 Identities=17% Similarity=0.249 Sum_probs=149.9
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
++|++.+.||+|+||.||+|.+ +++.||+|.+............+.+|+.++++++|+||+++++++......|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 4688899999999999999987 46789999987654434445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcc-CCCeEEEEEeecceee------
Q 011158 370 FMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEVSLLLSLCLFTVSI------ 441 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~-~~~~kl~DFGla~~~~------ 441 (492)
|++ ++|.+++..... .+++..+..++.||+.||.|||+++|+||||||+||+++. ++.+|++|||.+....
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~ 160 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcccc
Confidence 994 688888865332 3688889999999999999999999999999999999985 4578999999986431
Q ss_pred -eeeCCCceeecceecc-ccccCccceeee---ecccccCCCCCC
Q 011158 442 -LFCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 -~~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||+... ..+...+|+|++ +.....|.++|.
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~ 205 (294)
T PLN00009 161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFP 205 (294)
T ss_pred ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 1223456788886543 345566788884 223334666554
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-24 Score=212.21 Aligned_cols=174 Identities=25% Similarity=0.438 Sum_probs=148.9
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEec
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 370 (492)
-|++.++||+|+||.||+|.+ .++.||+|++..... ......+.+|+.++++++|+||+++++++...+..|+||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 466778999999999999987 467899999865432 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee-------e
Q 011158 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL-------F 443 (492)
Q Consensus 371 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~-------~ 443 (492)
+++++|.+++.. ..+++..+..++.|++.||.|||+++++|+||||+||+++.++.++++|||.+..... .
T Consensus 84 ~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (277)
T cd06641 84 LGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF 161 (277)
T ss_pred CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccc
Confidence 999999999965 5689999999999999999999999999999999999999999999999998764321 2
Q ss_pred eCCCceeecceeccccccCccceeee
Q 011158 444 CGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 444 ~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
.++..|++||+.........+|+|++
T Consensus 162 ~~~~~y~~PE~~~~~~~~~~~Dv~sl 187 (277)
T cd06641 162 VGTPFWMAPEVIKQSAYDSKADIWSL 187 (277)
T ss_pred cCCccccChhhhccCCCCchhhHHHH
Confidence 35566788888776666666788873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-24 Score=221.85 Aligned_cols=175 Identities=21% Similarity=0.247 Sum_probs=148.2
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC------C
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP------P 362 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------~ 362 (492)
.++|+..+.||+|+||.||+|.+ +++.||||++.....+......+.+|+.++++++|+||+++++++... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 36789999999999999999987 578899999875444445556788999999999999999999988644 3
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-
Q 011158 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI- 441 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~- 441 (492)
..|+||||+ .++|.+++.. .++...+..++.|++.||.|||++||+||||||+|||++.++.+|++|||.++...
T Consensus 95 ~~~lv~e~~-~~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 95 DVYLVMELM-DANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170 (353)
T ss_pred cEEEEEecc-CCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence 479999999 5689998865 28999999999999999999999999999999999999999999999999987542
Q ss_pred -----eeeCCCceeecceeccccccCccceeee
Q 011158 442 -----LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 442 -----~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
...++..|++||......+....|+|++
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 203 (353)
T cd07850 171 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 203 (353)
T ss_pred CCCCCCCcccccccCHHHHhCCCCCCchhhHhH
Confidence 1235566888888777777778899984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.3e-25 Score=219.97 Aligned_cols=184 Identities=21% Similarity=0.289 Sum_probs=152.7
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEec
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 370 (492)
.|.....||+|+||.||++.. ++..||||.+... .....+.+.+|+.++++++|+||+++++.+...+..|+||||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence 344457899999999999987 4688999998643 234456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------ee
Q 011158 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-------LF 443 (492)
Q Consensus 371 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-------~~ 443 (492)
+++++|.+++.. +.+++..+..++.||+.||.|||+++|+||||||+||++++++.++|+|||++.... ..
T Consensus 101 ~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~ 178 (292)
T cd06658 101 LEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL 178 (292)
T ss_pred CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCcee
Confidence 999999999865 468999999999999999999999999999999999999999999999999885431 23
Q ss_pred eCCCceeecceeccccccCccceeee---ecccccCCCCC
Q 011158 444 CGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNS 480 (492)
Q Consensus 444 ~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y 480 (492)
.++..|++||+.....+...+|+|++ +.....|..+|
T Consensus 179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~ 218 (292)
T cd06658 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPY 218 (292)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 46667888888877667777888884 22333455544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=217.93 Aligned_cols=189 Identities=19% Similarity=0.285 Sum_probs=149.6
Q ss_pred CceeeeeeeecCceEEEEEEE----CCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--CeEE
Q 011158 293 HLKFGSKVASGSYGDLYRGTY----CSQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLC 365 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~----~g~~vAvK~l~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~ 365 (492)
.|++.++||+|+||.||+|.+ .++.||+|.+.... ........+.+|+.++++++||||+++++++... ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 367889999999999999987 45789999998643 1223346678899999999999999999999988 7899
Q ss_pred EEEeccCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcc----CCCeEEEEEeec
Q 011158 366 IVTEFMSGGSVYDYLHKLK----GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE----NEVSLLLSLCLF 437 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~----~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~----~~~~kl~DFGla 437 (492)
+||||++ ++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+|++|||++
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9999995 57888775432 36899999999999999999999999999999999999999 899999999998
Q ss_pred ceeee----------eeCCCceeecceecc-ccccCccceeee---ecccccCCCCCCC
Q 011158 438 TVSIL----------FCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 438 ~~~~~----------~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
..... ..++..|++||+... ..+...+|+|++ +....+|.+.|..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~ 218 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKG 218 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence 75421 123455777775533 345666788884 3334456666653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=212.79 Aligned_cols=176 Identities=26% Similarity=0.400 Sum_probs=143.7
Q ss_pred ceeeeeeeecCceEEEEEEEC-----CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC------
Q 011158 294 LKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP------ 362 (492)
Q Consensus 294 ~~~~~~LG~G~fG~Vy~~~~~-----g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~------ 362 (492)
|++.+.||+|+||.||+|.+. ++.||||+++.+.......+++.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456789999999999999762 478999999876555666778999999999999999999999886532
Q ss_pred eEEEEEeccCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeec
Q 011158 363 SLCIVTEFMSGGSVYDYLHKL-----KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLF 437 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~-----~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla 437 (492)
..++++||+++|+|.+++... ...+++..++.++.||+.||.|||+++|+||||||+||+++.++.+|++|||.+
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 247899999999999988532 125788999999999999999999999999999999999999999999999998
Q ss_pred ceeee---------eeCCCceeecceeccccccCccceeee
Q 011158 438 TVSIL---------FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 438 ~~~~~---------~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
+.... ..+...|++||......+...+|+|++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~sl 201 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAF 201 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHH
Confidence 75321 112235666776666666777888884
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-24 Score=214.43 Aligned_cols=189 Identities=17% Similarity=0.215 Sum_probs=148.3
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCe-----
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPS----- 363 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~----- 363 (492)
++|++.+.||+|+||.||+|.+ +++.||+|+++...........+.+|+.++++++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 3578889999999999999987 4688999998765433334467888999999995 6999999999887665
Q ss_pred EEEEEeccCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcc-CCCeEEEEEeecc
Q 011158 364 LCIVTEFMSGGSVYDYLHKLK----GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEVSLLLSLCLFT 438 (492)
Q Consensus 364 ~~lV~Ey~~ggsL~~~L~~~~----~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~-~~~~kl~DFGla~ 438 (492)
.|+||||+++ +|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+||+++. ++.+|++|||.+.
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 8999999974 8999886532 35899999999999999999999999999999999999998 8899999999876
Q ss_pred eeee-------eeCCCceeecceecc-ccccCccceeee---ecccccCCCCCC
Q 011158 439 VSIL-------FCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 439 ~~~~-------~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
.... ..++..|++||+... ..+....|+|++ +.....|.+.|.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~ 213 (295)
T cd07837 160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFP 213 (295)
T ss_pred ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCC
Confidence 4321 123445777886533 345666788874 222334555543
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.2e-25 Score=227.87 Aligned_cols=176 Identities=22% Similarity=0.356 Sum_probs=153.6
Q ss_pred CceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHH------HHHHHHHHHHHHhcC---CCceeeEEEEEecC
Q 011158 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDM------QKEFAQEVFIMRKVR---HKNVVQFIGACTKP 361 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~------~~~~~~Ei~il~~l~---HpnIv~l~g~~~~~ 361 (492)
+|..++.+|+|+||.|+.|+++ ...|+||.+.+++.-.+. .-.+-.||.||..++ |+||++++++|++.
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 5788999999999999999985 357999999887542221 123556999999998 99999999999999
Q ss_pred CeEEEEEecc-CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 362 PSLCIVTEFM-SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 362 ~~~~lV~Ey~-~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
+++||+||-- +|.+|+++|.. +..++++.+..|+.||+.|+++||++||||||||-+|+.++.+|-+|++|||.+...
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~ 720 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYT 720 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhh
Confidence 9999999964 56799999976 567999999999999999999999999999999999999999999999999998765
Q ss_pred e-----eeeCCCceeecceeccccccCc-cceeee
Q 011158 441 I-----LFCGKGRELISLFLGNDVLLQF-GTYWII 469 (492)
Q Consensus 441 ~-----~~~g~~~~~ape~~~~e~~~~~-~d~W~l 469 (492)
+ .+.|+..|.+||.++++.|.+. .|+|++
T Consensus 721 ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwal 755 (772)
T KOG1152|consen 721 KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWAL 755 (772)
T ss_pred cCCCcceeeeeccccchhhhCCCccCCCcchhhhh
Confidence 4 5789999999999999888665 489984
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=210.86 Aligned_cols=177 Identities=23% Similarity=0.406 Sum_probs=150.0
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEec
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 370 (492)
+|.+.+.||+|+||.||++.+ .+..+|+|.+..........+.+.+|+.++++++|+||+++++.+......|+|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 477889999999999999988 467899999976544444556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCC-CeEEEEEeecceee-------
Q 011158 371 MSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-VSLLLSLCLFTVSI------- 441 (492)
Q Consensus 371 ~~ggsL~~~L~~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~-~~kl~DFGla~~~~------- 441 (492)
+++++|.+++.+..+ .+++..++.++.|++.||.|||+++|+|+||||+||++++++ .+|++|||.+....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY 160 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccccc
Confidence 999999999976443 579999999999999999999999999999999999999886 46999999886542
Q ss_pred eeeCCCceeecceeccccccCccceeee
Q 011158 442 LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 442 ~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
...++..|++||+.....+...+|+|++
T Consensus 161 ~~~~~~~~~ape~~~~~~~~~~~Dv~sl 188 (257)
T cd08225 161 TCVGTPYYLSPEICQNRPYNNKTDIWSL 188 (257)
T ss_pred ccCCCccccCHHHHcCCCCCchhhHHHH
Confidence 1235556788887766666677888884
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.7e-24 Score=211.44 Aligned_cols=186 Identities=18% Similarity=0.243 Sum_probs=148.6
Q ss_pred ceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCceeeEEEEEecC--CeEEEEE
Q 011158 294 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKP--PSLCIVT 368 (492)
Q Consensus 294 ~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~--~~~~lV~ 368 (492)
|++.++||+|+||.||+|.. +++.||+|+++....+.. .....+|+.++.++. |+||+++++++... +.+++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 56778999999999999987 468899999876432222 234457899999985 99999999999887 8899999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee------e
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------L 442 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------~ 442 (492)
||++ |+|.+++......+++..+..++.|++.||.|||+++|+||||||+||+++. +.+||+|||.+.... .
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~~ 157 (282)
T cd07831 80 ELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTE 157 (282)
T ss_pred ecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCcCC
Confidence 9995 6899998775667899999999999999999999999999999999999999 999999999986542 1
Q ss_pred eeCCCceeeccee-ccccccCccceeee---ecccccCCCCCCC
Q 011158 443 FCGKGRELISLFL-GNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 443 ~~g~~~~~ape~~-~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
..++..|++||+. ....+...+|+|++ +.....|.++|..
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~ 201 (282)
T cd07831 158 YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPG 201 (282)
T ss_pred CCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCC
Confidence 2345667888854 33445667888884 2233446666643
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.5e-24 Score=205.68 Aligned_cols=176 Identities=27% Similarity=0.462 Sum_probs=153.1
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEec
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 370 (492)
+|++.+.||+|++|.||+++. .++.|++|.+............+.+|+.++++++|+|++++++++......+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 467789999999999999987 457899999987655556667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------ee
Q 011158 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-------LF 443 (492)
Q Consensus 371 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-------~~ 443 (492)
+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||.+.... ..
T Consensus 81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 159 (254)
T cd06627 81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV 159 (254)
T ss_pred CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccccc
Confidence 9999999999774 678999999999999999999999999999999999999999999999999987542 23
Q ss_pred eCCCceeecceeccccccCccceeee
Q 011158 444 CGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 444 ~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
.++..|++||+..........|+|++
T Consensus 160 ~~~~~y~~pe~~~~~~~~~~~Dv~~l 185 (254)
T cd06627 160 VGTPYWMAPEVIEMSGASTASDIWSL 185 (254)
T ss_pred ccchhhcCHhhhcCCCCCcchhHHHH
Confidence 45566888887766666667788873
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-25 Score=235.89 Aligned_cols=195 Identities=19% Similarity=0.337 Sum_probs=154.0
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCC--CChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCe--EEE
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPER--INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS--LCI 366 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~--~~l 366 (492)
.+++..+||+|+|-+||+|.+ .|..||---++... -++...++|..|+.+|+.|+||||++++.+|.+..+ +.+
T Consensus 41 y~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~ 120 (632)
T KOG0584|consen 41 YLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINF 120 (632)
T ss_pred eeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeee
Confidence 456678999999999999987 45556543333222 234556899999999999999999999999987665 789
Q ss_pred EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CceecCCCCCCEEEc-cCCCeEEEEEeeccee---
Q 011158 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN--NIIHRDLKAANLLMD-ENEVSLLLSLCLFTVS--- 440 (492)
Q Consensus 367 V~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~--~IiHrDLKp~NILld-~~~~~kl~DFGla~~~--- 440 (492)
|+|+|..|+|..|+++. +.++...++.|++||++||.|||++ -|||||||-+||+|+ ..|.+||+|+|+|.+.
T Consensus 121 iTEL~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 121 ITELFTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred eeecccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 99999999999999884 5689999999999999999999998 499999999999997 5589999999999764
Q ss_pred --eeeeCCCceeecceeccccccCccceeee----ecccccCCC--CCCCccceeee
Q 011158 441 --ILFCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKK--NSDAPFLFYKI 489 (492)
Q Consensus 441 --~~~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~--~Y~aPE~~~ki 489 (492)
....||+.+||||... |.|....|+|++ ..+.++.+| ..+-|-++||=
T Consensus 200 ~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKK 255 (632)
T KOG0584|consen 200 HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKK 255 (632)
T ss_pred ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHH
Confidence 3467888888888776 778888887763 223333332 33445555543
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-24 Score=219.67 Aligned_cols=184 Identities=19% Similarity=0.237 Sum_probs=149.1
Q ss_pred eeeeec--CceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEeccCC
Q 011158 298 SKVASG--SYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG 373 (492)
Q Consensus 298 ~~LG~G--~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~g 373 (492)
..||+| +||+||++.+ .++.||+|++..........+.+.+|+.+++.++||||+++++++...+..|+||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 9999999988 679999999987655555667889999999999999999999999999999999999999
Q ss_pred CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee----------
Q 011158 374 GSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL---------- 442 (492)
Q Consensus 374 gsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~---------- 442 (492)
++|.+++.+.. ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.++++||+.+.....
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYD 163 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccc
Confidence 99999997643 3589999999999999999999999999999999999999999999999976432210
Q ss_pred ----eeCCCceeecceeccc--cccCccceeee---ecccccCCCCCC
Q 011158 443 ----FCGKGRELISLFLGND--VLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 443 ----~~g~~~~~ape~~~~e--~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
..+...|++||+.... .+...+|+|++ +.....|.++|.
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~ 211 (328)
T cd08226 164 FPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQ 211 (328)
T ss_pred ccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 1123457888877553 35567788884 333445666654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-24 Score=213.22 Aligned_cols=170 Identities=22% Similarity=0.309 Sum_probs=137.7
Q ss_pred eeeecCceEEEEEEE--CCceEEEEEecCCCCChH-HHHHHHHHHHHHHh---cCCCceeeEEEEEecCCeEEEEEeccC
Q 011158 299 KVASGSYGDLYRGTY--CSQDVAIKVLKPERINSD-MQKEFAQEVFIMRK---VRHKNVVQFIGACTKPPSLCIVTEFMS 372 (492)
Q Consensus 299 ~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~-~~~~~~~Ei~il~~---l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 372 (492)
.||+|+||.||++.+ +++.+|+|++........ ....+.+|..+++. .+|+||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999987 468899999876543222 22334455544443 479999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-----eeeCCC
Q 011158 373 GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-----LFCGKG 447 (492)
Q Consensus 373 ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-----~~~g~~ 447 (492)
+|+|.+++.. .+.+++..+..++.|++.||.|||+++|+||||||+|||+++++.++++|||++.... ...++.
T Consensus 81 ~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 159 (279)
T cd05633 81 GGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTH 159 (279)
T ss_pred CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCccCcCCCc
Confidence 9999999976 4569999999999999999999999999999999999999999999999999985331 234667
Q ss_pred ceeecceec-cccccCccceeee
Q 011158 448 RELISLFLG-NDVLLQFGTYWII 469 (492)
Q Consensus 448 ~~~ape~~~-~e~~~~~~d~W~l 469 (492)
.|++||... ...+...+|+|++
T Consensus 160 ~y~aPE~~~~~~~~~~~~Di~sl 182 (279)
T cd05633 160 GYMAPEVLQKGTAYDSSADWFSL 182 (279)
T ss_pred CccCHHHhcCCCCCCchhhhHHH
Confidence 788888764 3445666788884
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-24 Score=218.27 Aligned_cols=182 Identities=20% Similarity=0.283 Sum_probs=151.5
Q ss_pred eeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEeccC
Q 011158 295 KFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS 372 (492)
Q Consensus 295 ~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 372 (492)
....+||+|+||.||++.+ .++.||+|++.... ....+.+.+|+.+++.++||||+++++.+...+..|+||||++
T Consensus 24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~ 101 (297)
T cd06659 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ 101 (297)
T ss_pred HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc--cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence 3445899999999999987 47889999986543 2234668899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee-------eeeeC
Q 011158 373 GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS-------ILFCG 445 (492)
Q Consensus 373 ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~-------~~~~g 445 (492)
+++|.+++.. ..+++..++.++.|++.||.|||+++|+||||||+||+++.++.+||+|||++... ....+
T Consensus 102 ~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~ 179 (297)
T cd06659 102 GGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVG 179 (297)
T ss_pred CCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceec
Confidence 9999998865 56899999999999999999999999999999999999999999999999998542 12456
Q ss_pred CCceeecceeccccccCccceeee---ecccccCCCCC
Q 011158 446 KGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNS 480 (492)
Q Consensus 446 ~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y 480 (492)
+..|++||+.....+...+|+|++ +.....|.++|
T Consensus 180 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~ 217 (297)
T cd06659 180 TPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPY 217 (297)
T ss_pred CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 677889998876667777888884 22333455554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-24 Score=210.22 Aligned_cols=169 Identities=23% Similarity=0.374 Sum_probs=145.1
Q ss_pred eeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEeccCCCCH
Q 011158 300 VASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376 (492)
Q Consensus 300 LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ggsL 376 (492)
||+|+||.||++++. ++.+++|++..... .......+.+|+.++++++|+||+++++.+......|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999984 78999999976533 234557788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee--------------
Q 011158 377 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL-------------- 442 (492)
Q Consensus 377 ~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~-------------- 442 (492)
.+++.+. +.+++..+..++.||+.||.|||+++|+|+||+|+||+++.++.++++|||++.....
T Consensus 81 ~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~ 159 (265)
T cd05579 81 ASLLENV-GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK 159 (265)
T ss_pred HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccccc
Confidence 9999874 4789999999999999999999999999999999999999999999999998765422
Q ss_pred -eeCCCceeecceeccccccCccceeee
Q 011158 443 -FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 443 -~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
..+...|++||+.........+|+|++
T Consensus 160 ~~~~~~~~~~Pe~~~~~~~~~~~Dv~sl 187 (265)
T cd05579 160 RIVGTPDYIAPEVILGQGHSKTVDWWSL 187 (265)
T ss_pred CcccCccccCHHHhcCCCCCcchhhHHH
Confidence 234456788887766666667788874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-24 Score=212.61 Aligned_cols=182 Identities=28% Similarity=0.428 Sum_probs=148.1
Q ss_pred eeeecCceEEEEEEECC--------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEec
Q 011158 299 KVASGSYGDLYRGTYCS--------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (492)
Q Consensus 299 ~LG~G~fG~Vy~~~~~g--------~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 370 (492)
.||+|+||.||+|++.. +.+|||.+.... .......+.+|+.++++++||||+++++++......++||||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 68999999999998642 569999886532 233456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCC-----CeEEEEEeecce
Q 011158 371 MSGGSVYDYLHKL------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-----VSLLLSLCLFTV 439 (492)
Q Consensus 371 ~~ggsL~~~L~~~------~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~-----~~kl~DFGla~~ 439 (492)
+++++|.+++.+. ...+++..++.++.|++.||.|||+++++|+||||+||+++.++ .++++|||+++.
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence 9999999999752 23478899999999999999999999999999999999999887 899999999864
Q ss_pred eee---------eeCCCceeecceeccccccCccceeee----ecccccCCCCCC
Q 011158 440 SIL---------FCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSD 481 (492)
Q Consensus 440 ~~~---------~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~ 481 (492)
... ...+..|++||+.....+...+|+|++ +.....|..+|.
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~ 215 (269)
T cd05044 161 IYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYP 215 (269)
T ss_pred cccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCc
Confidence 321 122356888998877777888899884 222334665553
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.7e-24 Score=208.63 Aligned_cols=184 Identities=22% Similarity=0.274 Sum_probs=148.4
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCCC-hHHHHHHHHHHHHH-HhcCCCceeeEEEEEecCCeEEEEEeccCC
Q 011158 298 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIM-RKVRHKNVVQFIGACTKPPSLCIVTEFMSG 373 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~il-~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~g 373 (492)
+.||+|+||.||+|++ .++.||+|+++..... ......+..|..++ ...+|+||+++++++...+.+|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5789999999999987 5688999998754322 22233455565544 445899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee---eeeCCCcee
Q 011158 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI---LFCGKGREL 450 (492)
Q Consensus 374 gsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~---~~~g~~~~~ 450 (492)
++|.+++.. .+.+++..+..++.||+.||.|||+++|+|+||||+||+++.++.++++|||++.... ...++..|+
T Consensus 82 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~y~ 160 (260)
T cd05611 82 GDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPDYL 160 (260)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccccccCCCCcCcc
Confidence 999999976 3568999999999999999999999999999999999999999999999999887542 234666788
Q ss_pred ecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 451 ISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 451 ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
+||+.....+...+|+|++ +.....|+++|..
T Consensus 161 ~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 195 (260)
T cd05611 161 APETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA 195 (260)
T ss_pred ChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCC
Confidence 8888766667777899984 2334456666543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.3e-24 Score=210.37 Aligned_cols=187 Identities=22% Similarity=0.309 Sum_probs=149.7
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeEEEEEecC-----C
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKP-----P 362 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~-----~ 362 (492)
.++|.+.+.||+|+||.||++.. .++.+|+|++.... .....+.+|+.+++++ +||||+++++++... .
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 97 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG 97 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence 46788999999999999999987 46789999986532 2235678899999999 799999999998754 3
Q ss_pred eEEEEEeccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecce
Q 011158 363 SLCIVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTV 439 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~---~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~ 439 (492)
..|+||||+++|+|.++++. ....+++..++.++.|++.||.|||+++|+||||||+||+++.++.+|++|||++..
T Consensus 98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~ 177 (291)
T cd06639 98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177 (291)
T ss_pred eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchh
Confidence 58999999999999999864 235789999999999999999999999999999999999999999999999999865
Q ss_pred ee-------eeeCCCceeecceecccc-----ccCccceeee---ecccccCCCCC
Q 011158 440 SI-------LFCGKGRELISLFLGNDV-----LLQFGTYWII---FRRSSCDKKNS 480 (492)
Q Consensus 440 ~~-------~~~g~~~~~ape~~~~e~-----~~~~~d~W~l---~~~~~~gt~~Y 480 (492)
.. ...++..|++||+..... +...+|+|++ +.....|.++|
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~ 233 (291)
T cd06639 178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233 (291)
T ss_pred cccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCC
Confidence 32 223456678888764332 4556788884 22333455444
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=4e-24 Score=211.06 Aligned_cols=187 Identities=22% Similarity=0.378 Sum_probs=152.9
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC---CCceeeEEEEEecCCeEEEE
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNVVQFIGACTKPPSLCIV 367 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~g~~~~~~~~~lV 367 (492)
.|++.+.||+|+||.||+|.+ .++.||+|+++... ......++.+|+.++++++ ||||+++++++......|+|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 466778999999999999987 46889999987542 2334567889999999997 99999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee------
Q 011158 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------ 441 (492)
Q Consensus 368 ~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------ 441 (492)
|||+++++|.+++.. ..+++..++.++.|++.||.|||++||+|+||+|+||+++.++.++++|||.+....
T Consensus 81 ~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06917 81 MEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR 158 (277)
T ss_pred EecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccc
Confidence 999999999999866 478999999999999999999999999999999999999999999999999876432
Q ss_pred -eeeCCCceeecceecc-ccccCccceeee---ecccccCCCCCCC
Q 011158 442 -LFCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 442 -~~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
...++..|++||+... ..+....|.|++ +.....|.++|..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 204 (277)
T cd06917 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSD 204 (277)
T ss_pred ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCC
Confidence 1235556888887643 334666788873 2233346666544
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.1e-24 Score=211.59 Aligned_cols=183 Identities=20% Similarity=0.254 Sum_probs=144.2
Q ss_pred eeeecCceEEEEEEE--CCceEEEEEecCCCCCh-HHHHHHHHHHH---HHHhcCCCceeeEEEEEecCCeEEEEEeccC
Q 011158 299 KVASGSYGDLYRGTY--CSQDVAIKVLKPERINS-DMQKEFAQEVF---IMRKVRHKNVVQFIGACTKPPSLCIVTEFMS 372 (492)
Q Consensus 299 ~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~-~~~~~~~~Ei~---il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 372 (492)
.||+|+||.||++.+ +++.||+|++....... .....+..|.. +++...||||+++++++...+..|+||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 479999999999977 46889999987654322 11223344443 4444579999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-----eeeCCC
Q 011158 373 GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-----LFCGKG 447 (492)
Q Consensus 373 ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-----~~~g~~ 447 (492)
||+|.+++.. .+.+++..++.++.|++.||.|||+++|+||||||+||+++.++.++++|||++.... ...++.
T Consensus 81 g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 159 (278)
T cd05606 81 GGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTH 159 (278)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCcCcCCCc
Confidence 9999999876 4679999999999999999999999999999999999999999999999999875321 245677
Q ss_pred ceeecceeccc-cccCccceeee---ecccccCCCCCCC
Q 011158 448 RELISLFLGND-VLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 448 ~~~ape~~~~e-~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
.|++||+.... .+....|+|++ +.....|..+|..
T Consensus 160 ~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~ 198 (278)
T cd05606 160 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 198 (278)
T ss_pred CCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCC
Confidence 88889887543 46667788883 2233446666543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-24 Score=212.93 Aligned_cols=191 Identities=20% Similarity=0.340 Sum_probs=157.3
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCeEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIV 367 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV 367 (492)
++|.+.+.||+|+||.||+++. .++.||+|++..... .......+.+|+.++++++ |+||+++++++......++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 3688899999999999999988 578899999976433 2334567889999999998 99999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee-----
Q 011158 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL----- 442 (492)
Q Consensus 368 ~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~----- 442 (492)
|||+++++|.+++.+ .+.+++..++.++.|++.||.|||++|++|+||||+||+++.++.++++|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~ 159 (280)
T cd05581 81 LEYAPNGELLQYIRK-YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE 159 (280)
T ss_pred EcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence 999999999999987 34799999999999999999999999999999999999999999999999999865321
Q ss_pred ----------------------eeCCCceeecceeccccccCccceeee---ecccccCCCCCCCc
Q 011158 443 ----------------------FCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDAP 483 (492)
Q Consensus 443 ----------------------~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~aP 483 (492)
..++..|++||...........|+|++ +.....|..+|..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 225 (280)
T cd05581 160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS 225 (280)
T ss_pred cCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCc
Confidence 123456777777666666667788873 22334466665544
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-24 Score=219.88 Aligned_cols=190 Identities=20% Similarity=0.242 Sum_probs=153.5
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-----CeE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-----PSL 364 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-----~~~ 364 (492)
++|++.+.||+|+||.||++++ +++.||||.++...........+.+|+.+++.++|+||+++++++... ...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 4688899999999999999987 468899999876433333456778899999999999999999988654 348
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee--
Q 011158 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL-- 442 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~-- 442 (492)
|+||||+ +++|.+++.. .+.+++..+..++.||+.||.|||+++++||||||+||+++.++.+||+|||++.....
T Consensus 85 ~lv~e~~-~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 162 (337)
T cd07858 85 YIVYELM-DTDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG 162 (337)
T ss_pred EEEEeCC-CCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence 9999999 5799999876 46799999999999999999999999999999999999999999999999999865421
Q ss_pred -----eeCCCceeecceecc-ccccCccceeee---ecccccCCCCCCCc
Q 011158 443 -----FCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSDAP 483 (492)
Q Consensus 443 -----~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~aP 483 (492)
..++..|++||.... ..+...+|+|++ +.....|.+.|..+
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 212 (337)
T cd07858 163 DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK 212 (337)
T ss_pred ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence 245566888886654 456677889984 22334566655443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.1e-24 Score=212.52 Aligned_cols=189 Identities=20% Similarity=0.272 Sum_probs=153.8
Q ss_pred ceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEecc
Q 011158 294 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 371 (492)
Q Consensus 294 ~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 371 (492)
|++.++||.|++|.||+|.+ .++.||+|++..+.........+.+|+.++++++|+||+++++++...+..|++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 45678999999999999987 5788999999865444444567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------ee
Q 011158 372 SGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-------LF 443 (492)
Q Consensus 372 ~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-------~~ 443 (492)
+++|.+++.... ..+++..++.++.|++.||.|||+++++||||+|+||+++.++.++++|||.+.... ..
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~ 159 (283)
T cd07835 81 -DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHE 159 (283)
T ss_pred -CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCcc
Confidence 579999997644 368999999999999999999999999999999999999999999999999986431 11
Q ss_pred eCCCceeecceecc-ccccCccceeee---ecccccCCCCCCCc
Q 011158 444 CGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSDAP 483 (492)
Q Consensus 444 ~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~aP 483 (492)
.++..|++||+... ..+...+|+|++ +.....|.++|..+
T Consensus 160 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 203 (283)
T cd07835 160 VVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD 203 (283)
T ss_pred ccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 23456788886643 234566788884 33344566666544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.1e-24 Score=207.58 Aligned_cols=190 Identities=22% Similarity=0.333 Sum_probs=159.1
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEec
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 370 (492)
+|++.++||.|+||.||+++. +++.+|+|.+............+.+|+.++++++|+||+++++++......|+||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 467889999999999999987 467899999986555555567888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee-----
Q 011158 371 MSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL----- 442 (492)
Q Consensus 371 ~~ggsL~~~L~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~----- 442 (492)
+++++|.+++.+. ...+++..++.++.|++.||.|||++|++|+||||.||+++.++.+|++|||++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 160 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT 160 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccCCccc
Confidence 9999999998662 24689999999999999999999999999999999999999999999999999865432
Q ss_pred eeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 443 FCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 443 ~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
..++..|++||+.....+....|+|++ +.....|..+|..
T Consensus 161 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~ 203 (256)
T cd08530 161 QIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEA 203 (256)
T ss_pred ccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 335567788888777666777888884 2334456655544
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.3e-24 Score=204.15 Aligned_cols=176 Identities=24% Similarity=0.383 Sum_probs=152.8
Q ss_pred CceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--CeEEEEE
Q 011158 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLCIVT 368 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~lV~ 368 (492)
+|+..+.||+|++|.||+|... ++.|++|++............+.+|+.++++++|+||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3667789999999999999985 78899999987654455678899999999999999999999999988 8899999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee------
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL------ 442 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~------ 442 (492)
||+++++|.+++.+.. .+++..++.++.|++.||.|||+++++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 9999999999998744 889999999999999999999999999999999999999999999999999865432
Q ss_pred ---eeCCCceeecceeccccccCccceeee
Q 011158 443 ---FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 443 ---~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
..++..|++||+..........|+|++
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~sl 189 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGEEYGRAADIWSL 189 (260)
T ss_pred ccCCCCCccccCHhhhcCCCCCchhhHHHH
Confidence 235556778887766666777788884
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.8e-24 Score=211.29 Aligned_cols=187 Identities=25% Similarity=0.387 Sum_probs=150.0
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeEEEEEec------C
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTK------P 361 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~------~ 361 (492)
...|++.+.||+|+||.||+|.+ .++.+|+|++... ......+..|+.+++++ +|+||+++++++.. .
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 91 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD 91 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence 35677789999999999999988 4678999998653 23346788899999998 69999999999853 4
Q ss_pred CeEEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 362 PSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
..+|++|||+++|+|.+++.... ..+++..++.++.||+.||.|||+++|+|+||||+||++++++.++|+|||.+...
T Consensus 92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~ 171 (282)
T cd06636 92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 171 (282)
T ss_pred CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence 56899999999999999997643 45888899999999999999999999999999999999999999999999998643
Q ss_pred e-------eeeCCCceeecceec-----cccccCccceeee---ecccccCCCCC
Q 011158 441 I-------LFCGKGRELISLFLG-----NDVLLQFGTYWII---FRRSSCDKKNS 480 (492)
Q Consensus 441 ~-------~~~g~~~~~ape~~~-----~e~~~~~~d~W~l---~~~~~~gt~~Y 480 (492)
. ...++..|++||.+. ...+...+|+|++ +.....|.++|
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~ 226 (282)
T cd06636 172 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226 (282)
T ss_pred hccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCc
Confidence 2 234566788888764 2345556788884 22333455444
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.8e-24 Score=214.40 Aligned_cols=189 Identities=21% Similarity=0.301 Sum_probs=154.2
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
+.|+..+.||+|+||.||++++ .+..||+|++..... .......+.+|+.++++++|+|++++++++......|+||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 4577788999999999999987 468899999875422 3344567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee---eeeC
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI---LFCG 445 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~---~~~g 445 (492)
||++ |+|.+++......+++.++..++.||+.||.|||+++|+||||||+||+++.++.++++|||++.... ...+
T Consensus 105 e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 183 (317)
T cd06635 105 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVG 183 (317)
T ss_pred eCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCcccccC
Confidence 9995 58888887666779999999999999999999999999999999999999999999999999876543 2345
Q ss_pred CCceeecceec---cccccCccceeee---ecccccCCCCCC
Q 011158 446 KGRELISLFLG---NDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 446 ~~~~~ape~~~---~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
+..|++||+.. ...+...+|+|++ +.....|.++|.
T Consensus 184 ~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~ 225 (317)
T cd06635 184 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 225 (317)
T ss_pred CccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 66788888763 3445666788884 223334555443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-24 Score=212.59 Aligned_cols=176 Identities=18% Similarity=0.314 Sum_probs=146.8
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEec
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 370 (492)
+|+..+.||+|+||.||+|++ +++.||||.++...........+.+|+.++++++||||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 367889999999999999987 468899999876543344446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee-------
Q 011158 371 MSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL------- 442 (492)
Q Consensus 371 ~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~------- 442 (492)
+. ++|.+++.... ..+++..++.++.|++.||+|||+++++||||||+||+++.++.+|++|||.+.....
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 159 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccccc
Confidence 95 68999987643 5689999999999999999999999999999999999999999999999999864321
Q ss_pred eeCCCceeecceecc-ccccCccceeee
Q 011158 443 FCGKGRELISLFLGN-DVLLQFGTYWII 469 (492)
Q Consensus 443 ~~g~~~~~ape~~~~-e~~~~~~d~W~l 469 (492)
..++..|++||+... ..+...+|+|++
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 187 (284)
T cd07860 160 EVVTLWYRAPEILLGCKYYSTAVDIWSL 187 (284)
T ss_pred ccccccccCCeEEecCCCCCcHHHHHHH
Confidence 223456788886543 334556788884
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-24 Score=220.16 Aligned_cols=189 Identities=19% Similarity=0.250 Sum_probs=151.9
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEec----CCeEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK----PPSLC 365 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~~~~~ 365 (492)
.+|++.+.||+|+||.||+|.. +++.||+|++............+.+|+.+|++++||||+++++++.. ...+|
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 5678889999999999999987 47889999998654334455678889999999999999999998763 34689
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee---
Q 011158 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL--- 442 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~--- 442 (492)
+||||+ +|+|.+++.. ...+++..+..++.||+.||.|||+++|+||||||+||+++.++.+||+|||.+.....
T Consensus 85 lv~e~~-~~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 85 VVMDLM-ESDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEehh-hhhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 999999 5799999876 35689999999999999999999999999999999999999999999999999865421
Q ss_pred --------eeCCCceeecceecc-ccccCccceeee---ecccccCCCCCCC
Q 011158 443 --------FCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 443 --------~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
..++..|++||+... ..+....|+|++ +.....|.+.|.+
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 214 (334)
T cd07855 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPG 214 (334)
T ss_pred CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCC
Confidence 234556777886543 345666788884 2233456666643
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.8e-24 Score=210.61 Aligned_cols=175 Identities=22% Similarity=0.298 Sum_probs=146.4
Q ss_pred ceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--CeEEEEEe
Q 011158 294 LKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLCIVTE 369 (492)
Q Consensus 294 ~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~lV~E 369 (492)
|++.++||+|+||.||+|++. ++.+|+|++............+.+|+.++++++|+||+++++++... ...++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567789999999999999884 58899999986543344456788999999999999999999999987 78999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeeee------
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSILF------ 443 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~~------ 443 (492)
|++ ++|.+++......+++..++.++.||+.||.|||+++++|+||||+||++++++.++++|||.+......
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (287)
T cd07840 81 YMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159 (287)
T ss_pred ccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccccc
Confidence 996 5999999775567999999999999999999999999999999999999999999999999998754321
Q ss_pred --eCCCceeecceec-cccccCccceeee
Q 011158 444 --CGKGRELISLFLG-NDVLLQFGTYWII 469 (492)
Q Consensus 444 --~g~~~~~ape~~~-~e~~~~~~d~W~l 469 (492)
.++..|++||... ...+...+|+|++
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~sl 188 (287)
T cd07840 160 NRVITLWYRPPELLLGATRYGPEVDMWSV 188 (287)
T ss_pred ccccccccCCceeeEccccCChHHHHHHH
Confidence 2344577888543 3345566788874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=203.09 Aligned_cols=175 Identities=29% Similarity=0.485 Sum_probs=153.2
Q ss_pred CceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEec
Q 011158 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 370 (492)
+|...+.||+|++|.||++.+. ++.+++|++..... .....+.+|+.++++++|+||+++++++......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 3667789999999999999985 68899999976532 3457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee------eee
Q 011158 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------LFC 444 (492)
Q Consensus 371 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------~~~ 444 (492)
+++++|.+++......+++..+..++.|++.||.|||.+|++|+||+|+||+++.++.++|+|||.+.... ...
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 158 (253)
T cd05122 79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV 158 (253)
T ss_pred CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccccccee
Confidence 99999999998755679999999999999999999999999999999999999999999999999886543 234
Q ss_pred CCCceeecceeccccccCccceeee
Q 011158 445 GKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 445 g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
++..|++||+..........|+|++
T Consensus 159 ~~~~~~~PE~~~~~~~~~~~Dv~sl 183 (253)
T cd05122 159 GTPYWMAPEVINGKPYDYKADIWSL 183 (253)
T ss_pred cCCcccCHHHHcCCCCCccccHHHH
Confidence 5667888888776666777888884
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.7e-24 Score=218.76 Aligned_cols=191 Identities=23% Similarity=0.315 Sum_probs=152.7
Q ss_pred ceeeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC-
Q 011158 286 VWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP- 362 (492)
Q Consensus 286 ~~ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~- 362 (492)
.|.+ .++|++.+.||+|+||.||++.. .++.||||++............+.+|+.+|++++|+||+++++++....
T Consensus 10 ~~~~-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 10 IWEV-PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred hhcc-ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 4554 45699999999999999999987 4688999998754434445567889999999999999999999987553
Q ss_pred -----eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeec
Q 011158 363 -----SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLF 437 (492)
Q Consensus 363 -----~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla 437 (492)
.+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++++|||.+
T Consensus 89 ~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 89 LDRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred ccccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 358999999 8899998865 56899999999999999999999999999999999999999999999999998
Q ss_pred ceee----eeeCCCceeecceecc-ccccCccceeee---ecccccCCCCC
Q 011158 438 TVSI----LFCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNS 480 (492)
Q Consensus 438 ~~~~----~~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y 480 (492)
.... ...++..|++||+... ..+....|+|++ +.....|.++|
T Consensus 166 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf 216 (343)
T cd07880 166 RQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLF 216 (343)
T ss_pred cccccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 6542 1234556777886654 335556788884 22233455544
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=6e-24 Score=208.36 Aligned_cols=188 Identities=26% Similarity=0.370 Sum_probs=151.7
Q ss_pred CCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCC-----
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPP----- 362 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~----- 362 (492)
.++|++.+.||+|+||.||+|.+. ++.+++|++.... .....+.+|+.+++++ +|+||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 367888999999999999999884 5789999987543 2346789999999999 6999999999997644
Q ss_pred -eEEEEEeccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecc
Q 011158 363 -SLCIVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFT 438 (492)
Q Consensus 363 -~~~lV~Ey~~ggsL~~~L~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~ 438 (492)
.+|+||||+++++|.+++... +..+++..+..++.|++.||.|||+++|+|+||+|+||+++.++.++++|||.+.
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccce
Confidence 489999999999999998753 3578999999999999999999999999999999999999999999999999986
Q ss_pred eee-------eeeCCCceeecceecc-----ccccCccceeee---ecccccCCCCCC
Q 011158 439 VSI-------LFCGKGRELISLFLGN-----DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 439 ~~~-------~~~g~~~~~ape~~~~-----e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
... ...++..|++||+... ..+...+|+|++ +.....|.++|.
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 219 (275)
T cd06608 162 QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC 219 (275)
T ss_pred ecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcc
Confidence 532 2335556888887643 234556788884 223334555543
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=8e-24 Score=217.24 Aligned_cols=191 Identities=21% Similarity=0.292 Sum_probs=152.5
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC---
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--- 361 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--- 361 (492)
|++. ++|.+.+.||+|+||.||+|.+ +++.||+|+++.........+.+.+|+.++++++|+||+++++++...
T Consensus 13 ~~~~-~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~ 91 (345)
T cd07877 13 WEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 91 (345)
T ss_pred hhcc-CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccc
Confidence 4443 6799999999999999999986 578899999976443344456788999999999999999999988643
Q ss_pred ---CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecc
Q 011158 362 ---PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFT 438 (492)
Q Consensus 362 ---~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~ 438 (492)
...|++++++ +++|.+++.. ..+++..+..++.||+.||.|||+++|+||||||+||+++.++.+|++|||++.
T Consensus 92 ~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~ 168 (345)
T cd07877 92 EEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 168 (345)
T ss_pred cccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccc
Confidence 3478899988 8899998865 468999999999999999999999999999999999999999999999999987
Q ss_pred eee----eeeCCCceeecceecc-ccccCccceeee---ecccccCCCCCC
Q 011158 439 VSI----LFCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 439 ~~~----~~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
... ...++..|++||+... ..+....|+|++ +.....|.++|.
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~ 219 (345)
T cd07877 169 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 219 (345)
T ss_pred cccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 542 2344566788887644 345566788884 222344655553
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.7e-25 Score=243.96 Aligned_cols=147 Identities=20% Similarity=0.326 Sum_probs=126.0
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--------
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-------- 361 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-------- 361 (492)
.+|+.++.||+|+||.||+++. .|+.||||++.... +......+.+|+..|.+|+|||||+++..+...
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 4567788999999999999987 68999999998765 566677899999999999999999998654000
Q ss_pred --------------------------------------------------------------------------------
Q 011158 362 -------------------------------------------------------------------------------- 361 (492)
Q Consensus 362 -------------------------------------------------------------------------------- 361 (492)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred -------------------------------CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 011158 362 -------------------------------PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 410 (492)
Q Consensus 362 -------------------------------~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~ 410 (492)
-.+||-||||+..+|.++++++...-.....++++++|+.||.|+|++|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 1258999999998898888774322147788999999999999999999
Q ss_pred ceecCCCCCCEEEccCCCeEEEEEeecce
Q 011158 411 IIHRDLKAANLLMDENEVSLLLSLCLFTV 439 (492)
Q Consensus 411 IiHrDLKp~NILld~~~~~kl~DFGla~~ 439 (492)
||||||||.||++|+++.+||+|||+|..
T Consensus 718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~ 746 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRNSVKIGDFGLATD 746 (1351)
T ss_pred eeeccCCcceeEEcCCCCeeecccccchh
Confidence 99999999999999999999999999976
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.7e-24 Score=209.74 Aligned_cols=175 Identities=24% Similarity=0.396 Sum_probs=152.1
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
+.|+..+.||+|+||.||+|.+. ++.|++|++..... ....+.+|+.++++++|+||+++++.+......|+|+|
T Consensus 19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 45777789999999999999885 78899999975432 45678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------e
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-------L 442 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-------~ 442 (492)
|+++++|.+++......+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||.+.... .
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 175 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS 175 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhcc
Confidence 999999999998854479999999999999999999999999999999999999999999999999875432 1
Q ss_pred eeCCCceeecceeccccccCccceeee
Q 011158 443 FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 443 ~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
..++..|++||+.....+....|+|++
T Consensus 176 ~~~~~~y~~PE~~~~~~~~~~~Dv~sl 202 (286)
T cd06614 176 VVGTPYWMAPEVIKRKDYGPKVDIWSL 202 (286)
T ss_pred ccCCcccCCHhHhcCCCCCCccccHHH
Confidence 234566888888777667777888883
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.8e-24 Score=212.46 Aligned_cols=174 Identities=21% Similarity=0.377 Sum_probs=148.6
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
.+|++.+.||+|+||.||++.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++.+...+..|+|+|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 5788889999999999999986 56789999986432 2334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------e
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-------L 442 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-------~ 442 (492)
|+++++|.+++.+ ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||.+.... .
T Consensus 97 ~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~ 174 (293)
T cd06647 97 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 174 (293)
T ss_pred cCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccccc
Confidence 9999999999976 457899999999999999999999999999999999999999999999999875321 1
Q ss_pred eeCCCceeecceeccccccCccceeee
Q 011158 443 FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 443 ~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
..++..|++||+.....+....|+|++
T Consensus 175 ~~~~~~y~~PE~~~~~~~~~~~Dv~sl 201 (293)
T cd06647 175 MVGTPYWMAPEVVTRKAYGPKVDIWSL 201 (293)
T ss_pred ccCChhhcCchhhccCCCCchhhHHHH
Confidence 235556888887766666667788873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.4e-24 Score=215.03 Aligned_cols=187 Identities=18% Similarity=0.192 Sum_probs=150.9
Q ss_pred eeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEeccCCC
Q 011158 295 KFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG 374 (492)
Q Consensus 295 ~~~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~gg 374 (492)
.+++.+|.|+++.||++..+++.||||+++...........+.+|+.++++++|+||+++++++......|++|||+++|
T Consensus 5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 34556677777778887778899999999876455566778999999999999999999999999999999999999999
Q ss_pred CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee------------
Q 011158 375 SVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------------ 441 (492)
Q Consensus 375 sL~~~L~~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------------ 441 (492)
+|.+++.+. ...+++..+..++.|++.||+|||+++|+||||||+|||++.++.+|++|||.+....
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~ 164 (314)
T cd08216 85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF 164 (314)
T ss_pred CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccc
Confidence 999999864 3468999999999999999999999999999999999999999999999999875321
Q ss_pred --eeeCCCceeecceeccc--cccCccceeee---ecccccCCCCCC
Q 011158 442 --LFCGKGRELISLFLGND--VLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 --~~~g~~~~~ape~~~~e--~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||+.... .+...+|+|++ +.....|..+|.
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~ 211 (314)
T cd08216 165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFK 211 (314)
T ss_pred cccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence 12234457788876543 35666888883 223334555554
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.8e-24 Score=217.66 Aligned_cols=186 Identities=19% Similarity=0.323 Sum_probs=149.5
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-----CeE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-----PSL 364 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-----~~~ 364 (492)
++|++.++||+|+||.||+|.+ +++.||||+++... .......+.+|+.++++++|+||+++++++... ...
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 5688999999999999999987 57889999987432 233456788999999999999999999987644 348
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee--
Q 011158 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL-- 442 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~-- 442 (492)
|+|+||+. ++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+|++|||++.....
T Consensus 84 ~lv~e~~~-~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 84 YIVQELME-TDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred EEEehhcc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 99999994 689888854 5689999999999999999999999999999999999999999999999999865321
Q ss_pred --------eeCCCceeecceec-cccccCccceeee---ecccccCCCCCC
Q 011158 443 --------FCGKGRELISLFLG-NDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 443 --------~~g~~~~~ape~~~-~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
..++..|++||... ...+....|+|++ +.....|.+.|.
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~ 211 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFP 211 (336)
T ss_pred cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 23455678888653 3445666788884 333445666664
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.5e-24 Score=210.06 Aligned_cols=188 Identities=20% Similarity=0.293 Sum_probs=154.8
Q ss_pred ceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEecc
Q 011158 294 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 371 (492)
Q Consensus 294 ~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 371 (492)
|++.+.||+|++|.||+|.. .++.+++|.++...........+.+|+.++++++|+||+++++++......++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 45668999999999999987 4688999999866544455678889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee-------ee
Q 011158 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL-------FC 444 (492)
Q Consensus 372 ~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~-------~~ 444 (492)
+ ++|.+++......+++..+..++.||+.||.|||+++|+|+||||+||+++.++.++++|||.+..... ..
T Consensus 81 ~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~ 159 (283)
T cd05118 81 D-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV 159 (283)
T ss_pred C-CCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCcc
Confidence 6 599999877556899999999999999999999999999999999999999999999999999865432 22
Q ss_pred CCCceeecceeccc-cccCccceeee---ecccccCCCCCCC
Q 011158 445 GKGRELISLFLGND-VLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 445 g~~~~~ape~~~~e-~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
+...|++||..... .+...+|+|++ +.....|.+.|.+
T Consensus 160 ~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~ 201 (283)
T cd05118 160 VTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPG 201 (283)
T ss_pred CcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 44457778776554 55666788884 2234456666644
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-25 Score=246.53 Aligned_cols=188 Identities=20% Similarity=0.295 Sum_probs=155.2
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEec
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 370 (492)
+++.+.+||.|.||.||-|.. +|.-.|+|-++.............+|..++..++|||+|+++|+-...+..+|.|||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence 345567999999999999986 678899998887655555567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee---------
Q 011158 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI--------- 441 (492)
Q Consensus 371 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~--------- 441 (492)
|++|+|.+++.. .+..++.....+..|++.|+.|||++|||||||||+||+++.+|.+|++|||.|....
T Consensus 1316 C~~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1316 CEGGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred hccCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence 999999999976 4567888888899999999999999999999999999999999999999999986543
Q ss_pred --eeeCCCceeecceecc---ccccCccceeee---ecccccCCCCCC
Q 011158 442 --LFCGKGRELISLFLGN---DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 --~~~g~~~~~ape~~~~---e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...||+.|||||.+.. +.-.+..|+|++ ...+..|..+|.
T Consensus 1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~ 1442 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWA 1442 (1509)
T ss_pred HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchh
Confidence 2467777888876644 333445578874 334445555553
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=209.72 Aligned_cols=183 Identities=21% Similarity=0.290 Sum_probs=152.2
Q ss_pred ceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEecc
Q 011158 294 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 371 (492)
Q Consensus 294 ~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 371 (492)
|...++||+|++|.||++.. .++.+++|++... .....+.+.+|+.+++.++|+||+++++++...+..|+|+||+
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence 44457999999999999986 4678999988643 2333466889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------eee
Q 011158 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-------LFC 444 (492)
Q Consensus 372 ~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-------~~~ 444 (492)
++++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++++|||.+.... ...
T Consensus 99 ~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 176 (285)
T cd06648 99 EGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV 176 (285)
T ss_pred CCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccccccc
Confidence 99999999977 568999999999999999999999999999999999999999999999999876432 124
Q ss_pred CCCceeecceeccccccCccceeee---ecccccCCCCC
Q 011158 445 GKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNS 480 (492)
Q Consensus 445 g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y 480 (492)
++..|++||......+....|.|++ +....+|.++|
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~ 215 (285)
T cd06648 177 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPY 215 (285)
T ss_pred CCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCC
Confidence 5667888888877667777888883 22334455544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.8e-24 Score=211.32 Aligned_cols=188 Identities=21% Similarity=0.266 Sum_probs=149.3
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCeEEEE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIV 367 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV 367 (492)
.++|...++||+|+||.||++.+ +++.||+|.+...... .....+.+|+.++.++. |+||+++++++..+...+++
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 34667778999999999999988 4688999998754332 44567889999999996 99999999999999999999
Q ss_pred EeccCCCCHHHHHH---h-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEEccCCCeEEEEEeecceee-
Q 011158 368 TEFMSGGSVYDYLH---K-LKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVSLLLSLCLFTVSI- 441 (492)
Q Consensus 368 ~Ey~~ggsL~~~L~---~-~~~~l~~~~~~~i~~qI~~gL~yLH~~-~IiHrDLKp~NILld~~~~~kl~DFGla~~~~- 441 (492)
|||+. ++|.++.. . ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|++|||+++...
T Consensus 82 ~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 82 MELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred Eeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 99994 56655432 2 235789999999999999999999985 99999999999999999999999999986432
Q ss_pred -----eeeCCCceeecceeccc---cccCccceeee---ecccccCCCCC
Q 011158 442 -----LFCGKGRELISLFLGND---VLLQFGTYWII---FRRSSCDKKNS 480 (492)
Q Consensus 442 -----~~~g~~~~~ape~~~~e---~~~~~~d~W~l---~~~~~~gt~~Y 480 (492)
...++..|++||++... .+...+|+|++ +.....|.++|
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~ 210 (288)
T cd06616 161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPY 210 (288)
T ss_pred CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCc
Confidence 23456678888877655 56667888883 22233455544
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.7e-24 Score=216.55 Aligned_cols=187 Identities=21% Similarity=0.258 Sum_probs=154.4
Q ss_pred CceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC-----eEE
Q 011158 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP-----SLC 365 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-----~~~ 365 (492)
+|++.+.||+|+||.||+|+.. ++.||||++..........+.+.+|+.+++.++|+||+++++++.... .+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999874 688999999765433455678999999999999999999999988775 789
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeeee--
Q 011158 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSILF-- 443 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~~-- 443 (492)
+||||++ ++|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++++|||.+......
T Consensus 81 lv~e~~~-~~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 81 IVTELME-TDLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEecchh-hhHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 9999996 689999976 347999999999999999999999999999999999999999999999999998754322
Q ss_pred --------eCCCceeecceeccc-cccCccceeee---ecccccCCCCCC
Q 011158 444 --------CGKGRELISLFLGND-VLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 444 --------~g~~~~~ape~~~~e-~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
.++..|++||++... .+....|+|++ +.....|.+.|.
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~ 208 (330)
T cd07834 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFP 208 (330)
T ss_pred ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcC
Confidence 234457788877665 66667888884 223445666554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.91 E-value=5e-24 Score=213.43 Aligned_cols=190 Identities=22% Similarity=0.295 Sum_probs=149.3
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-------
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP------- 361 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------- 361 (492)
.++|++.++||+|+||.||+|++ +++.+|||++............+.+|+.++++++|+||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 36789999999999999999988 468899999875433333335677899999999999999999987543
Q ss_pred -CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 362 -PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 362 -~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
..+++||||+ .++|..++......+++..+..++.||++||.|||++||+|+||||+|||+++++.++++|||+++..
T Consensus 87 ~~~~~lv~~~~-~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 165 (311)
T cd07866 87 RGSVYMVTPYM-DHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY 165 (311)
T ss_pred CceEEEEEecC-CcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence 3479999999 45788888765568999999999999999999999999999999999999999999999999998653
Q ss_pred eee------------------eCCCceeecceecc-ccccCccceeee---ecccccCCCCCC
Q 011158 441 ILF------------------CGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 441 ~~~------------------~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
... .++..|++||.... ..+....|+|++ +.....|.+.|.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~ 228 (311)
T cd07866 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQ 228 (311)
T ss_pred cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCC
Confidence 211 22344777776543 335666788884 223344655554
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-23 Score=211.27 Aligned_cols=187 Identities=22% Similarity=0.290 Sum_probs=152.4
Q ss_pred ceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEec
Q 011158 294 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (492)
Q Consensus 294 ~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 370 (492)
|...++||+|+||.||+|++ .++.|++|++..... .......+.+|+.++++++|+|++++++++......|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 55567899999999999987 578899999875432 334456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee---eeeCCC
Q 011158 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI---LFCGKG 447 (492)
Q Consensus 371 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~---~~~g~~ 447 (492)
+ .|+|.+++......+++..++.++.||+.||.|||++||+|+||||+||+++.++.+|++|||++.... ...++.
T Consensus 103 ~-~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~~~~~~~ 181 (313)
T cd06633 103 C-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTP 181 (313)
T ss_pred C-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCCCCCccccc
Confidence 9 568888887766779999999999999999999999999999999999999999999999999986542 234566
Q ss_pred ceeecceec---cccccCccceeee---ecccccCCCCCC
Q 011158 448 RELISLFLG---NDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 448 ~~~ape~~~---~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
.|++||+.. ...+...+|+|++ +.....|.++|.
T Consensus 182 ~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~ 221 (313)
T cd06633 182 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 221 (313)
T ss_pred cccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 788888763 3445566788883 223334555544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=213.42 Aligned_cols=188 Identities=18% Similarity=0.233 Sum_probs=151.4
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEec-CCeEEEE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK-PPSLCIV 367 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~~~lV 367 (492)
.++|++.+.||.|+||.||++.+ +++.||||++..........+.+.+|+.++++++||||+++++++.. ....|+|
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv 88 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFV 88 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEE
Confidence 35699999999999999999986 46789999887543334445678899999999999999999999865 4578999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee----ee
Q 011158 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI----LF 443 (492)
Q Consensus 368 ~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~----~~ 443 (492)
|||+ +++|.+++.. ..+++..+..++.|++.||.|||+++|+||||||.|||++.++.++++|||.+.... ..
T Consensus 89 ~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 165 (328)
T cd07856 89 TELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGY 165 (328)
T ss_pred eehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCCcCCC
Confidence 9999 7799998865 467888899999999999999999999999999999999999999999999986432 12
Q ss_pred eCCCceeecceecc-ccccCccceeee---ecccccCCCCCC
Q 011158 444 CGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 444 ~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
.++..|++||++.. ..+....|+|++ +.....|.+.|.
T Consensus 166 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~ 207 (328)
T cd07856 166 VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFP 207 (328)
T ss_pred cccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 34556788887544 456666788884 223344555554
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=206.54 Aligned_cols=177 Identities=19% Similarity=0.328 Sum_probs=147.5
Q ss_pred CceeeeeeeecCceEEEEEEEC---CceEEEEEecCCC--------CChHHHHHHHHHHHHHHh-cCCCceeeEEEEEec
Q 011158 293 HLKFGSKVASGSYGDLYRGTYC---SQDVAIKVLKPER--------INSDMQKEFAQEVFIMRK-VRHKNVVQFIGACTK 360 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~~---g~~vAvK~l~~~~--------~~~~~~~~~~~Ei~il~~-l~HpnIv~l~g~~~~ 360 (492)
.|++.+.||+|+||.||+|.+. ++.+|+|.+.... .......++.+|+.++.+ ++|+||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 3677789999999999999884 4779999886432 123345667889998875 799999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEccCCCeEEEEEee
Q 011158 361 PPSLCIVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVSLLLSLCL 436 (492)
Q Consensus 361 ~~~~~lV~Ey~~ggsL~~~L~~---~~~~l~~~~~~~i~~qI~~gL~yLH~-~~IiHrDLKp~NILld~~~~~kl~DFGl 436 (492)
.+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+ .+|+|+||||+|||++.++.++++|||.
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999998854 24578999999999999999999996 6899999999999999999999999999
Q ss_pred cceee------eeeCCCceeecceeccccccCccceeee
Q 011158 437 FTVSI------LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 437 a~~~~------~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
+.... ...++..|++||+.....+....|+|++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~sl 199 (269)
T cd08528 161 AKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAF 199 (269)
T ss_pred eeecccccccccccCcccCcChhhhcCCCCchHHHHHHH
Confidence 87543 2345667888888877667777888873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=215.09 Aligned_cols=187 Identities=17% Similarity=0.258 Sum_probs=149.5
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeEEEEEecC--CeEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKP--PSLCI 366 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~--~~~~l 366 (492)
++|++.+.||+|+||.||+|.+ .++.+|+|++.....+......+.+|+.+++++ +|+||+++++++... ..+|+
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l 86 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence 4678889999999999999987 468899998865433344456678899999999 999999999998643 36899
Q ss_pred EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee----
Q 011158 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL---- 442 (492)
Q Consensus 367 V~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~---- 442 (492)
||||++ ++|.+++... .+++..++.++.||+.||.|||++||+||||||+||+++.++.+|++|||.+.....
T Consensus 87 v~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~ 163 (337)
T cd07852 87 VFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163 (337)
T ss_pred Eecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccccc
Confidence 999995 6999998763 788999999999999999999999999999999999999999999999999864321
Q ss_pred --------eeCCCceeecceec-cccccCccceeee---ecccccCCCCCC
Q 011158 443 --------FCGKGRELISLFLG-NDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 443 --------~~g~~~~~ape~~~-~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
..++..|++||+.. ...+...+|+|++ +.....|.+.|.
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~ 214 (337)
T cd07852 164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFP 214 (337)
T ss_pred ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCC
Confidence 23455678888653 3445666788873 223345665554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=211.00 Aligned_cols=183 Identities=21% Similarity=0.264 Sum_probs=151.4
Q ss_pred eeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEeccC
Q 011158 295 KFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS 372 (492)
Q Consensus 295 ~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 372 (492)
....+||+|+||.||++.. +++.||||.+... .......+.+|+.++++++|+||+++++.+...+..|+||||++
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence 3346899999999999987 5688999988643 23345678999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------eeeC
Q 011158 373 GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-------LFCG 445 (492)
Q Consensus 373 ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-------~~~g 445 (492)
+++|.+++.. ..+++..+..++.|++.||.|||++||+|+||||+||++++++.++++|||.+.... ...+
T Consensus 101 ~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 178 (292)
T cd06657 101 GGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVG 178 (292)
T ss_pred CCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccccccccc
Confidence 9999998854 468999999999999999999999999999999999999999999999999875432 1335
Q ss_pred CCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 446 KGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 446 ~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
+..|++||+.....+....|+|++ +.....|.++|.
T Consensus 179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~ 217 (292)
T cd06657 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF 217 (292)
T ss_pred CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 566888888776666777888884 223344655553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-23 Score=204.73 Aligned_cols=175 Identities=19% Similarity=0.336 Sum_probs=145.9
Q ss_pred ceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhc---CCCceeeEEEEEecCCe-----
Q 011158 294 LKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV---RHKNVVQFIGACTKPPS----- 363 (492)
Q Consensus 294 ~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~g~~~~~~~----- 363 (492)
|++.+.||+|+||.||+|++. ++.||+|+++...........+.+|+.+++++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567889999999999999984 68899999986544444445677888887766 59999999999988776
Q ss_pred EEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee
Q 011158 364 LCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL 442 (492)
Q Consensus 364 ~~lV~Ey~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~ 442 (492)
++++|||+. ++|.+++.... ..+++..++.++.|++.||.|||+++|+|+||||+||+++.++.++++|||.+.....
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~ 159 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF 159 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence 999999995 58999987643 3689999999999999999999999999999999999999999999999999866421
Q ss_pred ------eeCCCceeecceeccccccCccceeee
Q 011158 443 ------FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 443 ------~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
..++..|++||+.....+...+|+|++
T Consensus 160 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~ 192 (287)
T cd07838 160 EMALTSVVVTLWYRAPEVLLQSSYATPVDMWSV 192 (287)
T ss_pred CcccccccccccccChHHhccCCCCCcchhhhH
Confidence 224556788887776667777888884
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=209.48 Aligned_cols=196 Identities=17% Similarity=0.258 Sum_probs=156.0
Q ss_pred CceeeCCCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCceeeEEEEEecC
Q 011158 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKP 361 (492)
Q Consensus 285 ~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~ 361 (492)
..|.++.++|++.+.||+|+||.||+|.+. ++.||||+++.... ......+..|+.++.+.. |+||+++++++...
T Consensus 8 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 86 (296)
T cd06618 8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVKCYGYFITD 86 (296)
T ss_pred eeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-hHHHHHHHHHHHHHHhccCCCchHhhheeeecC
Confidence 346778889999999999999999999985 78899999975432 233456777887777775 99999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~-~~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
...|+||||+ +++|.+++......+++..+..++.||+.||.|||+ ++|+||||||+||++++++.+||+|||.++..
T Consensus 87 ~~~~~v~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 87 SDVFICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred CeEEEEeecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 9999999999 568888887656689999999999999999999997 59999999999999999999999999998653
Q ss_pred ee------eeCCCceeecceecccc----ccCccceeee---ecccccCCCCCCC
Q 011158 441 IL------FCGKGRELISLFLGNDV----LLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 441 ~~------~~g~~~~~ape~~~~e~----~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
.. ..++..|++||+..... +...+|+|++ +.....|..+|..
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 166 VDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred cCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 21 12344677888765443 5556788873 2233346655543
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=206.51 Aligned_cols=181 Identities=18% Similarity=0.260 Sum_probs=143.3
Q ss_pred Cceeeee--eeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCeEEEE
Q 011158 293 HLKFGSK--VASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIV 367 (492)
Q Consensus 293 ~~~~~~~--LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV 367 (492)
.|.+.+. ||+|+||.||++.. ++..+|+|++....... .|+.+...+ +|+||+++++.+...+..|+|
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv 87 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLI 87 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence 3444444 59999999999987 46789999987543221 122222222 699999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCC-CeEEEEEeecceee---ee
Q 011158 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-VSLLLSLCLFTVSI---LF 443 (492)
Q Consensus 368 ~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~-~~kl~DFGla~~~~---~~ 443 (492)
|||+++++|.+++... ..+++..++.++.||++||.|||+.+|+||||||+||+++.++ .++++|||++.... ..
T Consensus 88 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 166 (267)
T PHA03390 88 MDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY 166 (267)
T ss_pred EEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCccC
Confidence 9999999999999774 4899999999999999999999999999999999999999998 99999999886542 23
Q ss_pred eCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 444 CGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 444 ~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
.++..|++||+.....+....|+|++ +.....|..+|.
T Consensus 167 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~ 207 (267)
T PHA03390 167 DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFK 207 (267)
T ss_pred CCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 56678899998877777777888884 222334555554
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=209.01 Aligned_cols=192 Identities=15% Similarity=0.163 Sum_probs=144.0
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEECC-----ceEEEEEecCCCCChHH---------HHHHHHHHHHHHhcCCCceee
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDM---------QKEFAQEVFIMRKVRHKNVVQ 353 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~~g-----~~vAvK~l~~~~~~~~~---------~~~~~~Ei~il~~l~HpnIv~ 353 (492)
++..++|++.++||+|+||.||+|.+.+ ..+|+|+.......... ......+...+..+.|+||++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 4666789999999999999999998743 35677765433211100 011223344556678999999
Q ss_pred EEEEEecCC----eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCe
Q 011158 354 FIGACTKPP----SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVS 429 (492)
Q Consensus 354 l~g~~~~~~----~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~ 429 (492)
+++++.... ..++++|++ ..++.+++.. ....++..++.++.|++.||.|||+++|+||||||+|||++.++.+
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKL-VENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred EEEeeeEecCCceEEEEEEehh-ccCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence 999765443 347888887 5577777765 2346888899999999999999999999999999999999999999
Q ss_pred EEEEEeecceee--------------eeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 430 LLLSLCLFTVSI--------------LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 430 kl~DFGla~~~~--------------~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
+|+|||+++... ...|+..|++|+......++..+|+|++ +..+..|.++|.
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~ 234 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWK 234 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 999999986431 1347778899998888888888899994 333455666664
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=214.73 Aligned_cols=158 Identities=16% Similarity=0.135 Sum_probs=123.0
Q ss_pred CCCCceeeeeeeecCceEEEEEEE---CCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhcCCCceee-EEEEEecCC
Q 011158 290 DPKHLKFGSKVASGSYGDLYRGTY---CSQDVAIKVLKPERI---NSDMQKEFAQEVFIMRKVRHKNVVQ-FIGACTKPP 362 (492)
Q Consensus 290 ~~~~~~~~~~LG~G~fG~Vy~~~~---~g~~vAvK~l~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~-l~g~~~~~~ 362 (492)
-...|.+.+.||+|+||.||+|.+ .++.||||++..... .......|.+|+.+|++++|+||+. ++++ +
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~ 91 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G 91 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence 346789999999999999999987 356789998763311 2334567999999999999999985 5442 4
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCC-CCCCEEEccCCCeEEEEEeecceee
Q 011158 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL-KAANLLMDENEVSLLLSLCLFTVSI 441 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDL-Kp~NILld~~~~~kl~DFGla~~~~ 441 (492)
..|||||||+|++|.. +.. .. ...++.|+++||.|||++||+|||| ||+|||++.++.+||+|||+++...
T Consensus 92 ~~~LVmE~~~G~~L~~-~~~----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 92 KDGLVRGWTEGVPLHL-ARP----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred CcEEEEEccCCCCHHH-hCc----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 5899999999999963 211 11 1467889999999999999999999 9999999999999999999987432
Q ss_pred ---------------eeeCCCceeecceecccc
Q 011158 442 ---------------LFCGKGRELISLFLGNDV 459 (492)
Q Consensus 442 ---------------~~~g~~~~~ape~~~~e~ 459 (492)
...++..|++||++.++.
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~ 196 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTPRE 196 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCChhh
Confidence 123444577777776644
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=208.30 Aligned_cols=176 Identities=20% Similarity=0.332 Sum_probs=145.9
Q ss_pred CceeeeeeeecCceEEEEEEE-----CCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCeE
Q 011158 293 HLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERIN--SDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSL 364 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~-----~g~~vAvK~l~~~~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~ 364 (492)
+|++.+.||+|+||.||+++. .++.||||+++..... ......+.+|+.++.++ +|+||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 367889999999999999975 3467999998753221 23346788999999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee--
Q 011158 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL-- 442 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~-- 442 (492)
|+||||+++|+|.+++.. ...+++..++.++.|++.||.|||+.+++||||||.||+++.++.++++|||+++....
T Consensus 81 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE 159 (288)
T ss_pred EEEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence 999999999999999976 35689999999999999999999999999999999999999999999999998865321
Q ss_pred ------eeCCCceeecceecccc--ccCccceeee
Q 011158 443 ------FCGKGRELISLFLGNDV--LLQFGTYWII 469 (492)
Q Consensus 443 ------~~g~~~~~ape~~~~e~--~~~~~d~W~l 469 (492)
..++..|++||...... .....|+|++
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~sl 194 (288)
T cd05583 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSL 194 (288)
T ss_pred ccccccccCCccccCHHHhcCCCCCCcchhhhHHH
Confidence 23556678888765443 5556788873
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.8e-24 Score=201.67 Aligned_cols=184 Identities=16% Similarity=0.233 Sum_probs=155.2
Q ss_pred CCceeeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 011158 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (492)
Q Consensus 284 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 361 (492)
.+...|+.++|.+.+.||.|+|+.||.++. ++..+|+|++.... .+..+..++|++..++++||||++++++....
T Consensus 13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~ 90 (302)
T KOG2345|consen 13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLRE 90 (302)
T ss_pred CCcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHh
Confidence 344678999999999999999999999975 56889999997653 45668889999999999999999999887543
Q ss_pred -----CeEEEEEeccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCCEEEccCCCeEE
Q 011158 362 -----PSLCIVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEVSLL 431 (492)
Q Consensus 362 -----~~~~lV~Ey~~ggsL~~~L~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~~--IiHrDLKp~NILld~~~~~kl 431 (492)
...||+++|...|+|.+.+... ...+++.+++.|+.+|++||++||... +.||||||.|||+.+.+.+++
T Consensus 91 ~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl 170 (302)
T KOG2345|consen 91 EKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVL 170 (302)
T ss_pred hccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEE
Confidence 3499999999999999999754 237899999999999999999999998 999999999999999999999
Q ss_pred EEEeecceeee----------------eeCCCceeeccee---ccccccCccceeee
Q 011158 432 LSLCLFTVSIL----------------FCGKGRELISLFL---GNDVLLQFGTYWII 469 (492)
Q Consensus 432 ~DFGla~~~~~----------------~~g~~~~~ape~~---~~e~~~~~~d~W~l 469 (492)
.|||.+..+.. ...+..|.+||.. ....++...|+|++
T Consensus 171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSL 227 (302)
T KOG2345|consen 171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSL 227 (302)
T ss_pred EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhh
Confidence 99999977642 2344567777744 34556777788984
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-24 Score=205.51 Aligned_cols=183 Identities=20% Similarity=0.292 Sum_probs=155.0
Q ss_pred CceeeCCCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCceeeEEEEEecC
Q 011158 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKP 361 (492)
Q Consensus 285 ~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~ 361 (492)
.....+.++++++..||+|+.|.|+++++. |...|||.+... .+.+..++++..+.++.+.+ +|+||+.+|+|..+
T Consensus 85 ~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt-~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n 163 (391)
T KOG0983|consen 85 QRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT-GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN 163 (391)
T ss_pred cccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc-CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC
Confidence 345667788899999999999999999884 588999999864 35666788999999888876 89999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~-~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
..++|.||.| ...+..++++-++++++..+-++...+++||.||-.+ +|||||+||+|||+|+.|.+|++|||.++..
T Consensus 164 ~dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrl 242 (391)
T KOG0983|consen 164 TDVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRL 242 (391)
T ss_pred chHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeeccccccee
Confidence 9999999999 6788888888788999999999999999999999976 8999999999999999999999999999865
Q ss_pred ee------eeCCCceeecceeccc---cccCccceeee
Q 011158 441 IL------FCGKGRELISLFLGND---VLLQFGTYWII 469 (492)
Q Consensus 441 ~~------~~g~~~~~ape~~~~e---~~~~~~d~W~l 469 (492)
.. ..|-..||+||-+.++ .|.-.+|.|++
T Consensus 243 vdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSl 280 (391)
T KOG0983|consen 243 VDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSL 280 (391)
T ss_pred ecccccccccCCccccCccccCCCCCCccchhhhhhhh
Confidence 32 3344667777766654 34445678985
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=213.19 Aligned_cols=188 Identities=18% Similarity=0.258 Sum_probs=146.6
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChH------------HHHHHHHHHHHHHhcCCCceeeEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSD------------MQKEFAQEVFIMRKVRHKNVVQFIGA 357 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~------------~~~~~~~Ei~il~~l~HpnIv~l~g~ 357 (492)
+.+.+.+.||+|+||.||+|.+ .++.||||+++....... ....+.+|+.++++++|+||++++++
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 3344567899999999999987 468899999875432210 01257789999999999999999999
Q ss_pred EecCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeec
Q 011158 358 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLF 437 (492)
Q Consensus 358 ~~~~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla 437 (492)
+...+..|+||||+. |+|.+++.. ...+++..+..++.|++.||.|||++||+|+||||+||+++.++.++++|||.+
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~ 166 (335)
T PTZ00024 89 YVEGDFINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA 166 (335)
T ss_pred EecCCcEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccce
Confidence 999999999999995 699999965 456899999999999999999999999999999999999999999999999988
Q ss_pred ceee---------------------eeeCCCceeecceecc-ccccCccceeee---ecccccCCCCCC
Q 011158 438 TVSI---------------------LFCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 438 ~~~~---------------------~~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
.... ...++..|++||+... ..+....|+|++ +.....|.++|.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~ 235 (335)
T PTZ00024 167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP 235 (335)
T ss_pred eecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 6432 1122345677776543 334556788884 223334555543
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-24 Score=211.09 Aligned_cols=177 Identities=18% Similarity=0.295 Sum_probs=139.4
Q ss_pred CCceeeeeeeecCceEEEEEEEC------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEec-CCeE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK-PPSL 364 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~------g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~~ 364 (492)
..|+...+||+|+||.||+|..+ .+.+|||.++.+..........-+|+.+++.++||||+.+..++.. ...+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 46788899999999999999542 1369999998764333334566789999999999999999999877 7789
Q ss_pred EEEEeccCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccC----CCeEEEEEee
Q 011158 365 CIVTEFMSGGSVYDYLHKL----KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN----EVSLLLSLCL 436 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~----~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~----~~~kl~DFGl 436 (492)
++++||.+ -+|.+.|+-. ...++...++.|+.||+.|+.|||++=|+||||||+|||+.-+ |.+||+|||+
T Consensus 104 ~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl 182 (438)
T KOG0666|consen 104 WLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGL 182 (438)
T ss_pred EEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccH
Confidence 99999994 5999999643 2468999999999999999999999999999999999999877 8999999999
Q ss_pred cceeee-----eeCCCceeecceecc------ccccCccceeee
Q 011158 437 FTVSIL-----FCGKGRELISLFLGN------DVLLQFGTYWII 469 (492)
Q Consensus 437 a~~~~~-----~~g~~~~~ape~~~~------e~~~~~~d~W~l 469 (492)
+|+-.. ....+...+--|.+| .-|+...|.|++
T Consensus 183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAi 226 (438)
T KOG0666|consen 183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAI 226 (438)
T ss_pred HHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHH
Confidence 987532 222333233334444 445555566773
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-23 Score=211.17 Aligned_cols=175 Identities=17% Similarity=0.236 Sum_probs=141.9
Q ss_pred CceeeeeeeecCceEEEEEEEC----CceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeEEEEEecC----Ce
Q 011158 293 HLKFGSKVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKP----PS 363 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~~----g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~----~~ 363 (492)
+|++.+.||+|+||.||++.+. +..||+|++..........+.+.+|+.+++++ +|+||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 3678899999999999999884 45799999875433334456788999999999 599999999875432 45
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee--
Q 011158 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-- 441 (492)
Q Consensus 364 ~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-- 441 (492)
.|+++||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.+....
T Consensus 81 ~~~~~e~~-~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 81 LYLYEELM-EADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred EEEEEecc-cCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 78999999 5799999865 4578999999999999999999999999999999999999999999999999986432
Q ss_pred ---------eeeCCCceeecceecc-ccccCccceeee
Q 011158 442 ---------LFCGKGRELISLFLGN-DVLLQFGTYWII 469 (492)
Q Consensus 442 ---------~~~g~~~~~ape~~~~-e~~~~~~d~W~l 469 (492)
...++..|++||+... ..+....|+|++
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~sl 196 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSV 196 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHH
Confidence 1235566788886533 445666788873
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.9e-23 Score=221.03 Aligned_cols=175 Identities=29% Similarity=0.450 Sum_probs=148.3
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeEEEEEec-----CCe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTK-----PPS 363 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~-----~~~ 363 (492)
..+.+.+.||.|.+|.||+++. .++..|+|++... .+..+++..|..|++.. .|||++.++|++.. .+.
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~---~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT---EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC---ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 3456679999999999999865 6788999998764 33447788899999887 59999999999863 467
Q ss_pred EEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-
Q 011158 364 LCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI- 441 (492)
Q Consensus 364 ~~lV~Ey~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~- 441 (492)
+|||||||.|||..|+++... ..+.|..+..|++.++.|+.+||.+.+||||||-.|||++.++.+|++|||++....
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQlds 175 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS 175 (953)
T ss_pred EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeec
Confidence 999999999999999998764 479999999999999999999999999999999999999999999999999986542
Q ss_pred ------eeeCCCceeecceecccc-----ccCccceeee
Q 011158 442 ------LFCGKGRELISLFLGNDV-----LLQFGTYWII 469 (492)
Q Consensus 442 ------~~~g~~~~~ape~~~~e~-----~~~~~d~W~l 469 (492)
...|++.||+||+++-+. |..-.|.|++
T Consensus 176 T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsL 214 (953)
T KOG0587|consen 176 TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSL 214 (953)
T ss_pred ccccccCcCCCcccccceeeecccCCCCCcccccchhhc
Confidence 467999999999886643 3444567885
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.2e-23 Score=204.19 Aligned_cols=174 Identities=22% Similarity=0.321 Sum_probs=144.8
Q ss_pred ceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCeEEEEEec
Q 011158 294 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEF 370 (492)
Q Consensus 294 ~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~Ey 370 (492)
|++.+.||+|+||.||+|++ +++.|+||.+...... .......+|+..+++++ |+||+++++++...+..|+||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 56778999999999999998 4678999998754322 22234567999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee------e
Q 011158 371 MSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL------F 443 (492)
Q Consensus 371 ~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~------~ 443 (492)
+ +|+|.+++.... ..+++..++.++.|++.+|.|||+++|+|+||||+||+++.++.++++|||.+..... .
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 158 (283)
T cd07830 80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDY 158 (283)
T ss_pred C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCC
Confidence 9 889999997754 4789999999999999999999999999999999999999999999999999865432 2
Q ss_pred eCCCceeeccee-ccccccCccceeee
Q 011158 444 CGKGRELISLFL-GNDVLLQFGTYWII 469 (492)
Q Consensus 444 ~g~~~~~ape~~-~~e~~~~~~d~W~l 469 (492)
.++..|++||+. ....+...+|+|++
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~~Di~s~ 185 (283)
T cd07830 159 VSTRWYRAPEILLRSTSYSSPVDIWAL 185 (283)
T ss_pred CCcccccCceeeecCcCcCCccchhhH
Confidence 345567888865 33445667788884
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=205.93 Aligned_cols=175 Identities=20% Similarity=0.315 Sum_probs=147.3
Q ss_pred ceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEecc
Q 011158 294 LKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 371 (492)
Q Consensus 294 ~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 371 (492)
|++.+.||+|+||.||+|+.. ++.||+|++............+..|+.++++++|+||+++++++......++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456688999999999999884 688999999875433444567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee-------ee
Q 011158 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL-------FC 444 (492)
Q Consensus 372 ~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~-------~~ 444 (492)
+ ++|.+++.+....+++..++.++.|++.||.|||+++|+||||||+||++++++.++|+|||.+..... ..
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 159 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEV 159 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCccc
Confidence 6 699999987546799999999999999999999999999999999999999999999999999865421 12
Q ss_pred CCCceeecceeccc-cccCccceeee
Q 011158 445 GKGRELISLFLGND-VLLQFGTYWII 469 (492)
Q Consensus 445 g~~~~~ape~~~~e-~~~~~~d~W~l 469 (492)
.+..|++||+.... .+....|+|++
T Consensus 160 ~~~~~~aPE~~~~~~~~~~~~Dv~sl 185 (282)
T cd07829 160 VTLWYRAPEILLGSKHYSTAVDIWSV 185 (282)
T ss_pred cCcCcCChHHhcCCcCCCccccHHHH
Confidence 23457778766544 56666788874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=228.99 Aligned_cols=195 Identities=24% Similarity=0.451 Sum_probs=165.0
Q ss_pred ceeeCCCCceeeeeeeecCceEEEEEEEC---------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCceeeEE
Q 011158 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYC---------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFI 355 (492)
Q Consensus 286 ~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~---------g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~ 355 (492)
.|+++.+++++.+.||+|.||.|++|... ...||||.++..... ...+.+..|+.+|+.+. |+||+.++
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 79999999999999999999999999752 245999999876544 66788999999999994 99999999
Q ss_pred EEEecCCeEEEEEeccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCC
Q 011158 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 420 (492)
Q Consensus 356 g~~~~~~~~~lV~Ey~~ggsL~~~L~~~~---------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~N 420 (492)
|+|...+.+++|+||+..|+|.+||+..+ ..++...++.++.||+.||+||+++++|||||.++|
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRN 448 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARN 448 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhh
Confidence 99999999999999999999999998866 348999999999999999999999999999999999
Q ss_pred EEEccCCCeEEEEEeecceee---ee--eC-----CCceeecceeccccccCccceee----eecccccCCCCCC
Q 011158 421 LLMDENEVSLLLSLCLFTVSI---LF--CG-----KGRELISLFLGNDVLLQFGTYWI----IFRRSSCDKKNSD 481 (492)
Q Consensus 421 ILld~~~~~kl~DFGla~~~~---~~--~g-----~~~~~ape~~~~e~~~~~~d~W~----l~~~~~~gt~~Y~ 481 (492)
||+..+..+||+|||+++... .+ .+ ...||+||-+....+...+|.|+ ++...+.|-.+|-
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp 523 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYP 523 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCC
Confidence 999999999999999998431 11 11 23489999887778888888877 2333445555553
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.6e-23 Score=212.02 Aligned_cols=192 Identities=21% Similarity=0.284 Sum_probs=151.2
Q ss_pred ceeeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC-
Q 011158 286 VWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP- 362 (492)
Q Consensus 286 ~~ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~- 362 (492)
.|++. .+|.+.+.||+|+||.||+|++ +++.||||+++...........+.+|+.++++++|+||+++++++....
T Consensus 10 ~~~~~-~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 88 (342)
T cd07879 10 VWELP-ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVS 88 (342)
T ss_pred hhccc-cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheeccccc
Confidence 46664 5788999999999999999987 4788999998764333444466889999999999999999999987543
Q ss_pred -----eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeec
Q 011158 363 -----SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLF 437 (492)
Q Consensus 363 -----~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla 437 (492)
.+|+|+||+. .+|..++ ...+++..+..++.|++.||.|||+++|+||||||+|||++.++.+|++|||++
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 89 GDEFQDFYLVMPYMQ-TDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred CCCCceEEEEecccc-cCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 4699999995 5777765 236899999999999999999999999999999999999999999999999998
Q ss_pred ceee----eeeCCCceeecceecc-ccccCccceeee---ecccccCCCCCCC
Q 011158 438 TVSI----LFCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 438 ~~~~----~~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
+... ...++..|++||+... ..+....|+|++ +.....|...|.+
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~ 217 (342)
T cd07879 165 RHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 217 (342)
T ss_pred cCCCCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 6532 1234456778887644 345666788884 2233345555543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-24 Score=207.50 Aligned_cols=184 Identities=18% Similarity=0.254 Sum_probs=152.7
Q ss_pred CCceeeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHH-hcCCCceeeEEEEEec
Q 011158 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMR-KVRHKNVVQFIGACTK 360 (492)
Q Consensus 284 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~-~l~HpnIv~l~g~~~~ 360 (492)
...|++..++++-+..||.|+||.|++..+ .|+..|||.++.... ...+++++.|.+... .-+.||||+++|++..
T Consensus 56 ~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~ 134 (361)
T KOG1006|consen 56 AHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS 134 (361)
T ss_pred ccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc
Confidence 445788888999999999999999999987 478899999987544 455678888887654 4578999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEEccCCCeEEEEEe
Q 011158 361 PPSLCIVTEFMSGGSVYDYLHK----LKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVSLLLSLC 435 (492)
Q Consensus 361 ~~~~~lV~Ey~~ggsL~~~L~~----~~~~l~~~~~~~i~~qI~~gL~yLH~~-~IiHrDLKp~NILld~~~~~kl~DFG 435 (492)
++..||.||+| ..||..+.+. ++..+++..+..|+.-.+.||+||-.. +|||||+||+|||++..|.+|++|||
T Consensus 135 EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFG 213 (361)
T KOG1006|consen 135 EGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFG 213 (361)
T ss_pred CCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeeccc
Confidence 99999999999 6787766542 245789999999999999999999875 89999999999999999999999999
Q ss_pred ecceee------eeeCCCceeecceecccc--ccCccceeee
Q 011158 436 LFTVSI------LFCGKGRELISLFLGNDV--LLQFGTYWII 469 (492)
Q Consensus 436 la~~~~------~~~g~~~~~ape~~~~e~--~~~~~d~W~l 469 (492)
.++... ...|-..||+||-+.|.. |.-.+|.|++
T Consensus 214 IcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSL 255 (361)
T KOG1006|consen 214 ICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSL 255 (361)
T ss_pred chHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhh
Confidence 998642 345667889998776644 4445678885
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.7e-23 Score=199.67 Aligned_cols=182 Identities=25% Similarity=0.314 Sum_probs=151.2
Q ss_pred eeecCceEEEEEEEC--CceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEeccCCCCH
Q 011158 300 VASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376 (492)
Q Consensus 300 LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ggsL 376 (492)
||.|+||.||++.+. ++.+|+|++...... ......+..|+.++++++|+||+++++.+......|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999884 688999998765332 23556789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee-------eeCCCce
Q 011158 377 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL-------FCGKGRE 449 (492)
Q Consensus 377 ~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~-------~~g~~~~ 449 (492)
.+++... ..+++..+..++.|++.||.|||+++++|+||||+||+++.++.++++|||.+..... ..++..|
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 159 (250)
T cd05123 81 FSHLSKE-GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEY 159 (250)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccc
Confidence 9999773 4689999999999999999999999999999999999999999999999999865432 3455678
Q ss_pred eecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 450 LISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 450 ~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
++||...........|+|++ +.....|..+|..
T Consensus 160 ~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~ 195 (250)
T cd05123 160 LAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA 195 (250)
T ss_pred cChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 88887766666667788874 2223345555543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=6e-23 Score=207.06 Aligned_cols=177 Identities=25% Similarity=0.350 Sum_probs=148.1
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
+.|+..+.||+|+||.||+|++ +++.+|+|.+.... .......++.+|+.+++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 4577778999999999999987 46789999987532 23344567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee---eeeC
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI---LFCG 445 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~---~~~g 445 (492)
||+. |+|.+++......+++..+..++.|++.||.|||+++++||||||+|||++.++.++++|||++.... ...+
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 173 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVG 173 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCcccccC
Confidence 9995 68888887656678999999999999999999999999999999999999999999999999987543 2345
Q ss_pred CCceeecceec---cccccCccceeee
Q 011158 446 KGRELISLFLG---NDVLLQFGTYWII 469 (492)
Q Consensus 446 ~~~~~ape~~~---~e~~~~~~d~W~l 469 (492)
+..|++||+.. ...+...+|+|++
T Consensus 174 ~~~y~aPE~~~~~~~~~~~~~~Di~sl 200 (308)
T cd06634 174 TPYWMAPEVILAMDEGQYDGKVDVWSL 200 (308)
T ss_pred CccccCHHHHhhcccCCCCcccchHHH
Confidence 66788888753 2345566788873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.9e-23 Score=199.21 Aligned_cols=159 Identities=16% Similarity=0.187 Sum_probs=133.5
Q ss_pred cCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEeccCCCCHHHHH
Q 011158 303 GSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL 380 (492)
Q Consensus 303 G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ggsL~~~L 380 (492)
|.||.||++.+ +++.||+|+++... .+.+|...+....||||+++++++......|+||||+++|+|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 89999999988 56889999997542 2334555566677999999999999999999999999999999999
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee----eeCCCceeecceec
Q 011158 381 HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL----FCGKGRELISLFLG 456 (492)
Q Consensus 381 ~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~----~~g~~~~~ape~~~ 456 (492)
.+. ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.++++|||.+..... ..++..|++||+..
T Consensus 77 ~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~aPE~~~ 155 (237)
T cd05576 77 SKF-LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPEVGG 155 (237)
T ss_pred HHh-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccCCcccC
Confidence 763 4689999999999999999999999999999999999999999999999998754322 23344588888876
Q ss_pred cccccCccceeee
Q 011158 457 NDVLLQFGTYWII 469 (492)
Q Consensus 457 ~e~~~~~~d~W~l 469 (492)
...+....|+|++
T Consensus 156 ~~~~~~~~Dvwsl 168 (237)
T cd05576 156 ISEETEACDWWSL 168 (237)
T ss_pred CCCCCchhhHHHH
Confidence 6666777888884
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.5e-23 Score=211.39 Aligned_cols=192 Identities=22% Similarity=0.309 Sum_probs=153.2
Q ss_pred ceeeCCCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCe
Q 011158 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (492)
Q Consensus 286 ~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 363 (492)
.|++. ++|++...||+|+||.||+|.+. ++.||||++.....+......+.+|+.++++++|+||+++++++...+.
T Consensus 10 ~~~~~-~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07851 10 VWEVP-DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASS 88 (343)
T ss_pred eeccc-CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccc
Confidence 35553 56899999999999999999884 6789999987644344455678889999999999999999988766554
Q ss_pred ------EEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeec
Q 011158 364 ------LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLF 437 (492)
Q Consensus 364 ------~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla 437 (492)
.|+|+||+ +++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||.+
T Consensus 89 ~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 89 LEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred ccccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence 89999999 7899999875 56899999999999999999999999999999999999999999999999998
Q ss_pred ceee----eeeCCCceeecceecc-ccccCccceeee---ecccccCCCCCC
Q 011158 438 TVSI----LFCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 438 ~~~~----~~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
.... ...++..|++||.... ..+....|+|++ +.....|.++|.
T Consensus 166 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~ 217 (343)
T cd07851 166 RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFP 217 (343)
T ss_pred ccccccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 6542 2344556777876643 234556788884 222334555543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.7e-23 Score=201.52 Aligned_cols=176 Identities=22% Similarity=0.364 Sum_probs=143.1
Q ss_pred CceeeeeeeecCceEEEEEEEC--CceEEEEEecCCC---CChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEE
Q 011158 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPER---INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~---~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 367 (492)
+|.+.++||+|+||.||++.+. +..+++|+++... ........+.+|+.++++++||||+++++++......++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4778899999999999999874 3456667665422 2233345677899999999999999999999998999999
Q ss_pred EeccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee---
Q 011158 368 TEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI--- 441 (492)
Q Consensus 368 ~Ey~~ggsL~~~L~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~--- 441 (492)
|||+++++|.+++... ...+++..++.++.|++.||.|||++|++|+||||+||+++. +.++++|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 9999999999998642 356899999999999999999999999999999999999985 569999999886542
Q ss_pred ----eeeCCCceeecceeccccccCccceeee
Q 011158 442 ----LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 442 ----~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
...++..|++||+.....+....|+|++
T Consensus 160 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~sl 191 (260)
T cd08222 160 DLATTFTGTPYYMSPEALKHQGYDSKSDIWSL 191 (260)
T ss_pred ccccCCCCCcCccCHHHHccCCCCchhhHHHH
Confidence 2335556788887765556666788873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.89 E-value=7e-23 Score=209.89 Aligned_cols=185 Identities=21% Similarity=0.255 Sum_probs=147.1
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--------
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-------- 361 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-------- 361 (492)
.+|.+.+.||.|+||.||+|.+ +++.||+|++..... ...+.+.+|+.++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 5788999999999999999987 468899999875432 3446788999999999999999999776543
Q ss_pred ------CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcc-CCCeEEEEE
Q 011158 362 ------PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEVSLLLSL 434 (492)
Q Consensus 362 ------~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~-~~~~kl~DF 434 (492)
...|+||||++ ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++. ++.+|++||
T Consensus 83 ~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 83 GSLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred ccccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCc
Confidence 35799999995 699998864 46899999999999999999999999999999999999984 557899999
Q ss_pred eecceee----------eeeCCCceeecceec-cccccCccceeee---ecccccCCCCCC
Q 011158 435 CLFTVSI----------LFCGKGRELISLFLG-NDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 435 Gla~~~~----------~~~g~~~~~ape~~~-~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
|.+.... ...++..|++||+.. +..+...+|+|++ +....+|..+|.
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~ 220 (342)
T cd07854 160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFA 220 (342)
T ss_pred ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9986431 123455678888643 3445667788884 333445665554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-23 Score=205.84 Aligned_cols=184 Identities=20% Similarity=0.279 Sum_probs=161.7
Q ss_pred CceeeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChH-HHHHHHHHHHHHHhc-CCCceeeEEEEEec
Q 011158 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSD-MQKEFAQEVFIMRKV-RHKNVVQFIGACTK 360 (492)
Q Consensus 285 ~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~-~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~ 360 (492)
..|.+...+|.++.+||+|+|.+|..+.. +.+.+|+|+++++-.+.+ ...-...|-.+..+. +||.+|-++.+|..
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt 322 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT 322 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence 45778888999999999999999999976 457899999998755433 233345566666655 79999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 361 ~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
+..+++|.||++||+|.-.+++ ...+++..+..+...|+.||.|||++|||.||||.+|+|+|..|.+|+.|+|.++..
T Consensus 323 esrlffvieyv~ggdlmfhmqr-qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred cceEEEEEEEecCcceeeehhh-hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcC
Confidence 9999999999999999998877 457999999999999999999999999999999999999999999999999998654
Q ss_pred -------eeeeCCCceeecceeccccccCccceeee
Q 011158 441 -------ILFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 441 -------~~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
..++|++.|.+||.+..+.|....|||++
T Consensus 402 l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwal 437 (593)
T KOG0695|consen 402 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWAL 437 (593)
T ss_pred CCCCcccccccCCCcccchhhhcccccCceehHHHH
Confidence 46899999999999999999999999994
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-23 Score=225.29 Aligned_cols=188 Identities=24% Similarity=0.396 Sum_probs=151.8
Q ss_pred CCceeeeeeeecCceEEEEEEE--CC----ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CS----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g----~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 365 (492)
..++..++||+|+||+||+|.| .+ -+||||++.... ......+++.|+.+|.+++|||+++++++|.... +-
T Consensus 696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 3455668999999999999988 33 469999987543 3444578999999999999999999999998765 88
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee---
Q 011158 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL--- 442 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~--- 442 (492)
||++||++|+|.+|++.++..+.....+.|..||++||.|||.++++||||.++|+|+.+-..+|+.|||++++...
T Consensus 774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 99999999999999999899999999999999999999999999999999999999999999999999999987532
Q ss_pred -eeCC-----CceeecceeccccccCccceeee----ecccccCCCCCC
Q 011158 443 -FCGK-----GRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSD 481 (492)
Q Consensus 443 -~~g~-----~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~ 481 (492)
+... ..||+-|...-..+...+|.|+. ...+++|..+|.
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~ 902 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYD 902 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccC
Confidence 1111 23455554445555555665552 223446766665
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.9e-22 Score=190.65 Aligned_cols=139 Identities=17% Similarity=0.177 Sum_probs=108.5
Q ss_pred eeeeeecCceEEEEEEE-CCceEEEEEecCCCCChHH------------------------HHHHHHHHHHHHhcCCCce
Q 011158 297 GSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDM------------------------QKEFAQEVFIMRKVRHKNV 351 (492)
Q Consensus 297 ~~~LG~G~fG~Vy~~~~-~g~~vAvK~l~~~~~~~~~------------------------~~~~~~Ei~il~~l~HpnI 351 (492)
...||+|+||.||+|.. +|+.||||+++........ .....+|+.++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 36899999999999987 5889999999865321111 1122459999999988776
Q ss_pred eeEEEEEecCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HHCCceecCCCCCCEEEccCCCeE
Q 011158 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL-HQNNIIHRDLKAANLLMDENEVSL 430 (492)
Q Consensus 352 v~l~g~~~~~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yL-H~~~IiHrDLKp~NILld~~~~~k 430 (492)
.....+... ..+|||||++|+++...+.. ...++...+..++.|++.+|.|| |+.||+||||||+|||++ ++.++
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 443332222 23899999988877655433 35789999999999999999999 799999999999999998 47899
Q ss_pred EEEEeecce
Q 011158 431 LLSLCLFTV 439 (492)
Q Consensus 431 l~DFGla~~ 439 (492)
++|||++..
T Consensus 158 LiDFG~a~~ 166 (190)
T cd05147 158 IIDVSQSVE 166 (190)
T ss_pred EEEcccccc
Confidence 999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=7e-24 Score=223.19 Aligned_cols=177 Identities=27% Similarity=0.419 Sum_probs=155.4
Q ss_pred CCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEE
Q 011158 290 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (492)
Q Consensus 290 ~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 367 (492)
+..+|.+...+|+|+||.||++++ +++..|+|+++.+.. +...-+.+|+-+++.++|+|||.++|.+.....+||+
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~--dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG--DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCC--ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 346788899999999999999987 578899999987643 2345677899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee-------
Q 011158 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS------- 440 (492)
Q Consensus 368 ~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~------- 440 (492)
||||.||+|.+..+- .+++++.++..+.+..++||+|||++|-+|||||-+|||+++.|.+|++|||+++..
T Consensus 91 MEycgggslQdiy~~-TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Kr 169 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKR 169 (829)
T ss_pred EEecCCCcccceeee-cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhh
Confidence 999999999997765 678999999999999999999999999999999999999999999999999998643
Q ss_pred eeeeCCCceeecceecc---ccccCccceeee
Q 011158 441 ILFCGKGRELISLFLGN---DVLLQFGTYWII 469 (492)
Q Consensus 441 ~~~~g~~~~~ape~~~~---e~~~~~~d~W~l 469 (492)
+.+.|++.||+||+.+= ..|.+..|+|+.
T Consensus 170 ksfiGtpywmapEvaaverkggynqlcdiwa~ 201 (829)
T KOG0576|consen 170 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAL 201 (829)
T ss_pred hcccCCccccchhHHHHHhccccccccccccc
Confidence 46889999999997644 446666788883
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=7e-22 Score=211.79 Aligned_cols=151 Identities=21% Similarity=0.320 Sum_probs=119.3
Q ss_pred eCCCCceeeeeeeecCceEEEEEEE------------------CCceEEEEEecCCCCCh------------HHHHHHHH
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTY------------------CSQDVAIKVLKPERINS------------DMQKEFAQ 338 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~------------------~g~~vAvK~l~~~~~~~------------~~~~~~~~ 338 (492)
+..++|++.++||+|+||.||+|.+ .++.||||.++...... ...+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 4577899999999999999999964 23569999987532110 01123345
Q ss_pred HHHHHHhcCCCce-----eeEEEEEec--------CCeEEEEEeccCCCCHHHHHHhcCC--------------------
Q 011158 339 EVFIMRKVRHKNV-----VQFIGACTK--------PPSLCIVTEFMSGGSVYDYLHKLKG-------------------- 385 (492)
Q Consensus 339 Ei~il~~l~HpnI-----v~l~g~~~~--------~~~~~lV~Ey~~ggsL~~~L~~~~~-------------------- 385 (492)
|+.++.+++|.++ ++++++|.. .+..||||||+++++|.++|+...+
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7788888877654 677777753 3568999999999999999974211
Q ss_pred ---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecce
Q 011158 386 ---VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTV 439 (492)
Q Consensus 386 ---~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~ 439 (492)
.+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||++..
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~ 358 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVD 358 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccc
Confidence 235677889999999999999999999999999999999999999999999864
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.9e-24 Score=203.76 Aligned_cols=170 Identities=21% Similarity=0.289 Sum_probs=142.0
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC-----eEEEEEec
Q 011158 298 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP-----SLCIVTEF 370 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-----~~~lV~Ey 370 (492)
+.||.|+||.||.+++ .|+.||+|.+..-..+-...+++.+|+.+|.-.+|.|++..+++...+. ++|.++|+
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL 138 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL 138 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence 6899999999999988 5788999988644334445688999999999999999999998876543 36889999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee--------
Q 011158 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL-------- 442 (492)
Q Consensus 371 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~-------- 442 (492)
| ..+|.+.|-. ...++...++-+.+||++||+|||+.+|+||||||.|+|++.|...||+|||++|.-..
T Consensus 139 m-QSDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTq 216 (449)
T KOG0664|consen 139 M-QSDLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTH 216 (449)
T ss_pred H-Hhhhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhhhHH
Confidence 9 6688888866 67899999999999999999999999999999999999999999999999999987532
Q ss_pred eeCCCceeeccee-ccccccCccceeee
Q 011158 443 FCGKGRELISLFL-GNDVLLQFGTYWII 469 (492)
Q Consensus 443 ~~g~~~~~ape~~-~~e~~~~~~d~W~l 469 (492)
..-+..|.+||.+ +...|+...|+|++
T Consensus 217 EVVTQYYRAPEiLMGaRhYs~AvDiWSV 244 (449)
T KOG0664|consen 217 EVVTQYYRAPELLMGARRYTGAVDIWSV 244 (449)
T ss_pred HHHHHHhccHHHhhcchhhcCccceehh
Confidence 2334556777744 55677888889984
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.4e-24 Score=202.16 Aligned_cols=152 Identities=25% Similarity=0.428 Sum_probs=128.1
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC----
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP---- 361 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~---- 361 (492)
-++...|.-..+||+|.||.||+|+. .++.||+|++--+......-...++|+.+|..++|+|++.+++.|...
T Consensus 13 ~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~ 92 (376)
T KOG0669|consen 13 CDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPT 92 (376)
T ss_pred eecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence 34445677778999999999999976 567899987654332233345678999999999999999999988532
Q ss_pred ----CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeec
Q 011158 362 ----PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLF 437 (492)
Q Consensus 362 ----~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla 437 (492)
..+|+|+.+| ..+|.-+|......++...+.+++.++..||.|+|++.|+|||+||+|+||+.+|.+|++|||++
T Consensus 93 ~r~r~t~ylVf~~c-ehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 93 NRDRATFYLVFDFC-EHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ccccceeeeeHHHh-hhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 3489999999 55899999876678999999999999999999999999999999999999999999999999999
Q ss_pred cee
Q 011158 438 TVS 440 (492)
Q Consensus 438 ~~~ 440 (492)
+.-
T Consensus 172 r~f 174 (376)
T KOG0669|consen 172 RAF 174 (376)
T ss_pred cce
Confidence 654
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.6e-23 Score=192.04 Aligned_cols=143 Identities=21% Similarity=0.409 Sum_probs=124.6
Q ss_pred CCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCe--E
Q 011158 290 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPS--L 364 (492)
Q Consensus 290 ~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~--~ 364 (492)
..++|++.+++|+|.|+.||.|.. ++++++||++++- ..+.+.+|+.||..+. ||||++++++..++.. .
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 346899999999999999999975 6789999999854 2478899999999997 9999999999987643 6
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccC-CCeEEEEEeecceee
Q 011158 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-EVSLLLSLCLFTVSI 441 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~-~~~kl~DFGla~~~~ 441 (492)
.+|+||+.+.+...+.. .++...+..++.++++||.|||++||+|||+||.|++||.. ...+++|.|+|.+-.
T Consensus 111 aLiFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhHhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 79999998888777653 47888999999999999999999999999999999999954 478899999997643
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.5e-21 Score=182.55 Aligned_cols=188 Identities=27% Similarity=0.437 Sum_probs=154.5
Q ss_pred ceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEecc
Q 011158 294 LKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 371 (492)
Q Consensus 294 ~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 371 (492)
|.+.+.||+|++|.||++... ++.+++|.+...... .....+.+|+..+++++|+|++++++++......++++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 456789999999999999884 588999999865332 24678899999999999999999999999989999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee--------e
Q 011158 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL--------F 443 (492)
Q Consensus 372 ~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~--------~ 443 (492)
++++|.+++......+++..+..++.+++.++.|||+++++|+||+|.||+++.++.++++|||.+..... .
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 159 (225)
T smart00221 80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTV 159 (225)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccce
Confidence 99999999987443389999999999999999999999999999999999999999999999999876532 3
Q ss_pred eCCCceeeccee-ccccccCccceeee---ecccccCCCCCCC
Q 011158 444 CGKGRELISLFL-GNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 444 ~g~~~~~ape~~-~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
.+...|++||.. ....+....|+|++ +.....|.++|..
T Consensus 160 ~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 160 KGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 455567777776 44445556777773 2334457777744
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=3e-21 Score=182.17 Aligned_cols=139 Identities=15% Similarity=0.176 Sum_probs=110.6
Q ss_pred eeeeeecCceEEEEEEE-CCceEEEEEecCCCCChH------------------------HHHHHHHHHHHHHhcCCCce
Q 011158 297 GSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSD------------------------MQKEFAQEVFIMRKVRHKNV 351 (492)
Q Consensus 297 ~~~LG~G~fG~Vy~~~~-~g~~vAvK~l~~~~~~~~------------------------~~~~~~~Ei~il~~l~HpnI 351 (492)
.+.||+|+||.||+|++ +|+.||||+++....... ....+..|...+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46899999999999987 489999999986532100 01234679999999999987
Q ss_pred eeEEEEEecCCeEEEEEeccCCCCHHHH-HHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEccCCCe
Q 011158 352 VQFIGACTKPPSLCIVTEFMSGGSVYDY-LHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVS 429 (492)
Q Consensus 352 v~l~g~~~~~~~~~lV~Ey~~ggsL~~~-L~~~~~~l~~~~~~~i~~qI~~gL~yLH~-~~IiHrDLKp~NILld~~~~~ 429 (492)
.....+.... .||||||++|+++... +.. ..++...+..++.|++.+|.+||+ +||+||||||+|||++ ++.+
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence 5444443332 4899999988865443 433 567888999999999999999999 9999999999999999 7899
Q ss_pred EEEEEeeccee
Q 011158 430 LLLSLCLFTVS 440 (492)
Q Consensus 430 kl~DFGla~~~ 440 (492)
+++|||++...
T Consensus 157 ~liDFG~a~~~ 167 (190)
T cd05145 157 YIIDVSQAVEL 167 (190)
T ss_pred EEEEcccceec
Confidence 99999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.2e-21 Score=176.94 Aligned_cols=168 Identities=29% Similarity=0.506 Sum_probs=141.8
Q ss_pred eeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEeccCCCCHH
Q 011158 300 VASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377 (492)
Q Consensus 300 LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ggsL~ 377 (492)
||+|++|.||++... ++.+++|++....... ....+.+|+.+++.++|++|+++++++......++++||+.+++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 689999999999986 7899999998654322 3467899999999999999999999999989999999999999999
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcc-CCCeEEEEEeecceeee-------eeCCCce
Q 011158 378 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEVSLLLSLCLFTVSIL-------FCGKGRE 449 (492)
Q Consensus 378 ~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~-~~~~kl~DFGla~~~~~-------~~g~~~~ 449 (492)
+++......++...+..++.+++++|.|||+++++|+||+|.||+++. ++.++++|||.+..... ..+...|
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 159 (215)
T cd00180 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAY 159 (215)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCc
Confidence 999874456899999999999999999999999999999999999999 89999999999875432 2344556
Q ss_pred eecceeccc-cccCccceee
Q 011158 450 LISLFLGND-VLLQFGTYWI 468 (492)
Q Consensus 450 ~ape~~~~e-~~~~~~d~W~ 468 (492)
++|+..... ......|+|+
T Consensus 160 ~~pe~~~~~~~~~~~~D~~~ 179 (215)
T cd00180 160 MAPEVLLGKGYYSEKSDIWS 179 (215)
T ss_pred cChhHhcccCCCCchhhhHH
Confidence 666665554 5555566666
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.1e-22 Score=200.11 Aligned_cols=177 Identities=18% Similarity=0.279 Sum_probs=143.5
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCh-----HHHHHHHHHHHHHHhcCCCceeeEEEEEe-cCCe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS-----DMQKEFAQEVFIMRKVRHKNVVQFIGACT-KPPS 363 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~-~~~~ 363 (492)
++|-++..||+|+|+.||++.+ ..+.||||+-..++... .+.+...+|..|.+.|.||.||++|+++. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 4566788999999999999987 35789999876654322 23445678999999999999999999996 5567
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CceecCCCCCCEEEcc---CCCeEEEEEeecc
Q 011158 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN--NIIHRDLKAANLLMDE---NEVSLLLSLCLFT 438 (492)
Q Consensus 364 ~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~--~IiHrDLKp~NILld~---~~~~kl~DFGla~ 438 (492)
+|.|+|||+|.+|.-||+. ...++++.+..|+.||+.||.||... .|||-||||.|||+-. .|.+||.|||+++
T Consensus 543 FCTVLEYceGNDLDFYLKQ-hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQ-HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred ceeeeeecCCCchhHHHHh-hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 9999999999999999977 45689999999999999999999987 5999999999999954 4789999999997
Q ss_pred eee--------------eeeCCCceeecce--ec--cccccCccceeee
Q 011158 439 VSI--------------LFCGKGRELISLF--LG--NDVLLQFGTYWII 469 (492)
Q Consensus 439 ~~~--------------~~~g~~~~~ape~--~~--~e~~~~~~d~W~l 469 (492)
+.. ...|+.-|+.||- .+ |+.++...|.|++
T Consensus 622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSv 670 (775)
T KOG1151|consen 622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSV 670 (775)
T ss_pred hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEee
Confidence 642 2345555667762 23 6677777788874
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.2e-21 Score=209.62 Aligned_cols=161 Identities=15% Similarity=0.213 Sum_probs=113.8
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEEC------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEE----
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTYC------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA---- 357 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~~------g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~---- 357 (492)
.+..++|.+.++||+|+||.||+|++. +..||||++...... +....| .++...+.++..++..
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~----e~~~~e--~l~~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV----EIWMNE--RVRRACPNSCADFVYGFLEP 201 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh----HHHHHH--HHHhhchhhHHHHHHhhhcc
Confidence 345678999999999999999999884 568999987643211 111111 1112222222222211
Q ss_pred --EecCCeEEEEEeccCCCCHHHHHHhcCCC-------------------CCHHHHHHHHHHHHHHHHHHHHCCceecCC
Q 011158 358 --CTKPPSLCIVTEFMSGGSVYDYLHKLKGV-------------------FKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416 (492)
Q Consensus 358 --~~~~~~~~lV~Ey~~ggsL~~~L~~~~~~-------------------l~~~~~~~i~~qI~~gL~yLH~~~IiHrDL 416 (492)
+.....++|||||+.+++|.+++...... .....+..++.||+.||.|||+++|+||||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL 281 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV 281 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence 24556799999999999999999753211 123346679999999999999999999999
Q ss_pred CCCCEEEcc-CCCeEEEEEeecceee--------eeeCCCceeecce
Q 011158 417 KAANLLMDE-NEVSLLLSLCLFTVSI--------LFCGKGRELISLF 454 (492)
Q Consensus 417 Kp~NILld~-~~~~kl~DFGla~~~~--------~~~g~~~~~ape~ 454 (492)
||+|||++. ++.+||+|||+++... ...++..|++||.
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~ 328 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQ 328 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHH
Confidence 999999986 5789999999996431 2445667777773
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.2e-21 Score=191.16 Aligned_cols=175 Identities=18% Similarity=0.263 Sum_probs=148.6
Q ss_pred CCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCC--C----ceeeEEEEEecCC
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH--K----NVVQFIGACTKPP 362 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~H--p----nIv~l~g~~~~~~ 362 (492)
..+|.+...+|+|+||.|-.+.+. +..||||+++.- ..+.+..+-|+.+|.++.+ | -+|++.+||.-.+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 578999999999999999999874 567999999743 4556677789999999943 2 3888999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcc----------------
Q 011158 363 SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---------------- 425 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~---------------- 425 (492)
+.|||+|.| |-|++++|..+. .+++...+..++.|++.+++|||+.+++|-||||+|||+.+
T Consensus 165 hiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~ 243 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFI 243 (415)
T ss_pred ceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcccee
Confidence 999999999 889999998754 47999999999999999999999999999999999999843
Q ss_pred ----CCCeEEEEEeecceee----eeeCCCceeecceeccccccCccceeee
Q 011158 426 ----NEVSLLLSLCLFTVSI----LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 426 ----~~~~kl~DFGla~~~~----~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
+..++++|||.|.... ....|..|.|||++-.=.++...|.|++
T Consensus 244 r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSi 295 (415)
T KOG0671|consen 244 RPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSI 295 (415)
T ss_pred ccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceee
Confidence 2357899999998764 3456777888888877777888889984
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.8e-20 Score=177.47 Aligned_cols=177 Identities=27% Similarity=0.390 Sum_probs=146.5
Q ss_pred CceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEeccCCCCHHHHHH
Q 011158 304 SYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH 381 (492)
Q Consensus 304 ~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ggsL~~~L~ 381 (492)
+||.||+|++. ++.+|+|++........ .+.+.+|+.++++++|+||+++++++......++++||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 58999999984 58899999986543222 5789999999999999999999999999899999999999999999997
Q ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee------eeCCCceeeccee
Q 011158 382 KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL------FCGKGRELISLFL 455 (492)
Q Consensus 382 ~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~------~~g~~~~~ape~~ 455 (492)
... .+++..++.++.+++.++.|||+.+|+|+||+|.||+++.++.++++|||.+..... ..+...|++||..
T Consensus 80 ~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~ 158 (244)
T smart00220 80 KRG-RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL 158 (244)
T ss_pred hcc-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHH
Confidence 743 389999999999999999999999999999999999999999999999999875532 4456678888877
Q ss_pred ccccccCccceeee---ecccccCCCCCCC
Q 011158 456 GNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 456 ~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
....+....|+|++ +....+|..+|..
T Consensus 159 ~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 159 LGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred ccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 76666777788873 2233345444433
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.2e-21 Score=201.91 Aligned_cols=183 Identities=16% Similarity=0.243 Sum_probs=151.3
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCeEEEE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIV 367 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV 367 (492)
.+.|.+...+|.|+|+.|-++.. +++..++|++.... .+-.+|+.++... +||||+++++.+.+..+.|+|
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v 394 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV 394 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc------cccccccchhhhhcCCCcceeecceecCCceeeee
Confidence 45677788899999999999977 56889999998652 2234577666666 699999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE-ccCCCeEEEEEeecceeeee---
Q 011158 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM-DENEVSLLLSLCLFTVSILF--- 443 (492)
Q Consensus 368 ~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILl-d~~~~~kl~DFGla~~~~~~--- 443 (492)
||++.|+-|.+.+...+ ....++..|+.+|+.|+.|||.+|||||||||+|||+ +..+.++|+|||.++.....
T Consensus 395 ~e~l~g~ell~ri~~~~--~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~t 472 (612)
T KOG0603|consen 395 MELLDGGELLRRIRSKP--EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCDT 472 (612)
T ss_pred ehhccccHHHHHHHhcc--hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchhhcc
Confidence 99999999888887632 2336777899999999999999999999999999999 58899999999999877544
Q ss_pred -eCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 444 -CGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 444 -~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
+-+..|.+||+.+...|....|||++ ...+-+|...|.
T Consensus 473 p~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~ 514 (612)
T KOG0603|consen 473 PALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFA 514 (612)
T ss_pred cchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccc
Confidence 44466889999999999999999994 334556666555
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.6e-20 Score=176.81 Aligned_cols=134 Identities=15% Similarity=0.211 Sum_probs=105.1
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhc-----CCCceeeEEEEEecCC---eEE-EE
Q 011158 297 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-----RHKNVVQFIGACTKPP---SLC-IV 367 (492)
Q Consensus 297 ~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~l~g~~~~~~---~~~-lV 367 (492)
.+.||+|+||.||.-...+. .+||++..... ...+.+.+|+.+++++ .||||++++|++.++. .++ +|
T Consensus 7 ~~~LG~G~~~~Vy~hp~~~~-k~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 7 QSPLGTGRHRKCYAHPEDAQ-RCIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred cceecCCCceEEEECCCCcC-eEEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 46899999999996222333 46898875432 2346789999999999 5799999999998863 434 78
Q ss_pred Eec--cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHH-HHHHHCCceecCCCCCCEEEccC----CCeEEEEEeec
Q 011158 368 TEF--MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM-NYLHQNNIIHRDLKAANLLMDEN----EVSLLLSLCLF 437 (492)
Q Consensus 368 ~Ey--~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL-~yLH~~~IiHrDLKp~NILld~~----~~~kl~DFGla 437 (492)
+|| +.+|+|.+++.+ +.+++. ..++.|++.++ +|||+++|+||||||+|||++.. ..++|+||+.+
T Consensus 84 ~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred ecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 999 557999999966 346655 35678888888 99999999999999999999743 37999994444
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.7e-20 Score=202.24 Aligned_cols=167 Identities=22% Similarity=0.235 Sum_probs=134.6
Q ss_pred ceeeeeeeecCceE-EEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCeEEEEEecc
Q 011158 294 LKFGSKVASGSYGD-LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFM 371 (492)
Q Consensus 294 ~~~~~~LG~G~fG~-Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~Ey~ 371 (492)
+.-.+.+|.|+-|+ ||+|.+.++.||||.+-.+. .....+||..|+.-+ |||||++++.-.++..+||..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~-----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEF-----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCceehHHHHhhHh-----HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 33456789999885 89999999999999886432 245578999999884 999999999999999999999999
Q ss_pred CCCCHHHHHHhc--CCCC-CHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcc---C--CCeEEEEEeeccee---
Q 011158 372 SGGSVYDYLHKL--KGVF-KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---N--EVSLLLSLCLFTVS--- 440 (492)
Q Consensus 372 ~ggsL~~~L~~~--~~~l-~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~---~--~~~kl~DFGla~~~--- 440 (492)
..+|.+++... .... .....+.+..|++.||+|||+.+||||||||.||||+. + ..++|+|||+++..
T Consensus 586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 78999999763 1111 11345778899999999999999999999999999986 2 47899999998542
Q ss_pred -------eeeeCCCceeecceeccccccCccce
Q 011158 441 -------ILFCGKGRELISLFLGNDVLLQFGTY 466 (492)
Q Consensus 441 -------~~~~g~~~~~ape~~~~e~~~~~~d~ 466 (492)
....|+..|+|||.+....-....|+
T Consensus 665 ~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDi 697 (903)
T KOG1027|consen 665 KSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDI 697 (903)
T ss_pred cchhhcccCCCCcccccCHHHHhccccCcccch
Confidence 13567888999998877666655554
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-20 Score=184.72 Aligned_cols=174 Identities=20% Similarity=0.239 Sum_probs=144.9
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC------
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP------ 362 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~------ 362 (492)
+.+|.-+..+|.|.- .|..+.+ .++.||+|.+.....+....++..+|..++..++|+||++++.+++...
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 456777788888887 5666654 5789999998877666666788899999999999999999999997553
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee
Q 011158 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL 442 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~ 442 (492)
..|+||||| .++|.+.+.- .++-..+..|..|++.|++|||+.||+||||||+||++..++..||.|||+++....
T Consensus 95 e~y~v~e~m-~~nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~ 170 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVILM---ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT 170 (369)
T ss_pred hHHHHHHhh-hhHHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCc
Confidence 479999999 7799999873 467788999999999999999999999999999999999999999999999987632
Q ss_pred ------eeCCCceeecceeccccccCccceeee
Q 011158 443 ------FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 443 ------~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
+..+..|.+||...+-.+....|+|++
T Consensus 171 ~~~mtpyVvtRyyrapevil~~~~ke~vdiwSv 203 (369)
T KOG0665|consen 171 DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 203 (369)
T ss_pred ccccCchhheeeccCchheeccCCcccchhhhh
Confidence 344556667777766667777788883
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.1e-19 Score=170.04 Aligned_cols=137 Identities=22% Similarity=0.351 Sum_probs=117.0
Q ss_pred eeeeecCceEEEEEEECCceEEEEEecCCCCCh------HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEecc
Q 011158 298 SKVASGSYGDLYRGTYCSQDVAIKVLKPERINS------DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 371 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 371 (492)
+.||+|++|.||+|.+.+..+++|+........ .....+.+|+.++..++|++|.....++......++||||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 578999999999999999999999876543221 12346788999999999999887777777777889999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 372 ~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
+|++|.+++... .. ....++.+++.+|.+||+.+++|+|++|.|||++ ++.++++|||.++..
T Consensus 82 ~G~~L~~~~~~~----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 82 EGEPLKDLINSN----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred CCcCHHHHHHhc----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 999999998652 12 7889999999999999999999999999999999 788999999998764
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.80 E-value=9.3e-20 Score=187.58 Aligned_cols=177 Identities=16% Similarity=0.188 Sum_probs=144.7
Q ss_pred eCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCC------CceeeEEEEEec
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH------KNVVQFIGACTK 360 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~H------pnIv~l~g~~~~ 360 (492)
+-..+|.+....|+|-|++|.+|.+ .|+.||||+|..+ ..+.+.=+.|+.||++|+. -|+++|+..|..
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN---E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN---EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc---hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 3346788888999999999999988 4689999999754 4455666789999999963 479999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCC-CeEEEEEeec
Q 011158 361 PPSLCIVTEFMSGGSVYDYLHKLKG--VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-VSLLLSLCLF 437 (492)
Q Consensus 361 ~~~~~lV~Ey~~ggsL~~~L~~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~-~~kl~DFGla 437 (492)
.+++|||+|-+ ..+|.+.|++... .|....+..++.|+..||..|-.+||+|.||||.|||+++.. .+||||||.|
T Consensus 506 knHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 506 KNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred cceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccc
Confidence 99999999988 7799999987643 578889999999999999999999999999999999999764 7899999999
Q ss_pred ceeeeeeCC-----CceeecceeccccccCccceeee
Q 011158 438 TVSILFCGK-----GRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 438 ~~~~~~~g~-----~~~~ape~~~~e~~~~~~d~W~l 469 (492)
..+....-+ ..|-+||++-+-.|...-|.|++
T Consensus 585 ~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSv 621 (752)
T KOG0670|consen 585 SFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSV 621 (752)
T ss_pred cccccccccHHHHHHhccCcceeecCcccCCccceee
Confidence 877543333 34555565555555555667773
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.4e-19 Score=166.97 Aligned_cols=133 Identities=20% Similarity=0.315 Sum_probs=110.1
Q ss_pred eeeecCceEEEEEEECCceEEEEEecCCCCCh------HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEeccC
Q 011158 299 KVASGSYGDLYRGTYCSQDVAIKVLKPERINS------DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS 372 (492)
Q Consensus 299 ~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 372 (492)
.||+|+||.||+|.+.+..+++|+........ ....++.+|+.++..++|+++.....++...+..++||||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 37999999999999999999999976432211 123567889999999998876555555556667899999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 373 GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 373 ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
|++|.+++..... .++.+++.+|.+||+.|++|+|+||.|||++ ++.++++|||+++..
T Consensus 81 g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 81 GKPLKDVIEEGND--------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CccHHHHHhhcHH--------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999998865211 7899999999999999999999999999999 789999999998775
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.8e-19 Score=180.67 Aligned_cols=189 Identities=21% Similarity=0.246 Sum_probs=147.5
Q ss_pred CceeeeeeeecCceEEEEEEECC---ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCC----CceeeEEEEE-ecCCeE
Q 011158 293 HLKFGSKVASGSYGDLYRGTYCS---QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH----KNVVQFIGAC-TKPPSL 364 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~~g---~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~H----pnIv~l~g~~-~~~~~~ 364 (492)
.|++.++||+|+||.||++.+.. ..+|+|+......... ..+..|+.++..+.. +++..+++.. ......
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 78899999999999999999854 3689998765422211 267788999988873 6889999888 477789
Q ss_pred EEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccC-----CCeEEEEEeecc
Q 011158 365 CIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-----EVSLLLSLCLFT 438 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~-----~~~kl~DFGla~ 438 (492)
||||+.+ |.+|.++..... +.++..+++.|+.|++.+|.+||+.|+|||||||+|+++... ..+.++|||+++
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 9999999 999999886655 789999999999999999999999999999999999999865 368999999998
Q ss_pred --eee---------------eeeCCCceeecceeccccccCccceeeeec---ccccCCCCCCCcc
Q 011158 439 --VSI---------------LFCGKGRELISLFLGNDVLLQFGTYWIIFR---RSSCDKKNSDAPF 484 (492)
Q Consensus 439 --~~~---------------~~~g~~~~~ape~~~~e~~~~~~d~W~l~~---~~~~gt~~Y~aPE 484 (492)
.-. .+.|+.+|.++........+...|+|+++. ....|..+|...+
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~ 241 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE 241 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence 210 122556666666556666667778887543 3455656665443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.1e-19 Score=169.64 Aligned_cols=164 Identities=11% Similarity=0.077 Sum_probs=125.9
Q ss_pred CCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCChH-HHHH------HHHHHHHHHhcCCCceeeEEEEEecC--
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSD-MQKE------FAQEVFIMRKVRHKNVVQFIGACTKP-- 361 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~-~~~~------~~~Ei~il~~l~HpnIv~l~g~~~~~-- 361 (492)
..+|+..+.||.|+||.||+....+..+|||++........ .... +.+|+..+.+++|++|..+..++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~ 109 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER 109 (232)
T ss_pred hCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence 56899999999999999999877778999999986543322 2222 67899999999999999998886533
Q ss_pred ------CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEe
Q 011158 362 ------PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLC 435 (492)
Q Consensus 362 ------~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFG 435 (492)
...+|||||++|.+|.++.. ++. ....+++.+|..||+.|++|||+||+||+++.++ ++++|||
T Consensus 110 ~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg 179 (232)
T PRK10359 110 KTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLS 179 (232)
T ss_pred ccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECC
Confidence 35899999999999988742 232 2456999999999999999999999999999988 9999999
Q ss_pred ecceeeeeeCCCceeecceeccccccCccceeee
Q 011158 436 LFTVSILFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 436 la~~~~~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
.......... ...+.....+....|.|++
T Consensus 180 ~~~~~~e~~a-----~d~~vler~y~~~~di~~l 208 (232)
T PRK10359 180 GKRCTAQRKA-----KDRIDLERHYGIKNEIKDL 208 (232)
T ss_pred Ccccccchhh-----HHHHHHHhHhcccccccce
Confidence 8865421111 1123333334445677875
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-18 Score=189.03 Aligned_cols=137 Identities=21% Similarity=0.284 Sum_probs=114.8
Q ss_pred eeeeeeeecCceEEEEEEECCceEEEEEecCCCCC------hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 295 KFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERIN------SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 295 ~~~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~------~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
...++||+|+||.||+|.+.+..+++|+....... .....++.+|+.++++++|++|+....++......++||
T Consensus 336 ~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 415 (535)
T PRK09605 336 IPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVM 415 (535)
T ss_pred CccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEE
Confidence 44789999999999999998877777654332111 112356889999999999999998888877777789999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI 441 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~ 441 (492)
||++|++|.+++. ....++.|++.+|.|||+++|+||||||+|||+ .++.++++|||+++...
T Consensus 416 E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~~ 478 (535)
T PRK09605 416 EYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYSD 478 (535)
T ss_pred EecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccCC
Confidence 9999999999885 346789999999999999999999999999999 57789999999998753
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.3e-19 Score=181.37 Aligned_cols=139 Identities=21% Similarity=0.381 Sum_probs=122.5
Q ss_pred CCceeeeeeeecCceEEEEEEEC-----CceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCeEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLC 365 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~-----g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~ 365 (492)
+.|...++||.|+|+.||++++. .+.||+|.+.... ...++..|+++|..+. +.||+++.+++..++..+
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS----SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc----CchHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 45777899999999999999762 3679999886532 1256889999999996 899999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcc-CCCeEEEEEeecc
Q 011158 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEVSLLLSLCLFT 438 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~-~~~~kl~DFGla~ 438 (492)
+|+||++.....+++.. ++...+..+++.++.||.++|++|||||||||.|+|.+. .+.-.|+|||+|.
T Consensus 112 ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred EEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHH
Confidence 99999999999998865 788999999999999999999999999999999999984 4567899999996
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.77 E-value=8.1e-18 Score=164.35 Aligned_cols=145 Identities=30% Similarity=0.503 Sum_probs=128.9
Q ss_pred ceeeeeeeecCceEEEEEEECCceEEEEEecCCCCChH-HHHHHHHHHHHHHhcCCC-ceeeEEEEEecCCeEEEEEecc
Q 011158 294 LKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSD-MQKEFAQEVFIMRKVRHK-NVVQFIGACTKPPSLCIVTEFM 371 (492)
Q Consensus 294 ~~~~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~-~~~~~~~Ei~il~~l~Hp-nIv~l~g~~~~~~~~~lV~Ey~ 371 (492)
|.+.+.||.|+||.||++.+. ..+++|.+........ ....+.+|+.+++.+.|+ +|+++.+.+......+++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 567789999999999999888 7899999987654443 578899999999999988 7999999998777789999999
Q ss_pred CCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCC-CeEEEEEeecce
Q 011158 372 SGGSVYDYLHKLK--GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-VSLLLSLCLFTV 439 (492)
Q Consensus 372 ~ggsL~~~L~~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~-~~kl~DFGla~~ 439 (492)
.++++.+++.... ..+.......++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||.++.
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~ 151 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKL 151 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCccee
Confidence 9999998876643 2689999999999999999999999999999999999999988 699999999873
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.1e-18 Score=170.51 Aligned_cols=142 Identities=15% Similarity=0.205 Sum_probs=110.9
Q ss_pred CceeeeeeeecCceEEEEEE-E--CCceEEEEEecCCCCCh----------------------HHHHHHHHHHHHHHhcC
Q 011158 293 HLKFGSKVASGSYGDLYRGT-Y--CSQDVAIKVLKPERINS----------------------DMQKEFAQEVFIMRKVR 347 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~-~--~g~~vAvK~l~~~~~~~----------------------~~~~~~~~Ei~il~~l~ 347 (492)
.|++.+.||+|+||.||+|. . +|+.||||+++...... .....+..|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46677899999999999998 3 67899999997542110 01234578999999997
Q ss_pred CC--ceeeEEEEEecCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCCCCEEEc
Q 011158 348 HK--NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN-IIHRDLKAANLLMD 424 (492)
Q Consensus 348 Hp--nIv~l~g~~~~~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~-IiHrDLKp~NILld 424 (492)
+. .+.+++++ ...+|||||++|++|..++.. ...+....+..++.||+.+|.+||++| |+||||||+||+++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~ 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence 63 34444543 235899999998888766533 244566677899999999999999999 99999999999999
Q ss_pred cCCCeEEEEEeeccee
Q 011158 425 ENEVSLLLSLCLFTVS 440 (492)
Q Consensus 425 ~~~~~kl~DFGla~~~ 440 (492)
++.++++|||.+...
T Consensus 184 -~~~i~LiDFg~a~~~ 198 (237)
T smart00090 184 -DGKVVIIDVSQSVEL 198 (237)
T ss_pred -CCCEEEEEChhhhcc
Confidence 788999999998643
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.8e-18 Score=163.90 Aligned_cols=147 Identities=25% Similarity=0.364 Sum_probs=127.7
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCC-CceeeEEEEEecCCeE
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH-KNVVQFIGACTKPPSL 364 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~g~~~~~~~~ 364 (492)
.|-...|+++++||+|+||.+|.|.. .|..||||+-+... ...++..|..+.+.+++ ..|..+..+..+...-
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC----CCcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 45557899999999999999999987 57999999876432 22467789999999986 6788888888888889
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccC---CCeEEEEEeecce
Q 011158 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN---EVSLLLSLCLFTV 439 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~---~~~kl~DFGla~~ 439 (492)
.+||+++ |.||.++..-+...++..+++-++-|++.-++|+|.+++|||||||+|+|+.-+ ..+.++|||+++.
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhh
Confidence 9999999 999999998888889999999999999999999999999999999999999743 4678999999864
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.6e-18 Score=161.64 Aligned_cols=131 Identities=15% Similarity=0.196 Sum_probs=107.0
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCeEEEEEeccCC
Q 011158 297 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERIN--SDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFMSG 373 (492)
Q Consensus 297 ~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~--~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~Ey~~g 373 (492)
...|++|+||+||.+...+.+++.+.++..... .-....+.+|+.+|++++ |++|++++++ +..|++|||+.|
T Consensus 7 ~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G 82 (218)
T PRK12274 7 NEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAG 82 (218)
T ss_pred ceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecC
Confidence 468999999999988877888988887654321 112235889999999996 5889999886 347999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCC-CCCCEEEccCCCeEEEEEeecce
Q 011158 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL-KAANLLMDENEVSLLLSLCLFTV 439 (492)
Q Consensus 374 gsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDL-Kp~NILld~~~~~kl~DFGla~~ 439 (492)
.+|.+.+.. + ...++.|++.+|.++|++||+|||| ||+|||++.++.++|+|||++..
T Consensus 83 ~~L~~~~~~--~------~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~ 141 (218)
T PRK12274 83 AAMYQRPPR--G------DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVR 141 (218)
T ss_pred ccHHhhhhh--h------hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCcee
Confidence 999765422 1 1357889999999999999999999 79999999999999999999964
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.5e-18 Score=169.30 Aligned_cols=160 Identities=19% Similarity=0.300 Sum_probs=134.3
Q ss_pred eCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCeEE
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLC 365 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~ 365 (492)
+-.-+|+++++||.|+||.++.|+. +++.||||.-.... ...++..|.+..+.|. .++|.+.+-+-....+-.
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni 100 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI 100 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccC----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence 3445799999999999999999975 78999999754332 2256677888888885 689999888777777788
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccC-----CCeEEEEEeeccee
Q 011158 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-----EVSLLLSLCLFTVS 440 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~-----~~~kl~DFGla~~~ 440 (492)
||+|++ |.||.|+..-+...|+.+++..++.|++.-++|+|.+.+|.|||||+|+||..- ..+.++|||+|+.-
T Consensus 101 LVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 999999 999999999888999999999999999999999999999999999999999743 36789999999653
Q ss_pred --------------eeeeCCCceeecc
Q 011158 441 --------------ILFCGKGRELISL 453 (492)
Q Consensus 441 --------------~~~~g~~~~~ape 453 (492)
+...|+.+||+--
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSIN 206 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSIN 206 (449)
T ss_pred cCccccccCccccccccccceeeeEee
Confidence 2456777887654
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=7.2e-18 Score=172.96 Aligned_cols=133 Identities=24% Similarity=0.428 Sum_probs=115.4
Q ss_pred CCCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-----C---CceeeEEEEEe
Q 011158 290 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-----H---KNVVQFIGACT 359 (492)
Q Consensus 290 ~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~-----H---pnIv~l~g~~~ 359 (492)
...+|.+.++||-|.|++||+|.++ .+.||+|+.+.. +.+.+..+.||.+|++++ | .+||+|++.|.
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk 152 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK 152 (590)
T ss_pred cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence 3468999999999999999999884 578999999753 566777889999999984 3 46999999996
Q ss_pred c----CCeEEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEEccC
Q 011158 360 K----PPSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDEN 426 (492)
Q Consensus 360 ~----~~~~~lV~Ey~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~-~IiHrDLKp~NILld~~ 426 (492)
. ..++|||+|++ |-+|..+|.... ..++...++.|++||+.||.|||.+ ||||-||||+|||+..+
T Consensus 153 hsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 153 HSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCST 224 (590)
T ss_pred ecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeecc
Confidence 4 35799999999 999999997653 4689999999999999999999986 99999999999999765
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.9e-19 Score=168.04 Aligned_cols=186 Identities=16% Similarity=0.212 Sum_probs=138.0
Q ss_pred CCceeeeeeeecCceEEEEEEECC--ceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeEEEE-EecCCeEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGA-CTKPPSLCIV 367 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~g--~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~-~~~~~~~~lV 367 (492)
+.|.+.+.||+|.||.+-++.+++ +.+++|.+... ....++|.+|...--.| .|.||+..|+. |+..+.+.++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p---~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP---QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc---hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 467788999999999999998854 67999988754 33458899998876666 48999988764 6677788899
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc--cCCCeEEEEEeecceeee---
Q 011158 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD--ENEVSLLLSLCLFTVSIL--- 442 (492)
Q Consensus 368 ~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld--~~~~~kl~DFGla~~~~~--- 442 (492)
+||++-|+|..-+.. ..+-+....+++.|+++|+.|||++++||||||.+||||- +...+|++|||+.+....
T Consensus 101 qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~ 178 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK 178 (378)
T ss_pred eccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCceeh
Confidence 999999999987754 4578888999999999999999999999999999999994 334899999999865321
Q ss_pred -eeCCCceeecceec---cc--cccCccceeee---ecccccCCCCCCC
Q 011158 443 -FCGKGRELISLFLG---ND--VLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 443 -~~g~~~~~ape~~~---~e--~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
..-...|.+||.+. ++ ......|.|.+ +..-.-|.++|++
T Consensus 179 ~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk 227 (378)
T KOG1345|consen 179 YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK 227 (378)
T ss_pred hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh
Confidence 22233455555331 11 22344566662 2222346666653
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.8e-18 Score=161.06 Aligned_cols=135 Identities=19% Similarity=0.228 Sum_probs=106.7
Q ss_pred ceeeeeeeecCceEEEEEEE-CCceEEEEEecCCCCCh--------------------HHHHHHHHHHHHHHhcCCC--c
Q 011158 294 LKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINS--------------------DMQKEFAQEVFIMRKVRHK--N 350 (492)
Q Consensus 294 ~~~~~~LG~G~fG~Vy~~~~-~g~~vAvK~l~~~~~~~--------------------~~~~~~~~Ei~il~~l~Hp--n 350 (492)
|.+.+.||+|+||.||++.. .++.||||++....... .....+..|+.++.++.|+ .
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 55668999999999999987 58899999976542110 0112367799999999887 4
Q ss_pred eeeEEEEEecCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeE
Q 011158 351 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSL 430 (492)
Q Consensus 351 Iv~l~g~~~~~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~k 430 (492)
+...++. ...++||||++|++|.++... .....++.+++.++.++|+.||+||||||+||++++++.++
T Consensus 97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~ 165 (198)
T cd05144 97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY 165 (198)
T ss_pred CCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence 4455442 346899999999998765421 34567889999999999999999999999999999999999
Q ss_pred EEEEeecce
Q 011158 431 LLSLCLFTV 439 (492)
Q Consensus 431 l~DFGla~~ 439 (492)
++|||.++.
T Consensus 166 liDfg~~~~ 174 (198)
T cd05144 166 IIDWPQMVS 174 (198)
T ss_pred EEECCcccc
Confidence 999999854
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.70 E-value=2e-16 Score=154.93 Aligned_cols=137 Identities=13% Similarity=0.128 Sum_probs=108.7
Q ss_pred eeee-ecCceEEEEEEECCceEEEEEecCCCC-----------ChHHHHHHHHHHHHHHhcCCCce--eeEEEEEecCCe
Q 011158 298 SKVA-SGSYGDLYRGTYCSQDVAIKVLKPERI-----------NSDMQKEFAQEVFIMRKVRHKNV--VQFIGACTKPPS 363 (492)
Q Consensus 298 ~~LG-~G~fG~Vy~~~~~g~~vAvK~l~~~~~-----------~~~~~~~~~~Ei~il~~l~HpnI--v~l~g~~~~~~~ 363 (492)
..|| .|+.|+||.+...+..++||.+..... +......+.+|+.++.+++|++| ++.+++......
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 4687 899999999988889999998864211 11233568889999999998774 677776543222
Q ss_pred ----EEEEEeccCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecc
Q 011158 364 ----LCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFT 438 (492)
Q Consensus 364 ----~~lV~Ey~~g-gsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~ 438 (492)
.+|||||++| .+|.+++.. ..++.. .+.+|+.+|.+||++||+||||||+|||++.++.++++|||.+.
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~ 190 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGE 190 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCcc
Confidence 3599999997 699999865 345543 36789999999999999999999999999998899999999987
Q ss_pred ee
Q 011158 439 VS 440 (492)
Q Consensus 439 ~~ 440 (492)
..
T Consensus 191 ~~ 192 (239)
T PRK01723 191 LR 192 (239)
T ss_pred cC
Confidence 64
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.1e-17 Score=150.11 Aligned_cols=136 Identities=18% Similarity=0.274 Sum_probs=98.8
Q ss_pred eeeeeecCceEEEEEEEC-CceEEEEEecCCCCChHHHHH----------------------HHHHHHHHHhcCCC--ce
Q 011158 297 GSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKE----------------------FAQEVFIMRKVRHK--NV 351 (492)
Q Consensus 297 ~~~LG~G~fG~Vy~~~~~-g~~vAvK~l~~~~~~~~~~~~----------------------~~~Ei~il~~l~Hp--nI 351 (492)
.+.||+|+||.||+|.+. ++.||||+++........... ...|...+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999885 889999998764322111111 13566667666543 34
Q ss_pred eeEEEEEecCCeEEEEEeccCCCCHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEccCCCe
Q 011158 352 VQFIGACTKPPSLCIVTEFMSGGSVYD-YLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVS 429 (492)
Q Consensus 352 v~l~g~~~~~~~~~lV~Ey~~ggsL~~-~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~-~~IiHrDLKp~NILld~~~~~ 429 (492)
.+.++. ...++||||++++.+.. .+.... .. .....++.+++.++.++|. ++|+||||||+||+++ ++.+
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence 455543 23699999999854321 121111 11 5678899999999999999 9999999999999999 8899
Q ss_pred EEEEEeeccee
Q 011158 430 LLLSLCLFTVS 440 (492)
Q Consensus 430 kl~DFGla~~~ 440 (492)
+++|||.++..
T Consensus 154 ~liDfg~a~~~ 164 (187)
T cd05119 154 YIIDVPQAVEI 164 (187)
T ss_pred EEEECcccccc
Confidence 99999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.9e-17 Score=165.92 Aligned_cols=193 Identities=17% Similarity=0.258 Sum_probs=157.5
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 360 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~~g-------~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 360 (492)
.+...++++...+-+|.||.||+|.|.. +.|-+|.++. ..++-....+++|.-.+..+.|||+.++.+++..
T Consensus 280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~-~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ-HASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh-cccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 4555677888889999999999996632 4578888875 3455566789999999999999999999998865
Q ss_pred C-CeEEEEEeccCCCCHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEE
Q 011158 361 P-PSLCIVTEFMSGGSVYDYLHKLK-------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLL 432 (492)
Q Consensus 361 ~-~~~~lV~Ey~~ggsL~~~L~~~~-------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~ 432 (492)
. ...+.++.++..|+|..||..++ ..++..++..++.|++.||+|||+++|||.||.++|++||+.-.+|++
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEec
Confidence 4 45788899999999999998432 357778899999999999999999999999999999999999999999
Q ss_pred EEeecceee---------eeeCCCceeecceeccccccCccceeee----ecccccCCCCCC
Q 011158 433 SLCLFTVSI---------LFCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSD 481 (492)
Q Consensus 433 DFGla~~~~---------~~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~ 481 (492)
|-.++|... .......||++|.+.++.|...+|.|++ ....+.|..+|.
T Consensus 439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pya 500 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYA 500 (563)
T ss_pred cchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcc
Confidence 988887542 1223357899999999999999998883 334456666665
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.2e-16 Score=139.77 Aligned_cols=132 Identities=15% Similarity=0.181 Sum_probs=113.9
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCC--CceeeEEEEEecCCeEEEEEeccCCC
Q 011158 297 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH--KNVVQFIGACTKPPSLCIVTEFMSGG 374 (492)
Q Consensus 297 ~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~g~~~~~~~~~lV~Ey~~gg 374 (492)
.+.||+|.++.||++...+..+++|+.+.... ...+.+|+.+++.++| .++++++++....+..+++|||++++
T Consensus 3 ~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKDEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred ceecccccccceEEEEecCCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 46899999999999999888999999875432 4678899999999986 58999999988888899999999887
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 375 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN---NIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 375 sL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~---~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
.+..+ +......++.+++.+|.+||.. +++|+|+||+|||++..+.++++||+.++..
T Consensus 79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 77544 4566677899999999999985 6999999999999999899999999998754
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.4e-16 Score=181.28 Aligned_cols=123 Identities=11% Similarity=0.023 Sum_probs=92.1
Q ss_pred hcCC-CceeeEEEEE-------ecCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCC
Q 011158 345 KVRH-KNVVQFIGAC-------TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416 (492)
Q Consensus 345 ~l~H-pnIv~l~g~~-------~~~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDL 416 (492)
.++| +||++++++| .....+++++||+ +++|.++|......+++..++.++.||+.||.|||++|||||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 3455 5788888877 2334578889988 77999999875567999999999999999999999999999999
Q ss_pred CCCCEEEccCC-------------------CeEEEEEeecceee-----------------------eeeCCCceeecce
Q 011158 417 KAANLLMDENE-------------------VSLLLSLCLFTVSI-----------------------LFCGKGRELISLF 454 (492)
Q Consensus 417 Kp~NILld~~~-------------------~~kl~DFGla~~~~-----------------------~~~g~~~~~ape~ 454 (492)
||+||||+..+ .+|++|||+++... ...++..|++||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 99999996544 45555666554210 0123445777777
Q ss_pred eccccccCccceee
Q 011158 455 LGNDVLLQFGTYWI 468 (492)
Q Consensus 455 ~~~e~~~~~~d~W~ 468 (492)
+....+....|.|+
T Consensus 187 ~~~~~~~~~sDVwS 200 (793)
T PLN00181 187 DNGSSSNCASDVYR 200 (793)
T ss_pred hccCCCCchhhhhh
Confidence 66666666677777
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.59 E-value=9.2e-16 Score=168.02 Aligned_cols=190 Identities=17% Similarity=0.209 Sum_probs=149.1
Q ss_pred eeeeeeeecCceEEEEEEEC--CceEEEEEec----CCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 295 KFGSKVASGSYGDLYRGTYC--SQDVAIKVLK----PERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 295 ~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~----~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
.....+|.|++|.|+..... ...++.|..+ ...........+..|..+-..+.|+|++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45678999999977777552 2333333332 22222233333777888899999999988888777766666669
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------- 441 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------- 441 (492)
|||++ +|+.++.. .+.++...+..++.|++.|++|||..||.|||||++|+|+..+|.+||+|||.+.+..
T Consensus 401 E~~~~-Dlf~~~~~-~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~ 478 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS-NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNI 478 (601)
T ss_pred hcccH-HHHHHHhc-ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhh
Confidence 99999 99999976 3578999999999999999999999999999999999999999999999999986532
Q ss_pred ----eeeCCCceeecceeccccccCc-cceeee---ecccccCCCCCCCccce
Q 011158 442 ----LFCGKGRELISLFLGNDVLLQF-GTYWII---FRRSSCDKKNSDAPFLF 486 (492)
Q Consensus 442 ----~~~g~~~~~ape~~~~e~~~~~-~d~W~l---~~~~~~gt~~Y~aPE~~ 486 (492)
...|+..|++||+..+..|... .|.|+. +-.+.+|...|..|...
T Consensus 479 ~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~ 531 (601)
T KOG0590|consen 479 HESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKS 531 (601)
T ss_pred hhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccc
Confidence 3678889999998888777664 478885 66777888888877654
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.58 E-value=3.2e-15 Score=167.93 Aligned_cols=178 Identities=19% Similarity=0.220 Sum_probs=132.2
Q ss_pred CceeeCCCCceeeeeeeecCceEEEEEEE-CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC---CCceeeEEEEEec
Q 011158 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNVVQFIGACTK 360 (492)
Q Consensus 285 ~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~g~~~~ 360 (492)
..+++..+.|.+.+.||+|+||.||+|+. +++.||+|+-++..... |.-=..++.+|+ -+.|..+..++.-
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE-----fYI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE-----FYICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee-----eeehHHHHHhhchhhhcchHHHHHHHcc
Confidence 34678888999999999999999999987 57889999988754322 111222334444 2345555555666
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcc-------CCCeEEEE
Q 011158 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-------NEVSLLLS 433 (492)
Q Consensus 361 ~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~-------~~~~kl~D 433 (492)
.+.-+||+||.+-|+|.+++.. .+.+++..+..|+.|++.-+++||..+|||+||||+|+||.. +..++|+|
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~-~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINT-NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred CCcceeeeeccccccHHHhhcc-CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEe
Confidence 6778999999999999999984 567899999999999999999999999999999999999942 44789999
Q ss_pred Eeecceeee---------eeCCCceeecceeccccccCccceee
Q 011158 434 LCLFTVSIL---------FCGKGRELISLFLGNDVLLQFGTYWI 468 (492)
Q Consensus 434 FGla~~~~~---------~~g~~~~~ape~~~~e~~~~~~d~W~ 468 (492)
||-+--... ...+...-..|++.+.-+..-.||+.
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfG 888 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFG 888 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHH
Confidence 998743321 23333444455555555555555544
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.7e-15 Score=145.88 Aligned_cols=167 Identities=26% Similarity=0.518 Sum_probs=139.8
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEE
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 367 (492)
-|+-..+.+..+|.....|..|+|+|.|..+++|+++.........++|..|.-.|+-..||||+.+++.|..++++.++
T Consensus 186 gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~i 265 (448)
T KOG0195|consen 186 GIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVII 265 (448)
T ss_pred CcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEe
Confidence 45566777888999999999999999999999999998877777778899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCC-ce-ecCCCCCCEEEccCCCeEEEEEeecceeeeee
Q 011158 368 TEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNN-II-HRDLKAANLLMDENEVSLLLSLCLFTVSILFC 444 (492)
Q Consensus 368 ~Ey~~ggsL~~~L~~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~-Ii-HrDLKp~NILld~~~~~kl~DFGla~~~~~~~ 444 (492)
..||+.|+|+..|+...+ .++..++.+++.+|++||.|||+.. +| ---|....++||++.+++|. .++.+++.+..
T Consensus 266 sq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-mad~kfsfqe~ 344 (448)
T KOG0195|consen 266 SQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQEV 344 (448)
T ss_pred eeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-cccceeeeecc
Confidence 999999999999998644 5678899999999999999999974 33 33578889999999887764 56666654443
Q ss_pred CC---Cceeeccee
Q 011158 445 GK---GRELISLFL 455 (492)
Q Consensus 445 g~---~~~~ape~~ 455 (492)
|. +.+|+||.+
T Consensus 345 gr~y~pawmspeal 358 (448)
T KOG0195|consen 345 GRAYSPAWMSPEAL 358 (448)
T ss_pred ccccCcccCCHHHH
Confidence 32 456666644
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.2e-13 Score=146.58 Aligned_cols=140 Identities=16% Similarity=0.227 Sum_probs=98.3
Q ss_pred eeeeecCceEEEEEEE-CCceEEEEEecCCCCCh---H-------------------------H----H------HHHHH
Q 011158 298 SKVASGSYGDLYRGTY-CSQDVAIKVLKPERINS---D-------------------------M----Q------KEFAQ 338 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~-~g~~vAvK~l~~~~~~~---~-------------------------~----~------~~~~~ 338 (492)
+.||+|++|+||+|+. .|+.||||+.++..... + . . -+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 4699999999999988 68999999997652100 0 0 0 12455
Q ss_pred HHHHHHhcC----CCceeeEEEEE-ecCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHH-HHHHHHHCCce
Q 011158 339 EVFIMRKVR----HKNVVQFIGAC-TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK-GMNYLHQNNII 412 (492)
Q Consensus 339 Ei~il~~l~----HpnIv~l~g~~-~~~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~-gL~yLH~~~Ii 412 (492)
|...+.+++ |.+-+.+-.++ ......+|||||++|++|.++......... ...++.+++. .+..+|..|++
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~~ 279 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGFF 279 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCce
Confidence 666666653 22222222222 223346999999999999988754222222 3456666665 46889999999
Q ss_pred ecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 413 HRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 413 HrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
|+|+||.||+++.++.++++|||.++..
T Consensus 280 H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 280 HADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred eCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 9999999999999999999999998654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.5e-15 Score=159.14 Aligned_cols=167 Identities=22% Similarity=0.299 Sum_probs=141.0
Q ss_pred eeeecCceEEEEEE-----ECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCeEEEEEeccC
Q 011158 299 KVASGSYGDLYRGT-----YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFMS 372 (492)
Q Consensus 299 ~LG~G~fG~Vy~~~-----~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~Ey~~ 372 (492)
.+|+|+||.|+++. +.+.-+|+|+++..............|-.++..++ ||.+++++..++.+..++++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 36899999999763 34567999999876443333335566888888887 9999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee---eeeCCCce
Q 011158 373 GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI---LFCGKGRE 449 (492)
Q Consensus 373 ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~---~~~g~~~~ 449 (492)
||.|...+.+ ...+.+.....+...++.+++++|+.+|+|||+|++||+++.+|.+++.|||+.+... ..+|+..|
T Consensus 81 gg~lft~l~~-~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~cgt~ey 159 (612)
T KOG0603|consen 81 GGDLFTRLSK-EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIACGTYEY 159 (612)
T ss_pred cchhhhcccc-CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhcccchhh
Confidence 9999998876 4567888888899999999999999999999999999999999999999999998763 34788899
Q ss_pred eecceeccccccCccceee
Q 011158 450 LISLFLGNDVLLQFGTYWI 468 (492)
Q Consensus 450 ~ape~~~~e~~~~~~d~W~ 468 (492)
|+||+.. -.....|+|+
T Consensus 160 mApEI~~--gh~~a~D~ws 176 (612)
T KOG0603|consen 160 RAPEIIN--GHLSAADWWS 176 (612)
T ss_pred hhhHhhh--ccCCcccchh
Confidence 9998887 5566778998
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=5.6e-15 Score=163.70 Aligned_cols=176 Identities=19% Similarity=0.267 Sum_probs=137.3
Q ss_pred CceeeeeeeecCceEEEEEEECCceEEEEEecCCC--CChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEec
Q 011158 293 HLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPER--INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 370 (492)
++...+.||++.|=+|.+|++....|+||++-... .+-....+-+.|+. ...++|||++.+..+.......|||=+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 67778999999999999999977779999986543 22222233344555 5566899999998887777778999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeeeeeCCCcee
Q 011158 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSILFCGKGREL 450 (492)
Q Consensus 371 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~~~g~~~~~ 450 (492)
. .-+|+|.|.. +..+..-+.+.|+.|++.||.-+|..||+|+|||.+||||+.-+.+.+.||..|+-
T Consensus 103 v-khnLyDRlST-RPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKP----------- 169 (1431)
T KOG1240|consen 103 V-KHNLYDRLST-RPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKP----------- 169 (1431)
T ss_pred H-hhhhhhhhcc-chHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCC-----------
Confidence 9 6699999965 45677888899999999999999999999999999999999999999999998853
Q ss_pred ecceeccccccCccceeeeecccccCCCCCCCccceee
Q 011158 451 ISLFLGNDVLLQFGTYWIIFRRSSCDKKNSDAPFLFYK 488 (492)
Q Consensus 451 ape~~~~e~~~~~~d~W~l~~~~~~gt~~Y~aPE~~~k 488 (492)
.|+..+.-..++-|+....+..| |.|||.|++
T Consensus 170 --tYLPeDNPadf~fFFDTSrRRtC----YiAPERFv~ 201 (1431)
T KOG1240|consen 170 --TYLPEDNPADFTFFFDTSRRRTC----YIAPERFVS 201 (1431)
T ss_pred --ccCCCCCcccceEEEecCCceee----ecChHhhhc
Confidence 33444444444444444555555 999999986
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.42 E-value=7.1e-13 Score=121.42 Aligned_cols=129 Identities=16% Similarity=0.183 Sum_probs=98.8
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCce-eeEEEEEecCCeEEEEEeccCCCC
Q 011158 297 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV-VQFIGACTKPPSLCIVTEFMSGGS 375 (492)
Q Consensus 297 ~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~lV~Ey~~ggs 375 (492)
.+.|+.|.++.||+++..++.|++|+...... ....+..|+.+++.+.+.++ .+++.+.. ...++||||++|.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence 35789999999999999999999999865421 12346789999998865444 45555443 23589999999988
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCc-----eecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 376 VYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI-----IHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 376 L~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~I-----iHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
+.+. . . ....++.+++.+|..||+.++ +|+|+||.||+++ ++.++++||+.++..
T Consensus 78 l~~~--~----~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 78 LLTE--D----F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred cccc--c----c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 7643 0 1 113456789999999999985 9999999999999 667899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.2e-12 Score=141.28 Aligned_cols=136 Identities=15% Similarity=0.231 Sum_probs=88.7
Q ss_pred eeeeecCceEEEEEEEC--CceEEEEEecCCCC---------------------------Ch-----HHHH------HHH
Q 011158 298 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERI---------------------------NS-----DMQK------EFA 337 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~---------------------------~~-----~~~~------~~~ 337 (492)
+.||+|++|+||+|+.. |+.||||+++++.. +. +..+ +|.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 68999999999999873 79999999986521 00 1111 234
Q ss_pred HHHHHHHhcC----CCceeeEEEEEec-CCeEEEEEeccCCCCHHHHH--HhcCC---CCCHHHHHHHHHHHHHHHHHHH
Q 011158 338 QEVFIMRKVR----HKNVVQFIGACTK-PPSLCIVTEFMSGGSVYDYL--HKLKG---VFKLPSLLKVAIDVSKGMNYLH 407 (492)
Q Consensus 338 ~Ei~il~~l~----HpnIv~l~g~~~~-~~~~~lV~Ey~~ggsL~~~L--~~~~~---~l~~~~~~~i~~qI~~gL~yLH 407 (492)
+|...+.+++ +.+.+.+-.++.+ ....+|||||+.|+.+.++- ..... .+....+..++.| +.
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-------if 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-------VF 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH-------HH
Confidence 4444444442 3333332222221 33468999999999998753 22111 1223333333444 34
Q ss_pred HCCceecCCCCCCEEEccCC----CeEEEEEeeccee
Q 011158 408 QNNIIHRDLKAANLLMDENE----VSLLLSLCLFTVS 440 (492)
Q Consensus 408 ~~~IiHrDLKp~NILld~~~----~~kl~DFGla~~~ 440 (492)
..|++|+|+||.||+++.++ .++++|||..+..
T Consensus 278 ~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 278 RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 68999999999999999988 8999999998754
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.2e-11 Score=117.19 Aligned_cols=134 Identities=16% Similarity=0.212 Sum_probs=98.3
Q ss_pred eeeeecCceEEEEEEEC--------CceEEEEEecCCCC-----------C---------hHHHHHHH----HHHHHHHh
Q 011158 298 SKVASGSYGDLYRGTYC--------SQDVAIKVLKPERI-----------N---------SDMQKEFA----QEVFIMRK 345 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~--------g~~vAvK~l~~~~~-----------~---------~~~~~~~~----~Ei~il~~ 345 (492)
..||.|.=+.||.|... +..+|||+.+.... + ......+. +|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 57899999999999754 36899999875311 0 01122333 79999999
Q ss_pred cCC--CceeeEEEEEecCCeEEEEEeccCCCCHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHH-HHCCceecCCCCCCE
Q 011158 346 VRH--KNVVQFIGACTKPPSLCIVTEFMSGGSVYD-YLHKLKGVFKLPSLLKVAIDVSKGMNYL-HQNNIIHRDLKAANL 421 (492)
Q Consensus 346 l~H--pnIv~l~g~~~~~~~~~lV~Ey~~ggsL~~-~L~~~~~~l~~~~~~~i~~qI~~gL~yL-H~~~IiHrDLKp~NI 421 (492)
+.. -++.+.+++ ..-+|||||+.+..+.. .++. ..++......+..+++.+|..| |+.||||+||++.||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 863 466777764 34689999996544422 2322 2455566778889999999998 899999999999999
Q ss_pred EEccCCCeEEEEEeecc
Q 011158 422 LMDENEVSLLLSLCLFT 438 (492)
Q Consensus 422 Lld~~~~~kl~DFGla~ 438 (492)
|++. +.+.++|||.+-
T Consensus 157 L~~~-~~v~iIDF~qav 172 (197)
T cd05146 157 LWHD-GKVWFIDVSQSV 172 (197)
T ss_pred EEEC-CcEEEEECCCce
Confidence 9974 678999999763
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=7.7e-11 Score=108.78 Aligned_cols=146 Identities=23% Similarity=0.264 Sum_probs=111.1
Q ss_pred eeeeeeecCceEEEEEEECCceEEEEEecCCCCC-----h-HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 296 FGSKVASGSYGDLYRGTYCSQDVAIKVLKPERIN-----S-DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 296 ~~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~-----~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
....|-+|+-+.|+++.+.|+.+.||.-..+... . -...+..+|+++|.++.--.|.-..=++.+...-.|+||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 3467889999999999999999999865444331 1 234567889999999875454444445555666789999
Q ss_pred ccCC-CCHHHHHHhcCCCCCHH-HHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCC---CeEEEEEeecceee
Q 011158 370 FMSG-GSVYDYLHKLKGVFKLP-SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE---VSLLLSLCLFTVSI 441 (492)
Q Consensus 370 y~~g-gsL~~~L~~~~~~l~~~-~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~---~~kl~DFGla~~~~ 441 (492)
|++| .++.+++...-..-... ....++.+|-+.+.-||.++|||+||..+||++..++ .+.++|||++..+.
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s~ 167 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVSR 167 (229)
T ss_pred eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhccc
Confidence 9966 48999997654332333 3378899999999999999999999999999997665 34789999987764
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1e-10 Score=108.34 Aligned_cols=135 Identities=21% Similarity=0.274 Sum_probs=104.7
Q ss_pred eeeeecCceEEEEEEECCceEEEEEecCCCCC-----hH-HHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEecc
Q 011158 298 SKVASGSYGDLYRGTYCSQDVAIKVLKPERIN-----SD-MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 371 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~-----~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 371 (492)
..+++|+=+.+|.+.+.|.++++|.-.++... .. ...+-.+|..++.+++--.|.-.+=+..+++...|+|||+
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 35789999999999888888888865544332 11 2345678999999987555544444556677789999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee
Q 011158 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI 441 (492)
Q Consensus 372 ~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~ 441 (492)
+|-.|.+++... ...++..|-.-+.-||..||+|+||.++||++...+ +.++|||++.++.
T Consensus 82 ~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~ 142 (204)
T COG3642 82 EGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFSD 142 (204)
T ss_pred CChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccccc
Confidence 999999899763 245667777778889999999999999999998765 8899999998764
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.21 E-value=6.9e-11 Score=112.54 Aligned_cols=140 Identities=19% Similarity=0.258 Sum_probs=107.1
Q ss_pred eeeeecCceEEEEEEECC-ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCC--CceeeEEEEEecC---CeEEEEEecc
Q 011158 298 SKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH--KNVVQFIGACTKP---PSLCIVTEFM 371 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~g-~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~g~~~~~---~~~~lV~Ey~ 371 (492)
+.|+.|.++.||+++..+ +.+++|+....... .....+.+|+.+++.+++ .++.+++.+.... +..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 568999999999998865 88999998654321 134578899999999976 3467777776654 2568999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 011158 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ------------------------------------------- 408 (492)
Q Consensus 372 ~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~------------------------------------------- 408 (492)
+|.++.+.+.. ..++......++.+++++|.+||+
T Consensus 83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 99888765432 346666777777777777777773
Q ss_pred -------------CCceecCCCCCCEEEcc--CCCeEEEEEeeccee
Q 011158 409 -------------NNIIHRDLKAANLLMDE--NEVSLLLSLCLFTVS 440 (492)
Q Consensus 409 -------------~~IiHrDLKp~NILld~--~~~~kl~DFGla~~~ 440 (492)
..++|+|+.|.|||++. ++.+.++||+.++..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 23699999999999998 566789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.4e-11 Score=111.90 Aligned_cols=101 Identities=10% Similarity=0.035 Sum_probs=83.5
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee--eeeCCCceee
Q 011158 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI--LFCGKGRELI 451 (492)
Q Consensus 374 gsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~--~~~g~~~~~a 451 (492)
|+|.+++......+++..++.++.||+.||.|||+++ ||+|||++.++.+|+ ||.++... ...++..|++
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~~~g~~~y~a 72 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQSRVDPYFMA 72 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccccCCCcccccC
Confidence 7999999876667999999999999999999999998 999999999999998 99887653 2357788999
Q ss_pred cceeccccccCccceeee---ecccccCCCCCCC
Q 011158 452 SLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 452 pe~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
||+.....+....|+|++ +.....|.++|..
T Consensus 73 PE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~ 106 (176)
T smart00750 73 PEVIQGQSYTEKADIYSLGITLYEALDYELPYNE 106 (176)
T ss_pred hHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccc
Confidence 999988888888999984 2233445555543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.16 E-value=4.7e-11 Score=120.73 Aligned_cols=106 Identities=18% Similarity=0.305 Sum_probs=84.0
Q ss_pred CCCceeeEEEEEecC---------------------------CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHH
Q 011158 347 RHKNVVQFIGACTKP---------------------------PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 399 (492)
Q Consensus 347 ~HpnIv~l~g~~~~~---------------------------~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI 399 (492)
+|||||++.++|.+. ..+|+||.-+ ..+|.+|+.. ...+.....-++.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~--~~~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWT--RHRSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhc--CCCchHHHHHHHHHH
Confidence 599999999887432 3579999988 6699999976 446777788899999
Q ss_pred HHHHHHHHHCCceecCCCCCCEEEc--cCC--CeEEEEEeeccee-------------eeeeCCCceeeccee
Q 011158 400 SKGMNYLHQNNIIHRDLKAANLLMD--ENE--VSLLLSLCLFTVS-------------ILFCGKGRELISLFL 455 (492)
Q Consensus 400 ~~gL~yLH~~~IiHrDLKp~NILld--~~~--~~kl~DFGla~~~-------------~~~~g~~~~~ape~~ 455 (492)
+.|+.|||++||.|||+|.+|||+. +++ ...++|||.+--. ....|....|+||+.
T Consensus 351 LEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ 423 (598)
T KOG4158|consen 351 LEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA 423 (598)
T ss_pred HHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence 9999999999999999999999984 443 5678999986211 124566778888865
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.16 E-value=3.1e-12 Score=140.45 Aligned_cols=177 Identities=22% Similarity=0.308 Sum_probs=134.6
Q ss_pred CCceeeeeeeecCceEEEEEEEC---CceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCeEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC---SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIV 367 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~---g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV 367 (492)
..|.+.+.||+|+|+.|-..... ...+|+|.+...............|..+-+.+. |+|++++++....+...+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 34555677999999999887653 345777766654333344455666888888887 99999999999999999999
Q ss_pred EeccCCCCHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCCCCEEEccCC-CeEEEEEeecceeee--
Q 011158 368 TEFMSGGSVYDYL-HKLKGVFKLPSLLKVAIDVSKGMNYLH-QNNIIHRDLKAANLLMDENE-VSLLLSLCLFTVSIL-- 442 (492)
Q Consensus 368 ~Ey~~ggsL~~~L-~~~~~~l~~~~~~~i~~qI~~gL~yLH-~~~IiHrDLKp~NILld~~~-~~kl~DFGla~~~~~-- 442 (492)
++|..|+++.+.+ .......+......++.|+..++.|+| ..++.||||||+|.+++..+ ..++.|||++.....
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~ 179 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKN 179 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccC
Confidence 9999999999998 442225677888899999999999999 99999999999999999999 999999999854332
Q ss_pred --------eeC-CCceeecceeccc-cccCccceee
Q 011158 443 --------FCG-KGRELISLFLGND-VLLQFGTYWI 468 (492)
Q Consensus 443 --------~~g-~~~~~ape~~~~e-~~~~~~d~W~ 468 (492)
.+| +..|++||..... ......+.|+
T Consensus 180 g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S 215 (601)
T KOG0590|consen 180 GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWS 215 (601)
T ss_pred CcceeeecccCCCCCCCCcccccchhhcCCCccccc
Confidence 334 5555555554442 2233345565
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=9.9e-12 Score=138.18 Aligned_cols=161 Identities=22% Similarity=0.311 Sum_probs=109.3
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
.+|..++.|..|+||.||..+++ .+.+|+|+-+..- +.+- |+.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l--------ilRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL--------ILRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcccccch--------hhhc--cccccCCccee-----------------
Confidence 46777899999999999999775 6889996543221 1111 22222333333
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee---------
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS--------- 440 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~--------- 440 (492)
|+-...++. .+.++.. ++.+++|||+.||+|||+||+|+||..-|.+|+.|||+++..
T Consensus 136 ----gDc~tllk~-~g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 136 ----GDCATLLKN-IGPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred ----chhhhhccc-CCCCcch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence 555555543 3444433 278999999999999999999999999999999999998643
Q ss_pred -------------eeeeCCCceeecceeccccccCccceeee---ecc--cccCCCCCCCccceeeeccC
Q 011158 441 -------------ILFCGKGRELISLFLGNDVLLQFGTYWII---FRR--SSCDKKNSDAPFLFYKIFIS 492 (492)
Q Consensus 441 -------------~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~--~~~gt~~Y~aPE~~~ki~~~ 492 (492)
+..+|++.|.+|+++--..|+...|||++ ..+ ..|-...-.-||..++.+||
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vis 272 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS 272 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhh
Confidence 23467777777777777777778889985 111 22333334557766666654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.2e-10 Score=114.29 Aligned_cols=146 Identities=14% Similarity=0.249 Sum_probs=96.0
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCC----------CceeeEEEEEe
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRH----------KNVVQFIGACT 359 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~-~~~~~~~~~~~Ei~il~~l~H----------pnIv~l~g~~~ 359 (492)
.+..++.||.|+++.||.+++ +++++|+|++.... ......+.+.+|......+.+ -.++-.++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 466788999999999999999 46999999886543 223456777777755554322 12222222221
Q ss_pred ---------cCC--------eEEEEEeccCCCCHHHHHHh---cCC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCC
Q 011158 360 ---------KPP--------SLCIVTEFMSGGSVYDYLHK---LKG---VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416 (492)
Q Consensus 360 ---------~~~--------~~~lV~Ey~~ggsL~~~L~~---~~~---~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDL 416 (492)
... +.+++|+-+ -++|.+++.. ... .+.....+.+..|+++.+++||..||+|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 111 347788887 6788888642 111 1233445667789999999999999999999
Q ss_pred CCCCEEEccCCCeEEEEEeecce
Q 011158 417 KAANLLMDENEVSLLLSLCLFTV 439 (492)
Q Consensus 417 Kp~NILld~~~~~kl~DFGla~~ 439 (492)
||+|++++.+|.+++.||+....
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r 194 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVR 194 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEE
T ss_pred ceeeEEEcCCCCEEEcChHHHee
Confidence 99999999999999999977643
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.10 E-value=3e-09 Score=105.85 Aligned_cols=135 Identities=13% Similarity=0.048 Sum_probs=98.3
Q ss_pred ceEEEEEEECCceEEEEEecCCCCChHH---------HHHHHHHHHHHHhcCCCc--eeeEEEEEec-----CCeEEEEE
Q 011158 305 YGDLYRGTYCSQDVAIKVLKPERINSDM---------QKEFAQEVFIMRKVRHKN--VVQFIGACTK-----PPSLCIVT 368 (492)
Q Consensus 305 fG~Vy~~~~~g~~vAvK~l~~~~~~~~~---------~~~~~~Ei~il~~l~Hpn--Iv~l~g~~~~-----~~~~~lV~ 368 (492)
...|++..+.|+.|.||........... ...+.+|...+.++...+ .++.+++... ...-+|||
T Consensus 35 ~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 35 GRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred CceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 3447788888889999977433211100 114778999888885333 3344444432 23478999
Q ss_pred eccCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcc-------CCCeEEEEEeecce
Q 011158 369 EFMSGG-SVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-------NEVSLLLSLCLFTV 439 (492)
Q Consensus 369 Ey~~gg-sL~~~L~~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~-------~~~~kl~DFGla~~ 439 (492)
|++++. +|.+++... ....+......++.+++..+.-||..||+|+|+++.|||++. +..+.++||+.++.
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 999875 899998643 234566777899999999999999999999999999999985 45788999998854
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.84 E-value=3.6e-09 Score=112.24 Aligned_cols=98 Identities=33% Similarity=0.491 Sum_probs=92.1
Q ss_pred HHhcCCCceeeEEEEEecCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCc-eecCCCCCCE
Q 011158 343 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI-IHRDLKAANL 421 (492)
Q Consensus 343 l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~I-iHrDLKp~NI 421 (492)
|+.+.|.|+.+++|.+.+.+..++|.+||..|+|.|.+......+++.....++++|+.||.|||.-.| .|+.|++.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 467899999999999999999999999999999999998877789999999999999999999999876 8999999999
Q ss_pred EEccCCCeEEEEEeeccee
Q 011158 422 LMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 422 Lld~~~~~kl~DFGla~~~ 440 (492)
++|....+|+.|||+..+.
T Consensus 81 lvd~~w~lklt~~Gl~~~~ 99 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLL 99 (484)
T ss_pred eeeeeEEEEechhhhcccc
Confidence 9999999999999998776
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.83 E-value=2e-08 Score=94.66 Aligned_cols=125 Identities=17% Similarity=0.223 Sum_probs=81.5
Q ss_pred EEEEEEE-CCceEEEEEecCCCCC------------------------hHHHHHHHHHHHHHHhcCCC--ceeeEEEEEe
Q 011158 307 DLYRGTY-CSQDVAIKVLKPERIN------------------------SDMQKEFAQEVFIMRKVRHK--NVVQFIGACT 359 (492)
Q Consensus 307 ~Vy~~~~-~g~~vAvK~l~~~~~~------------------------~~~~~~~~~Ei~il~~l~Hp--nIv~l~g~~~ 359 (492)
.||.|.. .+..+|||+.+....+ ........+|..+|.++..- ++.+++.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899987 5789999998753110 01123467799999999865 567776553
Q ss_pred cCCeEEEEEeccC--CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH-HHHCCceecCCCCCCEEEccCCCeEEEEEee
Q 011158 360 KPPSLCIVTEFMS--GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY-LHQNNIIHRDLKAANLLMDENEVSLLLSLCL 436 (492)
Q Consensus 360 ~~~~~~lV~Ey~~--ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~y-LH~~~IiHrDLKp~NILld~~~~~kl~DFGl 436 (492)
.-+|||||++ |..+..+... .++......++.+++..+.. +|..||+|+||.+.|||++++ .+.++|||.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~---~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV---DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC---GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred ---CCEEEEEecCCCccchhhHHhc---cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 2479999997 5555443322 12234456777888886665 579999999999999999987 889999988
Q ss_pred cce
Q 011158 437 FTV 439 (492)
Q Consensus 437 a~~ 439 (492)
+-.
T Consensus 153 av~ 155 (188)
T PF01163_consen 153 AVD 155 (188)
T ss_dssp EEE
T ss_pred cee
Confidence 744
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.78 E-value=5.1e-08 Score=93.26 Aligned_cols=106 Identities=17% Similarity=0.249 Sum_probs=84.3
Q ss_pred HHHHHHHHHHHhcCC--CceeeEEEEEecC----CeEEEEEeccCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Q 011158 334 KEFAQEVFIMRKVRH--KNVVQFIGACTKP----PSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 406 (492)
Q Consensus 334 ~~~~~Ei~il~~l~H--pnIv~l~g~~~~~----~~~~lV~Ey~~gg-sL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yL 406 (492)
....+|...+..+.. -.+.+.+++.... ...+||||++++. +|.+++..... .+......++.+++..+.-|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence 467788888888753 3345556665542 2358999999874 89999976333 66777889999999999999
Q ss_pred HHCCceecCCCCCCEEEccCC---CeEEEEEeeccee
Q 011158 407 HQNNIIHRDLKAANLLMDENE---VSLLLSLCLFTVS 440 (492)
Q Consensus 407 H~~~IiHrDLKp~NILld~~~---~~kl~DFGla~~~ 440 (492)
|.+||+|+|+++.|||++.++ .+.++||+-++..
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999999999999999887 7889999887654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.75 E-value=4.2e-09 Score=112.01 Aligned_cols=165 Identities=24% Similarity=0.228 Sum_probs=129.9
Q ss_pred CCCCceeeeeeee--cCceEEEEEEE----CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCC
Q 011158 290 DPKHLKFGSKVAS--GSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPP 362 (492)
Q Consensus 290 ~~~~~~~~~~LG~--G~fG~Vy~~~~----~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~ 362 (492)
....+.+...+|. |.+|.||.+.. .+..+|+|.-+...........=.+|+...++++ |+|.++.+..+...+
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence 3345566678899 99999998876 3567999975543322233344456777777775 999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHH----HHHHHHHCCceecCCCCCCEEEccC-CCeEEEEEeec
Q 011158 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK----GMNYLHQNNIIHRDLKAANLLMDEN-EVSLLLSLCLF 437 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~----gL~yLH~~~IiHrDLKp~NILld~~-~~~kl~DFGla 437 (492)
.+++-+|+| +.+|.++.+.....++...++.+..+..+ ||.++|..+|+|-|+||+||++..+ ..+++.|||+.
T Consensus 192 ~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 192 ILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred cceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCccee
Confidence 999999999 78999999876566889999999999999 9999999999999999999999998 88899999886
Q ss_pred ceee------------eeeCCCceeeccee
Q 011158 438 TVSI------------LFCGKGRELISLFL 455 (492)
Q Consensus 438 ~~~~------------~~~g~~~~~ape~~ 455 (492)
.... ...+...|++++..
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~ 300 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELL 300 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhh
Confidence 4321 12455667777644
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.1e-08 Score=108.81 Aligned_cols=147 Identities=18% Similarity=0.172 Sum_probs=119.0
Q ss_pred CCCceeeeeeeecCceEEEEEEEC---CceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCeEEE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTYC---SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCI 366 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~~---g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~l 366 (492)
.-++..+..||.|.|+.|+..... +..|++|.+............-..|+.+...+. |.+++.++..+......||
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 346778899999999999988653 467899988765443333333456777777664 8889998888887778889
Q ss_pred EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccC-CCeEEEEEeecc
Q 011158 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-EVSLLLSLCLFT 438 (492)
Q Consensus 367 V~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~-~~~kl~DFGla~ 438 (492)
-.|||+++++...+ .....+.+...+++..|++.++.++|++.++|+|+||+||++..+ +..++.|||++.
T Consensus 344 p~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred chhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccc
Confidence 99999999987777 334567888899999999999999999999999999999999886 788899998874
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.64 E-value=9.8e-08 Score=102.92 Aligned_cols=121 Identities=16% Similarity=0.228 Sum_probs=99.8
Q ss_pred CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHH
Q 011158 314 CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLL 393 (492)
Q Consensus 314 ~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~ 393 (492)
.+.+|.|...+.... .......+-+.-|+.++||||++++..+...+.+|||+|-+. -|..++++ +....+.
T Consensus 36 ~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~----l~~~~v~ 107 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE----LGKEEVC 107 (690)
T ss_pred cCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH----hHHHHHH
Confidence 467788888875432 334556777888999999999999999999999999999873 57777766 3466677
Q ss_pred HHHHHHHHHHHHHH-HCCceecCCCCCCEEEccCCCeEEEEEeecceeee
Q 011158 394 KVAIDVSKGMNYLH-QNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL 442 (492)
Q Consensus 394 ~i~~qI~~gL~yLH-~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~ 442 (492)
.-+.||+.||.||| .++++|++|.-+-|++++.|.-||.+|-+...+..
T Consensus 108 ~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~ 157 (690)
T KOG1243|consen 108 LGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASG 157 (690)
T ss_pred HHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEecccc
Confidence 78899999999998 56899999999999999999999999988765543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.61 E-value=8.6e-07 Score=84.73 Aligned_cols=140 Identities=12% Similarity=0.068 Sum_probs=103.9
Q ss_pred eecCceEEEEEEECCceEEEEEecCC---CCC-hHHHHHHHHHHHHHHhcCC--CceeeEEEEEec--C--CeEEEEEec
Q 011158 301 ASGSYGDLYRGTYCSQDVAIKVLKPE---RIN-SDMQKEFAQEVFIMRKVRH--KNVVQFIGACTK--P--PSLCIVTEF 370 (492)
Q Consensus 301 G~G~fG~Vy~~~~~g~~vAvK~l~~~---~~~-~~~~~~~~~Ei~il~~l~H--pnIv~l~g~~~~--~--~~~~lV~Ey 370 (492)
|.||-+-|++..+.|+.+-+|..... ... +-....|.+|+..+.++.. -.+.+....... + -.-+||+|-
T Consensus 27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~ 106 (216)
T PRK09902 27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTED 106 (216)
T ss_pred CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEe
Confidence 66888899998888888888876521 001 2345789999999999863 234455422211 1 236899998
Q ss_pred cCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCC--eEEEEEeeccee
Q 011158 371 MSG-GSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV--SLLLSLCLFTVS 440 (492)
Q Consensus 371 ~~g-gsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~--~kl~DFGla~~~ 440 (492)
+.| -+|.+++.+.. .+.+......++.+|+..+.-||+.|+.|+|+-+.|||++.++. ++++||--++..
T Consensus 107 L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~~ 180 (216)
T PRK09902 107 MAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRRR 180 (216)
T ss_pred CCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccchh
Confidence 754 58999986532 34577778899999999999999999999999999999987676 888888776543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.60 E-value=2.9e-07 Score=90.34 Aligned_cols=133 Identities=17% Similarity=0.247 Sum_probs=98.1
Q ss_pred eeeeeeeecCceEEEEEEE-CCceEEEEEecCCCCC-------h-------------HHHHHHHHHHHHHHhcCCC--ce
Q 011158 295 KFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERIN-------S-------------DMQKEFAQEVFIMRKVRHK--NV 351 (492)
Q Consensus 295 ~~~~~LG~G~fG~Vy~~~~-~g~~vAvK~l~~~~~~-------~-------------~~~~~~~~Ei~il~~l~Hp--nI 351 (492)
.++.+||-|.=+.||.|.+ .|.++|||.=+....+ . .......+|..+|.++... .|
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 4568999999999999988 5899999975443110 0 1123457899999999755 67
Q ss_pred eeEEEEEecCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEE
Q 011158 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLL 431 (492)
Q Consensus 352 v~l~g~~~~~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl 431 (492)
.+.+++ +.-.+||||++|-.|...- ++....-.++..|+.-+.-+-..||||+|+.+-|||++++|.+.+
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~v 243 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVV 243 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEE
Confidence 777665 4568999999886664422 233444455666666666666899999999999999999999999
Q ss_pred EEEeec
Q 011158 432 LSLCLF 437 (492)
Q Consensus 432 ~DFGla 437 (492)
+||=-+
T Consensus 244 IDwPQ~ 249 (304)
T COG0478 244 IDWPQA 249 (304)
T ss_pred EeCccc
Confidence 998554
|
|
| >cd04928 ACT_TyrKc Uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains | Back alignment and domain information |
|---|
Probab=98.50 E-value=3.8e-07 Score=71.27 Aligned_cols=67 Identities=67% Similarity=1.026 Sum_probs=62.7
Q ss_pred ceeeEEecCCCcchhhhhhhhhcccccceeeeeccccCCCceEEEEEEcCCCcchHHHHHHHHHHHH
Q 011158 179 MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEV 245 (492)
Q Consensus 179 ~~e~~~s~~~~p~~ls~l~~~l~~~~l~i~~A~~fst~dg~sl~v~vv~~w~~e~~~~l~~~l~~~~ 245 (492)
++++++.+.|+|.++++++..|+..++||..|..|++.+|+.+++|.|..|..++++.+.+++++.+
T Consensus 1 ~~eI~V~~~Dr~gLFa~iag~L~~~~LnI~~A~i~tt~dG~~LDtF~V~d~~~~~~~~~~~~~~~~~ 67 (68)
T cd04928 1 MHEITFAAGDKPKLLSQLSSLLGDLGLNIAEAHAFSTDDGLALDIFVVTGWKRGETAALGHALQKEI 67 (68)
T ss_pred CEEEEEEECCCcchHHHHHHHHHHCCCceEEEEEEEcCCCeEEEEEEEecCCccchHHHHHHHHHhh
Confidence 4789999999999999999999999999999999999999999999999999999999998887653
|
This CD includes a novel, yet uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains. Members of this CD belong to the superfamily of ACT regulatory domains. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.8e-08 Score=105.71 Aligned_cols=103 Identities=17% Similarity=0.231 Sum_probs=85.8
Q ss_pred eEEEEEeccCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 363 SLCIVTEFMSGGSVYDYLHKLK--GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
++||.|++|...+|.+||...+ ...++...+.++.|++.|++| ++.+|||+||.||....+..+||.|||+....
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~ 406 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ 406 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence 5899999999999999996432 356788889999999999999 99999999999999999999999999996432
Q ss_pred e-------------eeeCCCceeecceeccccccCccceee
Q 011158 441 I-------------LFCGKGRELISLFLGNDVLLQFGTYWI 468 (492)
Q Consensus 441 ~-------------~~~g~~~~~ape~~~~e~~~~~~d~W~ 468 (492)
. ...|+.-||+||.+..+.|....++++
T Consensus 407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIya 447 (516)
T KOG1033|consen 407 DKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYA 447 (516)
T ss_pred ccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhh
Confidence 1 245667788888887777777777655
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.45 E-value=2.9e-06 Score=81.50 Aligned_cols=140 Identities=16% Similarity=0.166 Sum_probs=94.6
Q ss_pred CCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCChH-HHH------HHHHHHHHHHhcCC---CceeeEEEEEec
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSD-MQK------EFAQEVFIMRKVRH---KNVVQFIGACTK 360 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~-~~~------~~~~Ei~il~~l~H---pnIv~l~g~~~~ 360 (492)
..+|+..+.+-......|.+-...++.+++|..+....... ... ...+++..+.+++. .....++-+...
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ek 109 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEK 109 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeee
Confidence 45677778888877888888888899999999876432111 111 12334444444432 233333333322
Q ss_pred -----CCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEe
Q 011158 361 -----PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLC 435 (492)
Q Consensus 361 -----~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFG 435 (492)
....+|+|||++|..|.++.. +++ .+...+.++|.-||+.|+.|+|..|.|++++.++ ++++||+
T Consensus 110 k~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~ 179 (229)
T PF06176_consen 110 KIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQ 179 (229)
T ss_pred eeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECc
Confidence 234678999999988876542 222 2445677889999999999999999999999665 8899998
Q ss_pred eccee
Q 011158 436 LFTVS 440 (492)
Q Consensus 436 la~~~ 440 (492)
..+..
T Consensus 180 ~k~~~ 184 (229)
T PF06176_consen 180 GKRMS 184 (229)
T ss_pred ccccc
Confidence 88654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.1e-06 Score=94.74 Aligned_cols=139 Identities=17% Similarity=0.247 Sum_probs=92.9
Q ss_pred eeeeecCceEEEEEEEC-CceEEEEEecCCCCC---hH-------------------------HH----------HHHHH
Q 011158 298 SKVASGSYGDLYRGTYC-SQDVAIKVLKPERIN---SD-------------------------MQ----------KEFAQ 338 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~-g~~vAvK~l~~~~~~---~~-------------------------~~----------~~~~~ 338 (492)
+-|+.++-|+||+|+.. |+.||||+.+++-.. .+ .. -++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 57899999999999995 899999999875110 00 00 12345
Q ss_pred HHHHHHhcC-----CCce--eeEEEEEecCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 011158 339 EVFIMRKVR-----HKNV--VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411 (492)
Q Consensus 339 Ei~il~~l~-----HpnI--v~l~g~~~~~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~I 411 (492)
|...+.+++ .++| .+++. .-...-.|+|||+.|-.+.+........++...+.....++. +..+-..|+
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~w--e~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgf 286 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYW--EYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeeh--hccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCc
Confidence 555555553 2332 23332 223446899999999989888533334455444333332222 334445799
Q ss_pred eecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 412 IHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 412 iHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
+|.|..|.||+++.+|...+.|||..+..
T Consensus 287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 287 FHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred cccCCCccceEEecCCcEEEEcCcceecC
Confidence 99999999999999999999999998653
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.40 E-value=4.2e-06 Score=81.35 Aligned_cols=136 Identities=16% Similarity=0.232 Sum_probs=86.9
Q ss_pred eeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCc--eeeEEEEEecCCeEEEEEeccCCCC
Q 011158 298 SKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN--VVQFIGACTKPPSLCIVTEFMSGGS 375 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~g~~~~~~~~~lV~Ey~~ggs 375 (492)
..||+|..+.||+. .+..+++|...... ......+|..+++.+..-. +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 57899999999984 35678889876432 2245688999999986433 4677888877777899999998863
Q ss_pred -HH--------------HHH-------HhcC-CCCCHHHHH-HHHHH----------HHH-HHHHHHH----CCceecCC
Q 011158 376 -VY--------------DYL-------HKLK-GVFKLPSLL-KVAID----------VSK-GMNYLHQ----NNIIHRDL 416 (492)
Q Consensus 376 -L~--------------~~L-------~~~~-~~l~~~~~~-~i~~q----------I~~-gL~yLH~----~~IiHrDL 416 (492)
+. ..+ +... ......... .+..+ +.. ...+|.. ..++|+|+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 21 111 1100 011111111 11111 111 1223322 24789999
Q ss_pred CCCCEEEccCCCeEEEEEeeccee
Q 011158 417 KAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 417 Kp~NILld~~~~~kl~DFGla~~~ 440 (492)
.|.||++++++ +.++||+.++..
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~~G 183 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFGYG 183 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcCcC
Confidence 99999999888 899999998754
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.36 E-value=2.8e-06 Score=89.51 Aligned_cols=132 Identities=17% Similarity=0.188 Sum_probs=102.0
Q ss_pred eEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEec----CCeEEEEEeccCC-CCHHH
Q 011158 306 GDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK----PPSLCIVTEFMSG-GSVYD 378 (492)
Q Consensus 306 G~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~~~~~lV~Ey~~g-gsL~~ 378 (492)
.+.|++.. .|..|++|++...+... ......-+++++++.|.|||++.+++.. ...+++|++|.++ ++|++
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~--~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQS--TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccC--cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 46888865 58899999995443211 1122345778999999999999998863 3468999999986 68888
Q ss_pred HHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecce
Q 011158 379 YLHKL--------------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTV 439 (492)
Q Consensus 379 ~L~~~--------------~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~ 439 (492)
+-... ....++..+|.++.|+..||.++|+.|+.-+-|.|.+||++-+.+++|.--|...+
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dv 442 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDV 442 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceee
Confidence 76421 12467889999999999999999999999999999999999887777765555444
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.35 E-value=4e-06 Score=79.94 Aligned_cols=140 Identities=18% Similarity=0.222 Sum_probs=85.4
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCC--ceeeEEEEEec---CCeEEEEEecc
Q 011158 297 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK--NVVQFIGACTK---PPSLCIVTEFM 371 (492)
Q Consensus 297 ~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~g~~~~---~~~~~lV~Ey~ 371 (492)
++.|+.|..+.||+.+..+..+++|+.... .....+.+|..+++.+... .+.+++..... ....+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 468899999999999998889999997642 3456788899998888533 35667764432 33479999999
Q ss_pred CCCCHHH----------------HHH---hcC---CCCCHHH---------HHHH------------HHHHHH-HHHHHH
Q 011158 372 SGGSVYD----------------YLH---KLK---GVFKLPS---------LLKV------------AIDVSK-GMNYLH 407 (492)
Q Consensus 372 ~ggsL~~----------------~L~---~~~---~~l~~~~---------~~~i------------~~qI~~-gL~yLH 407 (492)
+|..+.. .+. ... ..+.... .... ...+.. .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9988877 111 110 0111100 0000 011222 233333
Q ss_pred H-------CCceecCCCCCCEEEc-cCCCeEEEEEeeccee
Q 011158 408 Q-------NNIIHRDLKAANLLMD-ENEVSLLLSLCLFTVS 440 (492)
Q Consensus 408 ~-------~~IiHrDLKp~NILld-~~~~~kl~DFGla~~~ 440 (492)
+ ..++|+|+.|.|||++ .++.+-++||+.++..
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence 2 3599999999999999 5555579999988765
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.1e-05 Score=78.69 Aligned_cols=137 Identities=18% Similarity=0.172 Sum_probs=86.7
Q ss_pred eeeecCc-eEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCeEEEEEeccCCCCH
Q 011158 299 KVASGSY-GDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFMSGGSV 376 (492)
Q Consensus 299 ~LG~G~f-G~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~Ey~~ggsL 376 (492)
.|..|.+ ..||+....+..+.+|+..... ...+.+|+.+++.+. +--+.+++++....+..++|||+++|.+|
T Consensus 5 ~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 5 RVTEGQSGATVYRLDGKNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred ecCCCCCcCeEEEEcCCCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 3445555 6899997767788899876432 245677999988884 34466778877766678999999998877
Q ss_pred HHHH-------------------HhcCC---CCCHH--HHHHHHH--------------------HHHHHHHHHH-----
Q 011158 377 YDYL-------------------HKLKG---VFKLP--SLLKVAI--------------------DVSKGMNYLH----- 407 (492)
Q Consensus 377 ~~~L-------------------~~~~~---~l~~~--~~~~i~~--------------------qI~~gL~yLH----- 407 (492)
.... +.... .+... ....... .+...+..|-
T Consensus 80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 159 (244)
T cd05150 80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA 159 (244)
T ss_pred hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence 6432 11000 11100 0000000 0111122221
Q ss_pred --HCCceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 408 --QNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 408 --~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
...++|+|+.|.|||++.++...|+||+.++..
T Consensus 160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~g 194 (244)
T cd05150 160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGVA 194 (244)
T ss_pred cCceEEECCCCCCccEEEeCCcEEEEEEccccccc
Confidence 124899999999999999877889999998765
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.16 E-value=6.5e-05 Score=71.43 Aligned_cols=127 Identities=18% Similarity=0.300 Sum_probs=93.2
Q ss_pred CCceeeeeeeecCc-eEEEEEEECCceEEEEEecC---C-------CCCh---------HHHHHHHHHHHHHHhcC---C
Q 011158 292 KHLKFGSKVASGSY-GDLYRGTYCSQDVAIKVLKP---E-------RINS---------DMQKEFAQEVFIMRKVR---H 348 (492)
Q Consensus 292 ~~~~~~~~LG~G~f-G~Vy~~~~~g~~vAvK~l~~---~-------~~~~---------~~~~~~~~Ei~il~~l~---H 348 (492)
.++++++.||.|.- |.||++...|+.+|+|+++. . .... ....-|..|.+...+++ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 68899999999999 99999999999999999332 1 0000 22346888999888775 4
Q ss_pred Cce--eeEEEEEecC------------------CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Q 011158 349 KNV--VQFIGACTKP------------------PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408 (492)
Q Consensus 349 pnI--v~l~g~~~~~------------------~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~ 408 (492)
.++ |+.+||..-. ....||.||.+... .++. .-+.+|.+-|..+|+
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~----~~~~~~~~dl~~~~k 182 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQI----RDIPQMLRDLKILHK 182 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccch----hHHHHHHHHHHHHHH
Confidence 456 9999987311 12468888886543 1222 235567777889999
Q ss_pred CCceecCCCCCCEEEccCCCeEEEEEeec
Q 011158 409 NNIIHRDLKAANLLMDENEVSLLLSLCLF 437 (492)
Q Consensus 409 ~~IiHrDLKp~NILld~~~~~kl~DFGla 437 (492)
.||+-+|+|+.|.. + -|++|||.+
T Consensus 183 ~gI~~~Dv~~~ny~---~--G~lvDfs~~ 206 (207)
T PF13095_consen 183 LGIVPRDVKPRNYR---G--GKLVDFSSS 206 (207)
T ss_pred CCeeeccCcccccc---C--CEEEecccC
Confidence 99999999999976 3 378999853
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.7e-05 Score=77.16 Aligned_cols=135 Identities=16% Similarity=0.189 Sum_probs=91.1
Q ss_pred eeeeecCceEEEEEEE-CCceEEEEEecCCCCChHH-----------------HH-----HHHHHHHHHHhcC--CCcee
Q 011158 298 SKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDM-----------------QK-----EFAQEVFIMRKVR--HKNVV 352 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~-~g~~vAvK~l~~~~~~~~~-----------------~~-----~~~~Ei~il~~l~--HpnIv 352 (492)
..|.+|.-..||+|.. .+..+|||+++.....-.. .+ -...|+..|+++. +-.+.
T Consensus 54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 3667777788999876 5789999999764221110 01 1234677777764 34455
Q ss_pred eEEEEEecCCeEEEEEeccCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEccCCCeE
Q 011158 353 QFIGACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVSL 430 (492)
Q Consensus 353 ~l~g~~~~~~~~~lV~Ey~~gg-sL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~-~~IiHrDLKp~NILld~~~~~k 430 (492)
+.+.+.. -.|||||+... .-.-.|+. -.+.......+..++++.|.-|-. .++||+||..-|||+. ++.+.
T Consensus 134 ~Pi~~~~----nVLvMEfIg~~g~pAP~LkD--v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~ 206 (268)
T COG1718 134 EPIAFRN----NVLVMEFIGDDGLPAPRLKD--VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPY 206 (268)
T ss_pred CceeecC----CeEEEEeccCCCCCCCCccc--CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEE
Confidence 5555542 47999999432 11111111 123333677888899999988877 8999999999999999 77889
Q ss_pred EEEEeecce
Q 011158 431 LLSLCLFTV 439 (492)
Q Consensus 431 l~DFGla~~ 439 (492)
++||+-+-.
T Consensus 207 iID~~QaV~ 215 (268)
T COG1718 207 IIDVSQAVT 215 (268)
T ss_pred EEECccccc
Confidence 999998743
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.11 E-value=2.5e-06 Score=85.29 Aligned_cols=91 Identities=25% Similarity=0.427 Sum_probs=78.2
Q ss_pred HHHHhcCCCceeeEEEEEecC-----CeEEEEEeccCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC--C
Q 011158 341 FIMRKVRHKNVVQFIGACTKP-----PSLCIVTEFMSGGSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQN--N 410 (492)
Q Consensus 341 ~il~~l~HpnIv~l~g~~~~~-----~~~~lV~Ey~~ggsL~~~L~~~~---~~l~~~~~~~i~~qI~~gL~yLH~~--~ 410 (492)
.-|-++-|.|||+++.|+.+. ....+++|||+.|+|.++|++.+ ..+......+|+.||+.||.|||+. -
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 445566799999999998654 45789999999999999998643 4678888999999999999999998 5
Q ss_pred ceecCCCCCCEEEccCCCeEE
Q 011158 411 IIHRDLKAANLLMDENEVSLL 431 (492)
Q Consensus 411 IiHrDLKp~NILld~~~~~kl 431 (492)
|+|+++.-.-|++..+|.+|+
T Consensus 199 iihgnlTc~tifiq~ngLIki 219 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKI 219 (458)
T ss_pred cccCCcchhheeecCCceEEe
Confidence 999999999999998887665
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.05 E-value=2.4e-05 Score=84.52 Aligned_cols=139 Identities=20% Similarity=0.275 Sum_probs=91.7
Q ss_pred eeeeecCceEEEEEEE-CCceEEEEEecCCCCCh---H--------------------------HHH------HHHHHHH
Q 011158 298 SKVASGSYGDLYRGTY-CSQDVAIKVLKPERINS---D--------------------------MQK------EFAQEVF 341 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~-~g~~vAvK~l~~~~~~~---~--------------------------~~~------~~~~Ei~ 341 (492)
+.||.-+.|+||+|+. .|+.||||+-++.-... + ..+ +|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5789999999999988 47889999988751110 0 011 2455555
Q ss_pred HHHhc----CCCc------eeeEEEEEecCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 011158 342 IMRKV----RHKN------VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411 (492)
Q Consensus 342 il~~l----~Hpn------Iv~l~g~~~~~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~I 411 (492)
...++ .|-+ |.+++..+.. .-.|+||||.|..+.|.-.-.+..++...+..-+.++..-+ |-..|+
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st--~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~q--If~~Gf 322 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLST--KRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQ--IFKTGF 322 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCc--ceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHH--HHhcCC
Confidence 44443 4555 5555554443 46899999999866655432234566665444444333222 334589
Q ss_pred eecCCCCCCEEEcc----CCCeEEEEEeeccee
Q 011158 412 IHRDLKAANLLMDE----NEVSLLLSLCLFTVS 440 (492)
Q Consensus 412 iHrDLKp~NILld~----~~~~kl~DFGla~~~ 440 (492)
+|+|=.|.||++.. ++.+.+.|||+.+..
T Consensus 323 fHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 323 FHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred ccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 99999999999994 568999999998764
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.02 E-value=5.5e-05 Score=86.92 Aligned_cols=78 Identities=14% Similarity=0.262 Sum_probs=57.0
Q ss_pred eeeeeecCceEEEEEEECC----ceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCce--eeEEEEEecC---CeEEE
Q 011158 297 GSKVASGSYGDLYRGTYCS----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNV--VQFIGACTKP---PSLCI 366 (492)
Q Consensus 297 ~~~LG~G~fG~Vy~~~~~g----~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~-HpnI--v~l~g~~~~~---~~~~l 366 (492)
.+.++.|.+..+|+....+ ..+++|+....... .....+.+|+.+|+.+. |.+| .+++.+|.+. +..|+
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 3678999999999987754 46788876543211 12356889999999996 6654 7888888764 45789
Q ss_pred EEeccCCCC
Q 011158 367 VTEFMSGGS 375 (492)
Q Consensus 367 V~Ey~~ggs 375 (492)
||||++|..
T Consensus 122 VME~v~G~~ 130 (822)
T PLN02876 122 IMEYLEGRI 130 (822)
T ss_pred EEEecCCcc
Confidence 999998754
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.97 E-value=0.00017 Score=68.71 Aligned_cols=129 Identities=22% Similarity=0.392 Sum_probs=91.5
Q ss_pred eeeeecCceEEEEEEECCceEEEEEecCCCC--------------ChHHHHHHHHHHHHHHhcC------CCceeeEEEE
Q 011158 298 SKVASGSYGDLYRGTYCSQDVAIKVLKPERI--------------NSDMQKEFAQEVFIMRKVR------HKNVVQFIGA 357 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~--------------~~~~~~~~~~Ei~il~~l~------HpnIv~l~g~ 357 (492)
..||+|+.-.||.-- .....+||+...... ......+..+|+.....+. +.+|.+++|+
T Consensus 7 ~~i~~G~~R~cy~HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 7 DLIAQGGERDCYQHP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred cccccCCCceEEECC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 578999999888632 234578899887640 1112456677777666665 7889999999
Q ss_pred EecCCeEEEEEeccCC------CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCC----
Q 011158 358 CTKPPSLCIVTEFMSG------GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE---- 427 (492)
Q Consensus 358 ~~~~~~~~lV~Ey~~g------gsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~---- 427 (492)
..+...+-+|+|.+.+ .+|.+++.+ +.++. .... .+-.-..||-.++|+.+||+|.||++....
T Consensus 86 veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~--~~~~~-~~~~---~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~ 159 (199)
T PF10707_consen 86 VETNLGLGLVVELIRDADGNISPTLEDYLKE--GGLTE-ELRQ---ALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEF 159 (199)
T ss_pred EecCCceEEEEEEEECCCCCcCccHHHHHHc--CCccH-HHHH---HHHHHHHHHHHcCCeecCCCcccEEEEecCCCce
Confidence 9999889999998642 378898855 44555 3322 333345788899999999999999997543
Q ss_pred CeEEEE
Q 011158 428 VSLLLS 433 (492)
Q Consensus 428 ~~kl~D 433 (492)
.+.++|
T Consensus 160 ~lvlID 165 (199)
T PF10707_consen 160 RLVLID 165 (199)
T ss_pred EEEEEe
Confidence 355665
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.87 E-value=4.3e-06 Score=94.17 Aligned_cols=148 Identities=19% Similarity=0.233 Sum_probs=106.9
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeE
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 364 (492)
....+.+.+.+-+-+|+++.++.++-. +...++|+..... +.....+...++-.++-..++|-++...-.+......
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 344556667778889999999987543 3334555443221 1111123334444444445667777666665566779
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEee
Q 011158 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCL 436 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGl 436 (492)
+++++|..+++|...|+.- +..+..-...++..+.++++|||...++|||+||.|+|+..++..++.+|+.
T Consensus 880 ~L~~~~~~~~~~~Skl~~~-~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t 950 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNS-GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGT 950 (1205)
T ss_pred chhhHHhccCCchhhhhcC-CCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccc
Confidence 9999999999999999873 4456666677778899999999999999999999999999999999999983
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.84 E-value=5.1e-05 Score=71.68 Aligned_cols=99 Identities=17% Similarity=0.272 Sum_probs=79.3
Q ss_pred HHHHHHHHhcCC-CceeeEEEEEecCCeEEEEEeccCCCCHHHH---HHhcCCCCCHHHHHHHHHHHHHHHHHHHH---C
Q 011158 337 AQEVFIMRKVRH-KNVVQFIGACTKPPSLCIVTEFMSGGSVYDY---LHKLKGVFKLPSLLKVAIDVSKGMNYLHQ---N 409 (492)
Q Consensus 337 ~~Ei~il~~l~H-pnIv~l~g~~~~~~~~~lV~Ey~~ggsL~~~---L~~~~~~l~~~~~~~i~~qI~~gL~yLH~---~ 409 (492)
..|..+|+.+++ +++++++|+|.. ++|+||...+++... +.. -...+|..+.+|+.+++..+.+|+. .
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~-~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQ-FLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccccccc-ccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 358888999986 699999999953 678999977755421 111 0235899999999999999999998 3
Q ss_pred CceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 410 NIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 410 ~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
.+.-.|++++|+-+++++.+|++|.......
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 5778999999999999999999999886543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.83 E-value=8.4e-05 Score=72.28 Aligned_cols=72 Identities=15% Similarity=0.235 Sum_probs=46.0
Q ss_pred eeeeecCce-EEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCC---ceeeEEEEEecC---CeEEEEEec
Q 011158 298 SKVASGSYG-DLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK---NVVQFIGACTKP---PSLCIVTEF 370 (492)
Q Consensus 298 ~~LG~G~fG-~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~g~~~~~---~~~~lV~Ey 370 (492)
+.|+.|+.. .||+. +..+++|+.+.. .....+.+|..+|..+... -+.++++..... ...+++|++
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAA----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCcc----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 456777766 48875 346778875532 1235788899999887532 344555544332 235889999
Q ss_pred cCCCCH
Q 011158 371 MSGGSV 376 (492)
Q Consensus 371 ~~ggsL 376 (492)
++|.++
T Consensus 76 i~G~~l 81 (235)
T cd05155 76 LEGETA 81 (235)
T ss_pred ecCCCC
Confidence 988665
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00022 Score=66.16 Aligned_cols=134 Identities=17% Similarity=0.197 Sum_probs=93.4
Q ss_pred CCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCcee-eEEEEEecCCeEEEEEe
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV-QFIGACTKPPSLCIVTE 369 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv-~l~g~~~~~~~~~lV~E 369 (492)
.......+.|++|++|.||+|.+.|..+|+|+-+.+. -...+..|.++|..++-.++. +++.+-. ..+.||
T Consensus 21 ~~~~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds----~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me 92 (201)
T COG2112 21 KYELRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDS----PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRME 92 (201)
T ss_pred chhhhhhhhhhcccccEEEEeeccCceEEEEEecCCc----chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhh
Confidence 3445566889999999999999999999999987543 246788899999999876654 3444422 345699
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC-CCCEEEccCCCeEEEEEeeccee
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK-AANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLK-p~NILld~~~~~kl~DFGla~~~ 440 (492)
|+.|-.|.++-.. .+...+.. ++..---|-..||-|..|. |..+++..++.+.|+||--|...
T Consensus 93 ~i~G~~L~~~~~~----~~rk~l~~----vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 93 YIDGRPLGKLEIG----GDRKHLLR----VLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhcCcchhhhhhc----ccHHHHHH----HHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 9988888776543 13333333 3333333445688888774 44455555558899999988743
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0008 Score=67.47 Aligned_cols=139 Identities=16% Similarity=0.176 Sum_probs=86.0
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCC--ceeeEEEE------EecCCeEEEEE
Q 011158 297 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK--NVVQFIGA------CTKPPSLCIVT 368 (492)
Q Consensus 297 ~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~g~------~~~~~~~~lV~ 368 (492)
.+.|..|....+|+....+..+++|+.... + ...+..|+.++..+.+. .+.+++.. ....+..++|+
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~~--~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEKV--S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCCC--C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 356777877899998777778999987641 1 24566788888887533 24454432 12345578999
Q ss_pred eccCCCCHHH-----------HH---HhcCCC----------CCHHHHH----------HHHHHHHHHHHHHHH------
Q 011158 369 EFMSGGSVYD-----------YL---HKLKGV----------FKLPSLL----------KVAIDVSKGMNYLHQ------ 408 (492)
Q Consensus 369 Ey~~ggsL~~-----------~L---~~~~~~----------l~~~~~~----------~i~~qI~~gL~yLH~------ 408 (492)
+|++|..+.. .+ +..... ..+.... .....+...+.++.+
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9998866421 11 110000 0111100 011123334455543
Q ss_pred -CCceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 409 -NNIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 409 -~~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
.+++|+|+.|.|||++.++...|+||..+...
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~g 206 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFACTD 206 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhcCc
Confidence 36999999999999999877789999998754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0011 Score=67.08 Aligned_cols=140 Identities=20% Similarity=0.263 Sum_probs=83.9
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCC--ceeeEEEEE------ecCCeEEEEE
Q 011158 297 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK--NVVQFIGAC------TKPPSLCIVT 368 (492)
Q Consensus 297 ~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~g~~------~~~~~~~lV~ 368 (492)
.+.++.|....+|+....+..+++|+..... . ...+..|+.++..|... .+.+++... ...+..++++
T Consensus 27 i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~-~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVGRYILTLYEKRV-K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred ccccCCccccceEEEEeCCCcEEEEEecCCC-C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence 4567777778899987666678899875421 1 23455677777777432 244444421 1235578999
Q ss_pred eccCCCCHH-----------HHH---HhcCCCC--------CHH---HHH------------HHHHHHHHHHHHHHH---
Q 011158 369 EFMSGGSVY-----------DYL---HKLKGVF--------KLP---SLL------------KVAIDVSKGMNYLHQ--- 408 (492)
Q Consensus 369 Ey~~ggsL~-----------~~L---~~~~~~l--------~~~---~~~------------~i~~qI~~gL~yLH~--- 408 (492)
||++|..+. ..+ +.....+ ... ... .....+.+.++++..
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 999885431 111 1110100 001 000 001123345555543
Q ss_pred ----CCceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 409 ----NNIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 409 ----~~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
.+++|+|+.+.||+++.++...++||+.+...
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~~ 218 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACTD 218 (307)
T ss_pred hcCCCccCCCCCCcCcEEEECCceEEEeecccccCc
Confidence 58999999999999999887789999998654
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0041 Score=63.11 Aligned_cols=138 Identities=13% Similarity=0.186 Sum_probs=77.7
Q ss_pred eeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCC--ceeeEEE------EEecCCeEEEEEe
Q 011158 298 SKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK--NVVQFIG------ACTKPPSLCIVTE 369 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~g------~~~~~~~~~lV~E 369 (492)
+.|+.|....+|+....+..+++|+.. .... ..+..|+.++..+... .+.+.+. +....+..++++|
T Consensus 28 ~~l~~G~~n~~y~v~t~~g~~vLK~~~--~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQGEYVLTLFE--RLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred chhccccccceEEEEeCCCcEEEEEec--cCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 456777778899987766689999876 2222 2333455555555321 2333332 1123456789999
Q ss_pred ccCCCCH-----------HHHHH---hcCCC----------CCH-HHHHH------------HHHH-HHHHHHHHH----
Q 011158 370 FMSGGSV-----------YDYLH---KLKGV----------FKL-PSLLK------------VAID-VSKGMNYLH---- 407 (492)
Q Consensus 370 y~~ggsL-----------~~~L~---~~~~~----------l~~-~~~~~------------i~~q-I~~gL~yLH---- 407 (492)
|++|..+ .+.|. ..... +.+ ..... .+.+ +...+..+-
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 9988643 12221 11000 111 11110 1111 111122332
Q ss_pred ---HCCceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 408 ---QNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 408 ---~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
..++||+|+.|.|||++.+...-++||+.++..
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~~ 218 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACND 218 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEecccccCC
Confidence 237999999999999997766689999998654
|
|
| >cd04900 ACT_UUR-like_1 ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD and related domains | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.00089 Score=52.99 Aligned_cols=51 Identities=41% Similarity=0.664 Sum_probs=47.0
Q ss_pred eeeEEecCCCcchhhhhhhhhcccccceeeeeccccCCCceEEEEEEcCCC
Q 011158 180 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWP 230 (492)
Q Consensus 180 ~e~~~s~~~~p~~ls~l~~~l~~~~l~i~~A~~fst~dg~sl~v~vv~~w~ 230 (492)
.++.+.+.|+|.+++.++..++..+++|..|..+++.+|+.+|+|.|..+.
T Consensus 2 ~~i~v~~~Dr~gLl~~i~~~l~~~~l~I~~A~i~T~~~~~v~D~F~v~~~~ 52 (73)
T cd04900 2 TEVFIYTPDRPGLFARIAGALDQLGLNILDARIFTTRDGYALDTFVVLDPD 52 (73)
T ss_pred EEEEEEecCCCCHHHHHHHHHHHCCCCeEEeEEEEeCCCeEEEEEEEECCC
Confidence 477888999999999999999999999999999999999999999997653
|
This ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD is the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted tyrosine kinase. Members of this CD belong to the superfamily of ACT regulatory domains. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0021 Score=62.10 Aligned_cols=72 Identities=13% Similarity=0.214 Sum_probs=47.3
Q ss_pred eeeeecCceEEEEEEEC---CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCC-ceeeEEEEEecCCeEEEEEeccCC
Q 011158 298 SKVASGSYGDLYRGTYC---SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK-NVVQFIGACTKPPSLCIVTEFMSG 373 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~---g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~Hp-nIv~l~g~~~~~~~~~lV~Ey~~g 373 (492)
+.|..|-...+|+.... ++.|++|+...... ......+|+.+++.+... -..++++.+. + .+||||++|
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G 76 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPG 76 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCC
Confidence 56777888899998765 46899998764321 112234688888888533 3445554432 2 379999988
Q ss_pred CCH
Q 011158 374 GSV 376 (492)
Q Consensus 374 gsL 376 (492)
.++
T Consensus 77 ~~l 79 (235)
T cd05157 77 RTL 79 (235)
T ss_pred CcC
Confidence 665
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK05092 PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0035 Score=73.12 Aligned_cols=100 Identities=32% Similarity=0.446 Sum_probs=82.8
Q ss_pred HHHHHHhccCCcccccccCCCchhhHHhHHHHHHHhcCCCCCCeEEEEEEEeecCCCCCccccccCCCCCccccCCCCCC
Q 011158 62 DELWTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDRNSAVSSLLDSEVPAQRQSIHPP 141 (492)
Q Consensus 62 ~~l~~hf~rlp~~y~~d~~~~~~~dvl~h~~ll~~~~~~~~~p~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p 141 (492)
+++.++|.+||.+|-+-..+ +++.-|-+++....+....|++.++. .+ +
T Consensus 681 ~~~~~~~~~~~~~yf~~~~~---~~i~~h~~~~~~~~~~~~~~~v~~~~---~~--~----------------------- 729 (931)
T PRK05092 681 ADRDAYLARHYPAYWLAVDL---DTQARHARFIRDADDAGRPLATEVRP---DP--A----------------------- 729 (931)
T ss_pred HHHHHHHHhCCcHHhcCCCH---HHHHHHHHHHHhccccCCCcEEEEEe---cC--C-----------------------
Confidence 57888999999999998664 99999999999876644556665543 00 0
Q ss_pred CCCCCCcchhhhhccccCCCCCCCCCCccCCcCCCCcceeeEEecCCCcchhhhhhhhhcccccceeeeeccccCCCceE
Q 011158 142 PAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSL 221 (492)
Q Consensus 142 p~~g~~~~l~~L~l~~n~~~g~~~~~~~~n~~l~~~~~~e~~~s~~~~p~~ls~l~~~l~~~~l~i~~A~~fst~dg~sl 221 (492)
.-.-++++.+.|+|.+++.++..++..|+||..|..|++.+|+.+
T Consensus 730 -----------------------------------~~~t~v~I~~~Dr~GLfa~i~~~L~~~glnI~~A~I~t~~dg~al 774 (931)
T PRK05092 730 -----------------------------------RGVTEVTVLAADHPGLFSRIAGACAAAGANIVDARIFTTTDGRAL 774 (931)
T ss_pred -----------------------------------CCeEEEEEEeCCCCcHHHHHHHHHHHCCCcEEEEEEEEecCCeEE
Confidence 113588999999999999999999999999999999999999999
Q ss_pred EEEEEc
Q 011158 222 DVFVVD 227 (492)
Q Consensus 222 ~v~vv~ 227 (492)
++|.|.
T Consensus 775 D~F~V~ 780 (931)
T PRK05092 775 DTFWIQ 780 (931)
T ss_pred EEEEEE
Confidence 999983
|
|
| >PRK00275 glnD PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0043 Score=71.87 Aligned_cols=106 Identities=19% Similarity=0.306 Sum_probs=82.1
Q ss_pred HHHHHHHhccCCcccccccCCCchhhHHhHHHHHHHhcCCCCCCeEEEEEEEeecCCCCCccccccCCCCCccccCCCCC
Q 011158 61 DDELWTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDRNSAVSSLLDSEVPAQRQSIHP 140 (492)
Q Consensus 61 ~~~l~~hf~rlp~~y~~d~~~~~~~dvl~h~~ll~~~~~~~~~p~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (492)
.+++.+++.+||.||-+--. ++++.-|-+++....++.. |.+.++. .+ +
T Consensus 650 ~~~~~~~~~~~~~~Y~l~~~---~~~I~~h~~~~~~~~~~~~-~~v~~~~---~~--~---------------------- 698 (895)
T PRK00275 650 PDDAEQLWSQLGDDYFLRHT---AGDIAWHTEAILQHPDDGG-PLVLIKE---TT--Q---------------------- 698 (895)
T ss_pred HHHHHHHHHhCCcHHhcCCC---HHHHHHHHHHHHhcccCCC-CeEEEEe---cC--c----------------------
Confidence 45788899999999998765 5899999999988654333 3332322 10 0
Q ss_pred CCCCCCCcchhhhhccccCCCCCCCCCCccCCcCCCCcceeeEEecCCCcchhhhhhhhhcccccceeeeeccccCCCce
Q 011158 141 PPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYS 220 (492)
Q Consensus 141 pp~~g~~~~l~~L~l~~n~~~g~~~~~~~~n~~l~~~~~~e~~~s~~~~p~~ls~l~~~l~~~~l~i~~A~~fst~dg~s 220 (492)
++. .-.-+|++.+.|+|.+++.++..++..|+||..|-.|++.+|+.
T Consensus 699 -~~~--------------------------------~~~t~V~V~~~DrpgLFa~i~g~L~~~~lnI~~A~I~Tt~dg~a 745 (895)
T PRK00275 699 -REF--------------------------------EGGTQIFIYAPDQHDFFAATVAAMDQLNLNIHDARIITSSSQFT 745 (895)
T ss_pred -cCC--------------------------------CCeEEEEEEeCCCCcHHHHHHHHHHHCCCeEEEEEEEEcCCCeE
Confidence 000 01348899999999999999999999999999999999999999
Q ss_pred EEEEEEcCCC
Q 011158 221 LDVFVVDGWP 230 (492)
Q Consensus 221 l~v~vv~~w~ 230 (492)
+|+|.|....
T Consensus 746 lD~F~V~d~~ 755 (895)
T PRK00275 746 LDTYIVLDDD 755 (895)
T ss_pred EEEEEEeCCC
Confidence 9999996544
|
|
| >PRK04374 PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0051 Score=70.93 Aligned_cols=104 Identities=19% Similarity=0.235 Sum_probs=81.2
Q ss_pred HHHHHHHhccCCcccccccCCCchhhHHhHHHHHHHhcCCCCCCeEEEEEEEeecCCCCCccccccCCCCCccccCCCCC
Q 011158 61 DDELWTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDRNSAVSSLLDSEVPAQRQSIHP 140 (492)
Q Consensus 61 ~~~l~~hf~rlp~~y~~d~~~~~~~dvl~h~~ll~~~~~~~~~p~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (492)
.+++.++|++||.||-+--. ++++.-|-+++.... ...|.+-++-. .+
T Consensus 639 ~~~~~~~~~~l~~~Y~~~~~---~~~I~~h~~~~~~~~--~~~~~v~~~~~--~~------------------------- 686 (869)
T PRK04374 639 DATIDRQFAGMPDENFLRFR---PEQLAWQAASLIEVE--IGQTLVKARRA--VP------------------------- 686 (869)
T ss_pred HHHHHHHHHhCCchhhcCCC---HHHHHHHHHHHHhcC--CCCCeEEEeee--cc-------------------------
Confidence 45788899999999998755 599999999998753 22232222110 00
Q ss_pred CCCCCCCcchhhhhccccCCCCCCCCCCccCCcCCCCcceeeEEecCCCcchhhhhhhhhcccccceeeeeccccCCCce
Q 011158 141 PPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYS 220 (492)
Q Consensus 141 pp~~g~~~~l~~L~l~~n~~~g~~~~~~~~n~~l~~~~~~e~~~s~~~~p~~ls~l~~~l~~~~l~i~~A~~fst~dg~s 220 (492)
....-++++.+.|+|.+.+.+++.++..|+||..|-.|++.||+.
T Consensus 687 -----------------------------------~~~~~~v~v~~~d~~gLFa~i~g~l~~~~lnI~~A~i~t~~~g~~ 731 (869)
T PRK04374 687 -----------------------------------DNDALEVFVYSPDRDGLFAAIVATLDRKGYGIHRARVLDAPHDAI 731 (869)
T ss_pred -----------------------------------CCCeEEEEEEeCCCccHHHHHHHHHHHCCCeEEEEEEEEcCCCEE
Confidence 011358899999999999999999999999999999999999999
Q ss_pred EEEEEEcCCCc
Q 011158 221 LDVFVVDGWPY 231 (492)
Q Consensus 221 l~v~vv~~w~~ 231 (492)
+|+|.|.....
T Consensus 732 ld~f~V~~~~~ 742 (869)
T PRK04374 732 FDVFEVLPQDT 742 (869)
T ss_pred EEEEEEeCCCC
Confidence 99999976544
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0029 Score=62.25 Aligned_cols=134 Identities=13% Similarity=0.114 Sum_probs=79.0
Q ss_pred eeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCce-eeEEEEEecCCeEEEEEeccCCCCHHH
Q 011158 300 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV-VQFIGACTKPPSLCIVTEFMSGGSVYD 378 (492)
Q Consensus 300 LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~lV~Ey~~ggsL~~ 378 (492)
+..|-...+|+....++.+++|+..... ....-...+|..+++.+....+ .+++.... -++||||++|..+..
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~--~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVC--KALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCccc--ccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 4567778899988777889999765321 1110134678888888864333 34444432 368999998866432
Q ss_pred --------------HHH---hcC---CCCCHH-HHHHHHHHH---------HHHHHHHHH--------CCceecCCCCCC
Q 011158 379 --------------YLH---KLK---GVFKLP-SLLKVAIDV---------SKGMNYLHQ--------NNIIHRDLKAAN 420 (492)
Q Consensus 379 --------------~L~---~~~---~~l~~~-~~~~i~~qI---------~~gL~yLH~--------~~IiHrDLKp~N 420 (492)
.+. ... ..++.. .+..+..++ ..-+..+-. ..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 111 111 112211 111222111 111222221 148999999999
Q ss_pred EEEccCCCeEEEEEeeccee
Q 011158 421 LLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 421 ILld~~~~~kl~DFGla~~~ 440 (492)
||++.++ +.++||..++..
T Consensus 158 il~~~~~-~~lIDwE~a~~g 176 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASDG 176 (256)
T ss_pred EEEeCCC-CEEEeccccCcC
Confidence 9999877 689999998765
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK03059 PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0084 Score=69.20 Aligned_cols=101 Identities=29% Similarity=0.449 Sum_probs=80.5
Q ss_pred HHHHHHHhccCCcccccccCCCchhhHHhHHHHHHHhcCCCCCCeEEEEEEEeecCCCCCccccccCCCCCccccCCCCC
Q 011158 61 DDELWTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDRNSAVSSLLDSEVPAQRQSIHP 140 (492)
Q Consensus 61 ~~~l~~hf~rlp~~y~~d~~~~~~~dvl~h~~ll~~~~~~~~~p~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (492)
.+.+.++|.++|.+|-+-- .++++.-|-+++....+.. .|.+-+|. .+.
T Consensus 627 ~~~~~~~~~~~~~~Yf~~~---~~~~I~~h~~~~~~~~~~~-~~~v~~~~---~~~------------------------ 675 (856)
T PRK03059 627 DDAHEALWDQLDVGYFLRH---DAADIAWHTRHLYRHVDTD-TPIVRARL---SPA------------------------ 675 (856)
T ss_pred HHHHHHHHHhCChHHhccC---CHHHHHHHHHHHHhcccCC-CCeEEEEe---cCC------------------------
Confidence 4578889999999998875 4599999999998754322 23332322 100
Q ss_pred CCCCCCCcchhhhhccccCCCCCCCCCCccCCcCCCCcceeeEEecCCCcchhhhhhhhhcccccceeeeeccccCCCce
Q 011158 141 PPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYS 220 (492)
Q Consensus 141 pp~~g~~~~l~~L~l~~n~~~g~~~~~~~~n~~l~~~~~~e~~~s~~~~p~~ls~l~~~l~~~~l~i~~A~~fst~dg~s 220 (492)
.-.-+|++-+.|+|.+.+.++..++..++||..|-.|++.||+.
T Consensus 676 ------------------------------------~~~~~v~i~~~d~~gLFa~i~g~l~~~~l~I~~A~i~t~~~g~~ 719 (856)
T PRK03059 676 ------------------------------------GEGLQVMVYTPDQPDLFARICGYFDRAGFSILDARVHTTRHGYA 719 (856)
T ss_pred ------------------------------------CCeEEEEEEecCCCcHHHHHHHHHHHCCCceeeeEEEEcCCCeE
Confidence 11358999999999999999999999999999999999999999
Q ss_pred EEEEEEcC
Q 011158 221 LDVFVVDG 228 (492)
Q Consensus 221 l~v~vv~~ 228 (492)
+|+|.|..
T Consensus 720 ld~f~V~~ 727 (856)
T PRK03059 720 LDTFQVLD 727 (856)
T ss_pred EEEEEEeC
Confidence 99999964
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.00018 Score=77.90 Aligned_cols=165 Identities=15% Similarity=0.094 Sum_probs=118.5
Q ss_pred ceeeeeeeecCceEEEEEEECCc-eEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCc-eeeEEEEEecCCeEEEEEecc
Q 011158 294 LKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN-VVQFIGACTKPPSLCIVTEFM 371 (492)
Q Consensus 294 ~~~~~~LG~G~fG~Vy~~~~~g~-~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~g~~~~~~~~~lV~Ey~ 371 (492)
+.+..-+++|+++++||.+.+.+ ....|.+... ....-++++|.+++||| .+..++-+..++..+++++++
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~ 316 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC 316 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence 34445678999999999876432 2335555432 34456889999999999 777788888888899999999
Q ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee------eeee
Q 011158 372 SGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS------ILFC 444 (492)
Q Consensus 372 ~gg-sL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~------~~~~ 444 (492)
.++ +-...+......+...+...+.+.-.++++|+|+.-=+||| |||..+ +..+..||+..... ....
T Consensus 317 s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~~ 391 (829)
T KOG0576|consen 317 STGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRTAI 391 (829)
T ss_pred cCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcccccccCC
Confidence 877 33222211122344555666777788899999998778999 888775 56788999886533 2356
Q ss_pred CCCceeecceeccccccCccceeeee
Q 011158 445 GKGRELISLFLGNDVLLQFGTYWIIF 470 (492)
Q Consensus 445 g~~~~~ape~~~~e~~~~~~d~W~l~ 470 (492)
++..+++|+......+..+.+.|+.-
T Consensus 392 ~~~~~~~pev~~~~~~~~~p~~~~~~ 417 (829)
T KOG0576|consen 392 GTPEPLAPEVIQENTIDGCPDSGSLA 417 (829)
T ss_pred CCCCCCCchhhcccccccCCCccCCC
Confidence 77788888888888888888888864
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.0054 Score=61.78 Aligned_cols=136 Identities=17% Similarity=0.291 Sum_probs=80.7
Q ss_pred eeeeecCceEEEEEEEC--------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCc-eeeEEEEEecCCeEEEEE
Q 011158 298 SKVASGSYGDLYRGTYC--------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN-VVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~--------g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~g~~~~~~~~~lV~ 368 (492)
+.|..|-...+|+.+.. ++.+++|+..... .......+|..++..+.... ..++++++.. .+|+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~ 76 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIE 76 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC---cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchh
Confidence 45666667788988764 3689999976532 11234567888888885333 3455555532 3589
Q ss_pred eccCCCCHHHH--------------H---HhcCCCC------CHH----HHHH--------------------------H
Q 011158 369 EFMSGGSVYDY--------------L---HKLKGVF------KLP----SLLK--------------------------V 395 (492)
Q Consensus 369 Ey~~ggsL~~~--------------L---~~~~~~l------~~~----~~~~--------------------------i 395 (492)
||++|..+... | ++..... ... .+.. +
T Consensus 77 e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (302)
T cd05156 77 EFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLF 156 (302)
T ss_pred heeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHH
Confidence 99988765321 1 1111110 001 1101 0
Q ss_pred HHHHHHHHHHHHH---------CCceecCCCCCCEEEccC----CCeEEEEEeeccee
Q 011158 396 AIDVSKGMNYLHQ---------NNIIHRDLKAANLLMDEN----EVSLLLSLCLFTVS 440 (492)
Q Consensus 396 ~~qI~~gL~yLH~---------~~IiHrDLKp~NILld~~----~~~kl~DFGla~~~ 440 (492)
...+..-+.+|-. ..++|+|+.+.|||++.+ +.+.++||..++..
T Consensus 157 ~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~ 214 (302)
T cd05156 157 LEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN 214 (302)
T ss_pred HHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence 1122222334432 257999999999999974 78999999998765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.024 Score=59.70 Aligned_cols=76 Identities=13% Similarity=0.025 Sum_probs=53.2
Q ss_pred eeeeecCceEEEEEEECC--ceEEEEEecCC-----CCChHHHHHHHHHHHHHHhcC---CCceeeEEEEEecCCeEEEE
Q 011158 298 SKVASGSYGDLYRGTYCS--QDVAIKVLKPE-----RINSDMQKEFAQEVFIMRKVR---HKNVVQFIGACTKPPSLCIV 367 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~g--~~vAvK~l~~~-----~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~g~~~~~~~~~lV 367 (492)
+.||.|.+..||++...+ +.++||.-.+. ..-+-...++..|...|+.+. ..++.+++.+. +...++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEEE
Confidence 578999999999998864 38999975421 000123466777888888763 24677787763 3557899
Q ss_pred EeccCCCC
Q 011158 368 TEFMSGGS 375 (492)
Q Consensus 368 ~Ey~~ggs 375 (492)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99997643
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.017 Score=58.15 Aligned_cols=31 Identities=16% Similarity=0.358 Sum_probs=26.8
Q ss_pred CCceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 409 NNIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 409 ~~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
.+++|+|+.+.|||++. +.+.++||+.+...
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~~ 217 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTID 217 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccccC
Confidence 47899999999999997 56789999988654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.001 Score=67.25 Aligned_cols=132 Identities=19% Similarity=0.295 Sum_probs=90.4
Q ss_pred ceeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCC-------hH-------------HHHHHHHHHHHHHhcCC--Cc
Q 011158 294 LKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERIN-------SD-------------MQKEFAQEVFIMRKVRH--KN 350 (492)
Q Consensus 294 ~~~~~~LG~G~fG~Vy~~~~~-g~~vAvK~l~~~~~~-------~~-------------~~~~~~~Ei~il~~l~H--pn 350 (492)
+.++++||-|.-+.||.+.+. |++.++|.=+..+.+ .+ ..-...+|+..|+.+.- =-
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 345688999999999999884 888888864432211 10 01234568888888853 23
Q ss_pred eeeEEEEEecCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeE
Q 011158 351 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSL 430 (492)
Q Consensus 351 Iv~l~g~~~~~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~k 430 (492)
+.+.+++ +..|+|||++.|-.|.+.-+ ..+.+.+. ..+..-+.-|-.+|+||+|..-=||+|++++.++
T Consensus 174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~----v~d~~~ly---~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 174 VPKPIDH----NRHCVVMELVDGYPLRQVRH----VEDPPTLY---DDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred CCCcccc----cceeeHHHhhcccceeeeee----cCChHHHH---HHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence 4455554 45789999998877765432 22333333 3333344567789999999999999999999999
Q ss_pred EEEEee
Q 011158 431 LLSLCL 436 (492)
Q Consensus 431 l~DFGl 436 (492)
++||=-
T Consensus 243 vIDFPQ 248 (465)
T KOG2268|consen 243 VIDFPQ 248 (465)
T ss_pred EeechH
Confidence 999954
|
|
| >PRK05007 PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.027 Score=65.39 Aligned_cols=101 Identities=24% Similarity=0.369 Sum_probs=80.5
Q ss_pred HHHHHHHhccCCcccccccCCCchhhHHhHHHHHHHhcCCCCCCeEEEEEEEeecCCCCCccccccCCCCCccccCCCCC
Q 011158 61 DDELWTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDRNSAVSSLLDSEVPAQRQSIHP 140 (492)
Q Consensus 61 ~~~l~~hf~rlp~~y~~d~~~~~~~dvl~h~~ll~~~~~~~~~p~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (492)
.+.+.++|.++|.+|-+--. ++++.-|-+++..+.. ..|.+.++. .+ +
T Consensus 651 ~~~~~~~~~~~~~~yf~~~~---~~~I~~h~~~~~~~~~--~~p~V~i~~---~~--~---------------------- 698 (884)
T PRK05007 651 EEALHQIWSRCRADYFLRHT---PNQLAWHARHLLQHDL--DKPLVLLSK---QA--T---------------------- 698 (884)
T ss_pred HHHHHHHHHhCChHHhcCCC---HHHHHHHHHHHHhccC--CCCeEEEEe---cC--C----------------------
Confidence 45788899999999998754 5999999999987643 234443221 00 0
Q ss_pred CCCCCCCcchhhhhccccCCCCCCCCCCccCCcCCCCcceeeEEecCCCcchhhhhhhhhcccccceeeeeccccCCCce
Q 011158 141 PPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYS 220 (492)
Q Consensus 141 pp~~g~~~~l~~L~l~~n~~~g~~~~~~~~n~~l~~~~~~e~~~s~~~~p~~ls~l~~~l~~~~l~i~~A~~fst~dg~s 220 (492)
...-+|.+.+.|+|.+++.++..++..+++|..|..|++.+|+.
T Consensus 699 ------------------------------------~~~t~V~V~a~DrpGLfa~Ia~~La~~~L~I~~A~I~T~~dg~a 742 (884)
T PRK05007 699 ------------------------------------RGGTEIFIWSPDRPYLFAAVCAELDRRNLSVHDAQIFTSRDGMA 742 (884)
T ss_pred ------------------------------------CCeEEEEEEecCCcCHHHHHHHHHHHCCCEEEEEEEEEcCCCeE
Confidence 11358899999999999999999999999999999999999999
Q ss_pred EEEEEEcCC
Q 011158 221 LDVFVVDGW 229 (492)
Q Consensus 221 l~v~vv~~w 229 (492)
+|+|.|...
T Consensus 743 lD~F~V~d~ 751 (884)
T PRK05007 743 MDTFIVLEP 751 (884)
T ss_pred EEEEEEECC
Confidence 999999543
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.015 Score=59.34 Aligned_cols=137 Identities=19% Similarity=0.301 Sum_probs=83.1
Q ss_pred cCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCC--CceeeEEEEEecCC--eEEEEEeccCCC----
Q 011158 303 GSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH--KNVVQFIGACTKPP--SLCIVTEFMSGG---- 374 (492)
Q Consensus 303 G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~g~~~~~~--~~~lV~Ey~~gg---- 374 (492)
|..-.+|.....++.+++. ...............+|..+|+.+.- --+...+++|.... ..|.||+|++|.
T Consensus 36 G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~ 114 (321)
T COG3173 36 GWSNDTFRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWS 114 (321)
T ss_pred CcccceEEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccC
Confidence 3333566666667788888 32212223345667788888888753 23455677777655 679999999872
Q ss_pred --------------CHHHHHHhcC-------------CCCCHHHHHHHHHH--------------HHHHHHHHHHC----
Q 011158 375 --------------SVYDYLHKLK-------------GVFKLPSLLKVAID--------------VSKGMNYLHQN---- 409 (492)
Q Consensus 375 --------------sL~~~L~~~~-------------~~l~~~~~~~i~~q--------------I~~gL~yLH~~---- 409 (492)
+|.++|..-. +.....++..+..+ ...-..||+.+
T Consensus 115 ~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~ 194 (321)
T COG3173 115 ALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPW 194 (321)
T ss_pred cCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCc
Confidence 2222221100 00111111111111 22234566654
Q ss_pred ----CceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 410 ----NIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 410 ----~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
.++|+|+.+.||+++..+..-|+||+.+.+.
T Consensus 195 ~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 195 AGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred CCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 4899999999999999988999999999775
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.021 Score=57.83 Aligned_cols=103 Identities=13% Similarity=0.075 Sum_probs=69.3
Q ss_pred eeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCC---CceeeEEEEEec---CCeEEEEEe
Q 011158 296 FGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH---KNVVQFIGACTK---PPSLCIVTE 369 (492)
Q Consensus 296 ~~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~H---pnIv~l~g~~~~---~~~~~lV~E 369 (492)
-.+.||.|..+.||+....+..+.+|..+... ....+..|...|+.+.- -.+.++++++.. .+..+||||
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~----~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQGNPMPLMARSFS----TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred eeeecCCccceeEEEEEcCCCCEEEEEecccc----cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 34689999999999988766677888854311 12578899999998853 367888888754 356899999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~ 408 (492)
+++|+++.+. ..+......+..+++++|.-||+
T Consensus 94 ~i~G~~~~~~------~~~~~~~~~l~~~l~~~La~LH~ 126 (297)
T PRK10593 94 RLRGVSVEAP------ARTPERWEQLKDQIVEGLLAWHR 126 (297)
T ss_pred ccCCEecCCC------CCCHHHHHHHHHHHHHHHHHHhC
Confidence 9998876431 01222233444455555555554
|
|
| >cd04927 ACT_ACR-like_2 Second ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein) | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.011 Score=47.16 Aligned_cols=48 Identities=27% Similarity=0.431 Sum_probs=43.5
Q ss_pred EEecCCCcchhhhhhhhhcccccceeeeeccccCCCceEEEEEEcCCC
Q 011158 183 TFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWP 230 (492)
Q Consensus 183 ~~s~~~~p~~ls~l~~~l~~~~l~i~~A~~fst~dg~sl~v~vv~~w~ 230 (492)
-+.+.|+|.+++.++..++..|++|..|..++|.+|..+|+|.|....
T Consensus 4 ei~~~Dr~gLfa~i~~~l~~~~l~I~~A~I~Tt~~~~v~D~F~V~d~~ 51 (76)
T cd04927 4 KLFCSDRKGLLHDVTEVLYELELTIERVKVSTTPDGRVLDLFFITDAR 51 (76)
T ss_pred EEEECCCCCHHHHHHHHHHHCCCeEEEEEEEECCCCEEEEEEEEeCCC
Confidence 355679999999999999999999999999999999999999996654
|
This CD includes the second ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) have been described, however, the ACR-like sequences in this CD are distinct from those characterized. This CD includes the Oryza sativa ACR-like protein (Os05g0113000) encoded on chromosome 5 and the Arabidopsis thaliana predicted gene product, At2g39570. Members of this CD belong to the superfamily of ACT regulatory domains. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.011 Score=61.02 Aligned_cols=134 Identities=18% Similarity=0.214 Sum_probs=89.0
Q ss_pred eeeeecCceEEEEEEE-CCceEEEEEecCCCC----------------------ChHHHH--HHHHHHHHHHhcCCCcee
Q 011158 298 SKVASGSYGDLYRGTY-CSQDVAIKVLKPERI----------------------NSDMQK--EFAQEVFIMRKVRHKNVV 352 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~-~g~~vAvK~l~~~~~----------------------~~~~~~--~~~~Ei~il~~l~HpnIv 352 (492)
..|..|.-..||.++- .|..+|||+++..-+ ++.-.- -...|++.|++|+...|.
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 5677888889999987 577899999875311 111111 124588888888765543
Q ss_pred eEEEEEecCCeEEEEEeccCCCCH--HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEccCCCe
Q 011158 353 QFIGACTKPPSLCIVTEFMSGGSV--YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVS 429 (492)
Q Consensus 353 ~l~g~~~~~~~~~lV~Ey~~ggsL--~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~-~~IiHrDLKp~NILld~~~~~ 429 (492)
-.--+... .-.|||+|+ |.+= .-.|+ ...++...+..+-.|++.-|.-|-+ +++||.||.--|+|+. +|.+
T Consensus 230 ~PePIlLk--~hVLVM~Fl-Grdgw~aPkLK--d~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG~l 303 (520)
T KOG2270|consen 230 CPEPILLK--NHVLVMEFL-GRDGWAAPKLK--DASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DGKL 303 (520)
T ss_pred CCCceeee--cceEeeeec-cCCCCcCcccc--cccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CCEE
Confidence 22222221 247999999 4321 11222 2457777788888888888877655 5899999999999997 4567
Q ss_pred EEEEEeec
Q 011158 430 LLLSLCLF 437 (492)
Q Consensus 430 kl~DFGla 437 (492)
.++|.+-+
T Consensus 304 yiIDVSQS 311 (520)
T KOG2270|consen 304 YIIDVSQS 311 (520)
T ss_pred EEEEcccc
Confidence 88887664
|
|
| >TIGR01693 UTase_glnD [Protein-PII] uridylyltransferase | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.051 Score=62.96 Aligned_cols=102 Identities=24% Similarity=0.324 Sum_probs=80.6
Q ss_pred HHHHHHHhccCCcccccccCCCchhhHHhHHHHHHHhcCCCCCCeEEEEEEEeecCCCCCccccccCCCCCccccCCCCC
Q 011158 61 DDELWTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDRNSAVSSLLDSEVPAQRQSIHP 140 (492)
Q Consensus 61 ~~~l~~hf~rlp~~y~~d~~~~~~~dvl~h~~ll~~~~~~~~~p~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (492)
.+++..++.++|.+|-+-..+ +++.-|-+++..+.+.. .|.+.+. .. .
T Consensus 617 ~~~~~~~~~~~~~~y~~~~~~---~~I~~h~~~~~~~~~~~-~~~v~~~----~~--~---------------------- 664 (850)
T TIGR01693 617 SNEAEVLWLRAYDDYFLRFTH---KEIAWHAESLRRALSSG-GPLALID----GT--R---------------------- 664 (850)
T ss_pred HHHHHHHHHhCCchhhcCCCH---HHHHHHHHHHHhcccCC-CCEEEEe----cc--C----------------------
Confidence 346788999999999998765 89999999999875422 2222111 00 0
Q ss_pred CCCCCCCcchhhhhccccCCCCCCCCCCccCCcCCCCcceeeEEecCCCcchhhhhhhhhcccccceeeeeccccCCCce
Q 011158 141 PPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYS 220 (492)
Q Consensus 141 pp~~g~~~~l~~L~l~~n~~~g~~~~~~~~n~~l~~~~~~e~~~s~~~~p~~ls~l~~~l~~~~l~i~~A~~fst~dg~s 220 (492)
.....++++.+.|+|.+++.++..++..+++|..|..|+|.+|+.
T Consensus 665 -----------------------------------~~~~t~i~V~~~DrpgLla~i~~~L~~~~l~I~~A~I~tt~~g~~ 709 (850)
T TIGR01693 665 -----------------------------------PSGGTEVFIYAPDQPGLFAKVAGALAMLSLSVHDAQVNTTKDGVA 709 (850)
T ss_pred -----------------------------------CCCeEEEEEEeCCCCcHHHHHHHHHHHCCCeEEEEEEEEecCCEE
Confidence 012458899999999999999999999999999999999999999
Q ss_pred EEEEEEcCC
Q 011158 221 LDVFVVDGW 229 (492)
Q Consensus 221 l~v~vv~~w 229 (492)
+|+|.|...
T Consensus 710 lD~F~V~~~ 718 (850)
T TIGR01693 710 LDTFVVQDL 718 (850)
T ss_pred EEEEEEECC
Confidence 999999654
|
This model describes GlnD, the uridylyltransferase/uridylyl-removing enzyme for the nitrogen regulatory protein PII. Not all homologs of PII share the property of uridylyltransferase modification on the characteristic Tyr residue (see Prosite pattern PS00496 and document PDOC00439), but the modification site is preserved in the PII homolog of all species with a member of this family. |
| >PRK01759 glnD PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.043 Score=63.46 Aligned_cols=100 Identities=23% Similarity=0.356 Sum_probs=79.2
Q ss_pred HHHHHHHhccCCcccccccCCCchhhHHhHHHHHHHhcCCCCCCeEEEEEEEeecCCCCCccccccCCCCCccccCCCCC
Q 011158 61 DDELWTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDRNSAVSSLLDSEVPAQRQSIHP 140 (492)
Q Consensus 61 ~~~l~~hf~rlp~~y~~d~~~~~~~dvl~h~~ll~~~~~~~~~p~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (492)
.+.+.++|.++|.+|-+- ..+|+++-|-+++..... .|.+.++- .+
T Consensus 628 ~~~~~~~~~~~~~~yf~~---~~~~~I~~h~~~~~~~~~---~~~V~i~~---~~------------------------- 673 (854)
T PRK01759 628 ETQIEQLWQRCPEDYFLR---NTPKQIAWHALLLLDFRG---DLLVKISN---RF------------------------- 673 (854)
T ss_pred HHHHHHHHHhCCcHHhcC---CCHHHHHHHHHHHHhcCC---CCEEEEEe---cC-------------------------
Confidence 457888999999999985 456999999999876543 23332211 00
Q ss_pred CCCCCCCcchhhhhccccCCCCCCCCCCccCCcCCCCcceeeEEecCCCcchhhhhhhhhcccccceeeeeccccCCCce
Q 011158 141 PPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYS 220 (492)
Q Consensus 141 pp~~g~~~~l~~L~l~~n~~~g~~~~~~~~n~~l~~~~~~e~~~s~~~~p~~ls~l~~~l~~~~l~i~~A~~fst~dg~s 220 (492)
....-++.+.+.|+|.+++.++..++..|++|..|..+++.+|+.
T Consensus 674 -----------------------------------~~~~t~V~V~~~DrpGLfa~Ia~~L~~~~L~I~~A~I~T~~~g~a 718 (854)
T PRK01759 674 -----------------------------------SRGGTEIFIYCQDQANLFLKVVSTIGAKKLSIHDAQIITSQDGYV 718 (854)
T ss_pred -----------------------------------CCCeEEEEEEecCCccHHHHHHHHHHHCCCeEEEEEEEEccCCEE
Confidence 011358899999999999999999999999999999999999999
Q ss_pred EEEEEEcCC
Q 011158 221 LDVFVVDGW 229 (492)
Q Consensus 221 l~v~vv~~w 229 (492)
+|+|.|...
T Consensus 719 lD~F~V~d~ 727 (854)
T PRK01759 719 LDSFIVTEL 727 (854)
T ss_pred EEEEEEeCC
Confidence 999999643
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.032 Score=55.92 Aligned_cols=31 Identities=26% Similarity=0.429 Sum_probs=26.1
Q ss_pred CceecCCCCCCEEEccCCC-eEEEEEeeccee
Q 011158 410 NIIHRDLKAANLLMDENEV-SLLLSLCLFTVS 440 (492)
Q Consensus 410 ~IiHrDLKp~NILld~~~~-~kl~DFGla~~~ 440 (492)
.++|+|+.|.|||++.++. .-|+||+.+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 4899999999999997454 569999998765
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.81 E-value=0.059 Score=55.73 Aligned_cols=136 Identities=14% Similarity=0.233 Sum_probs=78.3
Q ss_pred eeeeecCceEEEEEEEC------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCce-eeEEEEEecCCeEEEEEec
Q 011158 298 SKVASGSYGDLYRGTYC------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV-VQFIGACTKPPSLCIVTEF 370 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~------g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~lV~Ey 370 (492)
..|-.|-.-.+|+.... ++.|++|+..... ... -.-.+|..+++.+...++ .++++.+.. + .|+||
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~ef 114 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--ELF-FDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEF 114 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--Cee-echHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEe
Confidence 34544667789988752 2578999886532 111 122668888888864333 345565533 2 58999
Q ss_pred cCCCCHHHH-------H----------HhcC--C---CCCHHHHHHHHHHH-----------------HHHHHHHH----
Q 011158 371 MSGGSVYDY-------L----------HKLK--G---VFKLPSLLKVAIDV-----------------SKGMNYLH---- 407 (492)
Q Consensus 371 ~~ggsL~~~-------L----------~~~~--~---~l~~~~~~~i~~qI-----------------~~gL~yLH---- 407 (492)
+++.+|..- + |..+ . ...+..+..+..++ ...+..|.
T Consensus 115 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~ 194 (344)
T PLN02236 115 IHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELS 194 (344)
T ss_pred eCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhc
Confidence 977665311 1 1111 0 11122222322111 11122221
Q ss_pred ----HCCceecCCCCCCEEEcc-CCCeEEEEEeeccee
Q 011158 408 ----QNNIIHRDLKAANLLMDE-NEVSLLLSLCLFTVS 440 (492)
Q Consensus 408 ----~~~IiHrDLKp~NILld~-~~~~kl~DFGla~~~ 440 (492)
...++|+|+++.|||+++ ++.+.++||..++..
T Consensus 195 ~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 195 GDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred ccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 125899999999999986 467999999988765
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.71 E-value=0.063 Score=55.15 Aligned_cols=141 Identities=12% Similarity=0.194 Sum_probs=79.7
Q ss_pred CCceeeeeeeecCceEEEEEEECC-----ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCce-eeEEEEEecCCeEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV-VQFIGACTKPPSLC 365 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~g-----~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~ 365 (492)
+.+++. .|..|=.-.+|+....+ ..|++|+...... ..-.-.+|..+++.+..-++ .++++++. .+
T Consensus 15 ~~i~i~-~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G--- 86 (330)
T PLN02421 15 SDFSVE-RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG--- 86 (330)
T ss_pred CceEEE-EeCCcccceEEEEEecCCCCCCceEEEEEecCCcC---eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---
Confidence 444443 44446677899887643 2789998865321 11223568888888865444 35565553 22
Q ss_pred EEEeccCCCCHHH-------HH----------HhcCCC----C-CHHHHHHHHHHH----------------------HH
Q 011158 366 IVTEFMSGGSVYD-------YL----------HKLKGV----F-KLPSLLKVAIDV----------------------SK 401 (492)
Q Consensus 366 lV~Ey~~ggsL~~-------~L----------~~~~~~----l-~~~~~~~i~~qI----------------------~~ 401 (492)
+|.+|++|.+|.. .+ |..+.+ . .+..+..+..++ ..
T Consensus 87 ~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 166 (330)
T PLN02421 87 MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRD 166 (330)
T ss_pred EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHH
Confidence 5899997765421 11 111100 1 122222222221 11
Q ss_pred HHHHHH----HC----CceecCCCCCCEEEcc-CCCeEEEEEeeccee
Q 011158 402 GMNYLH----QN----NIIHRDLKAANLLMDE-NEVSLLLSLCLFTVS 440 (492)
Q Consensus 402 gL~yLH----~~----~IiHrDLKp~NILld~-~~~~kl~DFGla~~~ 440 (492)
-+..+. .. -++|.|+-+.|||+++ ++.++++||..++..
T Consensus 167 ~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n 214 (330)
T PLN02421 167 EIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS 214 (330)
T ss_pred HHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence 121111 11 2689999999999975 468999999998765
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.59 E-value=0.092 Score=55.05 Aligned_cols=141 Identities=15% Similarity=0.171 Sum_probs=90.3
Q ss_pred ceeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeEEEEE------ecC-CeEE
Q 011158 294 LKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGAC------TKP-PSLC 365 (492)
Q Consensus 294 ~~~~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~------~~~-~~~~ 365 (492)
+..+..||+|+-+.+|-.-.-+ ..+.|++...... ...+ .+..|.+. .||-+-.-+.|- -+. ..+-
T Consensus 13 i~~gr~LgqGgea~ly~l~e~~-d~VAKIYh~Pppa--~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG 86 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGEVR-DQVAKIYHAPPPA--AQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIG 86 (637)
T ss_pred cCCCccccCCccceeeecchhh-chhheeecCCCch--HHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence 3455789999999999643222 3445777644221 1111 22233333 355333212111 111 2266
Q ss_pred EEEeccCCC-CHHHHHH---h-c-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecce
Q 011158 366 IVTEFMSGG-SVYDYLH---K-L-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTV 439 (492)
Q Consensus 366 lV~Ey~~gg-sL~~~L~---~-~-~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~ 439 (492)
++|..++|. -+..++. + + -....|..+++.++.++.+..-||..|.+-+|+.++|+|+.+++.+.++|-.++.+
T Consensus 87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceee
Confidence 778877664 2333332 1 1 12478999999999999999999999999999999999999999999998766654
Q ss_pred e
Q 011158 440 S 440 (492)
Q Consensus 440 ~ 440 (492)
.
T Consensus 167 ~ 167 (637)
T COG4248 167 N 167 (637)
T ss_pred c
Confidence 3
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.56 E-value=0.18 Score=53.34 Aligned_cols=75 Identities=15% Similarity=0.046 Sum_probs=51.5
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEecCCCC--C---hHHHHHHHHHHHHHHhcC---CCceeeEEEEEecCCeEEEEE
Q 011158 297 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERI--N---SDMQKEFAQEVFIMRKVR---HKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 297 ~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~--~---~~~~~~~~~Ei~il~~l~---HpnIv~l~g~~~~~~~~~lV~ 368 (492)
.+.||.|..-.||+....++.++||.-..... . +....+-..|...|+.+. ..++.+++.++.+ ..+++|
T Consensus 37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlvM 114 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIGM 114 (418)
T ss_pred EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEEE
Confidence 36789999999999988777899997652211 0 112334445566666654 3578889988874 467889
Q ss_pred eccCC
Q 011158 369 EFMSG 373 (492)
Q Consensus 369 Ey~~g 373 (492)
||+++
T Consensus 115 E~L~~ 119 (418)
T PLN02756 115 RYLEP 119 (418)
T ss_pred eecCC
Confidence 99976
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.35 E-value=0.11 Score=52.45 Aligned_cols=75 Identities=17% Similarity=0.136 Sum_probs=48.9
Q ss_pred eeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC---CCceeeEEEEEecCCeEEEEEecc
Q 011158 295 KFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNVVQFIGACTKPPSLCIVTEFM 371 (492)
Q Consensus 295 ~~~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~g~~~~~~~~~lV~Ey~ 371 (492)
+-.+.|+-|....+|+....++.+.||+-.. .....|..|..-|+.|. --.+.+.+++....+.-+|||||+
T Consensus 20 ~~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~-----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLDTDGGSYFVKVNSE-----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp -EEEEE--SSSSEEEEEETTS-EEEEEEEEG-----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeEecCCCChhheEEEECCCccEEEEecCh-----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 3446788899999999887788999998762 22256778888888873 446788888887777779999999
Q ss_pred CCC
Q 011158 372 SGG 374 (492)
Q Consensus 372 ~gg 374 (492)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.34 E-value=0.17 Score=52.15 Aligned_cols=133 Identities=17% Similarity=0.254 Sum_probs=79.7
Q ss_pred CceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCc------eeeEEE----EEecCCeEEEEEeccCC
Q 011158 304 SYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN------VVQFIG----ACTKPPSLCIVTEFMSG 373 (492)
Q Consensus 304 ~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~Hpn------Iv~l~g----~~~~~~~~~lV~Ey~~g 373 (492)
.--.+|+....+..+++|+.... .+. .++..|...|..+.-.. |..+-| ....+...+-+++|++|
T Consensus 37 ~eN~~f~~~~~~g~~iLki~~~~-~~~---~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G 112 (331)
T COG2334 37 EENSNFRVQTEDGRYILKIYRPG-WTR---AEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPG 112 (331)
T ss_pred ccCceEEEEecCCCeEEEEecCC-CCH---HHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCC
Confidence 34468888887777799999875 333 45556777777663211 222222 12222367889999988
Q ss_pred CCHHH------------HH---Hh--------cCC---CCCHH----H---------HHHHHHHHHHHHHHHHHC-----
Q 011158 374 GSVYD------------YL---HK--------LKG---VFKLP----S---------LLKVAIDVSKGMNYLHQN----- 409 (492)
Q Consensus 374 gsL~~------------~L---~~--------~~~---~l~~~----~---------~~~i~~qI~~gL~yLH~~----- 409 (492)
..+.. ++ +. .+. ...|. . -.....++...+..+...
T Consensus 113 ~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~l 192 (331)
T COG2334 113 RPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHL 192 (331)
T ss_pred cCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhC
Confidence 77762 11 11 011 11221 0 011233444455555542
Q ss_pred ---C--ceecCCCCCCEEEccCC-CeEEEEEeeccee
Q 011158 410 ---N--IIHRDLKAANLLMDENE-VSLLLSLCLFTVS 440 (492)
Q Consensus 410 ---~--IiHrDLKp~NILld~~~-~~kl~DFGla~~~ 440 (492)
+ +||+|+-|.||+++.+. .+.++||++++..
T Consensus 193 p~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~~ 229 (331)
T COG2334 193 PALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGYG 229 (331)
T ss_pred CcccceeeecCCCccceeEcCCCCeeeEEEccccccc
Confidence 3 99999999999999887 4889999999765
|
|
| >cd04925 ACT_ACR_2 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein) | Back alignment and domain information |
|---|
Probab=95.29 E-value=0.06 Score=42.65 Aligned_cols=46 Identities=37% Similarity=0.518 Sum_probs=40.8
Q ss_pred eEEecCCCcchhhhhhhhhcccccceeeeeccccCCCceEEEEEEcC
Q 011158 182 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDG 228 (492)
Q Consensus 182 ~~~s~~~~p~~ls~l~~~l~~~~l~i~~A~~fst~dg~sl~v~vv~~ 228 (492)
+.+.+.|+|.++..++..++..|+||..|..++ .+|..+++|.|..
T Consensus 3 ~~v~~~Dr~gLl~~i~~~l~~~~lnI~~A~i~t-~~~~~~d~f~V~d 48 (74)
T cd04925 3 IELTGTDRPGLLSEVFAVLADLHCNVVEARAWT-HNGRLACVIYVRD 48 (74)
T ss_pred EEEEECCCCCHHHHHHHHHHHCCCcEEEEEEEE-ECCEEEEEEEEEc
Confidence 345677999999999999999999999999994 5999999999854
|
This CD includes the second ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.04 E-value=0.072 Score=55.04 Aligned_cols=73 Identities=18% Similarity=0.144 Sum_probs=57.3
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEEccCCCeEEEEEeecce
Q 011158 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVSLLLSLCLFTV 439 (492)
Q Consensus 361 ~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~-~IiHrDLKp~NILld~~~~~kl~DFGla~~ 439 (492)
..+.|++|++- |++|.-. ..-.+.++..|+++.+.-+.-+..+ ..=|||+.-.||||+ +|.+.++||-++|+
T Consensus 298 ~~y~yl~~kdh-gt~is~i-----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 298 TLYLYLHFKDH-GTPISII-----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred ceEEEEEEecC-Cceeeee-----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 34578888876 6666432 2246788899999877776666655 688999999999999 89999999999996
Q ss_pred e
Q 011158 440 S 440 (492)
Q Consensus 440 ~ 440 (492)
.
T Consensus 371 ~ 371 (488)
T COG5072 371 S 371 (488)
T ss_pred c
Confidence 4
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.77 E-value=0.6 Score=47.28 Aligned_cols=31 Identities=16% Similarity=0.319 Sum_probs=28.3
Q ss_pred CceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 410 NIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 410 ~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
+++|+|+.+.|+|++.++.+.++||-.+...
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~d 227 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASFA 227 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcccC
Confidence 7999999999999999988999999888765
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.64 E-value=1 Score=46.17 Aligned_cols=29 Identities=17% Similarity=0.166 Sum_probs=25.2
Q ss_pred CceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 410 NIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 410 ~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
++||+|+-+.|||++ + ...++||++++..
T Consensus 197 ~liHgD~h~~NvL~~-d-~~~iIDFDd~~~g 225 (325)
T PRK11768 197 LRLHGDCHPGNILWR-D-GPHFVDLDDARMG 225 (325)
T ss_pred cceecCCCchhcccc-C-CcEEEeCCCCCCC
Confidence 689999999999995 4 4679999999765
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=94.58 E-value=0.36 Score=50.19 Aligned_cols=80 Identities=13% Similarity=-0.029 Sum_probs=49.6
Q ss_pred eeeecCceEEEEEEECC--ceEEEEEecCC-----CCChHHHHHHHHHHHHHHhcC--CC-ceeeEEEEEecCCeEEEEE
Q 011158 299 KVASGSYGDLYRGTYCS--QDVAIKVLKPE-----RINSDMQKEFAQEVFIMRKVR--HK-NVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 299 ~LG~G~fG~Vy~~~~~g--~~vAvK~l~~~-----~~~~~~~~~~~~Ei~il~~l~--Hp-nIv~l~g~~~~~~~~~lV~ 368 (492)
.||-|....||++...+ +.|+||.-.+- ...+-...+...|..+|+... -| .+.+++.+ ++....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 57889999999998754 57999964321 111223345567778887664 24 45555544 444567999
Q ss_pred eccCCC-CHHHHH
Q 011158 369 EFMSGG-SVYDYL 380 (492)
Q Consensus 369 Ey~~gg-sL~~~L 380 (492)
|+++.. .|.+.|
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 999643 344444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 492 | ||||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-29 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-28 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-27 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-26 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-26 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-26 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-26 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-26 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-26 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-26 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-26 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-25 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-25 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-25 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-25 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-25 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-25 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-25 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-25 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-25 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-25 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-25 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-25 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-24 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-24 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-24 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-24 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-24 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-24 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-24 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-24 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-24 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-24 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 8e-24 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 8e-24 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 8e-24 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-24 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-24 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 8e-24 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-23 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-23 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-23 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-23 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-23 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-23 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-23 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-23 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-23 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-23 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-23 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-23 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-23 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-23 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-23 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-23 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-23 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-23 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-23 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-23 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-23 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-23 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-23 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-23 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-23 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-23 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-23 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-23 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-23 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-23 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-23 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-23 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-23 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-22 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-22 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-21 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-21 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-21 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-21 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-21 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-20 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-20 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-20 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-20 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 9e-20 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-19 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-19 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-18 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-18 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-18 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 9e-18 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-17 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-17 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-17 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-17 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-17 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-17 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-17 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-16 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-15 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-15 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-14 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-14 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-14 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-14 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-14 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-14 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-14 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-14 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-14 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-14 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-14 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-14 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-14 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-14 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-14 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 8e-14 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 9e-14 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 9e-14 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-13 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-13 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-13 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-13 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-13 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-13 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-13 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-13 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-13 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-13 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-13 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 7e-13 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 7e-13 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 8e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 9e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 9e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 7e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-12 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 7e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 7e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 7e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 8e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 8e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-11 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-11 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 8e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 9e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-10 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-10 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-10 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-10 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-10 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 6e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-10 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-10 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-10 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 9e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 9e-10 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 9e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-09 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-09 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-09 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-09 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-09 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-09 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-09 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-09 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-09 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-09 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-09 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-09 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-09 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-09 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-09 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 9e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 9e-09 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-08 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-08 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-08 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-08 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-08 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-08 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-08 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-08 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-08 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-08 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-08 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-08 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-08 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-08 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-08 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-08 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-08 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-08 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-08 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-08 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-08 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-08 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-08 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-08 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-08 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-08 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-08 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-08 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-08 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-08 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-08 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-08 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-08 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 7e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 8e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 8e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 9e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 9e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-07 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-07 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-07 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-07 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-07 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-07 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 5e-07 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-07 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-07 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-07 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 5e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-07 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-07 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 5e-07 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 5e-07 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-07 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-07 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-07 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 7e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-07 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-07 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-06 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-06 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-06 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-06 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-06 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-06 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-06 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-06 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-06 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-06 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 2e-06 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-06 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-06 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-06 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-06 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-06 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-06 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-06 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-06 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-06 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-06 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-06 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-06 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-06 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-06 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-06 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-06 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-06 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-06 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-06 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-06 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-06 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-06 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-06 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-06 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-06 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-06 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-06 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-06 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-06 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-06 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-06 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-06 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-06 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 6e-06 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-06 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-06 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 6e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 6e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 7e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-06 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 7e-06 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-06 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-06 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 8e-06 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-06 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 8e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 8e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 8e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 9e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 9e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 9e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-05 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 1e-05 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 1e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-05 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-05 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-05 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-05 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-05 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-05 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-05 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-05 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-05 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-05 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-05 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-05 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-05 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-05 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-05 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-05 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-05 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-05 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-05 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-05 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-05 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-05 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-05 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-05 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-05 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-05 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-05 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-05 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 3e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-05 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-05 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-05 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-05 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-05 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-05 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-05 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-05 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-05 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-05 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-05 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-05 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-05 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-05 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-05 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-05 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-05 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-05 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-05 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 5e-05 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-05 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-05 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 7e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 8e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-05 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 8e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-05 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 8e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 9e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 9e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 9e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-04 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-04 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-04 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-04 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-04 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 2e-04 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-04 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-04 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-04 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-04 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-04 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-04 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-04 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-04 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-04 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-04 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-04 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-04 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-04 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-04 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-04 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-04 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-04 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-04 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-04 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-04 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-04 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-04 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-04 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-04 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-04 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-04 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-04 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 3e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-04 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-04 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-04 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-04 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-04 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-04 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-04 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-04 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 7e-04 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-04 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-04 |
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 244 bits (626), Expect = 5e-78
Identities = 58/158 (36%), Positives = 91/158 (57%), Gaps = 2/158 (1%)
Query: 271 KSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINS 330
K H +H D D WEI + G ++ SGS+G +Y+G + DVA+K+L
Sbjct: 3 KGHHHHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWH-GDVAVKMLNVTAPTP 61
Query: 331 DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP 390
+ F EV ++RK RH N++ F+G T P L IVT++ G S+Y +LH + F++
Sbjct: 62 QQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETKFEMK 120
Query: 391 SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428
L+ +A ++GM+YLH +IIHRDLK+ N+ + E+
Sbjct: 121 KLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNT 158
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 241 bits (616), Expect = 3e-76
Identities = 66/177 (37%), Positives = 104/177 (58%), Gaps = 7/177 (3%)
Query: 256 HRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS 315
H P S+ + ++ + + D +I L K+ +GS+G ++R +
Sbjct: 4 HHHHHPMSDYDIPTTENLYFQGAMDGD---DMDIPWCDLNIKEKIGAGSFGTVHRAEWHG 60
Query: 316 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 375
DVA+K+L + +++ EF +EV IM+++RH N+V F+GA T+PP+L IVTE++S GS
Sbjct: 61 SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120
Query: 376 VYDYLHKLKGVFKLP--SLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEV 428
+Y LHK +L L +A DV+KGMNYLH N I+HR+LK+ NLL+D+
Sbjct: 121 LYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYT 177
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 241 bits (616), Expect = 3e-76
Identities = 56/168 (33%), Positives = 87/168 (51%), Gaps = 1/168 (0%)
Query: 261 PTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAI 320
P +S P + W+I + L+ G + G +G +Y G + +VAI
Sbjct: 2 PEMNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWH-GEVAI 60
Query: 321 KVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL 380
+++ ER N D K F +EV R+ RH+NVV F+GAC PP L I+T G ++Y +
Sbjct: 61 RLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV 120
Query: 381 HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428
K V + ++A ++ KGM YLH I+H+DLK+ N+ D +V
Sbjct: 121 RDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNGKV 168
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 8e-73
Identities = 43/142 (30%), Positives = 72/142 (50%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 346
P L G + G +G + T+ + + + R + + Q+ F +EV +MR +
Sbjct: 5 RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL 64
Query: 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 406
H NV++FIG K L +TE++ GG++ + + + + A D++ GM YL
Sbjct: 65 EHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL 124
Query: 407 HQNNIIHRDLKAANLLMDENEV 428
H NIIHRDL + N L+ EN+
Sbjct: 125 HSMNIIHRDLNSHNCLVRENKN 146
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 4e-71
Identities = 44/147 (29%), Positives = 80/147 (54%), Gaps = 5/147 (3%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 346
ID K L F +K+ G+L++G + D+ +KVLK ++ ++F +E +R
Sbjct: 5 SGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF 64
Query: 347 RHKNVVQFIGACTKPPS--LCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGM 403
H NV+ +GAC PP+ ++T +M GS+Y+ LH+ V +K A+D+++GM
Sbjct: 65 SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGM 124
Query: 404 NYLH--QNNIIHRDLKAANLLMDENEV 428
+LH + I L + ++++DE+
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMIDEDMT 151
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 225 bits (577), Expect = 5e-71
Identities = 45/145 (31%), Positives = 74/145 (51%), Gaps = 7/145 (4%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERIN--SDMQKEFAQEVFIM 343
+ EID L + G +G +YR + +VA+K + + S + QE +
Sbjct: 1 LLEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLF 60
Query: 344 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 403
++H N++ G C K P+LC+V EF GG + L + L+ A+ +++GM
Sbjct: 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGM 118
Query: 404 NYLHQNN---IIHRDLKAANLLMDE 425
NYLH IIHRDLK++N+L+ +
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQ 143
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 2e-67
Identities = 39/156 (25%), Positives = 73/156 (46%), Gaps = 11/156 (7%)
Query: 280 PNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQ---- 333
+ + + +++ ++ G +G +++G VAIK L + +
Sbjct: 7 EFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEK 66
Query: 334 -KEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSL 392
+EF +EVFIM + H N+V+ G PP +V EF+ G +Y L K
Sbjct: 67 FQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVK 124
Query: 393 LKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDEN 426
L++ +D++ G+ Y+ N I+HRDL++ N+ +
Sbjct: 125 LRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSL 160
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 4e-64
Identities = 46/146 (31%), Positives = 77/146 (52%), Gaps = 11/146 (7%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 345
+ ID K ++ V G++G + + + ++DVAIK ++ E +K F E+ + +
Sbjct: 2 LHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSR 57
Query: 346 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP--SLLKVAIDVSKGM 403
V H N+V+ GAC P +C+V E+ GGS+Y+ LH + + + + S+G+
Sbjct: 58 VNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115
Query: 404 NYLHQ---NNIIHRDLKAANLLMDEN 426
YLH +IHRDLK NLL+
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAG 141
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 8e-58
Identities = 43/153 (28%), Positives = 75/153 (49%), Gaps = 17/153 (11%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 345
V K ++ ++ G YG+++ G + + VA+KV S ++ E++
Sbjct: 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRE---TEIYQTVL 87
Query: 346 VRHKNVVQFIGACTKP----PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 401
+RH+N++ FI A K L ++T++ GS+YDYL S+LK+A
Sbjct: 88 MRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVS 145
Query: 402 GMNYLH--------QNNIIHRDLKAANLLMDEN 426
G+ +LH + I HRDLK+ N+L+ +N
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN 178
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 4e-54
Identities = 38/147 (25%), Positives = 74/147 (50%), Gaps = 17/147 (11%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV 351
+ + V G YG+++RG++ ++VA+K+ S ++ E++ +RH+N+
Sbjct: 8 RDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRE---TELYNTVMLRHENI 64
Query: 352 VQFIGACTK----PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 407
+ FI + L ++T + GS+YDYL S L++ + ++ G+ +LH
Sbjct: 65 LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLH 122
Query: 408 --------QNNIIHRDLKAANLLMDEN 426
+ I HRDLK+ N+L+ +N
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKN 149
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 1e-53
Identities = 41/158 (25%), Positives = 76/158 (48%), Gaps = 19/158 (12%)
Query: 283 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFI 342
GT+ L+ A G +G +++ ++ VA+K+ + + EV+
Sbjct: 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQ---DKQSWQNEYEVYS 71
Query: 343 MRKVRHKNVVQFIGACTKPPS----LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 398
+ ++H+N++QFIGA + S L ++T F GS+ D+L V L +A
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK--ANVVSWNELCHIAET 129
Query: 399 VSKGMNYLHQN----------NIIHRDLKAANLLMDEN 426
+++G+ YLH++ I HRD+K+ N+L+ N
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN 167
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 1e-53
Identities = 38/153 (24%), Positives = 78/153 (50%), Gaps = 17/153 (11%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 345
V + + + G +G+++RG + ++VA+K+ S ++ E++
Sbjct: 36 VQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFRE---AEIYQTVM 92
Query: 346 VRHKNVVQFIGACTK----PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 401
+RH+N++ FI A K L +V+++ GS++DYL++ + ++K+A+ +
Sbjct: 93 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTAS 150
Query: 402 GMNYLHQN--------NIIHRDLKAANLLMDEN 426
G+ +LH I HRDLK+ N+L+ +N
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 183
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 173 bits (439), Expect = 5e-50
Identities = 39/156 (25%), Positives = 69/156 (44%), Gaps = 23/156 (14%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQE--VFIMR 344
+D +LK + G YG +Y+G+ + VA+KV + Q F E ++ +
Sbjct: 8 PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFA----NRQ-NFINEKNIYRVP 62
Query: 345 KVRHKNVVQFIGACTKPPS-----LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 399
+ H N+ +FI + + +V E+ GS+ YL S ++A V
Sbjct: 63 LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS--LHTSDWVSSCRLAHSV 120
Query: 400 SKGMNYLH---------QNNIIHRDLKAANLLMDEN 426
++G+ YLH + I HRDL + N+L+ +
Sbjct: 121 TRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND 156
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 3e-49
Identities = 53/146 (36%), Positives = 77/146 (52%), Gaps = 6/146 (4%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMR 344
W ++ K LK + G +GD+ G Y VA+K +K + F E +M
Sbjct: 14 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKN----DATAQAFLAEASVMT 69
Query: 345 KVRHKNVVQFIGACTK-PPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKG 402
++RH N+VQ +G + L IVTE+M+ GS+ DYL V LLK ++DV +
Sbjct: 70 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 129
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEV 428
M YL NN +HRDL A N+L+ E+ V
Sbjct: 130 MEYLEGNNFVHRDLAARNVLVSEDNV 155
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 166 bits (424), Expect = 2e-48
Identities = 54/143 (37%), Positives = 86/143 (60%), Gaps = 4/143 (2%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRK 345
W IDP L F ++ SG +G ++ G + ++ VAIK ++ + +++F +E +M K
Sbjct: 3 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE---GAMSEEDFIEEAEVMMK 59
Query: 346 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 405
+ H +VQ G C + +C+VTEFM G + DYL +G+F +LL + +DV +GM Y
Sbjct: 60 LSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 119
Query: 406 LHQNNIIHRDLKAANLLMDENEV 428
L + +IHRDL A N L+ EN+V
Sbjct: 120 LEEACVIHRDLAARNCLVGENQV 142
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 3e-48
Identities = 53/145 (36%), Positives = 84/145 (57%), Gaps = 4/145 (2%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIM 343
WEIDPK L F ++ +G +G + G + Q DVAIK++K S + EF +E +M
Sbjct: 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE---GSMSEDEFIEEAKVM 73
Query: 344 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 403
+ H+ +VQ G CTK + I+TE+M+ G + +YL +++ F+ LL++ DV + M
Sbjct: 74 MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAM 133
Query: 404 NYLHQNNIIHRDLKAANLLMDENEV 428
YL +HRDL A N L+++ V
Sbjct: 134 EYLESKQFLHRDLAARNCLVNDQGV 158
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 9e-48
Identities = 46/146 (31%), Positives = 79/146 (54%), Gaps = 3/146 (2%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 342
D W ++ + L G ++ G++G+++ G + VA+K + E + D++ +F QE I
Sbjct: 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR-ETLPPDLKAKFLQEARI 165
Query: 343 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 402
+++ H N+V+ IG CT+ + IV E + GG +L ++ +LL++ D + G
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAG 225
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEV 428
M YL IHRDL A N L+ E V
Sbjct: 226 MEYLESKCCIHRDLAARNCLVTEKNV 251
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-47
Identities = 51/151 (33%), Positives = 81/151 (53%), Gaps = 7/151 (4%)
Query: 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQ-KEFA 337
+ I K L+ K+ GS+G + RG + + VA+K LKP+ ++ +F
Sbjct: 10 SLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI 69
Query: 338 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 397
+EV M + H+N+++ G PP + +VTE GS+ D L K +G F L +L + A+
Sbjct: 70 REVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV 128
Query: 398 DVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428
V++GM YL IHRDL A NLL+ ++
Sbjct: 129 QVAEGMGYLESKRFIHRDLAARNLLLATRDL 159
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 5e-47
Identities = 53/146 (36%), Positives = 78/146 (53%), Gaps = 6/146 (4%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMR 344
W ++ K LK + G +GD+ G Y VA+K +K + + F E +M
Sbjct: 186 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND----ATAQAFLAEASVMT 241
Query: 345 KVRHKNVVQFIGACTK-PPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKG 402
++RH N+VQ +G + L IVTE+M+ GS+ DYL V LLK ++DV +
Sbjct: 242 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 301
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEV 428
M YL NN +HRDL A N+L+ E+ V
Sbjct: 302 MEYLEGNNFVHRDLAARNVLVSEDNV 327
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 5e-47
Identities = 48/143 (33%), Positives = 77/143 (53%), Gaps = 4/143 (2%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRK 345
E+ + + ++ SG +G + G + Q DVA+K++K S + EF QE M K
Sbjct: 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKE---GSMSEDEFFQEAQTMMK 59
Query: 346 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 405
+ H +V+F G C+K + IVTE++S G + +YL + LL++ DV +GM +
Sbjct: 60 LSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAF 119
Query: 406 LHQNNIIHRDLKAANLLMDENEV 428
L + IHRDL A N L+D +
Sbjct: 120 LESHQFIHRDLAARNCLVDRDLC 142
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 7e-47
Identities = 40/151 (26%), Positives = 72/151 (47%), Gaps = 7/151 (4%)
Query: 283 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFA 337
G + I + + + G +G++Y G Y + VA+K K + D +++F
Sbjct: 3 GGPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-CTLDNKEKFM 61
Query: 338 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 397
E IM+ + H ++V+ IG + P I+ E G + YL + K K+ +L+ ++
Sbjct: 62 SEAVIMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL 120
Query: 398 DVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428
+ K M YL N +HRD+ N+L+ E
Sbjct: 121 QICKAMAYLESINCVHRDIAVRNILVASPEC 151
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-46
Identities = 45/151 (29%), Positives = 78/151 (51%), Gaps = 7/151 (4%)
Query: 283 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFA 337
T +EI + ++ G + G +GD+++G Y S + VAIK K + ++++F
Sbjct: 6 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFL 64
Query: 338 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 397
QE MR+ H ++V+ IG T+ P + I+ E + G + +L K L SL+ A
Sbjct: 65 QEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 123
Query: 398 DVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428
+S + YL +HRD+ A N+L+ N+
Sbjct: 124 QLSTALAYLESKRFVHRDIAARNVLVSSNDC 154
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 3e-46
Identities = 56/152 (36%), Positives = 86/152 (56%), Gaps = 8/152 (5%)
Query: 280 PNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFA 337
PN D WE++ + K+ G YG++Y G + S VA+K LK ++ +EF
Sbjct: 3 PNY--DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFL 57
Query: 338 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVA 396
+E +M++++H N+VQ +G CT+ P I+TEFM+ G++ DYL + LL +A
Sbjct: 58 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 117
Query: 397 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428
+S M YL + N IHRDL A N L+ EN +
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVGENHL 149
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 4e-46
Identities = 44/154 (28%), Positives = 79/154 (51%), Gaps = 10/154 (6%)
Query: 283 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEF 336
G+D + + +HLKF ++ G++G + Y + VA+K L+ + ++F
Sbjct: 1 GSDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDF 58
Query: 337 AQEVFIMRKVRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK 394
+E+ I++ ++H N+V++ G C +L ++ E++ GS+ DYL K K LL+
Sbjct: 59 EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 118
Query: 395 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428
+ KGM YL IHRDL N+L++
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENR 152
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 7e-46
Identities = 46/146 (31%), Positives = 82/146 (56%), Gaps = 6/146 (4%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIM 343
D WE+ + LK ++ +G +G+++ G Y VA+K LK S F E +M
Sbjct: 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMSPDAFLAEANLM 62
Query: 344 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKG 402
++++H+ +V+ T+ P + I+TE+M GS+ D+L G + LL +A +++G
Sbjct: 63 KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEV 428
M ++ + N IHRDL+AAN+L+ +
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLS 147
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 9e-46
Identities = 45/181 (24%), Positives = 82/181 (45%), Gaps = 10/181 (5%)
Query: 256 HRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY-- 313
H + T + + D + + +HLKF ++ G++G + Y
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDP 64
Query: 314 ----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLCIV 367
+ VA+K L+ + ++F +E+ I++ ++H N+V++ G C +L ++
Sbjct: 65 LQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI 122
Query: 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 427
E++ GS+ DYL K K LL+ + KGM YL IHRDL N+L++
Sbjct: 123 MEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN 182
Query: 428 V 428
Sbjct: 183 R 183
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 3e-45
Identities = 44/167 (26%), Positives = 78/167 (46%), Gaps = 10/167 (5%)
Query: 270 MKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVL 323
M H +H D + +HLK+ S++ G++G + Y VA+K L
Sbjct: 1 MGHHHHHHAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL 60
Query: 324 KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLH 381
+ D Q++F +E+ I++ + +V++ G P SL +V E++ G + D+L
Sbjct: 61 QHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ 118
Query: 382 KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428
+ + LL + + KGM YL +HRDL A N+L++
Sbjct: 119 RHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAH 165
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-45
Identities = 46/149 (30%), Positives = 68/149 (45%), Gaps = 6/149 (4%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQE 339
EI+ + + SG G++ G VAIK LK +++F E
Sbjct: 42 FTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ-RRDFLSE 100
Query: 340 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 399
IM + H N+++ G T+ IVTE+M GS+ +L G F + L+ + V
Sbjct: 101 ASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGV 160
Query: 400 SKGMNYLHQNNIIHRDLKAANLLMDENEV 428
GM YL +HRDL A N+L+D N V
Sbjct: 161 GAGMRYLSDLGYVHRDLAARNVLVDSNLV 189
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 4e-45
Identities = 42/149 (28%), Positives = 73/149 (48%), Gaps = 7/149 (4%)
Query: 285 DVWEIDPKHLKFGSKV-ASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQE 339
+D K L K SG++G + +G Y + VA+K+LK E + ++ E E
Sbjct: 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAE 68
Query: 340 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 399
+M+++ + +V+ IG C +V E G + YL + K +++++ V
Sbjct: 69 ANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQV 126
Query: 400 SKGMNYLHQNNIIHRDLKAANLLMDENEV 428
S GM YL ++N +HRDL A N+L+
Sbjct: 127 SMGMKYLEESNFVHRDLAARNVLLVTQHY 155
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 6e-45
Identities = 46/153 (30%), Positives = 77/153 (50%), Gaps = 11/153 (7%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQ-KEFA 337
D + + LK + G +G + Y + VA+K LKPE + +
Sbjct: 14 DPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGNHIADLK 71
Query: 338 QEVFIMRKVRHKNVVQFIGACTKPP--SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKV 395
+E+ I+R + H+N+V++ G CT+ + ++ EF+ GS+ +YL K K L LK
Sbjct: 72 KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKY 131
Query: 396 AIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428
A+ + KGM+YL +HRDL A N+L++
Sbjct: 132 AVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ 164
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 7e-45
Identities = 44/150 (29%), Positives = 74/150 (49%), Gaps = 7/150 (4%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQ 338
EI P + + +G +G++Y+G VAIK LK + +F
Sbjct: 37 FTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ-RVDFLG 95
Query: 339 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 398
E IM + H N+++ G +K + I+TE+M G++ +L + G F + L+ +
Sbjct: 96 EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 155
Query: 399 VSKGMNYLHQNNIIHRDLKAANLLMDENEV 428
++ GM YL N +HRDL A N+L++ N V
Sbjct: 156 IAAGMKYLANMNYVHRDLAARNILVNSNLV 185
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 8e-45
Identities = 33/149 (22%), Positives = 72/149 (48%), Gaps = 10/149 (6%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQ-KEFAQE 339
L+ + SG +G +++G + + V IKV++ + + +
Sbjct: 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK--SGRQSFQAVTDH 65
Query: 340 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 399
+ + + H ++V+ +G C L +VT+++ GS+ D++ + +G LL + +
Sbjct: 66 MLAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI 124
Query: 400 SKGMNYLHQNNIIHRDLKAANLLMDENEV 428
+KGM YL ++ ++HR+L A N+L+
Sbjct: 125 AKGMYYLEEHGMVHRNLAARNVLLKSPSQ 153
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-44
Identities = 38/150 (25%), Positives = 71/150 (47%), Gaps = 11/150 (7%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTY---------CSQDVAIKVLKPERINSDMQKEFA 337
+I + L F + G++ +++G +V +KVL + + + F
Sbjct: 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFF 60
Query: 338 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 397
+ +M K+ HK++V G C +V EF+ GS+ YL K K + L+VA
Sbjct: 61 EAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAK 120
Query: 398 DVSKGMNYLHQNNIIHRDLKAANLLMDENE 427
++ M++L +N +IH ++ A N+L+ E
Sbjct: 121 QLAAAMHFLEENTLIHGNVCAKNILLIREE 150
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-44
Identities = 42/156 (26%), Positives = 73/156 (46%), Gaps = 11/156 (7%)
Query: 280 PNDGTDVWE-IDPKHLKFGSKVASGSYGDLYRGTYCSQD------VAIKVLKPERINSDM 332
PN + + K + SG++G +Y+G + + VAIK L+
Sbjct: 4 PNQA--LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN 61
Query: 333 QKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSL 392
KE E ++M V + +V + +G C + ++T+ M G + DY+ + K L
Sbjct: 62 -KEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYL 119
Query: 393 LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428
L + ++KGMNYL ++HRDL A N+L+ +
Sbjct: 120 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH 155
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 3e-44
Identities = 54/161 (33%), Positives = 88/161 (54%), Gaps = 6/161 (3%)
Query: 271 KSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI 328
K + + + D WE++ + K+ G YG++Y G + S VA+K LK
Sbjct: 199 KRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--- 255
Query: 329 NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VF 387
++ +EF +E +M++++H N+VQ +G CT+ P I+TEFM+ G++ DYL +
Sbjct: 256 DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV 315
Query: 388 KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428
LL +A +S M YL + N IHR+L A N L+ EN +
Sbjct: 316 SAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHL 356
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 4e-44
Identities = 45/149 (30%), Positives = 72/149 (48%), Gaps = 6/149 (4%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERINSDMQKEFAQE 339
E+D ++ V +G +G++ G VAIK LK +++F E
Sbjct: 38 FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGE 96
Query: 340 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 399
IM + H N+++ G TK + IVTE+M GS+ +L K F + L+ + +
Sbjct: 97 ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGI 156
Query: 400 SKGMNYLHQNNIIHRDLKAANLLMDENEV 428
+ GM YL +HRDL A N+L++ N V
Sbjct: 157 ASGMKYLSDMGYVHRDLAARNILINSNLV 185
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-43
Identities = 41/150 (27%), Positives = 70/150 (46%), Gaps = 9/150 (6%)
Query: 285 DVWEIDPKHLKFG-SKVASGSYGDLYRGTYCSQ----DVAIKVLKPERINSDMQK-EFAQ 338
+ +L ++ G++G + +G Y + DVAIKVLK E +
Sbjct: 2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMR 59
Query: 339 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 398
E IM ++ + +V+ IG C L +V E GG ++ +L + + ++ ++
Sbjct: 60 EAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 118
Query: 399 VSKGMNYLHQNNIIHRDLKAANLLMDENEV 428
VS GM YL + N +HRDL A N+L+
Sbjct: 119 VSMGMKYLEEKNFVHRDLAARNVLLVNRHY 148
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 1e-43
Identities = 57/233 (24%), Positives = 106/233 (45%), Gaps = 16/233 (6%)
Query: 206 NIQEAHAFST-VDGY----SLDVFVVDGWPYEETEQLRAALEKEVLKLERQGWPSHRSSS 260
++ A + +DGY + P +E E+ ++ K ++ S S
Sbjct: 303 SLTIAENMADLIDGYCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVS 362
Query: 261 PTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD--- 317
T + + + Y +P+ +EI + ++ G + G +GD+++G Y S +
Sbjct: 363 ETDDYAEIIDEEDTY--TMPST--RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPA 418
Query: 318 --VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 375
VAIK K + ++++F QE MR+ H ++V+ IG T+ P + I+ E + G
Sbjct: 419 MAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGE 476
Query: 376 VYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428
+ +L K L SL+ A +S + YL +HRD+ A N+L+ N+
Sbjct: 477 LRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC 529
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 5e-43
Identities = 48/173 (27%), Positives = 81/173 (46%), Gaps = 20/173 (11%)
Query: 273 HPYHLKIPNDG---------TDVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQD 317
H +H + G D ++LK + G +G + Y +
Sbjct: 3 HHHHHHHHHHGALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEM 62
Query: 318 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLCIVTEFMSGGS 375
VA+K LK + + + QE+ I+R + H++++++ G C SL +V E++ GS
Sbjct: 63 VAVKALKADA-GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGS 121
Query: 376 VYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428
+ DYL + L LL A + +GM YLH + IHRDL A N+L+D + +
Sbjct: 122 LRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRL 172
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 6e-43
Identities = 52/146 (35%), Positives = 85/146 (58%), Gaps = 6/146 (4%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIM 343
D WEI + LK K+ +G +G+++ TY VA+K +KP S + F E +M
Sbjct: 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP---GSMSVEAFLAEANVM 237
Query: 344 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKG 402
+ ++H +V+ TK P + I+TEFM+ GS+ D+L +G LP L+ + +++G
Sbjct: 238 KTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG 296
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEV 428
M ++ Q N IHRDL+AAN+L+ + V
Sbjct: 297 MAFIEQRNYIHRDLRAANILVSASLV 322
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-42
Identities = 57/158 (36%), Positives = 90/158 (56%), Gaps = 6/158 (3%)
Query: 273 HPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSD 331
+ D WEI + L+ K+ G +G+++ GT+ VAIK LKP +
Sbjct: 165 PTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP---GTM 221
Query: 332 MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLP 390
+ F QE +M+K+RH+ +VQ ++ P + IVTE+MS GS+ D+L G +LP
Sbjct: 222 SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLP 280
Query: 391 SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428
L+ +A ++ GM Y+ + N +HRDL+AAN+L+ EN V
Sbjct: 281 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV 318
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-41
Identities = 42/156 (26%), Positives = 73/156 (46%), Gaps = 11/156 (7%)
Query: 280 PNDGTDVWE-IDPKHLKFGSKVASGSYGDLYRGTYCSQD------VAIKVLKPERINSDM 332
PN + + K + SG++G +Y+G + + VAIK L+
Sbjct: 4 PNQA--LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN 61
Query: 333 QKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSL 392
KE E ++M V + +V + +G C + ++T+ M G + DY+ + K L
Sbjct: 62 -KEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYL 119
Query: 393 LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428
L + ++KGMNYL ++HRDL A N+L+ +
Sbjct: 120 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH 155
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-41
Identities = 57/146 (39%), Positives = 89/146 (60%), Gaps = 6/146 (4%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIM 343
D WEI + L+ K+ G +G+++ GT+ VAIK LKP + + F QE +M
Sbjct: 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP---GTMSPEAFLQEAQVM 316
Query: 344 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKG 402
+K+RH+ +VQ ++ P + IVTE+MS GS+ D+L G +LP L+ +A ++ G
Sbjct: 317 KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 375
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEV 428
M Y+ + N +HRDL+AAN+L+ EN V
Sbjct: 376 MAYVERMNYVHRDLRAANILVGENLV 401
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 5e-41
Identities = 52/176 (29%), Positives = 82/176 (46%), Gaps = 21/176 (11%)
Query: 273 HPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC----SQDVAIKVLKPERI 328
H +H K D T +D +KF + G++G + + D AIK +K E
Sbjct: 6 HHHHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYA 64
Query: 329 NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL------- 380
+ D ++FA E+ ++ K+ H N++ +GAC L + E+ G++ D+L
Sbjct: 65 SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLE 124
Query: 381 --------HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428
+ LL A DV++GM+YL Q IHRDL A N+L+ EN V
Sbjct: 125 TDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 180
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-39
Identities = 40/170 (23%), Positives = 74/170 (43%), Gaps = 24/170 (14%)
Query: 281 NDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQ 333
+ G V I + + ++ G++G ++ VA+K LK +
Sbjct: 4 HSGIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAAR 61
Query: 334 KEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL------------- 380
K+F +E ++ ++H+++V+F G C L +V E+M G + +L
Sbjct: 62 KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDG 121
Query: 381 --HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428
+ KG L +L +A ++ GM YL + +HRDL N L+ N +
Sbjct: 122 QPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL 171
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 6e-39
Identities = 43/159 (27%), Positives = 72/159 (45%), Gaps = 15/159 (9%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQE 339
+ ID L G + G +G + G +D VA+K +K + + +EF E
Sbjct: 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSE 86
Query: 340 VFIMRKVRHKNVVQFIGACTK-----PPSLCIVTEFMSGGSVYDYLHKLK-----GVFKL 389
M+ H NV++ +G C + P ++ FM G ++ YL + L
Sbjct: 87 AACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL 146
Query: 390 PSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428
+LLK +D++ GM YL N +HRDL A N ++ ++
Sbjct: 147 QTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT 185
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 9e-39
Identities = 47/194 (24%), Positives = 82/194 (42%), Gaps = 25/194 (12%)
Query: 258 SSSPTSEPEDTGMKSHPYHLKIPN--DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY-- 313
S S S E G + ++ P V I + + ++ G++G ++
Sbjct: 5 SGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHN 64
Query: 314 -----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368
VA+K LK + +++F +E ++ ++H+++V+F G CT+ L +V
Sbjct: 65 LLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVF 122
Query: 369 EFMSGGSVYDYL--------------HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 414
E+M G + +L G L LL VA V+ GM YL + +HR
Sbjct: 123 EYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHR 182
Query: 415 DLKAANLLMDENEV 428
DL N L+ + V
Sbjct: 183 DLATRNCLVGQGLV 196
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-38
Identities = 38/165 (23%), Positives = 77/165 (46%), Gaps = 23/165 (13%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQ 338
+ EI ++F ++ +G +Y+G +Q VAIK LK + +++EF
Sbjct: 3 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK-AEGPLREEFRH 61
Query: 339 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------------HKL 383
E + +++H NVV +G TK L ++ + S G ++++L +
Sbjct: 62 EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121
Query: 384 KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428
K + P + + ++ GM YL ++++H+DL N+L+ +
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN 166
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-38
Identities = 46/181 (25%), Positives = 78/181 (43%), Gaps = 8/181 (4%)
Query: 253 WPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKV-ASGSYGDLYRG 311
P P DT + P+ + +L G++G + +G
Sbjct: 297 ARITSPDKPRPMPMDTSVFESPFSDPEELKDKK-LFLKRDNLLIADIELGCGNFGSVRQG 355
Query: 312 TYCSQ----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367
Y + DVAIKVLK +D +E +E IM ++ + +V+ IG C L +V
Sbjct: 356 VYRMRKKQIDVAIKVLKQGTEKAD-TEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLV 413
Query: 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 427
E GG ++ +L + + ++ ++ VS GM YL + N +HR+L A N+L+
Sbjct: 414 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH 473
Query: 428 V 428
Sbjct: 474 Y 474
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-38
Identities = 47/172 (27%), Positives = 80/172 (46%), Gaps = 22/172 (12%)
Query: 272 SHPYHLKIPN--------DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQ 316
+H +H PN +D+ E+ K++ + G++G++Y G
Sbjct: 2 AHHHHHHNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPL 61
Query: 317 DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376
VA+K L E + + +F E I+ K H+N+V+ IG + I+ E M+GG +
Sbjct: 62 QVAVKTLP-EVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDL 120
Query: 377 YDYLHKLK------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 422
+L + + + LL VA D++ G YL +N+ IHRD+ A N L
Sbjct: 121 KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCL 172
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-38
Identities = 37/150 (24%), Positives = 64/150 (42%), Gaps = 9/150 (6%)
Query: 287 WEI--DPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQE 339
I + + G +G +Y G Y Q AIK L ++ F +E
Sbjct: 14 VLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVE-AFLRE 72
Query: 340 VFIMRKVRHKNVVQFIGACTKP-PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 398
+MR + H NV+ IG P ++ +M G + ++ + + L+ +
Sbjct: 73 GLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQ 132
Query: 399 VSKGMNYLHQNNIIHRDLKAANLLMDENEV 428
V++GM YL + +HRDL A N ++DE+
Sbjct: 133 VARGMEYLAEQKFVHRDLAARNCMLDESFT 162
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-38
Identities = 40/160 (25%), Positives = 72/160 (45%), Gaps = 16/160 (10%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQE 339
+ I + G + G +G + +D VA+K+LK + I S +EF +E
Sbjct: 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLRE 75
Query: 340 VFIMRKVRHKNVVQFIGACTK------PPSLCIVTEFMSGGSVYDYLHKLK-----GVFK 388
M++ H +V + +G + P ++ FM G ++ +L +
Sbjct: 76 AACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLP 135
Query: 389 LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428
L +L++ +D++ GM YL N IHRDL A N ++ E+
Sbjct: 136 LQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT 175
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-38
Identities = 39/149 (26%), Positives = 63/149 (42%), Gaps = 7/149 (4%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQEV 340
V + F + G +G +Y GT D A+K L + +F E
Sbjct: 19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEG 77
Query: 341 FIMRKVRHKNVVQFIGACTKP-PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 399
IM+ H NV+ +G C + S +V +M G + +++ + L+ + V
Sbjct: 78 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 137
Query: 400 SKGMNYLHQNNIIHRDLKAANLLMDENEV 428
+KGM YL +HRDL A N ++DE
Sbjct: 138 AKGMKYLASKKFVHRDLAARNCMLDEKFT 166
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-38
Identities = 40/160 (25%), Positives = 75/160 (46%), Gaps = 17/160 (10%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFA 337
D WE+ + + ++ GS+G +Y G VAIK + E + + EF
Sbjct: 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFL 76
Query: 338 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK---------GVFK 388
E +M++ +VV+ +G ++ ++ E M+ G + YL L+
Sbjct: 77 NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136
Query: 389 LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428
L ++++A +++ GM YL+ N +HRDL A N ++ E+
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 176
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-37
Identities = 48/200 (24%), Positives = 84/200 (42%), Gaps = 32/200 (16%)
Query: 254 PSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 313
SH + +P G+ ++P D WE L G + G++G +
Sbjct: 3 SSHHHHHHSQDPMLAGVS----EYELPED--PKWEFPRDKLTLGKPLGEGAFGQVVMAEA 56
Query: 314 C---------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPS 363
+ VA+K+LK + + E+ +M+ + +HKN++ +GACT+
Sbjct: 57 VGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 115
Query: 364 LCIVTEFMSGGSVYDYL---------------HKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
L ++ E+ S G++ +YL + L+ +++GM YL
Sbjct: 116 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 175
Query: 409 NNIIHRDLKAANLLMDENEV 428
IHRDL A N+L+ EN V
Sbjct: 176 QKCIHRDLAARNVLVTENNV 195
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-37
Identities = 46/182 (25%), Positives = 82/182 (45%), Gaps = 14/182 (7%)
Query: 254 PSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 313
P ++ S + T + + +D+ E+ K++ + G++G++Y G
Sbjct: 33 PEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQV 92
Query: 314 -------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366
VA+K L E + + +F E I+ K H+N+V+ IG + I
Sbjct: 93 SGMPNDPSPLQVAVKTLP-EVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFI 151
Query: 367 VTEFMSGGSVYDYLHKLK------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 420
+ E M+GG + +L + + + LL VA D++ G YL +N+ IHRD+ A N
Sbjct: 152 LLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARN 211
Query: 421 LL 422
L
Sbjct: 212 CL 213
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-37
Identities = 38/149 (25%), Positives = 64/149 (42%), Gaps = 7/149 (4%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQEV 340
V + F + G +G +Y GT D A+K L ++ +F E
Sbjct: 83 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEG 141
Query: 341 FIMRKVRHKNVVQFIGACTKP-PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 399
IM+ H NV+ +G C + S +V +M G + +++ + L+ + V
Sbjct: 142 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 201
Query: 400 SKGMNYLHQNNIIHRDLKAANLLMDENEV 428
+KGM +L +HRDL A N ++DE
Sbjct: 202 AKGMKFLASKKFVHRDLAARNCMLDEKFT 230
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-37
Identities = 50/200 (25%), Positives = 85/200 (42%), Gaps = 28/200 (14%)
Query: 254 PSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 313
P R ++ S DT M + ++P D WE L G + G +G +
Sbjct: 45 PLVRITTRLSSTADTPMLAGVSEYELPED--PKWEFPRDKLTLGKPLGEGCFGQVVMAEA 102
Query: 314 C---------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPS 363
+ VA+K+LK + + E+ +M+ + +HKN++ +GACT+
Sbjct: 103 VGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 161
Query: 364 LCIVTEFMSGGSVYDYL---------------HKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
L ++ E+ S G++ +YL + L+ +++GM YL
Sbjct: 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 221
Query: 409 NNIIHRDLKAANLLMDENEV 428
IHRDL A N+L+ EN V
Sbjct: 222 QKCIHRDLAARNVLVTENNV 241
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 6e-37
Identities = 45/181 (24%), Positives = 79/181 (43%), Gaps = 33/181 (18%)
Query: 278 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINS 330
KI D WE K+L G + G +G + + T VA+K+LK E +
Sbjct: 11 KILED--PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK-ENASP 67
Query: 331 DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------- 380
++ E ++++V H +V++ GAC++ L ++ E+ GS+ +L
Sbjct: 68 SELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGY 127
Query: 381 -------------HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 427
H + + L+ A +S+GM YL + ++HRDL A N+L+ E
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGR 187
Query: 428 V 428
Sbjct: 188 K 188
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-36
Identities = 44/176 (25%), Positives = 76/176 (43%), Gaps = 28/176 (15%)
Query: 278 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINS 330
++P D WE L FG + +G++G + T + VA+K+LK +
Sbjct: 11 QLPYD--HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK-PSAHL 67
Query: 331 DMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL--------- 380
++ E+ ++ + H N+V +GACT ++TE+ G + ++L
Sbjct: 68 TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 127
Query: 381 --------HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428
+ L LL + V+KGM +L N IHRDL A N+L+ +
Sbjct: 128 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI 183
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-36
Identities = 45/172 (26%), Positives = 84/172 (48%), Gaps = 24/172 (13%)
Query: 278 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINS 330
++P + + WE +L+FG + +G++G + T VA+K+LK ++
Sbjct: 34 QLPYN--EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-STAHA 90
Query: 331 DMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK- 388
D ++ E+ IM + +H+N+V +GACT + ++TE+ G + ++L + V +
Sbjct: 91 DEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLET 150
Query: 389 ------------LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428
LL + V++GM +L N IHRD+ A N+L+ V
Sbjct: 151 DPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV 202
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-36
Identities = 54/193 (27%), Positives = 77/193 (39%), Gaps = 32/193 (16%)
Query: 260 SPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY------ 313
P P D + PY WE LK G + G++G +
Sbjct: 2 DPDELPLDEHCERLPYD-------ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKT 54
Query: 314 -CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKP-PSLCIVTEF 370
+ VA+K+LK E + E+ I+ + H NVV +GACTKP L ++ EF
Sbjct: 55 ATCRTVAVKMLK-EGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEF 113
Query: 371 MSGGSVYDYL---------------HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
G++ YL K L L+ + V+KGM +L IHRD
Sbjct: 114 CKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRD 173
Query: 416 LKAANLLMDENEV 428
L A N+L+ E V
Sbjct: 174 LAARNILLSEKNV 186
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 6e-36
Identities = 52/200 (26%), Positives = 86/200 (43%), Gaps = 29/200 (14%)
Query: 255 SHRSSSPTSE-PEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 313
H PT+E GM + ++P D WE+ L G + G++G +
Sbjct: 33 HHDYDIPTTENLYFQGMLAGVSEYELPED--PRWELPRDRLVLGKPLGEGAFGQVVLAEA 90
Query: 314 ---------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPS 363
VA+K+LK + E+ +M+ + +HKN++ +GACT+
Sbjct: 91 IGLDKDKPNRVTKVAVKMLK-SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP 149
Query: 364 LCIVTEFMSGGSVYDYL---------------HKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
L ++ E+ S G++ +YL H + L+ A V++GM YL
Sbjct: 150 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS 209
Query: 409 NNIIHRDLKAANLLMDENEV 428
IHRDL A N+L+ E+ V
Sbjct: 210 KKCIHRDLAARNVLVTEDNV 229
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 45/212 (21%), Positives = 89/212 (41%), Gaps = 34/212 (16%)
Query: 250 RQGWPSHRSSSPTSEPEDTGMKSHPYHLKIP---NDGTDVWEIDPKHLKFGSKVASGSYG 306
+ ++ SE + +P + ++P N E ++++ + G++G
Sbjct: 2 AMESAAVTLTTLPSELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFG 61
Query: 307 DLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359
+++ VA+K+LK E ++DMQ +F +E +M + + N+V+ +G C
Sbjct: 62 RVFQARAPGLLPYEPFTMVAVKMLK-EEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120
Query: 360 KPPSLCIVTEFMSGGSVYDYLHKLK-----------------------GVFKLPSLLKVA 396
+C++ E+M+ G + ++L + L +A
Sbjct: 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIA 180
Query: 397 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428
V+ GM YL + +HRDL N L+ EN V
Sbjct: 181 RQVAAGMAYLSERKFVHRDLATRNCLVGENMV 212
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 6e-35
Identities = 48/181 (26%), Positives = 83/181 (45%), Gaps = 33/181 (18%)
Query: 278 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINS 330
+ D WE ++L+FG + SG++G + T S VA+K+LK E+ +S
Sbjct: 33 EYEYD--LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK-EKADS 89
Query: 331 DMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKL 389
++ E+ +M ++ H+N+V +GACT + ++ E+ G + +YL + F
Sbjct: 90 SEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSE 149
Query: 390 PS----------------------LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 427
LL A V+KGM +L + +HRDL A N+L+ +
Sbjct: 150 DEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK 209
Query: 428 V 428
V
Sbjct: 210 V 210
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 8e-32
Identities = 41/158 (25%), Positives = 76/158 (48%), Gaps = 11/158 (6%)
Query: 279 IPNDGTDVWEIDP--KHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQK 334
I T + + LKF ++ GS+ +Y+G T + +VA L+ ++ ++
Sbjct: 11 IEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ 70
Query: 335 EFAQEVFIMRKVRHKNVVQFIGA----CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP 390
F +E +++ ++H N+V+F + + +VTE M+ G++ YL + V K+
Sbjct: 71 RFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIK 129
Query: 391 SLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDEN 426
L + KG+ +LH IIHRDLK N+ +
Sbjct: 130 VLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP 167
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-31
Identities = 42/149 (28%), Positives = 71/149 (47%), Gaps = 10/149 (6%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMR 344
W I+ + + SG+ + + VAIK + E+ + M E +E+ M
Sbjct: 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMD-ELLKEIQAMS 68
Query: 345 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYD-YLHKLKGVFKLPSLLK---VAI--- 397
+ H N+V + + L +V + +SGGSV D H + +L +A
Sbjct: 69 QCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 128
Query: 398 DVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
+V +G+ YLH+N IHRD+KA N+L+ E+
Sbjct: 129 EVLEGLEYLHKNGQIHRDVKAGNILLGED 157
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 119 bits (302), Expect = 1e-30
Identities = 47/134 (35%), Positives = 79/134 (58%), Gaps = 4/134 (2%)
Query: 297 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQ--KEFAQEVFIMRKVRHKNVVQF 354
G+K+ G +G +Y+G + VA+K L + + ++F QE+ +M K +H+N+V+
Sbjct: 36 GNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKL--PSLLKVAIDVSKGMNYLHQNNII 412
+G + LC+V +M GS+ D L L G L K+A + G+N+LH+N+ I
Sbjct: 96 LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHI 155
Query: 413 HRDLKAANLLMDEN 426
HRD+K+AN+L+DE
Sbjct: 156 HRDIKSANILLDEA 169
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-30
Identities = 46/160 (28%), Positives = 82/160 (51%), Gaps = 8/160 (5%)
Query: 270 MKSHPYHLKIPNDGTDVWEIDPKHL-KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPE 326
M P +P G + DP+ L K+ GS+G++++G + VAIK++ E
Sbjct: 1 MAHSPVQSGLP--GMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE 58
Query: 327 RINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV 386
+++ + QE+ ++ + V ++ G+ K L I+ E++ GGS D L G
Sbjct: 59 EAEDEIE-DIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE--PGP 115
Query: 387 FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
+ + ++ KG++YLH IHRD+KAAN+L+ E+
Sbjct: 116 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH 155
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-30
Identities = 42/153 (27%), Positives = 74/153 (48%), Gaps = 11/153 (7%)
Query: 276 HLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQ 333
H++ D +VWEI ++ G++G +Y+ A KV++ + + +
Sbjct: 10 HVRRDLDPNEVWEIV-------GELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEEL 60
Query: 334 KEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLL 393
+++ E+ I+ H +V+ +GA L I+ EF GG+V + +L P +
Sbjct: 61 EDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ 120
Query: 394 KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
V + + +N+LH IIHRDLKA N+LM
Sbjct: 121 VVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLE 153
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 38/183 (20%), Positives = 70/183 (38%), Gaps = 11/183 (6%)
Query: 246 LKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSY 305
L + W S + PE + K+ + E + + +V GS+
Sbjct: 13 LASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYRE-EVHWMTHQPRVGRGSF 71
Query: 306 GDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363
G+++R A+K + ++ +E+ + +V GA + P
Sbjct: 72 GEVHRMKDKQTGFQCAVKKV-------RLEVFRVEELVACAGLSSPRIVPLYGAVREGPW 124
Query: 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 423
+ I E + GGS+ + K G L +G+ YLH I+H D+KA N+L+
Sbjct: 125 VNIFMELLEGGSLGQLI-KQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLL 183
Query: 424 DEN 426
+
Sbjct: 184 SSD 186
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 32/182 (17%), Positives = 67/182 (36%), Gaps = 20/182 (10%)
Query: 255 SHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASG--SYGDLYRGT 312
+H GM S + + + + G +
Sbjct: 2 AHHHHHHMENLYFQGMSSFL--------------PEGGCYELLTVIGKGFEDLMTVNLAR 47
Query: 313 YCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370
Y + V ++ + E +++M E+ + + H N+V + L +VT F
Sbjct: 48 YKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 107
Query: 371 MSGGSVYDYL-HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-EV 428
M+ GS D + ++ + V K ++Y+H +HR +KA+++L+ + +V
Sbjct: 108 MAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKV 167
Query: 429 SL 430
L
Sbjct: 168 YL 169
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-28
Identities = 43/145 (29%), Positives = 68/145 (46%), Gaps = 7/145 (4%)
Query: 285 DVWEIDPKHL-KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVF 341
D P+ + K+ GSYG +Y+ + Q VAIK + E +E +E+
Sbjct: 21 DSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE----SDLQEIIKEIS 76
Query: 342 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 401
IM++ +VV++ G+ K L IV E+ GSV D + + + K
Sbjct: 77 IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLK 136
Query: 402 GMNYLHQNNIIHRDLKAANLLMDEN 426
G+ YLH IHRD+KA N+L++
Sbjct: 137 GLEYLHFMRKIHRDIKAGNILLNTE 161
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-27
Identities = 34/172 (19%), Positives = 70/172 (40%), Gaps = 17/172 (9%)
Query: 269 GMKSHPYHLKIPNDGTD----VWEIDPKHLKFGSKVASGSYGDLY--RGTYCSQDVAIKV 322
G H +H + + ID KH F K+ G + + G + A+K
Sbjct: 2 GSSHHHHHHSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKR 61
Query: 323 LKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIGACTKPPS----LCIVTEFMSGGSVY 377
+ + +E A +E + R H N+++ + C + ++ F G+++
Sbjct: 62 I---LCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLW 118
Query: 378 DYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
+ + +LK +L + + + +G+ +H HRDLK N+L+ +
Sbjct: 119 NEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDE 170
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-27
Identities = 32/138 (23%), Positives = 68/138 (49%), Gaps = 6/138 (4%)
Query: 297 GSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQ 353
K+ SG +G +++ AIK K S ++ +EV+ + +H +VV+
Sbjct: 16 LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR 75
Query: 354 FIGACTKPPSLCIVTEFMSGGSVYDYL---HKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 410
+ A + + I E+ +GGS+ D + +++ FK L + + V +G+ Y+H +
Sbjct: 76 YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS 135
Query: 411 IIHRDLKAANLLMDENEV 428
++H D+K +N+ + +
Sbjct: 136 LVHMDIKPSNIFISRTSI 153
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 46/177 (25%), Positives = 81/177 (45%), Gaps = 5/177 (2%)
Query: 254 PSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHL-KFGSKVASGSYGDLYRGT 312
P+ + + LK P+ ++ DP+ L ++ GS+G +Y
Sbjct: 15 PTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFAR 74
Query: 313 YCS--QDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369
+ VAIK + S + ++ +EV ++K+RH N +Q+ G + + +V E
Sbjct: 75 DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 134
Query: 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
+ GS D L K + + V +G+ YLH +N+IHRD+KA N+L+ E
Sbjct: 135 YC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP 190
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-27
Identities = 37/139 (26%), Positives = 64/139 (46%), Gaps = 7/139 (5%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ G+ +++RG + AIKV + + +E +++K+ HKN+V
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHKNIV 70
Query: 353 QFIGA--CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP--SLLKVAIDVSKGMNYLHQ 408
+ T ++ EF GS+Y L + + LP L V DV GMN+L +
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 409 NNIIHRDLKAANLLMDENE 427
N I+HR++K N++ E
Sbjct: 131 NGIVHRNIKPGNIMRVIGE 149
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-27
Identities = 37/132 (28%), Positives = 68/132 (51%), Gaps = 6/132 (4%)
Query: 297 GSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 354
+ G+YG +Y G S +AIK + +S + +E+ + + ++HKN+VQ+
Sbjct: 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQY 84
Query: 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP-SLLKV-AIDVSKGMNYLHQNNII 412
+G+ ++ + I E + GGS+ L G K + + +G+ YLH N I+
Sbjct: 85 LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 144
Query: 413 HRDLKAANLLMD 424
HRD+K N+L++
Sbjct: 145 HRDIKGDNVLIN 156
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 9e-27
Identities = 48/153 (31%), Positives = 80/153 (52%), Gaps = 15/153 (9%)
Query: 290 DPKHL-KFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 346
DP + + V +G+YG +Y+G + Q AIKV+ D ++E QE+ +++K
Sbjct: 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---GDEEEEIKQEINMLKKY 77
Query: 347 -RHKNVVQFIGA------CTKPPSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAID 398
H+N+ + GA L +V EF GSV D + K K + + +
Sbjct: 78 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICRE 137
Query: 399 VSKGMNYLHQNNIIHRDLKAANLLMDEN-EVSL 430
+ +G+++LHQ+ +IHRD+K N+L+ EN EV L
Sbjct: 138 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKL 170
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 39/131 (29%), Positives = 69/131 (52%), Gaps = 10/131 (7%)
Query: 302 SGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQ--KEFAQEVFIMRKVRHKNVVQFIGAC 358
G +G +Y+G VA+K PE Q +EF E+ + RH ++V IG C
Sbjct: 49 HGVFGKVYKGVLRDGAKVALKRRTPE----SSQGIEEFETEIETLSFCRHPHLVSLIGFC 104
Query: 359 TKPPSLCIVTEFMSGGSVYDYLH-KLKGVFKL--PSLLKVAIDVSKGMNYLHQNNIIHRD 415
+ + ++ ++M G++ +L+ + L++ I ++G++YLH IIHRD
Sbjct: 105 DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRD 164
Query: 416 LKAANLLMDEN 426
+K+ N+L+DEN
Sbjct: 165 VKSINILLDEN 175
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 44/167 (26%), Positives = 76/167 (45%), Gaps = 13/167 (7%)
Query: 282 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQE 339
W+ + LK ++ G+YG + + + Q +A+K ++ ++ QK+ +
Sbjct: 12 SPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST-VDEKEQKQLLMD 70
Query: 340 V-FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDY---LHKLKGVFKLPSLLKV 395
+ +MR +VQF GA + I E MS Y L V L K+
Sbjct: 71 LDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKI 130
Query: 396 AIDVSKGMNYLHQN-NIIHRDLKAANLLMDEN-EVSLLLSLCLFTVS 440
+ K +N+L +N IIHRD+K +N+L+D + + LC F +S
Sbjct: 131 TLATVKALNHLKENLKIIHRDIKPSNILLDRSGNI----KLCDFGIS 173
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 45/164 (27%), Positives = 80/164 (48%), Gaps = 10/164 (6%)
Query: 281 NDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQ 338
V E+ + S++ +G+ G +++ ++ +A K++ E I ++ + +
Sbjct: 22 TQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIR 80
Query: 339 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 398
E+ ++ + +V F GA + I E M GGS+ L K G L KV+I
Sbjct: 81 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSIA 139
Query: 399 VSKGMNYLHQN-NIIHRDLKAANLLMDEN-EVSLLLSLCLFTVS 440
V KG+ YL + I+HRD+K +N+L++ E+ LC F VS
Sbjct: 140 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEI----KLCDFGVS 179
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 3e-26
Identities = 37/139 (26%), Positives = 64/139 (46%), Gaps = 7/139 (5%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ G+ +++RG + AIKV + + +E +++K+ HKN+V
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHKNIV 70
Query: 353 QFIGA--CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP--SLLKVAIDVSKGMNYLHQ 408
+ T ++ EF GS+Y L + + LP L V DV GMN+L +
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 409 NNIIHRDLKAANLLMDENE 427
N I+HR++K N++ E
Sbjct: 131 NGIVHRNIKPGNIMRVIGE 149
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-26
Identities = 28/176 (15%), Positives = 68/176 (38%), Gaps = 13/176 (7%)
Query: 257 RSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRG--TYC 314
+S P + + + I K+ G + ++YR
Sbjct: 4 QSQGMQGPPVPQFQPQKALRPDMGYNTLANFRI-------EKKIGRGQFSEVYRAACLLD 56
Query: 315 SQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG 373
VA+K ++ + + +E+ +++++ H NV+++ + + L IV E
Sbjct: 57 GVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADA 116
Query: 374 GSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
G + + K + ++ K + + + ++H ++HRD+K AN+ +
Sbjct: 117 GDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITAT 172
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-26
Identities = 31/130 (23%), Positives = 68/130 (52%), Gaps = 6/130 (4%)
Query: 299 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
K+ G+ G +Y + Q+VAI+ + + ++ E+ +MR+ ++ N+V ++
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
+ L +V E+++GGS+ D + + + V + + + +LH N +IHRD+
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDI 142
Query: 417 KAANLLMDEN 426
K+ N+L+ +
Sbjct: 143 KSDNILLGMD 152
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 27/180 (15%), Positives = 67/180 (37%), Gaps = 5/180 (2%)
Query: 252 GWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRG 311
G ++ + D+ K + + + + ++ SG +++
Sbjct: 16 GMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQV 75
Query: 312 TYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN--VVQFIGACTKPPSLCIVT 368
Q AIK + E ++ + E+ + K++ + +++ + +V
Sbjct: 76 LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135
Query: 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428
E + +L K K ++ + ++ +HQ+ I+H DLK AN L+ + +
Sbjct: 136 EC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGML 193
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 8e-26
Identities = 37/160 (23%), Positives = 80/160 (50%), Gaps = 6/160 (3%)
Query: 273 HPYHLKIPNDGTDVWEIDPKHLK---FGSKVASGSYGD--LYRGTYCSQDVAIKVLKPER 327
H +H + + ++ K+ GS+G L + T + IK + R
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR 61
Query: 328 INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV- 386
++S ++E +EV ++ ++H N+VQ+ + + SL IV ++ GG ++ ++ KGV
Sbjct: 62 MSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVL 121
Query: 387 FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
F+ +L + + + ++H I+HRD+K+ N+ + ++
Sbjct: 122 FQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD 161
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-26
Identities = 33/130 (25%), Positives = 61/130 (46%), Gaps = 6/130 (4%)
Query: 299 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
K+ GS G + + VA+K++ ++ EV IMR +H NVV+
Sbjct: 52 KIGEGSTGIVCLAREKHSGRQVAVKMMDLR--KQQRRELLFNEVVIMRDYQHFNVVEMYK 109
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
+ L ++ EF+ GG++ D + + + V V + + YLH +IHRD+
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIVS--QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDI 167
Query: 417 KAANLLMDEN 426
K+ ++L+ +
Sbjct: 168 KSDSILLTLD 177
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 40/160 (25%), Positives = 73/160 (45%), Gaps = 12/160 (7%)
Query: 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEV-FIMR 344
E+ L+ ++ G+YG + + + Q +A+K ++ +NS QK ++ MR
Sbjct: 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT-VNSQEQKRLLMDLDISMR 61
Query: 345 KVRHKNVVQFIGACTKPPSLCIVTEFMSGG--SVYDYLHKLKGVFKLPSLLKVAIDVSKG 402
V V F GA + + I E M Y + L K+A+ + K
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121
Query: 403 MNYLHQN-NIIHRDLKAANLLMDEN-EVSLLLSLCLFTVS 440
+ +LH ++IHRD+K +N+L++ +V +C F +S
Sbjct: 122 LEHLHSKLSVIHRDVKPSNVLINALGQV----KMCDFGIS 157
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 27/135 (20%), Positives = 51/135 (37%), Gaps = 4/135 (2%)
Query: 295 KFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNV 351
+ S++ GSYG++++ + A+K + EV KV +H
Sbjct: 60 QRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCC 119
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
V+ A + L + TE G S+ + + D + +LH +
Sbjct: 120 VRLEQAWEEGGILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGL 178
Query: 412 IHRDLKAANLLMDEN 426
+H D+K AN+ +
Sbjct: 179 VHLDVKPANIFLGPR 193
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 24/143 (16%), Positives = 58/143 (40%), Gaps = 5/143 (3%)
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR 347
+ + ++ SG +++ Q AIK + E ++ + E+ + K++
Sbjct: 25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 84
Query: 348 HKN--VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 405
+ +++ + +V E + +L K K ++ + ++
Sbjct: 85 QHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHT 142
Query: 406 LHQNNIIHRDLKAANLLMDENEV 428
+HQ+ I+H DLK AN L+ + +
Sbjct: 143 IHQHGIVHSDLKPANFLIVDGML 165
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 24/137 (17%), Positives = 56/137 (40%), Gaps = 5/137 (3%)
Query: 295 KFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN--V 351
++ SG +++ Q AIK + E ++ + E+ + K++ + +
Sbjct: 12 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 71
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
++ + +V E + +L K K ++ + ++ +HQ+ I
Sbjct: 72 IRLYDYEITDQYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGI 129
Query: 412 IHRDLKAANLLMDENEV 428
+H DLK AN L+ + +
Sbjct: 130 VHSDLKPANFLIVDGML 146
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 9e-25
Identities = 33/159 (20%), Positives = 74/159 (46%), Gaps = 11/159 (6%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEV-FIM 343
++ + L+ ++ SG+ G +++ + +A+K ++ N + K ++ ++
Sbjct: 20 YQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS-GNKEENKRILMDLDVVL 78
Query: 344 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 403
+ +VQ G + I E M + +++G L K+ + + K +
Sbjct: 79 KSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKK-RMQGPIPERILGKMTVAIVKAL 137
Query: 404 NYLH-QNNIIHRDLKAANLLMDEN-EVSLLLSLCLFTVS 440
YL ++ +IHRD+K +N+L+DE ++ LC F +S
Sbjct: 138 YYLKEKHGVIHRDVKPSNILLDERGQI----KLCDFGIS 172
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 31/147 (21%), Positives = 64/147 (43%), Gaps = 18/147 (12%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ + + G++G + + + AIK ++ + EV ++ + H+ VV
Sbjct: 9 EEIAVLGQGAFGQVVKARNALDSRYYAIKKIR---HTEEKLSTILSEVMLLASLNHQYVV 65
Query: 353 QFIGA-------------CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 399
++ A K +L I E+ G++YD +H + ++ +
Sbjct: 66 RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI 125
Query: 400 SKGMNYLHQNNIIHRDLKAANLLMDEN 426
+ ++Y+H IIHRDLK N+ +DE+
Sbjct: 126 LEALSYIHSQGIIHRDLKPMNIFIDES 152
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 44/135 (32%), Positives = 72/135 (53%), Gaps = 8/135 (5%)
Query: 299 KVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 357
+ G +G +Y+G VA+K LK ER + +F EV ++ H+N+++ G
Sbjct: 37 ILGRGGFGKVYKGRLADGTLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGF 95
Query: 358 CTKPPSLCIVTEFMSGGSVYDYLH-KLKGVFKL--PSLLKVAIDVSKGMNYLHQN---NI 411
C P +V +M+ GSV L + + L P ++A+ ++G+ YLH + I
Sbjct: 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKI 155
Query: 412 IHRDLKAANLLMDEN 426
IHRD+KAAN+L+DE
Sbjct: 156 IHRDVKAANILLDEE 170
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 6e-24
Identities = 36/143 (25%), Positives = 65/143 (45%), Gaps = 11/143 (7%)
Query: 295 KFGSKVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ ++ +G +G + R + VAIK + E + ++ + E+ IM+K+ H NVV
Sbjct: 17 EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRER-WCLEIQIMKKLNHPNVV 75
Query: 353 QFI------GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP--SLLKVAIDVSKGMN 404
+ E+ GG + YL++ + L + + D+S +
Sbjct: 76 SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 135
Query: 405 YLHQNNIIHRDLKAANLLMDENE 427
YLH+N IIHRDLK N+++
Sbjct: 136 YLHENRIIHRDLKPENIVLQPGP 158
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-23
Identities = 33/160 (20%), Positives = 69/160 (43%), Gaps = 28/160 (17%)
Query: 289 IDPKHLK---FGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIM 343
+D + + SG +G +++ + + IK +K ++ +EV +
Sbjct: 5 VDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKAL 58
Query: 344 RKVRHKNVVQFIGA----------------CTKPPSLCIVTEFMSGGSVYDYLHKLKGV- 386
K+ H N+V + G +K L I EF G++ ++ K +G
Sbjct: 59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 387 FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
L++ ++KG++Y+H +I+RDLK +N+ + +
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT 158
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 3e-23
Identities = 37/179 (20%), Positives = 68/179 (37%), Gaps = 9/179 (5%)
Query: 254 PSHRSSSPTSEPEDTGMKSH---PYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYR 310
P+ P + P +IP D + G + G + +
Sbjct: 2 PAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSR--RRYVRGRFLGKGGFAKCFE 59
Query: 311 GT--YCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367
+ + A K++ + +++ + E+ I R + H++VV F G + +V
Sbjct: 60 ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119
Query: 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
E S+ + K + P + G YLH+N +IHRDLK NL ++E+
Sbjct: 120 LELCRRRSLLELH-KRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED 177
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 4e-23
Identities = 33/144 (22%), Positives = 63/144 (43%), Gaps = 7/144 (4%)
Query: 289 IDPKHLK---FGSKVASGSYGDLYRGT--YCSQDVAIKVLKPERI-NSDMQKEFAQEVFI 342
+DP+ + G + G + + + + A K++ + +++ + E+ I
Sbjct: 9 VDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISI 68
Query: 343 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 402
R + H++VV F G + +V E S+ + K + P + G
Sbjct: 69 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH-KRRKALTEPEARYYLRQIVLG 127
Query: 403 MNYLHQNNIIHRDLKAANLLMDEN 426
YLH+N +IHRDLK NL ++E+
Sbjct: 128 CQYLHRNRVIHRDLKLGNLFLNED 151
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 5e-23
Identities = 34/127 (26%), Positives = 56/127 (44%), Gaps = 3/127 (2%)
Query: 303 GSYGDLYRGTYCS--QDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359
GS+ +YR +VAIK++ K + M + EV I +++H ++++
Sbjct: 22 GSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE 81
Query: 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419
+ +V E G + YL F + GM YLH + I+HRDL +
Sbjct: 82 DSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLS 141
Query: 420 NLLMDEN 426
NLL+ N
Sbjct: 142 NLLLTRN 148
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 3e-22
Identities = 39/171 (22%), Positives = 72/171 (42%), Gaps = 20/171 (11%)
Query: 259 SSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGD-LYRGTYCSQD 317
SSP+ E +D ++ T V + + G+ G +YRG + ++D
Sbjct: 3 SSPSLEQDD------------GDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRD 50
Query: 318 VAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376
VA+K RI + +EV ++R+ H NV+++ I E ++
Sbjct: 51 VAVK-----RILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATL 104
Query: 377 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 427
+Y+ + + + + G+ +LH NI+HRDLK N+L+
Sbjct: 105 QEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPN 155
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 3e-21
Identities = 23/141 (16%), Positives = 58/141 (41%), Gaps = 17/141 (12%)
Query: 302 SGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC- 358
G +G + + AIK ++ +++ +EV + K+ H +V++ A
Sbjct: 15 RGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWL 73
Query: 359 -----------TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS--LLKVAIDVSKGMNY 405
+ L I + ++ D+++ + + L + + +++ + +
Sbjct: 74 EKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEF 133
Query: 406 LHQNNIIHRDLKAANLLMDEN 426
LH ++HRDLK +N+ +
Sbjct: 134 LHSKGLMHRDLKPSNIFFTMD 154
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 3e-21
Identities = 42/184 (22%), Positives = 77/184 (41%), Gaps = 27/184 (14%)
Query: 259 SSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLY--RGTYCSQ 316
+ P S +G + G V E+ L+ +A G + +Y + +
Sbjct: 2 AGPGSLGGASGRDQSDF------VGQTV-ELGELRLRVRRVLAEGGFAFVYEAQDVGSGR 54
Query: 317 DVAIK-VLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPS--------LCI 366
+ A+K +L + + QEV M+K+ H N+VQF A + +
Sbjct: 55 EYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLL 111
Query: 367 VTEFMSGGSVYDYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLL 422
+TE G + ++L + +G ++LK+ + + ++H+ IIHRDLK NLL
Sbjct: 112 LTEL-CKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLL 170
Query: 423 MDEN 426
+
Sbjct: 171 LSNQ 174
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-21
Identities = 32/127 (25%), Positives = 60/127 (47%), Gaps = 4/127 (3%)
Query: 303 GSYGDLY--RGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359
G +G++Y R +A+KVL ++ ++ + +E+ I +RH N+++
Sbjct: 25 GKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH 84
Query: 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419
+ ++ EF G +Y L K G F +++ ++Y H+ +IHRD+K
Sbjct: 85 DRKRIYLMLEFAPRGELYKELQK-HGRFDEQRSATFMEELADALHYCHERKVIHRDIKPE 143
Query: 420 NLLMDEN 426
NLLM
Sbjct: 144 NLLMGYK 150
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 4e-21
Identities = 26/155 (16%), Positives = 58/155 (37%), Gaps = 23/155 (14%)
Query: 295 KFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERI---------------NSDMQKEFAQE 339
+ + G + + ++ A+K + + +F E
Sbjct: 34 RIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNE 93
Query: 340 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-------KGVFKLPSL 392
+ I+ ++++ + G T + I+ E+M S+ + + +
Sbjct: 94 LQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVI 153
Query: 393 LKVAIDVSKGMNYLH-QNNIIHRDLKAANLLMDEN 426
+ V +Y+H + NI HRD+K +N+LMD+N
Sbjct: 154 KCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN 188
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 93.5 bits (232), Expect = 5e-21
Identities = 41/226 (18%), Positives = 82/226 (36%), Gaps = 37/226 (16%)
Query: 235 EQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHL 294
++L L L P SS P + + + +K + +++ K +
Sbjct: 24 DKLIFKL------LSGLSKPV--SSYPNTFEWQCKLPA----IKPKTE----FQLGSKLV 67
Query: 295 KFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR 347
+ G++ +Y T Q +KV KP + Q + ++
Sbjct: 68 YVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW-EFYIGT-QLMERLKPSM 125
Query: 348 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK----GVFKLPSLLKVAIDVSKGM 403
++F A +V E S G++ + ++ K V ++ A+ + +
Sbjct: 126 QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMI 185
Query: 404 NYLHQNNIIHRDLKAANLLM--------DENEVSLLLSLCLFTVSI 441
+H IIH D+K N ++ DE+++S L+L SI
Sbjct: 186 EQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 1e-20
Identities = 32/127 (25%), Positives = 61/127 (48%), Gaps = 4/127 (3%)
Query: 303 GSYGDLY--RGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359
G +G++Y R +A+KVL ++ + ++ + +EV I +RH N+++ G
Sbjct: 20 GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 79
Query: 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419
+ ++ E+ G+VY L K F +++ ++Y H +IHRD+K
Sbjct: 80 DATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE 138
Query: 420 NLLMDEN 426
NLL+
Sbjct: 139 NLLLGSA 145
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 38/126 (30%), Positives = 65/126 (51%), Gaps = 3/126 (2%)
Query: 303 GSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 360
G++ + + ++VAIK++ ++N ++ +EV IM+ + H N+V+
Sbjct: 26 GNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET 85
Query: 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 420
+L ++ E+ SGG V+DYL G K + + Y HQ I+HRDLKA N
Sbjct: 86 EKTLYLIMEYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAEN 144
Query: 421 LLMDEN 426
LL+D +
Sbjct: 145 LLLDAD 150
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-20
Identities = 38/154 (24%), Positives = 74/154 (48%), Gaps = 3/154 (1%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 349
+ + GS+G++ + Q+ A+KV+ + +EV +++K+ H
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 409
N+++ S IV E +GG ++D + K + F ++ V G+ Y+H++
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 410 NIIHRDLKAANLLMDENEVSLLLSLCLFTVSILF 443
NI+HRDLK N+L++ E + + F +S F
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 3e-20
Identities = 40/155 (25%), Positives = 62/155 (40%), Gaps = 15/155 (9%)
Query: 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-------VAIKVLKPERINSDMQKEF 336
WE LK G + G++G + D VA+K+LK E +
Sbjct: 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRAL 72
Query: 337 AQEVFIMRKV-RHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK 394
E+ I+ + H NVV +GACTKP L ++ EF G++ YL + F
Sbjct: 73 MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKG 132
Query: 395 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVS 429
+G +Y+ I DLK + ++ S
Sbjct: 133 A--RFRQGKDYV---GAIPVDLKRRLDSITSSQSS 162
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 6e-07
Identities = 18/48 (37%), Positives = 24/48 (50%)
Query: 381 HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428
K L L+ + V+KGM +L IHRDL A N+L+ E V
Sbjct: 184 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV 231
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 5e-20
Identities = 38/154 (24%), Positives = 74/154 (48%), Gaps = 3/154 (1%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 349
+ + GS+G++ + Q+ A+KV+ + +EV +++K+ H
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 409
N+++ S IV E +GG ++D + K + F ++ V G+ Y+H++
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 410 NIIHRDLKAANLLMDENEVSLLLSLCLFTVSILF 443
NI+HRDLK N+L++ E + + F +S F
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 6e-20
Identities = 38/154 (24%), Positives = 77/154 (50%), Gaps = 3/154 (1%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 349
+ + K+ SG+YG++ + AIK+++ +++ + +EV +++ + H
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 409
N+++ + +V E GG ++D + + F + V G+ YLH++
Sbjct: 97 NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH-RMKFNEVDAAVIIKQVLSGVTYLHKH 155
Query: 410 NIIHRDLKAANLLMDENEVSLLLSLCLFTVSILF 443
NI+HRDLK NLL++ E L+ + F +S +F
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 7e-20
Identities = 27/141 (19%), Positives = 61/141 (43%), Gaps = 6/141 (4%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 349
F K+ SG++GD++ S + IK + +R M++ E+ +++ + H
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQ-IEAEIEVLKSLDHP 80
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---HKLKGVFKLPSLLKVAIDVSKGMNYL 406
N+++ ++ IV E GG + + + + ++ + + Y
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 407 HQNNIIHRDLKAANLLMDENE 427
H +++H+DLK N+L +
Sbjct: 141 HSQHVVHKDLKPENILFQDTS 161
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 7e-20
Identities = 36/127 (28%), Positives = 62/127 (48%), Gaps = 4/127 (3%)
Query: 302 SGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359
G+YG++ + VA+K++ +R D + +E+ I + + H+NVV+F G
Sbjct: 17 EGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRR 75
Query: 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419
+ + E+ SGG ++D + P + + G+ YLH I HRD+K
Sbjct: 76 EGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPE 134
Query: 420 NLLMDEN 426
NLL+DE
Sbjct: 135 NLLLDER 141
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 7e-20
Identities = 31/137 (22%), Positives = 60/137 (43%), Gaps = 12/137 (8%)
Query: 302 SGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA-- 357
+GSYG R + + K L + ++ EV ++R+++H N+V++
Sbjct: 16 TGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII 75
Query: 358 CTKPPSLCIVTEFMSGGSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQ-----N 409
+L IV E+ GG + + K +L+V ++ + H+ +
Sbjct: 76 DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGH 135
Query: 410 NIIHRDLKAANLLMDEN 426
++HRDLK AN+ +D
Sbjct: 136 TVLHRDLKPANVFLDGK 152
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 7e-20
Identities = 28/151 (18%), Positives = 71/151 (47%), Gaps = 3/151 (1%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
++ G++ + R + + + A K++ +++++ ++ +E I RK++H N+V
Sbjct: 9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
+ + + +V + ++GG +++ + + + + + + Y H N I+
Sbjct: 69 RLHDSIQEESFHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIV 127
Query: 413 HRDLKAANLLMDENEVSLLLSLCLFTVSILF 443
HR+LK NLL+ + L F ++I
Sbjct: 128 HRNLKPENLLLASKAKGAAVKLADFGLAIEV 158
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 1e-19
Identities = 33/127 (25%), Positives = 71/127 (55%), Gaps = 4/127 (3%)
Query: 303 GSYGDLYRGTYCS--QDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIGACT 359
G++G + G + VA+K+L ++I S D+ + +E+ ++ RH ++++ +
Sbjct: 22 GTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS 81
Query: 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419
P +V E++SGG ++DY+ K G + ++ + ++Y H++ ++HRDLK
Sbjct: 82 TPTDFFMVMEYVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPE 140
Query: 420 NLLMDEN 426
N+L+D +
Sbjct: 141 NVLLDAH 147
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 36/127 (28%), Positives = 62/127 (48%), Gaps = 4/127 (3%)
Query: 302 SGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359
G+YG++ + VA+K++ +R D + +E+ I + + H+NVV+F G
Sbjct: 17 EGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRR 75
Query: 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419
+ + E+ SGG ++D + P + + G+ YLH I HRD+K
Sbjct: 76 EGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPE 134
Query: 420 NLLMDEN 426
NLL+DE
Sbjct: 135 NLLLDER 141
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 4e-19
Identities = 36/155 (23%), Positives = 72/155 (46%), Gaps = 4/155 (2%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRH 348
K + GS+G++ Q+ A+KV+ K + ++ +EV +++++ H
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 349 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
N+++ +V E +GG ++D + + F ++ V G+ Y+H+
Sbjct: 86 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHK 144
Query: 409 NNIIHRDLKAANLLMDENEVSLLLSLCLFTVSILF 443
N I+HRDLK NLL++ + + F +S F
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 5e-19
Identities = 25/158 (15%), Positives = 73/158 (46%), Gaps = 3/158 (1%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ ++ G++ + R Q+ A ++ +++++ ++ +E I R ++H N+V
Sbjct: 14 QLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIV 73
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
+ + ++ ++ + ++GG +++ + + + + + + + HQ ++
Sbjct: 74 RLHDSISEEGHHYLIFDLVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQMGVV 132
Query: 413 HRDLKAANLLMDENEVSLLLSLCLFTVSILFCGKGREL 450
HR+LK NLL+ + L F ++I G+ +
Sbjct: 133 HRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW 170
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 5e-19
Identities = 35/154 (22%), Positives = 66/154 (42%), Gaps = 5/154 (3%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 349
++ + + GS+G++ A K + + F QE+ IM+ + H
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHP 66
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 409
N+++ + +V E +GG +++ + K VF+ ++ DV + Y H+
Sbjct: 67 NIIRLYETFEDNTDIYLVMELCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKL 125
Query: 410 NIIHRDLKAANLLMDENEVSLLLSLCLFTVSILF 443
N+ HRDLK N L + L L F ++ F
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 9e-19
Identities = 35/182 (19%), Positives = 79/182 (43%), Gaps = 12/182 (6%)
Query: 254 PSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 313
+ + E+ +S ++P+ E + + G + R +
Sbjct: 58 AKKLNDAQPKGTENLYFQSMGPEDELPDWAAAK-EFY-QKYDPKDVIGRGVSSVVRRCVH 115
Query: 314 CS--QDVAIKVLK------PERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSL 364
+ + A+K+++ ++++ +E I+R+V H +++ I + +
Sbjct: 116 RATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFM 175
Query: 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD 424
+V + M G ++DYL + K + + + +++LH NNI+HRDLK N+L+D
Sbjct: 176 FLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLD 234
Query: 425 EN 426
+N
Sbjct: 235 DN 236
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 34/146 (23%), Positives = 61/146 (41%), Gaps = 10/146 (6%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERI------NSDMQKEFAQEVFIMRKV 346
+ SG+ G++ + VAI+++ + +D E+ I++K+
Sbjct: 138 IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL 197
Query: 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 406
H +++ IV E M GG ++D + K + + + YL
Sbjct: 198 NHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYL 255
Query: 407 HQNNIIHRDLKAANLLMDENEVSLLL 432
H+N IIHRDLK N+L+ E L+
Sbjct: 256 HENGIIHRDLKPENVLLSSQEEDCLI 281
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 2e-18
Identities = 34/127 (26%), Positives = 72/127 (56%), Gaps = 4/127 (3%)
Query: 303 GSYGDLYRGTYCS--QDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIGACT 359
G++G + G + VA+K+L ++I S D+ + +E+ ++ RH ++++ +
Sbjct: 27 GTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS 86
Query: 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419
P + +V E++SGG ++DY+ K G ++ + G++Y H++ ++HRDLK
Sbjct: 87 TPSDIFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPE 145
Query: 420 NLLMDEN 426
N+L+D +
Sbjct: 146 NVLLDAH 152
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 28/151 (18%), Positives = 71/151 (47%), Gaps = 3/151 (1%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
++ G++ + R + + + A K++ +++++ ++ +E I RK++H N+V
Sbjct: 32 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 91
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
+ + + +V + ++GG +++ + + + + + + Y H N I+
Sbjct: 92 RLHDSIQEESFHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIV 150
Query: 413 HRDLKAANLLMDENEVSLLLSLCLFTVSILF 443
HR+LK NLL+ + L F ++I
Sbjct: 151 HRNLKPENLLLASKAKGAAVKLADFGLAIEV 181
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-18
Identities = 34/142 (23%), Positives = 64/142 (45%), Gaps = 12/142 (8%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINS--DMQKEFAQEVFIMRKVRHKN 350
G + GSYG + A+K+LK +++ + + +E+ ++R++RHKN
Sbjct: 8 LMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKN 67
Query: 351 VVQF---IGACTKPPSLCIVTEFMSGGS--VYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 405
V+Q + K + +V E+ G + D + + F + + G+ Y
Sbjct: 68 VIQLVDVLYNEEKQ-KMYMVMEYCVCGMQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEY 124
Query: 406 LHQNNIIHRDLKAANLLMDENE 427
LH I+H+D+K NLL+
Sbjct: 125 LHSQGIVHKDIKPGNLLLTTGG 146
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 2e-18
Identities = 39/200 (19%), Positives = 79/200 (39%), Gaps = 12/200 (6%)
Query: 230 PYEETEQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTD-VWE 288
P E T + ++ + R+G+ Y I E
Sbjct: 93 PCEPTAPVLIPGDE---RKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVE 149
Query: 289 IDPKHLK----FGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFI 342
I H+ ++ +G++G ++R T + + A K + + ++ +E+
Sbjct: 150 IKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD--KETVRKEIQT 207
Query: 343 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 402
M +RH +V A + ++ EFMSGG +++ + ++ V KG
Sbjct: 208 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 267
Query: 403 MNYLHQNNIIHRDLKAANLL 422
+ ++H+NN +H DLK N++
Sbjct: 268 LCHMHENNYVHLDLKPENIM 287
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 35/146 (23%), Positives = 61/146 (41%), Gaps = 10/146 (6%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERI------NSDMQKEFAQEVFIMRKV 346
+ SG+ G++ + VAIK++ + +D E+ I++K+
Sbjct: 13 IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72
Query: 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 406
H +++ IV E M GG ++D + K + + + YL
Sbjct: 73 NHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYL 130
Query: 407 HQNNIIHRDLKAANLLMDENEVSLLL 432
H+N IIHRDLK N+L+ E L+
Sbjct: 131 HENGIIHRDLKPENVLLSSQEEDCLI 156
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 3e-18
Identities = 34/142 (23%), Positives = 66/142 (46%), Gaps = 11/142 (7%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINS-------DMQKEFAQEVFIMRK 345
+ + G + R + ++ A+K++ S ++++ +EV I+RK
Sbjct: 20 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 79
Query: 346 V-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 404
V H N++Q +V + M G ++DYL + K K+ + + +
Sbjct: 80 VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVIC 138
Query: 405 YLHQNNIIHRDLKAANLLMDEN 426
LH+ NI+HRDLK N+L+D++
Sbjct: 139 ALHKLNIVHRDLKPENILLDDD 160
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 3e-18
Identities = 31/144 (21%), Positives = 64/144 (44%), Gaps = 14/144 (9%)
Query: 292 KHLKFGSKVASGSYGDL-YRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHK 349
+ + GS G + ++G++ + VA+K R+ D E+ ++ + H
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVK-----RMLIDFCDIALMEIKLLTESDDHP 69
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYL------HKLKGVFKLPSLLKVAIDVSKGM 403
NV+++ + T L I E ++ D + + + K + + + ++ G+
Sbjct: 70 NVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 404 NYLHQNNIIHRDLKAANLLMDENE 427
+LH IIHRDLK N+L+ +
Sbjct: 129 AHLHSLKIIHRDLKPQNILVSTSS 152
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 5e-18
Identities = 38/161 (23%), Positives = 64/161 (39%), Gaps = 32/161 (19%)
Query: 295 KFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERI------------------------ 328
++ GSYG L + A+KVL +++
Sbjct: 16 TLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQ 75
Query: 329 NSDMQKEFAQEVFIMRKVRHKNVVQF---IGACTKPPSLCIVTEFMSGGSVYDYLHKLKG 385
++ QE+ I++K+ H NVV+ + + L +V E ++ G V +
Sbjct: 76 PRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNED-HLYMVFELVNQGPVMEVPTL--K 132
Query: 386 VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
D+ KG+ YLH IIHRD+K +NLL+ E+
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGED 173
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 6e-18
Identities = 36/132 (27%), Positives = 59/132 (44%), Gaps = 6/132 (4%)
Query: 302 SGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359
SG++G + VA+K ++ + + +E+ R +RH N+V+F
Sbjct: 30 SGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSLRHPNIVRFKEVIL 86
Query: 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419
P L I+ E+ SGG +Y+ + G F + G++Y H I HRDLK
Sbjct: 87 TPTHLAIIMEYASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLE 145
Query: 420 NLLMDENEVSLL 431
N L+D + L
Sbjct: 146 NTLLDGSPAPRL 157
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 9e-18
Identities = 30/141 (21%), Positives = 63/141 (44%), Gaps = 10/141 (7%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFA------QEVFIMRKV 346
S + SG++G ++ ++V +K +K E++ D E E+ I+ +V
Sbjct: 27 STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV 86
Query: 347 RHKNVVQFIGACTKPPSLCIVTEF-MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 405
H N+++ + +V E SG ++ ++ + P + + + Y
Sbjct: 87 EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGY 145
Query: 406 LHQNNIIHRDLKAANLLMDEN 426
L +IIHRD+K N+++ E+
Sbjct: 146 LRLKDIIHRDIKDENIVIAED 166
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 9e-18
Identities = 37/165 (22%), Positives = 66/165 (40%), Gaps = 10/165 (6%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSD---MQKEFAQEVFIMRKVRHK 349
+ + G + + R Q A+K++ + S ++ +E I ++H
Sbjct: 27 ELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHP 86
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK----GMNY 405
++V+ + + L +V EFM G + + K + VA + + Y
Sbjct: 87 HIVELLETYSSDGMLYMVFEFMDGADLCFEIVK-RADAGFVYSEAVASHYMRQILEALRY 145
Query: 406 LHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSILFCGKGREL 450
H NNIIHRD+K +L+ E S + L F V+I G
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA 190
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 36/127 (28%), Positives = 68/127 (53%), Gaps = 5/127 (3%)
Query: 303 GSYGDLYRGTYCS--QDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359
GS+G + T+ Q VA+K + + + SDM +E+ ++ +RH ++++ T
Sbjct: 20 GSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT 79
Query: 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419
P + +V E+ +GG ++DY+ + K + + + Y H++ I+HRDLK
Sbjct: 80 TPTDIVMVIEY-AGGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPE 137
Query: 420 NLLMDEN 426
NLL+D+N
Sbjct: 138 NLLLDDN 144
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 41/199 (20%), Positives = 81/199 (40%), Gaps = 11/199 (5%)
Query: 247 KLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYG 306
L + SS T+ P + ++ + + S++ G+
Sbjct: 12 DLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDAL----SDFFEVESELGRGATS 67
Query: 307 DLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364
+YR + A+KVLK ++ E+ ++ ++ H N+++ P +
Sbjct: 68 IVYRCKQKGTQKPYALKVLKKTVDKKIVR----TEIGVLLRLSHPNIIKLKEIFETPTEI 123
Query: 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD 424
+V E ++GG ++D + + KG + + + + YLH+N I+HRDLK NLL
Sbjct: 124 SLVLELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYA 182
Query: 425 ENEVSLLLSLCLFTVSILF 443
L + F +S +
Sbjct: 183 TPAPDAPLKIADFGLSKIV 201
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 2e-17
Identities = 34/136 (25%), Positives = 63/136 (46%), Gaps = 7/136 (5%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNV 351
F + SG++ +++ + A+K + K E+ +++K++H+N+
Sbjct: 12 IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSS---LENEIAVLKKIKHENI 68
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
V +V + +SGG ++D + + +GV+ V V + YLH+N I
Sbjct: 69 VTLEDIYESTTHYYLVMQLVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHENGI 127
Query: 412 IHRDLKAANLLMDENE 427
+HRDLK NLL E
Sbjct: 128 VHRDLKPENLLYLTPE 143
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 26/139 (18%), Positives = 61/139 (43%), Gaps = 5/139 (3%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ G +G ++R S + K +K + + + K +E+ I+ RH+N++
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHRNIL 64
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
+ L ++ EF+SG +++ ++ ++ V + + +LH +NI
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124
Query: 413 HRDLKAANLLMDENEVSLL 431
H D++ N++ S +
Sbjct: 125 HFDIRPENIIYQTRRSSTI 143
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 4e-17
Identities = 33/135 (24%), Positives = 67/135 (49%), Gaps = 7/135 (5%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQ----KEFAQEVFIMRKVRH 348
+ G ++ SG + + + ++ A K +K R++S + +E +EV I+R++RH
Sbjct: 8 EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67
Query: 349 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
N++ + ++ E +SGG ++D+L + K + + G++YLH
Sbjct: 68 PNIITLHDIFENKTDVVLILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHS 126
Query: 409 NNIIHRDLKAANLLM 423
I H DLK N+++
Sbjct: 127 KRIAHFDLKPENIML 141
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 38/182 (20%), Positives = 71/182 (39%), Gaps = 10/182 (5%)
Query: 255 SHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC 314
H S P + M E + G + SG +G +Y G
Sbjct: 6 HHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRV 65
Query: 315 S--QDVAIKVLKPERINS----DMQKEFAQEVFIMRKVRHK--NVVQFIGACTKPPSLCI 366
S VAIK ++ +RI+ EV +++KV V++ + +P S +
Sbjct: 66 SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL 125
Query: 367 VTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE 425
+ E ++D++ + +G + V + + + H ++HRD+K N+L+D
Sbjct: 126 ILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL 184
Query: 426 NE 427
N
Sbjct: 185 NR 186
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 5e-17
Identities = 24/139 (17%), Positives = 62/139 (44%), Gaps = 4/139 (2%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
++ SG++G ++R + + K + + E+ IM ++ H ++
Sbjct: 54 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--KYTVKNEISIMNQLHHPKLI 111
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
A + ++ EF+SGG ++D + ++ +G+ ++H+++I+
Sbjct: 112 NLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIV 171
Query: 413 HRDLKAANLLMDENEVSLL 431
H D+K N++ + + S +
Sbjct: 172 HLDIKPENIMCETKKASSV 190
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 7e-17
Identities = 37/165 (22%), Positives = 74/165 (44%), Gaps = 14/165 (8%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLK-----------PERINSDMQKEFAQ 338
+ K+ SG+YG++ + + AIKV+K + +E
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 339 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 398
E+ +++ + H N+++ +VTEF GG +++ + + F +
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQ 154
Query: 399 VSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSILF 443
+ G+ YLH++NI+HRD+K N+L++ L + + F +S F
Sbjct: 155 ILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF 199
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 7e-17
Identities = 34/181 (18%), Positives = 57/181 (31%), Gaps = 44/181 (24%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVL---KPERINSDMQKEFAQEVFIMRKVRHK 349
+ GSYG + AIK++ K +IN + EV +M+K+ H
Sbjct: 29 HLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHP 88
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLL---------------- 393
N+ + +C+V E GG + D L+ +
Sbjct: 89 NIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148
Query: 394 -----------------------KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSL 430
+ + ++YLH I HRD+K N L N+
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFE 208
Query: 431 L 431
+
Sbjct: 209 I 209
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 8e-17
Identities = 34/139 (24%), Positives = 63/139 (45%), Gaps = 7/139 (5%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQ----KEFAQEVFIMRKVRH 348
G ++ SG + + + S + A K +K + + + +E +EV I+R+V H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74
Query: 349 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
NV+ + ++ E +SGG ++D+L + K + G+NYLH
Sbjct: 75 HNVITLHDVYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHT 133
Query: 409 NNIIHRDLKAANLLMDENE 427
I H DLK N+++ +
Sbjct: 134 KKIAHFDLKPENIMLLDKN 152
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 9e-17
Identities = 30/130 (23%), Positives = 59/130 (45%), Gaps = 4/130 (3%)
Query: 302 SGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH-KNVVQFIGAC 358
G + + + S Q+ A K LK R D + E E+ ++ + V+
Sbjct: 39 RGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98
Query: 359 TKPPSLCIVTEFMSGGSVYDYL-HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 417
+ ++ E+ +GG ++ +L + ++++ + +G+ YLHQNNI+H DLK
Sbjct: 99 ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLK 158
Query: 418 AANLLMDENE 427
N+L+
Sbjct: 159 PQNILLSSIY 168
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 33/135 (24%), Positives = 60/135 (44%), Gaps = 7/135 (5%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLK----PERINSDMQKEFAQEVFIMRKVRH 348
G ++ SG + + + S + A K +K ++E +EV I+R+V H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74
Query: 349 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
N++ + ++ E +SGG ++D+L + K + G+NYLH
Sbjct: 75 PNIITLHDVYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHT 133
Query: 409 NNIIHRDLKAANLLM 423
I H DLK N+++
Sbjct: 134 KKIAHFDLKPENIML 148
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 37/145 (25%), Positives = 66/145 (45%), Gaps = 30/145 (20%)
Query: 299 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQ--------EVFIMRKVRH 348
+ G + +Y+ +Q VAIK +I + E E+ +++++ H
Sbjct: 17 FLGEGQFATVYKARDKNTNQIVAIK-----KIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 349 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS-------K 401
N++ + A ++ +V +FM L+ + K SL+ + +
Sbjct: 72 PNIIGLLDAFGHKSNISLVFDFME--------TDLEVIIKDNSLVLTPSHIKAYMLMTLQ 123
Query: 402 GMNYLHQNNIIHRDLKAANLLMDEN 426
G+ YLHQ+ I+HRDLK NLL+DEN
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDEN 148
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 3e-16
Identities = 31/134 (23%), Positives = 60/134 (44%), Gaps = 7/134 (5%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQK----EFAQEVFIMRKVRH 348
G ++ SG + + + S A K +K R S + + +EV I+++++H
Sbjct: 14 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 73
Query: 349 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
NV+ + ++ E ++GG ++D+L + K + + G+ YLH
Sbjct: 74 PNVITLHEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHS 132
Query: 409 NNIIHRDLKAANLL 422
I H DLK N++
Sbjct: 133 LQIAHFDLKPENIM 146
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 32/179 (17%), Positives = 71/179 (39%), Gaps = 12/179 (6%)
Query: 254 PSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSK--------VASGSY 305
S+ + + + + P D + K S + G +
Sbjct: 43 WSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRF 102
Query: 306 GDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363
G +++ + +A K++K + ++E E+ +M ++ H N++Q A
Sbjct: 103 GQVHKCEETATGLKLAAKIIKTRGMKD--KEEVKNEISVMNQLDHANLIQLYDAFESKND 160
Query: 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 422
+ +V E++ GG ++D + + + +G+ ++HQ I+H DLK N+L
Sbjct: 161 IVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENIL 219
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 31/152 (20%), Positives = 65/152 (42%), Gaps = 9/152 (5%)
Query: 302 SGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGAC 358
GS+ + + Q A+K+ I+ M+ +E+ ++ H N+V+
Sbjct: 21 EGSFSICRKCVHKKSNQAFAVKI-----ISKRMEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 359 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 418
+V E ++GG +++ + K K F + + ++++H ++HRDLK
Sbjct: 76 HDQLHTFLVMELLNGGELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKP 134
Query: 419 ANLLMDENEVSLLLSLCLFTVSILFCGKGREL 450
NLL + +L + + F + L + L
Sbjct: 135 ENLLFTDENDNLEIKIIDFGFARLKPPDNQPL 166
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 6e-16
Identities = 38/136 (27%), Positives = 68/136 (50%), Gaps = 11/136 (8%)
Query: 302 SGSYGDLYRGTYCS--QDVAIKVL--KPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIG 356
G++ + Q+ A+K++ +P I S + +EV ++ + + H+NV++ I
Sbjct: 23 EGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF----REVEMLYQCQGHRNVLELIE 78
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
+ +V E M GGS+ ++HK + F V DV+ +++LH I HRDL
Sbjct: 79 FFEEEDRFYLVFEKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHNKGIAHRDL 137
Query: 417 KAANLLM-DENEVSLL 431
K N+L N+VS +
Sbjct: 138 KPENILCEHPNQVSPV 153
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 8e-16
Identities = 39/146 (26%), Positives = 74/146 (50%), Gaps = 27/146 (18%)
Query: 299 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKE-F----AQEVFIMRKVRHKNV 351
K+ G++G++++ Q VA+K ++ + +KE F +E+ I++ ++H+NV
Sbjct: 24 KIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREIKILQLLKHENV 78
Query: 352 VQFIGACT--------KPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLKVAIDVS 400
V I C S+ +V +F +D L + F L + +V +
Sbjct: 79 VNLIEICRTKASPYNRCKGSIYLVFDFCE----HDLAGLLSNVLVKFTLSEIKRVMQMLL 134
Query: 401 KGMNYLHQNNIIHRDLKAANLLMDEN 426
G+ Y+H+N I+HRD+KAAN+L+ +
Sbjct: 135 NGLYYIHRNKILHRDMKAANVLITRD 160
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 21/224 (9%), Positives = 62/224 (27%), Gaps = 38/224 (16%)
Query: 237 LRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKF 296
+R L++E + + + + E + + + + + LK
Sbjct: 11 MRDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQ----GERKLKL 66
Query: 297 GSKVASGSYGDLYRGTYCS--QDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQ 353
+ G ++ +D A+KV + + + F ++ ++ +
Sbjct: 67 VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEE 126
Query: 354 FIGAC--------------------------TKPPSLCIVTEFMSG-----GSVYDYLHK 382
+ ++ S S D+++
Sbjct: 127 ARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYV 186
Query: 383 LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
+G + +L + + + L ++H NL + +
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPD 230
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 1e-15
Identities = 31/137 (22%), Positives = 61/137 (44%), Gaps = 18/137 (13%)
Query: 299 KVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFA-----QEVFIMRKVRHKNVV 352
K+ G+YG +Y+ + A+K +I + + E +E+ I+++++H N+V
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALK-----KIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 409
+ L +V E + D L +G + + + + G+ Y H
Sbjct: 64 KLYDVIHTKKRLVLVFEHLD----QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 410 NIIHRDLKAANLLMDEN 426
++HRDLK NLL++
Sbjct: 120 RVLHRDLKPQNLLINRE 136
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 35/160 (21%), Positives = 71/160 (44%), Gaps = 11/160 (6%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRK-VRHKNV 351
+ + GSY R + + + A+K++ +++ +E+ I+ + +H N+
Sbjct: 25 EVKEDIGVGSYSVCKRCIHKATNMEFAVKII------DKSKRDPTEEIEILLRYGQHPNI 78
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
+ + +VTE M GG + D + + + F V ++K + YLH +
Sbjct: 79 ITLKDVYDDGKYVYVVTELMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQGV 137
Query: 412 IHRDLKAANLLM-DENEVSLLLSLCLFTVSILFCGKGREL 450
+HRDLK +N+L DE+ + +C F + + L
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL 177
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 34/130 (26%), Positives = 64/130 (49%), Gaps = 3/130 (2%)
Query: 299 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
V GSYG + + + VAIK + ++K +E+ +++++RH+N+V +
Sbjct: 32 LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
C K +V EF+ ++ D L + K + G+ + H +NIIHRD+
Sbjct: 92 VCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDI 150
Query: 417 KAANLLMDEN 426
K N+L+ ++
Sbjct: 151 KPENILVSQS 160
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 2e-15
Identities = 32/139 (23%), Positives = 64/139 (46%), Gaps = 20/139 (14%)
Query: 299 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFA-----QEVFIMRKVRHKNV 351
K+ G+YG +Y+ + VA+K +I D + E +E+ +++++ H N+
Sbjct: 10 KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLK-VAIDVSKGMNYLH 407
V+ + L +V EF+ D ++ L+K + +G+ + H
Sbjct: 65 VKLLDVIHTENKLYLVFEFLH----QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 408 QNNIIHRDLKAANLLMDEN 426
+ ++HRDLK NLL++
Sbjct: 121 SHRVLHRDLKPQNLLINTE 139
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 3e-15
Identities = 33/139 (23%), Positives = 64/139 (46%), Gaps = 22/139 (15%)
Query: 299 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKE------FAQEVFIMRKVRHKN 350
K+ G+Y +Y+G VA+K ++ ++ E +EV +++ ++H N
Sbjct: 9 KLGEGTYATVYKGKSKLTDNLVALKEIR-------LEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 351 VVQFIGACTKPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLKVAIDVSKGMNYLH 407
+V SL +V E++ D YL + + ++ + +G+ Y H
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLD----KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH 117
Query: 408 QNNIIHRDLKAANLLMDEN 426
+ ++HRDLK NLL++E
Sbjct: 118 RQKVLHRDLKPQNLLINER 136
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 3e-15
Identities = 35/138 (25%), Positives = 62/138 (44%), Gaps = 19/138 (13%)
Query: 299 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFA-----QEVFIMRKVRHKNV 351
K+ G+YG +++ + VA+K R+ D E +E+ ++++++HKN+
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALK-----RVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
V+ L +V EF D Y G + + KG+ + H
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 409 NNIIHRDLKAANLLMDEN 426
N++HRDLK NLL++ N
Sbjct: 120 RNVLHRDLKPQNLLINRN 137
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 4e-15
Identities = 38/139 (27%), Positives = 65/139 (46%), Gaps = 22/139 (15%)
Query: 299 KVASGSYGDLYRG---TYCSQDVAIKVLKPERINSDMQKEFA-----QEVFIMRKVRHKN 350
KV G+YG +Y+ + VA+K RI D + E +E+ +++++ H N
Sbjct: 28 KVGEGTYGVVYKAKDSQ--GRIVALK-----RIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 351 VVQFIGACTKPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLKVAIDVSKGMNYLH 407
+V I L +V EFM D L + K + + + +G+ + H
Sbjct: 81 IVSLIDVIHSERCLTLVFEFME----KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 408 QNNIIHRDLKAANLLMDEN 426
Q+ I+HRDLK NLL++ +
Sbjct: 137 QHRILHRDLKPQNLLINSD 155
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 4e-15
Identities = 34/141 (24%), Positives = 70/141 (49%), Gaps = 6/141 (4%)
Query: 299 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
K+ GSYG +++ Q VAIK + ++K +E+ ++++++H N+V +
Sbjct: 10 KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
+ L +V E+ +V L + + + + + +N+ H++N IHRD+
Sbjct: 70 VFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDV 128
Query: 417 KAANLLMDENEVSLLLSLCLF 437
K N+L+ ++ V + LC F
Sbjct: 129 KPENILITKHSV---IKLCDF 146
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 6e-15
Identities = 31/143 (21%), Positives = 57/143 (39%), Gaps = 12/143 (8%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINS----DMQKEFAQEVFIMRKVR- 347
+ G + G +G ++ G + VAIKV+ R+ EV ++ KV
Sbjct: 34 RLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGA 93
Query: 348 ---HKNVVQFIGACTKPPSLCIVTEF-MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 403
H V++ + +V E + ++DY+ + KG V +
Sbjct: 94 GGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAI 152
Query: 404 NYLHQNNIIHRDLKAANLLMDEN 426
+ H ++HRD+K N+L+D
Sbjct: 153 QHCHSRGVVHRDIKDENILIDLR 175
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 7e-15
Identities = 31/147 (21%), Positives = 65/147 (44%), Gaps = 25/147 (17%)
Query: 295 KFGSKVASGSYGDLYRG----TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN 350
G KV G+YG +Y+ +D A+K ++ I+ +E + ++R+++H N
Sbjct: 24 YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACRE----IALLRELKHPN 79
Query: 351 VVQFIGACT--KPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLKVAIDVSK---- 401
V+ + ++ ++ +D + + +++ + K
Sbjct: 80 VISLQKVFLSHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKPVQLPRGMVKSLLY 135
Query: 402 ----GMNYLHQNNIIHRDLKAANLLMD 424
G++YLH N ++HRDLK AN+L+
Sbjct: 136 QILDGIHYLHANWVLHRDLKPANILVM 162
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 5e-14
Identities = 34/147 (23%), Positives = 67/147 (45%), Gaps = 33/147 (22%)
Query: 299 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFA-----QEVFIMRKVRHKNV 351
K+ +G+Y +Y+G + VA+K +K + +E +E+ +M++++H+N+
Sbjct: 12 KLGNGTYATVYKGLNKTTGVYVALKEVKLD------SEEGTPSTAIREISLMKELKHENI 65
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS----------- 400
V+ L +V EFM + LK ++ +
Sbjct: 66 VRLYDVIHTENKLTLVFEFMD--------NDLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117
Query: 401 -KGMNYLHQNNIIHRDLKAANLLMDEN 426
+G+ + H+N I+HRDLK NLL+++
Sbjct: 118 LQGLAFCHENKILHRDLKPQNLLINKR 144
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 9e-14
Identities = 36/191 (18%), Positives = 69/191 (36%), Gaps = 24/191 (12%)
Query: 254 PSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 313
P+ P ++P + P I + + G G + +
Sbjct: 24 PTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFN 83
Query: 314 CS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGAC----TKPPSLCI 366
+ A+K+L D K +EV + + + ++V+ + L I
Sbjct: 84 KRTQEKFALKML------QDCPKAR-REVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136
Query: 367 VTEFMSGGSVYDYLHKLKGVFKLP-----SLLKVAIDVSKGMNYLHQNNIIHRDLKAANL 421
V E + GG ++ + +G ++K + + + YLH NI HRD+K NL
Sbjct: 137 VMECLDGGELFSRIQD-RGDQAFTEREASEIMK---SIGEAIQYLHSINIAHRDVKPENL 192
Query: 422 LM-DENEVSLL 431
L + ++L
Sbjct: 193 LYTSKRPNAIL 203
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 9e-14
Identities = 33/133 (24%), Positives = 61/133 (45%), Gaps = 4/133 (3%)
Query: 297 GSKVASGSYGDLYRG--TYCSQDVAIKVLKPE-RINSDMQKEFAQEVFIMRKVRHKNVVQ 353
K+ G +Y T + VAIK + R + K F +EV ++ H+N+V
Sbjct: 16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 354 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 413
I + +V E++ G ++ +Y+ G + + + + G+ + H I+H
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHDMRIVH 134
Query: 414 RDLKAANLLMDEN 426
RD+K N+L+D N
Sbjct: 135 RDIKPQNILIDSN 147
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 32/142 (22%), Positives = 65/142 (45%), Gaps = 26/142 (18%)
Query: 299 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFA-----QEVFIMRKVRHKNV 351
K+ G+YG++Y+ + VAIK RI + ++E +EV ++++++H+N+
Sbjct: 41 KLGEGTYGEVYKAIDTVTNETVAIK-----RIRLEHEEEGVPGTAIREVSLLKELQHRNI 95
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS------KGMNY 405
++ L ++ E+ + LK + + + S G+N+
Sbjct: 96 IELKSVIHHNHRLHLIFEYAE--------NDLKKYMDKNPDVSMRVIKSFLYQLINGVNF 147
Query: 406 LHQNNIIHRDLKAANLLMDENE 427
H +HRDLK NLL+ ++
Sbjct: 148 CHSRRCLHRDLKPQNLLLSVSD 169
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 1e-13
Identities = 34/150 (22%), Positives = 61/150 (40%), Gaps = 31/150 (20%)
Query: 299 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQ--------EVFIMRKVR- 347
++ G+YG +Y+ + VA+K + EV ++R++
Sbjct: 16 EIGVGAYGTVYKARDPHSGHFVALK-----SVRVPNGGGGGGGLPISTVREVALLRRLEA 70
Query: 348 --HKNVVQFIGACT-----KPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLK-VA 396
H NVV+ + C + + +V E + D YL K +K +
Sbjct: 71 FEHPNVVRLMDVCATSRTDREIKVTLVFEHVD----QDLRTYLDKAPPPGLPAETIKDLM 126
Query: 397 IDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
+G+++LH N I+HRDLK N+L+
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSG 156
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 32/110 (29%), Positives = 57/110 (51%), Gaps = 2/110 (1%)
Query: 319 AIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A K L+ +RI + A E I+ KV + VV A +LC+V M+GG +
Sbjct: 213 ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK 272
Query: 378 DYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
+++ + + F + A ++ G+ LH+ I++RDLK N+L+D++
Sbjct: 273 FHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDH 322
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 39/189 (20%), Positives = 72/189 (38%), Gaps = 36/189 (19%)
Query: 256 HRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS 315
H S E G + Y + TD +++ + L G G G + +
Sbjct: 5 HHHHSSGLEVLFQGPEPKKYAV------TDDYQLSKQVL--GL----GVNGKVLECFHRR 52
Query: 316 --QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGAC----TKPPSLCIVT 368
Q A+K+L + QEV + ++V + L I+
Sbjct: 53 TGQKCALKLL-------YDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIM 105
Query: 369 EFMSGGSVYDYLHKLKGVFKLP-----SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 423
E M GG ++ + + +G +++ D+ + +LH +NI HRD+K NLL
Sbjct: 106 ECMEGGELFSRIQE-RGDQAFTEREAAEIMR---DIGTAIQFLHSHNIAHRDVKPENLLY 161
Query: 424 -DENEVSLL 431
+ + ++L
Sbjct: 162 TSKEKDAVL 170
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 4e-13
Identities = 35/137 (25%), Positives = 62/137 (45%), Gaps = 8/137 (5%)
Query: 297 GSKVASGSYGDLYRG--TYCSQDVAIKVLKPE-RINSDMQKEFAQEVFIMRKVRHKNVVQ 353
G + G +++ +DVA+KVL+ + + F +E + H +V
Sbjct: 17 GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 354 F--IGACTKPPSLC--IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 409
G P IV E++ G ++ D +H +G ++V D + +N+ HQN
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQN 135
Query: 410 NIIHRDLKAANLLMDEN 426
IIHRD+K AN+++
Sbjct: 136 GIIHRDVKPANIMISAT 152
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 5e-13
Identities = 35/127 (27%), Positives = 62/127 (48%), Gaps = 4/127 (3%)
Query: 303 GSYG--DLYRGTYCSQDVAIKVLKPERINSDMQKE-FAQEVFIMRKVRHKNVVQFIGACT 359
GS+G L + A+K+L +++ Q E E I++ V +V+ +
Sbjct: 52 GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419
+L +V E+++GG ++ +L + G F P A + YLH ++I+RDLK
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 420 NLLMDEN 426
NLL+D+
Sbjct: 171 NLLIDQQ 177
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 5e-13
Identities = 28/143 (19%), Positives = 58/143 (40%), Gaps = 12/143 (8%)
Query: 297 GSKVASGSYGDLYRGT---YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 353
+A G G +Y + V +K L +++ Q E + +V H ++VQ
Sbjct: 85 KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 354 FI-----GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
P IV E++ G S+ + + +++ ++YLH
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK---GQKLPVAEAIAYLLEILPALSYLHS 200
Query: 409 NNIIHRDLKAANLLMDENEVSLL 431
+++ DLK N+++ E ++ L+
Sbjct: 201 IGLVYNDLKPENIMLTEEQLKLI 223
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 6e-13
Identities = 32/129 (24%), Positives = 55/129 (42%), Gaps = 8/129 (6%)
Query: 303 GSYGDLY----RGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGA 357
GS+ + T S++ AIK+L+ I + + + E +M ++ H V+
Sbjct: 41 GSFSTVVLARELAT--SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT 98
Query: 358 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 417
L + G + Y+ K G F ++ + YLH IIHRDLK
Sbjct: 99 FQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLK 157
Query: 418 AANLLMDEN 426
N+L++E+
Sbjct: 158 PENILLNED 166
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 6e-13
Identities = 33/112 (29%), Positives = 56/112 (50%), Gaps = 4/112 (3%)
Query: 319 AIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A K L +R+ + A E I+ KV + +V A LC+V M+GG +
Sbjct: 214 ACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIR 273
Query: 378 DYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
+++ + F+ P + + G+ +LHQ NII+RDLK N+L+D++
Sbjct: 274 YHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDD 325
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 33/148 (22%), Positives = 64/148 (43%), Gaps = 29/148 (19%)
Query: 299 KVASGSYGDLYRGTYCSQD---VAIKVLKPERINSDMQKEFA-----QEVFIMRKVR--- 347
++ G+YG +++ VA+K R+ +E +EV ++R +
Sbjct: 18 EIGEGAYGKVFKARDLKNGGRFVALK-----RVRVQTGEEGMPLSTIREVAVLRHLETFE 72
Query: 348 HKNVVQFI-----GACTKPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLK-VAID 398
H NVV+ + L +V E + D YL K+ +K +
Sbjct: 73 HPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 399 VSKGMNYLHQNNIIHRDLKAANLLMDEN 426
+ +G+++LH + ++HRDLK N+L+ +
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSS 156
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 51/202 (25%), Positives = 85/202 (42%), Gaps = 39/202 (19%)
Query: 256 HRSSSPTSEPEDTGMKSHPYHLKIP-NDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC 314
S++P + + + +K+ +DG + + + + +GS+G +++
Sbjct: 4 TMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNC-KVIGNGSFGVVFQAKLV 62
Query: 315 -SQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGACTKPPS-------LC 365
S +VAIK ++ D K F E+ IMR V+H NVV + A L
Sbjct: 63 ESDEVAIK-----KVLQD--KRFKNRELQIMRIVKHPNVVD-LKAFFYSNGDKKDEVFLN 114
Query: 366 IVTEFMSGGSVYDYL-HKLKGVFKLPS---------LLKVAIDVSKGMNYLHQNNIIHRD 415
+V E++ +VY H K +P LL+ + Y+H I HRD
Sbjct: 115 LVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLR-------SLAYIHSIGICHRD 166
Query: 416 LKAANLLMDENEVSLLLSLCLF 437
+K NLL+D S +L L F
Sbjct: 167 IKPQNLLLDPP--SGVLKLIDF 186
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 33/154 (21%), Positives = 60/154 (38%), Gaps = 23/154 (14%)
Query: 296 FGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVV 352
+ G G + + + A+K+L D K +EV + + + ++V
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALKML------QDCPK-ARREVELHWRASQCPHIV 74
Query: 353 QFIGAC----TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP-----SLLKVAIDVSKGM 403
+ + L IV E + GG ++ + +G ++K + + +
Sbjct: 75 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMK---SIGEAI 130
Query: 404 NYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLF 437
YLH NI HRD+K NLL + +L L F
Sbjct: 131 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 164
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 17/120 (14%), Positives = 46/120 (38%), Gaps = 2/120 (1%)
Query: 309 YRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368
++ + + + + ++ M KN V + + L I
Sbjct: 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQM 140
Query: 369 EFMSGGSVYDYLHKLKGVFKLPS--LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
+ ++ D++++ + L + I +++ + +LH ++HRDLK +N+ +
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD 200
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 43/207 (20%), Positives = 80/207 (38%), Gaps = 35/207 (16%)
Query: 239 AALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGS 298
++ E + G S S + S +P +D W+I ++ +
Sbjct: 2 SSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSD-WQIPDRY-EIRH 59
Query: 299 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKE-FAQ----EVFIMRKVRHKNV 351
+ +GSYG + + VAIK +I + + E+ I+ ++ H +V
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIK-----KILRVFEDLIDCKRILREIAILNRLNHDHV 114
Query: 352 VQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI------DV 399
V+ + P + +V E D K +F+ P L ++
Sbjct: 115 VK-VLDIVIPKDVEKFDELYVVLEIAD----SD-FKK---LFRTPVYLTELHIKTLLYNL 165
Query: 400 SKGMNYLHQNNIIHRDLKAANLLMDEN 426
G+ Y+H I+HRDLK AN L++++
Sbjct: 166 LVGVKYVHSAGILHRDLKPANCLVNQD 192
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 39/158 (24%), Positives = 70/158 (44%), Gaps = 36/158 (22%)
Query: 299 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
+ +GS+G +Y+ C + VAIK ++ D + + +E+ IMRK+ H N+V+ +
Sbjct: 61 VIGNGSFGVVYQAKLCDSGELVAIK-----KVLQDKRFKN-RELQIMRKLDHCNIVR-LR 113
Query: 357 ACTKPPS-------LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS--------- 400
L +V +++ + V + S K + V
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVP--------ETVYRVARHYSRAKQTLPVIYVKLYMYQL 165
Query: 401 -KGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLF 437
+ + Y+H I HRD+K NLL+D + + +L LC F
Sbjct: 166 FRSLAYIHSFGICHRDIKPQNLLLDPD--TAVLKLCDF 201
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 3e-12
Identities = 31/112 (27%), Positives = 57/112 (50%), Gaps = 5/112 (4%)
Query: 319 AIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKN---VVQFIGACTKPPSLCIVTEFMSGG 374
A+K L +RI + A E ++ V + +V A P L + + M+GG
Sbjct: 218 AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG 277
Query: 375 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
++ +L + GVF + A ++ G+ ++H +++RDLK AN+L+DE+
Sbjct: 278 DLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH 328
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 24/109 (22%), Positives = 47/109 (43%), Gaps = 1/109 (0%)
Query: 319 AIKVLKPERINSDMQKE-FAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A+K+L + + F +E ++ K + A +L +V ++ GG +
Sbjct: 103 AMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLL 162
Query: 378 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
L K + ++ ++ +HQ + +HRD+K N+LMD N
Sbjct: 163 TLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMN 211
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 65.6 bits (161), Expect = 6e-12
Identities = 33/109 (30%), Positives = 55/109 (50%), Gaps = 2/109 (1%)
Query: 319 AIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A+KVLK E + Q E E ++ V H +++ G + ++ +++ GG ++
Sbjct: 35 AMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELF 94
Query: 378 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
L K F P A +V + YLH +II+RDLK N+L+D+N
Sbjct: 95 SLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKN 142
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 6e-12
Identities = 27/109 (24%), Positives = 55/109 (50%), Gaps = 2/109 (1%)
Query: 319 AIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A+K+L+ E I + + E +++ RH + A LC V E+ +GG ++
Sbjct: 34 AMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELF 93
Query: 378 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
+L + + VF ++ + YLH ++++RD+K NL++D++
Sbjct: 94 FHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD 141
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 25/171 (14%), Positives = 54/171 (31%), Gaps = 35/171 (20%)
Query: 291 PKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVL-KPERINSDMQKEFAQEVFIMRKVR 347
P+ L G+ + T + + V ER S+ K+ +EV +R +R
Sbjct: 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 131
Query: 348 -------------------------HKNVVQFIGACTKP--PSLCIVTEFMSG--GSVYD 378
K +++ S + M + +
Sbjct: 132 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 191
Query: 379 YLHKLKGVFKLPSL---LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
L K L++ + V + + LH ++H L+ ++++D+
Sbjct: 192 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR 242
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 65.8 bits (160), Expect = 8e-12
Identities = 24/171 (14%), Positives = 55/171 (32%), Gaps = 35/171 (20%)
Query: 291 PKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVL-KPERINSDMQKEFAQEVFIMRK-- 345
P+ L G+ + T + + V ER S+ K+ +EV +R
Sbjct: 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 136
Query: 346 --------------------VRHKNVVQFIGACTKPPSLCIVTEF-------MSGGSVYD 378
V+ + I + +++ F + + +
Sbjct: 137 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 196
Query: 379 YLHKLKGVFKLPSL---LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
L K L++ + V + + LH ++H L+ ++++D+
Sbjct: 197 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR 247
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 41/208 (19%), Positives = 70/208 (33%), Gaps = 36/208 (17%)
Query: 253 WPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGT 312
H SS E+ +S L+ GT + + + K S + G LY
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMTTSLEALPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAA 62
Query: 313 ----------YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362
Q ++K+ + + + E F R + V P
Sbjct: 63 PTSTLTCDSGPQKQKFSLKL---DAKDGRLFNEQN---FFQRAAKPLQV-NKWKKLYSTP 115
Query: 363 SLCIVTEFMSGGSVYDY-----------LHKL-----KGVFKLPSLLKVAIDVSKGMNYL 406
L I T G Y L K V S+L+VA + + +L
Sbjct: 116 LLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFL 175
Query: 407 HQNNIIHRDLKAANLLM---DENEVSLL 431
H+N +H ++ A N+ + D+++V+L
Sbjct: 176 HENEYVHGNVTAENIFVDPEDQSQVTLA 203
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 2e-11
Identities = 30/108 (27%), Positives = 55/108 (50%), Gaps = 1/108 (0%)
Query: 319 AIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYD 378
A+KVLK + + E I+ +V H +V+ A L ++ +F+ GG ++
Sbjct: 56 AMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFT 115
Query: 379 YLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
L K + +F + +++ +++LH II+RDLK N+L+DE
Sbjct: 116 RLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE 162
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 34/134 (25%), Positives = 60/134 (44%), Gaps = 8/134 (5%)
Query: 293 HLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH-K 349
+ + G K+ G++G+L G + VAIK+ E + S + E +++
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKL---EPMKSRAPQLH-LEYRFYKQLGSGD 65
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 409
+ Q +V E + G S+ D F L ++L +AI + M Y+H
Sbjct: 66 GIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK 124
Query: 410 NIIHRDLKAANLLM 423
N+I+RD+K N L+
Sbjct: 125 NLIYRDVKPENFLI 138
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 30/134 (22%), Positives = 57/134 (42%), Gaps = 8/134 (5%)
Query: 293 HLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH-K 349
H K G ++ GS+G ++ GT Q VAIK E SD + E + +
Sbjct: 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF---EPRRSDAP-QLRDEYRTYKLLAGCT 66
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 409
+ + +V + + G S+ D L F + ++ A + + +H+
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 125
Query: 410 NIIHRDLKAANLLM 423
++++RD+K N L+
Sbjct: 126 SLVYRDIKPDNFLI 139
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 39/155 (25%), Positives = 72/155 (46%), Gaps = 8/155 (5%)
Query: 293 HLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH-K 349
+ G K+ SGS+GD+Y GT + ++VAIK+ E + + + E I + ++
Sbjct: 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHPQ-LHIESKIYKMMQGGV 65
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 409
+ + +V E + G S+ D + F L ++L +A + + Y+H
Sbjct: 66 GIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 124
Query: 410 NIIHRDLKAANLLMDENEVSLLLSLCLFTVSILFC 444
N IHRD+K N LM + L+ + F ++ +
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 3e-11
Identities = 30/151 (19%), Positives = 64/151 (42%), Gaps = 29/151 (19%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIM 343
W + K+ G Y +++ + + V +K+LKP + +K+ +E+ I+
Sbjct: 31 EWGN-QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKIL 84
Query: 344 RKVR-HKNVVQ----FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI- 397
+R N++ ++ P+L + + D +L +L I
Sbjct: 85 ENLRGGPNIITLADIVKDPVSRTPAL-VFEHVNN----TD-FKQL-----YQTLTDYDIR 133
Query: 398 ----DVSKGMNYLHQNNIIHRDLKAANLLMD 424
++ K ++Y H I+HRD+K N+++D
Sbjct: 134 FYMYEILKALDYCHSMGIMHRDVKPHNVMID 164
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 34/184 (18%), Positives = 73/184 (39%), Gaps = 9/184 (4%)
Query: 249 ERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDL 308
+ + + + + ++ + + F + GS+G +
Sbjct: 298 GNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKV 357
Query: 309 ----YRGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKV-RHKNVVQFIGACTKPP 362
+GT + A+K+LK + + D E E ++ + + Q
Sbjct: 358 MLSERKGT--DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 415
Query: 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 422
L V E+++GG + ++ + G FK P + A +++ G+ +L II+RDLK N++
Sbjct: 416 RLYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVM 474
Query: 423 MDEN 426
+D
Sbjct: 475 LDSE 478
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 32/190 (16%), Positives = 62/190 (32%), Gaps = 52/190 (27%)
Query: 269 GMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS------QDVAIKV 322
GM++ + + + ++SGSYG C+ VAIK
Sbjct: 1 GMQAKGEAAMRDLIAE-LHAMQSPY-TVQRFISSGSYG-----AVCAGVDSEGIPVAIKR 53
Query: 323 LKPERINSDMQKEF-----AQ----EVFIMRKVRHKNVVQFIGACTKPPSLC------IV 367
+ + + E+ ++ H N++ + +V
Sbjct: 54 VFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG-LRDIFVHFEEPAMHKLYLV 112
Query: 368 TEFMSGGSVYDYLHKL--KGVFKLPS---------LLKVAIDVSKGMNYLHQNNIIHRDL 416
TE M D L ++ + +L G++ LH+ ++HRDL
Sbjct: 113 TELMR----TD-LAQVIHDQRIVISPQHIQYFMYHILL-------GLHVLHEAGVVHRDL 160
Query: 417 KAANLLMDEN 426
N+L+ +N
Sbjct: 161 HPGNILLADN 170
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 5e-11
Identities = 42/201 (20%), Positives = 89/201 (44%), Gaps = 15/201 (7%)
Query: 232 EETEQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDP 291
EE E+ A++ L++Q + S +++G + L P +
Sbjct: 94 EEREEWTTAIQTVADGLKKQ-AAAEMDFRSGSPSDNSGAEEMEVSLAKPKH-----RVTM 147
Query: 292 KHLKFGSKVASGSYGDLY----RGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKV 346
++ + G++G + + T + A+K+LK E I + + E +++
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKAT--GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 205
Query: 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 406
RH + + LC V E+ +GG ++ +L + + VF ++ ++YL
Sbjct: 206 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYL 264
Query: 407 H-QNNIIHRDLKAANLLMDEN 426
H + N+++RDLK NL++D++
Sbjct: 265 HSEKNVVYRDLKLENLMLDKD 285
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 5e-11
Identities = 30/110 (27%), Positives = 54/110 (49%), Gaps = 3/110 (2%)
Query: 319 AIKVLKPERINSDMQKEFAQ-EVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376
A+KV+K E +N D ++ Q E + + H +V L V E+++GG +
Sbjct: 38 AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 97
Query: 377 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
++ + + + ++S +NYLH+ II+RDLK N+L+D
Sbjct: 98 MFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 146
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 5e-11
Identities = 23/129 (17%), Positives = 51/129 (39%), Gaps = 7/129 (5%)
Query: 303 GSYGDLY----RGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGA 357
G++ ++ + T Q A+K++ + + + E ++ + + Q A
Sbjct: 72 GAFSEVAVVKMKQT--GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFA 129
Query: 358 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 417
L +V E+ GG + L K ++ ++ +H+ +HRD+K
Sbjct: 130 FQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIK 189
Query: 418 AANLLMDEN 426
N+L+D
Sbjct: 190 PDNILLDRC 198
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 7e-11
Identities = 40/164 (24%), Positives = 68/164 (41%), Gaps = 32/164 (19%)
Query: 281 NDGTDVWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQ 338
G + + + GSYG +Y ++VAIK K R+ D +
Sbjct: 16 FQGIKNVHVPDNY-IIKHLIGRGSYGYVYLAYDKNTEKNVAIK--KVNRMFED--LIDCK 70
Query: 339 ----EVFIMRKVRHKNVVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFK 388
E+ I+ +++ +++ P L IV E D L K +FK
Sbjct: 71 RILREITILNRLKSDYIIRLYDLI-IPDDLLKFDELYIVLEIAD----SD-LKK---LFK 121
Query: 389 LPSLLK------VAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
P L + ++ G N++H++ IIHRDLK AN L++++
Sbjct: 122 TPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQD 165
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 9e-11
Identities = 29/110 (26%), Positives = 54/110 (49%), Gaps = 3/110 (2%)
Query: 319 AIKVLKPERINSDMQKEFAQ-EVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376
A++V+K E +N D ++ Q E + + H +V L V E+++GG +
Sbjct: 81 AMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 140
Query: 377 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
++ + + + ++S +NYLH+ II+RDLK N+L+D
Sbjct: 141 MFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 189
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 33/110 (30%), Positives = 49/110 (44%), Gaps = 3/110 (2%)
Query: 319 AIKVLKPERINSDMQKEFAQ-EVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376
A+KVLK + I D E E I+ H + Q P L V EF++GG +
Sbjct: 52 AVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL 111
Query: 377 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
++ K F A ++ + +LH II+RDLK N+L+D
Sbjct: 112 MFHIQK-SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHE 160
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 25/109 (22%), Positives = 53/109 (48%), Gaps = 2/109 (1%)
Query: 319 AIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A+K + ++ + +E+ IM+ + H +V + + +V + + GG +
Sbjct: 44 AMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLR 103
Query: 378 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
+L + FK ++ ++ ++YL IIHRD+K N+L+DE+
Sbjct: 104 YHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEH 151
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 2e-10
Identities = 34/111 (30%), Positives = 60/111 (54%), Gaps = 5/111 (4%)
Query: 319 AIKVLKPERINSDMQKEFAQ---EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 375
A+KVLK I + K+ A E I+ +V+H +V I A L ++ E++SGG
Sbjct: 49 AMKVLKKAMIVRN-AKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGE 107
Query: 376 VYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
++ L + +G+F + ++S + +LHQ II+RDLK N++++
Sbjct: 108 LFMQLER-EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQ 157
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 33/155 (21%), Positives = 70/155 (45%), Gaps = 8/155 (5%)
Query: 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HK 349
+ G K+ SGS+G++Y GT +++VAIK+ E + + + E I R ++
Sbjct: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHP-QLLYESKIYRILQGGT 63
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 409
+ + +V + + G S+ D + L ++L +A + + ++H
Sbjct: 64 GIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
Query: 410 NIIHRDLKAANLLMDENEVSLLLSLCLFTVSILFC 444
+ +HRD+K N LM + + + F ++ +
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 39/154 (25%), Positives = 71/154 (46%), Gaps = 24/154 (15%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 343
V+++ P++ S + G+YG + VAIK + P + Q+ +E+ I+
Sbjct: 22 VFDVGPRY-TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKIL 79
Query: 344 RKVRHKNVVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 397
+ RH+N++ P++ IV + M D L+K + K L I
Sbjct: 80 LRFRHENIIGINDIIR-APTIEQMKDVYIVQDLME----TD-LYK---LLKTQHLSNDHI 130
Query: 398 D-----VSKGMNYLHQNNIIHRDLKAANLLMDEN 426
+ +G+ Y+H N++HRDLK +NLL++
Sbjct: 131 CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT 164
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 2e-10
Identities = 24/134 (17%), Positives = 52/134 (38%), Gaps = 4/134 (2%)
Query: 297 GSKVASGSYGDLYRG--TYCSQDVAIKVLKPE-RINSDMQKEFAQEVFIMRKVRHKNVVQ 353
V G GD+Y T + VA+K++ + + +E +++ +VV
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 354 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 413
L + ++G + L + +G P + + + ++ H H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHAAGATH 157
Query: 414 RDLKAANLLMDENE 427
RD+K N+L+ ++
Sbjct: 158 RDVKPENILVSADD 171
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 28/110 (25%), Positives = 53/110 (48%), Gaps = 3/110 (2%)
Query: 319 AIKVLKPERINSDMQKEFAQ-EVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376
A+K+LK + + D E E ++ + + Q L V E+++GG +
Sbjct: 49 AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL 108
Query: 377 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
++ + G FK P + A +++ G+ +L II+RDLK N+++D
Sbjct: 109 MYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE 157
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 42/200 (21%), Positives = 80/200 (40%), Gaps = 31/200 (15%)
Query: 255 SHRSSSPTSEPEDTGMKSHPYHLKIP-NDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 313
H SS + Y +P +G + +++ G K+ SG +G +Y
Sbjct: 4 HHHHSSGVDLGTENL-----YFQSMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFP 58
Query: 314 --CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 371
+ A V+K E + E+ ++V K+ ++ + L I +
Sbjct: 59 TNKPEKDARHVVKVEYQENGPLF---SELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115
Query: 372 SGGSVY---DY--------------LHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 414
SG + + Y + G FK ++L++ I + + Y+H+N +H
Sbjct: 116 SGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHG 175
Query: 415 DLKAANLLM---DENEVSLL 431
D+KAANLL+ + ++V L
Sbjct: 176 DIKAANLLLGYKNPDQVYLA 195
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 2e-10
Identities = 28/111 (25%), Positives = 48/111 (43%), Gaps = 5/111 (4%)
Query: 319 AIKVLKPERINSDMQKEFAQ---EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 375
AIK LK + + D E V H + +L V E+++GG
Sbjct: 46 AIKALKKDVVLMDDDVECTMVEKRVL-SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGD 104
Query: 376 VYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
+ ++ F L A ++ G+ +LH I++RDLK N+L+D++
Sbjct: 105 LMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD 154
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 2e-10
Identities = 42/159 (26%), Positives = 68/159 (42%), Gaps = 34/159 (21%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQ 338
V+ I + S + G+YG CS + VAIK ++P + +
Sbjct: 6 VYNISSDF-QLKSLLGEGAYG-----VVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-R 58
Query: 339 EVFIMRKVRHKNVVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLPSL 392
E+ I++ +H+N++ I +P S I+ E M D LH+ V L
Sbjct: 59 EIKILKHFKHENIIT-IFNIQRPDSFENFNEVYIIQELMQ----TD-LHR---VISTQML 109
Query: 393 LKVAI-----DVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
I + + LH +N+IHRDLK +NLL++ N
Sbjct: 110 SDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSN 148
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 60.7 bits (146), Expect = 3e-10
Identities = 32/174 (18%), Positives = 59/174 (33%), Gaps = 48/174 (27%)
Query: 299 KVASGSYGDLYRGTYCSQDVAIKVL---KPERINSDMQK---EFAQEVFIMRKV------ 346
K+ G +G++++ VAIK++ P+ +N QK E E+ I +++
Sbjct: 27 KIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86
Query: 347 ---RHKNVVQFIGAC----TKPPSLC--------------------------IVTEFMSG 373
R + + + PP L IV EF G
Sbjct: 87 VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146
Query: 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDEN 426
G D + L + + ++ + + HRDL N+L+ +
Sbjct: 147 GI--DLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKT 198
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 45/158 (28%), Positives = 69/158 (43%), Gaps = 30/158 (18%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQ----E 339
WE+ + V SG+YG + VAIK K R + FA+ E
Sbjct: 20 AWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK--KLYRPFQS--ELFAKRAYRE 74
Query: 340 VFIMRKVRHKNVVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLPSLL 393
+ +++ +RH+NV+ + T +L +V FM D L K + K L
Sbjct: 75 LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMG----TD-LGK---LMKHEKLG 126
Query: 394 KVAID-----VSKGMNYLHQNNIIHRDLKAANLLMDEN 426
+ I + KG+ Y+H IIHRDLK NL ++E+
Sbjct: 127 EDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED 164
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 4e-10
Identities = 27/109 (24%), Positives = 44/109 (40%), Gaps = 3/109 (2%)
Query: 319 AIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A+K+L + F E IM VVQ A L +V E+M GG +
Sbjct: 98 AMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV 157
Query: 378 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
+ + +V ++ +H IHRD+K N+L+D++
Sbjct: 158 NLMSNYD--VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS 204
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 9e-10
Identities = 13/133 (9%), Positives = 43/133 (32%), Gaps = 6/133 (4%)
Query: 297 GSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQ 353
++ T + VA+ + P+ + D+ +E + ++ V +
Sbjct: 36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 354 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 413
+ +V E++ GGS+ + ++ ++ + H+ +
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVAD---TSPSPVGAIRAMQSLAAAADAAHRAGVAL 152
Query: 414 RDLKAANLLMDEN 426
+ + + +
Sbjct: 153 SIDHPSRVRVSID 165
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 9e-10
Identities = 43/154 (27%), Positives = 73/154 (47%), Gaps = 23/154 (14%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQ----E 339
WE+ PK + V SG+YG + + VAIK K R + FA+ E
Sbjct: 19 AWEL-PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK--KLSRPFQS--EIFAKRAYRE 73
Query: 340 VFIMRKVRHKNVVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLPSLL 393
+ +++ ++H+NV+ + T SL +V FM D L K+ G+ +
Sbjct: 74 LLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ----TD-LQKIMGLKFSEEKI 128
Query: 394 KVAI-DVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
+ + + KG+ Y+H ++HRDLK NL ++E+
Sbjct: 129 QYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNED 162
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 29/110 (26%), Positives = 58/110 (52%), Gaps = 3/110 (2%)
Query: 319 AIKVLKPERINSDMQKEFAQ-EVFIM-RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376
A+KVL+ + I +++ E ++ + V+H +V + L V ++++GG +
Sbjct: 67 AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL 126
Query: 377 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
+ +L + + F P A +++ + YLH NI++RDLK N+L+D
Sbjct: 127 FYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ 175
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 25/160 (15%), Positives = 58/160 (36%), Gaps = 24/160 (15%)
Query: 295 KFGSKVASGSYGDLYRGT-YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 353
K G + G +G +Y S+ V ++ E+ ++ +Q
Sbjct: 38 KVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQ 97
Query: 354 FIGACTKPPSLCI-------------------VTEFMSGGSVYDYLHKLKGVFKLPSLLK 394
K L + + + G + F ++L+
Sbjct: 98 KWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQ 156
Query: 395 VAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVSLL 431
+++ + + Y+H++ +H D+KA+NLL+ + ++V L+
Sbjct: 157 LSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLV 196
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 42/158 (26%), Positives = 73/158 (46%), Gaps = 30/158 (18%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQ----E 339
+WE+ ++ + S V SG+YG + T VA+K K R A+ E
Sbjct: 24 IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQS--IIHAKRTYRE 78
Query: 340 VFIMRKVRHKNVVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLPSLL 393
+ +++ ++H+NV+ + T SL +VT M D L+ + K L
Sbjct: 79 LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG----AD-LNN---IVKCQKLT 130
Query: 394 KVAID-----VSKGMNYLHQNNIIHRDLKAANLLMDEN 426
+ + +G+ Y+H +IIHRDLK +NL ++E+
Sbjct: 131 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 168
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 37/165 (22%), Positives = 61/165 (36%), Gaps = 44/165 (26%)
Query: 299 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFA----QEVFIMRKVRHKNVV 352
G++G + G S VAIK ++ D F Q + + + H N+V
Sbjct: 30 MAGQGTFGTVQLGKEKSTGMSVAIK-----KVIQD--PRFRNRELQIMQDLAVLHHPNIV 82
Query: 353 QFIGACTKPPS--------LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS---- 400
Q + + L +V E++ D LH+ + +VA
Sbjct: 83 Q-LQSYFYTLGERDRRDIYLNVVMEYVP-----DTLHR---CCRNYYRRQVAPPPILIKV 133
Query: 401 ------KGMNYLHQN--NIIHRDLKAANLLMDENEVSLLLSLCLF 437
+ + LH N+ HRD+K N+L++E L LC F
Sbjct: 134 FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEA--DGTLKLCDF 176
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 34/159 (21%), Positives = 68/159 (42%), Gaps = 33/159 (20%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQ----E 339
+ + ++ + + SG+ G + ++VAIK K R + + A+ E
Sbjct: 57 TFTVLKRY-QNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQN--QTHAKRAYRE 111
Query: 340 VFIMRKVRHKNVVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLPSLL 393
+ +M+ V HKN++ + T +L +V E M + L ++ + L
Sbjct: 112 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD----AN-LCQV-----IQMEL 161
Query: 394 K------VAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
+ + G+ +LH IIHRDLK +N+++ +
Sbjct: 162 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 200
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 26/157 (16%), Positives = 65/157 (41%), Gaps = 35/157 (22%)
Query: 298 SKVASGSYG------DLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR---- 347
K+ G + D+ T+ VA+K+++ + + E+ ++++V
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTH----VAMKIVRG---DKVYTEAAEDEIKLLQRVNDADN 77
Query: 348 -------HKNVVQ------FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLL 393
++++ G + +V E + G ++ + K + L +
Sbjct: 78 TKEDSMGANHILKLLDHFNHKGPNGVH--VVMVFEVL-GENLLALIKKYEHRGIPLIYVK 134
Query: 394 KVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVS 429
+++ + G++Y+H+ IIH D+K N+LM+ +
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 171
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 34/160 (21%), Positives = 65/160 (40%), Gaps = 39/160 (24%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQ- 338
+ K+ + K+ G+YG + VA+K K + AQ
Sbjct: 5 RHVLRKY-ELVKKLGKGAYG-----IVWKSIDRRTGEVVAVK--KIFDAFQN--STDAQR 54
Query: 339 ---EVFIMRKVR-HKNVVQFIGACTKPPS---LCIVTEFMSGGSVYDYLHKLKGVFKLPS 391
E+ I+ ++ H+N+V + + + + +V ++M D LH V +
Sbjct: 55 TFREIMILTELSGHENIVNLLNVL-RADNDRDVYLVFDYME----TD-LHA---VIRANI 105
Query: 392 LLKVAI-----DVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
L V + K + YLH ++HRD+K +N+L++
Sbjct: 106 LEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAE 145
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 7e-09
Identities = 34/184 (18%), Positives = 74/184 (40%), Gaps = 15/184 (8%)
Query: 254 PSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYG------- 306
+S + + + L+ N ++ ++ + + +G+YG
Sbjct: 16 GGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRK 75
Query: 307 DLYRGTYCSQDVAIKVLKPERINSDMQKEFAQ---EVFIMRKVRHKN-VVQFIGACTKPP 362
T + A+KVLK I K E ++ +R +V A
Sbjct: 76 ISGHDT--GKLYAMKVLKKATIVQK-AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132
Query: 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 422
L ++ ++++GG ++ +L + + F + ++ + +LH+ II+RD+K N+L
Sbjct: 133 KLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENIL 191
Query: 423 MDEN 426
+D N
Sbjct: 192 LDSN 195
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 34/122 (27%), Positives = 65/122 (53%), Gaps = 13/122 (10%)
Query: 316 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK------NVVQFIGACTKPPSLCIVTE 369
Q VA+K+++ ++ A+E+ I+ +R + NV+ + T +C+ E
Sbjct: 123 QHVALKMVRN---EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFE 179
Query: 370 FMSGGSVYDYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 427
+S ++Y+ + +K +G F LP + K A + + ++ LH+N IIH DLK N+L+ +
Sbjct: 180 LLSM-NLYELIKKNKFQG-FSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQG 237
Query: 428 VS 429
S
Sbjct: 238 RS 239
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 37/164 (22%), Positives = 68/164 (41%), Gaps = 43/164 (26%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQ----E 339
+ + ++ + + SG+ G + ++VAIK K R + + A+ E
Sbjct: 20 TFTVLKRY-QNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQN--QTHAKRAYRE 74
Query: 340 VFIMRKVRHKNVVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLP--- 390
+ +M+ V HKN++ + T SL IV E M + L + V ++
Sbjct: 75 LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD----AN-LCQ---VIQMELDH 126
Query: 391 --------SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
+L G+ +LH IIHRDLK +N+++ +
Sbjct: 127 ERMSYLLYQMLC-------GIKHLHSAGIIHRDLKPSNIVVKSD 163
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 30/120 (25%), Positives = 62/120 (51%), Gaps = 14/120 (11%)
Query: 316 QDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRH-----KNVVQFIGACTKPPSLCIVTE 369
+ A+KV++ N A+ E I++K+++ N+V++ G +C++ E
Sbjct: 61 KYYAVKVVR----NIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFE 116
Query: 370 FMSGGSVYDYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 427
+ G S+Y+ + + G F + + I++ K +NYL + ++ H DLK N+L+D+
Sbjct: 117 PL-GPSLYEIITRNNYNG-FHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPY 174
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 30/121 (24%), Positives = 56/121 (46%), Gaps = 13/121 (10%)
Query: 315 SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK------NVVQFIGACTKPPSLCIVT 368
+ VA+K++K + E+ ++ + VQ + +CIV
Sbjct: 40 GRHVAVKIVKN---VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVF 96
Query: 369 EFMSGGSVYDYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
E + G S YD++ + F+L + K+A + K +N+LH N + H DLK N+L ++
Sbjct: 97 ELL-GLSTYDFIKENGFLP-FRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQS 154
Query: 427 E 427
+
Sbjct: 155 D 155
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 28/121 (23%), Positives = 58/121 (47%), Gaps = 15/121 (12%)
Query: 316 QDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHK------NVVQFIGACTKPPSLCIVT 368
VA+K+++ N +E A+ E+ +++K++ K V +CI
Sbjct: 46 SQVALKIIR----NVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAF 101
Query: 369 EFMSGGSVYDYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
E + G + +++L + + + LP + +A + + +LH+N + H DLK N+L +
Sbjct: 102 ELL-GKNTFEFLKENNFQP-YPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNS 159
Query: 427 E 427
E
Sbjct: 160 E 160
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 6e-08
Identities = 39/178 (21%), Positives = 68/178 (38%), Gaps = 44/178 (24%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQ 338
+++ ++ + G G S + VAIK + ++ +
Sbjct: 6 GFDLGSRY-MDLKPLGCGGNG-----LVFSAVDNDCDKRVAIKKIVLTDP-QSVKHAL-R 57
Query: 339 EVFIMRKVRHKNVVQFIGACTKPPSLC--------------IVTEFMSGGSVYDYLHKLK 384
E+ I+R++ H N+V+ S IV E+M D L
Sbjct: 58 EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME----TD-LAN-- 110
Query: 385 GVFKLPSLLKVAID-----VSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLF 437
V + LL+ + +G+ Y+H N++HRDLK ANL + N L+L + F
Sbjct: 111 -VLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFI--NTEDLVLKIGDF 165
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.9 bits (126), Expect = 2e-07
Identities = 71/541 (13%), Positives = 131/541 (24%), Gaps = 201/541 (37%)
Query: 22 SSPPPQHQSRQHRQKL------GVY-----------NEVLGRLKESNNDEAIQPRFDDEL 64
S P + RQ +L + +V +Q + D ++
Sbjct: 132 SRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVC-------LSYKVQCKMDFKI 184
Query: 65 -WTHFNRLPTRYALDVNVERAEDVL-MHKRLLHLA---------HDPRNRPAIEV----- 108
W + N E VL M ++LL+ H + I
Sbjct: 185 FWLNLK----------NCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAEL 234
Query: 109 -RLVQVHP----------VSD-----------------RNSAVSSLLDSEVPAQRQSIHP 140
RL++ P V + R V+ L + H
Sbjct: 235 RRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHH 294
Query: 141 PPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRPMHEITFSTDDKPKLLSQLTAL- 199
L + D P+ +
Sbjct: 295 SMTLTPDEVKSLLLKYLDCR-------------------------PQDLPREVLTTNPRR 329
Query: 200 LADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEVLKLERQGWPSHRSS 259
L+ I +I++ A D W + ++L +E + L
Sbjct: 330 LSIIAESIRDGLATW------------DNWKHVNCDKLTTIIESSLNVL----------- 366
Query: 260 SPTSEPEDTGMKSH-------PYHLKIPNDGTDV----W----EIDPKHL--KFGSKVAS 302
EP + + P IP T + W + D + K S
Sbjct: 367 ----EPAE--YRKMFDRLSVFPPSAHIP---TILLSLIWFDVIKSDVMVVVNKLHKY--S 415
Query: 303 GSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362
T + +++ + + I + + P
Sbjct: 416 LVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDD-------LIPPY 468
Query: 363 SLCIVTEFMSGGSVYDYL-HKLKGVF---KLPSLLKVAIDVSKGMNYLHQNNIIHRDL-- 416
Y ++ H LK + ++ V +D +L + I H
Sbjct: 469 ---------LDQYFYSHIGHHLKNIEHPERMTLFRMVFLD----FRFL-EQKIRHDSTAW 514
Query: 417 ----KAANLLMD---------ENEVS---LLLSLCLFTVSI---LFCGKGRELISLFLGN 457
N L +N+ L+ ++ F I L C K +L+ + L
Sbjct: 515 NASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMA 574
Query: 458 D 458
+
Sbjct: 575 E 575
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.5 bits (117), Expect = 2e-06
Identities = 32/202 (15%), Positives = 71/202 (35%), Gaps = 58/202 (28%)
Query: 313 YCSQDVAIKVLKPERI-NSDMQ--KEFAQEVFIMRKVRH----KNVVQ-----FIGACTK 360
Y +D+ + V + + N D + ++ + + ++ H K+ V F +K
Sbjct: 16 YQYKDI-LSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSK 74
Query: 361 PPSLCIVTEFMSGGSVYDY---LHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 417
+V +F+ +Y + +K + PS++ Y+ Q + ++ D
Sbjct: 75 QEE--MVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTR--------MYIEQRDRLYND-- 122
Query: 418 AANLLMDENEVS---LLLSL--CLFTVS-----ILF----CGKGRELISLFLGNDVLLQ- 462
N + + VS L L L + ++ GK + + DV L
Sbjct: 123 --NQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGK-----TW-VALDVCLSY 174
Query: 463 -------FGTYWIIFRRSSCDK 477
F +W+ + + +
Sbjct: 175 KVQCKMDFKIFWLNLKNCNSPE 196
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 35/149 (23%), Positives = 66/149 (44%), Gaps = 20/149 (13%)
Query: 298 SKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-------- 347
K+ G + ++ + VA+KV+K + E+ +++ VR
Sbjct: 43 RKLGWGHFSTVWLSWDIQGKKFVAMKVVK---SAEHYTETALDEIRLLKSVRNSDPNDPN 99
Query: 348 HKNVVQFIGACT-KPPS---LCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKG 402
+ VVQ + + +C+V E + G + ++ K LP + K+ V +G
Sbjct: 100 REMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQG 158
Query: 403 MNYLH-QNNIIHRDLKAANLLMDENEVSL 430
++YLH + IIH D+K N+L+ NE +
Sbjct: 159 LDYLHTKCRIIHTDIKPENILLSVNEQYI 187
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 26/183 (14%), Positives = 62/183 (33%), Gaps = 66/183 (36%)
Query: 299 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQ-- 353
+ +GS+G + + A+K ++ D + E+ IM+ + H N+++
Sbjct: 14 TLGTGSFGIVCEVFDIESGKRFALK-----KVLQD--PRYKNRELDIMKVLDHVNIIKLV 66
Query: 354 ------------------------------FIGACTKPPS------LCIVTEFMSGGSVY 377
+ + L ++ E++ +++
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-PDTLH 125
Query: 378 DYL-HKLKGVFKLPS---------LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 427
L ++ +P L + + ++H I HRD+K NLL++ +
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQLFR-------AVGFIHSLGICHRDIKPQNLLVNSKD 178
Query: 428 VSL 430
+L
Sbjct: 179 NTL 181
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 31/132 (23%), Positives = 52/132 (39%), Gaps = 16/132 (12%)
Query: 316 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH------KNVVQFIGACTKPPSLCIVTE 369
+ VAIK++K + EV ++ + +V LC+V E
Sbjct: 80 EWVAIKIIKN---KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE 136
Query: 370 FMSGGSVYDYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQN--NIIHRDLKAANLLMDE 425
+S ++YD L +G L K A + + +L +IIH DLK N+L+
Sbjct: 137 MLSY-NLYDLLRNTNFRG-VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILL-C 193
Query: 426 NEVSLLLSLCLF 437
N + + F
Sbjct: 194 NPKRSAIKIVDF 205
|
| >1u8s_A Glycine cleavage system transcriptional repressor, putative; structural genomics, protein structure initiative (PSI), domain swapping; 2.45A {Vibrio cholerae} SCOP: d.58.18.5 d.58.18.5 Length = 192 | Back alignment and structure |
|---|
Score = 40.1 bits (93), Expect = 5e-04
Identities = 11/84 (13%), Positives = 27/84 (32%), Gaps = 2/84 (2%)
Query: 182 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAAL 241
IT D+P + +++ L+ G NI ++ ++L + + ++ L
Sbjct: 9 ITAVGTDRPGICNEVVRLVTQAGCNIIDSRIAMFGKEFTLLMLI--SGSPSNITRVETTL 66
Query: 242 EKEVLKLERQGWPSHRSSSPTSEP 265
+ + S
Sbjct: 67 PLLGQQHDLITMMKRTSPHDHQTH 90
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 492 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.97 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.97 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.97 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.97 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.97 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.97 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.97 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.97 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.97 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.97 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.97 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.97 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.97 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.97 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.97 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.97 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.97 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.97 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.97 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.97 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.97 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.97 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.97 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.97 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.97 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.97 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.97 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.97 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.97 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.97 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.97 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.97 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.97 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.97 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.97 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.97 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.97 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.97 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.97 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.97 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.97 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.97 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.97 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.97 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.96 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.96 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.96 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.96 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.96 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.96 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.96 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.96 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.96 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.96 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.96 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.96 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.96 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.96 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.96 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.96 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.96 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.96 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.96 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.96 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.96 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.96 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.96 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.96 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.96 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.96 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.96 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.96 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.96 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.96 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.96 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.96 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.96 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.96 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.96 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.96 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.96 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.96 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.96 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.96 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.96 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.96 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.96 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.96 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.96 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.96 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.96 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.96 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.96 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.96 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.96 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.96 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.96 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.96 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.96 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.96 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.96 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.96 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.96 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.96 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.96 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.96 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.96 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.96 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.96 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.96 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.96 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.96 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.96 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.96 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.96 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.96 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.96 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.96 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.96 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.96 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.96 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.96 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.96 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.96 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.96 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.96 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.96 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.96 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.96 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.96 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.96 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.96 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.96 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.96 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.96 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.96 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.96 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.96 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.96 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.95 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.95 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.95 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.95 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.95 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.95 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.95 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.95 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.95 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.95 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.95 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.95 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.95 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.95 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.95 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.95 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.95 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.95 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.95 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.95 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.95 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.95 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.95 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.95 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.95 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.95 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.95 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.95 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.95 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.95 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.95 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.95 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.95 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.95 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.95 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.95 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.95 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.95 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.95 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.95 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.95 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.95 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.95 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.95 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.95 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.95 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.95 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.95 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.95 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.95 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.95 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.95 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.95 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.95 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.95 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.95 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.95 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.95 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.95 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.95 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.95 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.95 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.95 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.95 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.95 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.95 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.94 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.94 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.94 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.94 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.94 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.94 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.94 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.94 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.94 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.94 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.94 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.94 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.94 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.94 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.94 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.94 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.93 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.93 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.93 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.92 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.83 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.71 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.39 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.18 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.16 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.78 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.65 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.59 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.49 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.47 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.23 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.2 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.2 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.97 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.64 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.62 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.41 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.38 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.23 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.18 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.0 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.63 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.59 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.52 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.35 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.15 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.1 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.83 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 91.12 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 90.87 | |
| 1u8s_A | 192 | Glycine cleavage system transcriptional repressor, | 80.56 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=338.04 Aligned_cols=196 Identities=29% Similarity=0.484 Sum_probs=168.5
Q ss_pred CCceeeCCCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCe
Q 011158 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (492)
Q Consensus 284 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 363 (492)
.+.|+|+.+++++.++||+|+||.||+|++.+ .||||+++....+....+.|.+|+.+|++++|||||++++++.. +.
T Consensus 28 ~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~ 105 (307)
T 3omv_A 28 SYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DN 105 (307)
T ss_dssp -CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS
T ss_pred CcCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-Ce
Confidence 45799999999999999999999999998765 69999998766667778899999999999999999999999865 56
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee--
Q 011158 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-- 441 (492)
Q Consensus 364 ~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-- 441 (492)
+|||||||+||+|.++|+..+..+++.+++.|+.||+.||.|||+++||||||||+|||+++++.+||+|||+++...
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 899999999999999998877789999999999999999999999999999999999999999999999999997532
Q ss_pred -------eeeCCCceeecceecc---ccccCccceeee---ecccccCCCCCC
Q 011158 442 -------LFCGKGRELISLFLGN---DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 -------~~~g~~~~~ape~~~~---e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...||..||+||++.. ..|+..+|+|++ +....+|.++|.
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~ 238 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYS 238 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCC
Confidence 3468889999998753 346667788883 223344666664
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=337.45 Aligned_cols=192 Identities=20% Similarity=0.308 Sum_probs=167.3
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
.++|+++++||+|+||.||+|++ +++.||||+++....+....+.+.+|+.+|++++|||||++++++.+.+.+||||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 46899999999999999999998 4789999999887777777889999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee------
Q 011158 369 EFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------ 441 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------ 441 (492)
|||+||+|.++|...+ ..+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++...
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 182 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA 182 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcccc
Confidence 9999999999997644 467999999999999999999999999999999999999999999999999997642
Q ss_pred -eeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 442 -LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 442 -~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
..+||..||+||.+....|....|+|++ +....+|.++|..
T Consensus 183 ~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~ 227 (350)
T 4b9d_A 183 RACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA 227 (350)
T ss_dssp HHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 3579999999999999889999999994 4455677777764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=331.05 Aligned_cols=195 Identities=23% Similarity=0.331 Sum_probs=165.3
Q ss_pred CceeeCCCCceeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEE
Q 011158 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 357 (492)
Q Consensus 285 ~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~-------g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~ 357 (492)
..+.|+.+++.+.++||+|+||.||+|++. ++.||||+++.. +....++|.+|+.+|++++|||||+++|+
T Consensus 34 ~~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~ 111 (329)
T 4aoj_A 34 CVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGV 111 (329)
T ss_dssp CSCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hhcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 346788899999999999999999999874 467999999753 45567889999999999999999999999
Q ss_pred EecCCeEEEEEeccCCCCHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE
Q 011158 358 CTKPPSLCIVTEFMSGGSVYDYLHKLK--------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 423 (492)
Q Consensus 358 ~~~~~~~~lV~Ey~~ggsL~~~L~~~~--------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILl 423 (492)
|.+.+.+|||||||++|+|.++|++.. +.+++.+++.|+.||+.||.|||+++||||||||+||||
T Consensus 112 ~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl 191 (329)
T 4aoj_A 112 CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV 191 (329)
T ss_dssp ECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE
Confidence 999999999999999999999997632 468999999999999999999999999999999999999
Q ss_pred ccCCCeEEEEEeecceee---------eeeCCCceeecceeccccccCccceeee----ecccccCCCCCC
Q 011158 424 DENEVSLLLSLCLFTVSI---------LFCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSD 481 (492)
Q Consensus 424 d~~~~~kl~DFGla~~~~---------~~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~ 481 (492)
++++.+||+|||+++... ...|+..||+||++....++..+|+|++ +...++|.++|.
T Consensus 192 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~ 262 (329)
T 4aoj_A 192 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWY 262 (329)
T ss_dssp ETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred CCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCC
Confidence 999999999999997531 2457788999999998889888999883 323344666664
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=328.39 Aligned_cols=194 Identities=20% Similarity=0.337 Sum_probs=166.7
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~~-------g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~ 359 (492)
+.|+.++|.+.++||+|+||.||+|++. ++.||||+++.. +....++|.+|+.+|++++|||||+++|+|.
T Consensus 8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 85 (299)
T 4asz_A 8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCV 85 (299)
T ss_dssp CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence 4788899999999999999999999873 467999999753 4556788999999999999999999999999
Q ss_pred cCCeEEEEEeccCCCCHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCC
Q 011158 360 KPPSLCIVTEFMSGGSVYDYLHKL------------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 427 (492)
Q Consensus 360 ~~~~~~lV~Ey~~ggsL~~~L~~~------------~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~ 427 (492)
+++.+|||||||++|+|.++|++. ...+++.+++.|+.||+.||.|||+++||||||||+|||++.++
T Consensus 86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 165 (299)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence 999999999999999999999763 24699999999999999999999999999999999999999999
Q ss_pred CeEEEEEeecceee---------eeeCCCceeecceeccccccCccceeee----ecccccCCCCCCC
Q 011158 428 VSLLLSLCLFTVSI---------LFCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSDA 482 (492)
Q Consensus 428 ~~kl~DFGla~~~~---------~~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~a 482 (492)
.+||+|||+++... ...|+..||+||++....++..+|+|++ +...++|.++|..
T Consensus 166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~ 233 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ 233 (299)
T ss_dssp CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999997431 2357788999999988889888999983 3333456666653
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=331.87 Aligned_cols=192 Identities=21% Similarity=0.336 Sum_probs=169.7
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 367 (492)
.++|+++++||+|+||+||+|++ +++.||||++..... +....+.+.+|+.+|++++|||||++++++.+.+.+|||
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 45799999999999999999998 478999999975422 223357799999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee-------
Q 011158 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS------- 440 (492)
Q Consensus 368 ~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~------- 440 (492)
||||+||+|.++|.+ .+.+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++..
T Consensus 111 mEy~~gG~L~~~i~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~ 189 (311)
T 4aw0_A 111 LSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189 (311)
T ss_dssp ECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred EecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence 999999999999987 467999999999999999999999999999999999999999999999999999753
Q ss_pred --eeeeCCCceeecceeccccccCccceeee---ecccccCCCCCCCc
Q 011158 441 --ILFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDAP 483 (492)
Q Consensus 441 --~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~aP 483 (492)
...+||..||+||.+....|....|+|++ +..+.+|.++|...
T Consensus 190 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~ 237 (311)
T 4aw0_A 190 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 237 (311)
T ss_dssp CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 24579999999999988889888999994 44566788887653
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=330.93 Aligned_cols=187 Identities=20% Similarity=0.257 Sum_probs=166.7
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
+.|++.++||+|+||.||+|++ +|+.||||+++..... ..+.+.+|+.+|++++|||||++++++.+.+.+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5689999999999999999998 4789999999754332 23568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee-------ee
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS-------IL 442 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~-------~~ 442 (492)
||+||+|.+++.+ +.+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.. ..
T Consensus 152 y~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~ 229 (346)
T 4fih_A 152 FLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 229 (346)
T ss_dssp CCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred CCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccc
Confidence 9999999999976 56999999999999999999999999999999999999999999999999998753 24
Q ss_pred eeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 443 FCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 443 ~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
.+||..||+||.+....|+...|+|++ +....+|.++|..
T Consensus 230 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~ 272 (346)
T 4fih_A 230 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 272 (346)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 679999999999999899999999994 4456678877754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=326.96 Aligned_cols=195 Identities=23% Similarity=0.372 Sum_probs=166.2
Q ss_pred ceeeCCCCceeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEE
Q 011158 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 358 (492)
Q Consensus 286 ~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~-------g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~ 358 (492)
.++|+..++++.++||+|+||.||+|++. ++.||||+++... +....++|.+|+.+|++++|||||+++|+|
T Consensus 20 ~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~ 98 (308)
T 4gt4_A 20 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVV 98 (308)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEE
Confidence 35788889999999999999999999873 4679999997543 344567899999999999999999999999
Q ss_pred ecCCeEEEEEeccCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE
Q 011158 359 TKPPSLCIVTEFMSGGSVYDYLHKL---------------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 423 (492)
Q Consensus 359 ~~~~~~~lV~Ey~~ggsL~~~L~~~---------------~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILl 423 (492)
...+.+|||||||++|+|.++|... +..+++..++.|+.||+.||.|||+++||||||||+||||
T Consensus 99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl 178 (308)
T 4gt4_A 99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV 178 (308)
T ss_dssp CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE
Confidence 9999999999999999999999653 2468999999999999999999999999999999999999
Q ss_pred ccCCCeEEEEEeecceee---------eeeCCCceeecceeccccccCccceeee----ecccccCCCCCC
Q 011158 424 DENEVSLLLSLCLFTVSI---------LFCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSD 481 (492)
Q Consensus 424 d~~~~~kl~DFGla~~~~---------~~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~ 481 (492)
++++.+||+|||+++... ...|+..||+||++....++..+|+|++ +...++|.++|.
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~ 249 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC 249 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCC
Confidence 999999999999997531 2356778999999888888888898883 223344666664
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=330.55 Aligned_cols=194 Identities=23% Similarity=0.315 Sum_probs=165.3
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEE-----CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~-----~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 362 (492)
.+++++|+++++||+|+||.||+|+. +++.||||+++...........+.+|+.+|++++|||||++++++.+++
T Consensus 20 ~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 99 (304)
T 3ubd_A 20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG 99 (304)
T ss_dssp CCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETT
T ss_pred cCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 45678899999999999999999987 3567999999865443333456889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee--
Q 011158 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS-- 440 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~-- 440 (492)
.+|||||||+||+|.++|.+ .+.+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||+++..
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEEEEEcCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 99999999999999999987 467999999999999999999999999999999999999999999999999999753
Q ss_pred -----eeeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 441 -----ILFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 441 -----~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
...+||..||+||.+....|....|+|++ +....+|.++|..
T Consensus 179 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~ 228 (304)
T 3ubd_A 179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG 228 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCC
Confidence 23578999999999998899999999994 4455678877765
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=317.35 Aligned_cols=187 Identities=22% Similarity=0.379 Sum_probs=162.5
Q ss_pred CceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEec----CCeEEE
Q 011158 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK----PPSLCI 366 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~~~~~l 366 (492)
.|++.++||+|+||.||+|.+. +..||||++..........+.|.+|+.+|++++|||||+++++|.. ...+||
T Consensus 27 ~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l 106 (290)
T 3fpq_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred eEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence 3577889999999999999984 6789999998766677777889999999999999999999999864 345899
Q ss_pred EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCCEEEc-cCCCeEEEEEeeccee---
Q 011158 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMD-ENEVSLLLSLCLFTVS--- 440 (492)
Q Consensus 367 V~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~--IiHrDLKp~NILld-~~~~~kl~DFGla~~~--- 440 (492)
|||||+||+|.++|.+ .+.+++..++.++.||+.||.|||+++ ||||||||+||||+ .++.+||+|||+|+..
T Consensus 107 vmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~ 185 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185 (290)
T ss_dssp EEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred EEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC
Confidence 9999999999999987 467999999999999999999999998 99999999999998 4789999999999754
Q ss_pred --eeeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 441 --ILFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 441 --~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...+||..|||||.... .|....|+|++ +....+|.++|.
T Consensus 186 ~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~ 230 (290)
T 3fpq_A 186 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYS 230 (290)
T ss_dssp SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 35679999999998765 48888899994 444556777764
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=332.91 Aligned_cols=187 Identities=20% Similarity=0.257 Sum_probs=167.1
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
+.|++.++||+|+||.||+|++ +|+.||||++...... ..+.+.+|+.+|++++|||||+++++|...+.+|||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE 228 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 228 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS--SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence 5689999999999999999998 4789999999765332 23568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee-------ee
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS-------IL 442 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~-------~~ 442 (492)
||+||+|.+++.. +.+++..+..|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+++.. ..
T Consensus 229 y~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~ 306 (423)
T 4fie_A 229 FLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 306 (423)
T ss_dssp CCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCC
T ss_pred CCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccc
Confidence 9999999999976 56999999999999999999999999999999999999999999999999998753 24
Q ss_pred eeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 443 FCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 443 ~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
.+||..||+||.+....|+...|+|++ +..+.+|.++|..
T Consensus 307 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~ 349 (423)
T 4fie_A 307 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 349 (423)
T ss_dssp CEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 679999999999999999999999994 4456678887754
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=323.08 Aligned_cols=187 Identities=18% Similarity=0.240 Sum_probs=163.7
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEE
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 365 (492)
....+.|++.++||+|+||.||+|++ +|+.||||+++.+.. +.+|+.+|++++|||||++++++.+.+.+|
T Consensus 54 ~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ 126 (336)
T 4g3f_A 54 REEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWVN 126 (336)
T ss_dssp CBTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEEE
T ss_pred hcchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 34456789999999999999999998 478999999986532 246999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCC-CeEEEEEeecceee---
Q 011158 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-VSLLLSLCLFTVSI--- 441 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~-~~kl~DFGla~~~~--- 441 (492)
||||||+||+|.++|++ .+.+++..++.|+.||+.||.|||++|||||||||+||||+.++ .+||+|||+++...
T Consensus 127 ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQ-MGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp EEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred EEEeccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 99999999999999987 46799999999999999999999999999999999999999987 59999999997532
Q ss_pred ---------eeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 442 ---------LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 442 ---------~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
..+||..||+||.+....|....|+|++ +....+|.++|..
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~ 258 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQ 258 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCC
Confidence 2468999999999988889999999984 4455667777754
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=311.95 Aligned_cols=189 Identities=21% Similarity=0.379 Sum_probs=154.6
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
.+|++.+.||+|+||.||+|++ +++.||||+++..... ......+.+|+.+|++++|||||++++++.+++.+||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 4799999999999999999987 4789999999865433 344567999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee------ee
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS------IL 442 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~------~~ 442 (492)
||| +|+|.+++.+ .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.. ..
T Consensus 93 Ey~-~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 170 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT 170 (275)
T ss_dssp ECC-CEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred eCC-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccCC
Confidence 999 7899999987 567999999999999999999999999999999999999999999999999999754 24
Q ss_pred eeCCCceeecceecccccc-Cccceeee---ecccccCCCCCCC
Q 011158 443 FCGKGRELISLFLGNDVLL-QFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 443 ~~g~~~~~ape~~~~e~~~-~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
.+||..||+||.+....+. ...|+|++ +....+|.++|..
T Consensus 171 ~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~ 214 (275)
T 3hyh_A 171 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 214 (275)
T ss_dssp ----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC
Confidence 6789999999998877764 56899994 4455677777754
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=322.59 Aligned_cols=198 Identities=26% Similarity=0.408 Sum_probs=168.7
Q ss_pred CCceeeCCCCceeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCC-CceeeEE
Q 011158 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH-KNVVQFI 355 (492)
Q Consensus 284 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g-------~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~ 355 (492)
.+.|||+.++|+++++||+|+||.||+|++.+ +.||||+++... .....+.|.+|+.+|++++| ||||+++
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 34699999999999999999999999998743 469999997643 34556789999999999975 8999999
Q ss_pred EEEecC-CeEEEEEeccCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q 011158 356 GACTKP-PSLCIVTEFMSGGSVYDYLHKL---------------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419 (492)
Q Consensus 356 g~~~~~-~~~~lV~Ey~~ggsL~~~L~~~---------------~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~ 419 (492)
|+|..+ ..+|||||||++|+|.++|++. +..+++..++.++.||++||.|||+++||||||||+
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~ 214 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 214 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcc
Confidence 999764 5689999999999999999753 235899999999999999999999999999999999
Q ss_pred CEEEccCCCeEEEEEeecceee---------eeeCCCceeecceeccccccCccceeee----ecccccCCCCCCC
Q 011158 420 NLLMDENEVSLLLSLCLFTVSI---------LFCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSDA 482 (492)
Q Consensus 420 NILld~~~~~kl~DFGla~~~~---------~~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~a 482 (492)
|||+++++.+||+|||+++... ...++..|||||++....++..+|+|++ +...++|.++|..
T Consensus 215 NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 215 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred ceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999997531 2457778999999988889988999984 3334457776643
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=310.13 Aligned_cols=176 Identities=15% Similarity=0.234 Sum_probs=145.9
Q ss_pred CceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC--------
Q 011158 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP-------- 362 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-------- 362 (492)
+|++++.||+|+||.||+|++. ++.||||+++... .....+.+.+|+.+|++++|||||++++++...+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 5889999999999999999984 7899999997543 3445678999999999999999999999987543
Q ss_pred ----eEEEEEeccCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEee
Q 011158 363 ----SLCIVTEFMSGGSVYDYLHKLKG--VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCL 436 (492)
Q Consensus 363 ----~~~lV~Ey~~ggsL~~~L~~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGl 436 (492)
.+|||||||+||+|.+++..... ...+..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGl 164 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGL 164 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCcc
Confidence 37999999999999999986422 345677899999999999999999999999999999999999999999999
Q ss_pred cceee-------------------eeeCCCceeecceeccccccCccceeee
Q 011158 437 FTVSI-------------------LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 437 a~~~~-------------------~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
++... ..+||..|||||.+....|+...|+|++
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSl 216 (299)
T 4g31_A 165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSL 216 (299)
T ss_dssp C--------------------------CCCTTSCHHHHTTCCCCTHHHHHHH
T ss_pred ceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHH
Confidence 97532 1357888888888877778888888883
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=305.05 Aligned_cols=184 Identities=23% Similarity=0.429 Sum_probs=144.7
Q ss_pred CCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC----eEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP----SLCIV 367 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~----~~~lV 367 (492)
++|.+.++||+|+||.||+|+++|+.||||+++.. ......+..|+.++.+++|||||+++++|...+ .+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 35788899999999999999999999999999643 222223345666677899999999999998653 58999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CceecCCCCCCEEEccCCCeEEEEEeecce
Q 011158 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN--------NIIHRDLKAANLLMDENEVSLLLSLCLFTV 439 (492)
Q Consensus 368 ~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~--------~IiHrDLKp~NILld~~~~~kl~DFGla~~ 439 (492)
||||++|+|.++|++ ..+++..+.+++.|++.||.|||++ +||||||||+|||++.++.+||+|||+++.
T Consensus 80 ~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 999999999999987 4689999999999999999999987 999999999999999999999999999875
Q ss_pred ee-----------eeeCCCceeecceeccc------cccCccceeee---ecccccCCCCC
Q 011158 440 SI-----------LFCGKGRELISLFLGND------VLLQFGTYWII---FRRSSCDKKNS 480 (492)
Q Consensus 440 ~~-----------~~~g~~~~~ape~~~~e------~~~~~~d~W~l---~~~~~~gt~~Y 480 (492)
.. ...||..||+||++... .++..+|+|++ +.....|.+.+
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~ 218 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 218 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBT
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCC
Confidence 42 12456666666665443 23445566663 33444444433
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-36 Score=310.83 Aligned_cols=188 Identities=19% Similarity=0.260 Sum_probs=162.7
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEec------CCe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK------PPS 363 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~------~~~ 363 (492)
++|+++++||+|+||.||+|++ +|+.||||+++.........+.+.+|+.+|++++|||||++++++.. ...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5799999999999999999998 47899999998766566667889999999999999999999998764 357
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee---
Q 011158 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS--- 440 (492)
Q Consensus 364 ~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~--- 440 (492)
+||||||| +|+|.+++.+ .+.+++..+..|+.||+.||.|||++|||||||||+|||++.++.+||+|||+++..
T Consensus 134 ~~ivmE~~-~g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~ 211 (398)
T 4b99_A 134 VYVVLDLM-ESDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 211 (398)
T ss_dssp EEEEEECC-SEEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred EEEEEeCC-CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence 99999999 5789999976 568999999999999999999999999999999999999999999999999999743
Q ss_pred --------eeeeCCCceeecceecc-ccccCccceeee---ecccccCCCCCC
Q 011158 441 --------ILFCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 441 --------~~~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...+||..|++||.+.. ..++...|+|++ +....+|.++|.
T Consensus 212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~ 264 (398)
T 4b99_A 212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFP 264 (398)
T ss_dssp ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSC
T ss_pred ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCC
Confidence 13578889999997655 445777899994 445667777764
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-35 Score=319.51 Aligned_cols=191 Identities=18% Similarity=0.232 Sum_probs=162.7
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC----ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI----NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~----~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 364 (492)
.++|+++++||+|+||.||+|++ +|+.||||+++.... ..........++.+++.++|||||+++++|.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 45799999999999999999998 578999999975422 112222333456677788999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee----
Q 011158 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS---- 440 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~---- 440 (492)
|||||||+||+|.++|.+ .+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+..
T Consensus 268 ylVmEy~~GGdL~~~l~~-~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~ 346 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 346 (689)
T ss_dssp EEEECCCCSCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC
T ss_pred EEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCCC
Confidence 999999999999999987 467999999999999999999999999999999999999999999999999999653
Q ss_pred -eeeeCCCceeecceec-cccccCccceeee---ecccccCCCCCCC
Q 011158 441 -ILFCGKGRELISLFLG-NDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 441 -~~~~g~~~~~ape~~~-~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
...+||..|||||++. ...|....|+|++ +..+.+|.++|..
T Consensus 347 ~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~ 393 (689)
T 3v5w_A 347 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 393 (689)
T ss_dssp CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCG
T ss_pred CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 3468999999999885 4678888999994 5566788888864
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=312.22 Aligned_cols=189 Identities=18% Similarity=0.277 Sum_probs=167.5
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
++|+++++||+|+||.||+|.+ +|+.||||+++... ....+.+.+|+.+|++++|||||++++++.+...+|||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 5799999999999999999998 47899999997543 3445778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccC--CCeEEEEEeeccee------e
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN--EVSLLLSLCLFTVS------I 441 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~--~~~kl~DFGla~~~------~ 441 (492)
||+||+|.++|.+..+.+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++.. .
T Consensus 235 ~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~ 314 (573)
T 3uto_A 235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 314 (573)
T ss_dssp CCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEE
T ss_pred ecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCcee
Confidence 999999999997666789999999999999999999999999999999999999854 79999999999753 3
Q ss_pred eeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 442 LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 442 ~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
..+|+..||+||.+....|....|+|++ +..+.+|.++|..
T Consensus 315 ~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~ 358 (573)
T 3uto_A 315 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG 358 (573)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred eeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 5679999999999988889888999984 4455677777754
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=294.66 Aligned_cols=182 Identities=19% Similarity=0.243 Sum_probs=152.7
Q ss_pred CCceeeeeeeecCceEEEEEEEC-----CceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCeEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLC 365 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~-----g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~ 365 (492)
+.|++.++||+|+||.||+|++. ++.||||++.... ...++.+|+.+|+.+ +||||+++++++...+.+|
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 46899999999999999999862 4679999987542 235688999999998 6999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccC-CCeEEEEEeeccee----
Q 011158 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-EVSLLLSLCLFTVS---- 440 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~-~~~kl~DFGla~~~---- 440 (492)
||||||+||+|.+++. .+++.+++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+..
T Consensus 97 lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172 (361)
T ss_dssp EEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred EEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence 9999999999999984 48999999999999999999999999999999999999877 79999999999632
Q ss_pred -------------------------------eeeeCCCceeecceecc-ccccCccceeee---ecccccCCCCCC
Q 011158 441 -------------------------------ILFCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 441 -------------------------------~~~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...+||..|++||.+.. ..++...|+|++ +....+|.++|.
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 12357888888887654 456777788884 445556765553
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-32 Score=271.68 Aligned_cols=198 Identities=33% Similarity=0.508 Sum_probs=165.3
Q ss_pred CCceeeCCCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCe
Q 011158 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (492)
Q Consensus 284 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 363 (492)
.+.+++...+|++.++||+|+||.||+|++.++.||||++..........+.+.+|+.++++++||||+++++++...+.
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 45678889999999999999999999999999999999998776667777889999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCCEEEccCCCeEEEEEeecce
Q 011158 364 LCIVTEFMSGGSVYDYLHKLKG--VFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEVSLLLSLCLFTV 439 (492)
Q Consensus 364 ~~lV~Ey~~ggsL~~~L~~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~--IiHrDLKp~NILld~~~~~kl~DFGla~~ 439 (492)
+++||||+++|+|.+++.+... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 9999999999999999976322 3899999999999999999999999 99999999999999999999999999865
Q ss_pred ee-------eeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 440 SI-------LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 440 ~~-------~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
.. ...++..|++||......+....|+|++ +.....|..+|.
T Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~ 240 (309)
T 3p86_A 189 KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG 240 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTT
T ss_pred ccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 32 3467888999998888888888899884 223334544443
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.97 E-value=9.8e-32 Score=272.78 Aligned_cols=190 Identities=23% Similarity=0.360 Sum_probs=164.6
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
..+|++.+.||+|+||.||+|.+ +++.||||++.....+....+.+.+|+.+|++++||||+++++++...+.+|+||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 35799999999999999999998 5789999999876666777788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee------ee
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS------IL 442 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~------~~ 442 (492)
|||++|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.. ..
T Consensus 94 e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 172 (328)
T 3fe3_A 94 EYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA 172 (328)
T ss_dssp CCCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGT
T ss_pred ECCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCcccc
Confidence 99999999999977 367999999999999999999999999999999999999999999999999998643 23
Q ss_pred eeCCCceeecceecccccc-Cccceeee---ecccccCCCCCC
Q 011158 443 FCGKGRELISLFLGNDVLL-QFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 443 ~~g~~~~~ape~~~~e~~~-~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
..|+..|++||......+. ...|+|++ +....+|.++|.
T Consensus 173 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 215 (328)
T 3fe3_A 173 FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215 (328)
T ss_dssp TSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCC
Confidence 4677888999987766654 46788884 333445666654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-31 Score=265.19 Aligned_cols=181 Identities=25% Similarity=0.420 Sum_probs=162.4
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeE
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 364 (492)
+.+..++|.+.++||+|+||.||+|.+. ++.||+|++.. .+....+.+.+|+.++++++||||+++++++......
T Consensus 5 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 82 (310)
T 3s95_A 5 RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRL 82 (310)
T ss_dssp EEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred eeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCee
Confidence 4567789999999999999999999984 68899999864 3466678899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee---
Q 011158 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI--- 441 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~--- 441 (492)
++||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 99999999999999998877789999999999999999999999999999999999999999999999999986531
Q ss_pred ------------------eeeCCCceeecceeccccccCccceeee
Q 011158 442 ------------------LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 442 ------------------~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
...|+..|++||......+....|+|++
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 208 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSF 208 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHH
Confidence 2357777999998888778888888884
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=9.9e-32 Score=273.96 Aligned_cols=193 Identities=20% Similarity=0.343 Sum_probs=165.5
Q ss_pred eCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEE
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 365 (492)
+..++|++.+.||+|+||.||+|+. +++.||||+++.... .......+.+|+.+|++++||||+++++++...+.+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 3456899999999999999999998 478899999975321 1223467889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee-----
Q 011158 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS----- 440 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~----- 440 (492)
+||||++||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 82 lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred EEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence 99999999999999976 457899999999999999999999999999999999999999999999999998742
Q ss_pred --eeeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 441 --ILFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 441 --~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
....|+..|++||......+....|+|++ +....+|.++|..
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 207 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 207 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCC
Confidence 24568888999999888888888999984 3344456666643
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=262.11 Aligned_cols=183 Identities=30% Similarity=0.516 Sum_probs=160.6
Q ss_pred CCceeeCCCCceeeeeeeecCceEEEEEEE-CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 011158 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (492)
Q Consensus 284 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 362 (492)
...|.++.++|++.+.||+|+||.||+|.+ .++.||+|++....... +.+.+|+.++++++||||+++++++....
T Consensus 2 ~~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 78 (269)
T 4hcu_A 2 SGKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQA 78 (269)
T ss_dssp ---CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CccEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 346899999999999999999999999998 56789999998654333 67899999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-
Q 011158 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI- 441 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~- 441 (492)
..|+||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 79 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp SEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred ceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence 9999999999999999998767789999999999999999999999999999999999999999999999999987542
Q ss_pred -------eeeCCCceeecceeccccccCccceeee
Q 011158 442 -------LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 442 -------~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
...++..|++||......+....|+|++
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 193 (269)
T 4hcu_A 159 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSF 193 (269)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred cccccccCcccccccCCHHHhcCCCCCchhhhHHH
Confidence 1223446888988877777778888884
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=278.35 Aligned_cols=194 Identities=19% Similarity=0.279 Sum_probs=165.6
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCC-hHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCC
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPP 362 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~ 362 (492)
..+..++|++.++||+|+||.||+|++. ++.||||+++..... ......+.+|..++.++ +||||+++++++....
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 126 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence 3456678999999999999999999984 678999999865432 23345678899999887 8999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee--
Q 011158 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS-- 440 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~-- 440 (492)
.+|||||||+||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEEEEcCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 99999999999999999987 457999999999999999999999999999999999999999999999999998752
Q ss_pred -----eeeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 441 -----ILFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 441 -----~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...+|+..|++||++....+....|+|++ +....+|.++|.
T Consensus 206 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~ 254 (396)
T 4dc2_A 206 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254 (396)
T ss_dssp TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSST
T ss_pred CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCc
Confidence 24578889999999988888888999994 334456777764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=274.46 Aligned_cols=194 Identities=23% Similarity=0.335 Sum_probs=162.1
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCe
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPS 363 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~ 363 (492)
.+..++|++.++||+|+||.||+|++. ++.||||+++.... .......+.+|..+++.+ +||||+++++++.....
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 455678999999999999999999984 68899999975321 123346688899999998 69999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee---
Q 011158 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS--- 440 (492)
Q Consensus 364 ~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~--- 440 (492)
+|||||||+||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 99 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 9999999999999999987 367999999999999999999999999999999999999999999999999998752
Q ss_pred ----eeeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 441 ----ILFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 441 ----~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
...+|+..|++||......+....|+|++ +....+|.++|..
T Consensus 178 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~ 226 (353)
T 3txo_A 178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA 226 (353)
T ss_dssp --------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCC
Confidence 24568889999999888888888999994 3344456666643
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-31 Score=269.27 Aligned_cols=192 Identities=19% Similarity=0.286 Sum_probs=166.7
Q ss_pred eCCCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCeE
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSL 364 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~ 364 (492)
+..++|++.+.||+|+||.||+|++. ++.||||+++.... .......+.+|..+++++ +||||+++++++.....+
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 85 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 85 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence 44568999999999999999999984 68899999986543 344566788999999998 899999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee----
Q 011158 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS---- 440 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~---- 440 (492)
|+||||+++|+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 86 ~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp EEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 999999999999999976 357999999999999999999999999999999999999999999999999998752
Q ss_pred ---eeeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 441 ---ILFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 441 ---~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
....|+..|++||......+....|+|++ +....+|.++|.
T Consensus 165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 211 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcC
Confidence 23568889999999888888888999984 334456766664
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=283.11 Aligned_cols=196 Identities=16% Similarity=0.196 Sum_probs=164.8
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCe
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 363 (492)
+.+..++|++.++||+|+||.||+|++. ++.||||+++.... .......+.+|+.++..++||||++++++|.+...
T Consensus 69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 148 (437)
T 4aw2_A 69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN 148 (437)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCE
Confidence 3455678999999999999999999984 57899999974211 11112348889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee--
Q 011158 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-- 441 (492)
Q Consensus 364 ~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-- 441 (492)
+|||||||+||+|.+++.+..+.+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++...
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 228 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 228 (437)
T ss_dssp EEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccC
Confidence 999999999999999998766789999999999999999999999999999999999999999999999999985431
Q ss_pred ------eeeCCCceeecceec-----cccccCccceeee---ecccccCCCCCCC
Q 011158 442 ------LFCGKGRELISLFLG-----NDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 442 ------~~~g~~~~~ape~~~-----~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
...|+..|++||++. ...+....|+|++ +....+|.++|..
T Consensus 229 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~ 283 (437)
T 4aw2_A 229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA 283 (437)
T ss_dssp SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCC
Confidence 246888899999875 4567778899984 3345567777654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=276.59 Aligned_cols=185 Identities=25% Similarity=0.451 Sum_probs=161.2
Q ss_pred CCceeeCCCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 011158 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (492)
Q Consensus 284 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 361 (492)
.+.|+++.++|++.++||+|+||.||+|++. ++.||||+++.. ........|.+|+.+|++++||||+++++++...
T Consensus 106 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 184 (377)
T 3cbl_A 106 KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK 184 (377)
T ss_dssp CCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC
Confidence 4568999999999999999999999999994 788999999754 3455566789999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee
Q 011158 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI 441 (492)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~ 441 (492)
+.+|||||||++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 185 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 185 QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 99999999999999999998766679999999999999999999999999999999999999999999999999987531
Q ss_pred e----e-----eCCCceeecceeccccccCccceeee
Q 011158 442 L----F-----CGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 442 ~----~-----~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
. . .++..|++||......+....|+|++
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 301 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSF 301 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHH
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHH
Confidence 1 1 12335888887776667777888884
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-31 Score=266.62 Aligned_cols=194 Identities=26% Similarity=0.338 Sum_probs=164.0
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEEC-----CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~~-----g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 361 (492)
.++...+|++.+.||+|+||.||+|.+. +..||||+++.. ......+.+.+|+.++++++||||+++++++...
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 122 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 4677889999999999999999999983 245999999854 3455667899999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee
Q 011158 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI 441 (492)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~ 441 (492)
...||||||+++|+|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 99999999999999999998766789999999999999999999999999999999999999999999999999987542
Q ss_pred e----------eeCCCceeecceeccccccCccceeee----ecccccCCCCCC
Q 011158 442 L----------FCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSD 481 (492)
Q Consensus 442 ~----------~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~ 481 (492)
. ..++..|++||......+....|+|++ +....+|..+|.
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~ 256 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYW 256 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcc
Confidence 1 122345888988877777778888884 222233666653
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-31 Score=278.56 Aligned_cols=181 Identities=31% Similarity=0.483 Sum_probs=159.9
Q ss_pred CceeeCCCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC-e
Q 011158 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP-S 363 (492)
Q Consensus 285 ~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-~ 363 (492)
..|+++.++|++.++||+|+||.||+|.+.++.||||+++... ..+.|.+|+.+|++++||||+++++++.... .
T Consensus 186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 261 (450)
T 1k9a_A 186 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 261 (450)
T ss_dssp TTCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred cccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence 4589999999999999999999999999999999999998643 3467999999999999999999999987665 7
Q ss_pred EEEEEeccCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-
Q 011158 364 LCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI- 441 (492)
Q Consensus 364 ~~lV~Ey~~ggsL~~~L~~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~- 441 (492)
+|||||||++|+|.+++.+... .+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 9999999999999999987543 47999999999999999999999999999999999999999999999999987542
Q ss_pred ---eeeCCCceeecceeccccccCccceeee
Q 011158 442 ---LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 442 ---~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
...++..|++||......+....|+|++
T Consensus 342 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwsl 372 (450)
T 1k9a_A 342 TQDTGKLPVKWTAPEALREKKFSTKSDVWSF 372 (450)
T ss_dssp -----CCCTTTSCHHHHHSSCCCHHHHHHHH
T ss_pred cccCCCCCcceeCHHHhcCCCCCcHHHHHHH
Confidence 2244567899998877778888888884
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-31 Score=267.95 Aligned_cols=192 Identities=19% Similarity=0.319 Sum_probs=165.2
Q ss_pred CCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEE
Q 011158 290 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (492)
Q Consensus 290 ~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 366 (492)
..++|++.+.||+|+||.||+|+. +++.||+|+++.... .....+.+.+|+.+++.++||||+++++++.+...+|+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 346799999999999999999998 478899999975321 11234667889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee----ee
Q 011158 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS----IL 442 (492)
Q Consensus 367 V~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~----~~ 442 (492)
||||++||+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.. ..
T Consensus 84 v~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~~~ 162 (318)
T 1fot_A 84 IMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT 162 (318)
T ss_dssp EECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCC
T ss_pred EEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCcccc
Confidence 9999999999999987 467899999999999999999999999999999999999999999999999998754 24
Q ss_pred eeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 443 FCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 443 ~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
..|+..|++||......+....|+|++ +....+|.++|..
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 205 (318)
T 1fot_A 163 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD 205 (318)
T ss_dssp CCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence 568889999999888888888999994 3344556666643
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-31 Score=272.31 Aligned_cols=196 Identities=23% Similarity=0.405 Sum_probs=163.8
Q ss_pred CceeeCCCCceeeeeeeecCceEEEEEEEC---------CceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeE
Q 011158 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC---------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQF 354 (492)
Q Consensus 285 ~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~---------g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l 354 (492)
..|++..++|++.+.||+|+||.||+|++. +..||||+++.. ......+.+.+|+.+|+++ +||||+++
T Consensus 74 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~ 152 (370)
T 2psq_A 74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINL 152 (370)
T ss_dssp TTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCE
T ss_pred ccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 346788889999999999999999999863 245999999764 2345567899999999999 89999999
Q ss_pred EEEEecCCeEEEEEeccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q 011158 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419 (492)
Q Consensus 355 ~g~~~~~~~~~lV~Ey~~ggsL~~~L~~~~---------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~ 419 (492)
++++...+.+|+||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 153 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~ 232 (370)
T 2psq_A 153 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 232 (370)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred EEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchh
Confidence 999999999999999999999999998643 35899999999999999999999999999999999
Q ss_pred CEEEccCCCeEEEEEeecceeee---------eeCCCceeecceeccccccCccceeee----ecccccCCCCCC
Q 011158 420 NLLMDENEVSLLLSLCLFTVSIL---------FCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSD 481 (492)
Q Consensus 420 NILld~~~~~kl~DFGla~~~~~---------~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~ 481 (492)
|||++.++.+||+|||+++.... ..++..|++||......+....|+|++ +.....|.++|.
T Consensus 233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~ 307 (370)
T 2psq_A 233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 307 (370)
T ss_dssp GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence 99999999999999999874321 223456889998877778888899884 222233655554
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=259.73 Aligned_cols=191 Identities=18% Similarity=0.288 Sum_probs=162.8
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 367 (492)
.++|++.+.||+|+||.||+|.+ .++.||+|++..... .....+.+.+|+.++++++||||+++++++...+.+|+|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 46899999999999999999987 468899999865433 345567899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee------
Q 011158 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------ 441 (492)
Q Consensus 368 ~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------ 441 (492)
|||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 90 ~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 168 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ 168 (294)
T ss_dssp EECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------
T ss_pred EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccccc
Confidence 9999999999999773 579999999999999999999999999999999999999999999999999986432
Q ss_pred --eeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 442 --LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 442 --~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
...++..|++||......+....|+|++ +....+|.++|..
T Consensus 169 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~ 214 (294)
T 4eqm_A 169 TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNG 214 (294)
T ss_dssp ------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCS
T ss_pred cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 2457888999998888888888899884 2334456666653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=263.30 Aligned_cols=188 Identities=15% Similarity=0.226 Sum_probs=163.4
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
++|++.+.||+|+||.||+|++. ++.||+|+++.. ......+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 57899999999999999999984 688999999754 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcc--CCCeEEEEEeeccee------e
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE--NEVSLLLSLCLFTVS------I 441 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~--~~~~kl~DFGla~~~------~ 441 (492)
||++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++... .
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 161 (321)
T 1tki_A 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR 161 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEE
T ss_pred eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccc
Confidence 99999999999775567999999999999999999999999999999999999997 789999999998653 2
Q ss_pred eeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 442 LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 442 ~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
...++..|++||......+....|+|++ +....+|.++|..
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 205 (321)
T 1tki_A 162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA 205 (321)
T ss_dssp EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred cccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcC
Confidence 4567888999998887777888899984 3344566666643
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=255.10 Aligned_cols=181 Identities=26% Similarity=0.397 Sum_probs=159.1
Q ss_pred ceeeCCCCceeeeeeeecCceEEEEEEECC-ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeE
Q 011158 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (492)
Q Consensus 286 ~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g-~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 364 (492)
.|++..++|++.+.||+|+||.||+|.+.+ ..||+|+++..... ...+.+|+.++++++||||+++++++......
T Consensus 2 ~~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 2 HMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS---EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred ceEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence 367888999999999999999999998865 57999999865433 36789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee---
Q 011158 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI--- 441 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~--- 441 (492)
++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.+....
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 99999999999999998866679999999999999999999999999999999999999999999999999986432
Q ss_pred -----eeeCCCceeecceeccccccCccceeee
Q 011158 442 -----LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 442 -----~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
...++..|++||......+....|+|++
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 191 (268)
T 3sxs_A 159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAF 191 (268)
T ss_dssp EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHH
T ss_pred hhcccCCCcCcccCCHHHHhccCCchhhhhHHH
Confidence 1223345888888877778888899884
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.6e-31 Score=265.37 Aligned_cols=194 Identities=24% Similarity=0.365 Sum_probs=157.5
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEE-----CCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 360 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~-----~g~~vAvK~l~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 360 (492)
.+..++|++.+.||+|+||.||+++. .++.||+|+++.... .......+.+|+.+|++++||||+++++++..
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 56667899999999999999999987 467899999986532 22334568899999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 361 ~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
.+.+|+|||||++|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred CCEEEEEEeCCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 9999999999999999999976 456899999999999999999999999999999999999999999999999998653
Q ss_pred e-------eeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 441 I-------LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 441 ~-------~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
. ...|+..|++||......+....|+|++ +....+|.++|..
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 223 (327)
T 3a62_A 172 IHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG 223 (327)
T ss_dssp -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCC
Confidence 2 2457788999998887778888899984 3334456666654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.5e-31 Score=260.97 Aligned_cols=187 Identities=19% Similarity=0.307 Sum_probs=161.2
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
++|++.++||+|+||.||+|.+ +++.||||++...... ..+.+.+|+.++++++||||+++++++...+.+|+|||
T Consensus 20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 5688889999999999999987 5788999999754322 24678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------e
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-------L 442 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-------~ 442 (492)
|+++|+|.+++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... .
T Consensus 98 ~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 175 (297)
T 3fxz_A 98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (297)
T ss_dssp CCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred CCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCC
Confidence 9999999999977 468999999999999999999999999999999999999999999999999876432 3
Q ss_pred eeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 443 FCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 443 ~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
..++..|++||......+....|+|++ +....+|.++|..
T Consensus 176 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 218 (297)
T 3fxz_A 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218 (297)
T ss_dssp CCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 467888999998888888888899984 2234456666543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.6e-31 Score=269.21 Aligned_cols=190 Identities=20% Similarity=0.298 Sum_probs=163.8
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCh----HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS----DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 365 (492)
+.|++.+.||+|+||.||+|++. ++.||+|+++...... ...+.+.+|+.+|++++||||+++++++.....+|
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 46899999999999999999984 7889999998654322 13567899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCC----CeEEEEEeeccee-
Q 011158 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE----VSLLLSLCLFTVS- 440 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~----~~kl~DFGla~~~- 440 (492)
+||||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 92 lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~ 170 (361)
T 2yab_A 92 LILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (361)
T ss_dssp EEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred EEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence 99999999999999976 46799999999999999999999999999999999999998877 7999999998653
Q ss_pred -----eeeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 441 -----ILFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 441 -----~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
....|+..|++||......+....|+|++ +....+|.++|..
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~ 220 (361)
T 2yab_A 171 DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220 (361)
T ss_dssp TTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred CCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 23467888999998888788888899994 3345567776643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=267.83 Aligned_cols=190 Identities=17% Similarity=0.270 Sum_probs=165.6
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
++|++.+.||+|+||.||+|.+. ++.||+|++..........+.+.+|+.++++++||||+++++++...+..|+|||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 47899999999999999999984 7889999998776666677889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCC---CeEEEEEeecceee-----
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE---VSLLLSLCLFTVSI----- 441 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~---~~kl~DFGla~~~~----- 441 (492)
||++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 109 ~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~ 187 (362)
T 2bdw_A 109 LVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 187 (362)
T ss_dssp CCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSC
T ss_pred cCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCccc
Confidence 9999999999976 45789999999999999999999999999999999999998654 59999999986532
Q ss_pred -eeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 442 -LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 442 -~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
...|+..|++||......+....|+|++ +....+|.++|..
T Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~ 232 (362)
T 2bdw_A 188 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 232 (362)
T ss_dssp CCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 3467888999999888888888899984 3345566666543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=266.58 Aligned_cols=193 Identities=17% Similarity=0.202 Sum_probs=164.2
Q ss_pred CCceeeCCCCceeeeeeeecCceEEEEEE-------ECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC---CCceee
Q 011158 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGT-------YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNVVQ 353 (492)
Q Consensus 284 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~~~-------~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~ 353 (492)
...+++..++|.+.++||+|+||.||+|+ ..++.||||+++... ..++.+|+.++++++ |+||++
T Consensus 57 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~ 131 (365)
T 3e7e_A 57 KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMK 131 (365)
T ss_dssp SCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCC
T ss_pred ceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhh
Confidence 35678888999999999999999999994 256889999997542 356788888888887 899999
Q ss_pred EEEEEecCCeEEEEEeccCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcc----
Q 011158 354 FIGACTKPPSLCIVTEFMSGGSVYDYLHK----LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---- 425 (492)
Q Consensus 354 l~g~~~~~~~~~lV~Ey~~ggsL~~~L~~----~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~---- 425 (492)
+++++...+..|||||||++|+|.+++.. ....+++..++.++.||+.||.|||++|||||||||+|||++.
T Consensus 132 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~ 211 (365)
T 3e7e_A 132 FYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLE 211 (365)
T ss_dssp EEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTC
T ss_pred hheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccC
Confidence 99999999999999999999999999975 2457999999999999999999999999999999999999998
Q ss_pred -------CCCeEEEEEeeccee---------eeeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 426 -------NEVSLLLSLCLFTVS---------ILFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 426 -------~~~~kl~DFGla~~~---------~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
++.+||+|||+++.. ....|+..|++||+.....+....|+|++ +....+|.++|.
T Consensus 212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 286 (365)
T 3e7e_A 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKV 286 (365)
T ss_dssp C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCE
T ss_pred ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccc
Confidence 899999999999532 23457889999999888888888899984 333445554443
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-31 Score=274.39 Aligned_cols=194 Identities=16% Similarity=0.274 Sum_probs=164.5
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCe
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 363 (492)
..+..++|++.+.||+|+||.||+|.+. ++.||+|++..... .......+.+|+.+|++++||||+++++++.....
T Consensus 10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 89 (384)
T 4fr4_A 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED 89 (384)
T ss_dssp CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 4667789999999999999999999984 57899999975321 12234678899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee---
Q 011158 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS--- 440 (492)
Q Consensus 364 ~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~--- 440 (492)
+|+|||||.||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 90 ~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp EEEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 9999999999999999976 567999999999999999999999999999999999999999999999999999753
Q ss_pred ---eeeeCCCceeecceecc---ccccCccceeee---ecccccCCCCCC
Q 011158 441 ---ILFCGKGRELISLFLGN---DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 441 ---~~~~g~~~~~ape~~~~---e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
....|+..|++||++.. ..+....|+|++ +....+|.++|.
T Consensus 169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~ 218 (384)
T 4fr4_A 169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYH 218 (384)
T ss_dssp CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCC
Confidence 24568888999998753 346777899984 333445666664
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7.3e-31 Score=258.34 Aligned_cols=195 Identities=29% Similarity=0.478 Sum_probs=163.2
Q ss_pred CCceeeCCCCceeeeeeeecCceEEEEEEECC-ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 011158 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (492)
Q Consensus 284 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g-~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 362 (492)
...|+++.++|++.+.||+|+||.||+|.+.+ ..||||+++...... +++.+|+.++++++||||+++++++....
T Consensus 16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 92 (283)
T 3gen_A 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQR 92 (283)
T ss_dssp CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEecCC
Confidence 34689999999999999999999999999864 579999998654433 67899999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee
Q 011158 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL 442 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~ 442 (492)
..|+||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 93 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 99999999999999999987667799999999999999999999999999999999999999999999999999875421
Q ss_pred --------eeCCCceeecceeccccccCccceeee----ecccccCCCCCC
Q 011158 443 --------FCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSD 481 (492)
Q Consensus 443 --------~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~ 481 (492)
..++..|++||......+....|+|++ +.....|.++|.
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~ 223 (283)
T 3gen_A 173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 223 (283)
T ss_dssp HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 223446888888877777777888884 222223665554
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=278.79 Aligned_cols=196 Identities=15% Similarity=0.159 Sum_probs=165.2
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCe
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 363 (492)
+.+..++|++.++||+|+||.||+|++ +++.||||+++.... .......+.+|..++.+++||||+++++++.+.+.
T Consensus 56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 135 (412)
T 2vd5_A 56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY 135 (412)
T ss_dssp HSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 345667899999999999999999998 478999999974321 11223457889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee--
Q 011158 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-- 441 (492)
Q Consensus 364 ~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-- 441 (492)
+|||||||+||+|.+++.+....+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++...
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~ 215 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD 215 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence 999999999999999998766689999999999999999999999999999999999999999999999999986531
Q ss_pred ------eeeCCCceeecceec-------cccccCccceeee---ecccccCCCCCCC
Q 011158 442 ------LFCGKGRELISLFLG-------NDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 442 ------~~~g~~~~~ape~~~-------~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
...|+..|++||++. ...+....|+|++ +....+|.++|..
T Consensus 216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 272 (412)
T 2vd5_A 216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA 272 (412)
T ss_dssp SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC
Confidence 246788899998775 3567778899984 3344567776654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-31 Score=269.40 Aligned_cols=194 Identities=19% Similarity=0.302 Sum_probs=163.7
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCe
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPS 363 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~ 363 (492)
.+..++|++.+.||+|+||.||+|++. ++.||||+++.... .......+..|..++.++ +||||+++++++.....
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 456678999999999999999999984 68899999975321 112345678899999987 89999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee---
Q 011158 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS--- 440 (492)
Q Consensus 364 ~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~--- 440 (492)
+|+||||++||+|.+++.+ .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171 (345)
T ss_dssp EEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence 9999999999999999987 357899999999999999999999999999999999999999999999999998743
Q ss_pred ----eeeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 441 ----ILFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 441 ----~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
....|+..|++||......+....|+|++ +....+|.++|..
T Consensus 172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 220 (345)
T 1xjd_A 172 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 220 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCC
Confidence 24568888999999888888888899984 3344567666643
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-31 Score=280.34 Aligned_cols=195 Identities=21% Similarity=0.341 Sum_probs=157.6
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCe
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 363 (492)
+.+..++|++.++||+|+||.||+|.+ +++.||||+++.... .......+.+|+.++++++||||+++++++...+.
T Consensus 143 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 222 (446)
T 4ejn_A 143 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR 222 (446)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTE
T ss_pred cCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCE
Confidence 455667899999999999999999998 468899999975421 23344678899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEccCCCeEEEEEeeccee--
Q 011158 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVSLLLSLCLFTVS-- 440 (492)
Q Consensus 364 ~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~-~~IiHrDLKp~NILld~~~~~kl~DFGla~~~-- 440 (492)
+|||||||++|+|.+++.+ ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++..
T Consensus 223 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 223 LCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EEEEECCCSSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEEEEeeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 9999999999999999977 4578999999999999999999998 99999999999999999999999999998752
Q ss_pred -----eeeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 441 -----ILFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 441 -----~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
....|+..|++||+.....+....|+|++ +....+|.++|..
T Consensus 302 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 351 (446)
T 4ejn_A 302 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 351 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCC
Confidence 23567889999999888888888899984 3334456666643
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=278.99 Aligned_cols=194 Identities=18% Similarity=0.173 Sum_probs=161.9
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCe
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 363 (492)
+.+..++|++.++||+|+||.||+|++. ++.||+|+++.... .......+.+|+.+++.++||||+++++++.+...
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 3455678999999999999999999984 67899999964211 01112347889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee--
Q 011158 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-- 441 (492)
Q Consensus 364 ~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-- 441 (492)
+|||||||+||+|.+++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 144 ~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~ 221 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 221 (410)
T ss_dssp EEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccC
Confidence 9999999999999999976 468999999999999999999999999999999999999999999999999986431
Q ss_pred ------eeeCCCceeecceecccc----ccCccceeee---ecccccCCCCCCC
Q 011158 442 ------LFCGKGRELISLFLGNDV----LLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 442 ------~~~g~~~~~ape~~~~e~----~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
...|+..|++||++.... +....|+|++ +....+|.++|..
T Consensus 222 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 275 (410)
T 3v8s_A 222 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 275 (410)
T ss_dssp SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCC
Confidence 356888888888776543 6677899984 3345567776654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=257.00 Aligned_cols=177 Identities=20% Similarity=0.288 Sum_probs=155.1
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
++|++.++||+|+||.||+|.+ +++.||||+++...........+.+|+.++++++||||+++++++.....+|||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 5789999999999999999998 46889999998766666667889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------e
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-------L 442 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-------~ 442 (492)
|+. |+|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.++... .
T Consensus 82 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (292)
T 3o0g_A 82 FCD-QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160 (292)
T ss_dssp CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCS
T ss_pred cCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccC
Confidence 995 57777777767789999999999999999999999999999999999999999999999999986532 2
Q ss_pred eeCCCceeecceecccc-ccCccceeee
Q 011158 443 FCGKGRELISLFLGNDV-LLQFGTYWII 469 (492)
Q Consensus 443 ~~g~~~~~ape~~~~e~-~~~~~d~W~l 469 (492)
..++..|++||...... +....|+|++
T Consensus 161 ~~~t~~y~aPE~~~~~~~~~~~~Diwsl 188 (292)
T 3o0g_A 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSA 188 (292)
T ss_dssp CCSCGGGCCHHHHTTCSCCCTHHHHHHH
T ss_pred CccccCCcChHHHcCCCCcCchHHHHHH
Confidence 35567788888775544 6777888884
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.1e-31 Score=270.48 Aligned_cols=194 Identities=18% Similarity=0.293 Sum_probs=164.2
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCe
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPS 363 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~ 363 (492)
.+...+|++.+.||+|+||.||+|++. ++.||||+++.... .......+..|..++..+ +||||+++++++...+.
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 456678999999999999999999985 47799999975421 122346688899999988 79999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee---
Q 011158 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS--- 440 (492)
Q Consensus 364 ~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~--- 440 (492)
+||||||++||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 96 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 9999999999999999986 356999999999999999999999999999999999999999999999999998752
Q ss_pred ----eeeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 441 ----ILFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 441 ----~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
...+|+..|++||......+....|+|++ +....+|.++|..
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~ 223 (353)
T 2i0e_A 175 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 223 (353)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC
Confidence 24568889999999888888888899994 3344457666653
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.1e-31 Score=265.72 Aligned_cols=195 Identities=23% Similarity=0.354 Sum_probs=160.2
Q ss_pred CCCCceeeCCCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 011158 282 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (492)
Q Consensus 282 ~~~~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 361 (492)
++...+.++.++|++.++||+|+||.||+|++.++.||||+++.. ......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (322)
T 3soc_A 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRG 90 (322)
T ss_dssp CCCCCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred cCccccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccC
Confidence 345668899999999999999999999999999999999999643 33345567799999999999999999999874
Q ss_pred C----eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC----------CceecCCCCCCEEEccCC
Q 011158 362 P----SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN----------NIIHRDLKAANLLMDENE 427 (492)
Q Consensus 362 ~----~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~----------~IiHrDLKp~NILld~~~ 427 (492)
. .+|+|||||++|+|.+++.. ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++
T Consensus 91 ~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~ 168 (322)
T 3soc_A 91 TSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL 168 (322)
T ss_dssp CSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC
T ss_pred CCCCceEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC
Confidence 4 47999999999999999977 4589999999999999999999999 999999999999999999
Q ss_pred CeEEEEEeecceee---------eeeCCCceeecceecc-----ccccCccceeee---ecccccCCCCCC
Q 011158 428 VSLLLSLCLFTVSI---------LFCGKGRELISLFLGN-----DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 428 ~~kl~DFGla~~~~---------~~~g~~~~~ape~~~~-----e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
.+||+|||+++... ...++..|++||.... ..+....|+|++ +.....|.++|.
T Consensus 169 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~ 239 (322)
T 3soc_A 169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239 (322)
T ss_dssp CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSS
T ss_pred eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCC
Confidence 99999999996532 1346677888887654 334445577773 223334544443
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-30 Score=266.99 Aligned_cols=195 Identities=16% Similarity=0.169 Sum_probs=166.2
Q ss_pred eeeCCCCceeeeeeeec--CceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 011158 287 WEIDPKHLKFGSKVASG--SYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G--~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 362 (492)
+..+..+|++.++||+| +||.||+|++. ++.||||+++...........+.+|+.++++++||||+++++++...+
T Consensus 20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 99 (389)
T 3gni_B 20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN 99 (389)
T ss_dssp CCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC
Confidence 45566789999999999 99999999984 788999999877666677788999999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee
Q 011158 363 SLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI 441 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~ 441 (492)
.+|+|||||++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.+....
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 999999999999999999874 2569999999999999999999999999999999999999999999999999874321
Q ss_pred --------------eeeCCCceeecceecc--ccccCccceeee---ecccccCCCCCC
Q 011158 442 --------------LFCGKGRELISLFLGN--DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 --------------~~~g~~~~~ape~~~~--e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||.... ..+....|+|++ +....+|.++|.
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 238 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 238 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCC
Confidence 1245666888888766 567777888884 333445666664
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=260.76 Aligned_cols=177 Identities=16% Similarity=0.257 Sum_probs=149.0
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC-------
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP------- 362 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~------- 362 (492)
++|++.+.||+|+||.||+|++ +++.||||+++... .....+.+.+|+.+|++++||||+++++++....
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 4688899999999999999998 47889999998643 3445678999999999999999999999986543
Q ss_pred --------------------------------------------------eEEEEEeccCCCCHHHHHHhcC--CCCCHH
Q 011158 363 --------------------------------------------------SLCIVTEFMSGGSVYDYLHKLK--GVFKLP 390 (492)
Q Consensus 363 --------------------------------------------------~~~lV~Ey~~ggsL~~~L~~~~--~~l~~~ 390 (492)
.+++|||||++|+|.+++.... ...++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 3899999999999999998743 245677
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee-------------------eeCCCceee
Q 011158 391 SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL-------------------FCGKGRELI 451 (492)
Q Consensus 391 ~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~-------------------~~g~~~~~a 451 (492)
.++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ..++..|++
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 7899999999999999999999999999999999999999999999875422 246777888
Q ss_pred cceeccccccCccceeee
Q 011158 452 SLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 452 pe~~~~e~~~~~~d~W~l 469 (492)
||......+....|+|++
T Consensus 245 PE~~~~~~~~~~~Di~sl 262 (332)
T 3qd2_B 245 PEQIHGNNYSHKVDIFSL 262 (332)
T ss_dssp HHHHHCCCCCTHHHHHHH
T ss_pred hHHhcCCCCcchhhHHHH
Confidence 888777777777888874
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-30 Score=273.71 Aligned_cols=189 Identities=15% Similarity=0.240 Sum_probs=163.9
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
++|++.++||+|+||.||+|.+ +++.||+|++..........+.+.+|+.++++++||||+++++++...+..|+|||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 4688999999999999999988 57899999998776666667789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc---cCCCeEEEEEeecceee-----
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD---ENEVSLLLSLCLFTVSI----- 441 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld---~~~~~kl~DFGla~~~~----- 441 (492)
||+||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 91 ~~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~ 169 (444)
T 3soa_A 91 LVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA 169 (444)
T ss_dssp CCBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCB
T ss_pred eCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCce
Confidence 9999999999987 46799999999999999999999999999999999999998 45789999999986532
Q ss_pred --eeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 442 --LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 --~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...|+..|++||......+....|+|++ +....+|.++|.
T Consensus 170 ~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~ 214 (444)
T 3soa_A 170 WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFW 214 (444)
T ss_dssp CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCC
Confidence 2467888999999888888888899984 334456766664
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=7.9e-31 Score=259.89 Aligned_cols=181 Identities=25% Similarity=0.413 Sum_probs=154.7
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEE------CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 360 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 360 (492)
.++..++|++.++||+|+||.||+|++ .++.||||++... .....+.+.+|+.++++++||||+++++++..
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 82 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 456778999999999999999999985 4678999999753 45556789999999999999999999999864
Q ss_pred C--CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecc
Q 011158 361 P--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFT 438 (492)
Q Consensus 361 ~--~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~ 438 (492)
. ..+++||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 3 55899999999999999998866679999999999999999999999999999999999999999999999999997
Q ss_pred eeee----------eeCCCceeecceeccccccCccceeee
Q 011158 439 VSIL----------FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 439 ~~~~----------~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
.... ..++..|++||......+....|+|++
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 203 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSF 203 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHH
Confidence 5421 123344889998877777777888884
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=7.4e-31 Score=268.76 Aligned_cols=191 Identities=19% Similarity=0.301 Sum_probs=164.3
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 367 (492)
.++|++.+.||+|+||.||+|++ +++.||||+++.... .....+.+.+|+.++++++||||+++++++.....+|||
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 46789999999999999999998 478899999975321 122346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee----eee
Q 011158 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS----ILF 443 (492)
Q Consensus 368 ~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~----~~~ 443 (492)
|||++||+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.. ...
T Consensus 120 ~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~~~~ 198 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL 198 (350)
T ss_dssp EECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBCCC
T ss_pred EcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCCcccc
Confidence 9999999999999873 56999999999999999999999999999999999999999999999999998754 245
Q ss_pred eCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 444 CGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 444 ~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
.|+..|++||......+....|+|++ +....+|.++|..
T Consensus 199 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 240 (350)
T 1rdq_E 199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240 (350)
T ss_dssp EECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCC
Confidence 67888999998888888888899984 3344456666543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=260.54 Aligned_cols=191 Identities=21% Similarity=0.233 Sum_probs=158.7
Q ss_pred CCCCceeeeeeeecCceEEEEEEE-CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 290 DPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 290 ~~~~~~~~~~LG~G~fG~Vy~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
-.++|++.++||+|+||.||+|++ .++.||+|+++...........+.+|+.++++++||||+++++++.....+|+||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 346899999999999999999998 5788999999876555555678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------- 441 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------- 441 (492)
|||+ |+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 99 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 177 (311)
T 3niz_A 99 EFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYT 177 (311)
T ss_dssp ECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---
T ss_pred cCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCccccc
Confidence 9996 58999998866779999999999999999999999999999999999999999999999999986531
Q ss_pred eeeCCCceeecceecc-ccccCccceeee---ecccccCCCCCC
Q 011158 442 LFCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 ~~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||.... ..+....|+|++ +....+|.++|.
T Consensus 178 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 221 (311)
T 3niz_A 178 HEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFP 221 (311)
T ss_dssp CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCC
Confidence 2356777889987654 556777888884 223345555553
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=263.42 Aligned_cols=183 Identities=23% Similarity=0.391 Sum_probs=159.4
Q ss_pred ceeeCCCCceeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEE
Q 011158 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 358 (492)
Q Consensus 286 ~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g-------~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~ 358 (492)
.+++..++|++.+.||+|+||.||+|++.+ +.||||+++... .....+.+.+|+.++++++||||+++++++
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 357778899999999999999999999854 679999998643 455667899999999999999999999999
Q ss_pred ecCCeEEEEEeccCCCCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecC
Q 011158 359 TKPPSLCIVTEFMSGGSVYDYLHKLK-----------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415 (492)
Q Consensus 359 ~~~~~~~lV~Ey~~ggsL~~~L~~~~-----------------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrD 415 (492)
...+..|+||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+|||
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D 199 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 199 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 99999999999999999999998642 5689999999999999999999999999999
Q ss_pred CCCCCEEEccCCCeEEEEEeeccee---------eeeeCCCceeecceeccccccCccceeee
Q 011158 416 LKAANLLMDENEVSLLLSLCLFTVS---------ILFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 416 LKp~NILld~~~~~kl~DFGla~~~---------~~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
|||+|||++.++.+||+|||++... ....++..|++||......+....|+|++
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 262 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAY 262 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHH
Confidence 9999999999999999999998542 12345566888988777777778888884
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.9e-31 Score=266.10 Aligned_cols=197 Identities=26% Similarity=0.405 Sum_probs=163.5
Q ss_pred CceeeCCCCceeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeEEE
Q 011158 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIG 356 (492)
Q Consensus 285 ~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~-------g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g 356 (492)
..|++..++|++.++||+|+||.||+|.+. ++.||||+++.. ......+.+.+|+.+++++ +||||+++++
T Consensus 15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~~~ 93 (359)
T 3vhe_A 15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLG 93 (359)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence 458999999999999999999999999852 367999999754 3445567899999999999 7899999999
Q ss_pred EEecCCe-EEEEEeccCCCCHHHHHHhcCC--------------------------------------------------
Q 011158 357 ACTKPPS-LCIVTEFMSGGSVYDYLHKLKG-------------------------------------------------- 385 (492)
Q Consensus 357 ~~~~~~~-~~lV~Ey~~ggsL~~~L~~~~~-------------------------------------------------- 385 (492)
++...+. +++|||||++|+|.+++.....
T Consensus 94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (359)
T 3vhe_A 94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173 (359)
T ss_dssp EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence 9987654 8999999999999999976432
Q ss_pred ---------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee---------e
Q 011158 386 ---------------VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS---------I 441 (492)
Q Consensus 386 ---------------~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~---------~ 441 (492)
.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++... .
T Consensus 174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 253 (359)
T 3vhe_A 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253 (359)
T ss_dssp ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC-
T ss_pred chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcc
Confidence 1899999999999999999999999999999999999999999999999998643 1
Q ss_pred eeeCCCceeecceeccccccCccceeee----ecccccCCCCCCC
Q 011158 442 LFCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSDA 482 (492)
Q Consensus 442 ~~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~a 482 (492)
...++..|++||......+....|+|++ +.....|.++|..
T Consensus 254 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 298 (359)
T 3vhe_A 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 298 (359)
T ss_dssp -CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred ccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCc
Confidence 2345567889998877777888898884 2222236666643
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=257.93 Aligned_cols=196 Identities=29% Similarity=0.514 Sum_probs=156.8
Q ss_pred CCceeeCCCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCe
Q 011158 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (492)
Q Consensus 284 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 363 (492)
.+.++|...+|++.++||+|+||.||+|++.+ .||||+++.........+.+.+|+.++++++||||+++++++. .+.
T Consensus 16 ~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~ 93 (289)
T 3og7_A 16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQ 93 (289)
T ss_dssp --CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred CCCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCc
Confidence 45689999999999999999999999998755 5999999877666777788999999999999999999999664 456
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee--
Q 011158 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-- 441 (492)
Q Consensus 364 ~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-- 441 (492)
.++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp CEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred cEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccc
Confidence 899999999999999998766789999999999999999999999999999999999999999999999999986432
Q ss_pred -------eeeCCCceeecceec---cccccCccceeee---ecccccCCCCCC
Q 011158 442 -------LFCGKGRELISLFLG---NDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 -------~~~g~~~~~ape~~~---~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||... ...+....|+|++ +....+|..+|.
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 226 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS 226 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCcc
Confidence 235677788888764 4445556788874 223334555554
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-30 Score=266.91 Aligned_cols=197 Identities=23% Similarity=0.402 Sum_probs=165.8
Q ss_pred CCceeeCCCCceeeeeeeecCceEEEEEEECC---------ceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceee
Q 011158 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS---------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQ 353 (492)
Q Consensus 284 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g---------~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~ 353 (492)
...|++..++|.+.++||+|+||.||+|++.+ ..||||+++.. ........+.+|+.+++++ +||||++
T Consensus 61 ~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~ 139 (382)
T 3tt0_A 61 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIIN 139 (382)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhh
Confidence 34578999999999999999999999998732 46999999864 3455667899999999999 8999999
Q ss_pred EEEEEecCCeEEEEEeccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 011158 354 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 418 (492)
Q Consensus 354 l~g~~~~~~~~~lV~Ey~~ggsL~~~L~~~~---------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp 418 (492)
+++++...+.+|+||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 219 (382)
T 3tt0_A 140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 219 (382)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred heeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCc
Confidence 9999999999999999999999999998743 3589999999999999999999999999999999
Q ss_pred CCEEEccCCCeEEEEEeecceee---------eeeCCCceeecceeccccccCccceeee----ecccccCCCCCC
Q 011158 419 ANLLMDENEVSLLLSLCLFTVSI---------LFCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSD 481 (492)
Q Consensus 419 ~NILld~~~~~kl~DFGla~~~~---------~~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~ 481 (492)
+|||++.++.+||+|||+++... ...++..|++||......+....|+|++ +....+|..+|.
T Consensus 220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~ 295 (382)
T 3tt0_A 220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 295 (382)
T ss_dssp GGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999987532 1233456888888877777778899884 222233655554
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=9.5e-31 Score=270.02 Aligned_cols=193 Identities=26% Similarity=0.362 Sum_probs=156.9
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEEC-----CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~~-----g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 361 (492)
.+++..+|++.+.||+|+||.||+|++. +..||||+++... .....+.|.+|+.++++++||||+++++++...
T Consensus 40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 118 (373)
T 2qol_A 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS 118 (373)
T ss_dssp CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 4677789999999999999999999864 4679999997643 455667899999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee
Q 011158 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI 441 (492)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~ 441 (492)
..+|||||||++|+|.+++.+....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 99999999999999999998866689999999999999999999999999999999999999999999999999987542
Q ss_pred e----------eeCCCceeecceeccccccCccceeee----ecccccCCCCC
Q 011158 442 L----------FCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNS 480 (492)
Q Consensus 442 ~----------~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y 480 (492)
. ..++..|++||+.....+....|+|++ +....+|..+|
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~ 251 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTT
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCC
Confidence 1 112346889998877777778888884 22233465555
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-30 Score=252.22 Aligned_cols=181 Identities=30% Similarity=0.530 Sum_probs=159.6
Q ss_pred ceeeCCCCceeeeeeeecCceEEEEEEE-CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeE
Q 011158 286 VWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (492)
Q Consensus 286 ~~ei~~~~~~~~~~LG~G~fG~Vy~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 364 (492)
.|.++.++|++.+.||+|+||.||+|.+ .++.||+|+++..... .+.+.+|+.++++++||||+++++++...+..
T Consensus 2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (267)
T 3t9t_A 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 78 (267)
T ss_dssp -CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred ceEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCe
Confidence 4889999999999999999999999998 4678999999865433 36789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee---
Q 011158 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI--- 441 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~--- 441 (492)
++||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||.+....
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 79 CLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp EEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred EEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc
Confidence 99999999999999998866789999999999999999999999999999999999999999999999999987542
Q ss_pred -----eeeCCCceeecceeccccccCccceeee
Q 011158 442 -----LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 442 -----~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
...++..|++||......+....|+|++
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 191 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSF 191 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred ccccccccccccccChhhhcCCCccchhchhhh
Confidence 1233446888888776677777888884
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-30 Score=262.62 Aligned_cols=196 Identities=26% Similarity=0.407 Sum_probs=161.2
Q ss_pred CceeeCCCCceeeeeeeecCceEEEEEEE-------CCceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeEEE
Q 011158 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIG 356 (492)
Q Consensus 285 ~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~-------~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g 356 (492)
..|+++.++|++.+.||+|+||.||+|++ .+..||||+++... .....+.+.+|+.+++++ +||||+++++
T Consensus 38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 116 (344)
T 1rjb_A 38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLG 116 (344)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 46899999999999999999999999987 23579999997542 333457899999999999 8999999999
Q ss_pred EEecCCeEEEEEeccCCCCHHHHHHhcCC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 011158 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKG----------------------VFKLPSLLKVAIDVSKGMNYLHQNNIIHR 414 (492)
Q Consensus 357 ~~~~~~~~~lV~Ey~~ggsL~~~L~~~~~----------------------~l~~~~~~~i~~qI~~gL~yLH~~~IiHr 414 (492)
++...+.+|+||||+++|+|.+++..... .+++..++.++.||+.||.|||++||+||
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 196 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 196 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 99999999999999999999999986432 37899999999999999999999999999
Q ss_pred CCCCCCEEEccCCCeEEEEEeecceee---------eeeCCCceeecceeccccccCccceeee----ecccccCCCCCC
Q 011158 415 DLKAANLLMDENEVSLLLSLCLFTVSI---------LFCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSD 481 (492)
Q Consensus 415 DLKp~NILld~~~~~kl~DFGla~~~~---------~~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~ 481 (492)
||||+|||++.++.+||+|||++.... ...++..|++||......+....|+|++ +.....|.++|.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 999999999999999999999986431 1234456888887777777777888884 222223665554
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-30 Score=269.76 Aligned_cols=193 Identities=22% Similarity=0.350 Sum_probs=157.0
Q ss_pred eCCCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCC-hHHHHHHHHHHHH-HHhcCCCceeeEEEEEecCCeE
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFI-MRKVRHKNVVQFIGACTKPPSL 364 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~-~~~~~~~~~Ei~i-l~~l~HpnIv~l~g~~~~~~~~ 364 (492)
+..++|++.+.||+|+||.||+|++. ++.||||+++..... ......+.+|..+ ++.++||||+++++++...+.+
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 45578999999999999999999984 578999999765432 2334566777776 5778999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee----
Q 011158 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS---- 440 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~---- 440 (492)
|+||||++||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 115 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~ 193 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 193 (373)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred EEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence 999999999999999987 457899999999999999999999999999999999999999999999999998752
Q ss_pred ---eeeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 441 ---ILFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 441 ---~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
...+|+..|++||......+....|+|++ +....+|.++|..
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~ 241 (373)
T 2r5t_A 194 STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 241 (373)
T ss_dssp CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 23568888999999888888888999984 3344567666653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-30 Score=254.02 Aligned_cols=195 Identities=24% Similarity=0.353 Sum_probs=155.7
Q ss_pred CceeeCCCCceeeeeeeecCceEEEEEEEC-----CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Q 011158 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359 (492)
Q Consensus 285 ~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~-----g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~ 359 (492)
..|++..++|++.+.||+|+||.||+|.+. +..||+|+++.. ......+.+.+|+.++++++||||+++++++.
T Consensus 8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 86 (281)
T 1mp8_A 8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 86 (281)
T ss_dssp -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence 347888999999999999999999999874 245999998753 24455678999999999999999999999985
Q ss_pred cCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecce
Q 011158 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTV 439 (492)
Q Consensus 360 ~~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~ 439 (492)
.+..|+||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 87 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 87 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred -cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccc
Confidence 4568999999999999999987666799999999999999999999999999999999999999999999999999875
Q ss_pred ee--------eeeCCCceeecceeccccccCccceeee----ecccccCCCCCC
Q 011158 440 SI--------LFCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSD 481 (492)
Q Consensus 440 ~~--------~~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~ 481 (492)
.. ...++..|++||......+....|+|++ +.....|.++|.
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~ 219 (281)
T 1mp8_A 166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 219 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCC
Confidence 42 1233456888888776677777888884 222234665554
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-30 Score=255.73 Aligned_cols=189 Identities=17% Similarity=0.255 Sum_probs=158.7
Q ss_pred CCceeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEec
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 370 (492)
++|++.++||+|+||.||+|.+. ++.||+|+++...........+.+|+.++++++||||+++++++...+.+|+||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57899999999999999999984 78899999976544444456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee-------eee
Q 011158 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS-------ILF 443 (492)
Q Consensus 371 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~-------~~~ 443 (492)
++ ++|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.+... ...
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (288)
T 1ob3_A 82 LD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE 160 (288)
T ss_dssp CS-EEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred cC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccccccc
Confidence 96 5999999876678999999999999999999999999999999999999999999999999998642 123
Q ss_pred eCCCceeecceecc-ccccCccceeee---ecccccCCCCCC
Q 011158 444 CGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 444 ~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
.++..|++||.... ..+....|+|++ +....+|.++|.
T Consensus 161 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 202 (288)
T 1ob3_A 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFP 202 (288)
T ss_dssp -CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 56778899997754 456777888884 233445655554
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-30 Score=273.16 Aligned_cols=176 Identities=18% Similarity=0.218 Sum_probs=142.1
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-----CeE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-----PSL 364 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-----~~~ 364 (492)
++|++.++||+|+||.||+|.+ +++.||||++.....+....+.+.+|+.+|++++||||+++++++... ..+
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 6799999999999999999987 468899999986655666678899999999999999999999998433 569
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee---
Q 011158 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI--- 441 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~--- 441 (492)
||||||+ +|+|.+++.. ...+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++...
T Consensus 133 ~lv~e~~-~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 210 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210 (458)
T ss_dssp EEEECCC-SEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCT
T ss_pred EEEEecc-ccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCcc
Confidence 9999998 7899999976 5679999999999999999999999999999999999999999999999999997531
Q ss_pred -------------------------------eeeCCCceeeccee-ccccccCccceeee
Q 011158 442 -------------------------------LFCGKGRELISLFL-GNDVLLQFGTYWII 469 (492)
Q Consensus 442 -------------------------------~~~g~~~~~ape~~-~~e~~~~~~d~W~l 469 (492)
...++..|++||.+ ....+....|+|++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSl 270 (458)
T 3rp9_A 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSI 270 (458)
T ss_dssp TCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHH
T ss_pred ccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHH
Confidence 23456668888854 45556777788873
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.1e-30 Score=258.62 Aligned_cols=189 Identities=19% Similarity=0.273 Sum_probs=162.3
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCh----HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS----DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 365 (492)
+.|++.+.||+|+||.||+|.+. ++.||+|+++...... ...+.+.+|+.+|++++||||+++++++.....+|
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 46889999999999999999984 7889999997653321 13577999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCC----CeEEEEEeecceee
Q 011158 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE----VSLLLSLCLFTVSI 441 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~----~~kl~DFGla~~~~ 441 (492)
+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 91 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~ 169 (326)
T 2y0a_A 91 LILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169 (326)
T ss_dssp EEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence 99999999999999976 46799999999999999999999999999999999999999887 79999999986542
Q ss_pred ------eeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 442 ------LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 ------~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||......+....|+|++ +....+|.++|.
T Consensus 170 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 218 (326)
T 2y0a_A 170 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218 (326)
T ss_dssp TTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred CCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCC
Confidence 3457888999998887778888899984 334445666654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-30 Score=256.05 Aligned_cols=181 Identities=23% Similarity=0.356 Sum_probs=157.4
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEEC--C-------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEE
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC--S-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 357 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~~--g-------~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~ 357 (492)
.++..++|++.+.||+|+||.||+|.+. + ..||+|++... .....+.+.+|+.++++++||||++++++
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSKLSHKHLVLNYGV 80 (289)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG--GGGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred EEechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 3567789999999999999999999874 2 46999999643 24455789999999999999999999999
Q ss_pred EecCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCC--------e
Q 011158 358 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV--------S 429 (492)
Q Consensus 358 ~~~~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~--------~ 429 (492)
+...+..++||||+++|+|.+++.+....+++..++.++.||+.||.|||+++|+||||||+|||++.++. +
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 99999999999999999999999886666999999999999999999999999999999999999998887 9
Q ss_pred EEEEEeecceee---eeeCCCceeecceecc-ccccCccceeee
Q 011158 430 LLLSLCLFTVSI---LFCGKGRELISLFLGN-DVLLQFGTYWII 469 (492)
Q Consensus 430 kl~DFGla~~~~---~~~g~~~~~ape~~~~-e~~~~~~d~W~l 469 (492)
||+|||.+.... ...++..|++||.... ..+....|+|++
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl 204 (289)
T 4fvq_A 161 KLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSF 204 (289)
T ss_dssp EECCCCSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHH
T ss_pred eeccCcccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHH
Confidence 999999986542 2356778999998766 667777888884
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-30 Score=274.33 Aligned_cols=194 Identities=26% Similarity=0.439 Sum_probs=163.8
Q ss_pred CCceeeCCCCceeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 011158 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (492)
Q Consensus 284 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 362 (492)
.+.|++..++|++.++||+|+||.||+|.+. +..||||+++.... ..+.|.+|+.+|++++||||+++++++. .+
T Consensus 180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~ 255 (454)
T 1qcf_A 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVT-KE 255 (454)
T ss_dssp TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB---CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc---cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence 4569999999999999999999999999985 67899999986543 3478999999999999999999999987 55
Q ss_pred eEEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee
Q 011158 363 SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI 441 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~ 441 (492)
.+|||||||++|+|.++++... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 7899999999999999997543 368999999999999999999999999999999999999999999999999997642
Q ss_pred e--------eeCCCceeecceeccccccCccceeee----ecccccCCCCCC
Q 011158 442 L--------FCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSD 481 (492)
Q Consensus 442 ~--------~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~ 481 (492)
. ..++..|++||......+....|+|++ +....+|.++|.
T Consensus 336 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~ 387 (454)
T 1qcf_A 336 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYP 387 (454)
T ss_dssp CHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCC
Confidence 1 123446889998877777778888884 222334666553
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-30 Score=278.32 Aligned_cols=195 Identities=29% Similarity=0.492 Sum_probs=166.0
Q ss_pred CCceeeCCCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 011158 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (492)
Q Consensus 284 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 361 (492)
.+.|++...+|++.++||+|+||.||+|.+. +..||||+++..... .+.|.+|+.+|++++||||++++++|...
T Consensus 212 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 288 (495)
T 1opk_A 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTRE 288 (495)
T ss_dssp SSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 4569999999999999999999999999985 678999999865332 47899999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 362 PSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
..+|||||||++|+|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus 289 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 289 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM 368 (495)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceec
Confidence 99999999999999999998743 46899999999999999999999999999999999999999999999999998754
Q ss_pred ee--------eeCCCceeecceeccccccCccceeee----ecccccCCCCCC
Q 011158 441 IL--------FCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSD 481 (492)
Q Consensus 441 ~~--------~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~ 481 (492)
.. ..++..|++||......+....|+|++ +....+|.++|.
T Consensus 369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~ 421 (495)
T 1opk_A 369 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 421 (495)
T ss_dssp TTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCC
Confidence 21 122346888888877777778888884 222334665554
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-30 Score=251.20 Aligned_cols=195 Identities=24% Similarity=0.360 Sum_probs=164.8
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--CeE
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSL 364 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~ 364 (492)
+.++.++|++.+.||+|+||.||+|++.++.||||+++.........+.+.+|+.++++++||||+++++++... ...
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence 567788999999999999999999999999999999998766677778899999999999999999999999887 778
Q ss_pred EEEEeccCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCCEEEccCCCeEEEEEeecce--
Q 011158 365 CIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEVSLLLSLCLFTV-- 439 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~--IiHrDLKp~NILld~~~~~kl~DFGla~~-- 439 (492)
++||||+++|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+++.|||....
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 999999999999999987543 5899999999999999999999999 99999999999999999999988776533
Q ss_pred eeeeeCCCceeecceeccccccC---ccceeee---ecccccCCCCCC
Q 011158 440 SILFCGKGRELISLFLGNDVLLQ---FGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 440 ~~~~~g~~~~~ape~~~~e~~~~---~~d~W~l---~~~~~~gt~~Y~ 481 (492)
.....++..|++||......... ..|+|++ +....+|..+|.
T Consensus 165 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 212 (271)
T 3kmu_A 165 SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFA 212 (271)
T ss_dssp CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTT
T ss_pred ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 23456677888888876655544 4788884 222334555543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4.4e-30 Score=263.74 Aligned_cols=191 Identities=21% Similarity=0.275 Sum_probs=155.6
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEE
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 365 (492)
....++|++.++||+|+||.||++++ +++.||||++...... .+.+.+|+.++++++||||+++++++.....+|
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS---CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc---cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence 34567899999999999999999998 4788999999764322 256889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCC--eEEEEEeeccee---
Q 011158 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV--SLLLSLCLFTVS--- 440 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~--~kl~DFGla~~~--- 440 (492)
+|||||++|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++..
T Consensus 93 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 93 IIMEYASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred EEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 99999999999999976 456999999999999999999999999999999999999987765 999999998743
Q ss_pred ---eeeeCCCceeecceeccccccCc-cceeee---ecccccCCCCCCC
Q 011158 441 ---ILFCGKGRELISLFLGNDVLLQF-GTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 441 ---~~~~g~~~~~ape~~~~e~~~~~-~d~W~l---~~~~~~gt~~Y~a 482 (492)
....++..|++||......+... .|+|++ +....+|.++|..
T Consensus 172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 220 (361)
T 3uc3_A 172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFED 220 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC-
T ss_pred CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCC
Confidence 23467788899988766665544 688884 3344456666654
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-31 Score=271.29 Aligned_cols=179 Identities=16% Similarity=0.215 Sum_probs=148.3
Q ss_pred eCCCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCC------ChHHHHHHHHHHHHHHhcC---------CCceee
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERI------NSDMQKEFAQEVFIMRKVR---------HKNVVQ 353 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~------~~~~~~~~~~Ei~il~~l~---------HpnIv~ 353 (492)
+..++|++.++||+|+||.||+|+++++.||||+++.... .....+.+.+|+.++++++ ||||++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 4557889999999999999999999999999999986532 2334477899999999886 777777
Q ss_pred EEEEEe-----------------c-------------CCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Q 011158 354 FIGACT-----------------K-------------PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 403 (492)
Q Consensus 354 l~g~~~-----------------~-------------~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL 403 (492)
+.+++. . ...+|||||||++|++.+.+.+ ..+++..++.++.||+.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence 776542 2 6789999999999977776644 5689999999999999999
Q ss_pred HHHH-HCCceecCCCCCCEEEccCC--------------------CeEEEEEeecceee--eeeCCCceeecceeccccc
Q 011158 404 NYLH-QNNIIHRDLKAANLLMDENE--------------------VSLLLSLCLFTVSI--LFCGKGRELISLFLGNDVL 460 (492)
Q Consensus 404 ~yLH-~~~IiHrDLKp~NILld~~~--------------------~~kl~DFGla~~~~--~~~g~~~~~ape~~~~e~~ 460 (492)
.||| ++||+||||||+|||++.++ .+||+|||+++... ...|+..|++||......
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~~~~gt~~y~aPE~~~g~~- 253 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDG- 253 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETTEEECCCCTTCSGGGCCCS-
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCCcEEEeecccChhhhcCCC-
Confidence 9999 99999999999999999887 89999999998653 346778888888776554
Q ss_pred cCccceeeee
Q 011158 461 LQFGTYWIIF 470 (492)
Q Consensus 461 ~~~~d~W~l~ 470 (492)
....|+|++.
T Consensus 254 ~~~~Diwsl~ 263 (336)
T 2vuw_A 254 DYQFDIYRLM 263 (336)
T ss_dssp SHHHHHHHHH
T ss_pred ccceehhhhh
Confidence 5567888863
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-30 Score=266.12 Aligned_cols=195 Identities=23% Similarity=0.339 Sum_probs=162.2
Q ss_pred ceeeCCCCceeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEE
Q 011158 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 358 (492)
Q Consensus 286 ~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~-------g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~ 358 (492)
.+++..++|++.++||+|+||.||+|++. ++.||||+++.. ........+.+|+.++++++||||+++++++
T Consensus 65 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 143 (367)
T 3l9p_A 65 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVS 143 (367)
T ss_dssp SCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 35777889999999999999999999853 457999999743 3455566799999999999999999999999
Q ss_pred ecCCeEEEEEeccCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCC---Ce
Q 011158 359 TKPPSLCIVTEFMSGGSVYDYLHKLK------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE---VS 429 (492)
Q Consensus 359 ~~~~~~~lV~Ey~~ggsL~~~L~~~~------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~---~~ 429 (492)
......|+|||||++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+
T Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence 99999999999999999999998653 3589999999999999999999999999999999999999554 59
Q ss_pred EEEEEeeccee---------eeeeCCCceeecceeccccccCccceeee----ecccccCCCCCC
Q 011158 430 LLLSLCLFTVS---------ILFCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSD 481 (492)
Q Consensus 430 kl~DFGla~~~---------~~~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~ 481 (492)
||+|||+++.. ....++..|++||......+....|+|++ +.....|.++|.
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~ 288 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP 288 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999998642 12345667889998877777888899984 222223666654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-30 Score=264.95 Aligned_cols=190 Identities=17% Similarity=0.180 Sum_probs=159.0
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI---NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 366 (492)
+.|++.+.||+|+||.||+|.+ +++.||||++..... .....+.+.+|+.++++++||||+++++++...+.+||
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 5789999999999999999988 478899999864311 11234778999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCC---eEEEEEeeccee
Q 011158 367 VTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV---SLLLSLCLFTVS 440 (492)
Q Consensus 367 V~Ey~~ggsL~~~L~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~---~kl~DFGla~~~ 440 (492)
|||||++|+|.+++.+. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++...
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 183 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence 99999999999888653 235899999999999999999999999999999999999987654 999999998653
Q ss_pred e-------eeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 441 I-------LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 441 ~-------~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
. ...++..|++||......+....|+|++ +....+|.++|.
T Consensus 184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 234 (351)
T 3c0i_A 184 GESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY 234 (351)
T ss_dssp CTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCC
Confidence 2 2457888999998888888888899984 333445655554
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-30 Score=261.59 Aligned_cols=189 Identities=23% Similarity=0.358 Sum_probs=156.2
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
++|++.++||+|+||.||+|.+. ++.||||++..... ....+.+.+|+.++++++||||+++++++...+..|+|||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 57899999999999999999884 68899999975432 2234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee--------
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-------- 441 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-------- 441 (492)
||++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 86 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 164 (323)
T 3tki_A 86 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (323)
T ss_dssp CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred cCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccccc
Confidence 9999999999965 4569999999999999999999999999999999999999999999999999986432
Q ss_pred -eeeCCCceeecceeccccc-cCccceeee---ecccccCCCCCCC
Q 011158 442 -LFCGKGRELISLFLGNDVL-LQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 442 -~~~g~~~~~ape~~~~e~~-~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
...|+..|++||......+ ....|+|++ +.....|..+|..
T Consensus 165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 210 (323)
T 3tki_A 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210 (323)
T ss_dssp CSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred CCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Confidence 3457778888887765544 455788884 3334456666644
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.5e-30 Score=254.14 Aligned_cols=182 Identities=26% Similarity=0.416 Sum_probs=153.5
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEE------CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 360 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 360 (492)
..+..+.|++.++||+|+||.||+|++ .++.||||+++... .......+.+|+.++++++||||+++++++..
T Consensus 16 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (302)
T 4e5w_A 16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTE 94 (302)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 355667799999999999999999985 46789999998643 23345778999999999999999999999987
Q ss_pred C--CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecc
Q 011158 361 P--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFT 438 (492)
Q Consensus 361 ~--~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~ 438 (492)
. ..+++||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.+.
T Consensus 95 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 95 DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp ---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccc
Confidence 6 66899999999999999998777789999999999999999999999999999999999999999999999999986
Q ss_pred eee----------eeeCCCceeecceeccccccCccceeee
Q 011158 439 VSI----------LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 439 ~~~----------~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
... ...++..|++||......+....|+|++
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 215 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSF 215 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHH
Confidence 532 1234455888887777777777788884
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.7e-30 Score=255.73 Aligned_cols=184 Identities=23% Similarity=0.415 Sum_probs=159.2
Q ss_pred CceeeCCCCceeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEE
Q 011158 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 357 (492)
Q Consensus 285 ~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~-------g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~ 357 (492)
..|++..++|++.+.||+|+||.||+|++. ++.||||+++.. ......+.+.+|+.++++++||||++++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 94 (314)
T 2ivs_A 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGA 94 (314)
T ss_dssp TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence 457888999999999999999999999872 267999999754 345566789999999999999999999999
Q ss_pred EecCCeEEEEEeccCCCCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 011158 358 CTKPPSLCIVTEFMSGGSVYDYLHKLK-----------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 414 (492)
Q Consensus 358 ~~~~~~~~lV~Ey~~ggsL~~~L~~~~-----------------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHr 414 (492)
+...+..|+||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~ 174 (314)
T 2ivs_A 95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR 174 (314)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence 999999999999999999999998643 238999999999999999999999999999
Q ss_pred CCCCCCEEEccCCCeEEEEEeecceee---------eeeCCCceeecceeccccccCccceeee
Q 011158 415 DLKAANLLMDENEVSLLLSLCLFTVSI---------LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 415 DLKp~NILld~~~~~kl~DFGla~~~~---------~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
||||+|||++.++.+||+|||++.... ...++..|++||......+....|+|++
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 238 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSF 238 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHH
T ss_pred ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHH
Confidence 999999999999999999999986431 1234456888888777777778888884
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.9e-30 Score=257.46 Aligned_cols=197 Identities=21% Similarity=0.331 Sum_probs=151.1
Q ss_pred ceeeCCCCceeeeeeeecCceEEEEEEECC-----ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Q 011158 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 360 (492)
Q Consensus 286 ~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g-----~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 360 (492)
.+.+..++|++.+.||+|+||.||+|++.. ..||||+++.........+.+.+|+.++++++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 357788899999999999999999998743 279999998765556667889999999999999999999999987
Q ss_pred CCeE------EEEEeccCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCe
Q 011158 361 PPSL------CIVTEFMSGGSVYDYLHKLK-----GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVS 429 (492)
Q Consensus 361 ~~~~------~lV~Ey~~ggsL~~~L~~~~-----~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~ 429 (492)
.... ++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCE
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCE
Confidence 7655 99999999999999996532 258999999999999999999999999999999999999999999
Q ss_pred EEEEEeecceee---------eeeCCCceeecceeccccccCccceeee----ecccccCCCCCCC
Q 011158 430 LLLSLCLFTVSI---------LFCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSDA 482 (492)
Q Consensus 430 kl~DFGla~~~~---------~~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~a 482 (492)
||+|||+++... ...++..|++||......+....|+|++ +.....|.++|..
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~ 242 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAG 242 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 999999986532 1233456888888777777778899884 2222336666653
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=267.02 Aligned_cols=177 Identities=18% Similarity=0.237 Sum_probs=153.1
Q ss_pred CCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-----Ce
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-----PS 363 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-----~~ 363 (492)
.++|++.+.||+|+||.||+|.+. ++.||||+++.........+.+.+|+.+|++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 367999999999999999999884 67899999987655566678899999999999999999999999766 56
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee---
Q 011158 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS--- 440 (492)
Q Consensus 364 ~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~--- 440 (492)
+||||||| +|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 105 ~~lv~e~~-~~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 182 (432)
T 3n9x_A 105 LYIVLEIA-DSDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182 (432)
T ss_dssp EEEEEECC-SEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred EEEEEecC-CcCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence 99999999 5799999976 467999999999999999999999999999999999999999999999999999753
Q ss_pred --------------------------eeeeCCCceeeccee-ccccccCccceeee
Q 011158 441 --------------------------ILFCGKGRELISLFL-GNDVLLQFGTYWII 469 (492)
Q Consensus 441 --------------------------~~~~g~~~~~ape~~-~~e~~~~~~d~W~l 469 (492)
....++..|++||.+ ....+....|+|++
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSl 238 (432)
T 3n9x_A 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWST 238 (432)
T ss_dssp ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHH
T ss_pred ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchH
Confidence 234566778888864 55567777788884
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=253.57 Aligned_cols=177 Identities=18% Similarity=0.161 Sum_probs=152.9
Q ss_pred CCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCeEEEE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIV 367 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV 367 (492)
.++|++.++||+|+||.||+|.+. ++.||||++............+..|+..+.++ +|+||++++++|...+.+|+|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 367999999999999999999984 78899999876655555556667777766666 899999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee------
Q 011158 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------ 441 (492)
Q Consensus 368 ~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------ 441 (492)
|||+ +++|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++....
T Consensus 136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 214 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE 214 (311)
T ss_dssp EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCCCc
Confidence 9999 889999998877789999999999999999999999999999999999999999999999999986542
Q ss_pred eeeCCCceeecceeccccccCccceeee
Q 011158 442 LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 442 ~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
...|+..|++||+... .+....|+|++
T Consensus 215 ~~~gt~~y~aPE~~~~-~~~~~~Diwsl 241 (311)
T 3p1a_A 215 VQEGDPRYMAPELLQG-SYGTAADVFSL 241 (311)
T ss_dssp CCCCCGGGCCGGGGGT-CCSTHHHHHHH
T ss_pred ccCCCccccCHhHhcC-CCCchhhHHHH
Confidence 2346778899997765 46667788884
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.3e-30 Score=254.23 Aligned_cols=185 Identities=25% Similarity=0.433 Sum_probs=159.8
Q ss_pred CCceeeCCCCceeeeeeeecCceEEEEEEE-------CCceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeEE
Q 011158 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFI 355 (492)
Q Consensus 284 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~-------~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~ 355 (492)
...|++..++|++.+.||+|+||.||+|++ .++.||||+++... .....+.+.+|+.+++++ +||||++++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 93 (313)
T 1t46_A 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLL 93 (313)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEE
Confidence 456899999999999999999999999986 24679999998643 344567899999999999 899999999
Q ss_pred EEEecCCeEEEEEeccCCCCHHHHHHhcCC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 011158 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKG-----------------VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 418 (492)
Q Consensus 356 g~~~~~~~~~lV~Ey~~ggsL~~~L~~~~~-----------------~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp 418 (492)
+++...+..++||||+++|+|.+++..... .+++..++.++.||+.||.|||++||+||||||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp 173 (313)
T 1t46_A 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (313)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCcc
Confidence 999999999999999999999999987432 489999999999999999999999999999999
Q ss_pred CCEEEccCCCeEEEEEeecceee---------eeeCCCceeecceeccccccCccceeee
Q 011158 419 ANLLMDENEVSLLLSLCLFTVSI---------LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 419 ~NILld~~~~~kl~DFGla~~~~---------~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
+|||++.++.+||+|||++.... ...++..|++||......+....|+|++
T Consensus 174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 233 (313)
T 1t46_A 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSY 233 (313)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHH
Confidence 99999999999999999986532 1223446888887777777777888884
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=263.63 Aligned_cols=189 Identities=14% Similarity=0.231 Sum_probs=163.0
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
+.|++.+.||+|+||.||+|.+ +++.||+|++.... ......+.+|+.+|++++||||+++++++.....+|+|||
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 5789999999999999999998 46889999997542 3345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcc--CCCeEEEEEeeccee------e
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE--NEVSLLLSLCLFTVS------I 441 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~--~~~~kl~DFGla~~~------~ 441 (492)
||++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.. .
T Consensus 129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~ 208 (387)
T 1kob_A 129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 208 (387)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCccee
Confidence 99999999999875567999999999999999999999999999999999999974 467999999998653 2
Q ss_pred eeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 442 LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 442 ~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
...++..|++||......+....|+|++ +....+|.++|..
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 252 (387)
T 1kob_A 209 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG 252 (387)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred eeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCC
Confidence 4568889999999888888888899984 3344456666643
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.5e-30 Score=263.28 Aligned_cols=187 Identities=17% Similarity=0.272 Sum_probs=150.1
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCC--eEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPP--SLCI 366 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~--~~~l 366 (492)
++|++.++||+|+||.||+|.+ +++.||||++............+.+|+.+++++. ||||+++++++...+ .+||
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 88 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL 88 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence 5799999999999999999988 4788999999765555666788899999999997 999999999997544 6999
Q ss_pred EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee------
Q 011158 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS------ 440 (492)
Q Consensus 367 V~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~------ 440 (492)
|||||+ |+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 89 v~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 165 (388)
T 3oz6_A 89 VFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165 (388)
T ss_dssp EEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCC
T ss_pred EecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccc
Confidence 999995 699999976 57899999999999999999999999999999999999999999999999998643
Q ss_pred ----------------------eeeeCCCceeecceecc-ccccCccceeee---ecccccCCCCCC
Q 011158 441 ----------------------ILFCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 441 ----------------------~~~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
....++..|++||.+.. ..+....|+|++ +....+|.++|.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 232 (388)
T 3oz6_A 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFP 232 (388)
T ss_dssp CCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCC
Confidence 12357777888887654 566777888884 334556766664
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-29 Score=248.00 Aligned_cols=189 Identities=17% Similarity=0.270 Sum_probs=162.5
Q ss_pred CCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
.++|++.++||+|+||.||+|.+. ++.||+|++..........+.+.+|+.++++++||||+++++++......|+||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 367899999999999999999884 688999999877666667788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCC---eEEEEEeecceee----
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV---SLLLSLCLFTVSI---- 441 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~---~kl~DFGla~~~~---- 441 (492)
||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||.+....
T Consensus 85 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163 (284)
T ss_dssp CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence 999999999999773 56899999999999999999999999999999999999986655 9999999985432
Q ss_pred --eeeCCCceeecceeccccccCccceeee---ecccccCCCCC
Q 011158 442 --LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNS 480 (492)
Q Consensus 442 --~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y 480 (492)
...++..|++||......+....|+|++ +.....|.++|
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 207 (284)
T 3kk8_A 164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 207 (284)
T ss_dssp CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCC
Confidence 2457778899998888778888898884 22333455444
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-30 Score=258.22 Aligned_cols=190 Identities=19% Similarity=0.289 Sum_probs=156.8
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC----e
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP----S 363 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~----~ 363 (492)
.++|++.+.||+|+||.||+|.+ .++.||||+++.... +......+.+|+.++++++||||+++++++.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46799999999999999999997 468899999987543 3455678999999999999999999999987544 3
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee--
Q 011158 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-- 441 (492)
Q Consensus 364 ~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-- 441 (492)
.|+||||+++|+|.+++.. .+.+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++....
T Consensus 91 ~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred cEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence 4999999999999999976 3578999999999999999999999999999999999999999999999999986431
Q ss_pred --------eeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 442 --------LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 --------~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...|+..|++||......+....|+|++ +....+|..+|.
T Consensus 170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~ 220 (311)
T 3ork_A 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220 (311)
T ss_dssp ------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 2346788999998877777778888884 223344665554
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.3e-30 Score=258.13 Aligned_cols=187 Identities=19% Similarity=0.225 Sum_probs=160.7
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCeEEEE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIV 367 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV 367 (492)
..+|++.+.||+|+||.||+|++ +++.||||++..... ...+.+|+.+++++ +||||+++++++......|+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 83 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV 83 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence 46899999999999999999996 578899999975432 23578899999999 899999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCC-----eEEEEEeeccee--
Q 011158 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV-----SLLLSLCLFTVS-- 440 (492)
Q Consensus 368 ~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~-----~kl~DFGla~~~-- 440 (492)
|||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++..
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~ 162 (330)
T 2izr_A 84 LELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162 (330)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred EEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence 9999 99999999876678999999999999999999999999999999999999998886 999999999753
Q ss_pred ------------eeeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 441 ------------ILFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 441 ------------~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
....|+..|++||......+....|+|++ +....+|.++|..
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~ 219 (330)
T 2izr_A 163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQG 219 (330)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccc
Confidence 23467788999998888778888899884 3334457666654
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=252.02 Aligned_cols=189 Identities=18% Similarity=0.207 Sum_probs=158.4
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
++|++.++||+|+||.||+|.+. ++.||||++..........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57899999999999999999984 7889999998766566667788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------e
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-------L 442 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-------~ 442 (492)
|+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||.+.... .
T Consensus 83 ~~~~~~l~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 161 (311)
T 4agu_A 83 YCDHTVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD 161 (311)
T ss_dssp CCSEEHHHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred eCCCchHHHHHhh-hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCC
Confidence 9999999998865 4668999999999999999999999999999999999999999999999999986532 2
Q ss_pred eeCCCceeecceecc-ccccCccceeee---ecccccCCCCCC
Q 011158 443 FCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 443 ~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
..++..|++||.... ..+....|+|++ +.....|.++|.
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 204 (311)
T 4agu_A 162 EVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWP 204 (311)
T ss_dssp ----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 356677888887754 556777788884 233445666554
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.96 E-value=8.9e-30 Score=248.70 Aligned_cols=192 Identities=26% Similarity=0.432 Sum_probs=153.8
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEE
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERIN--SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 365 (492)
+++..+|++.+.||+|+||.||+|.+.++.||||+++..... ....+.+.+|+.++++++||||+++++++...+..|
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 567789999999999999999999999999999998764322 233567899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCCCCEEEcc--------CCCeEEEEE
Q 011158 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN---IIHRDLKAANLLMDE--------NEVSLLLSL 434 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~---IiHrDLKp~NILld~--------~~~~kl~DF 434 (492)
+||||+++++|.+++.. ..+++..++.++.|++.||.|||+++ |+||||||+|||++. ++.+||+||
T Consensus 83 lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEEECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999999954 57899999999999999999999999 999999999999986 678999999
Q ss_pred eecceee-----eeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 435 CLFTVSI-----LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 435 Gla~~~~-----~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
|.+.... ...++..|++||......+....|+|++ +.....|..+|.
T Consensus 161 g~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 215 (271)
T 3dtc_A 161 GLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFR 215 (271)
T ss_dssp CC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTT
T ss_pred CcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9986432 3457778888988877777777888884 223334555554
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.6e-30 Score=277.66 Aligned_cols=194 Identities=20% Similarity=0.259 Sum_probs=166.0
Q ss_pred eCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEE
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 365 (492)
+..++|++.+.||+|+||.||+|++ +++.||||++..... .......+.+|+.+|++++||||+++++++.....+|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 4456789999999999999999998 478999999975321 1123456889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee----
Q 011158 366 IVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS---- 440 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~---- 440 (492)
||||||+||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~ 340 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence 9999999999999997643 35999999999999999999999999999999999999999999999999998653
Q ss_pred --eeeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 441 --ILFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 441 --~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
....|+..|++||+.....+....|+|++ +....+|.++|..
T Consensus 341 ~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~ 387 (576)
T 2acx_A 341 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 387 (576)
T ss_dssp CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSC
T ss_pred cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcc
Confidence 23568889999999888888888999994 3344567766654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.8e-30 Score=261.50 Aligned_cols=188 Identities=22% Similarity=0.369 Sum_probs=158.0
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
.+|.+.+.||+|+||.||+|.+ +++.||||++...... ......+.+|+.+++.++||||+++++++.....+|+||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5789999999999999999998 5789999998743211 122357889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee------ee
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS------IL 442 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~------~~ 442 (492)
||+ +|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++... ..
T Consensus 89 E~~-~g~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~~ 166 (336)
T 3h4j_B 89 EYA-GGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT 166 (336)
T ss_dssp CCC-CEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTCC
T ss_pred ECC-CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCccccc
Confidence 999 8899999976 467999999999999999999999999999999999999999999999999998653 24
Q ss_pred eeCCCceeecceeccccc-cCccceeee---ecccccCCCCCC
Q 011158 443 FCGKGRELISLFLGNDVL-LQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 443 ~~g~~~~~ape~~~~e~~-~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
..|+..|++||......+ ....|+|++ +....+|..+|.
T Consensus 167 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~ 209 (336)
T 3h4j_B 167 SCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209 (336)
T ss_dssp CTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSB
T ss_pred ccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCC
Confidence 567888999998876665 456788884 223345655554
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-29 Score=253.86 Aligned_cols=185 Identities=20% Similarity=0.273 Sum_probs=158.8
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEec
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 370 (492)
.|...++||+|+||.||+|++ .|+.||||++..... ...+.+.+|+.++++++||||+++++++...+..|+||||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 123 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence 366678999999999999998 478999999976532 3346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------ee
Q 011158 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-------LF 443 (492)
Q Consensus 371 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-------~~ 443 (492)
+++|+|.+++.+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... ..
T Consensus 124 ~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 201 (321)
T 2c30_A 124 LQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL 201 (321)
T ss_dssp CCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred CCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccc
Confidence 999999999865 569999999999999999999999999999999999999999999999999986532 34
Q ss_pred eCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 444 CGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 444 ~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
.|+..|++||+.....+....|+|++ +.....|.++|.
T Consensus 202 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~ 242 (321)
T 2c30_A 202 VGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYF 242 (321)
T ss_dssp CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 67788999998888888888899884 223344655553
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=6.9e-30 Score=270.08 Aligned_cols=182 Identities=31% Similarity=0.504 Sum_probs=156.3
Q ss_pred CCceeeCCCCceeeeeeeecCceEEEEEEECC-ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 011158 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (492)
Q Consensus 284 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g-~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 362 (492)
.+.|+++.++|++.++||+|+||.||+|.+.+ ..||||+++..... .+.|.+|+.+|++++||||+++++++.. +
T Consensus 176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~ 251 (452)
T 1fmk_A 176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 251 (452)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-C
Confidence 45699999999999999999999999999965 67999999865433 3679999999999999999999999976 6
Q ss_pred eEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee
Q 011158 363 SLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI 441 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~ 441 (492)
.+|||||||++|+|.+++... ...+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 689999999999999999753 3468999999999999999999999999999999999999999999999999997542
Q ss_pred e--------eeCCCceeecceeccccccCccceeee
Q 011158 442 L--------FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 442 ~--------~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
. ..++..|++||......+....|+|++
T Consensus 332 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwsl 367 (452)
T 1fmk_A 332 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 367 (452)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred CCceecccCCcccccccCHhHHhcCCCCccccHHhH
Confidence 1 223456888888776677777888884
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=255.46 Aligned_cols=182 Identities=26% Similarity=0.390 Sum_probs=155.7
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEECC------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCS------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 360 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g------~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 360 (492)
+++...+|++.+.||+|+||.||+|.+.. ..||||+++... .......+.+|+.++++++||||+++++++..
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 47888999999999999999999998742 349999998543 44556789999999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 361 ~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
.+..+|||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.++..
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999999999999886678999999999999999999999999999999999999999999999999998754
Q ss_pred ee----------eeCCCceeecceeccccccCccceeee
Q 011158 441 IL----------FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 441 ~~----------~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
.. ..++..|++||......+....|+|++
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 236 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSF 236 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHH
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHH
Confidence 21 122446888888877777777888884
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=254.57 Aligned_cols=192 Identities=21% Similarity=0.276 Sum_probs=157.7
Q ss_pred eCCCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC--eE
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP--SL 364 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~--~~ 364 (492)
+...+|++.++||+|+||.||+|.+. ++.||||+++.... ....+.+.+|+.++++++||||+++++++.... ..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 34567999999999999999999985 78899999975432 223467889999999999999999999998655 78
Q ss_pred EEEEeccCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE----ccCCCeEEEEEeecc
Q 011158 365 CIVTEFMSGGSVYDYLHKLKG--VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM----DENEVSLLLSLCLFT 438 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILl----d~~~~~kl~DFGla~ 438 (492)
|+||||+++|+|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999999986432 38999999999999999999999999999999999999 777889999999987
Q ss_pred eee------eeeCCCceeecceec--------cccccCccceeee---ecccccCCCCCC
Q 011158 439 VSI------LFCGKGRELISLFLG--------NDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 439 ~~~------~~~g~~~~~ape~~~--------~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
... ...++..|++||... ...+....|+|++ +.....|..+|.
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 224 (319)
T 4euu_A 165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224 (319)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEE
T ss_pred ecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 542 345777888888765 3566677888884 223344665553
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.3e-30 Score=253.56 Aligned_cols=191 Identities=21% Similarity=0.237 Sum_probs=151.0
Q ss_pred CCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCh------------------------HHHHHHHHHHHHH
Q 011158 290 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS------------------------DMQKEFAQEVFIM 343 (492)
Q Consensus 290 ~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~------------------------~~~~~~~~Ei~il 343 (492)
..++|++.+.||+|+||.||+|.+ .++.||||++....... ...+.+.+|+.++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 346899999999999999999988 46889999997653211 1235688999999
Q ss_pred HhcCCCceeeEEEEEec--CCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCE
Q 011158 344 RKVRHKNVVQFIGACTK--PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANL 421 (492)
Q Consensus 344 ~~l~HpnIv~l~g~~~~--~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NI 421 (492)
++++||||+++++++.. ...+|+||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL 168 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence 99999999999999986 5679999999999999887543 5799999999999999999999999999999999999
Q ss_pred EEccCCCeEEEEEeecceee-------eeeCCCceeecceecccc---ccCccceeee---ecccccCCCCCCC
Q 011158 422 LMDENEVSLLLSLCLFTVSI-------LFCGKGRELISLFLGNDV---LLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 422 Lld~~~~~kl~DFGla~~~~-------~~~g~~~~~ape~~~~e~---~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
|++.++.+||+|||++.... ...++..|++||...... +....|+|++ +.....|.++|..
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999999999999986532 245677788888775543 2445688884 2233456555543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=255.27 Aligned_cols=197 Identities=24% Similarity=0.403 Sum_probs=164.3
Q ss_pred CCceeeCCCCceeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeEE
Q 011158 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFI 355 (492)
Q Consensus 284 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g-------~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~ 355 (492)
...|++..++|++.+.||+|+||.||+|.+.+ ..||+|+++... .....+.+.+|+.+++++ +||||++++
T Consensus 38 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 116 (333)
T 2i1m_A 38 NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLL 116 (333)
T ss_dssp CGGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence 34689999999999999999999999999843 369999997643 345567899999999999 899999999
Q ss_pred EEEecCCeEEEEEeccCCCCHHHHHHhc-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEE
Q 011158 356 GACTKPPSLCIVTEFMSGGSVYDYLHKL-------------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 422 (492)
Q Consensus 356 g~~~~~~~~~lV~Ey~~ggsL~~~L~~~-------------~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NIL 422 (492)
+++...+.+|+||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 117 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 117 GACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVL 196 (333)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCE
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEE
Confidence 9999999999999999999999999753 235799999999999999999999999999999999999
Q ss_pred EccCCCeEEEEEeecceee---------eeeCCCceeecceeccccccCccceeee----ecccccCCCCCC
Q 011158 423 MDENEVSLLLSLCLFTVSI---------LFCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSD 481 (492)
Q Consensus 423 ld~~~~~kl~DFGla~~~~---------~~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~ 481 (492)
++.++.+||+|||++.... ...++..|++||......+....|+|++ +.....|.++|.
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 268 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP 268 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCc
Confidence 9999999999999987432 1223446888887777677777888884 222233665554
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-29 Score=245.93 Aligned_cols=178 Identities=22% Similarity=0.326 Sum_probs=152.5
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCeEEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
.+|++.+.||+|+||.||+|.+. ++.||||+++...........+.+|+.++.++ +||||+++++++...+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 46889999999999999999984 78999999987655566677899999999999 8999999999999999999999
Q ss_pred eccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccC-------------------
Q 011158 369 EFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN------------------- 426 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~------------------- 426 (492)
||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 170 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK 170 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------C
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence 999999999999764 2568999999999999999999999999999999999999844
Q ss_pred CCeEEEEEeecceee---eeeCCCceeecceeccc-cccCccceeee
Q 011158 427 EVSLLLSLCLFTVSI---LFCGKGRELISLFLGND-VLLQFGTYWII 469 (492)
Q Consensus 427 ~~~kl~DFGla~~~~---~~~g~~~~~ape~~~~e-~~~~~~d~W~l 469 (492)
..+|++|||.+.... ...++..|++||..... .+....|+|++
T Consensus 171 ~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~sl 217 (289)
T 1x8b_A 171 VMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFAL 217 (289)
T ss_dssp CCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHH
T ss_pred eEEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHH
Confidence 478999999886542 34577788888877554 44456788884
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=8.5e-30 Score=251.06 Aligned_cols=195 Identities=29% Similarity=0.484 Sum_probs=165.4
Q ss_pred CCceeeCCCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 011158 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (492)
Q Consensus 284 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 361 (492)
.+.|++..++|++.+.||+|+||.||+|.+. +..||+|+++.. ....+.+.+|+.++++++||||+++++++...
T Consensus 5 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 81 (288)
T 3kfa_A 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81 (288)
T ss_dssp CCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC---STHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 3568999999999999999999999999985 678999999754 33457899999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 362 PSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
...|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.+...
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 99999999999999999998743 46899999999999999999999999999999999999999999999999998653
Q ss_pred e--------eeeCCCceeecceeccccccCccceeee----ecccccCCCCCC
Q 011158 441 I--------LFCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSD 481 (492)
Q Consensus 441 ~--------~~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~ 481 (492)
. ...++..|++||......+....|+|++ +....+|.++|.
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~ 214 (288)
T 3kfa_A 162 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 214 (288)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 2 1233456888888877777777888884 222223665554
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.96 E-value=9.1e-30 Score=275.21 Aligned_cols=194 Identities=21% Similarity=0.263 Sum_probs=165.9
Q ss_pred eCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEE
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 365 (492)
+..++|.+.+.||+|+||.||+|++ +++.||||+++..... ......+.+|+.+|++++||||+++++++.....+|
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 3456788999999999999999998 4789999999754221 123467889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee--
Q 011158 366 IVTEFMSGGSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS-- 440 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~---~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~-- 440 (492)
+|||||+||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 9999999999999997642 46999999999999999999999999999999999999999999999999998653
Q ss_pred -----eeeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 441 -----ILFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 441 -----~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
....|+..|++||......+....|+|++ +....+|.++|..
T Consensus 342 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~ 391 (543)
T 3c4z_A 342 GQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391 (543)
T ss_dssp TCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCC
Confidence 12478889999999988888888999994 3345567766654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=254.97 Aligned_cols=185 Identities=25% Similarity=0.441 Sum_probs=158.8
Q ss_pred CCceeeCCCCceeeeeeeecCceEEEEEEEC---------CceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceee
Q 011158 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC---------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQ 353 (492)
Q Consensus 284 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~---------g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~ 353 (492)
...|++..++|++.+.||+|+||.||+|.+. +..||||+++... .......+.+|+.+++++ +||||++
T Consensus 27 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~ 105 (334)
T 2pvf_A 27 DPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIIN 105 (334)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEee
Confidence 3458899999999999999999999999873 3569999997543 445567899999999999 8999999
Q ss_pred EEEEEecCCeEEEEEeccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 011158 354 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 418 (492)
Q Consensus 354 l~g~~~~~~~~~lV~Ey~~ggsL~~~L~~~~---------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp 418 (492)
+++++...+.+|+||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 106 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 185 (334)
T 2pvf_A 106 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA 185 (334)
T ss_dssp EEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred EEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCcc
Confidence 9999999999999999999999999998643 2489999999999999999999999999999999
Q ss_pred CCEEEccCCCeEEEEEeecceee---------eeeCCCceeecceeccccccCccceeee
Q 011158 419 ANLLMDENEVSLLLSLCLFTVSI---------LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 419 ~NILld~~~~~kl~DFGla~~~~---------~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
+|||++.++.+||+|||++.... ...++..|++||......+....|+|++
T Consensus 186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 245 (334)
T 2pvf_A 186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 245 (334)
T ss_dssp GGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHH
T ss_pred ceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHH
Confidence 99999999999999999986432 1233456888887777777777888884
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.1e-29 Score=254.04 Aligned_cols=191 Identities=18% Similarity=0.262 Sum_probs=163.7
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-----CCceeeEEEEEec
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-----HKNVVQFIGACTK 360 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~-----HpnIv~l~g~~~~ 360 (492)
.+-.++|++.++||+|+||.||+|++ +++.||||+++.. ......+..|+.++++++ ||||+++++++..
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~ 107 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY 107 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE
Confidence 44467899999999999999999998 5688999999742 445567888999999997 9999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcc--------------
Q 011158 361 PPSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-------------- 425 (492)
Q Consensus 361 ~~~~~lV~Ey~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~-------------- 425 (492)
.+.+||||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 108 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~ 186 (360)
T 3llt_A 108 YDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVT 186 (360)
T ss_dssp TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred CCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccc
Confidence 99999999999 999999998754 35899999999999999999999999999999999999975
Q ss_pred -----------CCCeEEEEEeecceee----eeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 426 -----------NEVSLLLSLCLFTVSI----LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 426 -----------~~~~kl~DFGla~~~~----~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
++.+||+|||++.... ...++..|++||......+....|+|++ +....+|.++|..
T Consensus 187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 187 DGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp TCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCC
Confidence 7889999999987542 3467788999998888888888999984 3344556666643
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=8.9e-30 Score=255.21 Aligned_cols=185 Identities=23% Similarity=0.414 Sum_probs=158.9
Q ss_pred CCceeeCCCCceeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEE
Q 011158 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356 (492)
Q Consensus 284 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~-------g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g 356 (492)
.+.|++..++|++.+.||+|+||.||+|++. ++.||||++.... .......+.+|+.++++++||||+++++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 3568899999999999999999999999764 4679999997542 3445567999999999999999999999
Q ss_pred EEecCCeEEEEEeccCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCC
Q 011158 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLK---------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 427 (492)
Q Consensus 357 ~~~~~~~~~lV~Ey~~ggsL~~~L~~~~---------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~ 427 (492)
++......++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC
Confidence 9999999999999999999999997532 4579999999999999999999999999999999999999999
Q ss_pred CeEEEEEeecceee---------eeeCCCceeecceeccccccCccceeee
Q 011158 428 VSLLLSLCLFTVSI---------LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 428 ~~kl~DFGla~~~~---------~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
.+||+|||++.... ...++..|++||......+....|+|++
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 226 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 226 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHH
Confidence 99999999986431 1233456888888777777777888884
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=256.30 Aligned_cols=192 Identities=15% Similarity=0.194 Sum_probs=160.0
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEE-CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCC--CceeeEEEEEecCCe
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH--KNVVQFIGACTKPPS 363 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~g~~~~~~~ 363 (492)
..+..+.|++.+.||+|+||.||++.+ .++.||||++............+.+|+.+|++++| +||+++++++.....
T Consensus 4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 4 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp EESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eeeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 467778899999999999999999987 46789999998776667777889999999999986 999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee--
Q 011158 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-- 441 (492)
Q Consensus 364 ~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-- 441 (492)
+|||||| .+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++...
T Consensus 84 ~~lv~e~-~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 84 IYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EEEEECC-CSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EEEEEeC-CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 9999995 48999999987 56789999999999999999999999999999999999997 6789999999986532
Q ss_pred -------eeeCCCceeecceecc-----------ccccCccceeee---ecccccCCCCCC
Q 011158 442 -------LFCGKGRELISLFLGN-----------DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 -------~~~g~~~~~ape~~~~-----------e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...|+..|++||+... ..+....|+|++ +....+|.++|.
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 221 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 221 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcch
Confidence 3457788888887643 455666788884 223445655554
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-29 Score=248.51 Aligned_cols=194 Identities=23% Similarity=0.347 Sum_probs=161.8
Q ss_pred ceeeCCCCceeee-eeeecCceEEEEEEE----CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Q 011158 286 VWEIDPKHLKFGS-KVASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 360 (492)
Q Consensus 286 ~~ei~~~~~~~~~-~LG~G~fG~Vy~~~~----~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 360 (492)
.|.++.++|.+.+ .||+|+||.||+|++ .+..||||+++.. ......+.+.+|+.++++++||||+++++++.
T Consensus 3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~- 80 (287)
T 1u59_A 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ- 80 (287)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred cccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-
Confidence 3677788888887 999999999999986 3567999999864 24556678999999999999999999999994
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 361 ~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
.+..++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.+...
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 81 AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp SSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 45699999999999999999876677999999999999999999999999999999999999999999999999998653
Q ss_pred e----------eeeCCCceeecceeccccccCccceeee----ecccccCCCCCC
Q 011158 441 I----------LFCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSD 481 (492)
Q Consensus 441 ~----------~~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~ 481 (492)
. ...++..|++||......+....|+|++ +....+|.++|.
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 215 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 215 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 1 1123456888888877777778888884 222223666664
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-29 Score=253.53 Aligned_cols=180 Identities=23% Similarity=0.399 Sum_probs=155.8
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEE------CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEe--
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT-- 359 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~-- 359 (492)
.++.++|++.++||+|+||.||+|++ .++.||||++... .....+.+.+|+.++++++||||+++++++.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96 (327)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence 46678999999999999999999985 4578999999754 3555678999999999999999999999987
Q ss_pred cCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecce
Q 011158 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTV 439 (492)
Q Consensus 360 ~~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~ 439 (492)
....+|+||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.+..
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccccee
Confidence 45669999999999999999987666799999999999999999999999999999999999999999999999999875
Q ss_pred ee----------eeeCCCceeecceeccccccCccceeee
Q 011158 440 SI----------LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 440 ~~----------~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
.. ...++..|++||......+....|+|++
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 216 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSF 216 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHH
Confidence 32 1234445888888777777777888884
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-29 Score=255.85 Aligned_cols=189 Identities=24% Similarity=0.300 Sum_probs=159.7
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
+.|+..+.||+|+||.||+|++ +++.||||++...... ....+.+.+|+.++++++||||+++++++...+..||||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588899999999999999997 5788999999765332 344577999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee---eeeeC
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS---ILFCG 445 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~---~~~~g 445 (492)
||+. |+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++... ....+
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~g 212 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVG 212 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCCCCS
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCCCcccC
Confidence 9995 7899999776778999999999999999999999999999999999999999999999999998654 23567
Q ss_pred CCceeecceec---cccccCccceeee---ecccccCCCCCC
Q 011158 446 KGRELISLFLG---NDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 446 ~~~~~ape~~~---~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
+..|++||... ...+....|+|++ +.....|.++|.
T Consensus 213 t~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 254 (348)
T 1u5q_A 213 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 254 (348)
T ss_dssp CGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 78889998763 4556777888884 223344555543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-29 Score=247.75 Aligned_cols=190 Identities=22% Similarity=0.349 Sum_probs=145.2
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
++|++.+.||+|+||.||+|++ .++.||||++..... .......+.+|+.++++++||||+++++++...+..|+||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 4688999999999999999997 578899999964321 1123467899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------- 441 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------- 441 (492)
||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.+....
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 170 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY 170 (278)
T ss_dssp ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-------
T ss_pred ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcce
Confidence 9999999999998766789999999999999999999999999999999999999999999999999986532
Q ss_pred eeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 442 LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 ~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||......+....|+|++ +.....|.++|.
T Consensus 171 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 213 (278)
T 3cok_A 171 TLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213 (278)
T ss_dssp ---------------------CTHHHHHHHHHHHHHHSSCSSC
T ss_pred eccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 2456778899998887777778888884 223334555544
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=248.23 Aligned_cols=182 Identities=25% Similarity=0.450 Sum_probs=156.1
Q ss_pred CCceeeCCCCceeeeeeeecCceEEEEEEECC-ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 011158 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (492)
Q Consensus 284 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g-~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 362 (492)
.+.|++..++|++.+.||+|+||.||+|.+.+ +.||||+++..... .+.+.+|+.++++++||||+++++++.. +
T Consensus 5 ~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~ 80 (279)
T 1qpc_A 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (279)
T ss_dssp TCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred hhhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcC-C
Confidence 45699999999999999999999999999864 68999999765433 4678999999999999999999999875 4
Q ss_pred eEEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee
Q 011158 363 SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI 441 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~ 441 (492)
..++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.+....
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 5899999999999999997532 268999999999999999999999999999999999999999999999999986542
Q ss_pred e--------eeCCCceeecceeccccccCccceeee
Q 011158 442 L--------FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 442 ~--------~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
. ..++..|++||......+....|+|++
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 196 (279)
T 1qpc_A 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSF 196 (279)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHH
T ss_pred CcccccccCCCCccCccChhhhccCCCCchhhhHHH
Confidence 1 123446888888776667777888884
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=254.38 Aligned_cols=188 Identities=21% Similarity=0.265 Sum_probs=144.2
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
.+|++.++||+|+||.||+|.+ +++.||||+++... .......+.+|+.++++++||||+++++++...+.+|||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 5788899999999999999987 47889999997653 22234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee---
Q 011158 370 FMSGGSVYDYLHKLK-----GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI--- 441 (492)
Q Consensus 370 y~~ggsL~~~L~~~~-----~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~--- 441 (492)
|++ |+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 162 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV 162 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc
Confidence 996 69999997542 358999999999999999999999999999999999999999999999999986531
Q ss_pred ----eeeCCCceeecceecc-ccccCccceeee---ecccccCCCCCC
Q 011158 442 ----LFCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 ----~~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||.... ..+....|+|++ +....+|.++|.
T Consensus 163 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 210 (317)
T 2pmi_A 163 NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFP 210 (317)
T ss_dssp CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 2456778899997754 456777888884 333445665553
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-29 Score=260.31 Aligned_cols=185 Identities=17% Similarity=0.251 Sum_probs=152.9
Q ss_pred eeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEeccC
Q 011158 295 KFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS 372 (492)
Q Consensus 295 ~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 372 (492)
...+.||+|+||.||+|.+ +++.||+|+++... ....+.+.+|+.+|++++||||+++++++...+.+|||||||+
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 169 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVD 169 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence 3467899999999999988 47889999998643 3455789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE--ccCCCeEEEEEeecceee------eee
Q 011158 373 GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM--DENEVSLLLSLCLFTVSI------LFC 444 (492)
Q Consensus 373 ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILl--d~~~~~kl~DFGla~~~~------~~~ 444 (492)
+|+|.+++......+++..++.++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||+++... ...
T Consensus 170 ~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~ 249 (373)
T 2x4f_A 170 GGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF 249 (373)
T ss_dssp TCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCC
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccccccc
Confidence 999999998766679999999999999999999999999999999999999 566789999999987542 245
Q ss_pred CCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 445 GKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 445 g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
++..|++||+.....+....|+|++ +....+|.++|.
T Consensus 250 gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 289 (373)
T 2x4f_A 250 GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFL 289 (373)
T ss_dssp SSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCC
Confidence 7788999998887777778888884 333445665554
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-29 Score=256.65 Aligned_cols=186 Identities=22% Similarity=0.337 Sum_probs=147.9
Q ss_pred CCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
.+.|++.+.||+|+||.||+|++. ++.||||+++... ..+.+.+|+.++++++||||+++++++.....+++||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 357899999999999999999985 5789999998542 2356889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcc---CCCeEEEEEeecceee----
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVSLLLSLCLFTVSI---- 441 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~---~~~~kl~DFGla~~~~---- 441 (492)
||+++|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++...
T Consensus 128 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 206 (349)
T 2w4o_A 128 ELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL 206 (349)
T ss_dssp CCCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred EeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc
Confidence 99999999999976 456899999999999999999999999999999999999975 8899999999987542
Q ss_pred --eeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 442 --LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 --~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||+.....+....|+|++ +....+|..+|.
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 251 (349)
T 2w4o_A 207 MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFY 251 (349)
T ss_dssp ------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCC
Confidence 3457888999998888788888899984 333445555553
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=255.21 Aligned_cols=193 Identities=23% Similarity=0.373 Sum_probs=156.3
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEEC--Cc----eEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQ----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~~--g~----~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 361 (492)
.+..++|++.++||+|+||.||+|++. ++ +||+|.++... .....+.+.+|+.++++++||||++++++|...
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp ECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 456678999999999999999999873 33 36888876432 334457899999999999999999999999875
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee
Q 011158 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI 441 (492)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~ 441 (492)
. .++|+||+.+|+|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 4 889999999999999998877789999999999999999999999999999999999999999999999999986431
Q ss_pred ---------eeeCCCceeecceeccccccCccceeee----ecccccCCCCCCC
Q 011158 442 ---------LFCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSDA 482 (492)
Q Consensus 442 ---------~~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~a 482 (492)
...++..|++||+.....+....|+|++ +.....|.++|..
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 222 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccC
Confidence 1234557899998877778888899884 2223336666653
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=274.32 Aligned_cols=182 Identities=31% Similarity=0.504 Sum_probs=158.4
Q ss_pred CCceeeCCCCceeeeeeeecCceEEEEEEECC-ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 011158 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (492)
Q Consensus 284 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g-~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 362 (492)
.+.|+|..++|++.++||+|+||.||+|++.+ ..||||+++..... .+.|.+|+.+|++++|+||+++++++.. +
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-~ 334 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 334 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence 46799999999999999999999999999965 67999999865433 3679999999999999999999999976 6
Q ss_pred eEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee
Q 011158 363 SLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI 441 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~ 441 (492)
.+|||||||++|+|.++|... ...+++..++.++.||+.||.|||+++||||||||+|||++.++.+||+|||+++...
T Consensus 335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 789999999999999999753 3468999999999999999999999999999999999999999999999999997642
Q ss_pred e--------eeCCCceeecceeccccccCccceeee
Q 011158 442 L--------FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 442 ~--------~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
. ..++..|++||......+....|+|++
T Consensus 415 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSl 450 (535)
T 2h8h_A 415 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 450 (535)
T ss_dssp CHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred CCceecccCCcCcccccCHHHhccCCCCchhhHHHH
Confidence 1 123356888988776677777888884
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-29 Score=246.72 Aligned_cols=182 Identities=23% Similarity=0.378 Sum_probs=156.5
Q ss_pred ceeeCCCCceeeeeeeecCceEEEEEEECC-----ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Q 011158 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 360 (492)
Q Consensus 286 ~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g-----~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 360 (492)
.|.+..++|++.+.||+|+||.||+|++.+ ..||+|+++... .....+.+.+|+.++++++||||+++++++..
T Consensus 6 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 84 (281)
T 3cc6_A 6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE 84 (281)
T ss_dssp CCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred cceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence 467788899999999999999999998742 349999997643 44556789999999999999999999999875
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 361 ~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
. ..|+||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.+...
T Consensus 85 ~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 85 E-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp S-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred C-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 4 578999999999999999887777999999999999999999999999999999999999999999999999998754
Q ss_pred e--------eeeCCCceeecceeccccccCccceeee
Q 011158 441 I--------LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 441 ~--------~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
. ...++..|++||......+....|+|++
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 200 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMF 200 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred ccccccccccCCCCcceeCchhhccCCCCchhccHHH
Confidence 2 1234456888888777777777888884
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-29 Score=267.26 Aligned_cols=187 Identities=19% Similarity=0.218 Sum_probs=156.3
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC------C
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP------P 362 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------~ 362 (492)
.++|++.++||+|+||.||+|.+ +++.||||++..........+++.+|+.+|+.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 46899999999999999999988 478899999986655566678899999999999999999999999654 3
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-
Q 011158 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI- 441 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~- 441 (492)
.+|||||||. ++|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 141 ~~~lv~E~~~-~~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 141 DVYLVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp EEEEEEECCS-EEHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred eEEEEEeCCC-CCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 5799999995 567777743 48999999999999999999999999999999999999999999999999997542
Q ss_pred -----eeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 442 -----LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 -----~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||.+....+....|+|++ +....+|.++|.
T Consensus 217 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~ 264 (464)
T 3ttj_A 217 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 264 (464)
T ss_dssp CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCC
Confidence 3567888999999888888888999994 334445666654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=281.50 Aligned_cols=195 Identities=18% Similarity=0.289 Sum_probs=165.2
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCC
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPP 362 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~ 362 (492)
..+...+|+++++||+|+||.||+|.+. ++.||||+++.... .....+.+..|..++..+ +||||+++++++...+
T Consensus 336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~ 415 (674)
T 3pfq_A 336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 415 (674)
T ss_dssp ----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS
T ss_pred ccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC
Confidence 4566788999999999999999999984 57799999975321 122346678899999988 6999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee--
Q 011158 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS-- 440 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~-- 440 (492)
.+||||||++||+|.+++.+. +.+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+++..
T Consensus 416 ~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 416 RLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred EEEEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 999999999999999999874 57999999999999999999999999999999999999999999999999998752
Q ss_pred -----eeeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 441 -----ILFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 441 -----~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
....|+..|++||++....+....|+|++ +.....|.++|..
T Consensus 495 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~ 544 (674)
T 3pfq_A 495 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 544 (674)
T ss_dssp TTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCC
Confidence 24578899999999988889889999994 3344567777654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-29 Score=248.37 Aligned_cols=183 Identities=24% Similarity=0.374 Sum_probs=152.9
Q ss_pred CceeeCCCCceeee-eeeecCceEEEEEEEC----CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Q 011158 285 DVWEIDPKHLKFGS-KVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359 (492)
Q Consensus 285 ~~~ei~~~~~~~~~-~LG~G~fG~Vy~~~~~----g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~ 359 (492)
..+.++.++|++.+ .||+|+||.||+|.+. ++.||||+++....+....+.+.+|+.++++++||||+++++++
T Consensus 9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~- 87 (291)
T 1xbb_A 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC- 87 (291)
T ss_dssp --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence 34677888999998 9999999999999662 46799999987655556678899999999999999999999999
Q ss_pred cCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecce
Q 011158 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTV 439 (492)
Q Consensus 360 ~~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~ 439 (492)
..+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 88 EAESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp ESSSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CCCCcEEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 55679999999999999999987 45689999999999999999999999999999999999999999999999999865
Q ss_pred ee----------eeeCCCceeecceeccccccCccceeee
Q 011158 440 SI----------LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 440 ~~----------~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
.. ...++..|++||......+....|+|++
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 206 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSF 206 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHH
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHH
Confidence 32 1123355888888776667777888884
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=249.70 Aligned_cols=173 Identities=25% Similarity=0.470 Sum_probs=145.0
Q ss_pred CCCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHh--cCCCceeeEEEEEec----CCe
Q 011158 290 DPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK--VRHKNVVQFIGACTK----PPS 363 (492)
Q Consensus 290 ~~~~~~~~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~g~~~~----~~~ 363 (492)
-.++|++.++||+|+||.||+|+++++.||||++... ....+.+|.+++.. ++||||+++++++.. ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 3468999999999999999999999999999998643 23556677777776 789999999998654 345
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------HCCceecCCCCCCEEEccCCCeEEEEEe
Q 011158 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH--------QNNIIHRDLKAANLLMDENEVSLLLSLC 435 (492)
Q Consensus 364 ~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH--------~~~IiHrDLKp~NILld~~~~~kl~DFG 435 (492)
+|+||||+++|+|.++++. ..+++..++.++.||+.||.||| +++|+||||||+|||++.++.+||+|||
T Consensus 81 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 158 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG 158 (301)
T ss_dssp EEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred eEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCC
Confidence 8999999999999999954 57899999999999999999999 9999999999999999999999999999
Q ss_pred ecceee-----------eeeCCCceeecceeccc------cccCccceeee
Q 011158 436 LFTVSI-----------LFCGKGRELISLFLGND------VLLQFGTYWII 469 (492)
Q Consensus 436 la~~~~-----------~~~g~~~~~ape~~~~e------~~~~~~d~W~l 469 (492)
+++... ...++..|++||..... .+....|+|++
T Consensus 159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Dvwsl 209 (301)
T 3q4u_A 159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAF 209 (301)
T ss_dssp TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHH
T ss_pred CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHH
Confidence 986432 12567778888877655 33445677873
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=249.11 Aligned_cols=181 Identities=31% Similarity=0.481 Sum_probs=152.1
Q ss_pred CceeeCCCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-Ce
Q 011158 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-PS 363 (492)
Q Consensus 285 ~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-~~ 363 (492)
..|.++.++|++.+.||+|+||.||++++.++.||||+++... ..+.+.+|+.++++++||||+++++++... +.
T Consensus 14 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (278)
T 1byg_A 14 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 89 (278)
T ss_dssp -CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred ccccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence 3578888999999999999999999999999999999997542 346789999999999999999999997654 46
Q ss_pred EEEEEeccCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-
Q 011158 364 LCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI- 441 (492)
Q Consensus 364 ~~lV~Ey~~ggsL~~~L~~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~- 441 (492)
+|+||||+++|+|.+++..... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||.+....
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 8999999999999999976432 38999999999999999999999999999999999999999999999999986542
Q ss_pred ---eeeCCCceeecceeccccccCccceeee
Q 011158 442 ---LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 442 ---~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
...++..|++||......+....|+|++
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 200 (278)
T 1byg_A 170 TQDTGKLPVKWTAPEALREKKFSTKSDVWSF 200 (278)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHH
T ss_pred cccCCCccccccCHHHhCCCCCCchhcHHHH
Confidence 2345567888988877777777888884
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.2e-29 Score=245.54 Aligned_cols=192 Identities=22% Similarity=0.410 Sum_probs=157.4
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHH-----HHHHHHHHHHHhcCCCceeeEEEEEec
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQ-----KEFAQEVFIMRKVRHKNVVQFIGACTK 360 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~-----~~~~~Ei~il~~l~HpnIv~l~g~~~~ 360 (492)
.+..++|++.+.||+|+||.||+|++ +++.||||++.......... +.+.+|+.++++++||||+++++++..
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN 94 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence 45667899999999999999999998 46889999997654322211 678999999999999999999999977
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCCEEEccCCC-----eEEEE
Q 011158 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEV-----SLLLS 433 (492)
Q Consensus 361 ~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~--IiHrDLKp~NILld~~~~-----~kl~D 433 (492)
.. ++||||+++|+|.+++.+....+++..++.++.|++.||.|||++| |+||||||+|||++.++. +||+|
T Consensus 95 ~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 95 PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 65 7999999999999999876678999999999999999999999999 999999999999988776 99999
Q ss_pred Eeecceee----eeeCCCceeeccee--ccccccCccceeee---ecccccCCCCCC
Q 011158 434 LCLFTVSI----LFCGKGRELISLFL--GNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 434 FGla~~~~----~~~g~~~~~ape~~--~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
||+++... ...++..|++||.. ....+....|+|++ +....+|..+|.
T Consensus 173 fg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 229 (287)
T 4f0f_A 173 FGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229 (287)
T ss_dssp CTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCc
Confidence 99986442 34577788888877 34445666788884 223334555543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-29 Score=255.52 Aligned_cols=193 Identities=22% Similarity=0.318 Sum_probs=165.5
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEE
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 365 (492)
++..++|++.++||+|+||.||+|.+. ++.||+|+++.. ......+.+.+|+.++++++||||+++++++...+.+|
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 107 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc-cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEE
Confidence 455678999999999999999999985 788999999865 34556678999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEEccCCCeEEEEEeeccee----
Q 011158 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVSLLLSLCLFTVS---- 440 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~-~IiHrDLKp~NILld~~~~~kl~DFGla~~~---- 440 (492)
+||||+++|+|.+++... +.+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+++..
T Consensus 108 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 186 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 186 (360)
T ss_dssp EEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC
T ss_pred EEEECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccccc
Confidence 999999999999999873 5689999999999999999999996 9999999999999999999999999998532
Q ss_pred -eeeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 441 -ILFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 441 -~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
....++..|++||......+....|+|++ +....+|..+|..
T Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 187 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp ----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 34567888999998888777888888884 3334456666544
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.96 E-value=5e-29 Score=250.61 Aligned_cols=189 Identities=21% Similarity=0.299 Sum_probs=161.0
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCh----HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS----DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 365 (492)
+.|++.+.||+|+||.||+|++. ++.||||+++...... ...+.+.+|+.++++++||||+++++++.....+|
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 46889999999999999999984 6889999998653322 13577999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCC----CeEEEEEeecceee
Q 011158 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE----VSLLLSLCLFTVSI 441 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~----~~kl~DFGla~~~~ 441 (492)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 92 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~ 170 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (321)
T ss_dssp EEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred EEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence 99999999999999976 46789999999999999999999999999999999999999888 79999999986532
Q ss_pred ------eeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 442 ------LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 ------~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||......+....|+|++ +....+|..+|.
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 219 (321)
T 2a2a_A 171 DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 219 (321)
T ss_dssp TTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred ccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCC
Confidence 3457778999998877777888899884 223445555553
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-29 Score=258.57 Aligned_cols=193 Identities=22% Similarity=0.290 Sum_probs=157.2
Q ss_pred ceeeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC-
Q 011158 286 VWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP- 362 (492)
Q Consensus 286 ~~ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~- 362 (492)
.|++ .++|++.+.||+|+||.||+|.+ +++.||||++..........+.+.+|+.+|++++||||+++++++....
T Consensus 20 ~~~~-~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 98 (367)
T 1cm8_A 20 AWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 98 (367)
T ss_dssp EECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred eeee-cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCc
Confidence 4555 36799999999999999999998 4788999999765555666788999999999999999999999997653
Q ss_pred -----eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeec
Q 011158 363 -----SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLF 437 (492)
Q Consensus 363 -----~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla 437 (492)
.+|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 99 LDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp TTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred cccCceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 469999999 8999999976 56899999999999999999999999999999999999999999999999999
Q ss_pred ceee----eeeCCCceeecceecc-ccccCccceeee---ecccccCCCCCCC
Q 011158 438 TVSI----LFCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 438 ~~~~----~~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
+... ...++..|++||.... ..+....|+|++ +....+|.+.|..
T Consensus 176 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 228 (367)
T 1cm8_A 176 RQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 228 (367)
T ss_dssp EECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCC
Confidence 7642 3456777888887655 567778899984 3344566666653
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.96 E-value=8.6e-29 Score=244.62 Aligned_cols=192 Identities=22% Similarity=0.384 Sum_probs=160.9
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEec----C
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK----P 361 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~ 361 (492)
..+...|++.+.||+|+||.||+|.+. +..||+|++.....+....+.+.+|+.++++++||||+++++++.. .
T Consensus 22 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (290)
T 1t4h_A 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 101 (290)
T ss_dssp CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred ccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCC
Confidence 344566888999999999999999984 5779999998766667777889999999999999999999999865 3
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCCEEEc-cCCCeEEEEEeecc
Q 011158 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMD-ENEVSLLLSLCLFT 438 (492)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~--IiHrDLKp~NILld-~~~~~kl~DFGla~ 438 (492)
..+|+||||+++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 102 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 102 KCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred ceEEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 5689999999999999999773 56899999999999999999999999 99999999999998 78899999999986
Q ss_pred ee-----eeeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 439 VS-----ILFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 439 ~~-----~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
.. ....++..|++||.... .+....|+|++ +.....|..+|.
T Consensus 181 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~ 230 (290)
T 1t4h_A 181 LKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYS 230 (290)
T ss_dssp GCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cccccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCC
Confidence 43 23567888999997764 36777788884 223344555554
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4.7e-29 Score=252.15 Aligned_cols=179 Identities=16% Similarity=0.270 Sum_probs=139.9
Q ss_pred eeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCeEEEEEeccCCC
Q 011158 298 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFMSGG 374 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~Ey~~gg 374 (492)
++||+|+||.||+|.+. ++.||||++... ....+.+|+.+++++. ||||+++++++......|||||||++|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~ 91 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence 68999999999999984 688999999642 3467789999999997 999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCC---CeEEEEEeecceee-------eee
Q 011158 375 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE---VSLLLSLCLFTVSI-------LFC 444 (492)
Q Consensus 375 sL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~---~~kl~DFGla~~~~-------~~~ 444 (492)
+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++... ...
T Consensus 92 ~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 170 (325)
T 3kn6_A 92 ELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC 170 (325)
T ss_dssp BHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---------
T ss_pred cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccC
Confidence 99999987 46799999999999999999999999999999999999998765 79999999987532 345
Q ss_pred CCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 445 GKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 445 g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
++..|++||......+....|+|++ +....+|.++|..
T Consensus 171 ~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 211 (325)
T 3kn6_A 171 FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQS 211 (325)
T ss_dssp -------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-
T ss_pred CCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 6778999998888778888899984 3334456666653
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=270.60 Aligned_cols=192 Identities=21% Similarity=0.422 Sum_probs=161.8
Q ss_pred CCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEE
Q 011158 290 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (492)
Q Consensus 290 ~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 366 (492)
...+|.+.+.||+|+||.||+|++ +++.||||++...... ......+.+|+.+++.++||||+++++++.....+|+
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 346799999999999999999998 4789999999753211 1234678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee------
Q 011158 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS------ 440 (492)
Q Consensus 367 V~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~------ 440 (492)
||||+++|+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 94 v~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~ 172 (476)
T 2y94_A 94 VMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL 172 (476)
T ss_dssp EEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCB
T ss_pred EEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccccc
Confidence 9999999999999976 467999999999999999999999999999999999999999999999999998753
Q ss_pred eeeeCCCceeecceeccccc-cCccceeee---ecccccCCCCCCC
Q 011158 441 ILFCGKGRELISLFLGNDVL-LQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 441 ~~~~g~~~~~ape~~~~e~~-~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
...+|+..|++||......+ ....|+|++ +....+|.++|..
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~ 218 (476)
T 2y94_A 173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD 218 (476)
T ss_dssp CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCC
Confidence 23567888889988776655 456788884 3344456666543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.8e-30 Score=256.78 Aligned_cols=192 Identities=18% Similarity=0.329 Sum_probs=156.6
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEEC--Cce----EEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQD----VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~----vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 361 (492)
.+..++|++.++||+|+||.||+|.+. ++. ||+|++.... .......+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~- 86 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG- 86 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-
Confidence 456778999999999999999999984 333 7888876432 22223567789999999999999999999874
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee-
Q 011158 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS- 440 (492)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~- 440 (492)
...++||||+++|+|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 5699999999999999999876668999999999999999999999999999999999999999999999999999753
Q ss_pred --------eeeeCCCceeecceeccccccCccceeee----ecccccCCCCCC
Q 011158 441 --------ILFCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSD 481 (492)
Q Consensus 441 --------~~~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~ 481 (492)
....++..|++||......+....|+|++ +.....|..+|.
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 219 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYA 219 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCcc
Confidence 12345557899998877777878888884 222233666664
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.96 E-value=5.5e-29 Score=259.27 Aligned_cols=182 Identities=19% Similarity=0.267 Sum_probs=148.9
Q ss_pred Cceee-eeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHH-hcCCCceeeEEEEEec----CCeE
Q 011158 293 HLKFG-SKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMR-KVRHKNVVQFIGACTK----PPSL 364 (492)
Q Consensus 293 ~~~~~-~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~-~l~HpnIv~l~g~~~~----~~~~ 364 (492)
+|.+. ++||+|+||.||+|.+. ++.||||+++.. ..+.+|+.++. ..+||||+++++++.. ...+
T Consensus 62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 45555 68999999999999984 688999999742 45678888875 4589999999999875 5678
Q ss_pred EEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcc---CCCeEEEEEeeccee
Q 011158 365 CIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVSLLLSLCLFTVS 440 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~---~~~~kl~DFGla~~~ 440 (492)
|||||||+||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++..
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~ 214 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 214 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccccc
Confidence 99999999999999998643 36999999999999999999999999999999999999998 789999999998754
Q ss_pred e------eeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 441 I------LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 441 ~------~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
. ...++..|++||++....+....|+|++ +....+|.++|.
T Consensus 215 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 264 (400)
T 1nxk_A 215 TSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 264 (400)
T ss_dssp C-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Confidence 2 3467788999999988888888899984 334445665554
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-29 Score=267.29 Aligned_cols=188 Identities=21% Similarity=0.320 Sum_probs=154.3
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
+.|++.++||+|+||.||+|++ ++..||||+++...........+.+|+.++++++||||+++++++.....+|+|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 3689999999999999999998 46789999998654444445778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccC---CCeEEEEEeeccee------
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN---EVSLLLSLCLFTVS------ 440 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~---~~~kl~DFGla~~~------ 440 (492)
||++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.. +.+||+|||+++..
T Consensus 117 ~~~~g~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~ 195 (494)
T 3lij_A 117 CYKGGELFDEIIH-RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM 195 (494)
T ss_dssp CCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCB
T ss_pred cCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccc
Confidence 9999999999976 3578999999999999999999999999999999999999764 45999999998653
Q ss_pred eeeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 441 ILFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 441 ~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
....++..|++||.+.. .+....|+|++ +....+|.++|.
T Consensus 196 ~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~ 238 (494)
T 3lij_A 196 KERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFG 238 (494)
T ss_dssp CCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCC
Confidence 23457888999998764 47777888884 334455666664
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-29 Score=258.56 Aligned_cols=193 Identities=16% Similarity=0.186 Sum_probs=155.5
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCChH---------HHHHHHHHHHHHHhcCCCce
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSD---------MQKEFAQEVFIMRKVRHKNV 351 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~~-------g~~vAvK~l~~~~~~~~---------~~~~~~~Ei~il~~l~HpnI 351 (492)
++..++|++.++||+|+||.||+|.+. ++.||||++........ ....+.+|+..++.++|+||
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i 110 (364)
T 3op5_A 31 DMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGV 110 (364)
T ss_dssp CTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred ccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence 456779999999999999999999884 36799999876431100 01224456667788899999
Q ss_pred eeEEEEEecC----CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc--c
Q 011158 352 VQFIGACTKP----PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD--E 425 (492)
Q Consensus 352 v~l~g~~~~~----~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld--~ 425 (492)
+++++++... ...||||||| +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSC
T ss_pred CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCC
Confidence 9999998764 4589999999 9999999988667899999999999999999999999999999999999999 8
Q ss_pred CCCeEEEEEeecceee--------------eeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 426 NEVSLLLSLCLFTVSI--------------LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 426 ~~~~kl~DFGla~~~~--------------~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
++.+||+|||+++... ...|+..|++||......+....|+|++ +....+|..+|.
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~ 262 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWE 262 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 8999999999996431 2237788999998887778888888884 333445666665
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-29 Score=246.14 Aligned_cols=192 Identities=20% Similarity=0.348 Sum_probs=160.7
Q ss_pred CCCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEE
Q 011158 290 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (492)
Q Consensus 290 ~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 366 (492)
..++|++.+.||+|+||.||+|.+. ++.||+|++...... ......+.+|+.++++++||||+++++++......++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3468999999999999999999984 567999998643211 1224678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee-----e
Q 011158 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS-----I 441 (492)
Q Consensus 367 V~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~-----~ 441 (492)
||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.+... .
T Consensus 87 v~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 165 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT 165 (279)
T ss_dssp EECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred EEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccccc
Confidence 99999999999999774 56899999999999999999999999999999999999999999999999988543 2
Q ss_pred eeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 442 LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 442 ~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
...++..|++||......+....|+|++ +.....|.++|..
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 209 (279)
T 3fdn_A 166 DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209 (279)
T ss_dssp --CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCC
Confidence 3467788999998888777888888884 2234456665543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=244.12 Aligned_cols=190 Identities=20% Similarity=0.285 Sum_probs=161.8
Q ss_pred CCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 367 (492)
..+|.+.+.||+|+||.||++.+. ++.||+|++..... .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 357889999999999999999984 67899999876533 345567889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee------
Q 011158 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------ 441 (492)
Q Consensus 368 ~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------ 441 (492)
|||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.+....
T Consensus 94 ~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 172 (294)
T 2rku_A 94 LELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 172 (294)
T ss_dssp EECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred EecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcccc
Confidence 999999999999876 4578999999999999999999999999999999999999999999999999986532
Q ss_pred -eeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 442 -LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 -~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||......+....|+|++ +.....|..+|.
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 216 (294)
T 2rku_A 173 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 216 (294)
T ss_dssp CCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred ccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 2456777899998877777778888884 223334555554
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-29 Score=250.41 Aligned_cols=197 Identities=26% Similarity=0.408 Sum_probs=162.7
Q ss_pred CceeeCCCCceeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeEEE
Q 011158 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIG 356 (492)
Q Consensus 285 ~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~-------g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g 356 (492)
..|++..++|++.+.||+|+||.||+|.+. ++.||||+++... .....+.+.+|+.+++++ +||||+++++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 357888899999999999999999999852 3679999998643 344567899999999999 6899999999
Q ss_pred EEecCC-eEEEEEeccCCCCHHHHHHhcCCC---------------CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCC
Q 011158 357 ACTKPP-SLCIVTEFMSGGSVYDYLHKLKGV---------------FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 420 (492)
Q Consensus 357 ~~~~~~-~~~lV~Ey~~ggsL~~~L~~~~~~---------------l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~N 420 (492)
++...+ .+++||||+++|+|.+++...... +++..++.++.||+.||.|||++||+||||||+|
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~N 178 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 178 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccce
Confidence 988754 489999999999999999874332 8899999999999999999999999999999999
Q ss_pred EEEccCCCeEEEEEeecceee---------eeeCCCceeecceeccccccCccceeee----ecccccCCCCCCC
Q 011158 421 LLMDENEVSLLLSLCLFTVSI---------LFCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSDA 482 (492)
Q Consensus 421 ILld~~~~~kl~DFGla~~~~---------~~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~a 482 (492)
||++.++.+||+|||+++... ...++..|++||......+....|+|++ +.....|.++|..
T Consensus 179 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 179 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred EEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999986431 2334556888888877777778888884 2222336666643
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-29 Score=253.84 Aligned_cols=189 Identities=19% Similarity=0.264 Sum_probs=150.7
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
.++|++.++||+|+||.||+|.+ +++.||||+++...........+.+|+.++++++||||+++++++.....+||||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 35799999999999999999987 4688999999876555555677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc-----cCCCeEEEEEeeccee---
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD-----ENEVSLLLSLCLFTVS--- 440 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld-----~~~~~kl~DFGla~~~--- 440 (492)
||++ |+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||.+...
T Consensus 113 e~~~-~~L~~~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~ 190 (329)
T 3gbz_A 113 EYAE-NDLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190 (329)
T ss_dssp ECCS-EEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred ecCC-CCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence 9996 699999987 45689999999999999999999999999999999999994 4556999999998643
Q ss_pred ----eeeeCCCceeecceecc-ccccCccceeee---ecccccCCCCCC
Q 011158 441 ----ILFCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 441 ----~~~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
....++..|++||.... ..+....|+|++ +....+|.++|.
T Consensus 191 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 239 (329)
T 3gbz_A 191 IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFP 239 (329)
T ss_dssp ---------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 12356778899997765 446777888884 333445665554
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-29 Score=274.95 Aligned_cols=194 Identities=23% Similarity=0.343 Sum_probs=161.1
Q ss_pred ceeeCCCCceeee-eeeecCceEEEEEEEC----CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Q 011158 286 VWEIDPKHLKFGS-KVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 360 (492)
Q Consensus 286 ~~ei~~~~~~~~~-~LG~G~fG~Vy~~~~~----g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 360 (492)
.|.+..+++.+.+ +||+|+||.||+|.+. +..||||+++... .....+.|.+|+.+|++++||||+++++++..
T Consensus 329 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~ 407 (613)
T 2ozo_A 329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA 407 (613)
T ss_dssp CSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES
T ss_pred ceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc
Confidence 4667777888777 8999999999999873 3569999998653 33446789999999999999999999999986
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 361 ~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
+.+|||||||++|+|.+++......+++..++.++.||+.||.|||+++||||||||+|||++.++.+||+|||+++..
T Consensus 408 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 408 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp -SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred -CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 5699999999999999999876678999999999999999999999999999999999999999999999999999753
Q ss_pred ee----------eeCCCceeecceeccccccCccceeee----ecccccCCCCCC
Q 011158 441 IL----------FCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSD 481 (492)
Q Consensus 441 ~~----------~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~ 481 (492)
.. ..++..|++||+.....+....|+|++ +....+|..+|.
T Consensus 487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~ 541 (613)
T 2ozo_A 487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 541 (613)
T ss_dssp C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 21 122356899998877778888898884 222334666664
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=246.72 Aligned_cols=194 Identities=16% Similarity=0.263 Sum_probs=158.4
Q ss_pred CceeeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEe---
Q 011158 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT--- 359 (492)
Q Consensus 285 ~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~--- 359 (492)
+.+.++.++|++.+.||+|+||.||++.+ .++.||||++... .....+.+.+|+.++++++||||+++++++.
T Consensus 22 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 99 (317)
T 2buj_A 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRER 99 (317)
T ss_dssp EEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE
T ss_pred cEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc
Confidence 45778889999999999999999999997 5788999998653 3556678999999999999999999999987
Q ss_pred -cCCeEEEEEeccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEe
Q 011158 360 -KPPSLCIVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLC 435 (492)
Q Consensus 360 -~~~~~~lV~Ey~~ggsL~~~L~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFG 435 (492)
.....|+||||+++|+|.+++... ...+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||
T Consensus 100 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg 179 (317)
T 2buj_A 100 GAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLG 179 (317)
T ss_dssp TTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCS
T ss_pred CCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecC
Confidence 345789999999999999999763 4679999999999999999999999999999999999999999999999999
Q ss_pred ecceeee----------------eeCCCceeecceeccc---cccCccceeee---ecccccCCCCC
Q 011158 436 LFTVSIL----------------FCGKGRELISLFLGND---VLLQFGTYWII---FRRSSCDKKNS 480 (492)
Q Consensus 436 la~~~~~----------------~~g~~~~~ape~~~~e---~~~~~~d~W~l---~~~~~~gt~~Y 480 (492)
.+..... ..++..|++||..... .+....|+|++ +....+|..+|
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~ 246 (317)
T 2buj_A 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY 246 (317)
T ss_dssp SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTT
T ss_pred cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCCh
Confidence 8865421 2246778888876543 25666788884 22333455444
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.2e-29 Score=257.92 Aligned_cols=192 Identities=15% Similarity=0.190 Sum_probs=160.5
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCChHHHHHHHHHHHHHHhcC--CCceeeEEEEEecCCe
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR--HKNVVQFIGACTKPPS 363 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~g~~~~~~~ 363 (492)
..+....|++.++||+|+||.||+|.+. ++.||||++.....+......+.+|+.+|++++ ||||+++++++...+.
T Consensus 51 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~ 130 (390)
T 2zmd_A 51 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 130 (390)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred ccccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCE
Confidence 4566678999999999999999999874 678999999877666677788999999999997 5999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee--
Q 011158 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-- 441 (492)
Q Consensus 364 ~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-- 441 (492)
+|||||+ .+++|.+++.+ ...+++..++.++.||+.||.|||+++|+||||||+|||++ ++.+||+|||+++...
T Consensus 131 ~~lv~E~-~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 131 IYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp EEEEEEC-CSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred EEEEEec-CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9999995 58999999987 45789999999999999999999999999999999999996 5789999999997532
Q ss_pred -------eeeCCCceeecceecc-----------ccccCccceeee---ecccccCCCCCC
Q 011158 442 -------LFCGKGRELISLFLGN-----------DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 -------~~~g~~~~~ape~~~~-----------e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...|+..|++||++.. ..+....|+|++ +....+|.++|.
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~ 268 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcch
Confidence 2357778888887643 345666788884 334456766664
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.7e-29 Score=249.19 Aligned_cols=186 Identities=25% Similarity=0.385 Sum_probs=152.2
Q ss_pred CCceeeCCCCceeeeeeeecCceEEEEEEEC-----CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEE
Q 011158 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 358 (492)
Q Consensus 284 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~-----g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~ 358 (492)
...+.++.++|.+.+.||+|+||.||+|.+. ++.||+|+++.........+.+.+|+.++++++||||+++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 3456788899999999999999999999873 24799999987666666778899999999999999999999999
Q ss_pred ecCC-----eEEEEEeccCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCC
Q 011158 359 TKPP-----SLCIVTEFMSGGSVYDYLHKL-----KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428 (492)
Q Consensus 359 ~~~~-----~~~lV~Ey~~ggsL~~~L~~~-----~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~ 428 (492)
.... ..++||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~ 185 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT 185 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc
Confidence 8654 359999999999999999532 356999999999999999999999999999999999999999999
Q ss_pred eEEEEEeecceee---------eeeCCCceeecceeccccccCccceeee
Q 011158 429 SLLLSLCLFTVSI---------LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 429 ~kl~DFGla~~~~---------~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
+||+|||++.... ...++..|++||......+....|+|++
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 235 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAF 235 (313)
T ss_dssp EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHH
T ss_pred EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHH
Confidence 9999999986532 2234456888888777777777888884
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=241.75 Aligned_cols=187 Identities=20% Similarity=0.286 Sum_probs=157.7
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
++|++.++||+|+||.||+|.+. +..||+|++...... ..+.+.+|+.++++++||||+++++++......|+|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 46889999999999999999985 467999998754322 24678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE---ccCCCeEEEEEeeccee------
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVSLLLSLCLFTVS------ 440 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILl---d~~~~~kl~DFGla~~~------ 440 (492)
|+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||.+...
T Consensus 87 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~ 165 (277)
T 3f3z_A 87 LCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM 165 (277)
T ss_dssp CCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCB
T ss_pred ccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccch
Confidence 9999999999977 4568999999999999999999999999999999999999 78889999999998643
Q ss_pred eeeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 441 ILFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 441 ~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
....++..|++||..... +....|+|++ +....+|.++|..
T Consensus 166 ~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (277)
T 3f3z_A 166 RTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSA 209 (277)
T ss_dssp CCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred hccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCC
Confidence 234577788899877654 6777788884 2233456666654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.1e-29 Score=248.58 Aligned_cols=179 Identities=26% Similarity=0.394 Sum_probs=152.8
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEE------CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEec-
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK- 360 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~- 360 (492)
.++.+.|++.++||+|+||.||++.+ +++.||||+++.. ........+.+|+.++++++||||+++++++..
T Consensus 27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (318)
T 3lxp_A 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA 105 (318)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence 34555569999999999999999876 4678999999864 345556789999999999999999999999987
Q ss_pred -CCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecce
Q 011158 361 -PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTV 439 (492)
Q Consensus 361 -~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~ 439 (492)
...+++||||+++|+|.+++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.+..
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 106 GAASLQLVMEYVPLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp TTTEEEEEECCCTTCBHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred CCceEEEEEecccCCcHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccc
Confidence 4678999999999999999976 4589999999999999999999999999999999999999999999999999865
Q ss_pred ee----------eeeCCCceeecceeccccccCccceeee
Q 011158 440 SI----------LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 440 ~~----------~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
.. ...++..|++||......+....|+|++
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 223 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSF 223 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHH
T ss_pred ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHH
Confidence 32 2234455888888777677777788884
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=242.39 Aligned_cols=189 Identities=21% Similarity=0.337 Sum_probs=159.9
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCh----HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS----DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 365 (492)
++|++.+.||+|+||.||+|.+. ++.||+|+++...... ...+.+.+|+.++++++||||+++++++......+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46889999999999999999984 7899999998654322 13578999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCC----CeEEEEEeecceee
Q 011158 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE----VSLLLSLCLFTVSI 441 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~----~~kl~DFGla~~~~ 441 (492)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||.+....
T Consensus 85 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~ 163 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163 (283)
T ss_dssp EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence 99999999999999976 45789999999999999999999999999999999999999877 79999999986532
Q ss_pred ------eeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 442 ------LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 ------~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||......+....|+|++ +....+|..+|.
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 212 (283)
T 3bhy_A 164 AGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 212 (283)
T ss_dssp --------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCC
Confidence 2357778899998877777778888884 223344555554
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-29 Score=267.65 Aligned_cols=188 Identities=21% Similarity=0.324 Sum_probs=158.1
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
++|++.++||+|+||.||+|++. ++.||||++............+.+|+.+|++++||||+++++++.....+|+|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 57889999999999999999984 7889999996533223335778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc---cCCCeEEEEEeecceee-----
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD---ENEVSLLLSLCLFTVSI----- 441 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld---~~~~~kl~DFGla~~~~----- 441 (492)
||++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 102 ~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~ 180 (486)
T 3mwu_A 102 LYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180 (486)
T ss_dssp CCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC---
T ss_pred cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCcc
Confidence 99999999999773 5799999999999999999999999999999999999995 45679999999986432
Q ss_pred -eeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 442 -LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 -~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||..... +....|+|++ +....+|.++|.
T Consensus 181 ~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~~ll~g~~pf~ 223 (486)
T 3mwu_A 181 KDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFY 223 (486)
T ss_dssp -CCTTGGGGCCGGGGGSC-CCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCcCCCCCCCHHHhCCC-CCchhhHHHHHHHHHHHHhCCCCCC
Confidence 34577888899887653 6667788884 334455666664
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=250.05 Aligned_cols=190 Identities=20% Similarity=0.285 Sum_probs=162.1
Q ss_pred CCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 367 (492)
..+|.+.+.||+|+||.||++.+. ++.||+|++..... .....+.+.+|+.++++++|+||+++++++...+.+|+|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 457899999999999999999984 57899999976532 345567889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee------
Q 011158 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------ 441 (492)
Q Consensus 368 ~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------ 441 (492)
|||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 120 ~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 198 (335)
T 2owb_A 120 LELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 198 (335)
T ss_dssp ECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred EecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcccc
Confidence 999999999999876 4578999999999999999999999999999999999999999999999999986532
Q ss_pred -eeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 442 -LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 -~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||......+....|+|++ +.....|..+|.
T Consensus 199 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 242 (335)
T 2owb_A 199 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 242 (335)
T ss_dssp CCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred cccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCC
Confidence 2456778899998877777777888884 223334555554
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-28 Score=253.03 Aligned_cols=187 Identities=19% Similarity=0.203 Sum_probs=154.8
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC------
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP------ 362 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~------ 362 (492)
.++|++.+.||+|+||.||+|.+ .++.||||++............+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 36899999999999999999988 4788999999876555666788999999999999999999999997665
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-
Q 011158 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI- 441 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~- 441 (492)
.+|+|||||. |+|.+++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 104 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred ceEEEEEcCC-CCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 7899999995 68988885 358999999999999999999999999999999999999999999999999987542
Q ss_pred -----eeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 442 -----LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 -----~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||......+....|+|++ +....+|.++|.
T Consensus 180 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 227 (371)
T 2xrw_A 180 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFP 227 (371)
T ss_dssp ----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 3467788999998888888888899984 333445665554
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.6e-29 Score=265.39 Aligned_cols=189 Identities=20% Similarity=0.350 Sum_probs=156.8
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCh-----------HHHHHHHHHHHHHHhcCCCceeeEEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS-----------DMQKEFAQEVFIMRKVRHKNVVQFIGAC 358 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~-----------~~~~~~~~Ei~il~~l~HpnIv~l~g~~ 358 (492)
+.|++.++||+|+||.||+|++. ++.||||+++...... ...+.+.+|+.+|++++||||+++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 57999999999999999999984 5789999998653321 2356789999999999999999999999
Q ss_pred ecCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCC---CeEEEEEe
Q 011158 359 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE---VSLLLSLC 435 (492)
Q Consensus 359 ~~~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~---~~kl~DFG 435 (492)
.....+|||||||++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 194 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFG 194 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCT
T ss_pred EcCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECC
Confidence 999999999999999999999977 45799999999999999999999999999999999999999776 69999999
Q ss_pred eccee------eeeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 436 LFTVS------ILFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 436 la~~~------~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
++... ....|+..|++||.... .+....|+|++ +....+|.++|..
T Consensus 195 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~ 249 (504)
T 3q5i_A 195 LSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGG 249 (504)
T ss_dssp TCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 98653 23467888999998764 46777888884 3344567666653
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.6e-29 Score=250.79 Aligned_cols=194 Identities=20% Similarity=0.230 Sum_probs=162.3
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEE
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 365 (492)
....++|++.+.||+|+||.||+|.+. ++.||||++..........+.+.+|+.++++++||||+++++++......|
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 100 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWY 100 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEE
Confidence 344578999999999999999999985 788999999876666666778899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee----
Q 011158 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI---- 441 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~---- 441 (492)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.++...
T Consensus 101 lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELF-PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp EEEECCSEEHHHHHHHS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEEecCCcchHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 99999999888887755 4679999999999999999999999999999999999999999999999999986532
Q ss_pred ---eeeCCCceeecceeccc-cccCccceeee---ecccccCCCCCCC
Q 011158 442 ---LFCGKGRELISLFLGND-VLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 442 ---~~~g~~~~~ape~~~~e-~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
...++..|++||..... .+....|+|++ +....+|.++|..
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 227 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPG 227 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCC
Confidence 24567778899877654 56677788884 3334456665543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=246.65 Aligned_cols=190 Identities=13% Similarity=0.210 Sum_probs=155.5
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 367 (492)
..+|++.+.||+|+||.||+|.+ .++.||||++..... +....+.+.+|+.++++++||||+++++++...+.+|+|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 46799999999999999999998 468899999976532 344557899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee------
Q 011158 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------ 441 (492)
Q Consensus 368 ~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------ 441 (492)
|||+++++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 113 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 191 (309)
T 2h34_A 113 MRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ 191 (309)
T ss_dssp EECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred EEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccccc
Confidence 999999999999987 3578999999999999999999999999999999999999999999999999986532
Q ss_pred --eeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 442 --LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 --~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||......+....|+|++ +.....|..+|.
T Consensus 192 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (309)
T 2h34_A 192 LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQ 236 (309)
T ss_dssp -----CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCC
Confidence 2356778999998888888888899884 223334665554
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=256.15 Aligned_cols=189 Identities=17% Similarity=0.288 Sum_probs=158.0
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCh------HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS------DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 363 (492)
++|++.+.||+|+||.||+|.+ +++.||||+++...... .....+.+|+.++++++||||+++++++...+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 4789999999999999999987 56889999998754322 133467789999999999999999999999999
Q ss_pred EEEEEeccCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee--
Q 011158 364 LCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS-- 440 (492)
Q Consensus 364 ~~lV~Ey~~gg-sL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~-- 440 (492)
+++||||+.+| +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 182 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER 182 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCC
Confidence 99999999776 99999976 457999999999999999999999999999999999999999999999999998653
Q ss_pred ----eeeeCCCceeecceeccccc-cCccceeee---ecccccCCCCCC
Q 011158 441 ----ILFCGKGRELISLFLGNDVL-LQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 441 ----~~~~g~~~~~ape~~~~e~~-~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
....++..|++||......+ ....|+|++ +....+|..+|.
T Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 231 (335)
T 3dls_A 183 GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFC 231 (335)
T ss_dssp TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCS
T ss_pred CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchh
Confidence 23557888999998776655 556688884 223345555543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-29 Score=275.33 Aligned_cols=196 Identities=23% Similarity=0.357 Sum_probs=160.9
Q ss_pred CceeeCCCCceeee-eeeecCceEEEEEEE----CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Q 011158 285 DVWEIDPKHLKFGS-KVASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359 (492)
Q Consensus 285 ~~~ei~~~~~~~~~-~LG~G~fG~Vy~~~~----~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~ 359 (492)
..|.++...+.+.. +||+|+||.||+|.+ .++.||||+++....+....+++.+|+.+|++++||||+++++++.
T Consensus 361 ~~~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 440 (635)
T 4fl3_A 361 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE 440 (635)
T ss_dssp SSSBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 34667777776654 899999999999976 2467999999876555666788999999999999999999999997
Q ss_pred cCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecce
Q 011158 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTV 439 (492)
Q Consensus 360 ~~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~ 439 (492)
. +.++||||||++|+|.+++.. ...+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++.
T Consensus 441 ~-~~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 518 (635)
T 4fl3_A 441 A-ESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 518 (635)
T ss_dssp S-SSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHH
T ss_pred c-CCEEEEEEccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccc
Confidence 5 458999999999999999976 46789999999999999999999999999999999999999999999999999864
Q ss_pred ee----------eeeCCCceeecceeccccccCccceeee----ecccccCCCCCCC
Q 011158 440 SI----------LFCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSDA 482 (492)
Q Consensus 440 ~~----------~~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~a 482 (492)
.. ...++..|++||......+....|+|++ +....+|..+|..
T Consensus 519 ~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~ 575 (635)
T 4fl3_A 519 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 575 (635)
T ss_dssp TTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred cccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 31 1223456888888877777888899984 2223346666643
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.8e-29 Score=247.70 Aligned_cols=192 Identities=20% Similarity=0.297 Sum_probs=154.4
Q ss_pred eCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhcC---CCceeeEEEEEec
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI---NSDMQKEFAQEVFIMRKVR---HKNVVQFIGACTK 360 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~---~~~~~~~~~~Ei~il~~l~---HpnIv~l~g~~~~ 360 (492)
+..++|++.++||+|+||.||+|++ +++.||||+++.... .......+.+|+.++++++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3456899999999999999999996 578899999874321 1112345667888777765 9999999999987
Q ss_pred CC-----eEEEEEeccCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEE
Q 011158 361 PP-----SLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSL 434 (492)
Q Consensus 361 ~~-----~~~lV~Ey~~ggsL~~~L~~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DF 434 (492)
.. .+++||||+. |+|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence 55 4899999995 699999987543 4899999999999999999999999999999999999999999999999
Q ss_pred eecceee------eeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 435 CLFTVSI------LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 435 Gla~~~~------~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
|.++... ...++..|++||......+....|+|++ +.....|.++|.
T Consensus 165 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 220 (308)
T 3g33_A 165 GLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC 220 (308)
T ss_dssp SCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCC
T ss_pred ccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCC
Confidence 9986432 3456788999998877778888899984 334445666553
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=258.73 Aligned_cols=193 Identities=18% Similarity=0.277 Sum_probs=157.9
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEE-----CCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhc-CCCceeeEEEEEe
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACT 359 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~-----~g~~vAvK~l~~~~~--~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~ 359 (492)
.+..++|++.++||+|+||.||+|++ .++.||||+++.... .......+.+|+.+++++ +||||+++++++.
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 129 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 129 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence 44557899999999999999999988 568899999975321 112235577899999999 6999999999999
Q ss_pred cCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecce
Q 011158 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTV 439 (492)
Q Consensus 360 ~~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~ 439 (492)
....+|||||||++|+|.+++... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus 130 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 130 TETKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eCceEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 999999999999999999999873 5789999999999999999999999999999999999999999999999999864
Q ss_pred ee--------eeeCCCceeecceecc--ccccCccceeee---ecccccCCCCCC
Q 011158 440 SI--------LFCGKGRELISLFLGN--DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 440 ~~--------~~~g~~~~~ape~~~~--e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
.. ...++..|++||.... ..+....|+|++ +....+|..+|.
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~ 263 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 263 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTS
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCc
Confidence 31 2457788888988764 345666788884 333345655554
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=4.9e-29 Score=245.61 Aligned_cols=195 Identities=19% Similarity=0.332 Sum_probs=163.9
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeE
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 364 (492)
.+..++|++.+.||+|+||.||+|++. ++.||||++...... ......+.+|+.++++++||||+++++++...+..
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 89 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI 89 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence 344568999999999999999999984 578999998643211 12246788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee---
Q 011158 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI--- 441 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~--- 441 (492)
|+||||+++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.+....
T Consensus 90 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR 168 (284)
T ss_dssp EEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred EEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence 9999999999999999874 568999999999999999999999999999999999999999999999999875432
Q ss_pred --eeeCCCceeecceeccccccCccceeee---ecccccCCCCCCCc
Q 011158 442 --LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDAP 483 (492)
Q Consensus 442 --~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~aP 483 (492)
...++..|++||......+....|+|++ +....+|.++|..+
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 215 (284)
T 2vgo_A 169 RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP 215 (284)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCC
Confidence 3457778999998888888888899984 22344566666543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.96 E-value=7.1e-29 Score=244.39 Aligned_cols=182 Identities=19% Similarity=0.251 Sum_probs=144.4
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeE
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 364 (492)
+++..++|++.++||+|+||.||+|.+ +++.||||+++.........+.+.++..+++.++||||+++++++...+..
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 467778999999999999999999998 578899999986543344444455566668889999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 365 CIVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~---~~~~l~~~~~~~i~~qI~~gL~yLH~~-~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
|+||||++ |+|.+++.. ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 82 WICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99999995 699888764 346799999999999999999999998 9999999999999999999999999998653
Q ss_pred e------eeeCCCceeeccee----ccccccCccceeee
Q 011158 441 I------LFCGKGRELISLFL----GNDVLLQFGTYWII 469 (492)
Q Consensus 441 ~------~~~g~~~~~ape~~----~~e~~~~~~d~W~l 469 (492)
. ...++..|++||.. ....+....|+|++
T Consensus 161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~sl 199 (290)
T 3fme_A 161 VDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSL 199 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHH
T ss_pred cccccccccCCCccccChhhcChhhcCcCCCcHHHHHHH
Confidence 2 23577778888885 34455666788874
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-29 Score=253.47 Aligned_cols=178 Identities=24% Similarity=0.406 Sum_probs=155.3
Q ss_pred CCCCceeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 290 DPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 290 ~~~~~~~~~~LG~G~fG~Vy~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
..++|++.+.||+|+||.||+|++. ++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 114 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIY 114 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEE
T ss_pred HHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 4568889999999999999999974 6889999987643 344578999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee----
Q 011158 369 EFMSGGSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI---- 441 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~---~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~---- 441 (492)
||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 194 (321)
T 2qkw_B 115 KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ 194 (321)
T ss_dssp ECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSC
T ss_pred EcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 9999999999996543 358999999999999999999999999999999999999999999999999986431
Q ss_pred -----eeeCCCceeecceeccccccCccceeee
Q 011158 442 -----LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 442 -----~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
...++..|++||......+....|+|++
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 227 (321)
T 2qkw_B 195 THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSF 227 (321)
T ss_dssp CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHH
T ss_pred cccccccCCCccccCHHHhcCCCCCcccchHhH
Confidence 2346777889988877777888888884
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-28 Score=246.78 Aligned_cols=187 Identities=20% Similarity=0.285 Sum_probs=153.1
Q ss_pred CCceee-eeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCeEEEE
Q 011158 292 KHLKFG-SKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIV 367 (492)
Q Consensus 292 ~~~~~~-~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV 367 (492)
+.|++. +.||+|+||.||+|.+ +++.||||+++... ......+.+|+.+++++ +||||+++++++...+.+|+|
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 456664 6899999999999987 57889999997653 23357789999999995 799999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCC---eEEEEEeecceee---
Q 011158 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV---SLLLSLCLFTVSI--- 441 (492)
Q Consensus 368 ~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~---~kl~DFGla~~~~--- 441 (492)
|||+++|+|.+++... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++. +||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 168 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168 (316)
T ss_dssp EECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------
T ss_pred EEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCC
Confidence 9999999999999873 56899999999999999999999999999999999999998775 9999999986432
Q ss_pred -----------eeeCCCceeecceecc-----ccccCccceeee---ecccccCCCCCC
Q 011158 442 -----------LFCGKGRELISLFLGN-----DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 -----------~~~g~~~~~ape~~~~-----e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||.... ..+....|+|++ +....+|.++|.
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 227 (316)
T 2ac3_A 169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV 227 (316)
T ss_dssp -------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCc
Confidence 2337778888887754 456677888884 333445665554
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-29 Score=255.53 Aligned_cols=183 Identities=19% Similarity=0.284 Sum_probs=153.8
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCeEEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
++|++.+.||+|+||.||+|.+. ++.||||+++.... .+.+|+.++.++ +||||+++++++.+...+|+||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 56889999999999999999984 68899999976532 234688888888 7999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccC----CCeEEEEEeecceee---
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN----EVSLLLSLCLFTVSI--- 441 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~----~~~kl~DFGla~~~~--- 441 (492)
|||+||+|.+++.+ .+.+++..+..++.||+.||.|||++||+||||||+|||+..+ +.+||+|||+++...
T Consensus 96 E~~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~ 174 (342)
T 2qr7_A 96 ELMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174 (342)
T ss_dssp CCCCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred eCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence 99999999999976 4679999999999999999999999999999999999998543 249999999987532
Q ss_pred ----eeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 442 ----LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 ----~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||......+....|+|++ +....+|.++|.
T Consensus 175 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~ 221 (342)
T 2qr7_A 175 GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFA 221 (342)
T ss_dssp CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCC
Confidence 3456778888888877777778899984 334445666664
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-29 Score=253.48 Aligned_cols=188 Identities=20% Similarity=0.267 Sum_probs=152.7
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
++|++.++||+|+||.||+|.+. ++.||||+++.... ......+.+|+.++++++||||+++++++......|+|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 57899999999999999999984 68899999975432 1112245679999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------e
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-------L 442 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-------~ 442 (492)
|+. |+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... .
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 159 (324)
T 3mtl_A 81 YLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN 159 (324)
T ss_dssp CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccccc
Confidence 995 69999998877789999999999999999999999999999999999999999999999999986432 2
Q ss_pred eeCCCceeecceecc-ccccCccceeee---ecccccCCCCCC
Q 011158 443 FCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 443 ~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
..++..|++||.... ..+....|+|++ +....+|.++|.
T Consensus 160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 202 (324)
T 3mtl_A 160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFP 202 (324)
T ss_dssp ---CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 345777888887654 556777888884 333445655553
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=8e-29 Score=245.56 Aligned_cols=177 Identities=23% Similarity=0.344 Sum_probs=149.6
Q ss_pred CCceeeeeeeecCceEEEEEEECC-----ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEe-cCCeEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT-KPPSLC 365 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~g-----~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~-~~~~~~ 365 (492)
..|++.++||+|+||.||+|++.. ..||+|+++.. ......+.+.+|+.++++++||||+++++++. ..+..|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 357888999999999999998632 24899998753 34455678999999999999999999999865 456789
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee----
Q 011158 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI---- 441 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~---- 441 (492)
+||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.+....
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 183 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccch
Confidence 9999999999999998766778999999999999999999999999999999999999999999999999986431
Q ss_pred -------eeeCCCceeecceeccccccCccceeee
Q 011158 442 -------LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 442 -------~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
...++..|++||......+....|+|++
T Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 218 (298)
T 3f66_A 184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 218 (298)
T ss_dssp CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred hccccccCCCCCccccChHHhcCCCCChHHHHHHH
Confidence 1233456888887777677777888884
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.3e-29 Score=248.24 Aligned_cols=188 Identities=26% Similarity=0.416 Sum_probs=155.2
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEE
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 367 (492)
.++.++|++.+.||+|+||.||+|++.++.||||++... ...+.|.+|+.++++++||||+++++++.+ ..|+|
T Consensus 4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv 77 (307)
T 2eva_A 4 MIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLV 77 (307)
T ss_dssp BCCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEE
T ss_pred cCCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEE
Confidence 466788999999999999999999999999999998643 345789999999999999999999998874 47999
Q ss_pred EeccCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCCCCEEEccCCC-eEEEEEeecceee
Q 011158 368 TEFMSGGSVYDYLHKLKG--VFKLPSLLKVAIDVSKGMNYLHQ---NNIIHRDLKAANLLMDENEV-SLLLSLCLFTVSI 441 (492)
Q Consensus 368 ~Ey~~ggsL~~~L~~~~~--~l~~~~~~~i~~qI~~gL~yLH~---~~IiHrDLKp~NILld~~~~-~kl~DFGla~~~~ 441 (492)
|||+++|+|.+++..... .+++..++.++.||++||.|||+ +||+||||||+|||++.++. +||+|||.+....
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 999999999999986432 47899999999999999999999 89999999999999998886 7999999986432
Q ss_pred ----eeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 442 ----LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 ----~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||......+....|+|++ +.....|..+|.
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 204 (307)
T 2eva_A 158 THMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD 204 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTT
T ss_pred cccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCch
Confidence 3457888999998888888888899884 223334555543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=5.3e-29 Score=256.49 Aligned_cols=194 Identities=21% Similarity=0.299 Sum_probs=148.8
Q ss_pred CceeeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-
Q 011158 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP- 361 (492)
Q Consensus 285 ~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~- 361 (492)
..|++. ++|++.+.||+|+||.||+|.+ +++.||||++.....+....+.+.+|+.++++++||||+++++++...
T Consensus 23 ~~~~~~-~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 101 (367)
T 2fst_X 23 TIWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 101 (367)
T ss_dssp EEEEEE-TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred cccCCC-CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence 456665 6799999999999999999987 478899999986555566678899999999999999999999999754
Q ss_pred -----CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEee
Q 011158 362 -----PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCL 436 (492)
Q Consensus 362 -----~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGl 436 (492)
..+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 102 SLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp SGGGCCCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---
T ss_pred ccccCCeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 5689999999 8999999875 5799999999999999999999999999999999999999999999999999
Q ss_pred cceee----eeeCCCceeecceecc-ccccCccceeee---ecccccCCCCCCC
Q 011158 437 FTVSI----LFCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 437 a~~~~----~~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
++... ...++..|++||.+.. ..+....|+|++ +....+|.++|..
T Consensus 179 a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 232 (367)
T 2fst_X 179 ARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 97642 3467788899997765 567777899984 3344456666643
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.2e-29 Score=243.75 Aligned_cols=190 Identities=18% Similarity=0.271 Sum_probs=159.2
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEe--cCCeEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT--KPPSLCIV 367 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~--~~~~~~lV 367 (492)
++|++.+.||+|+||.||+|.+ .++.||+|++..........+.+.+|+.++++++||||+++++++. ....+|+|
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 85 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence 5788999999999999999998 4688999999877666677788999999999999999999999874 45679999
Q ss_pred EeccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCCCCEEEccCCCeEEEEEeecce
Q 011158 368 TEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNN-----IIHRDLKAANLLMDENEVSLLLSLCLFTV 439 (492)
Q Consensus 368 ~Ey~~ggsL~~~L~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~~-----IiHrDLKp~NILld~~~~~kl~DFGla~~ 439 (492)
|||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||.+..
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~ 165 (279)
T 2w5a_A 86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165 (279)
T ss_dssp EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHH
T ss_pred EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhee
Confidence 9999999999999753 235899999999999999999999999 99999999999999999999999999865
Q ss_pred ee-------eeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 440 SI-------LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 440 ~~-------~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
.. ...++..|++||......+....|+|++ +.....|.++|.
T Consensus 166 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 217 (279)
T 2w5a_A 166 LNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT 217 (279)
T ss_dssp C---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred eccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCc
Confidence 42 2357778999998877777777888884 223334554443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=243.13 Aligned_cols=190 Identities=16% Similarity=0.183 Sum_probs=161.0
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCeE
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSL 364 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~ 364 (492)
.+-.++|++.+.||+|+||.||+|.+ .++.||||++..... ...+.+|+.+++++ +|+||+++++++......
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 81 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 81 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence 34567899999999999999999996 578999999875432 24578899999999 799999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCC-----eEEEEEeecce
Q 011158 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV-----SLLLSLCLFTV 439 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~-----~kl~DFGla~~ 439 (492)
++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||.+..
T Consensus 82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 9999999 99999999886667999999999999999999999999999999999999987775 99999999865
Q ss_pred ee--------------eeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 440 SI--------------LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 440 ~~--------------~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
.. ...++..|++||......+....|+|++ +....+|..+|..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 220 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG 220 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcch
Confidence 32 2347778899998877777778888884 3334456666654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.1e-29 Score=252.84 Aligned_cols=189 Identities=22% Similarity=0.277 Sum_probs=156.1
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEec--------C
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--------P 361 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--------~ 361 (492)
.+|++.++||+|+||.||+|++ +++.||||++............+.+|+.++++++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5799999999999999999998 46889999997665444445678899999999999999999999976 3
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee
Q 011158 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI 441 (492)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~ 441 (492)
+.+|+||||+. |+|.+.+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 97 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 175 (351)
T 3mi9_A 97 GSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 175 (351)
T ss_dssp CEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred ceEEEEEeccC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccccc
Confidence 46899999995 58888887766789999999999999999999999999999999999999999999999999986432
Q ss_pred -----------eeeCCCceeecceecc-ccccCccceeee---ecccccCCCCCC
Q 011158 442 -----------LFCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 -----------~~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||.... ..+....|+|++ +.....|.++|.
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 230 (351)
T 3mi9_A 176 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 230 (351)
T ss_dssp CCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCC
Confidence 2345667888886654 446777888884 223334555554
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-28 Score=245.74 Aligned_cols=186 Identities=27% Similarity=0.430 Sum_probs=155.5
Q ss_pred eeeeeeeecCceEEEEEEECCceEEEEEecCCC--CChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEeccC
Q 011158 295 KFGSKVASGSYGDLYRGTYCSQDVAIKVLKPER--INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS 372 (492)
Q Consensus 295 ~~~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 372 (492)
..+++||+|+||.||+|.+.++.||||++.... ......+.+.+|+.++++++||||+++++++...+..|+||||++
T Consensus 34 ~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 113 (307)
T 2nru_A 34 VGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMP 113 (307)
T ss_dssp TTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred ccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecC
Confidence 345899999999999999999999999997542 234456789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee---------
Q 011158 373 GGSVYDYLHKL--KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI--------- 441 (492)
Q Consensus 373 ggsL~~~L~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~--------- 441 (492)
+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.+....
T Consensus 114 ~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 193 (307)
T 2nru_A 114 NGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTS 193 (307)
T ss_dssp TCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECS
T ss_pred CCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccccccc
Confidence 99999999753 3468999999999999999999999999999999999999999999999999986532
Q ss_pred eeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 442 LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 ~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||..... +....|+|++ +....+|.++|.
T Consensus 194 ~~~g~~~y~aPE~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~ 235 (307)
T 2nru_A 194 RIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVD 235 (307)
T ss_dssp SCCSCGGGCCHHHHTTE-ECTHHHHHHHHHHHHHHHHCCCSBC
T ss_pred ccCCCcCcCChHHhcCC-CCccchhHHHHHHHHHHHHCCCCcc
Confidence 23567788888877654 5666788884 223344555554
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-29 Score=254.17 Aligned_cols=194 Identities=24% Similarity=0.382 Sum_probs=161.5
Q ss_pred ceeeCCCCceeeeeeeecCceEEEEEEE-CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeE
Q 011158 286 VWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (492)
Q Consensus 286 ~~ei~~~~~~~~~~LG~G~fG~Vy~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 364 (492)
.+.+..++|++.+.||+|+||.||+|.+ .++.||||+++..... .....+.+|+.++++++||||+++++++......
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (326)
T 3uim_A 24 ELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 102 (326)
T ss_dssp HHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCC
T ss_pred HHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEecCCce
Confidence 4566778899999999999999999987 4788999999765322 1223688999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCCCCEEEccCCCeEEEEEeecc
Q 011158 365 CIVTEFMSGGSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQN---NIIHRDLKAANLLMDENEVSLLLSLCLFT 438 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~---~~l~~~~~~~i~~qI~~gL~yLH~~---~IiHrDLKp~NILld~~~~~kl~DFGla~ 438 (492)
++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++.
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~ 182 (326)
T 3uim_A 103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182 (326)
T ss_dssp EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccc
Confidence 99999999999999998643 2489999999999999999999999 99999999999999999999999999986
Q ss_pred eee--------eeeCCCceeecceeccccccCccceeee---ecccccCCCCC
Q 011158 439 VSI--------LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNS 480 (492)
Q Consensus 439 ~~~--------~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y 480 (492)
... ...++..|++||......+....|+|++ +.....|.++|
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 235 (326)
T 3uim_A 183 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 235 (326)
T ss_dssp ECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSB
T ss_pred ccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcc
Confidence 531 2347788999998877777778888884 22334455555
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-28 Score=248.84 Aligned_cols=181 Identities=25% Similarity=0.412 Sum_probs=154.2
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEE------CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 360 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 360 (492)
..+..++|++.++||+|+||.||+|++ .++.||||++... .....+.+.+|+.++++++||||+++++++..
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 113 (326)
T 2w1i_A 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 113 (326)
T ss_dssp -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC
T ss_pred cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Confidence 355667899999999999999999985 4678999999754 34556789999999999999999999999876
Q ss_pred CC--eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecc
Q 011158 361 PP--SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFT 438 (492)
Q Consensus 361 ~~--~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~ 438 (492)
.+ .+++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 114 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 114 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp ----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred cCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 54 6899999999999999998866779999999999999999999999999999999999999999999999999987
Q ss_pred eeee----------eeCCCceeecceeccccccCccceeee
Q 011158 439 VSIL----------FCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 439 ~~~~----------~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
.... ..++..|++||......+....|+|++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 234 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSF 234 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHH
Confidence 5421 123345888888777667777888884
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-29 Score=260.99 Aligned_cols=193 Identities=12% Similarity=0.144 Sum_probs=153.0
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCC-CChHHHHHHHHHH---HHHHhcCCCceeeEE------
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPER-INSDMQKEFAQEV---FIMRKVRHKNVVQFI------ 355 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~-~~~~~~~~~~~Ei---~il~~l~HpnIv~l~------ 355 (492)
....++|++.+.||+|+||.||+|++ +++.||||++.... ......+.+.+|+ .++++++||||++++
T Consensus 69 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~ 148 (377)
T 3byv_A 69 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 148 (377)
T ss_dssp SCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCC
T ss_pred CCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhh
Confidence 33456899999999999999999986 47899999997542 2344567899999 455566899999998
Q ss_pred -EEEecCC-----------------eEEEEEeccCCCCHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHCCc
Q 011158 356 -GACTKPP-----------------SLCIVTEFMSGGSVYDYLHKLKG------VFKLPSLLKVAIDVSKGMNYLHQNNI 411 (492)
Q Consensus 356 -g~~~~~~-----------------~~~lV~Ey~~ggsL~~~L~~~~~------~l~~~~~~~i~~qI~~gL~yLH~~~I 411 (492)
+++...+ ..||||||+ +|+|.+++..... .+++..++.++.||+.||.|||++||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 227 (377)
T 3byv_A 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL 227 (377)
T ss_dssp SEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCe
Confidence 6666553 289999999 7899999986421 22348888899999999999999999
Q ss_pred eecCCCCCCEEEccCCCeEEEEEeeccee----eeeeCCCceeecceeccc-----------cccCccceeee---eccc
Q 011158 412 IHRDLKAANLLMDENEVSLLLSLCLFTVS----ILFCGKGRELISLFLGND-----------VLLQFGTYWII---FRRS 473 (492)
Q Consensus 412 iHrDLKp~NILld~~~~~kl~DFGla~~~----~~~~g~~~~~ape~~~~e-----------~~~~~~d~W~l---~~~~ 473 (492)
+||||||+|||++.++.+||+|||+++.. ....| ..|++||+.... .+....|+|++ +...
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el 306 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence 99999999999999999999999998753 23456 889999988776 77888899884 3334
Q ss_pred ccCCCCCCC
Q 011158 474 SCDKKNSDA 482 (492)
Q Consensus 474 ~~gt~~Y~a 482 (492)
.+|.++|..
T Consensus 307 ltg~~Pf~~ 315 (377)
T 3byv_A 307 WCADLPITK 315 (377)
T ss_dssp HHSSCCC--
T ss_pred HHCCCCCcc
Confidence 456666643
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-28 Score=244.06 Aligned_cols=176 Identities=16% Similarity=0.283 Sum_probs=149.3
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
++|.+.++||+|+||.||++.+. ++.||+|++..... ....+.+.+|+.++++++||||+++++++......|+|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 46888999999999999999984 67899999976532 2335788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE---ccCCCeEEEEEeeccee---
Q 011158 370 FMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVSLLLSLCLFTVS--- 440 (492)
Q Consensus 370 y~~ggsL~~~L~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILl---d~~~~~kl~DFGla~~~--- 440 (492)
|+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 180 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD 180 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc
Confidence 99999999999643 3679999999999999999999999999999999999999 45678999999999653
Q ss_pred ---eeeeCCCceeecceeccccccCccceeee
Q 011158 441 ---ILFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 441 ---~~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
....++..|++||.... .+....|+|++
T Consensus 181 ~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~sl 211 (285)
T 3is5_A 181 EHSTNAAGTALYMAPEVFKR-DVTFKCDIWSA 211 (285)
T ss_dssp ------CTTGGGCCHHHHTT-CCCHHHHHHHH
T ss_pred ccCcCcccccCcCChHHhcc-CCCcccCeehH
Confidence 23457778888987754 35566788874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.8e-29 Score=249.23 Aligned_cols=181 Identities=28% Similarity=0.446 Sum_probs=151.8
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEE--CCce--EEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCC
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQD--VAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPP 362 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~--vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~ 362 (492)
.++.++|++.+.||+|+||.||+|++ .+.. +|+|+++.. ......+.+.+|+.+++++ +||||+++++++...+
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred cccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 46667899999999999999999987 4554 599998753 2334456789999999999 8999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCC
Q 011158 363 SLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 427 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~~---------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~ 427 (492)
.+|+||||+++|+|.+++.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 9999999999999999997643 3689999999999999999999999999999999999999999
Q ss_pred CeEEEEEeecceee------eeeCCCceeecceeccccccCccceeee
Q 011158 428 VSLLLSLCLFTVSI------LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 428 ~~kl~DFGla~~~~------~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
.+||+|||+++... ...++..|++||......+....|+|++
T Consensus 180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 227 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSY 227 (327)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHH
T ss_pred eEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHH
Confidence 99999999986432 2334556888888877777778888884
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=4.2e-29 Score=257.92 Aligned_cols=188 Identities=21% Similarity=0.319 Sum_probs=149.7
Q ss_pred CceeeeeeeecCceEEEEEEEC--C---ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEec-CCeEEE
Q 011158 293 HLKFGSKVASGSYGDLYRGTYC--S---QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK-PPSLCI 366 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~~--g---~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~~~l 366 (492)
.|++.++||+|+||.||+|++. + ..||||+++.. .+....+.|.+|+.++++++||||+++++++.. .+..|+
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 4678899999999999999873 2 35899998753 344566889999999999999999999998754 457899
Q ss_pred EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-----
Q 011158 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI----- 441 (492)
Q Consensus 367 V~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~----- 441 (492)
||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 248 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 248 (373)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccccc
Confidence 999999999999998766778999999999999999999999999999999999999999999999999997431
Q ss_pred ------eeeCCCceeecceeccccccCccceeee----ecccccCCCCCC
Q 011158 442 ------LFCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSD 481 (492)
Q Consensus 442 ------~~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~ 481 (492)
...++..|++||......+....|+|++ +.....|.++|.
T Consensus 249 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~ 298 (373)
T 3c1x_A 249 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 298 (373)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCT
T ss_pred cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCC
Confidence 1233456888888877777778888884 222233565554
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.6e-29 Score=263.64 Aligned_cols=190 Identities=19% Similarity=0.309 Sum_probs=161.5
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 367 (492)
.++|++.++||+|+||.||+|.+ +++.||||++...... ......+.+|+.++++++||||+++++++...+.+|+|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 35789999999999999999998 4788999999765432 33457899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE---ccCCCeEEEEEeecceee---
Q 011158 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVSLLLSLCLFTVSI--- 441 (492)
Q Consensus 368 ~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILl---d~~~~~kl~DFGla~~~~--- 441 (492)
||||.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 105 ~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 183 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 183 (484)
T ss_dssp ECCCCSCBHHHHHHT-CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC
T ss_pred EecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc
Confidence 999999999999976 4679999999999999999999999999999999999999 467899999999986432
Q ss_pred ---eeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 442 ---LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 442 ---~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
...++..|++||.... .+....|+|++ +....+|.++|..
T Consensus 184 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~ 229 (484)
T 3nyv_A 184 KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNG 229 (484)
T ss_dssp SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCC
Confidence 2457888999998765 46777888884 3344567776654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=242.87 Aligned_cols=175 Identities=19% Similarity=0.305 Sum_probs=146.1
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEec---------
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--------- 360 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--------- 360 (492)
++|++.+.||+|+||.||+|++ .++.||||+++.. ......+.+|+.++++++||||+++++++..
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 4688899999999999999997 4788999999642 4456789999999999999999999998864
Q ss_pred ----CCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEee
Q 011158 361 ----PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCL 436 (492)
Q Consensus 361 ----~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGl 436 (492)
....|+||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence 3568999999999999999987666788999999999999999999999999999999999999999999999999
Q ss_pred cceee---------------------eeeCCCceeecceeccc-cccCccceeee
Q 011158 437 FTVSI---------------------LFCGKGRELISLFLGND-VLLQFGTYWII 469 (492)
Q Consensus 437 a~~~~---------------------~~~g~~~~~ape~~~~e-~~~~~~d~W~l 469 (492)
+.... ...++..|++||..... .+....|+|++
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 217 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSL 217 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHH
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHH
Confidence 86431 23456667777776543 45666677773
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-28 Score=249.53 Aligned_cols=193 Identities=23% Similarity=0.375 Sum_probs=157.1
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEEC--Cce----EEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQD----VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~----vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 361 (492)
.+...+|++.++||+|+||.||+|.+. ++. ||+|.+.... .......+.+|+.++++++||||+++++++...
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 466788999999999999999999983 443 5777776432 334457899999999999999999999999876
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee
Q 011158 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI 441 (492)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~ 441 (492)
. .++|+||+.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 4 889999999999999998877789999999999999999999999999999999999999999999999999997542
Q ss_pred ---------eeeCCCceeecceeccccccCccceeee----ecccccCCCCCCC
Q 011158 442 ---------LFCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSDA 482 (492)
Q Consensus 442 ---------~~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~a 482 (492)
...++..|++||......+....|+|++ +....+|.++|..
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~ 222 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 1223446888988877777888899984 2223337766654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5e-29 Score=251.21 Aligned_cols=176 Identities=25% Similarity=0.390 Sum_probs=142.9
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHH--HHhcCCCceeeEEEEEec----
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFI--MRKVRHKNVVQFIGACTK---- 360 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~i--l~~l~HpnIv~l~g~~~~---- 360 (492)
+.++.++|++.+.||+|+||.||+|++.++.||||+++... ...+..|..+ +..++|+||+++++.+..
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 82 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTAD 82 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred CCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence 46778899999999999999999999999999999997432 2344444444 456899999999986532
Q ss_pred -CCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---------CceecCCCCCCEEEccCCCeE
Q 011158 361 -PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN---------NIIHRDLKAANLLMDENEVSL 430 (492)
Q Consensus 361 -~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~---------~IiHrDLKp~NILld~~~~~k 430 (492)
...+|||||||++|+|.+++.. ...++..++.++.||+.||.|||++ +|+||||||+|||++.++.+|
T Consensus 83 ~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 83 GRMEYLLVMEYYPNGSLXKYLSL--HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp SCEEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred CCceEEEEEecCCCCcHHHHHhh--cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence 3357999999999999999976 3458999999999999999999999 999999999999999999999
Q ss_pred EEEEeecceee---------------eeeCCCceeecceecc-------ccccCccceeee
Q 011158 431 LLSLCLFTVSI---------------LFCGKGRELISLFLGN-------DVLLQFGTYWII 469 (492)
Q Consensus 431 l~DFGla~~~~---------------~~~g~~~~~ape~~~~-------e~~~~~~d~W~l 469 (492)
|+|||++.... ...++..|++||.... ..+....|+|++
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Diwsl 221 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYAL 221 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHH
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHH
Confidence 99999986431 2246777888887655 344455677773
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.8e-29 Score=248.60 Aligned_cols=183 Identities=23% Similarity=0.389 Sum_probs=138.8
Q ss_pred ceeeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCe
Q 011158 286 VWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (492)
Q Consensus 286 ~~ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 363 (492)
.|.+..++|++.+.||+|+||.||+|.+ +++.||||++..... ......+.+|+.++++++||||+++++++...+.
T Consensus 9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 3788889999999999999999999986 578899999875432 2345678899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEee
Q 011158 364 LCIVTEFMSGGSVYDYLHK-------LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCL 436 (492)
Q Consensus 364 ~~lV~Ey~~ggsL~~~L~~-------~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGl 436 (492)
.++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999999999974 235689999999999999999999999999999999999999999999999999
Q ss_pred cceee------------eeeCCCceeecceecc-ccccCccceeee
Q 011158 437 FTVSI------------LFCGKGRELISLFLGN-DVLLQFGTYWII 469 (492)
Q Consensus 437 a~~~~------------~~~g~~~~~ape~~~~-e~~~~~~d~W~l 469 (492)
+.... ...++..|++||.... ..+....|+|++
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 213 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSF 213 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHH
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHH
Confidence 85431 2356777888887754 446667788874
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=244.06 Aligned_cols=177 Identities=23% Similarity=0.353 Sum_probs=150.5
Q ss_pred CCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
.+.|++.+.||+|+||.||+|.+. ++.||+|++.... ......+.+|+.++++++||||+++++++...+..|+||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 457899999999999999999985 6889999997542 334578899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee-------e
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS-------I 441 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~-------~ 441 (492)
||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++... .
T Consensus 96 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 175 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD 175 (302)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC--
T ss_pred EeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccccccc
Confidence 999999999999876778999999999999999999999999999999999999999999999999987432 2
Q ss_pred eeeCCCceeecceec-----cccccCccceeee
Q 011158 442 LFCGKGRELISLFLG-----NDVLLQFGTYWII 469 (492)
Q Consensus 442 ~~~g~~~~~ape~~~-----~e~~~~~~d~W~l 469 (492)
...++..|++||... ...+....|+|++
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~sl 208 (302)
T 2j7t_A 176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSL 208 (302)
T ss_dssp ---CCGGGCCHHHHHHHHTTSTTTTTHHHHHHH
T ss_pred cccCChhhcCCeeeccccCCCCCCchhhhHHHH
Confidence 346778899999773 4455667788884
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.9e-28 Score=242.20 Aligned_cols=179 Identities=17% Similarity=0.317 Sum_probs=148.5
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 367 (492)
..+|++.+.||+|+||.||+|.+ .++.||||+++... .+......+.+|+.++++++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35789999999999999999997 47889999998643 3455667899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee---
Q 011158 368 TEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI--- 441 (492)
Q Consensus 368 ~Ey~~ggsL~~~L~~---~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~--- 441 (492)
|||+++|+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~ 190 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 190 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC----------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC
Confidence 999999999999974 24578999999999999999999999999999999999999999999999999986532
Q ss_pred ----eeeCCCceeecceeccccccCccceeee
Q 011158 442 ----LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 442 ----~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
...++..|++||......+....|+|++
T Consensus 191 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 222 (310)
T 2wqm_A 191 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSL 222 (310)
T ss_dssp --------CCSSCCHHHHTTCCCCHHHHHHHH
T ss_pred ccccccCCCeeEeChHHhCCCCCCchhhHHHH
Confidence 2356777889998877777777888884
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-28 Score=242.74 Aligned_cols=188 Identities=23% Similarity=0.398 Sum_probs=161.1
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
.+.|++.+.||+|+||.||+|++ .++.||||++..... ....+.+.+|+.++++++||||+++++++.....+|+||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 35689999999999999999988 468899999976543 334578999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------- 441 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------- 441 (492)
||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.+....
T Consensus 100 e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 177 (303)
T 3a7i_A 100 EYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN 177 (303)
T ss_dssp ECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBC
T ss_pred EeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccC
Confidence 99999999999965 578999999999999999999999999999999999999999999999999986532
Q ss_pred eeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 442 LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 ~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||......+....|+|++ +....+|.++|.
T Consensus 178 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 220 (303)
T 3a7i_A 178 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHS 220 (303)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCC
Confidence 2456778899998888777888888884 223345555553
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-28 Score=246.61 Aligned_cols=195 Identities=22% Similarity=0.330 Sum_probs=149.4
Q ss_pred CCceeeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCceeeEEEEEe-
Q 011158 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACT- 359 (492)
Q Consensus 284 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~- 359 (492)
...+++...+|++.++||+|+||.||+|.+ +++.||||++... .......+.+|+.+++++. ||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 97 (337)
T 3ll6_A 20 GQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASI 97 (337)
T ss_dssp TCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccc
Confidence 345788889999999999999999999998 5789999998643 3455678899999999996 999999999994
Q ss_pred -------cCCeEEEEEeccCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCCEEEccCCC
Q 011158 360 -------KPPSLCIVTEFMSGGSVYDYLHK--LKGVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEV 428 (492)
Q Consensus 360 -------~~~~~~lV~Ey~~ggsL~~~L~~--~~~~l~~~~~~~i~~qI~~gL~yLH~~~--IiHrDLKp~NILld~~~~ 428 (492)
....+++||||+ +|+|.+++.. ..+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 98 ~~~~~~~~~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~ 176 (337)
T 3ll6_A 98 GKEESDTGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT 176 (337)
T ss_dssp CTTTSTTSSEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC
T ss_pred cccccccCCceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC
Confidence 344589999999 5899999965 3457999999999999999999999999 999999999999999999
Q ss_pred eEEEEEeecceee-------------------eeeCCCceeeccee---ccccccCccceeee---ecccccCCCCCC
Q 011158 429 SLLLSLCLFTVSI-------------------LFCGKGRELISLFL---GNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 429 ~kl~DFGla~~~~-------------------~~~g~~~~~ape~~---~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
+||+|||++.... ...++..|++||.. ....+....|+|++ +....+|..+|.
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 254 (337)
T 3ll6_A 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254 (337)
T ss_dssp EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence 9999999986532 23366778888876 44555666788874 223334554443
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.1e-28 Score=243.14 Aligned_cols=190 Identities=24% Similarity=0.300 Sum_probs=156.7
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEE
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 365 (492)
....++|++.+.||+|+||.||+|.+. ++.||||++.... ....+.+|+.++++++||||+++++++...+.+|
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW 100 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 445678999999999999999999985 7889999997643 2367889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee----
Q 011158 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI---- 441 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~---- 441 (492)
+||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.+....
T Consensus 101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 9999999999999998666789999999999999999999999999999999999999999999999999986432
Q ss_pred ---eeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 442 ---LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 ---~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||......+....|+|++ +....+|..+|.
T Consensus 181 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 226 (314)
T 3com_A 181 KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYA 226 (314)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTT
T ss_pred ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 2356777899998887778888899884 223445655554
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.4e-29 Score=252.53 Aligned_cols=191 Identities=21% Similarity=0.294 Sum_probs=153.2
Q ss_pred CCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCC---CChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPER---INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~---~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 365 (492)
.++|++.+.||+|+||.||+|.+. ++.||+|++.... .+....+.+.+|+.++++++||||+++++++...+..|
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 367899999999999999999884 5789999986532 23445678999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhc---------------------------------------CCCCCHHHHHHHHHHHHHHHHHH
Q 011158 366 IVTEFMSGGSVYDYLHKL---------------------------------------KGVFKLPSLLKVAIDVSKGMNYL 406 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~---------------------------------------~~~l~~~~~~~i~~qI~~gL~yL 406 (492)
+|||||++|+|.+++... ...+++..++.++.||+.||.||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 999999999999998521 11235778889999999999999
Q ss_pred HHCCceecCCCCCCEEEccCC--CeEEEEEeeccee-----------eeeeCCCceeecceecc--ccccCccceeee--
Q 011158 407 HQNNIIHRDLKAANLLMDENE--VSLLLSLCLFTVS-----------ILFCGKGRELISLFLGN--DVLLQFGTYWII-- 469 (492)
Q Consensus 407 H~~~IiHrDLKp~NILld~~~--~~kl~DFGla~~~-----------~~~~g~~~~~ape~~~~--e~~~~~~d~W~l-- 469 (492)
|+++|+||||||+|||++.++ .+||+|||++... ....++..|++||.... ..+....|+|++
T Consensus 185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~ 264 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264 (345)
T ss_dssp HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence 999999999999999998776 8999999998642 23456777888887743 556677888884
Q ss_pred -ecccccCCCCCC
Q 011158 470 -FRRSSCDKKNSD 481 (492)
Q Consensus 470 -~~~~~~gt~~Y~ 481 (492)
+....+|..+|.
T Consensus 265 il~el~~g~~pf~ 277 (345)
T 3hko_A 265 LLHLLLMGAVPFP 277 (345)
T ss_dssp HHHHHHHSSCSSC
T ss_pred HHHHHHHCCCCCC
Confidence 223445555553
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=240.56 Aligned_cols=190 Identities=24% Similarity=0.369 Sum_probs=158.7
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
++|++.+.||+|+||.||+|.+. ++.||||++..... ....+.+.+|+.++++++||||+++++++...+..|+|||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 46888999999999999999984 78899999975432 3345788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee--------
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-------- 441 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-------- 441 (492)
|+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||.+....
T Consensus 86 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 164 (276)
T 2yex_A 86 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (276)
T ss_dssp CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred ecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcc
Confidence 9999999999865 4568999999999999999999999999999999999999999999999999986432
Q ss_pred -eeeCCCceeecceeccccc-cCccceeee---ecccccCCCCCCCc
Q 011158 442 -LFCGKGRELISLFLGNDVL-LQFGTYWII---FRRSSCDKKNSDAP 483 (492)
Q Consensus 442 -~~~g~~~~~ape~~~~e~~-~~~~d~W~l---~~~~~~gt~~Y~aP 483 (492)
...++..|++||......+ ....|+|++ +.....|..+|..+
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 211 (276)
T 2yex_A 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 211 (276)
T ss_dssp CCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCS
T ss_pred cCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Confidence 2346777888887765544 456788884 22344566666543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=3.1e-28 Score=244.95 Aligned_cols=171 Identities=29% Similarity=0.482 Sum_probs=144.4
Q ss_pred CCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhc--CCCceeeEEEEEecC----CeEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV--RHKNVVQFIGACTKP----PSLC 365 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l--~HpnIv~l~g~~~~~----~~~~ 365 (492)
++|++.++||+|+||.||+|++.++.||||++... ....+.+|.+++..+ +||||+++++++... ..+|
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 111 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY 111 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred cceEEEeEeecCCCeEEEEEEECCceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence 57899999999999999999999999999998643 124455566665554 899999999999877 7899
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CceecCCCCCCEEEccCCCeEEEEEeec
Q 011158 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN--------NIIHRDLKAANLLMDENEVSLLLSLCLF 437 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~--------~IiHrDLKp~NILld~~~~~kl~DFGla 437 (492)
+||||+++|+|.++++. ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 112 lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a 189 (337)
T 3mdy_A 112 LITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 189 (337)
T ss_dssp EEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCc
Confidence 99999999999999976 4689999999999999999999999 9999999999999999999999999998
Q ss_pred ceee-----------eeeCCCceeecceeccccccCc------cceeee
Q 011158 438 TVSI-----------LFCGKGRELISLFLGNDVLLQF------GTYWII 469 (492)
Q Consensus 438 ~~~~-----------~~~g~~~~~ape~~~~e~~~~~------~d~W~l 469 (492)
.... ...++..|++||.......... +|+|++
T Consensus 190 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Diwsl 238 (337)
T 3mdy_A 190 VKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSF 238 (337)
T ss_dssp EECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHH
T ss_pred eeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHH
Confidence 5431 2356777888887766555554 688773
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-28 Score=242.71 Aligned_cols=176 Identities=22% Similarity=0.342 Sum_probs=149.8
Q ss_pred CceeeeeeeecCceEEEEEEEC--C---ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeE-EE
Q 011158 293 HLKFGSKVASGSYGDLYRGTYC--S---QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL-CI 366 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~~--g---~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~-~l 366 (492)
.|+..++||+|+||.||+|.+. + ..||+|+++.. ......+.+.+|+.++++++||||+++++++...+.. ++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 4556799999999999999872 2 26999999753 3445567899999999999999999999999876665 99
Q ss_pred EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee------
Q 011158 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS------ 440 (492)
Q Consensus 367 V~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~------ 440 (492)
||||+.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.+...
T Consensus 101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 180 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY 180 (298)
T ss_dssp EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG
T ss_pred EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccc
Confidence 99999999999999876678999999999999999999999999999999999999999999999999998632
Q ss_pred -----eeeeCCCceeecceeccccccCccceeee
Q 011158 441 -----ILFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 441 -----~~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
....++..|++||......+....|+|++
T Consensus 181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 214 (298)
T 3pls_A 181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSF 214 (298)
T ss_dssp CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHH
T ss_pred ccccCcCCCCCccccChhhhccCCCChhhchhhH
Confidence 12234556788888777777777888884
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.1e-29 Score=256.61 Aligned_cols=191 Identities=12% Similarity=0.066 Sum_probs=141.4
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhc--CCCceeeEE-------EEE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV--RHKNVVQFI-------GAC 358 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l--~HpnIv~l~-------g~~ 358 (492)
...|++.++||+|+||.||+|++ +++.||||+++.... .....+.+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 44689999999999999999997 468899999987654 234556777886555555 699988755 444
Q ss_pred ecC-----------------CeEEEEEeccCCCCHHHHHHhcCCCCCHHHH------HHHHHHHHHHHHHHHHCCceecC
Q 011158 359 TKP-----------------PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSL------LKVAIDVSKGMNYLHQNNIIHRD 415 (492)
Q Consensus 359 ~~~-----------------~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~------~~i~~qI~~gL~yLH~~~IiHrD 415 (492)
..+ ..+|||||||+ |+|.+++......+.+..+ +.++.||+.||.|||++||+|||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 433 33899999997 8999999875445555556 67889999999999999999999
Q ss_pred CCCCCEEEccCCCeEEEEEeecceee----eeeCCCceeecceecc--ccccCccceeee---ecccccCCCCCCC
Q 011158 416 LKAANLLMDENEVSLLLSLCLFTVSI----LFCGKGRELISLFLGN--DVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 416 LKp~NILld~~~~~kl~DFGla~~~~----~~~g~~~~~ape~~~~--e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
|||+|||++.++.+||+|||+++... ...++..|++||.... ..+....|+|++ +....+|.++|..
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred CCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999987542 2345578899998876 667777888884 2233446555543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.9e-29 Score=258.82 Aligned_cols=192 Identities=21% Similarity=0.268 Sum_probs=155.3
Q ss_pred eCCCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC--eE
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP--SL 364 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~--~~ 364 (492)
...++|++.++||+|+||.||+|.+. ++.||||+++.... ....+.+.+|+.++++++||||+++++++.... ..
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 34567999999999999999999985 78899999975432 223467889999999999999999999998655 78
Q ss_pred EEEEeccCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE----ccCCCeEEEEEeecc
Q 011158 365 CIVTEFMSGGSVYDYLHKLK--GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM----DENEVSLLLSLCLFT 438 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILl----d~~~~~kl~DFGla~ 438 (492)
|+|||||++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999999997643 238999999999999999999999999999999999999 777789999999997
Q ss_pred eee------eeeCCCceeecceecc--------ccccCccceeee---ecccccCCCCCC
Q 011158 439 VSI------LFCGKGRELISLFLGN--------DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 439 ~~~------~~~g~~~~~ape~~~~--------e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
... ...++..|++||.... ..+....|+|++ +....+|..+|.
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~ 224 (396)
T 4eut_A 165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224 (396)
T ss_dssp ECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEE
T ss_pred EccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 542 2346777888886643 445556788874 223344555553
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-28 Score=247.99 Aligned_cols=182 Identities=24% Similarity=0.386 Sum_probs=153.2
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEE-------CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~-------~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~ 359 (492)
.++..++|++.+.||+|+||.||+|++ .++.||||++... ........+.+|+.++++++||||+++++++.
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (327)
T 2yfx_A 25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSL 103 (327)
T ss_dssp CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence 467788999999999999999999984 3467999999743 34455678999999999999999999999999
Q ss_pred cCCeEEEEEeccCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcc---CCCeE
Q 011158 360 KPPSLCIVTEFMSGGSVYDYLHKLK------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVSL 430 (492)
Q Consensus 360 ~~~~~~lV~Ey~~ggsL~~~L~~~~------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~---~~~~k 430 (492)
.....|+||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++. +..+|
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence 9999999999999999999998753 35899999999999999999999999999999999999984 44699
Q ss_pred EEEEeecceee---------eeeCCCceeecceeccccccCccceeee
Q 011158 431 LLSLCLFTVSI---------LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 431 l~DFGla~~~~---------~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
|+|||.+.... ...++..|++||......+....|+|++
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 231 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF 231 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHH
Confidence 99999986321 1234567889988877777778888884
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.95 E-value=3.1e-28 Score=242.45 Aligned_cols=187 Identities=23% Similarity=0.388 Sum_probs=157.2
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
++|.+.+.||+|+||.||+|++ .++.||+|+++... ......+.+|+.++++++||||+++++++......|+|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP--AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 4688899999999999999998 47889999998543 2233578899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE---ccCCCeEEEEEeecceee-----
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVSLLLSLCLFTVSI----- 441 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILl---d~~~~~kl~DFGla~~~~----- 441 (492)
|+++++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||.+....
T Consensus 87 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (304)
T 2jam_A 87 LVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS 165 (304)
T ss_dssp CCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTTH
T ss_pred cCCCccHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCccc
Confidence 9999999999976 3568999999999999999999999999999999999999 778899999999987543
Q ss_pred eeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 442 LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 ~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||......+....|+|++ +....+|.++|.
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 208 (304)
T 2jam_A 166 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFY 208 (304)
T ss_dssp HHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 2347788999998887777778888884 223344555553
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=5.5e-28 Score=242.97 Aligned_cols=181 Identities=17% Similarity=0.273 Sum_probs=152.5
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCceeeEEEEEec--CCeEE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTK--PPSLC 365 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~--~~~~~ 365 (492)
.++|++.++||+|+||.||+|.+ .++.||||+++... .+.+.+|+.++++++ ||||+++++++.. ....+
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 46899999999999999999987 56889999997432 367899999999997 9999999999987 56799
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCC-CeEEEEEeecceee---
Q 011158 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-VSLLLSLCLFTVSI--- 441 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~-~~kl~DFGla~~~~--- 441 (492)
+||||+.+++|.+++.. +++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 110 lv~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp EEEECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred EEEeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 99999999999999854 89999999999999999999999999999999999999776 89999999996532
Q ss_pred ---eeeCCCceeecceecc-ccccCccceeee---ecccccCCCCC
Q 011158 442 ---LFCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNS 480 (492)
Q Consensus 442 ---~~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y 480 (492)
...++..|++||.... ..+....|+|++ +....+|..+|
T Consensus 186 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~ 231 (330)
T 3nsz_A 186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231 (330)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCc
Confidence 2456677888887765 556777888884 22334455554
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.95 E-value=5.1e-28 Score=248.56 Aligned_cols=189 Identities=20% Similarity=0.293 Sum_probs=157.9
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC--Ch----HHHHHHHHHHHHHHhc-CCCceeeEEEEEecCC
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI--NS----DMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPP 362 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~--~~----~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~ 362 (492)
.+|++.+.||+|+||.||+|++. |+.||||++..... .. ...+.+.+|+.+++++ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 46888999999999999999984 78999999976532 11 2345688999999999 7999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee--
Q 011158 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS-- 440 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~-- 440 (492)
..|+||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+|++|||+++..
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~ 252 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence 99999999999999999976 457899999999999999999999999999999999999999999999999988643
Q ss_pred ----eeeeCCCceeecceecc------ccccCccceeee---ecccccCCCCCC
Q 011158 441 ----ILFCGKGRELISLFLGN------DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 441 ----~~~~g~~~~~ape~~~~------e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
....++..|++||+... ..+....|+|++ +....+|.++|.
T Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~ 306 (365)
T 2y7j_A 253 GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFW 306 (365)
T ss_dssp TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCC
Confidence 23467778888887642 246667788884 333445665553
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-28 Score=240.34 Aligned_cols=192 Identities=21% Similarity=0.408 Sum_probs=153.9
Q ss_pred eCCCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEE
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 365 (492)
+...+|++.+.||+|+||.||+|.+. ++.||||++..... .......+.+|+.++++++||||+++++++......|
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 87 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFF 87 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEE
Confidence 44568999999999999999999984 78999999975321 1223467889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee----
Q 011158 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI---- 441 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~---- 441 (492)
+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.+....
T Consensus 88 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (276)
T 2h6d_A 88 MVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166 (276)
T ss_dssp EEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred EEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCcc
Confidence 999999999999999773 568999999999999999999999999999999999999999999999999987542
Q ss_pred --eeeCCCceeecceeccccc-cCccceeee---ecccccCCCCCC
Q 011158 442 --LFCGKGRELISLFLGNDVL-LQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 --~~~g~~~~~ape~~~~e~~-~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||......+ ....|+|++ +....+|..+|.
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 212 (276)
T 2h6d_A 167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212 (276)
T ss_dssp ----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 2346677888887766544 456778874 223334555553
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-28 Score=240.64 Aligned_cols=172 Identities=20% Similarity=0.303 Sum_probs=149.4
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEec---------
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--------- 360 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--------- 360 (492)
.+|++.+.||+|+||.||+|.+. ++.||+|+++... ..+.+|+.++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 46889999999999999999985 7899999997642 356789999999999999999998854
Q ss_pred -------CCeEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEE
Q 011158 361 -------PPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLL 432 (492)
Q Consensus 361 -------~~~~~lV~Ey~~ggsL~~~L~~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~ 432 (492)
...+|+||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 164 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIG 164 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEEC
Confidence 34589999999999999999764 3578999999999999999999999999999999999999999999999
Q ss_pred EEeecceee------eeeCCCceeecceeccccccCccceeee
Q 011158 433 SLCLFTVSI------LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 433 DFGla~~~~------~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
|||++.... ...++..|++||......+....|+|++
T Consensus 165 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 207 (284)
T 2a19_B 165 DFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYAL 207 (284)
T ss_dssp CCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHH
T ss_pred cchhheeccccccccccCCcccccChhhhccCCCcchhhhHHH
Confidence 999986532 2456778888888877777777888884
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=6e-28 Score=242.28 Aligned_cols=191 Identities=25% Similarity=0.365 Sum_probs=154.4
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeEEEEEec----
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTK---- 360 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~---- 360 (492)
.....+|++.+.||+|+||.||+|++ .++.||||++..... ....+.+|+.+++++ +||||+++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc---cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 34457899999999999999999998 578999999975432 236788999999999 79999999999976
Q ss_pred --CCeEEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeec
Q 011158 361 --PPSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLF 437 (492)
Q Consensus 361 --~~~~~lV~Ey~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla 437 (492)
...+|+||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 176 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence 467999999999999999998643 57899999999999999999999999999999999999999999999999998
Q ss_pred ceee-------eeeCCCceeecceec-----cccccCccceeee---ecccccCCCCCC
Q 011158 438 TVSI-------LFCGKGRELISLFLG-----NDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 438 ~~~~-------~~~g~~~~~ape~~~-----~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
.... ...++..|++||... ...+....|+|++ +.....|.++|.
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 235 (326)
T 2x7f_A 177 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 235 (326)
T ss_dssp C-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTT
T ss_pred eecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 6532 245677888888775 4456667788884 223344555543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-28 Score=251.27 Aligned_cols=190 Identities=21% Similarity=0.246 Sum_probs=150.9
Q ss_pred CCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCh---HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS---DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 365 (492)
.++|++.+.||+|+||.||+|++. ++.||||+++...... .....+.+|+.++++++||||+++++++......+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 467899999999999999999884 7889999997543221 22346889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee-----
Q 011158 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS----- 440 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~----- 440 (492)
+||||+++ +|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 167 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 167 (346)
T ss_dssp EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcc
Confidence 99999964 999999876667999999999999999999999999999999999999999999999999998643
Q ss_pred --eeeeCCCceeecceecc-ccccCccceeee---ecccccCCCCCC
Q 011158 441 --ILFCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 441 --~~~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
....++..|++||.... ..+....|+|++ +....+|.+.|.
T Consensus 168 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~ 214 (346)
T 1ua2_A 168 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLP 214 (346)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 12456777888887743 446667788884 223334655543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-29 Score=251.03 Aligned_cols=155 Identities=36% Similarity=0.709 Sum_probs=137.7
Q ss_pred CCceeeCCCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCe
Q 011158 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (492)
Q Consensus 284 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 363 (492)
...|+++.++|++.+.||+|+||.||+|.+.+ .+|+|+++....+....+.+.+|+.++++++||||+++++++...+.
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 35689999999999999999999999999865 59999998765444445668889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 364 ~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
+++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence 9999999999999999987666799999999999999999999999999999999999998 678999999997654
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.95 E-value=9.9e-29 Score=258.76 Aligned_cols=189 Identities=20% Similarity=0.297 Sum_probs=148.7
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC------hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN------SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~------~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 362 (492)
.++|.+.++||+|+||.||+|.+ +++.||||++...... ......+.+|+.+|++++||||+++++++.. +
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 36799999999999999999988 4678999999764321 1222358899999999999999999999865 5
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCC---CeEEEEEeecce
Q 011158 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE---VSLLLSLCLFTV 439 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~---~~kl~DFGla~~ 439 (492)
..|+|||||++|+|.+++.. ...+++..++.++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+++.
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~ 291 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred ceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence 58999999999999998866 46799999999999999999999999999999999999997544 599999999975
Q ss_pred ee------eeeCCCceeecceec---cccccCccceeee---ecccccCCCCCC
Q 011158 440 SI------LFCGKGRELISLFLG---NDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 440 ~~------~~~g~~~~~ape~~~---~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
.. ...|+..|++||+.. ...+....|+|++ +....+|.++|.
T Consensus 292 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~ 345 (419)
T 3i6u_A 292 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 345 (419)
T ss_dssp CC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 42 345777888888764 2445556788884 333445666554
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-28 Score=250.29 Aligned_cols=194 Identities=22% Similarity=0.309 Sum_probs=161.4
Q ss_pred CCceeeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 011158 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (492)
Q Consensus 284 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 361 (492)
...|++. ++|.+.+.||+|+||.||+|.+ +++.||||+++...........+.+|+.++++++||||+++++++...
T Consensus 35 ~~~~~l~-~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 113 (371)
T 4exu_A 35 KTAWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPA 113 (371)
T ss_dssp TEEEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred cceeccc-ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheecc
Confidence 3456665 6899999999999999999988 478999999987665666678899999999999999999999999877
Q ss_pred CeE------EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEe
Q 011158 362 PSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLC 435 (492)
Q Consensus 362 ~~~------~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFG 435 (492)
... |+||||+. ++|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 114 ~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg 189 (371)
T 4exu_A 114 SSLRNFYDFYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFG 189 (371)
T ss_dssp SSSTTCCCCEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTT
T ss_pred CCcccceeEEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecC
Confidence 654 99999995 78988873 458999999999999999999999999999999999999999999999999
Q ss_pred ecceee----eeeCCCceeecceecc-ccccCccceeee---ecccccCCCCCCC
Q 011158 436 LFTVSI----LFCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 436 la~~~~----~~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
.++... ...++..|++||.... ..+....|+|++ +....+|.++|..
T Consensus 190 ~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 244 (371)
T 4exu_A 190 LARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 244 (371)
T ss_dssp CC--------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence 997543 2456778888987765 567777888884 3344557766654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=5e-28 Score=247.90 Aligned_cols=187 Identities=19% Similarity=0.280 Sum_probs=156.3
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-----CeE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-----PSL 364 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-----~~~ 364 (492)
.+|++.++||+|+||.||+|.+ +++.||||++.... .......+.+|+.++++++||||+++++++... ...
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 5799999999999999999988 46789999997532 345567899999999999999999999999755 368
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee---
Q 011158 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI--- 441 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~--- 441 (492)
|+||||+. |+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.+....
T Consensus 106 ~iv~e~~~-~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp EEEEECCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEEcccC-cCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 99999995 699999976 569999999999999999999999999999999999999999999999999987542
Q ss_pred -------eeeCCCceeecceec-cccccCccceeee---ecccccCCCCCCC
Q 011158 442 -------LFCGKGRELISLFLG-NDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 442 -------~~~g~~~~~ape~~~-~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
...++..|++||... ...+....|+|++ +....+|.++|..
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 234 (364)
T 3qyz_A 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234 (364)
T ss_dssp CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCC
Confidence 235677788888653 4446777788884 3344456666644
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.7e-29 Score=253.71 Aligned_cols=191 Identities=20% Similarity=0.207 Sum_probs=152.3
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEEC-----CceEEEEEecCCCCChH---------HHHHHHHHHHHHHhcCCCceee
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSD---------MQKEFAQEVFIMRKVRHKNVVQ 353 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~~-----g~~vAvK~l~~~~~~~~---------~~~~~~~Ei~il~~l~HpnIv~ 353 (492)
++..++|++.+.||+|+||.||+|.+. +..||||++........ ....+.+|+.+++.++||||++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~ 112 (345)
T 2v62_A 33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL 112 (345)
T ss_dssp CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence 455688999999999999999999984 46799999976532110 1134677889999999999999
Q ss_pred EEEEEec----CCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCC--
Q 011158 354 FIGACTK----PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-- 427 (492)
Q Consensus 354 l~g~~~~----~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~-- 427 (492)
+++++.. ...+||||||+ +++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN-GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG-GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTT
T ss_pred eecccccccCCCcEEEEEEecc-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCC
Confidence 9999987 67899999999 99999999764 3799999999999999999999999999999999999999887
Q ss_pred CeEEEEEeeccee--------------eeeeCCCceeecceeccccccCccceeee---ecccccCCCCC
Q 011158 428 VSLLLSLCLFTVS--------------ILFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNS 480 (492)
Q Consensus 428 ~~kl~DFGla~~~--------------~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y 480 (492)
.+||+|||+++.. ....++..|++||......+....|+|++ +....+|..+|
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf 260 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPW 260 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 9999999999653 23457788899998887777888888884 33344566666
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.9e-28 Score=237.39 Aligned_cols=189 Identities=20% Similarity=0.258 Sum_probs=156.5
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC---C----hHHHHHHHHHHHHHHhcC-CCceeeEEEEEec
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI---N----SDMQKEFAQEVFIMRKVR-HKNVVQFIGACTK 360 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~---~----~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~ 360 (492)
.++|++.+.||+|+||.||+|.+ +++.||||+++.... . ....+.+.+|+.+++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 46889999999999999999998 468899999976531 1 133567889999999996 9999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 361 ~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
....++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.+...
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 174 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence 9999999999999999999987 457899999999999999999999999999999999999999999999999998653
Q ss_pred e------eeeCCCceeecceec------cccccCccceeee---ecccccCCCCC
Q 011158 441 I------LFCGKGRELISLFLG------NDVLLQFGTYWII---FRRSSCDKKNS 480 (492)
Q Consensus 441 ~------~~~g~~~~~ape~~~------~e~~~~~~d~W~l---~~~~~~gt~~Y 480 (492)
. ...++..|++||... ...+....|+|++ +.....|..+|
T Consensus 175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 229 (298)
T 1phk_A 175 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229 (298)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCC
Confidence 2 245677788888763 3345666788874 22333455544
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.6e-28 Score=244.17 Aligned_cols=188 Identities=21% Similarity=0.307 Sum_probs=151.1
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCC------hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN------SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~------~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 363 (492)
++|++.+.||+|+||.||+|.+. ++.||||++...... ......+.+|+.++++++||||+++++++....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 46889999999999999999984 688999999764321 122345889999999999999999999997655
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCC---eEEEEEeeccee
Q 011158 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV---SLLLSLCLFTVS 440 (492)
Q Consensus 364 ~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~---~kl~DFGla~~~ 440 (492)
.|+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||.+...
T Consensus 89 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 167 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167 (322)
T ss_dssp EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence 8999999999999999976 467899999999999999999999999999999999999987664 999999998754
Q ss_pred e------eeeCCCceeeccee---ccccccCccceeee---ecccccCCCCCC
Q 011158 441 I------LFCGKGRELISLFL---GNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 441 ~------~~~g~~~~~ape~~---~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
. ...++..|++||.. ....+....|+|++ +.....|.++|.
T Consensus 168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 220 (322)
T 2ycf_A 168 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 220 (322)
T ss_dssp CCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 2 23577889999975 34556677888884 223344555553
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-28 Score=252.23 Aligned_cols=189 Identities=16% Similarity=0.214 Sum_probs=150.4
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEec----
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK---- 360 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~---- 360 (492)
++...++|++.++||+|+||.||+|++ +++.||||++..+.. ...+|+.+|+.++||||+++++++..
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 75 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDE 75 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCcc
Confidence 345667899999999999999999988 578999999875432 22369999999999999999999844
Q ss_pred ----------------------------------CCeEEEEEeccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHH
Q 011158 361 ----------------------------------PPSLCIVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGM 403 (492)
Q Consensus 361 ----------------------------------~~~~~lV~Ey~~ggsL~~~L~~---~~~~l~~~~~~~i~~qI~~gL 403 (492)
...+++|||||+ |+|.+++.. ....+++..++.++.||+.||
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp ----------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence 334899999996 688888763 346799999999999999999
Q ss_pred HHHHHCCceecCCCCCCEEEc-cCCCeEEEEEeeccee------eeeeCCCceeecceecc-ccccCccceeee---ecc
Q 011158 404 NYLHQNNIIHRDLKAANLLMD-ENEVSLLLSLCLFTVS------ILFCGKGRELISLFLGN-DVLLQFGTYWII---FRR 472 (492)
Q Consensus 404 ~yLH~~~IiHrDLKp~NILld-~~~~~kl~DFGla~~~------~~~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~ 472 (492)
.|||++||+||||||+|||++ .++.+||+|||+++.. ....++..|++||.... ..+....|+|++ +..
T Consensus 155 ~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 234 (383)
T 3eb0_A 155 GFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234 (383)
T ss_dssp HHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred HHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHH
Confidence 999999999999999999998 6889999999999753 23456777889987654 447777899984 334
Q ss_pred cccCCCCCCC
Q 011158 473 SSCDKKNSDA 482 (492)
Q Consensus 473 ~~~gt~~Y~a 482 (492)
..+|.++|..
T Consensus 235 ll~g~~pf~~ 244 (383)
T 3eb0_A 235 LILGKPLFSG 244 (383)
T ss_dssp HHHSSCSSCC
T ss_pred HHhCCCCCCC
Confidence 4556666653
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.6e-28 Score=253.36 Aligned_cols=187 Identities=19% Similarity=0.275 Sum_probs=159.3
Q ss_pred CCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhc------CCCceeeEEEEEecCC
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV------RHKNVVQFIGACTKPP 362 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l------~HpnIv~l~g~~~~~~ 362 (492)
..+|++.++||+|+||.||+|.+. ++.||||+++.. ......+.+|+.+++.+ +|+||+++++++....
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 457999999999999999999884 688999999753 44456788899998887 5679999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCC--eEEEEEeecce
Q 011158 363 SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV--SLLLSLCLFTV 439 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~--~kl~DFGla~~ 439 (492)
.+||||||+ +++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++. +||+|||++..
T Consensus 173 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~ 251 (429)
T 3kvw_A 173 HICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY 251 (429)
T ss_dssp EEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred eEEEEEecc-CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence 999999999 579999998754 35999999999999999999999999999999999999999887 99999999865
Q ss_pred ee----eeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 440 SI----LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 440 ~~----~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
.. ...++..|++||++....+....|+|++ +....+|.++|.
T Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~ 300 (429)
T 3kvw_A 252 EHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLP 300 (429)
T ss_dssp TTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCC
Confidence 32 3467788999998888888888899984 334455666664
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=242.36 Aligned_cols=194 Identities=28% Similarity=0.429 Sum_probs=152.3
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEEC---Cc--eEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC---SQ--DVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 360 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~~---g~--~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 360 (492)
..+..++|++.++||+|+||.||+|++. ++ .||||+++.... .....+.+.+|+.++++++||||+++++++..
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 92 (291)
T 1u46_A 13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 92 (291)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence 4667789999999999999999999862 22 589999876533 33556789999999999999999999999987
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 361 ~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
.. .++||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.+...
T Consensus 93 ~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 93 PP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp SS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred CC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 65 89999999999999999876677999999999999999999999999999999999999999999999999998654
Q ss_pred e----------eeeCCCceeecceeccccccCccceeee----ecccccCCCCCC
Q 011158 441 I----------LFCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSD 481 (492)
Q Consensus 441 ~----------~~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~ 481 (492)
. ...++..|++||......+....|+|++ +....+|.++|.
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~ 226 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI 226 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 2 1234446888888877777777888884 222223666554
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-28 Score=246.01 Aligned_cols=190 Identities=18% Similarity=0.269 Sum_probs=159.7
Q ss_pred CCceee-eeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCeEEEE
Q 011158 292 KHLKFG-SKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIV 367 (492)
Q Consensus 292 ~~~~~~-~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV 367 (492)
+.|.+. ++||+|+||.||+|.+. ++.||||+++...........+.+|+.++++++ ||||+++++++.....+|+|
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv 107 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI 107 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence 455665 88999999999999984 789999999876555555678999999999995 69999999999999999999
Q ss_pred EeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcc---CCCeEEEEEeecceee--
Q 011158 368 TEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVSLLLSLCLFTVSI-- 441 (492)
Q Consensus 368 ~Ey~~ggsL~~~L~~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~---~~~~kl~DFGla~~~~-- 441 (492)
|||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187 (327)
T ss_dssp EECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence 9999999999998643 357999999999999999999999999999999999999997 7899999999987542
Q ss_pred ----eeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 442 ----LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 ----~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||......+....|+|++ +....+|.++|.
T Consensus 188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 234 (327)
T 3lm5_A 188 CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFV 234 (327)
T ss_dssp ------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 2457888999998888888888899884 223345555554
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-28 Score=248.55 Aligned_cols=192 Identities=18% Similarity=0.232 Sum_probs=153.0
Q ss_pred CCCCceeeeeeeecCceEEEEEEE-CCceEEEEEecCCCC---------ChHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Q 011158 290 DPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERI---------NSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359 (492)
Q Consensus 290 ~~~~~~~~~~LG~G~fG~Vy~~~~-~g~~vAvK~l~~~~~---------~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~ 359 (492)
-..+|++.+.||+|+||.||+|.+ .++.||||++..... +....+.+.+|+.++++++||||+++++++.
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 346799999999999999999987 468899999865322 2233578999999999999999999999984
Q ss_pred c-----CCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEE
Q 011158 360 K-----PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSL 434 (492)
Q Consensus 360 ~-----~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DF 434 (492)
. ...+|+||||+. |+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Df 178 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDF 178 (362)
T ss_dssp ECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCT
T ss_pred eccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEec
Confidence 3 346899999995 7999999876668999999999999999999999999999999999999999999999999
Q ss_pred eecceee------eeeCCCceeecceecc-ccccCccceeee---ecccccCCCCCCC
Q 011158 435 CLFTVSI------LFCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 435 Gla~~~~------~~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
|.+.... ...++..|++||.... ..+....|+|++ +....+|.++|..
T Consensus 179 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 236 (362)
T 3pg1_A 179 NLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRG 236 (362)
T ss_dssp TC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCC
Confidence 9996432 2456677888887655 556777788884 3334456666554
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.8e-28 Score=243.22 Aligned_cols=172 Identities=24% Similarity=0.493 Sum_probs=146.5
Q ss_pred CCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHh--cCCCceeeEEEEEecCC----eE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK--VRHKNVVQFIGACTKPP----SL 364 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~g~~~~~~----~~ 364 (492)
.++|++.+.||+|+||.||+|+++++.||||+++.. ....+.+|+.+++. ++||||+++++++.... .+
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~ 115 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 115 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred cccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence 357899999999999999999999999999999642 24667889999988 78999999999998776 79
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------HCCceecCCCCCCEEEccCCCeEEEEEee
Q 011158 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH--------QNNIIHRDLKAANLLMDENEVSLLLSLCL 436 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH--------~~~IiHrDLKp~NILld~~~~~kl~DFGl 436 (492)
|+||||+++|+|.+++.+ ..+++..++.++.||+.||.||| +++|+||||||+|||++.++.+||+|||+
T Consensus 116 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 193 (342)
T 1b6c_B 116 WLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 193 (342)
T ss_dssp EEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCC
Confidence 999999999999999976 46899999999999999999999 89999999999999999999999999999
Q ss_pred cceee-----------eeeCCCceeecceeccc------cccCccceeee
Q 011158 437 FTVSI-----------LFCGKGRELISLFLGND------VLLQFGTYWII 469 (492)
Q Consensus 437 a~~~~-----------~~~g~~~~~ape~~~~e------~~~~~~d~W~l 469 (492)
+.... ...++..|++||..... .+....|+|++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~sl 243 (342)
T 1b6c_B 194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM 243 (342)
T ss_dssp CEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHH
T ss_pred ceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHH
Confidence 86542 12466677888776554 22244677773
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.3e-28 Score=237.73 Aligned_cols=192 Identities=21% Similarity=0.330 Sum_probs=155.0
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeE
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 364 (492)
+.+..+++.....||+|+||.||+|.+ +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..
T Consensus 17 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 94 (295)
T 2clq_A 17 YDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFI 94 (295)
T ss_dssp EEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred ccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcE
Confidence 455555666667999999999999998 46789999997542 34457799999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcc-CCCeEEEEEeecceee
Q 011158 365 CIVTEFMSGGSVYDYLHKLKG--VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEVSLLLSLCLFTVSI 441 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~-~~~~kl~DFGla~~~~ 441 (492)
++||||+++++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||.+....
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~ 174 (295)
T 2clq_A 95 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA 174 (295)
T ss_dssp EEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred EEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence 999999999999999987533 4678899999999999999999999999999999999997 8899999999986532
Q ss_pred -------eeeCCCceeecceeccc--cccCccceeee---ecccccCCCCC
Q 011158 442 -------LFCGKGRELISLFLGND--VLLQFGTYWII---FRRSSCDKKNS 480 (492)
Q Consensus 442 -------~~~g~~~~~ape~~~~e--~~~~~~d~W~l---~~~~~~gt~~Y 480 (492)
...++..|++||..... .+....|+|++ +....+|..+|
T Consensus 175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 225 (295)
T 2clq_A 175 GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF 225 (295)
T ss_dssp C-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTT
T ss_pred CCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 23566778888876543 25566788874 22233455554
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.9e-28 Score=248.09 Aligned_cols=187 Identities=20% Similarity=0.251 Sum_probs=156.7
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC--------CCceeeEEEEEe-
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR--------HKNVVQFIGACT- 359 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~--------HpnIv~l~g~~~- 359 (492)
..+|++.++||+|+||.||+|++ .++.||||+++.. ....+.+.+|+.++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 57899999999999999999987 4688999999743 445678899999999996 788999999987
Q ss_pred ---cCCeEEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEEccCC-------
Q 011158 360 ---KPPSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENE------- 427 (492)
Q Consensus 360 ---~~~~~~lV~Ey~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~-~IiHrDLKp~NILld~~~------- 427 (492)
....+||||||+ +++|.+++.... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 113 SGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp EETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred cCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhh
Confidence 556799999999 777777776543 5799999999999999999999999 999999999999999775
Q ss_pred ------------------------------------------CeEEEEEeecceee----eeeCCCceeecceecccccc
Q 011158 428 ------------------------------------------VSLLLSLCLFTVSI----LFCGKGRELISLFLGNDVLL 461 (492)
Q Consensus 428 ------------------------------------------~~kl~DFGla~~~~----~~~g~~~~~ape~~~~e~~~ 461 (492)
.+||+|||.+.... ...++..|++||......+.
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 271 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYN 271 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSCCC
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCCCCC
Confidence 79999999986542 34578889999988887788
Q ss_pred Cccceeee---ecccccCCCCCC
Q 011158 462 QFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 462 ~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...|+|++ +....+|.++|.
T Consensus 272 ~~~DiwslG~il~elltg~~pf~ 294 (397)
T 1wak_A 272 TPADIWSTACMAFELATGDYLFE 294 (397)
T ss_dssp THHHHHHHHHHHHHHHHSSCSCC
T ss_pred cHHHHHHHHHHHHHHhhCCCCCC
Confidence 88899984 333445666654
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.7e-28 Score=266.50 Aligned_cols=195 Identities=24% Similarity=0.355 Sum_probs=162.2
Q ss_pred CceeeCCCCceeeeeeeecCceEEEEEEEC-----CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Q 011158 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359 (492)
Q Consensus 285 ~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~-----g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~ 359 (492)
..+++..++|++.+.||+|+||.||+|.+. +..||||+++.. ......+.+.+|+.++++++||||+++++++.
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 461 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 461 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 356788889999999999999999999884 245999998753 24555678999999999999999999999985
Q ss_pred cCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecce
Q 011158 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTV 439 (492)
Q Consensus 360 ~~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~ 439 (492)
. +..|+||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 462 ~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 462 E-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred c-CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCee
Confidence 4 568999999999999999987666799999999999999999999999999999999999999999999999999875
Q ss_pred ee--------eeeCCCceeecceeccccccCccceeee----ecccccCCCCCC
Q 011158 440 SI--------LFCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSD 481 (492)
Q Consensus 440 ~~--------~~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~ 481 (492)
.. ...++..|++||......+....|+|++ +.....|.++|.
T Consensus 541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~ 594 (656)
T 2j0j_A 541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 594 (656)
T ss_dssp CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCC
Confidence 42 1233457889998877777778888884 222233665554
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=239.31 Aligned_cols=188 Identities=20% Similarity=0.263 Sum_probs=158.8
Q ss_pred CCCCceeeeeeeecCceEEEEEEE---CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCc------eeeEEEEEec
Q 011158 290 DPKHLKFGSKVASGSYGDLYRGTY---CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN------VVQFIGACTK 360 (492)
Q Consensus 290 ~~~~~~~~~~LG~G~fG~Vy~~~~---~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~Hpn------Iv~l~g~~~~ 360 (492)
-.++|++.++||+|+||.||+|.+ .++.||||+++.. ....+.+.+|+.++++++|+| |+++++++..
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~ 88 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH 88 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence 356899999999999999999987 4678999999743 445677889999999997654 9999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcc--------------
Q 011158 361 PPSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-------------- 425 (492)
Q Consensus 361 ~~~~~lV~Ey~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~-------------- 425 (492)
.+.+|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 89 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 89 HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999999 999999998753 36899999999999999999999999999999999999987
Q ss_pred -----CCCeEEEEEeecceee----eeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 426 -----NEVSLLLSLCLFTVSI----LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 426 -----~~~~kl~DFGla~~~~----~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
++.+||+|||.+.... ...++..|++||......+....|+|++ +....+|.++|.
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 235 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFP 235 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 6689999999987542 3467788999998887778888899984 223445665554
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-27 Score=241.15 Aligned_cols=196 Identities=22% Similarity=0.291 Sum_probs=146.4
Q ss_pred CCceeeCCCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHH-HHHhcCCCceeeEEEEEec
Q 011158 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVF-IMRKVRHKNVVQFIGACTK 360 (492)
Q Consensus 284 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~g~~~~ 360 (492)
...|.+..++|++.+.||+|+||.||+|.+. ++.||||+++... ......++..|+. +++.++||||+++++++..
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~ 92 (327)
T 3aln_A 14 EQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR 92 (327)
T ss_dssp CEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred HHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence 4568899999999999999999999999985 7889999998653 3344455666666 7778899999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEEccCCCeEEEEEe
Q 011158 361 PPSLCIVTEFMSGGSVYDYLHK----LKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVSLLLSLC 435 (492)
Q Consensus 361 ~~~~~lV~Ey~~ggsL~~~L~~----~~~~l~~~~~~~i~~qI~~gL~yLH~~-~IiHrDLKp~NILld~~~~~kl~DFG 435 (492)
.+..++||||++ |+|.+++.. ....+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 171 (327)
T 3aln_A 93 EGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFG 171 (327)
T ss_dssp SSEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred CCceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCC
Confidence 999999999996 588888863 246789999999999999999999999 99999999999999999999999999
Q ss_pred ecceee------eeeCCCceeeccee----ccccccCccceeee---ecccccCCCCCC
Q 011158 436 LFTVSI------LFCGKGRELISLFL----GNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 436 la~~~~------~~~g~~~~~ape~~----~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
+++... ...++..|++||.. ....+....|+|++ +....+|..+|.
T Consensus 172 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 230 (327)
T 3aln_A 172 ISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYP 230 (327)
T ss_dssp SSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSS
T ss_pred CceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 986542 23577778899887 34556677788884 222334554443
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=242.08 Aligned_cols=187 Identities=18% Similarity=0.223 Sum_probs=154.4
Q ss_pred CCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-----Ce
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-----PS 363 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-----~~ 363 (492)
.++|++.+.||+|+||.||+|++. ++.||||+++.. ........+.+|+.++++++||||+++++++... ..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 367999999999999999999985 788999999753 2345567788999999999999999999988754 67
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee--
Q 011158 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-- 441 (492)
Q Consensus 364 ~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-- 441 (492)
.|+||||+. |+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 89 ~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence 999999995 799999976 568999999999999999999999999999999999999999999999999986532
Q ss_pred ---------------eeeCCCceeecceec-cccccCccceeee---ecccccCCCCCC
Q 011158 442 ---------------LFCGKGRELISLFLG-NDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 ---------------~~~g~~~~~ape~~~-~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||... ...+....|+|++ +....+|.++|.
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 224 (353)
T 2b9h_A 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFP 224 (353)
T ss_dssp --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCC
Confidence 124566788888653 3556666788884 223345665554
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-28 Score=248.53 Aligned_cols=185 Identities=16% Similarity=0.119 Sum_probs=153.0
Q ss_pred eCCCCceeeeeeeecCceEEEEEEEC----------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceee-----
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTYC----------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ----- 353 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~~----------g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~----- 353 (492)
...++|++.+.||+|+||.||+|++. ++.||||++... ..+.+|+.++++++||||++
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~ 111 (352)
T 2jii_A 39 KSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKL 111 (352)
T ss_dssp TTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred ccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhh
Confidence 34578999999999999999999874 578999999754 46789999999999999988
Q ss_pred ----------EEEEEec-CCeEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCE
Q 011158 354 ----------FIGACTK-PPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANL 421 (492)
Q Consensus 354 ----------l~g~~~~-~~~~~lV~Ey~~ggsL~~~L~~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NI 421 (492)
+++++.. ....||||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI 190 (352)
T 2jii_A 112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI 190 (352)
T ss_dssp TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence 6677765 67899999999 99999999874 36799999999999999999999999999999999999
Q ss_pred EEccCC--CeEEEEEeecceee--------------eeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 422 LMDENE--VSLLLSLCLFTVSI--------------LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 422 Lld~~~--~~kl~DFGla~~~~--------------~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
|++.++ .+||+|||+++... ...++..|++||......+....|+|++ +....+|..+|.
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 999998 89999999996432 1256678888888777777777888884 223334555543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-28 Score=249.33 Aligned_cols=193 Identities=17% Similarity=0.218 Sum_probs=159.8
Q ss_pred eCCCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCCh---------------HHHHHHHHHHHHHHhcCCCceee
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINS---------------DMQKEFAQEVFIMRKVRHKNVVQ 353 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~---------------~~~~~~~~Ei~il~~l~HpnIv~ 353 (492)
+...+|++.+.||+|+||.||+|.+.++.||||++....... .....+.+|+.++++++||||++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 335689999999999999999999989999999997532111 11278999999999999999999
Q ss_pred EEEEEecCCeEEEEEeccCCCCHHHH------HHhc-CCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEcc
Q 011158 354 FIGACTKPPSLCIVTEFMSGGSVYDY------LHKL-KGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDE 425 (492)
Q Consensus 354 l~g~~~~~~~~~lV~Ey~~ggsL~~~------L~~~-~~~l~~~~~~~i~~qI~~gL~yLH~-~~IiHrDLKp~NILld~ 425 (492)
+++++...+..|+||||+++|+|.++ +... ...+++..++.++.||+.||.|||+ +||+||||||+|||++.
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK 187 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECT
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcC
Confidence 99999999999999999999999998 5442 4579999999999999999999999 99999999999999999
Q ss_pred CCCeEEEEEeeccee-----eeeeCCCceeecceeccc-cccC-ccceeee---ecccccCCCCCC
Q 011158 426 NEVSLLLSLCLFTVS-----ILFCGKGRELISLFLGND-VLLQ-FGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 426 ~~~~kl~DFGla~~~-----~~~~g~~~~~ape~~~~e-~~~~-~~d~W~l---~~~~~~gt~~Y~ 481 (492)
++.+||+|||.+... ....++..|++||..... .+.. ..|+|++ +....+|.++|.
T Consensus 188 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 253 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253 (348)
T ss_dssp TSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCC
Confidence 999999999998753 234577788888877665 4544 6788884 223334555554
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-27 Score=234.40 Aligned_cols=186 Identities=22% Similarity=0.275 Sum_probs=154.4
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEE-ecCCeEEEE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC-TKPPSLCIV 367 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~-~~~~~~~lV 367 (492)
.++|++.+.||+|+||.||+|++ .++.||||++...... ..+.+|+.++++++|++++..+..+ ......++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence 36799999999999999999997 5789999998765332 4588999999999988766655555 567778999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE---ccCCCeEEEEEeecceee---
Q 011158 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVSLLLSLCLFTVSI--- 441 (492)
Q Consensus 368 ~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILl---d~~~~~kl~DFGla~~~~--- 441 (492)
|||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||.+....
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 9999 999999998766789999999999999999999999999999999999999 588899999999986532
Q ss_pred -----------eeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 442 -----------LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 -----------~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||......+....|+|++ +....+|..+|.
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 216 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ 216 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred cccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 2356778888988877777778888884 223345655554
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=235.59 Aligned_cols=185 Identities=22% Similarity=0.279 Sum_probs=151.4
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEE-ecCCeEEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC-TKPPSLCIVT 368 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~-~~~~~~~lV~ 368 (492)
++|++.+.||+|+||.||+|++ .++.||||++...... ..+.+|+.++++++|++++..+..+ ......++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 5789999999999999999997 5788999987654322 3578899999999988776666555 6677889999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE---ccCCCeEEEEEeecceee----
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVSLLLSLCLFTVSI---- 441 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILl---d~~~~~kl~DFGla~~~~---- 441 (492)
||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||.++...
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~ 163 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence 999 999999998766789999999999999999999999999999999999999 788999999999986532
Q ss_pred ----------eeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 442 ----------LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 ----------~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||......+....|+|++ +.....|.++|.
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 216 (296)
T 4hgt_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ 216 (296)
T ss_dssp CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred CccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCc
Confidence 2356778888888877777777888884 223445555554
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.95 E-value=7.7e-28 Score=241.23 Aligned_cols=190 Identities=20% Similarity=0.318 Sum_probs=155.2
Q ss_pred CCCceeeeeeeecCceEEEEEEEC---CceEEEEEecCCCCChHHHHHHHHHHHHHHhc---CCCceeeEEEEEe-----
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTYC---SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV---RHKNVVQFIGACT----- 359 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~~---g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~g~~~----- 359 (492)
.++|++.+.||+|+||.||+|.+. ++.||+|+++...........+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 367999999999999999999983 57899999975433332234566788777766 8999999999987
Q ss_pred cCCeEEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecc
Q 011158 360 KPPSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFT 438 (492)
Q Consensus 360 ~~~~~~lV~Ey~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~ 438 (492)
....+++||||+. |+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.++
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 5567899999996 79999998753 358999999999999999999999999999999999999999999999999986
Q ss_pred eee------eeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 439 VSI------LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 439 ~~~------~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
... ...++..|++||......+....|+|++ +....+|.++|.
T Consensus 169 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 220 (326)
T 1blx_A 169 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 220 (326)
T ss_dssp CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCC
Confidence 542 3456778899998877778888888884 223345555554
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.1e-28 Score=237.15 Aligned_cols=188 Identities=21% Similarity=0.327 Sum_probs=155.5
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
++|++.+.||+|+||.||+|++ .++.||||++............+.+|+.++++++||||+++++++......|+|||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 5789999999999999999998 47889999997654444456789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccC---CCeEEEEEeecceeee----
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN---EVSLLLSLCLFTVSIL---- 442 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~---~~~kl~DFGla~~~~~---- 442 (492)
|+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.....
T Consensus 102 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~ 180 (287)
T 2wei_A 102 LYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180 (287)
T ss_dssp CCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSC
T ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCcc
Confidence 99999999999763 568999999999999999999999999999999999999764 4699999999865422
Q ss_pred --eeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 443 --FCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 443 --~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
..++..|++||..... +....|+|++ +....+|.++|.
T Consensus 181 ~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~ 223 (287)
T 2wei_A 181 KDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFY 223 (287)
T ss_dssp SCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCC
Confidence 2345567888876554 5666788884 223334555543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=9.7e-28 Score=244.36 Aligned_cols=192 Identities=21% Similarity=0.307 Sum_probs=158.9
Q ss_pred ceeeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCe
Q 011158 286 VWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (492)
Q Consensus 286 ~~ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 363 (492)
.|++. .+|.+.+.||+|+||.||+|.+ +++.||||++............+.+|+.++++++||||+++++++.....
T Consensus 19 ~~~l~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 97 (353)
T 3coi_A 19 AWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS 97 (353)
T ss_dssp EEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred ccccC-ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccc
Confidence 45554 6799999999999999999988 47899999998765556667889999999999999999999999987654
Q ss_pred ------EEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeec
Q 011158 364 ------LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLF 437 (492)
Q Consensus 364 ------~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla 437 (492)
+|+||||+. ++|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.+
T Consensus 98 ~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 98 LRNFYDFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp GGGCCCCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred cccceeEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999995 68888774 35899999999999999999999999999999999999999999999999998
Q ss_pred ceee----eeeCCCceeecceecc-ccccCccceeee---ecccccCCCCCCC
Q 011158 438 TVSI----LFCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 438 ~~~~----~~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
+... ...++..|++||.... ..+....|+|++ +....+|.++|..
T Consensus 174 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 226 (353)
T 3coi_A 174 RHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 226 (353)
T ss_dssp TC--------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBS
T ss_pred cCCCCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 7642 2456778889987765 566777888884 3334456666643
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-27 Score=237.61 Aligned_cols=194 Identities=14% Similarity=0.191 Sum_probs=159.7
Q ss_pred CceeeCCCCceeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCChHHHHHHHHHHHHHHhcC--CCceeeEEEEEecC
Q 011158 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR--HKNVVQFIGACTKP 361 (492)
Q Consensus 285 ~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~g~~~~~ 361 (492)
....+..++|++.+.||+|+||.||++.+. ++.||||++............+.+|+.++++++ |+||+++++++...
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 100 (313)
T 3cek_A 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 100 (313)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred eeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence 446788889999999999999999999874 678999999876666677788999999999997 59999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee
Q 011158 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI 441 (492)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~ 441 (492)
..+|+|||+ .+++|.+++.. ...+++..++.++.||+.||.|||+++|+||||||+|||+++ +.+||+|||.+....
T Consensus 101 ~~~~lv~e~-~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 101 QYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQ 177 (313)
T ss_dssp SEEEEEECC-CSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred CEEEEEEec-CCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeecccccccc
Confidence 999999995 58999999987 457899999999999999999999999999999999999974 789999999987532
Q ss_pred ---------eeeCCCceeecceecc-----------ccccCccceeee---ecccccCCCCCC
Q 011158 442 ---------LFCGKGRELISLFLGN-----------DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 ---------~~~g~~~~~ape~~~~-----------e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||.... ..+....|+|++ +.....|..+|.
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 240 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 240 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchh
Confidence 2346778888887654 345556788884 223344555443
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-27 Score=237.51 Aligned_cols=186 Identities=21% Similarity=0.246 Sum_probs=147.3
Q ss_pred CCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEe---------
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT--------- 359 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~--------- 359 (492)
..+|++.+.||+|+||.||+|.+. ++.||||++... +....+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 467999999999999999999985 788999999754 3556678999999999999999999999874
Q ss_pred -----cCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc-cCCCeEEEE
Q 011158 360 -----KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD-ENEVSLLLS 433 (492)
Q Consensus 360 -----~~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld-~~~~~kl~D 433 (492)
.....|+||||+. |+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++ +++.+||+|
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred cccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence 3467899999996 699999965 5789999999999999999999999999999999999997 567899999
Q ss_pred Eeecceee----------eeeCCCceeecceecc-ccccCccceeee---ecccccCCCCCC
Q 011158 434 LCLFTVSI----------LFCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 434 FGla~~~~----------~~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
||.++... ...++..|++||.... ..+....|+|++ +....+|.++|.
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 226 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFA 226 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCC
Confidence 99987542 1234566888886543 556667788884 233445665554
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=7.4e-28 Score=252.19 Aligned_cols=184 Identities=19% Similarity=0.225 Sum_probs=148.3
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC------Ce
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP------PS 363 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------~~ 363 (492)
.+|++.+.||+|+||.||+|++ +++.||||++.... ..+.+|+.+|++++||||+++++++... ..
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 4689999999999999999998 47889999987542 1234699999999999999999988532 23
Q ss_pred EEEEEeccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccC-CCeEEEEEeecce
Q 011158 364 LCIVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-EVSLLLSLCLFTV 439 (492)
Q Consensus 364 ~~lV~Ey~~ggsL~~~L~~---~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~-~~~kl~DFGla~~ 439 (492)
+++||||++ ++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus 128 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 128 LNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEEEEECCC-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeehhccc-ccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 779999996 477776653 35679999999999999999999999999999999999999965 5689999999975
Q ss_pred e------eeeeCCCceeecceecc-ccccCccceeee---ecccccCCCCCCC
Q 011158 440 S------ILFCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 440 ~------~~~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
. ....++..|++||++.. ..+....|+|++ +....+|.+.|..
T Consensus 207 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~ 259 (420)
T 1j1b_A 207 LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 259 (420)
T ss_dssp CCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 3 23456778899997754 467777899984 3345567666643
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-27 Score=237.05 Aligned_cols=197 Identities=16% Similarity=0.260 Sum_probs=148.1
Q ss_pred CCceeeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 011158 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (492)
Q Consensus 284 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 361 (492)
...+.+..++|++.+.||+|+||.||+|.+ +++.||||++..........+.+.++..+++.++||||+++++++...
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~ 96 (318)
T 2dyl_A 17 GQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN 96 (318)
T ss_dssp SSEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred chhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Confidence 345777888999999999999999999998 478999999986544344444455566678888999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~-~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
+.+|+||||+ ++.+..++......+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus 97 ~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 97 TDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRL 175 (318)
T ss_dssp SEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred CcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence 9999999999 6777777766567899999999999999999999995 9999999999999999999999999998643
Q ss_pred e------eeeCCCceeecceec-----cccccCccceeee---ecccccCCCCCC
Q 011158 441 I------LFCGKGRELISLFLG-----NDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 441 ~------~~~g~~~~~ape~~~-----~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
. ...++..|++||... ...+....|+|++ +....+|..+|.
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 230 (318)
T 2dyl_A 176 VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYK 230 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCC
Confidence 2 245777888888873 3445666788874 222334555553
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=9.3e-28 Score=249.56 Aligned_cols=183 Identities=19% Similarity=0.302 Sum_probs=140.4
Q ss_pred cee-eeeeeecCceEEEEEEEC----CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEe--cCCeEEE
Q 011158 294 LKF-GSKVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT--KPPSLCI 366 (492)
Q Consensus 294 ~~~-~~~LG~G~fG~Vy~~~~~----g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~--~~~~~~l 366 (492)
|.+ +++||+|+||.||+|++. ++.||||++...... ..+.+|+.+|++++||||+++++++. ....+||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 444 458999999999999964 578999999764332 46789999999999999999999995 4678999
Q ss_pred EEeccCCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE----ccCCCeEEEEE
Q 011158 367 VTEFMSGGSVYDYLHKLK--------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM----DENEVSLLLSL 434 (492)
Q Consensus 367 V~Ey~~ggsL~~~L~~~~--------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILl----d~~~~~kl~DF 434 (492)
||||+ +|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 98 v~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 176 (405)
T 3rgf_A 98 LFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 176 (405)
T ss_dssp EEECC-SEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCT
T ss_pred EEeCC-CCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEEC
Confidence 99999 568998886321 248999999999999999999999999999999999999 77889999999
Q ss_pred eecceee----------eeeCCCceeecceecc-ccccCccceeee---ecccccCCCCCC
Q 011158 435 CLFTVSI----------LFCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 435 Gla~~~~----------~~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
|+++... ...++..|++||.+.. ..+....|+|++ +....+|.++|.
T Consensus 177 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 237 (405)
T 3rgf_A 177 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 237 (405)
T ss_dssp TCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCC
Confidence 9996532 2456778889987755 446777888884 334455666664
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.6e-27 Score=236.91 Aligned_cols=188 Identities=16% Similarity=0.275 Sum_probs=158.6
Q ss_pred CCCceeeeeeeecCceEEEEEEEC--C-ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCc------eeeEEEEEecC
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTYC--S-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN------VVQFIGACTKP 361 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~~--g-~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~Hpn------Iv~l~g~~~~~ 361 (492)
.++|++.+.||+|+||.||+|.+. + +.||+|+++.. ......+.+|+.++++++|++ ++.+++++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 578999999999999999999984 3 67999999743 445577889999999998766 99999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE-----------------
Q 011158 362 PSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM----------------- 423 (492)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILl----------------- 423 (492)
+.+||||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred CeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccc
Confidence 9999999999 778888887643 479999999999999999999999999999999999999
Q ss_pred --ccCCCeEEEEEeeccee----eeeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 424 --DENEVSLLLSLCLFTVS----ILFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 424 --d~~~~~kl~DFGla~~~----~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
+.++.+||+|||+++.. ....++..|++||......+....|+|++ +....+|.++|..
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT 241 (355)
T ss_dssp EEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 66789999999998753 23467788999998887778888899984 3334457666654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.7e-27 Score=250.21 Aligned_cols=187 Identities=18% Similarity=0.223 Sum_probs=156.3
Q ss_pred CCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCC-CceeeEEEEEecCCeEEEE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH-KNVVQFIGACTKPPSLCIV 367 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~g~~~~~~~~~lV 367 (492)
.++|++.++||+|+||.||+|++. ++.||||++...... ..+.+|+.+++.++| ++|..+..++......|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence 367899999999999999999974 789999998765332 347889999999987 5666677777788889999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE---ccCCCeEEEEEeecceee---
Q 011158 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVSLLLSLCLFTVSI--- 441 (492)
Q Consensus 368 ~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILl---d~~~~~kl~DFGla~~~~--- 441 (492)
|||+ +++|.+++......+++..++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+++...
T Consensus 82 me~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (483)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence 9999 999999998767789999999999999999999999999999999999999 688999999999986532
Q ss_pred -----------eeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 442 -----------LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 442 -----------~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
...++..|++||......+....|+|++ +....+|..+|..
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~ 215 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 3457778888888887777777888884 3334456666643
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-27 Score=235.82 Aligned_cols=189 Identities=19% Similarity=0.270 Sum_probs=149.2
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCceeeEEEEEe--cCCeEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNVVQFIGACT--KPPSLC 365 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~--~~~~~~ 365 (492)
.+|++.+.||+|+||.||+|.+ +++.||+|+++.... .......+.+|+.++++++||||+++++++. .....|
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 5788899999999999999998 467899999975421 1234577999999999999999999999984 456799
Q ss_pred EEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee---
Q 011158 366 IVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI--- 441 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~--- 441 (492)
+||||+.++ |.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.+....
T Consensus 85 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 163 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163 (305)
T ss_dssp EEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred EEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence 999999766 88887654 3579999999999999999999999999999999999999999999999999986532
Q ss_pred ------eeeCCCceeecceeccc--cccCccceeee---ecccccCCCCCC
Q 011158 442 ------LFCGKGRELISLFLGND--VLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 ------~~~g~~~~~ape~~~~e--~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||..... ......|+|++ +....+|..+|.
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 214 (305)
T 2wtk_C 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214 (305)
T ss_dssp SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCC
Confidence 23466778888876542 22445678874 223334555554
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.2e-27 Score=243.60 Aligned_cols=185 Identities=21% Similarity=0.258 Sum_probs=146.5
Q ss_pred CCCceeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC------e
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP------S 363 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~------~ 363 (492)
..+|++.++||+|+||.||+|++. +..||+|++..... ...+|+.+|+.++||||+++++++.... .
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 357999999999999999999984 45699998865421 1236999999999999999999996543 3
Q ss_pred EEEEEeccCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc-cCCCeEEEEEeecce
Q 011158 364 LCIVTEFMSGGSVYDYLH---KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD-ENEVSLLLSLCLFTV 439 (492)
Q Consensus 364 ~~lV~Ey~~ggsL~~~L~---~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld-~~~~~kl~DFGla~~ 439 (492)
+|+|||||++ ++.+.+. .....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.
T Consensus 113 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 113 LNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 8899999965 4444443 2256799999999999999999999999999999999999999 789999999999975
Q ss_pred e------eeeeCCCceeecceecc-ccccCccceeee---ecccccCCCCCCC
Q 011158 440 S------ILFCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 440 ~------~~~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
. ....++..|++||.+.. ..+....|+|++ +....+|.++|..
T Consensus 192 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 244 (394)
T 4e7w_A 192 LIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPG 244 (394)
T ss_dssp CCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 3 23456777888887644 347777899984 3344556666643
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-27 Score=238.99 Aligned_cols=193 Identities=20% Similarity=0.302 Sum_probs=147.2
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCh----HHHHHHHHHHHHHHhc----CCCceeeEEEE
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS----DMQKEFAQEVFIMRKV----RHKNVVQFIGA 357 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~----~~~~~~~~Ei~il~~l----~HpnIv~l~g~ 357 (492)
+.-.++|++.+.||+|+||.||+|.+ .++.||||++....... .....+.+|+.+++++ +|+||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 44467899999999999999999987 46789999997654322 1234466799999999 89999999999
Q ss_pred EecCCeEEEEEec-cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc-cCCCeEEEEEe
Q 011158 358 CTKPPSLCIVTEF-MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD-ENEVSLLLSLC 435 (492)
Q Consensus 358 ~~~~~~~~lV~Ey-~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld-~~~~~kl~DFG 435 (492)
+...+..++|||| +.+++|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg 185 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG 185 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCS
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcc
Confidence 9998899999999 789999999987 45689999999999999999999999999999999999999 88999999999
Q ss_pred ecceee-----eeeCCCceeecceeccccccC-ccceeee---ecccccCCCCCC
Q 011158 436 LFTVSI-----LFCGKGRELISLFLGNDVLLQ-FGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 436 la~~~~-----~~~g~~~~~ape~~~~e~~~~-~~d~W~l---~~~~~~gt~~Y~ 481 (492)
.+.... ...++..|++||......+.. ..|+|++ +....+|..+|.
T Consensus 186 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 240 (312)
T 2iwi_A 186 SGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE 240 (312)
T ss_dssp SCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred hhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCC
Confidence 986542 345667788888765544433 5677774 223334555553
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-27 Score=239.89 Aligned_cols=195 Identities=19% Similarity=0.305 Sum_probs=157.2
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCh----HHHHHHHHHHHHHHhcC--CCceeeEEEEE
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS----DMQKEFAQEVFIMRKVR--HKNVVQFIGAC 358 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~----~~~~~~~~Ei~il~~l~--HpnIv~l~g~~ 358 (492)
.+.-..+|++.+.||+|+||.||+|++ .++.||||+++...... .....+.+|+.++++++ |+||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 345567899999999999999999988 56889999997653322 12245678999999996 59999999999
Q ss_pred ecCCeEEEEEeccCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc-cCCCeEEEEEee
Q 011158 359 TKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD-ENEVSLLLSLCL 436 (492)
Q Consensus 359 ~~~~~~~lV~Ey~~g-gsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld-~~~~~kl~DFGl 436 (492)
...+..++||||+.+ ++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 999999999999976 899999987 46789999999999999999999999999999999999999 788999999999
Q ss_pred cceee-----eeeCCCceeecceeccccc-cCccceeee---ecccccCCCCCCC
Q 011158 437 FTVSI-----LFCGKGRELISLFLGNDVL-LQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 437 a~~~~-----~~~g~~~~~ape~~~~e~~-~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
+.... ...++..|++||......+ ....|+|++ +.....|..+|..
T Consensus 197 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 251 (320)
T 3a99_A 197 GALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251 (320)
T ss_dssp CEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred ccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCC
Confidence 86542 2456777888887655444 455688874 2233446655543
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.8e-27 Score=256.35 Aligned_cols=166 Identities=12% Similarity=0.121 Sum_probs=122.3
Q ss_pred eeeeecCceEEEEEE--ECCceEEEEEecCCCC----C----hHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCeEEE
Q 011158 298 SKVASGSYGDLYRGT--YCSQDVAIKVLKPERI----N----SDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCI 366 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~--~~g~~vAvK~l~~~~~----~----~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~l 366 (492)
...+.|++|.+..+. +.|+.+++|++..... . ....++|.+|+.+|+++ .|+||+++++++++...+||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 456777777766553 4789999999976522 1 23456799999999999 69999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-----
Q 011158 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI----- 441 (492)
Q Consensus 367 V~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~----- 441 (492)
||||++|++|.++|.+ .+.++.. .|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+++...
T Consensus 320 VMEyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~ 395 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSW 395 (569)
T ss_dssp EEECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CC
T ss_pred EEecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcc
Confidence 9999999999999987 4667764 588999999999999999999999999999999999999999987542
Q ss_pred --eeeCCCceeecceeccccccCccceee
Q 011158 442 --LFCGKGRELISLFLGNDVLLQFGTYWI 468 (492)
Q Consensus 442 --~~~g~~~~~ape~~~~e~~~~~~d~W~ 468 (492)
..+|+..|++||...+. +....++|+
T Consensus 396 ~~t~vGTp~YmAPE~l~g~-~~~~~d~~s 423 (569)
T 4azs_A 396 PTNLVQSFFVFVNELFAEN-KSWNGFWRS 423 (569)
T ss_dssp SHHHHHHHHHHHHHHC-------------
T ss_pred ccCceechhhccHHHhCCC-CCCcccccc
Confidence 23466677777776543 233455665
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.94 E-value=6.1e-27 Score=239.06 Aligned_cols=190 Identities=14% Similarity=0.168 Sum_probs=158.1
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-----------CCceeeE
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-----------HKNVVQF 354 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~-----------HpnIv~l 354 (492)
.+...+|++.+.||+|+||.||+|++ .++.||||++... ......+.+|+.++++++ |+||+++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~ 91 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 91 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence 45667899999999999999999997 5788999999753 344577889999999886 8899999
Q ss_pred EEEEecCC----eEEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEEcc---
Q 011158 355 IGACTKPP----SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDE--- 425 (492)
Q Consensus 355 ~g~~~~~~----~~~lV~Ey~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~-~IiHrDLKp~NILld~--- 425 (492)
++++...+ .+++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC
Confidence 99987644 789999999 999999998743 4699999999999999999999998 9999999999999953
Q ss_pred ---CCCeEEEEEeecceee----eeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 426 ---NEVSLLLSLCLFTVSI----LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 426 ---~~~~kl~DFGla~~~~----~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
.+.+||+|||++.... ...++..|++||......+....|+|++ +.....|.++|.
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 236 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 236 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred CcCcceEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 3479999999986542 3467788999998887778888899984 334445666665
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-26 Score=238.44 Aligned_cols=188 Identities=18% Similarity=0.204 Sum_probs=157.5
Q ss_pred CCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CC-----ceeeEEEEEecCC
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HK-----NVVQFIGACTKPP 362 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~-Hp-----nIv~l~g~~~~~~ 362 (492)
.++|++.++||+|+||.||+|.+. ++.||||+++.. ......+..|+.+++.++ |+ +|+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 468999999999999999999884 678999999743 344567888999998885 54 4999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCCCCEEEc--cCCCeEEEEEeec
Q 011158 363 SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLH--QNNIIHRDLKAANLLMD--ENEVSLLLSLCLF 437 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH--~~~IiHrDLKp~NILld--~~~~~kl~DFGla 437 (492)
.+||||||+ +|+|.+++.... ..+++..++.++.||+.||.||| ++||+||||||+|||++ .++.+||+|||++
T Consensus 130 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 130 HLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred ceEEEEecC-CCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 999999999 569999998754 46899999999999999999999 57999999999999995 4778999999998
Q ss_pred cee----eeeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 438 TVS----ILFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 438 ~~~----~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
+.. ....++..|++||......+....|+|++ +....+|.++|..
T Consensus 209 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 209 CQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp EETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eecccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 654 23567788999998888788888899984 3344567666653
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.2e-27 Score=261.03 Aligned_cols=173 Identities=17% Similarity=0.217 Sum_probs=143.8
Q ss_pred CCCceeeeeeeecCceEEEEEEE---CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCe----
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY---CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS---- 363 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~---~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~---- 363 (492)
..+|++.++||+|+||.||+|.+ .++.||||++... .+......+.+|+.++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 47899999999999999999998 3688999998753 244556788999999999999999999999987655
Q ss_pred -EEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-
Q 011158 364 -LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI- 441 (492)
Q Consensus 364 -~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~- 441 (492)
.|||||||+|++|.+++.. .+++..++.++.||+.||.|||++|||||||||+|||++.+ .+||+|||+++...
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS 233 (681)
T ss_dssp EEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred eeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhccc
Confidence 7999999999999998754 68999999999999999999999999999999999999986 89999999986542
Q ss_pred --eeeCCCceeecceeccccccCccceeee
Q 011158 442 --LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 442 --~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
...|+..|++||+..... ...+|+|++
T Consensus 234 ~~~~~gt~~y~aPE~~~~~~-~~~sDi~sl 262 (681)
T 2pzi_A 234 FGYLYGTPGFQAPEIVRTGP-TVATDIYTV 262 (681)
T ss_dssp CSCCCCCTTTSCTTHHHHCS-CHHHHHHHH
T ss_pred CCccCCCccccCHHHHcCCC-CCceehhhh
Confidence 345777788888665432 445677773
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.2e-27 Score=246.96 Aligned_cols=179 Identities=20% Similarity=0.263 Sum_probs=145.6
Q ss_pred CceeeCCCCceeeeeeeecCceE-EEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCC
Q 011158 285 DVWEIDPKHLKFGSKVASGSYGD-LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPP 362 (492)
Q Consensus 285 ~~~ei~~~~~~~~~~LG~G~fG~-Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~ 362 (492)
..+.+...+|.+.+.||+|+||. ||++...++.||||++..... ..+.+|+.+|+++ +||||+++++++....
T Consensus 17 ~~~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 91 (432)
T 3p23_A 17 SVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDRQ 91 (432)
T ss_dssp -CEEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEETT
T ss_pred CcEEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence 45678888899999999999998 556666889999999975432 2356799999999 7999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcc---C--CCeEEEEEeec
Q 011158 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---N--EVSLLLSLCLF 437 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~---~--~~~kl~DFGla 437 (492)
..||||||| +|+|.+++......+....++.++.||+.||.|||++||+||||||+|||++. + ..+||+|||++
T Consensus 92 ~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 92 FQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EEEEEEECC-SEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EEEEEEECC-CCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 999999999 57999999876656666677899999999999999999999999999999953 2 35789999998
Q ss_pred ceee----------eeeCCCceeecceecc---ccccCccceeee
Q 011158 438 TVSI----------LFCGKGRELISLFLGN---DVLLQFGTYWII 469 (492)
Q Consensus 438 ~~~~----------~~~g~~~~~ape~~~~---e~~~~~~d~W~l 469 (492)
+... ...|+..|++||.+.. ..+....|+|++
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSl 215 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSA 215 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHH
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHH
Confidence 6532 2357788888887763 344446788884
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=235.83 Aligned_cols=182 Identities=20% Similarity=0.285 Sum_probs=132.9
Q ss_pred CCceeee-eeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHH-HHHHhcCCCceeeEEEEEec----CCe
Q 011158 292 KHLKFGS-KVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEV-FIMRKVRHKNVVQFIGACTK----PPS 363 (492)
Q Consensus 292 ~~~~~~~-~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei-~il~~l~HpnIv~l~g~~~~----~~~ 363 (492)
++|.+.+ .||+|+||.||+|.+. ++.||||++... . ...+|+ ..++.++||||+++++++.. ...
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---P----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---H----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---H----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 4677754 6999999999999985 789999999753 2 222333 34667799999999999875 445
Q ss_pred EEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcc---CCCeEEEEEeecce
Q 011158 364 LCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVSLLLSLCLFTV 439 (492)
Q Consensus 364 ~~lV~Ey~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~---~~~~kl~DFGla~~ 439 (492)
+++|||||++|+|.+++.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||.+..
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~ 180 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence 899999999999999998753 36999999999999999999999999999999999999986 45599999999865
Q ss_pred ee-----eeeCCCceeecceeccccccCccceeee---ecccccCCCCC
Q 011158 440 SI-----LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNS 480 (492)
Q Consensus 440 ~~-----~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y 480 (492)
.. ...++..|++||......+....|+|++ +....+|.++|
T Consensus 181 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 229 (336)
T 3fhr_A 181 TTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPF 229 (336)
T ss_dssp C----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC
T ss_pred ccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 42 3456777888988877777777888884 22334455555
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.93 E-value=9e-27 Score=236.90 Aligned_cols=191 Identities=15% Similarity=0.149 Sum_probs=141.1
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCe--
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-- 363 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~-- 363 (492)
....++|++.+.||+|+||.||+|++. ++.||||++..... ....+.+|+..++.++||||+++++++.....
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR---FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT---CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc---ccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 344568999999999999999999984 78899999865432 22456778888999999999999999965433
Q ss_pred -----EEEEEeccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCCCCEEEcc-CCCeEEE
Q 011158 364 -----LCIVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLH--QNNIIHRDLKAANLLMDE-NEVSLLL 432 (492)
Q Consensus 364 -----~~lV~Ey~~ggsL~~~L~~---~~~~l~~~~~~~i~~qI~~gL~yLH--~~~IiHrDLKp~NILld~-~~~~kl~ 432 (492)
+++||||+++ +|.+.+.. ....+++..+..++.||+.||.||| ++||+||||||+|||++. ++.+||+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~ 174 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLC 174 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEe
Confidence 8999999965 66655542 3457899999999999999999999 999999999999999997 8999999
Q ss_pred EEeecceee------eeeCCCceeecceecc-ccccCccceeee---ecccccCCCCCCC
Q 011158 433 SLCLFTVSI------LFCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 433 DFGla~~~~------~~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
|||+++... ...++..|++||.... ..+....|+|++ +....+|.++|..
T Consensus 175 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 234 (360)
T 3e3p_A 175 DFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRG 234 (360)
T ss_dssp CCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCC
Confidence 999987542 2356777888887644 446777888884 3334456666643
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.1e-26 Score=227.93 Aligned_cols=166 Identities=20% Similarity=0.306 Sum_probs=136.3
Q ss_pred Cceee-eeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHH-HhcCCCceeeEEEEEec----CCeE
Q 011158 293 HLKFG-SKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIM-RKVRHKNVVQFIGACTK----PPSL 364 (492)
Q Consensus 293 ~~~~~-~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~g~~~~----~~~~ 364 (492)
+|.+. +.||+|+||.||+|.+ +++.||||+++.. ..+.+|+.++ +.++||||+++++++.. ...+
T Consensus 18 ~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred chhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 45565 7899999999999998 4688999999742 4577889888 56689999999999876 6679
Q ss_pred EEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcc---CCCeEEEEEeeccee
Q 011158 365 CIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVSLLLSLCLFTVS 440 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~---~~~~kl~DFGla~~~ 440 (492)
|+||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++...
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 170 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 170 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccccc
Confidence 99999999999999998753 36999999999999999999999999999999999999998 788999999998643
Q ss_pred eeeeCCCceeecceeccccccCccceeee---ecccccCCCCC
Q 011158 441 ILFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNS 480 (492)
Q Consensus 441 ~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y 480 (492)
.+..+....|+|++ +.....|.++|
T Consensus 171 ---------------~~~~~~~~~DiwslG~il~el~tg~~pf 198 (299)
T 3m2w_A 171 ---------------TGEKYDKSCDMWSLGVIMYILLCGYPPF 198 (299)
T ss_dssp ---------------TTCGGGGHHHHHHHHHHHHHHHHSSCSC
T ss_pred ---------------ccccCCchhhHHHHHHHHHHHHHCCCCC
Confidence 23345556677773 22233455554
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.93 E-value=9.4e-26 Score=224.17 Aligned_cols=143 Identities=10% Similarity=0.139 Sum_probs=127.5
Q ss_pred eCCCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEE
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 365 (492)
+-..+|++.+.||+|+||.||+|.+. ++.||||++...... ....+.+.+|+.++++++||||+++++++...+..|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 33467999999999999999999985 789999999876443 455678999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEE
Q 011158 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSL 434 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DF 434 (492)
|||||++|++|.+++.. + .....+..++.||+.||.|||++||+||||||+|||++.++.+||+++
T Consensus 108 lv~e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~ 173 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYP 173 (286)
T ss_dssp EEEECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSC
T ss_pred EEEEecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEec
Confidence 99999999999999954 3 366678999999999999999999999999999999999999998744
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-26 Score=254.31 Aligned_cols=189 Identities=23% Similarity=0.341 Sum_probs=158.1
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEec------CCe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK------PPS 363 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~------~~~ 363 (492)
.+|++.++||+|+||.||+|.+ +++.||||+++.. ......+.+.+|+.++++++||||+++++++.. .+.
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 5688889999999999999987 4788999998764 345566789999999999999999999998765 667
Q ss_pred EEEEEeccCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCC---eEEEEEeecc
Q 011158 364 LCIVTEFMSGGSVYDYLHKLKG--VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV---SLLLSLCLFT 438 (492)
Q Consensus 364 ~~lV~Ey~~ggsL~~~L~~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~---~kl~DFGla~ 438 (492)
.|+|||||++|+|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||.+.
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence 8999999999999999986432 6899999999999999999999999999999999999997765 8999999986
Q ss_pred ee------eeeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 439 VS------ILFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 439 ~~------~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
.. ....++..|++||......+....|+|++ +....+|..+|.
T Consensus 173 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~ 224 (676)
T 3qa8_A 173 ELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL 224 (676)
T ss_dssp BTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 53 23467788999999888888888899984 333445666654
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.4e-26 Score=239.04 Aligned_cols=183 Identities=19% Similarity=0.166 Sum_probs=140.0
Q ss_pred CceeeeeeeecCceEEEEE-EECCceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCeEEEEEec
Q 011158 293 HLKFGSKVASGSYGDLYRG-TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEF 370 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~-~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~Ey 370 (492)
.|...+.||+|+||+||.+ ...++.||||++..+ ....+.+|+.+++++ +||||+++++++.....+||||||
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 4555688999999999654 447899999998643 235678899999986 899999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCC------CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccC-------------CCeEE
Q 011158 371 MSGGSVYDYLHKLKGV------FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-------------EVSLL 431 (492)
Q Consensus 371 ~~ggsL~~~L~~~~~~------l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~-------------~~~kl 431 (492)
| +|+|.+++...... .++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||
T Consensus 91 ~-~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 91 C-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp C-SEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred C-CCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 9 57999999764221 1233457899999999999999999999999999999754 47999
Q ss_pred EEEeecceee-----------eeeCCCceeecceecc-------ccccCccceeee----ecccccCCCCCC
Q 011158 432 LSLCLFTVSI-----------LFCGKGRELISLFLGN-------DVLLQFGTYWII----FRRSSCDKKNSD 481 (492)
Q Consensus 432 ~DFGla~~~~-----------~~~g~~~~~ape~~~~-------e~~~~~~d~W~l----~~~~~~gt~~Y~ 481 (492)
+|||++.... ...|+..|++||.... ..+....|+|++ +.....|.++|.
T Consensus 170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~ 241 (434)
T 2rio_A 170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241 (434)
T ss_dssp CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence 9999986532 2357778889987754 556777888884 222223666654
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6.2e-26 Score=245.38 Aligned_cols=133 Identities=20% Similarity=0.281 Sum_probs=109.6
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEecCCCCChH------HHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEec
Q 011158 297 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSD------MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (492)
Q Consensus 297 ~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~------~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 370 (492)
.++||+|+||.||+|.+.++.+++|+......... ..+++.+|+.+|++++||||+++..++...+..||||||
T Consensus 341 ~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~ 420 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSY 420 (540)
T ss_dssp -------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEEC
T ss_pred CCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEEC
Confidence 56899999999999988899999998765433221 245689999999999999999666666667778999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 371 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
|+|++|.+++.+ ++.++.||+.||.|||+++|+||||||+|||++. .+||+|||+++..
T Consensus 421 ~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 421 INGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp CCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred CCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 999999999865 5689999999999999999999999999999998 9999999999764
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-25 Score=234.17 Aligned_cols=191 Identities=15% Similarity=0.132 Sum_probs=141.0
Q ss_pred CCCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCC-Ccee-------------
Q 011158 290 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRH-KNVV------------- 352 (492)
Q Consensus 290 ~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~-~~~~~~~~~~~Ei~il~~l~H-pnIv------------- 352 (492)
....|+..+.||+|+||.||+|++. ++.||||+++... ......+.|.+|+.+++.++| +|+.
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 4456888899999999999999985 8899999998432 222335779999999999987 2211
Q ss_pred --e------EEEEEec-----CCeEEEEEeccCCCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 011158 353 --Q------FIGACTK-----PPSLCIVTEFMSGGSVYDYLHKL------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 413 (492)
Q Consensus 353 --~------l~g~~~~-----~~~~~lV~Ey~~ggsL~~~L~~~------~~~l~~~~~~~i~~qI~~gL~yLH~~~IiH 413 (492)
. ++.++.. ...++++|+++ +++|.+++... ...+++..++.++.||+.||.|||++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH 234 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 234 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 1 1111111 23468888877 78999999521 345778899999999999999999999999
Q ss_pred cCCCCCCEEEccCCCeEEEEEeecceee----eeeCCCceeeccee----------ccccccCccceeee---ecccccC
Q 011158 414 RDLKAANLLMDENEVSLLLSLCLFTVSI----LFCGKGRELISLFL----------GNDVLLQFGTYWII---FRRSSCD 476 (492)
Q Consensus 414 rDLKp~NILld~~~~~kl~DFGla~~~~----~~~g~~~~~ape~~----------~~e~~~~~~d~W~l---~~~~~~g 476 (492)
|||||+|||++.++.+||+|||+++... ...| ..|++||+. ....+....|+|++ +....+|
T Consensus 235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg 313 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313 (413)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHS
T ss_pred CCcccceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHC
Confidence 9999999999999999999999986542 2355 788888887 55556667788884 2233446
Q ss_pred CCCCCC
Q 011158 477 KKNSDA 482 (492)
Q Consensus 477 t~~Y~a 482 (492)
..+|..
T Consensus 314 ~~Pf~~ 319 (413)
T 3dzo_A 314 DLPNTD 319 (413)
T ss_dssp SCCCCT
T ss_pred CCCCCC
Confidence 555543
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-23 Score=208.78 Aligned_cols=135 Identities=13% Similarity=0.125 Sum_probs=109.3
Q ss_pred CCceeeeeeeecCceEEEEEEE-CCceEEEEEecCCCCCh----------------HHHHHHHHHHHHHHhcCCCceeeE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINS----------------DMQKEFAQEVFIMRKVRHKNVVQF 354 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~-~g~~vAvK~l~~~~~~~----------------~~~~~~~~Ei~il~~l~HpnIv~l 354 (492)
..|.+++.||+|+||.||+|.+ +++.||||+++...... .....+.+|+.+|++++ | +++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v 166 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV 166 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred eEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence 3466779999999999999998 47899999997542211 13567899999999999 4 555
Q ss_pred EEEEecCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEE
Q 011158 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSL 434 (492)
Q Consensus 355 ~g~~~~~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DF 434 (492)
.+++.. +..|+|||||+||+|.+ +.. .....++.||+.||.|||++||+||||||+|||++ ++.+||+||
T Consensus 167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DF 236 (282)
T 1zar_A 167 PKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDF 236 (282)
T ss_dssp CCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCC
T ss_pred CeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEEC
Confidence 555543 45699999999999988 421 23457999999999999999999999999999999 999999999
Q ss_pred eecce
Q 011158 435 CLFTV 439 (492)
Q Consensus 435 Gla~~ 439 (492)
|+++.
T Consensus 237 G~a~~ 241 (282)
T 1zar_A 237 PQSVE 241 (282)
T ss_dssp TTCEE
T ss_pred CCCeE
Confidence 99864
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.1e-20 Score=184.87 Aligned_cols=137 Identities=13% Similarity=0.178 Sum_probs=107.1
Q ss_pred ceeeeeeeecCceEEEEEEE--CCce--EEEEEecCCCCCh----------------------HHHHHHHHHHHHHHhcC
Q 011158 294 LKFGSKVASGSYGDLYRGTY--CSQD--VAIKVLKPERINS----------------------DMQKEFAQEVFIMRKVR 347 (492)
Q Consensus 294 ~~~~~~LG~G~fG~Vy~~~~--~g~~--vAvK~l~~~~~~~----------------------~~~~~~~~Ei~il~~l~ 347 (492)
|.+.+.||+|+||.||+|.+ .|+. ||||+++...... .....+.+|+.+|++++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56789999999999999988 7888 9999986542110 11236789999999998
Q ss_pred CCce--eeEEEEEecCCeEEEEEeccCC-C----CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCCC
Q 011158 348 HKNV--VQFIGACTKPPSLCIVTEFMSG-G----SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH-QNNIIHRDLKAA 419 (492)
Q Consensus 348 HpnI--v~l~g~~~~~~~~~lV~Ey~~g-g----sL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH-~~~IiHrDLKp~ 419 (492)
|++| ..+++. ...+|||||+.+ | +|.+++.. .++..+..++.||+.||.||| ++||+||||||+
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~ 200 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADLSEY 200 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence 8754 444443 246899999932 3 77776533 234567889999999999999 999999999999
Q ss_pred CEEEccCCCeEEEEEeeccee
Q 011158 420 NLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 420 NILld~~~~~kl~DFGla~~~ 440 (492)
|||++. .++|+|||++...
T Consensus 201 NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 201 NIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SEEESS--SEEECCCTTCEET
T ss_pred HEEEcC--cEEEEECcccccC
Confidence 999998 8999999998653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.71 E-value=9.3e-18 Score=173.37 Aligned_cols=133 Identities=16% Similarity=0.240 Sum_probs=97.3
Q ss_pred ceeeeeeeecCceEEEEEEE-CCceEEEEEecCCCCC---------------hHH-----HHHHHHHHHHHHhcCCCcee
Q 011158 294 LKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERIN---------------SDM-----QKEFAQEVFIMRKVRHKNVV 352 (492)
Q Consensus 294 ~~~~~~LG~G~fG~Vy~~~~-~g~~vAvK~l~~~~~~---------------~~~-----~~~~~~Ei~il~~l~HpnIv 352 (492)
|.++..||+|+||.||+|.. .|+.||||+++....+ ... .....+|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 77889999999999999987 5789999998753211 000 01123577777777654432
Q ss_pred --eEEEEEecCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCC--
Q 011158 353 --QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV-- 428 (492)
Q Consensus 353 --~l~g~~~~~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~-- 428 (492)
..++. . ..+|||||+.|++|.++.. ......++.||+.+|.|||++|||||||||.|||+++++.
T Consensus 177 vp~p~~~--~--~~~LVME~i~G~~L~~l~~-------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 177 VPEPIAQ--S--RHTIVMSLVDALPMRQVSS-------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp CCCEEEE--E--TTEEEEECCSCEEGGGCCC-------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred CCeeeec--c--CceEEEEecCCccHhhhcc-------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence 22322 2 2379999999988865431 1234678899999999999999999999999999998773
Q ss_pred --------eEEEEEeec
Q 011158 429 --------SLLLSLCLF 437 (492)
Q Consensus 429 --------~kl~DFGla 437 (492)
+.|+||+-+
T Consensus 246 d~~~~~~~~~iID~~Q~ 262 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQM 262 (397)
T ss_dssp CTTSEEEEEEECCCTTC
T ss_pred cccccccceEEEEeCCc
Confidence 778888765
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=8.6e-13 Score=128.00 Aligned_cols=140 Identities=12% Similarity=0.063 Sum_probs=112.6
Q ss_pred CceeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCeEEEEEecc
Q 011158 293 HLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFM 371 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~Ey~ 371 (492)
.|++...++.|+++.||++...++.+++|+........ ...+.+|+.+++.+. +..+.++++++...+..|+||||+
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i 92 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA 92 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred cceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCC--HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEec
Confidence 46677788888999999998778899999987531111 245888999999985 677889999999888999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 011158 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ------------------------------------------- 408 (492)
Q Consensus 372 ~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~------------------------------------------- 408 (492)
+|.+|.+.+. +......++.+++.+|..||+
T Consensus 93 ~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T 3tm0_A 93 DGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp SSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred CCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence 9999987631 112234788899999999998
Q ss_pred ----------------CCceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 409 ----------------NNIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 409 ----------------~~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
..++|+|++|.|||++.++...|+||+.++..
T Consensus 167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T 3tm0_A 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccC
Confidence 34899999999999987666679999988765
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.18 E-value=2e-11 Score=117.24 Aligned_cols=126 Identities=12% Similarity=0.107 Sum_probs=95.8
Q ss_pred eecCceEEEEEEEC-CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCc--eeeEEEEEecCCeEEEEEeccCCCCHH
Q 011158 301 ASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN--VVQFIGACTKPPSLCIVTEFMSGGSVY 377 (492)
Q Consensus 301 G~G~fG~Vy~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~g~~~~~~~~~lV~Ey~~ggsL~ 377 (492)
+.|..+.||++... |+.+++|+..... ...+.+|+.+++.+.+.+ +.+++++....+..++||||++|.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~ 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence 45566999999764 5679999986531 245778999999986544 567888888878899999999998883
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC-----------------------------------------------
Q 011158 378 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN----------------------------------------------- 410 (492)
Q Consensus 378 ~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~----------------------------------------------- 410 (492)
.. ... ...++.+++..|..||+..
T Consensus 104 --~~----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (264)
T 1nd4_A 104 --SS----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 174 (264)
T ss_dssp --TS----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred --cC----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence 21 112 1256677777777777643
Q ss_pred -----------ceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 411 -----------IIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 411 -----------IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
++|+|++|.|||++.++.+.++||+.++..
T Consensus 175 ~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 175 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred HHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 999999999999987766779999998765
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.16 E-value=5.4e-11 Score=120.99 Aligned_cols=140 Identities=15% Similarity=0.220 Sum_probs=107.6
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEec--CCCCChHHHHHHHHHHHHHHhcC--CCceeeEEEEEecC---CeEEEEEe
Q 011158 297 GSKVASGSYGDLYRGTYCSQDVAIKVLK--PERINSDMQKEFAQEVFIMRKVR--HKNVVQFIGACTKP---PSLCIVTE 369 (492)
Q Consensus 297 ~~~LG~G~fG~Vy~~~~~g~~vAvK~l~--~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~g~~~~~---~~~~lV~E 369 (492)
.+.|+.|.++.||+....+..+++|+.. ..... .....+.+|+.+++.+. +..+.+++.++... +..|+|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECSSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEECCceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 3678999999999998878889999876 33211 12356888999999997 45688999988776 45899999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ----------------------------------------- 408 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~----------------------------------------- 408 (492)
|++|..+.+.. ...++......++.+++..|..||+
T Consensus 122 ~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (359)
T 3dxp_A 122 FVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD 198 (359)
T ss_dssp CCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred ecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence 99988774311 2346788888999999999999997
Q ss_pred -----------------CCceecCCCCCCEEEccCCC--eEEEEEeeccee
Q 011158 409 -----------------NNIIHRDLKAANLLMDENEV--SLLLSLCLFTVS 440 (492)
Q Consensus 409 -----------------~~IiHrDLKp~NILld~~~~--~kl~DFGla~~~ 440 (492)
..++|+|+++.|||++.++. +.++||+.+...
T Consensus 199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 35899999999999997753 689999988765
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.65 E-value=4.4e-08 Score=97.13 Aligned_cols=133 Identities=17% Similarity=0.183 Sum_probs=99.6
Q ss_pred eeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCc--eeeEEEEEecCC---eEEEEEecc
Q 011158 298 SKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKN--VVQFIGACTKPP---SLCIVTEFM 371 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~-Hpn--Iv~l~g~~~~~~---~~~lV~Ey~ 371 (492)
+.++.|.+..||+.. ..+++|+... ......+.+|..+|+.+. +.. +.+++....... ..|+|||++
T Consensus 26 ~~~~~G~~n~v~~v~---~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN---RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CEEEECSSEEEEEST---TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred EecCCCCcceEEEEC---CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 468999999999863 6799998653 234567899999999884 332 445555543333 248999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 011158 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ------------------------------------------- 408 (492)
Q Consensus 372 ~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~------------------------------------------- 408 (492)
+|.+|.+... ..++..+...++.+++..|..||+
T Consensus 99 ~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 99 KGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp CCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred CCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 9988865432 246777788888888888888886
Q ss_pred ---------------CCceecCCCCCCEEEcc--CCCeEEEEEeeccee
Q 011158 409 ---------------NNIIHRDLKAANLLMDE--NEVSLLLSLCLFTVS 440 (492)
Q Consensus 409 ---------------~~IiHrDLKp~NILld~--~~~~kl~DFGla~~~ 440 (492)
..++|+|++|.|||++. .+.+.++||+.+...
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 13699999999999998 556789999988654
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.59 E-value=6.5e-07 Score=89.10 Aligned_cols=133 Identities=14% Similarity=0.118 Sum_probs=94.6
Q ss_pred eeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCC---ceeeEEEEEe-cCCeEEEEEeccCC
Q 011158 298 SKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK---NVVQFIGACT-KPPSLCIVTEFMSG 373 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~g~~~-~~~~~~lV~Ey~~g 373 (492)
+.++.|....||+. +..+++|+... ......+.+|..+|+.+.+. .+.+.+.++. ..+..++||||++|
T Consensus 25 ~~l~~G~~n~v~~v---g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 25 ESLGEGFRNYAILV---NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEECSSEEEEEE---TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eecCCCcceeEEEE---CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 56788888899987 78899998532 34457789999999999752 3667777764 44567899999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------------------------------------------
Q 011158 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN-------------------------------------------- 409 (492)
Q Consensus 374 gsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~-------------------------------------------- 409 (492)
.+|.+..- ..++......++.++...|..||+.
T Consensus 98 ~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 98 QILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp EECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred eECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 88876321 1234444445555555555555532
Q ss_pred ----------------CceecCCCCCCEEEcc---CCC-eEEEEEeeccee
Q 011158 410 ----------------NIIHRDLKAANLLMDE---NEV-SLLLSLCLFTVS 440 (492)
Q Consensus 410 ----------------~IiHrDLKp~NILld~---~~~-~kl~DFGla~~~ 440 (492)
.++|+|++|.|||++. ++. ..|+||+.+...
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 3599999999999997 344 479999988765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.49 E-value=1.2e-06 Score=84.77 Aligned_cols=132 Identities=15% Similarity=0.195 Sum_probs=95.2
Q ss_pred eeeecCce-EEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCeEEEEEeccCCC
Q 011158 299 KVASGSYG-DLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFMSGG 374 (492)
Q Consensus 299 ~LG~G~fG-~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~Ey~~gg 374 (492)
.+..|..| .||+.... +..+++|+-... ....+.+|..+|+.+. +--+.++++++...+..|+|||+++|.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 44556555 68987653 467999987532 3467888999999885 334778899999889999999999998
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------------
Q 011158 375 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ---------------------------------------------- 408 (492)
Q Consensus 375 sL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~---------------------------------------------- 408 (492)
++.+..... ......+..+++..|.-||+
T Consensus 106 ~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 106 TAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp EHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 887765431 11223445555555555552
Q ss_pred -----C-------CceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 409 -----N-------NIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 409 -----~-------~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
. .++|+|+.+.|||++.++..-|+||+.++..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 1 2789999999999998777779999988765
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.23 E-value=6.5e-07 Score=90.44 Aligned_cols=80 Identities=14% Similarity=0.042 Sum_probs=55.3
Q ss_pred eeee-eecCceEEEEEEEC--------CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCC---CceeeEEEEEecC--
Q 011158 297 GSKV-ASGSYGDLYRGTYC--------SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRH---KNVVQFIGACTKP-- 361 (492)
Q Consensus 297 ~~~L-G~G~fG~Vy~~~~~--------g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~H---pnIv~l~g~~~~~-- 361 (492)
.+.| +.|....+|+.... ++.+++|+...... .......+.+|+.+|+.+.. -.+.+++.++...
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4677 78888999998765 67899998754320 00001456788888888852 3577888887655
Q ss_pred -CeEEEEEeccCCCCH
Q 011158 362 -PSLCIVTEFMSGGSV 376 (492)
Q Consensus 362 -~~~~lV~Ey~~ggsL 376 (492)
+..|+||||++|.++
T Consensus 105 ~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVP 120 (357)
T ss_dssp TSSCEEEEECCCCBCC
T ss_pred cCCceEEEEecCCCCh
Confidence 356899999988654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.20 E-value=1.6e-05 Score=78.99 Aligned_cols=137 Identities=18% Similarity=0.185 Sum_probs=81.2
Q ss_pred eeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCC--CceeeEEE------EEecCCeEEEEEe
Q 011158 298 SKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH--KNVVQFIG------ACTKPPSLCIVTE 369 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~g------~~~~~~~~~lV~E 369 (492)
+.|+.|..+.||+....+..+++|+.... . ..+..|..+++.+.. -.+.+++. +....+..++||+
T Consensus 38 ~~l~gG~~n~~~~v~~~~~~~vlk~~~~~---~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSGAVCLKRIHRP---E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEETTEEEEEEEECSC---H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEeCCCCEEEEecCCC---H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 45666778899999887777999998752 2 334445555555531 12333332 1234567899999
Q ss_pred ccCCCCHH-----------HH---HHhcCC----C---------CCHHH-------------------------------
Q 011158 370 FMSGGSVY-----------DY---LHKLKG----V---------FKLPS------------------------------- 391 (492)
Q Consensus 370 y~~ggsL~-----------~~---L~~~~~----~---------l~~~~------------------------------- 391 (492)
|++|.++. .. ++.... + -.+..
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99886431 11 121111 0 01111
Q ss_pred HHHHHHHHHHHHHHHHH-------------CCceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 392 LLKVAIDVSKGMNYLHQ-------------NNIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 392 ~~~i~~qI~~gL~yLH~-------------~~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
+..+..++..++.+|+. ..++|+|+++.|||++.++.+.++||+.++..
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~g 253 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSFD 253 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcccC
Confidence 11111234445666652 57999999999999987888999999988654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.97 E-value=1.7e-05 Score=81.33 Aligned_cols=76 Identities=12% Similarity=-0.016 Sum_probs=49.8
Q ss_pred eeeeeecCceEEEEEEE--CCceEEEEEecCCCC--C---hHHHHHHHHHHHHHHhcCC--C-ceeeEEEEEecCCeEEE
Q 011158 297 GSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI--N---SDMQKEFAQEVFIMRKVRH--K-NVVQFIGACTKPPSLCI 366 (492)
Q Consensus 297 ~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~--~---~~~~~~~~~Ei~il~~l~H--p-nIv~l~g~~~~~~~~~l 366 (492)
.+.||.|.++.||+++. .++.++||....... . .....++..|..+++.+.. + .+.+++.+. .+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence 35789999999999954 467899998754211 0 0122456779999888742 3 345666543 344689
Q ss_pred EEeccCCC
Q 011158 367 VTEFMSGG 374 (492)
Q Consensus 367 V~Ey~~gg 374 (492)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00023 Score=71.05 Aligned_cols=75 Identities=16% Similarity=0.129 Sum_probs=61.3
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC---CCceeeEEEEEecCCeEEEEEeccCC
Q 011158 297 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNVVQFIGACTKPPSLCIVTEFMSG 373 (492)
Q Consensus 297 ~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~g~~~~~~~~~lV~Ey~~g 373 (492)
.+.|+.|.+..+|+....+..+++|+.... ....+..|...|+.+. ...+.+++.++...+..++||||++|
T Consensus 41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDEVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEECCSSSSEEEEEESSSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEeCCccceeeeEEEECCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 367899999999999877788999987632 2467889999998884 35688899988888889999999998
Q ss_pred CCH
Q 011158 374 GSV 376 (492)
Q Consensus 374 gsL 376 (492)
..+
T Consensus 116 ~~~ 118 (312)
T 3jr1_A 116 SKN 118 (312)
T ss_dssp CCC
T ss_pred CCC
Confidence 754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00016 Score=74.80 Aligned_cols=74 Identities=15% Similarity=0.138 Sum_probs=46.0
Q ss_pred eeeeecCceEEEEEEECCceEEEEEecCC-C-CCh-----HHHHHHHHHHHHHH-hcCCCceeeEEEEEecCCeEEEEEe
Q 011158 298 SKVASGSYGDLYRGTYCSQDVAIKVLKPE-R-INS-----DMQKEFAQEVFIMR-KVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~-~-~~~-----~~~~~~~~Ei~il~-~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
+.||.|..+.||++...++.++||...+. . ... .....+..|+..+. ......+.+++.+. .+..++|||
T Consensus 40 ~~l~~G~~n~vyrv~~~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv~e 117 (420)
T 2pyw_A 40 KEVGDGNLNFVFIVVGSSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIGMR 117 (420)
T ss_dssp EECCCSSSCEEEEEECSSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEEEC
T ss_pred EEccCCCcEEEEEEEcCCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEEEe
Confidence 57899999999999776788999943221 0 011 01233444443322 22334667777765 456799999
Q ss_pred cc-CC
Q 011158 370 FM-SG 373 (492)
Q Consensus 370 y~-~g 373 (492)
|+ ++
T Consensus 118 ~l~~g 122 (420)
T 2pyw_A 118 YLEPP 122 (420)
T ss_dssp CCCTT
T ss_pred ecCCc
Confidence 99 77
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00033 Score=69.79 Aligned_cols=135 Identities=11% Similarity=0.056 Sum_probs=73.3
Q ss_pred eeeecCceE-EEEEEEC-CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCC--CceeeEEEEEecCCeEEEEEeccCCC
Q 011158 299 KVASGSYGD-LYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH--KNVVQFIGACTKPPSLCIVTEFMSGG 374 (492)
Q Consensus 299 ~LG~G~fG~-Vy~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~g~~~~~~~~~lV~Ey~~gg 374 (492)
.|+.|.... +|+.+.. ++.+++|....... ..+..|+.+++.+.. -.+.+++.+....+ +++||++.+.
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~-----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~ 97 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG-----GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA 97 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTTT-----CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC-----ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence 455554444 6676653 66777776543210 234456777776642 23566777654443 7899999776
Q ss_pred CHHHHHHhcC-------------------------CCCCHHHHH-------H-HH------------HHHHHHHHHHH--
Q 011158 375 SVYDYLHKLK-------------------------GVFKLPSLL-------K-VA------------IDVSKGMNYLH-- 407 (492)
Q Consensus 375 sL~~~L~~~~-------------------------~~l~~~~~~-------~-i~------------~qI~~gL~yLH-- 407 (492)
++.+++.... ..+...... . +. ..+...+..+-
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 7765543210 011221110 0 00 01112223331
Q ss_pred ----HCCceecCCCCCCEEEccC----CCeEEEEEeeccee
Q 011158 408 ----QNNIIHRDLKAANLLMDEN----EVSLLLSLCLFTVS 440 (492)
Q Consensus 408 ----~~~IiHrDLKp~NILld~~----~~~kl~DFGla~~~ 440 (492)
...++|+|+.+.|||++.+ +.+.++||+++...
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 2369999999999999874 67899999998765
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00054 Score=67.65 Aligned_cols=141 Identities=13% Similarity=0.154 Sum_probs=81.7
Q ss_pred eeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCc--eeeEEEE------EecCCeEEEE
Q 011158 296 FGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN--VVQFIGA------CTKPPSLCIV 367 (492)
Q Consensus 296 ~~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~g~------~~~~~~~~lV 367 (492)
-.+.|+.|....+|+....+..+++|+..... . ...+..|+.+++.+.... +.+++.. ....+..+++
T Consensus 26 ~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~-~---~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l 101 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTTKDPLILTLYEKRV-E---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAAL 101 (322)
T ss_dssp EEEEECC---EEEEEEEESSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred EeeccCCCcccceEEEEeCCccEEEEEeCCCC-C---HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEE
Confidence 34677888889999998776789999987521 1 134556777777764222 2333321 1223567899
Q ss_pred EeccCCCCHH-----------HH---HHhcCC----C----CC---HHHHHH------------HHHHHHHHHHHHHH--
Q 011158 368 TEFMSGGSVY-----------DY---LHKLKG----V----FK---LPSLLK------------VAIDVSKGMNYLHQ-- 408 (492)
Q Consensus 368 ~Ey~~ggsL~-----------~~---L~~~~~----~----l~---~~~~~~------------i~~qI~~gL~yLH~-- 408 (492)
|+|++|..+. .. ++.... . .. |..... +...+...+.++..
T Consensus 102 ~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~ 181 (322)
T 2ppq_A 102 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW 181 (322)
T ss_dssp EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred EEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhC
Confidence 9999875431 11 122110 0 11 111000 00123445566653
Q ss_pred -----CCceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 409 -----NNIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 409 -----~~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
.+++|+|+.+.|||++.++.+.++||+.+...
T Consensus 182 ~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~g 218 (322)
T 2ppq_A 182 PKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACND 218 (322)
T ss_dssp CCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred cccCCcccCCCCCCccCEEEeCCceEEEecchhccCc
Confidence 36899999999999998766679999888654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.23 E-value=0.00054 Score=67.33 Aligned_cols=134 Identities=16% Similarity=0.182 Sum_probs=74.9
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCce-eeEEEEEecCCeEEEEEecc-CCC
Q 011158 297 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV-VQFIGACTKPPSLCIVTEFM-SGG 374 (492)
Q Consensus 297 ~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~lV~Ey~-~gg 374 (492)
.+.|+.|....+|+. +.+++|+....... .....+|+.+++.+....+ .++++.+ .+.-++|+||+ +|.
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~---~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEE---YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee----eeEEEECCCCCccc---eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence 468888999999998 67999988653110 1122457777777643222 4555543 33347899999 654
Q ss_pred CHHH---------------HH---HhcCCCC----C-HHHHHHHHH--------------HHHHHHHHHH----H----C
Q 011158 375 SVYD---------------YL---HKLKGVF----K-LPSLLKVAI--------------DVSKGMNYLH----Q----N 409 (492)
Q Consensus 375 sL~~---------------~L---~~~~~~l----~-~~~~~~i~~--------------qI~~gL~yLH----~----~ 409 (492)
+|.. .| +.....+ . ...+..+.. .+...+..+. . .
T Consensus 94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~ 173 (301)
T 3dxq_A 94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL 173 (301)
T ss_dssp ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence 4421 11 1111111 1 111111111 1111122221 1 1
Q ss_pred CceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 410 NIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 410 ~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
.++|+|+.+.||| ..++.+.++||..++..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 3899999999999 55667899999887654
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.18 E-value=0.001 Score=64.79 Aligned_cols=78 Identities=14% Similarity=0.130 Sum_probs=55.2
Q ss_pred CCceeeeeeeecCceEEEEEEE-CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCC---CceeeEEEEEecCCeEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH---KNVVQFIGACTKPPSLCIV 367 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~H---pnIv~l~g~~~~~~~~~lV 367 (492)
..+.-.+.+|.|..+.||+.+. .|+.|.+|+....... ....|..|...|+.+.- --+.+++++. .-++|
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv 88 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPA--LDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLA 88 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCC--CTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcc--hhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEE
Confidence 3445568899999999999988 4789999987644221 22457889999998842 2355566543 23789
Q ss_pred EeccCCCC
Q 011158 368 TEFMSGGS 375 (492)
Q Consensus 368 ~Ey~~ggs 375 (492)
|||+.++.
T Consensus 89 ~e~l~~~~ 96 (288)
T 3f7w_A 89 MEWVDERP 96 (288)
T ss_dssp EECCCCCC
T ss_pred EEeecccC
Confidence 99997764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.00 E-value=0.0037 Score=61.75 Aligned_cols=136 Identities=15% Similarity=0.140 Sum_probs=78.7
Q ss_pred eeeecCceEEEEEEEC-CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCC--ceeeEEEE-----EecCCeEEEEEec
Q 011158 299 KVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK--NVVQFIGA-----CTKPPSLCIVTEF 370 (492)
Q Consensus 299 ~LG~G~fG~Vy~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~g~-----~~~~~~~~lV~Ey 370 (492)
.|+ |....||+.... |+.+++|+......+ ...+..|..+++.+... .+++++.. ....+..+++|+|
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCCC---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence 455 777889988663 567999998754332 24566788888777422 24444443 1224567899999
Q ss_pred cCCCCHH-----------HHH---Hhc--C------CCCCHHHH----HHHH---------------HHHHHHHHHHH--
Q 011158 371 MSGGSVY-----------DYL---HKL--K------GVFKLPSL----LKVA---------------IDVSKGMNYLH-- 407 (492)
Q Consensus 371 ~~ggsL~-----------~~L---~~~--~------~~l~~~~~----~~i~---------------~qI~~gL~yLH-- 407 (492)
++|..+. ..| +.. . ..++.... ..++ ..+...+..+.
T Consensus 109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 188 (328)
T 1zyl_A 109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH 188 (328)
T ss_dssp CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence 9874321 111 111 0 01222111 0010 01111223332
Q ss_pred -----HCCceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 408 -----QNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 408 -----~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
...++|+|+++.|||++ + .+.++||..++..
T Consensus 189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 23589999999999999 4 7899999888765
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.63 E-value=0.0016 Score=65.82 Aligned_cols=71 Identities=13% Similarity=0.181 Sum_probs=43.3
Q ss_pred eeeeecCceEEEEEEECC----------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCc-eeeEEEEEecCCeEEE
Q 011158 298 SKVASGSYGDLYRGTYCS----------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN-VVQFIGACTKPPSLCI 366 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~g----------~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~g~~~~~~~~~l 366 (492)
+.|+.|..-.+|+....+ +.+++|+..... ........|..+++.+...+ +.++++.. .+ ++
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~ 111 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GR 111 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEec--CC--cE
Confidence 567778888999998754 678899875431 11112356888888775333 44666554 22 68
Q ss_pred EEeccCCCC
Q 011158 367 VTEFMSGGS 375 (492)
Q Consensus 367 V~Ey~~ggs 375 (492)
||||++|.+
T Consensus 112 v~e~i~G~~ 120 (369)
T 3c5i_A 112 IEEWLYGDP 120 (369)
T ss_dssp EEECCCSEE
T ss_pred EEEEecCCc
Confidence 999998753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.59 E-value=0.0054 Score=63.72 Aligned_cols=70 Identities=13% Similarity=0.242 Sum_probs=48.1
Q ss_pred eeeeeecCceEEEEEEEC---------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCce-eeEEEEEecCCeEEE
Q 011158 297 GSKVASGSYGDLYRGTYC---------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV-VQFIGACTKPPSLCI 366 (492)
Q Consensus 297 ~~~LG~G~fG~Vy~~~~~---------g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~l 366 (492)
.+.|+.|-...+|++... ++.+++|+..... . ...+..|..+++.+...++ .++++.+.+ .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence 357888888999999874 4679999984321 1 1345579998888853333 567776542 38
Q ss_pred EEeccCCC
Q 011158 367 VTEFMSGG 374 (492)
Q Consensus 367 V~Ey~~gg 374 (492)
|+||++|.
T Consensus 150 v~e~l~G~ 157 (429)
T 1nw1_A 150 LEEYIPSR 157 (429)
T ss_dssp EECCCCEE
T ss_pred EEEEeCCc
Confidence 99999763
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.52 E-value=0.0049 Score=63.09 Aligned_cols=136 Identities=12% Similarity=0.199 Sum_probs=81.1
Q ss_pred eeeeecCceEEEEEEEC---------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCeEEEE
Q 011158 298 SKVASGSYGDLYRGTYC---------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIV 367 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~---------g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV 367 (492)
+.|..|-...+|++... ++.+++|+..... .....+.+|..+++.+. +.-..++++.+.+ .+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL---QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 45666777788988763 3679999863321 12355668999988875 3223566766643 289
Q ss_pred EeccCCCCHH--------------HHH---HhcC----CCCC--HHHHHHHHHHHHH-------------------HHHH
Q 011158 368 TEFMSGGSVY--------------DYL---HKLK----GVFK--LPSLLKVAIDVSK-------------------GMNY 405 (492)
Q Consensus 368 ~Ey~~ggsL~--------------~~L---~~~~----~~l~--~~~~~~i~~qI~~-------------------gL~y 405 (492)
|||++|.+|. +.| +... .... +.++.++..++.. .+..
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 9999875432 111 1111 1112 3455555544422 2344
Q ss_pred HHH----C----CceecCCCCCCEEEccC----CCeEEEEEeeccee
Q 011158 406 LHQ----N----NIIHRDLKAANLLMDEN----EVSLLLSLCLFTVS 440 (492)
Q Consensus 406 LH~----~----~IiHrDLKp~NILld~~----~~~kl~DFGla~~~ 440 (492)
|.. . .++|+|+.+.|||++.+ +.+.++||..++..
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~ 255 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYN 255 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcC
Confidence 432 2 58999999999999876 68899999888754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.35 E-value=0.012 Score=58.93 Aligned_cols=31 Identities=19% Similarity=0.304 Sum_probs=27.8
Q ss_pred CceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 410 NIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 410 ~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
.++|+|+.+.|||++.++.+.++||..++..
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 5899999999999998888999999888765
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.15 E-value=0.022 Score=59.72 Aligned_cols=73 Identities=19% Similarity=0.146 Sum_probs=47.7
Q ss_pred eeeeeecCceEEEEEEECC--ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCce-eeEEEEEecCCeEEEEEeccCC
Q 011158 297 GSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV-VQFIGACTKPPSLCIVTEFMSG 373 (492)
Q Consensus 297 ~~~LG~G~fG~Vy~~~~~g--~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~lV~Ey~~g 373 (492)
.+.|+.|-...+|++...+ ..+++|+..... .. .-...+|..+++.+...++ .++++.+. + .+||||++|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~--~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DE--IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CS--CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hh--hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCC
Confidence 3578888889999999876 789999875431 11 0112578889998865444 56777763 2 259999987
Q ss_pred CCH
Q 011158 374 GSV 376 (492)
Q Consensus 374 gsL 376 (492)
.+|
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 433
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.83 E-value=0.19 Score=51.97 Aligned_cols=71 Identities=13% Similarity=0.175 Sum_probs=46.0
Q ss_pred eeeeecCceEEEEEEEC---------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCeEEEE
Q 011158 298 SKVASGSYGDLYRGTYC---------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIV 367 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~---------g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV 367 (492)
+.|..|-...+|+.... ++.+++|+..... ...-...+|..+++.+. +.-..++++.+. + ++|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~~--~--~~I 148 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADFP--E--GRI 148 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEET--T--EEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--CEE
Confidence 56677778889998875 5789999865431 11112356888888774 222455665432 2 789
Q ss_pred EeccCCCC
Q 011158 368 TEFMSGGS 375 (492)
Q Consensus 368 ~Ey~~ggs 375 (492)
|||++|.+
T Consensus 149 ~efI~G~~ 156 (424)
T 3mes_A 149 EEFIDGEP 156 (424)
T ss_dssp EECCCSEE
T ss_pred EEEeCCcc
Confidence 99998865
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=91.12 E-value=0.02 Score=63.59 Aligned_cols=42 Identities=14% Similarity=0.150 Sum_probs=27.8
Q ss_pred CCCCCCCCCcchhhhhccccCCCCC----------CCCCCccCCcCCCCcce
Q 011158 139 HPPPAFGSSPNLEALAIEANNSHNL----------DGDNSVHANVQFSRPMH 180 (492)
Q Consensus 139 ~~pp~~g~~~~l~~L~l~~n~~~g~----------~~~~~~~n~~l~~~~~~ 180 (492)
..|.+|+++++|+.|+|++|+++|. ...+|.||++|||.|+.
T Consensus 695 ~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~ 746 (768)
T 3rgz_A 695 RIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP 746 (768)
T ss_dssp CCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC
T ss_pred cCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCc
Confidence 3455566666666666666666654 33457788888888865
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=90.87 E-value=0.018 Score=60.47 Aligned_cols=60 Identities=8% Similarity=0.029 Sum_probs=16.9
Q ss_pred eeeeeecCceEEEEEEECC--ceEEE------EEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Q 011158 297 GSKVASGSYGDLYRGTYCS--QDVAI------KVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359 (492)
Q Consensus 297 ~~~LG~G~fG~Vy~~~~~g--~~vAv------K~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~ 359 (492)
.++|| ||.||+|.+.+ .+||| |..+......+....|.+|..++++++|+|+++.+++..
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 35666 99999999865 57888 777655555555667889999999999999999988753
|
| >1u8s_A Glycine cleavage system transcriptional repressor, putative; structural genomics, protein structure initiative (PSI), domain swapping; 2.45A {Vibrio cholerae} SCOP: d.58.18.5 d.58.18.5 | Back alignment and structure |
|---|
Probab=80.56 E-value=2.4 Score=38.28 Aligned_cols=62 Identities=18% Similarity=0.318 Sum_probs=47.4
Q ss_pred eeeEEecCCCcchhhhhhhhhcccccceeeeeccccCCCceEEEEEEcCCCcchHHHHHHHHHH
Q 011158 180 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEK 243 (492)
Q Consensus 180 ~e~~~s~~~~p~~ls~l~~~l~~~~l~i~~A~~fst~dg~sl~v~vv~~w~~e~~~~l~~~l~~ 243 (492)
..+++...|+|.+.+.++..|++.|+||.++..+.+.+++.+ .++|.. +....+++++.+..
T Consensus 7 ~~itv~~~DrpGiva~vt~~La~~g~NI~d~~~~~~~~~f~~-~~~v~~-~~~~~~~l~~~L~~ 68 (192)
T 1u8s_A 7 LVITAVGTDRPGICNEVVRLVTQAGCNIIDSRIAMFGKEFTL-LMLISG-SPSNITRVETTLPL 68 (192)
T ss_dssp EEEEEEEECCTTHHHHHHHHHHHTTCEEEEEEEEEETTEEEE-EEEEEE-CHHHHHHHHHHHHH
T ss_pred EEEEEEcCCCCcHHHHHHHHHHHCCCCEEeeeeeecCCceEE-EEEEec-CCCCHHHHHHHHHH
Confidence 568999999999999999999999999999999998877777 444432 22344555555543
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 492 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-46 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-40 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-37 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-36 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-35 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-35 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-35 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-34 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-34 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-34 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-33 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-33 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-32 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-32 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-32 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-32 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-32 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-32 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-32 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-32 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-30 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-30 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-30 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-30 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-30 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-30 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-29 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-29 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-29 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-28 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-28 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-28 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-28 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 9e-28 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-28 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 9e-27 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-26 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-26 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-25 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-25 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-24 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-24 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-24 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-23 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-23 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-23 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-23 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-23 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-23 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-23 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-22 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-22 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-22 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-21 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-21 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-21 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-20 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-20 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-20 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-20 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-19 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-14 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-12 | |
| d1ygya3 | 78 | d.58.18.1 (A:452-529) Phosphoglycerate dehydrogena | 9e-05 | |
| d1u8sa1 | 86 | d.58.18.5 (A:2-87) putative transcriptional repres | 9e-05 | |
| d1sc6a3 | 84 | d.58.18.1 (A:327-410) Phosphoglycerate dehydrogena | 1e-04 | |
| d1y7pa2 | 77 | d.58.18.12 (A:2-78) Hypothetical protein AF1403, N | 4e-04 | |
| d1zpva1 | 83 | d.58.18.7 (A:1-83) UPF0237 protein SP0238 {Strepto | 9e-04 | |
| d2pc6a2 | 77 | d.58.18.6 (A:1-77) Acetolactate synthase small sub | 0.001 | |
| d2f06a1 | 71 | d.58.18.11 (A:71-141) Hypothetical protein BT0572 | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (402), Expect = 8e-46
Identities = 54/142 (38%), Positives = 87/142 (61%), Gaps = 2/142 (1%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMR 344
D WEI + G ++ SGS+G +Y+G + DVA+K+L + F EV ++R
Sbjct: 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 345 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 404
K RH N++ F+G T P L IVT++ G S+Y +LH ++ F++ L+ +A ++GM+
Sbjct: 60 KTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 405 YLHQNNIIHRDLKAANLLMDEN 426
YLH +IIHRDLK+ N+ + E+
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHED 140
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 2e-40
Identities = 54/144 (37%), Positives = 80/144 (55%), Gaps = 6/144 (4%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 346
W ++ K LK + G +GD+ G Y VA+K +K N + F E +M ++
Sbjct: 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQL 57
Query: 347 RHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMN 404
RH N+VQ +G + L IVTE+M+ GS+ DYL + + V LLK ++DV + M
Sbjct: 58 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117
Query: 405 YLHQNNIIHRDLKAANLLMDENEV 428
YL NN +HRDL A N+L+ E+ V
Sbjct: 118 YLEGNNFVHRDLAARNVLVSEDNV 141
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 5e-37
Identities = 45/144 (31%), Positives = 84/144 (58%), Gaps = 6/144 (4%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIM 343
D WE+ + LK ++ +G +G+++ G Y VA+K LK ++ F E +M
Sbjct: 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLM 62
Query: 344 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKG 402
++++H+ +V+ T+ P + I+TE+M GS+ D+L G+ + LL +A +++G
Sbjct: 63 KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 403 MNYLHQNNIIHRDLKAANLLMDEN 426
M ++ + N IHRDL+AAN+L+ +
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDT 145
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 5e-36
Identities = 50/149 (33%), Positives = 84/149 (56%), Gaps = 4/149 (2%)
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR 347
IDPK L F ++ +G +G + G + DVAIK++K ++ + EF +E +M +
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLS 57
Query: 348 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 407
H+ +VQ G CTK + I+TE+M+ G + +YL +++ F+ LL++ DV + M YL
Sbjct: 58 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 408 QNNIIHRDLKAANLLMDENEVSLLLSLCL 436
+HRDL A N L+++ V + L
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGL 146
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (329), Expect = 2e-35
Identities = 52/139 (37%), Positives = 84/139 (60%), Gaps = 4/139 (2%)
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTYCSQD-VAIKVLKPERINSDMQKEFAQEVFIMRKVR 347
IDP L F ++ SG +G ++ G + ++D VAIK ++ ++ +++F +E +M K+
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLS 58
Query: 348 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 407
H +VQ G C + +C+V EFM G + DYL +G+F +LL + +DV +GM YL
Sbjct: 59 HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 408 QNNIIHRDLKAANLLMDEN 426
+ +IHRDL A N L+ EN
Sbjct: 119 EACVIHRDLAARNCLVGEN 137
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 3e-35
Identities = 45/176 (25%), Positives = 77/176 (43%), Gaps = 28/176 (15%)
Query: 278 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINS 330
++P D WE L FG + +G++G + T VA+K+LKP +
Sbjct: 11 QLPYD--HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HL 67
Query: 331 DMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK----- 384
++ E+ ++ + H N+V +GACT ++TE+ G + ++L + +
Sbjct: 68 TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 127
Query: 385 ------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428
L LL + V+KGM +L N IHRDL A N+L+ +
Sbjct: 128 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI 183
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 130 bits (328), Expect = 4e-35
Identities = 54/145 (37%), Positives = 84/145 (57%), Gaps = 6/145 (4%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 342
D WE++ + K+ G YG++Y G + S VA+K LK + + +EF +E +
Sbjct: 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAV 66
Query: 343 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 401
M++++H N+VQ +G CT+ P I+TEFM+ G++ DYL + + LL +A +S
Sbjct: 67 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 126
Query: 402 GMNYLHQNNIIHRDLKAANLLMDEN 426
M YL + N IHRDL A N L+ EN
Sbjct: 127 AMEYLEKKNFIHRDLAARNCLVGEN 151
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 1e-34
Identities = 56/144 (38%), Positives = 89/144 (61%), Gaps = 6/144 (4%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIM 343
D WEI + L+ K+ G +G+++ GT+ VAIK LKP ++ + F QE +M
Sbjct: 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVM 66
Query: 344 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKG 402
+K+RH+ +VQ ++ P + IVTE+MS GS+ D+L G +LP L+ +A ++ G
Sbjct: 67 KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 125
Query: 403 MNYLHQNNIIHRDLKAANLLMDEN 426
M Y+ + N +HRDL+AAN+L+ EN
Sbjct: 126 MAYVERMNYVHRDLRAANILVGEN 149
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 1e-34
Identities = 46/170 (27%), Positives = 79/170 (46%), Gaps = 31/170 (18%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRG-------TYCSQDVAIKVLKPERINSDMQKEFAQE 339
WE ++L+FG + SG++G + T S VA+K+LK E+ +S ++ E
Sbjct: 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK-EKADSSEREALMSE 90
Query: 340 VFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK-------------- 384
+ +M ++ H+N+V +GACT + ++ E+ G + +YL +
Sbjct: 91 LKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 150
Query: 385 --------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
V LL A V+KGM +L + +HRDL A N+L+
Sbjct: 151 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG 200
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 2e-34
Identities = 38/142 (26%), Positives = 72/142 (50%), Gaps = 5/142 (3%)
Query: 288 EIDPK-HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMR 344
+++P+ + ++ G++G +Y+ S A KV+ + + + +++ E+ I+
Sbjct: 7 DLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILA 64
Query: 345 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 404
H N+V+ + A +L I+ EF +GG+V + +L+ + V +N
Sbjct: 65 SCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALN 124
Query: 405 YLHQNNIIHRDLKAANLLMDEN 426
YLH N IIHRDLKA N+L +
Sbjct: 125 YLHDNKIIHRDLKAGNILFTLD 146
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 2e-33
Identities = 51/144 (35%), Positives = 79/144 (54%), Gaps = 7/144 (4%)
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINS-DMQKEFAQEVFI 342
I K L+ K+ GS+G + RG + + VA+K LKP+ ++ + +F +EV
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 343 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 402
M + H+N+++ G PP + +VTE GS+ D L K +G F L +L + A+ V++G
Sbjct: 65 MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 403 MNYLHQNNIIHRDLKAANLLMDEN 426
M YL IHRDL A NLL+
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATR 147
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (311), Expect = 6e-33
Identities = 33/143 (23%), Positives = 65/143 (45%), Gaps = 6/143 (4%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINS-DMQKEFAQEVFIM 343
W ++ + G + G +G++Y +A+KVL ++ ++ + +EV I
Sbjct: 3 WALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 60
Query: 344 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 403
+RH N+++ G + ++ E+ G+VY L K F +++ +
Sbjct: 61 SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANAL 119
Query: 404 NYLHQNNIIHRDLKAANLLMDEN 426
+Y H +IHRD+K NLL+
Sbjct: 120 SYCHSKRVIHRDIKPENLLLGSA 142
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 2e-32
Identities = 44/147 (29%), Positives = 77/147 (52%), Gaps = 7/147 (4%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQEVF 341
+EI + ++ G + G +GD+++G Y S + VAIK K + ++++F QE
Sbjct: 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEAL 60
Query: 342 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 401
MR+ H ++V+ IG T+ P + I+ E + G + +L K L SL+ A +S
Sbjct: 61 TMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 119
Query: 402 GMNYLHQNNIIHRDLKAANLLMDENEV 428
+ YL +HRD+ A N+L+ N+
Sbjct: 120 ALAYLESKRFVHRDIAARNVLVSSNDC 146
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 123 bits (309), Expect = 2e-32
Identities = 50/160 (31%), Positives = 78/160 (48%), Gaps = 8/160 (5%)
Query: 274 PYHLKIPNDGTD--VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPE 326
P+ + PN+ EID +K + +G +G++ G VAIK LK
Sbjct: 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG 65
Query: 327 RINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV 386
+++F E IM + H NV+ G TK + I+TEFM GS+ +L + G
Sbjct: 66 Y-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ 124
Query: 387 FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
F + L+ + ++ GM YL N +HRDL A N+L++ N
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSN 164
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 3e-32
Identities = 41/145 (28%), Positives = 70/145 (48%), Gaps = 7/145 (4%)
Query: 287 WEIDPKHLKFGS-KVASGSYGDLYRGTYCS----QDVAIKVLKPERINSDMQKEFAQEVF 341
+ +L ++ G++G + +G Y DVAIKVLK +E +E
Sbjct: 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQ 61
Query: 342 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 401
IM ++ + +V+ IG C L +V E GG ++ +L + + ++ ++ VS
Sbjct: 62 IMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 120
Query: 402 GMNYLHQNNIIHRDLKAANLLMDEN 426
GM YL + N +HRDL A N+L+
Sbjct: 121 GMKYLEEKNFVHRDLAARNVLLVNR 145
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 4e-32
Identities = 41/157 (26%), Positives = 73/157 (46%), Gaps = 7/157 (4%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ G+YG++ + VA+K++ +R D + +E+ I + + H+NVV
Sbjct: 8 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVV 66
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
+F G + + E+ SGG ++D + P + + G+ YLH I
Sbjct: 67 KFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGIT 125
Query: 413 HRDLKAANLLMDENEVSLLLSLCLFTVSILFCGKGRE 449
HRD+K NLL+DE + L + F ++ +F RE
Sbjct: 126 HRDIKPENLLLDERDN---LKISDFGLATVFRYNNRE 159
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 5e-32
Identities = 38/142 (26%), Positives = 73/142 (51%), Gaps = 5/142 (3%)
Query: 288 EIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRK 345
E+ + S++ +G+ G +++ ++ +A K++ E I ++ + +E+ ++ +
Sbjct: 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHE 60
Query: 346 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 405
+V F GA + I E M GGS+ L K G L KV+I V KG+ Y
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTY 119
Query: 406 LHQ-NNIIHRDLKAANLLMDEN 426
L + + I+HRD+K +N+L++
Sbjct: 120 LREKHKIMHRDVKPSNILVNSR 141
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 5e-32
Identities = 43/143 (30%), Positives = 74/143 (51%), Gaps = 7/143 (4%)
Query: 289 IDPKHLKFGSKV-ASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIM 343
+D K L K SG++G + +G Y + VA+K+LK E + ++ E E +M
Sbjct: 3 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 62
Query: 344 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 403
+++ + +V+ IG C S +V E G + YL + K +++++ VS GM
Sbjct: 63 QQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGM 120
Query: 404 NYLHQNNIIHRDLKAANLLMDEN 426
YL ++N +HRDL A N+L+
Sbjct: 121 KYLEESNFVHRDLAARNVLLVTQ 143
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 5e-32
Identities = 40/153 (26%), Positives = 75/153 (49%), Gaps = 9/153 (5%)
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV 346
D + LKF ++ GS+ +Y+G +VA L+ ++ ++ F +E +++ +
Sbjct: 6 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL 65
Query: 347 RHKNVVQFIGACTKP----PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 402
+H N+V+F + + +VTE M+ G++ YL + V K+ L + KG
Sbjct: 66 QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKG 124
Query: 403 MNYLHQNN--IIHRDLKAANLLMDENEVSLLLS 433
+ +LH IIHRDLK N+ + S+ +
Sbjct: 125 LQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIG 157
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 122 bits (307), Expect = 6e-32
Identities = 40/151 (26%), Positives = 74/151 (49%), Gaps = 5/151 (3%)
Query: 280 PNDGTDVWEIDPKHL-KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQ-KE 335
P+ ++ DP+ L ++ GS+G +Y + VAIK + S+ + ++
Sbjct: 2 PDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD 61
Query: 336 FAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKV 395
+EV ++K+RH N +Q+ G + + +V E+ G + K + + V
Sbjct: 62 IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH-KKPLQEVEIAAV 120
Query: 396 AIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
+G+ YLH +N+IHRD+KA N+L+ E
Sbjct: 121 THGALQGLAYLHSHNMIHRDVKAGNILLSEP 151
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 119 bits (300), Expect = 1e-30
Identities = 36/163 (22%), Positives = 72/163 (44%), Gaps = 9/163 (5%)
Query: 287 WEIDPKHL----KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEV 340
EI H+ ++ +G++G ++R T + + A K + + ++ +E+
Sbjct: 17 VEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEI 74
Query: 341 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS 400
M +RH +V A + ++ EFMSGG +++ + ++ V
Sbjct: 75 QTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 134
Query: 401 KGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSILF 443
KG+ ++H+NN +H DLK N++ S L L F ++
Sbjct: 135 KGLCHMHENNYVHLDLKPENIMFTTKR-SNELKLIDFGLTAHL 176
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 119 bits (299), Expect = 1e-30
Identities = 24/153 (15%), Positives = 67/153 (43%), Gaps = 5/153 (3%)
Query: 293 HLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN 350
+ ++ SG++G ++R + + K + + E+ IM ++ H
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--KYTVKNEISIMNQLHHPK 87
Query: 351 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 410
++ A + ++ EF+SGG ++D + ++ +G+ ++H+++
Sbjct: 88 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 147
Query: 411 IIHRDLKAANLLMDENEVSLLLSLCLFTVSILF 443
I+H D+K N++ + + + + + F ++
Sbjct: 148 IVHLDIKPENIMCETKK-ASSVKIIDFGLATKL 179
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 3e-30
Identities = 48/184 (26%), Positives = 82/184 (44%), Gaps = 28/184 (15%)
Query: 279 IPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERIN 329
+P D WE+ L G + G++G + D VA+K+LK +
Sbjct: 2 LPED--PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE 59
Query: 330 SDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH------- 381
D+ + E+ +M+ + +HKN++ +GACT+ L ++ E+ S G++ +YL
Sbjct: 60 KDL-SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 118
Query: 382 --------KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLS 433
+ L+ A V++GM YL IHRDL A N+L+ E+ V +
Sbjct: 119 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIAD 178
Query: 434 LCLF 437
L
Sbjct: 179 FGLA 182
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 6e-30
Identities = 39/169 (23%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFA 337
D WE+ + + ++ GS+G +Y G VAIK + + + EF
Sbjct: 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE-RIEFL 71
Query: 338 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--------- 388
E +M++ +VV+ +G ++ ++ E M+ G + YL L+
Sbjct: 72 NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 131
Query: 389 LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLF 437
L ++++A +++ GM YL+ N +HRDL A N ++ E+ + +
Sbjct: 132 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT 180
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 6e-30
Identities = 43/146 (29%), Positives = 74/146 (50%), Gaps = 7/146 (4%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEV 340
EI P + + +G +G++Y+G + VAIK LK + +F E
Sbjct: 2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEA 60
Query: 341 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS 400
IM + H N+++ G +K + I+TE+M G++ +L + G F + L+ + ++
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120
Query: 401 KGMNYLHQNNIIHRDLKAANLLMDEN 426
GM YL N +HRDL A N+L++ N
Sbjct: 121 AGMKYLANMNYVHRDLAARNILVNSN 146
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 6e-30
Identities = 49/171 (28%), Positives = 74/171 (43%), Gaps = 24/171 (14%)
Query: 279 IPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-------VAIKVLKPERINSD 331
+P D WE LK G + G++G + D VA+K+LK +S+
Sbjct: 1 LPYD-ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE 59
Query: 332 MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLHK-------- 382
+ ++ ++ H NVV +GACTKP L ++ EF G++ YL
Sbjct: 60 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 119
Query: 383 -------LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
K L L+ + V+KGM +L IHRDL A N+L+ E
Sbjct: 120 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 170
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 1e-29
Identities = 48/169 (28%), Positives = 78/169 (46%), Gaps = 21/169 (12%)
Query: 288 EIDPKHLKFGSKVASGSYGDLYRGTYCS----QDVAIKVLKPERINSDMQKEFAQEVFIM 343
+D +KF + G++G + + D AIK +K + D ++FA E+ ++
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVL 64
Query: 344 RKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHK---------------LKGVF 387
K+ H N++ +GAC L + E+ G++ D+L K
Sbjct: 65 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124
Query: 388 KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCL 436
LL A DV++GM+YL Q IHRDL A N+L+ EN V+ + L
Sbjct: 125 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 173
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 1e-29
Identities = 34/140 (24%), Positives = 71/140 (50%), Gaps = 7/140 (5%)
Query: 290 DP-KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV 346
DP K K+ G+ G +Y + Q+VAI+ + + ++ E+ +MR+
Sbjct: 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMREN 74
Query: 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 406
++ N+V ++ + L +V E+++GGS+ D + + + V + + + +L
Sbjct: 75 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFL 132
Query: 407 HQNNIIHRDLKAANLLMDEN 426
H N +IHRD+K+ N+L+ +
Sbjct: 133 HSNQVIHRDIKSDNILLGMD 152
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 113 bits (284), Expect = 6e-29
Identities = 39/170 (22%), Positives = 75/170 (44%), Gaps = 31/170 (18%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQE 339
E ++++ + G++G +++ VA+K+LK E ++DMQ +F +E
Sbjct: 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQRE 66
Query: 340 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-------------- 385
+M + + N+V+ +G C +C++ E+M+ G + ++L +
Sbjct: 67 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 386 ---------VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
L +A V+ GM YL + +HRDL N L+ EN
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGEN 176
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 1e-28
Identities = 26/139 (18%), Positives = 59/139 (42%), Gaps = 5/139 (3%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ G +G ++R S + K +K + Q +E+ I+ RH+N++
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNIL 64
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
+ L ++ EF+SG +++ ++ ++ V + + +LH +NI
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124
Query: 413 HRDLKAANLLMDENEVSLL 431
H D++ N++ S +
Sbjct: 125 HFDIRPENIIYQTRRSSTI 143
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 1e-28
Identities = 31/146 (21%), Positives = 65/146 (44%), Gaps = 12/146 (8%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ + +GSYG + S + + K L + ++ EV ++R+++H N+V
Sbjct: 7 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 66
Query: 353 QFIGACTKPPS--LCIVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLH 407
++ + L IV E+ GG + + K + +L+V ++ + H
Sbjct: 67 RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126
Query: 408 Q-----NNIIHRDLKAANLLMDENEV 428
+ + ++HRDLK AN+ +D +
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQN 152
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 1e-28
Identities = 34/142 (23%), Positives = 60/142 (42%), Gaps = 4/142 (2%)
Query: 288 EIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSD-MQKEFAQEVFIMR 344
+ P+ KFG + GS+ + + ++ AIK+L+ I + +E +M
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 345 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 404
++ H V+ L + G + Y+ K G F ++ +
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALE 122
Query: 405 YLHQNNIIHRDLKAANLLMDEN 426
YLH IIHRDLK N+L++E+
Sbjct: 123 YLHGKGIIHRDLKPENILLNED 144
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 7e-28
Identities = 36/147 (24%), Positives = 75/147 (51%), Gaps = 17/147 (11%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV 351
+ + + G +G+++RG + ++VA+K+ + E++ +RH+N+
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENI 59
Query: 352 VQFIGACTKP----PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 407
+ FI A K L +V+++ GS++DYL+ + + ++K+A+ + G+ +LH
Sbjct: 60 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLH 117
Query: 408 Q--------NNIIHRDLKAANLLMDEN 426
I HRDLK+ N+L+ +N
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKN 144
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 109 bits (274), Expect = 9e-28
Identities = 37/158 (23%), Positives = 67/158 (42%), Gaps = 12/158 (7%)
Query: 291 PKHL----KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINS-DMQKEFAQEVFIM 343
P HL + G + G +++ +DVA+KVL+ + F +E
Sbjct: 2 PSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNA 61
Query: 344 RKVRHKNVVQFIGAC----TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 399
+ H +V P IV E++ G ++ D +H +G ++V D
Sbjct: 62 AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADA 120
Query: 400 SKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLF 437
+ +N+ HQN IIHRD+K AN+++ ++ +
Sbjct: 121 CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIA 158
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 110 bits (276), Expect = 9e-28
Identities = 33/151 (21%), Positives = 68/151 (45%), Gaps = 4/151 (2%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
F + +G++ ++ + VAIK + + + + E+ ++ K++H N+V
Sbjct: 12 DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIV 70
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
L ++ + +SGG ++D + + KG + ++ V + YLH I+
Sbjct: 71 ALDDIYESGGHLYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIV 129
Query: 413 HRDLKAANLLMDENEVSLLLSLCLFTVSILF 443
HRDLK NLL + + + F +S +
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKME 160
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 107 bits (267), Expect = 9e-27
Identities = 34/142 (23%), Positives = 66/142 (46%), Gaps = 11/142 (7%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINS-------DMQKEFAQEVFIMRK 345
+ + G + R + ++ A+K++ S ++++ +EV I+RK
Sbjct: 6 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 65
Query: 346 VR-HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 404
V H N++Q +V + M G ++DYL + K K+ + + +
Sbjct: 66 VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVIC 124
Query: 405 YLHQNNIIHRDLKAANLLMDEN 426
LH+ NI+HRDLK N+L+D++
Sbjct: 125 ALHKLNIVHRDLKPENILLDDD 146
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 1e-26
Identities = 40/150 (26%), Positives = 64/150 (42%), Gaps = 9/150 (6%)
Query: 287 WEIDPKHLK--FGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQE 339
I P L F + G +G +Y GT D A+K L + +F E
Sbjct: 20 VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTE 78
Query: 340 VFIMRKVRHKNVVQFIGACTKPP-SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 398
IM+ H NV+ +G C + S +V +M G + +++ + L+ +
Sbjct: 79 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 138
Query: 399 VSKGMNYLHQNNIIHRDLKAANLLMDENEV 428
V+KGM +L +HRDL A N ++DE
Sbjct: 139 VAKGMKFLASKKFVHRDLAARNCMLDEKFT 168
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 106 bits (265), Expect = 8e-26
Identities = 33/155 (21%), Positives = 68/155 (43%), Gaps = 10/155 (6%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQ----EVFIMRKVRH 348
+ G +G++Y + A+K L +RI + A + ++
Sbjct: 7 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 66
Query: 349 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
+V A P L + + M+GG ++ +L + GVF + A ++ G+ ++H
Sbjct: 67 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHN 125
Query: 409 NNIIHRDLKAANLLMDENEVSLLLSLCLFTVSILF 443
+++RDLK AN+L+DE+ + + ++ F
Sbjct: 126 RFVVYRDLKPANILLDEHGH---VRISDLGLACDF 157
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 2e-25
Identities = 31/152 (20%), Positives = 66/152 (43%), Gaps = 5/152 (3%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKN 350
+ GS+G ++ + Q AIK LK + + + D++ ++ + H
Sbjct: 5 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 64
Query: 351 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 410
+ +L V E+++GG + ++ F L A ++ G+ +LH
Sbjct: 65 LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKG 123
Query: 411 IIHRDLKAANLLMDENEVSLLLSLCLFTVSIL 442
I++RDLK N+L+D++ + + ++L
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 5e-25
Identities = 41/144 (28%), Positives = 72/144 (50%), Gaps = 8/144 (5%)
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFI 342
+ K + SG++G +Y+G + + VAIK L+ E + KE E ++
Sbjct: 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYV 64
Query: 343 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 402
M V + +V + +G C ++ ++T+ M G + DY+ + K LL + ++KG
Sbjct: 65 MASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 123
Query: 403 MNYLHQNNIIHRDLKAANLLMDEN 426
MNYL ++HRDL A N+L+
Sbjct: 124 MNYLEDRRLVHRDLAARNVLVKTP 147
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 101 bits (252), Expect = 2e-24
Identities = 36/138 (26%), Positives = 66/138 (47%), Gaps = 4/138 (2%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKE-FAQEVFIMRKVRH 348
+ + + +GS+G ++ + A+KVLK E + Q E E ++ V H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 349 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
+++ G + ++ +++ GG ++ L K F P A +V + YLH
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHS 122
Query: 409 NNIIHRDLKAANLLMDEN 426
+II+RDLK N+L+D+N
Sbjct: 123 KDIIYRDLKPENILLDKN 140
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.8 bits (248), Expect = 4e-24
Identities = 34/147 (23%), Positives = 62/147 (42%), Gaps = 8/147 (5%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQ----KEFAQEVFIMRKVR- 347
+ G + SG +G +Y G S VAIK ++ +RI+ + EV +++KV
Sbjct: 7 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 348 -HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 406
V++ + +P S ++ E +G + V + + +
Sbjct: 67 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 126
Query: 407 HQNNIIHRDLKAANLLMDENEVSLLLS 433
H ++HRD+K N+L+D N L L
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLI 153
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 99 bits (248), Expect = 5e-24
Identities = 38/151 (25%), Positives = 70/151 (46%), Gaps = 6/151 (3%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ G K+ SGS+GD+Y GT + ++VAIK+ + + E I + ++ +
Sbjct: 10 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK----TKHPQLHIESKIYKMMQGGVGI 65
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
I C ++ + G S+ D + F L ++L +A + + Y+H N I
Sbjct: 66 PTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFI 125
Query: 413 HRDLKAANLLMDENEVSLLLSLCLFTVSILF 443
HRD+K N LM + L+ + F ++ +
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.8 bits (245), Expect = 1e-23
Identities = 29/146 (19%), Positives = 65/146 (44%), Gaps = 11/146 (7%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYCS---QDVAIKVLKPERINSDMQKEFAQEVFIMRK--- 345
+ + +++ G+YG +++ + VA+K ++ + M +EV ++R
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 346 VRHKNVVQFIGACTKPPS-----LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS 400
H NVV+ CT + L +V E + + ++ + +
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 401 KGMNYLHQNNIIHRDLKAANLLMDEN 426
+G+++LH + ++HRDLK N+L+ +
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSS 152
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.5 bits (247), Expect = 1e-23
Identities = 33/157 (21%), Positives = 65/157 (41%), Gaps = 10/157 (6%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIM 343
V+++ P++ S + G+YG + VAIK + P + + +E+ I+
Sbjct: 3 VFDVGPRY-TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKIL 60
Query: 344 RKVRHKNVVQFIGACTKPP----SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 399
+ RH+N++ P + + G +Y L + +
Sbjct: 61 LRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQI 118
Query: 400 SKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCL 436
+G+ Y+H N++HRDLK +NLL++ + L
Sbjct: 119 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGL 155
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.4 bits (244), Expect = 1e-23
Identities = 28/134 (20%), Positives = 61/134 (45%), Gaps = 2/134 (1%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ K+ G+YG +Y+ + VA+K ++ + + +E+ +++++ H N+V
Sbjct: 5 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 64
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
+ + L +V EF+ LP + + +G+ + H + ++
Sbjct: 65 KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 124
Query: 413 HRDLKAANLLMDEN 426
HRDLK NLL++
Sbjct: 125 HRDLKPQNLLINTE 138
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 98.0 bits (243), Expect = 2e-23
Identities = 29/133 (21%), Positives = 61/133 (45%), Gaps = 2/133 (1%)
Query: 295 KFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 353
K+ G+YG +Y+ + A+K ++ E+ + + +E+ I+++++H N+V+
Sbjct: 5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVK 64
Query: 354 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 413
L +V E + L +G + + + + G+ Y H ++H
Sbjct: 65 LYDVIHTKKRLVLVFEHLDQDL-KKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLH 123
Query: 414 RDLKAANLLMDEN 426
RDLK NLL++
Sbjct: 124 RDLKPQNLLINRE 136
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.9 bits (243), Expect = 2e-23
Identities = 32/141 (22%), Positives = 64/141 (45%), Gaps = 7/141 (4%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSD----MQKEFAQEVFIMRKVRH 348
G ++ SG + + + S A K +K R S +++ +EV I+++++H
Sbjct: 13 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 72
Query: 349 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
NV+ + ++ E ++GG ++D+L + K + + G+ YLH
Sbjct: 73 PNVITLHEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHS 131
Query: 409 NNIIHRDLKAANLLMDENEVS 429
I H DLK N+++ + V
Sbjct: 132 LQIAHFDLKPENIMLLDRNVP 152
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.6 bits (245), Expect = 2e-23
Identities = 30/155 (19%), Positives = 58/155 (37%), Gaps = 15/155 (9%)
Query: 302 SGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGAC 358
G G + + + A+K+L+ + +EV + + + ++V+ +
Sbjct: 22 LGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVY 74
Query: 359 ----TKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIH 413
L IV E + GG ++ + F ++ + + + YLH NI H
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAH 134
Query: 414 RDLKAANLLMDENEVSLLLSLCLFTVSILFCGKGR 448
RD+K NLL + +L L F +
Sbjct: 135 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 169
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.6 bits (242), Expect = 6e-23
Identities = 39/150 (26%), Positives = 64/150 (42%), Gaps = 8/150 (5%)
Query: 283 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEV 340
WE+ + V SG+YG + VAIK L + K +E+
Sbjct: 10 TKTAWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYREL 68
Query: 341 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFM----SGGSVYDYLHKLKGVFKLPSLLKVA 396
+++ +RH+NV+ + T +L T+F G+ L K + +
Sbjct: 69 RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-HEKLGEDRIQFLV 127
Query: 397 IDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
+ KG+ Y+H IIHRDLK NL ++E+
Sbjct: 128 YQMLKGLRYIHAAGIIHRDLKPGNLAVNED 157
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.2 bits (233), Expect = 5e-22
Identities = 33/130 (25%), Positives = 63/130 (48%), Gaps = 6/130 (4%)
Query: 302 SGSYGDLYRGTYCS--QDVAIKVLKPERI---NSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
G + +Y+ + Q VAIK +K + + +E+ +++++ H N++ +
Sbjct: 8 EGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLD 67
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
A ++ +V +FM + + V + + +G+ YLHQ+ I+HRDL
Sbjct: 68 AFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDL 126
Query: 417 KAANLLMDEN 426
K NLL+DEN
Sbjct: 127 KPNNLLLDEN 136
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.5 bits (231), Expect = 6e-22
Identities = 32/147 (21%), Positives = 66/147 (44%), Gaps = 3/147 (2%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ K+ G+YG +++ + VA+K ++ + + + +E+ ++++++HKN+V
Sbjct: 5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 64
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
+ L +V EF + G + + KG+ + H N++
Sbjct: 65 RLHDVLHSDKKLTLVFEFCDQDLKKYF-DSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVL 123
Query: 413 HRDLKAANLLMDENEVSLLLSLCLFTV 439
HRDLK NLL++ N L + L
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARA 150
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 94.5 bits (234), Expect = 8e-22
Identities = 34/145 (23%), Positives = 65/145 (44%), Gaps = 4/145 (2%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKE-FAQEVFIMRKVRHKNV 351
+ +GS+G + + A+K+L +++ Q E E I++ V +
Sbjct: 44 DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL 103
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
V+ + +L +V E+++GG ++ +L + G F P A + YLH ++
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 412 IHRDLKAANLLMDENEVSLLLSLCL 436
I+RDLK NLL+D+ +
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGF 187
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.9 bits (230), Expect = 2e-21
Identities = 32/162 (19%), Positives = 70/162 (43%), Gaps = 7/162 (4%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRH 348
+ + G++G + + + A+K+L+ E I + D E +++ RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 349 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
+ A LC V E+ +GG ++ +L + + VF ++ + YLH
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHS 123
Query: 409 NNIIHRDLKAANLLMDENEVSLLLSLCLFTVSILFCGKGREL 450
++++RD+K NL++D++ + + F + G +
Sbjct: 124 RDVVYRDIKLENLMLDKDGH---IKITDFGLCKEGISDGATM 162
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.3 bits (228), Expect = 3e-21
Identities = 41/159 (25%), Positives = 77/159 (48%), Gaps = 14/159 (8%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ +K+ G++G++++ + Q VA+K + E +E+ I++ ++H+NVV
Sbjct: 13 EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVV 72
Query: 353 QFIGACTKPPS--------LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 404
I C S + +V +F + L F L + +V + G+
Sbjct: 73 NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVMQMLLNGLY 131
Query: 405 YLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSILF 443
Y+H+N I+HRD+KAAN+L+ + V L L F ++ F
Sbjct: 132 YIHRNKILHRDMKAANVLITRDGV---LKLADFGLARAF 167
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.4 bits (226), Expect = 7e-21
Identities = 32/142 (22%), Positives = 61/142 (42%), Gaps = 16/142 (11%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ +GS+G +Y+ C + VAIK + ++ + +E+ IMRK+ H N+V
Sbjct: 23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIV 76
Query: 353 QFIGACTKPPS------LCIVTEFMSGGSVYDYLH--KLKGVFKLPSLLKVAIDVSKGMN 404
+ L +V +++ H + K + + + + +
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 405 YLHQNNIIHRDLKAANLLMDEN 426
Y+H I HRD+K NLL+D +
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPD 158
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.3 bits (223), Expect = 2e-20
Identities = 35/149 (23%), Positives = 69/149 (46%), Gaps = 10/149 (6%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFI 342
+WE+ P+ + S V SG+YG + VA+K L + K +E+ +
Sbjct: 12 TIWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 343 MRKVRHKNVVQFIGACTKPPSLC-----IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 397
++ ++H+NV+ + T SL + + G + + + + +
Sbjct: 71 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIY 128
Query: 398 DVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
+ +G+ Y+H +IIHRDLK +NL ++E+
Sbjct: 129 QILRGLKYIHSADIIHRDLKPSNLAVNED 157
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.1 bits (220), Expect = 3e-20
Identities = 32/158 (20%), Positives = 72/158 (45%), Gaps = 9/158 (5%)
Query: 277 LKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSD 331
L+ N ++ ++ + + +G+YG ++ S + A+KVLK I
Sbjct: 9 LRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK 68
Query: 332 MQ--KEFAQEVFIMRKVRHK-NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK 388
+ + E ++ +R +V A L ++ ++++GG ++ +L + + F
Sbjct: 69 AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ-RERFT 127
Query: 389 LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
+ ++ + +LH+ II+RD+K N+L+D N
Sbjct: 128 EHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN 165
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 88.4 bits (218), Expect = 7e-20
Identities = 32/164 (19%), Positives = 70/164 (42%), Gaps = 22/164 (13%)
Query: 283 GTDVWEIDPKHLKFGS--------KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDM 332
+ W+ + +++G+ K+ G Y +++ + + V +K+LKP +
Sbjct: 18 PREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----- 72
Query: 333 QKEFAQEVFIMRKVR-HKNVVQFIGACTKPPS--LCIVTEFMSGGSVYDYLHKLKGVFKL 389
+K+ +E+ I+ +R N++ P S +V E ++ +L
Sbjct: 73 KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD----FKQLYQTLTD 128
Query: 390 PSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLS 433
+ ++ K ++Y H I+HRD+K N+++D L L
Sbjct: 129 YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLI 172
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 87.6 bits (216), Expect = 7e-20
Identities = 26/137 (18%), Positives = 54/137 (39%), Gaps = 6/137 (4%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 349
H K G ++ GS+G ++ GT Q VAIK + E + +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP----RRSDAPQLRDEYRTYKLLAGC 60
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 409
+ + + ++ + G S+ D L F + ++ A + + +H+
Sbjct: 61 TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 120
Query: 410 NIIHRDLKAANLLMDEN 426
++++RD+K N L+
Sbjct: 121 SLVYRDIKPDNFLIGRP 137
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.2 bits (212), Expect = 6e-19
Identities = 33/152 (21%), Positives = 63/152 (41%), Gaps = 13/152 (8%)
Query: 283 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEV 340
G + + K + + SG+ G + ++VAIK L N K +E+
Sbjct: 9 GDSTFTV-LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYREL 67
Query: 341 FIMRKVRHKNVVQFIGACTKPPS------LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK 394
+M+ V HKN++ + T + + +V E M ++ +
Sbjct: 68 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN----LCQVIQMELDHERMSY 123
Query: 395 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
+ + G+ +LH IIHRDLK +N+++ +
Sbjct: 124 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 155
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 67.9 bits (165), Expect = 8e-14
Identities = 17/147 (11%), Positives = 45/147 (30%), Gaps = 21/147 (14%)
Query: 297 GSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQK--------EFAQEVFIMRKVR 347
G + G ++ + +K K + K F+ +
Sbjct: 5 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 348 HKNVVQFIGACTKPP----SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 403
+ + + G ++ E + +Y ++ + +V + + +
Sbjct: 65 FRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV--------RVENPDEVLDMILEEV 116
Query: 404 NYLHQNNIIHRDLKAANLLMDENEVSL 430
+ I+H DL N+L+ E + +
Sbjct: 117 AKFYHRGIVHGDLSQYNVLVSEEGIWI 143
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 64.3 bits (155), Expect = 8e-12
Identities = 21/150 (14%), Positives = 56/150 (37%), Gaps = 21/150 (14%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
K+ G + ++ VA+K+++ +++ + E+ ++++V +
Sbjct: 16 ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV---YTEAAEDEIKLLQRVNDADNT 72
Query: 353 QFIGACTKPP---------------SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 397
+ + +V E + + L + +++
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 398 DVSKGMNYLH-QNNIIHRDLKAANLLMDEN 426
+ G++Y+H + IIH D+K N+LM+
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIV 162
|
| >d1ygya3 d.58.18.1 (A:452-529) Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 78 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain domain: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 38.7 bits (90), Expect = 9e-05
Identities = 12/62 (19%), Positives = 23/62 (37%), Gaps = 2/62 (3%)
Query: 180 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVD-GYSLDVFVVDGWP-YEETEQL 237
+ D+P L ++ LL G+NIQ A + + + +D + +
Sbjct: 4 INLIIHYVDRPGALGKIGTLLGTAGVNIQAAQLSEDAEGPGATILLRLDQDVPDDVRTAI 63
Query: 238 RA 239
A
Sbjct: 64 AA 65
|
| >d1u8sa1 d.58.18.5 (A:2-87) putative transcriptional repressor VC2159 {Vibrio cholerae [TaxId: 666]} Length = 86 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: Glycine cleavage system transcriptional repressor domain: putative transcriptional repressor VC2159 species: Vibrio cholerae [TaxId: 666]
Score = 39.0 bits (91), Expect = 9e-05
Identities = 10/62 (16%), Positives = 22/62 (35%), Gaps = 2/62 (3%)
Query: 182 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAAL 241
IT D+P + +++ L+ G NI + + ++ G ++ L
Sbjct: 8 ITAVGTDRPGICNEVVRLVTQAGCNI-IDSRIAMFGKEFTLLMLISG-SPSNITRVETTL 65
Query: 242 EK 243
Sbjct: 66 PL 67
|
| >d1sc6a3 d.58.18.1 (A:327-410) Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain {Escherichia coli [TaxId: 562]} Length = 84 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain domain: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain species: Escherichia coli [TaxId: 562]
Score = 38.5 bits (90), Expect = 1e-04
Identities = 12/62 (19%), Positives = 29/62 (46%), Gaps = 2/62 (3%)
Query: 180 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVD-GYSLDVFVVDGWPYEET-EQL 237
+ +++P +L+ L + A+ G+NI + ++ GY + D E+ + +
Sbjct: 12 RRLMHIHENRPGVLTALNKIFAEQGVNIAAQYLQTSAQMGYVVIDIEADEDVAEKALQAM 71
Query: 238 RA 239
+A
Sbjct: 72 KA 73
|
| >d1y7pa2 d.58.18.12 (A:2-78) Hypothetical protein AF1403, N-terminal domain {Archaeon Archaeoglobus fulgidus [TaxId: 2234]} Length = 77 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: AF1403 N-terminal domain-like domain: Hypothetical protein AF1403, N-terminal domain species: Archaeon Archaeoglobus fulgidus [TaxId: 2234]
Score = 37.0 bits (86), Expect = 4e-04
Identities = 13/73 (17%), Positives = 32/73 (43%), Gaps = 3/73 (4%)
Query: 182 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYE-ETEQLRAA 240
+ ++K +L LT ++A+ G NI A F G ++ + E++
Sbjct: 4 LRIIAENKIGVLRDLTTIIAEEGGNITFAQTFLIKHGEHEGKALIYFEIEGGDFEKILER 63
Query: 241 LEK--EVLKLERQ 251
++ ++++E +
Sbjct: 64 VKTFDYIIEIEEE 76
|
| >d1zpva1 d.58.18.7 (A:1-83) UPF0237 protein SP0238 {Streptococcus pneumoniae [TaxId: 1313]} Length = 83 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: SP0238-like domain: UPF0237 protein SP0238 species: Streptococcus pneumoniae [TaxId: 1313]
Score = 36.3 bits (84), Expect = 9e-04
Identities = 13/62 (20%), Positives = 27/62 (43%), Gaps = 1/62 (1%)
Query: 182 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAAL 241
IT DK +++ ++ +A++GLNI + + +++ V + LR
Sbjct: 5 ITVVGKDKSGIVAGVSGKIAELGLNIDDISQTVLDEYFTMMAVVSSDEKQDF-TYLRNEF 63
Query: 242 EK 243
E
Sbjct: 64 EA 65
|
| >d2pc6a2 d.58.18.6 (A:1-77) Acetolactate synthase small subunit, IlvH {Nitrosomonas europaea [TaxId: 915]} Length = 77 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: IlvH-like domain: Acetolactate synthase small subunit, IlvH species: Nitrosomonas europaea [TaxId: 915]
Score = 35.8 bits (83), Expect = 0.001
Identities = 23/73 (31%), Positives = 34/73 (46%), Gaps = 4/73 (5%)
Query: 180 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVD-GYSLDVFVVDGWPYEETEQLR 238
H I+ +++ LS++ L + G NI+ T D S V +G P E EQ+
Sbjct: 3 HIISLLMENEAGALSRVAGLFSARGYNIESLSVAPTEDPTLSRMTLVTNG-PDEIVEQIT 61
Query: 239 AALEK--EVLKLE 249
L K EV+KL
Sbjct: 62 KQLNKLIEVVKLI 74
|
| >d2f06a1 d.58.18.11 (A:71-141) Hypothetical protein BT0572 {Bacteroides thetaiotaomicron [TaxId: 818]} Length = 71 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: BT0572-like domain: Hypothetical protein BT0572 species: Bacteroides thetaiotaomicron [TaxId: 818]
Score = 34.2 bits (79), Expect = 0.003
Identities = 9/63 (14%), Positives = 27/63 (42%), Gaps = 6/63 (9%)
Query: 182 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAAL 241
+ S + P L+++ L+ G+ I+ ++F+ + + V ++ L
Sbjct: 2 VGISCPNVPGALAKVLGFLSAEGVFIEYMYSFANNN-VANVVIRPS-----NMDKCIEVL 55
Query: 242 EKE 244
+++
Sbjct: 56 KEK 58
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 492 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.98 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.98 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.98 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.98 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.97 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.97 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.97 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.97 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.97 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.97 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.97 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.97 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.97 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.97 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.97 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.92 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.43 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.72 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.15 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.73 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.43 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.01 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 90.68 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-39 Score=319.60 Aligned_cols=195 Identities=30% Similarity=0.512 Sum_probs=166.1
Q ss_pred CceeeCCCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeE
Q 011158 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (492)
Q Consensus 285 ~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 364 (492)
|+|||+.++|++.++||+|+||.||+|++.+ .||||+++....+....+.|.+|+.+|++++|||||++++++.. +.+
T Consensus 1 ddwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~ 78 (276)
T d1uwha_ 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQL 78 (276)
T ss_dssp CCCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred CCcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEE
Confidence 5699999999999999999999999998654 69999998776667778899999999999999999999998865 568
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee---
Q 011158 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI--- 441 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~--- 441 (492)
|||||||++|+|.+++...+..+++..++.++.||++||.|||+++||||||||+|||++.++.+||+|||+++...
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 99999999999999998877789999999999999999999999999999999999999999999999999986542
Q ss_pred ------eeeCCCceeecceecc---ccccCccceeee---ecccccCCCCCC
Q 011158 442 ------LFCGKGRELISLFLGN---DVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 ------~~~g~~~~~ape~~~~---e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...|+..|++||.+.. ..++..+|+|++ +-...+|..+|.
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~ 210 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 210 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCC
Confidence 2457788999997743 235566788873 223334666664
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-38 Score=315.03 Aligned_cols=183 Identities=31% Similarity=0.534 Sum_probs=163.8
Q ss_pred CCceeeCCCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 011158 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (492)
Q Consensus 284 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 361 (492)
.+.|||+.++|++.++||+|+||.||+|++. ++.||||+++.+... .++|.+|+.+|++++|||||+++++|.+.
T Consensus 9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 85 (287)
T d1opja_ 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTRE 85 (287)
T ss_dssp CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEeeC
Confidence 4679999999999999999999999999984 678999999765432 46799999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 362 PSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~L~~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
+.+|||||||++|+|.+++.+. ...+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++..
T Consensus 86 ~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 86 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeec
Confidence 9999999999999999999764 457899999999999999999999999999999999999999999999999999754
Q ss_pred e--------eeeCCCceeecceeccccccCccceeee
Q 011158 441 I--------LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 441 ~--------~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
. ...++..|++||++....++..+|+|++
T Consensus 166 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~ 202 (287)
T d1opja_ 166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF 202 (287)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHH
T ss_pred CCCCceeeccccccccccChHHHcCCCCCchhhhhhH
Confidence 2 1235667899999888888888899884
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-38 Score=316.75 Aligned_cols=194 Identities=22% Similarity=0.325 Sum_probs=169.7
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEE
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 365 (492)
+|..++|++.++||+|+||.||+|++ +++.||+|+++... .......+.+|+.+|++++|||||+++++|.+++.+|
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 56678899999999999999999998 47889999998643 3455678999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEccCCCeEEEEEeeccee----
Q 011158 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVSLLLSLCLFTVS---- 440 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~-~~IiHrDLKp~NILld~~~~~kl~DFGla~~~---- 440 (492)
||||||+||+|.+++.+ .+.+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+|+..
T Consensus 81 iVmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 159 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159 (322)
T ss_dssp EEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT
T ss_pred EEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc
Confidence 99999999999999987 4579999999999999999999997 59999999999999999999999999999753
Q ss_pred -eeeeCCCceeecceeccccccCccceeee---ecccccCCCCCCCc
Q 011158 441 -ILFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDAP 483 (492)
Q Consensus 441 -~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~aP 483 (492)
....|+..|++||++....++...|+|++ +....+|..+|.++
T Consensus 160 ~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 35689999999999999899999999994 44455677666543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-37 Score=304.88 Aligned_cols=190 Identities=29% Similarity=0.478 Sum_probs=160.3
Q ss_pred eCCCCceeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEE
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 367 (492)
|++++|++.++||+|+||.||+|.+. ++.||||+++..... .++|.+|+.++++++|||||+++|+|..++.+|||
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 78 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc---HHHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence 67889999999999999999999985 577999999865433 36799999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee------
Q 011158 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------ 441 (492)
Q Consensus 368 ~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------ 441 (492)
||||++|+|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 99999999999998877789999999999999999999999999999999999999999999999999987542
Q ss_pred --eeeCCCceeecceeccccccCccceeee----ecccccCCCCCC
Q 011158 442 --LFCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSD 481 (492)
Q Consensus 442 --~~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~ 481 (492)
...++..|++||.+....++..+|.|++ +.....|.+.|.
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~ 204 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE 204 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCC
Confidence 2456678999999988888888899884 223334555554
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-38 Score=309.54 Aligned_cols=190 Identities=24% Similarity=0.368 Sum_probs=160.7
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
++|++.++||+|+||.||+|++. ++.||||+++.... ....+.+.+|+.+|++++|||||++++++.+++.+|||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 46899999999999999999984 78899999976532 2334678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee---------
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS--------- 440 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~--------- 440 (492)
||++|+|.++|.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 84 y~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~ 162 (271)
T d1nvra_ 84 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 162 (271)
T ss_dssp CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred ccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccc
Confidence 9999999999965 467999999999999999999999999999999999999999999999999999753
Q ss_pred eeeeCCCceeecceeccccc-cCccceeee---ecccccCCCCCCCc
Q 011158 441 ILFCGKGRELISLFLGNDVL-LQFGTYWII---FRRSSCDKKNSDAP 483 (492)
Q Consensus 441 ~~~~g~~~~~ape~~~~e~~-~~~~d~W~l---~~~~~~gt~~Y~aP 483 (492)
....||..|++||......+ ....|+|++ +....+|.++|..+
T Consensus 163 ~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~ 209 (271)
T d1nvra_ 163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 209 (271)
T ss_dssp CCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSS
T ss_pred cceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCC
Confidence 23468889999998876655 456799994 33455677777543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-37 Score=305.00 Aligned_cols=190 Identities=20% Similarity=0.350 Sum_probs=165.5
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
++|++++.||+|+||.||+|++. ++.||||++..... +......+.+|+.+|++++|||||++++++.+++.+||||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 47999999999999999999984 67899999875322 1233567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee-----eee
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS-----ILF 443 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~-----~~~ 443 (492)
|||++|+|.+++.+ .+.+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||++... ...
T Consensus 86 Ey~~~g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (263)
T d2j4za1 86 EYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL 164 (263)
T ss_dssp ECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCCEET
T ss_pred eecCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCccccc
Confidence 99999999999987 457999999999999999999999999999999999999999999999999999654 235
Q ss_pred eCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 444 CGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 444 ~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
.|+..|++||.+....++...|+|++ +....+|.++|..
T Consensus 165 ~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 206 (263)
T d2j4za1 165 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 206 (263)
T ss_dssp TEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCC
Confidence 68889999999988888889999994 3345567766654
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-37 Score=306.51 Aligned_cols=182 Identities=25% Similarity=0.449 Sum_probs=159.7
Q ss_pred CCceeeCCCCceeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 011158 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (492)
Q Consensus 284 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 362 (492)
.+.|+|+.++|++.++||+|+||.||+|++. ++.||||+++..... .+.|.+|+.+|++++|||||++++++.. +
T Consensus 5 ~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~ 80 (272)
T d1qpca_ 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (272)
T ss_dssp TCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred CCCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeecc-C
Confidence 5679999999999999999999999999996 467999999765433 3679999999999999999999998865 5
Q ss_pred eEEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee
Q 011158 363 SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI 441 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~ 441 (492)
.+|||||||++|+|.+++.... ..+++..++.++.||++||.|||+++|+||||||+||||++++.+||+|||+++...
T Consensus 81 ~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEcc
Confidence 6799999999999999886533 369999999999999999999999999999999999999999999999999997642
Q ss_pred --------eeeCCCceeecceeccccccCccceeee
Q 011158 442 --------LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 442 --------~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
...++..|++||.+....++..+|+|++
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~ 196 (272)
T d1qpca_ 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSF 196 (272)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHH
T ss_pred CCccccccccCCcccccChHHHhCCCCCchhhhhhh
Confidence 1345667999998887788888898884
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-37 Score=307.39 Aligned_cols=187 Identities=19% Similarity=0.305 Sum_probs=164.0
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
++|++.++||+|+||.||+|.+ +|+.||||+++..... ..+.+.+|+.+|++++|||||++++++...+.+|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 4688899999999999999987 4789999999764332 24678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee-------ee
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS-------IL 442 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~-------~~ 442 (492)
||+||+|.+++.+ +.+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++.. ..
T Consensus 98 y~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 175 (293)
T d1yhwa1 98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (293)
T ss_dssp CCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred ecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccccc
Confidence 9999999999876 56999999999999999999999999999999999999999999999999998753 23
Q ss_pred eeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 443 FCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 443 ~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
..|+..|++||......++...|+|++ +....+|.++|..
T Consensus 176 ~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~ 218 (293)
T d1yhwa1 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218 (293)
T ss_dssp CCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCC
Confidence 468889999999988888888999984 3344557666654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-37 Score=306.96 Aligned_cols=188 Identities=22% Similarity=0.318 Sum_probs=162.6
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
+.|+++++||+|+||.||+|.+ +++.||||+++... ....+.+.+|+.+|++++|||||++++++.+.+.+|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 3579999999999999999998 46789999997542 3445778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee-------ee
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS-------IL 442 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~-------~~ 442 (492)
||++|+|.+++.+..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.. ..
T Consensus 90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~ 169 (288)
T d2jfla1 90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 169 (288)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTC
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccccc
Confidence 99999999998876778999999999999999999999999999999999999999999999999998653 24
Q ss_pred eeCCCceeecceec-----cccccCccceeee---ecccccCCCCCC
Q 011158 443 FCGKGRELISLFLG-----NDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 443 ~~g~~~~~ape~~~-----~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
..|+..|++||++. ...++..+|+|++ +....+|.++|.
T Consensus 170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~ 216 (288)
T d2jfla1 170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH 216 (288)
T ss_dssp CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCC
Confidence 67888999999874 3445667899984 334455666664
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.9e-37 Score=306.75 Aligned_cols=193 Identities=27% Similarity=0.369 Sum_probs=159.0
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEEC--Cc---eEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQ---DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~~--g~---~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 362 (492)
+++.++|++.++||+|+||+||+|++. ++ .||||++... ......+.|.+|+.+|++++|||||+++|+|...+
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 567788999999999999999999874 22 4888888653 34556678999999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceeee
Q 011158 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSIL 442 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~~ 442 (492)
.+|||||||++|+|.+++....+.+++.+++.++.||+.||.|||+++||||||||+|||++.++.+||+|||+++....
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence 99999999999999999988777899999999999999999999999999999999999999999999999999975321
Q ss_pred ------------eeCCCceeecceeccccccCccceeee----ecccccCCCCCC
Q 011158 443 ------------FCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSD 481 (492)
Q Consensus 443 ------------~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~ 481 (492)
..++..|++||......+...+|+|++ +...++|.++|.
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~ 235 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW 235 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCC
Confidence 235667899998888888888899884 333345666664
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-37 Score=303.42 Aligned_cols=191 Identities=19% Similarity=0.275 Sum_probs=158.3
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEec--CCeEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--PPSLCIV 367 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~~~lV 367 (492)
++|++.+.||+|+||.||+|++ +|+.||||+++....++...+.+.+|+.+|++++|||||++++++.+ .+.+|||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5789999999999999999998 47889999998877777777889999999999999999999999864 4568999
Q ss_pred EeccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCCCCEEEccCCCeEEEEEeecce
Q 011158 368 TEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNN-----IIHRDLKAANLLMDENEVSLLLSLCLFTV 439 (492)
Q Consensus 368 ~Ey~~ggsL~~~L~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~~-----IiHrDLKp~NILld~~~~~kl~DFGla~~ 439 (492)
||||++|+|.+++.+. ...+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999999643 467999999999999999999999976 99999999999999999999999999975
Q ss_pred e-------eeeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 440 S-------ILFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 440 ~-------~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
. ....|+..|++||.+....++...|+|++ +....+|.++|.+
T Consensus 164 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~ 216 (269)
T d2java1 164 LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA 216 (269)
T ss_dssp C-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCC
Confidence 3 23568889999999988888888999984 3344456666653
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-37 Score=307.52 Aligned_cols=192 Identities=21% Similarity=0.338 Sum_probs=166.5
Q ss_pred CCCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEE
Q 011158 290 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (492)
Q Consensus 290 ~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 366 (492)
.+++|++++.||+|+||.||+|++. ++.||||+++.... +....+.+.+|+.+|++++||||+++++++.+.+.+||
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence 3467999999999999999999984 78899999975322 22334678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-----
Q 011158 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI----- 441 (492)
Q Consensus 367 V~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~----- 441 (492)
|||||+||+|.+++.. .+.+++..++.++.||+.||.|||++|||||||||+|||+++++.+||+|||+++...
T Consensus 86 vmEy~~gg~L~~~~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp EECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEccCCCCHHHhhhc-cCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 9999999999999876 4679999999999999999999999999999999999999999999999999997532
Q ss_pred ----eeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 442 ----LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 442 ----~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
...||..|++||.+....++...|+|++ +....+|.++|.+
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 212 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 212 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCC
Confidence 2468889999999988888888999994 3345567777654
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-36 Score=299.27 Aligned_cols=188 Identities=22% Similarity=0.382 Sum_probs=161.8
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEec----CCeEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK----PPSLC 365 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~~~~~ 365 (492)
+.|++.++||+|+||.||+|++. ++.||+|++..........+.|.+|+.+|++++|||||++++++.. ...+|
T Consensus 9 ry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ 88 (270)
T d1t4ha_ 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 88 (270)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred CEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence 34578889999999999999984 6789999998776667777889999999999999999999999864 35689
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCCEEEc-cCCCeEEEEEeeccee--
Q 011158 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMD-ENEVSLLLSLCLFTVS-- 440 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~--IiHrDLKp~NILld-~~~~~kl~DFGla~~~-- 440 (492)
||||||++|+|.+++.+ ...+++..++.++.||+.||.|||+++ ||||||||+|||++ +++.+||+|||+++..
T Consensus 89 ivmE~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 89 LVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEeCCCCCcHHHHHhc-cccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 99999999999999977 457899999999999999999999998 99999999999996 5789999999999753
Q ss_pred ---eeeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 441 ---ILFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 441 ---~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
....||..|++||.... .+....|+|++ +....+|.++|.
T Consensus 168 ~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~ 213 (270)
T d1t4ha_ 168 SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYS 213 (270)
T ss_dssp TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCC
Confidence 34578999999998765 47888899994 334556766664
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-37 Score=309.99 Aligned_cols=194 Identities=20% Similarity=0.341 Sum_probs=169.7
Q ss_pred eCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEE
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 365 (492)
|..++|++++.||+|+||.||+|++ +++.||||+++.... .....+.+.+|+.+|++++||||+++++++.+.+.+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 3456899999999999999999998 478999999975422 2234577899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee-----
Q 011158 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS----- 440 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~----- 440 (492)
||||||+||+|.+++.+ .+.+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+++..
T Consensus 82 iv~ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred cceeccCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence 99999999999999987 467899999999999999999999999999999999999999999999999999753
Q ss_pred --eeeeCCCceeecceeccccccCccceeee---ecccccCCCCCCCc
Q 011158 441 --ILFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDAP 483 (492)
Q Consensus 441 --~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~aP 483 (492)
...+||..|++||+.....+....|+|++ +....+|.++|.+.
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~ 208 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 208 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCc
Confidence 23678899999999999999999999994 44456677777654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-37 Score=309.11 Aligned_cols=196 Identities=25% Similarity=0.405 Sum_probs=164.2
Q ss_pred CceeeCCCCceeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeEEE
Q 011158 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIG 356 (492)
Q Consensus 285 ~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g-------~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g 356 (492)
..|+|+.++|+++++||+|+||.||+|++.+ ..||+|++.... .......+.+|+.+|+++ +|||||++++
T Consensus 30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~ 108 (325)
T d1rjba_ 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLG 108 (325)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence 4599999999999999999999999998742 259999987543 334456789999999998 8999999999
Q ss_pred EEecCCeEEEEEeccCCCCHHHHHHhcC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 011158 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLK----------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 414 (492)
Q Consensus 357 ~~~~~~~~~lV~Ey~~ggsL~~~L~~~~----------------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHr 414 (492)
++...+.+|||||||++|+|.++|+... ..+++..++.++.||++||.|||+++||||
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHR 188 (325)
T d1rjba_ 109 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 188 (325)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 9999999999999999999999997643 248899999999999999999999999999
Q ss_pred CCCCCCEEEccCCCeEEEEEeecceee---------eeeCCCceeecceeccccccCccceeee----ecccccCCCCCC
Q 011158 415 DLKAANLLMDENEVSLLLSLCLFTVSI---------LFCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSD 481 (492)
Q Consensus 415 DLKp~NILld~~~~~kl~DFGla~~~~---------~~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~ 481 (492)
||||+|||++.++.+||+|||+++... ...++..|++||.+....++..+|+|++ +....+|.++|.
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 999999999999999999999997532 2345778999998888888888899984 333445776664
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-36 Score=300.23 Aligned_cols=193 Identities=23% Similarity=0.351 Sum_probs=163.8
Q ss_pred eeeCCCCceeee-eeeecCceEEEEEEEC----CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 011158 287 WEIDPKHLKFGS-KVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (492)
Q Consensus 287 ~ei~~~~~~~~~-~LG~G~fG~Vy~~~~~----g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 361 (492)
+.++.+++.+.+ +||+|+||.||+|++. +..||||+++.. .+....++|.+|+.+|++++|||||++++++..
T Consensus 3 l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~- 80 (285)
T d1u59a_ 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA- 80 (285)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred eeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-
Confidence 456777888888 4999999999999873 346999999764 345567889999999999999999999999975
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee
Q 011158 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI 441 (492)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~ 441 (492)
+.+|||||||++|+|.+++...+..+++..++.++.||+.||.|||+++||||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 81 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence 46899999999999999997767789999999999999999999999999999999999999999999999999997531
Q ss_pred ----------eeeCCCceeecceeccccccCccceeee----ecccccCCCCCC
Q 011158 442 ----------LFCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSD 481 (492)
Q Consensus 442 ----------~~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~ 481 (492)
...++..|++||++....++..+|+|++ +.....|.++|.
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~ 214 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 214 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCC
Confidence 2345677999998888888888898884 223345776664
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-36 Score=297.25 Aligned_cols=181 Identities=27% Similarity=0.400 Sum_probs=158.4
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEECC------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTYCS------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~~g------~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 361 (492)
||+++.|++.++||+|+||.||+|.+.+ ..||||+++.. .......+|.+|+.+|++++|||||+++|++...
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc-cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 7888999999999999999999998742 35999999754 3455567899999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee
Q 011158 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI 441 (492)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~ 441 (492)
+.+++|||||.+|++.+++......+++..++.++.||+.||.|||+++||||||||+||||+.++.+||+|||+++...
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhccc
Confidence 99999999999999999998877889999999999999999999999999999999999999999999999999997532
Q ss_pred ----------eeeCCCceeecceeccccccCccceeee
Q 011158 442 ----------LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 442 ----------~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
...|+..|++||++....+...+|+|++
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~ 199 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSF 199 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHH
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCccccccc
Confidence 1345677999999888888888898884
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.2e-36 Score=305.75 Aligned_cols=189 Identities=18% Similarity=0.277 Sum_probs=166.0
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
++|++++.||+|+||.||+|++ +|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+.+.+|||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 4799999999999999999998 47899999997543 3445778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcc--CCCeEEEEEeeccee------e
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE--NEVSLLLSLCLFTVS------I 441 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~--~~~~kl~DFGla~~~------~ 441 (492)
||+||+|.+++.+..+.+++..++.++.||+.||.|||++|||||||||+|||++. ++.+||+|||+++.. .
T Consensus 104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~ 183 (350)
T d1koaa2 104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 183 (350)
T ss_dssp CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEE
T ss_pred cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccccc
Confidence 99999999999766678999999999999999999999999999999999999964 578999999998653 2
Q ss_pred eeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 442 LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 442 ~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
...|+..|++||.+....+....|+|++ +....+|.++|..
T Consensus 184 ~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 227 (350)
T d1koaa2 184 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG 227 (350)
T ss_dssp EECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCC
Confidence 4678999999999988888888999994 3344567777654
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-36 Score=298.41 Aligned_cols=190 Identities=24% Similarity=0.370 Sum_probs=155.7
Q ss_pred CCCCceee-eeeeecCceEEEEEEEC----CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeE
Q 011158 290 DPKHLKFG-SKVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (492)
Q Consensus 290 ~~~~~~~~-~~LG~G~fG~Vy~~~~~----g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 364 (492)
+.+.+.+. ++||+|+||.||+|.+. ++.||||+++....+....++|.+|+.+|++++|||||+++++|..+ ..
T Consensus 4 d~~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~ 82 (277)
T d1xbba_ 4 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SW 82 (277)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SE
T ss_pred chhhCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CE
Confidence 34445554 46999999999999873 25799999987655666678899999999999999999999999754 58
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee---
Q 011158 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI--- 441 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~--- 441 (492)
|||||||++|+|.+++++ ...+++..++.++.||+.||.|||+++||||||||+|||++.++.+|++|||+++...
T Consensus 83 ~lvmE~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~ 161 (277)
T d1xbba_ 83 MLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 161 (277)
T ss_dssp EEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred EEEEEcCCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccc
Confidence 999999999999999987 5679999999999999999999999999999999999999999999999999997531
Q ss_pred -------eeeCCCceeecceeccccccCccceeee----ecccccCCCCCC
Q 011158 442 -------LFCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSD 481 (492)
Q Consensus 442 -------~~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~ 481 (492)
...++..|++||.+....++..+|+|++ +.....|.++|.
T Consensus 162 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~ 212 (277)
T d1xbba_ 162 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 212 (277)
T ss_dssp SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred cccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCC
Confidence 2346678999998888888888898884 223345666665
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.8e-36 Score=305.56 Aligned_cols=189 Identities=14% Similarity=0.233 Sum_probs=166.7
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
++|+++++||+|+||.||+|.+ +|+.||||+++... ......+.+|+.+|++++|||||++++++.+++.+|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 4689999999999999999998 47899999997643 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc--cCCCeEEEEEeeccee------e
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD--ENEVSLLLSLCLFTVS------I 441 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld--~~~~~kl~DFGla~~~------~ 441 (492)
||+||+|.+++......+++..++.|+.||+.||.|||++|||||||||+|||++ .++.+||+|||+++.. .
T Consensus 107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~ 186 (352)
T d1koba_ 107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 186 (352)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCcee
Confidence 9999999999877666899999999999999999999999999999999999998 5789999999999753 3
Q ss_pred eeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 442 LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 442 ~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
...++..|++||++....++...|+|++ +....+|.++|..
T Consensus 187 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 230 (352)
T d1koba_ 187 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG 230 (352)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred eccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 4678899999999999989999999994 4445567777654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.4e-36 Score=300.59 Aligned_cols=189 Identities=22% Similarity=0.262 Sum_probs=161.4
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
.|+.+++||+|+||.||+|++ +++.||||+++..... ....+.+.+|+.+|++++|||||++++++.+++.+|||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 589999999999999999997 4688999999876443 3455779999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee---eeeeCC
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS---ILFCGK 446 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~---~~~~g~ 446 (492)
||.+|+|..++.. ++.+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++.. ....||
T Consensus 96 ~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~GT 174 (309)
T d1u5ra_ 96 YCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGT 174 (309)
T ss_dssp CCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCCCCSC
T ss_pred ecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCCCccccC
Confidence 9999999776655 567999999999999999999999999999999999999999999999999998754 345788
Q ss_pred Cceeecceecc---ccccCccceeee---ecccccCCCCCCC
Q 011158 447 GRELISLFLGN---DVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 447 ~~~~ape~~~~---e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
..|+|||.+.. ..|+...|+|++ +....+|.++|..
T Consensus 175 ~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~ 216 (309)
T d1u5ra_ 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (309)
T ss_dssp GGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCC
Confidence 88999998743 346777899984 3334456666643
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-36 Score=295.77 Aligned_cols=195 Identities=24% Similarity=0.359 Sum_probs=160.5
Q ss_pred ceeeCCCCceeeeeeeecCceEEEEEEECC-----ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Q 011158 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 360 (492)
Q Consensus 286 ~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g-----~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 360 (492)
+|||+.++|++++.||+|+||.||+|++.. ..||||+++.. ......+.|.+|+.+|++++|||||++++++.+
T Consensus 1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 79 (273)
T d1mp8a_ 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE 79 (273)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 489999999999999999999999998742 35888888643 345556789999999999999999999999964
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 361 ~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
+.+|||||||++|+|.+++......+++..++.++.||+.||.|||+++||||||||+|||++.++.+||+|||+++..
T Consensus 80 -~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 80 -NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp -SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred -CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheec
Confidence 6789999999999999999887778999999999999999999999999999999999999999999999999998753
Q ss_pred e--------eeeCCCceeecceeccccccCccceeee----ecccccCCCCCCC
Q 011158 441 I--------LFCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSDA 482 (492)
Q Consensus 441 ~--------~~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~a 482 (492)
. ...++..|++||......+...+|+|++ +.....|.++|..
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~ 212 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 212 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCC
Confidence 2 2345678999999888888888899984 3334457777654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-36 Score=302.72 Aligned_cols=189 Identities=21% Similarity=0.356 Sum_probs=152.1
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
+.|++.+.||+|+||.||+|++. ++.||||++....... ....+.+|+.+|++++|||||++++++.+.+.+|||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 45899999999999999999984 7889999998654332 34568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc---cCCCeEEEEEeeccee------
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD---ENEVSLLLSLCLFTVS------ 440 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld---~~~~~kl~DFGla~~~------ 440 (492)
||+||+|.++|.+ .+.+++..+..++.||+.||.|||++|||||||||+|||+. +++.+||+|||+++..
T Consensus 88 ~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~ 166 (307)
T d1a06a_ 88 LVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL 166 (307)
T ss_dssp CCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred ccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCee
Confidence 9999999999976 56799999999999999999999999999999999999995 5789999999999754
Q ss_pred eeeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 441 ILFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 441 ~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
....||..|++||......++...|+|++ +....+|.++|..
T Consensus 167 ~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 211 (307)
T d1a06a_ 167 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD 211 (307)
T ss_dssp ------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCC
Confidence 23568899999999988889999999994 3345567777653
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-36 Score=293.37 Aligned_cols=178 Identities=30% Similarity=0.493 Sum_probs=159.5
Q ss_pred eCCCCceeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEE
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 367 (492)
+++++|++.++||+|+||.||+|++. ++.||||+++..... .++|.+|+.++++++||||++++|+|.+++.+++|
T Consensus 1 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~---~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC---HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred CChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC---HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence 46789999999999999999999995 568999999876543 36799999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee------
Q 011158 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------ 441 (492)
Q Consensus 368 ~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------ 441 (492)
|||+++|+|.+++......+++..+++++.||++||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 99999999999998777789999999999999999999999999999999999999999999999999997432
Q ss_pred --eeeCCCceeecceeccccccCccceeee
Q 011158 442 --LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 442 --~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
...++..|++||......+...+|+|++
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~ 187 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAF 187 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeeccc
Confidence 2346667899998888778888888884
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.5e-36 Score=303.30 Aligned_cols=190 Identities=19% Similarity=0.322 Sum_probs=166.5
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
++|+++++||+|+||+||+|++. |+.||||+++.... .....+.+.+|+.+|++++|||||++++++.+.+.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 47999999999999999999984 78999999975322 1233577899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee----eee
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI----LFC 444 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~----~~~ 444 (492)
|||+||+|.+++.. ...+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++... ...
T Consensus 84 E~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~ 162 (316)
T d1fota_ 84 DYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC 162 (316)
T ss_dssp CCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCCCC
T ss_pred eecCCccccccccc-cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecccccccc
Confidence 99999999999877 5678999999999999999999999999999999999999999999999999997652 467
Q ss_pred CCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 445 GKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 445 g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
|+..|++||.+....++...|+|++ +....+|.++|..
T Consensus 163 Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~ 203 (316)
T d1fota_ 163 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD 203 (316)
T ss_dssp SCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCC
Confidence 8899999999988889999999984 3345567777654
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-36 Score=298.06 Aligned_cols=183 Identities=31% Similarity=0.501 Sum_probs=159.4
Q ss_pred CCCceeeCCCCceeeeeeeecCceEEEEEEECC-ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 011158 283 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (492)
Q Consensus 283 ~~~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g-~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 361 (492)
..+.|+|+.++|++++.||+|+||.||+|++.+ +.||||+++....+ .+.|.+|+.+|++++|||||+++++|..
T Consensus 8 ~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~- 83 (285)
T d1fmka3 8 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE- 83 (285)
T ss_dssp STTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEEec-
Confidence 367899999999999999999999999999854 67999999765433 3679999999999999999999999865
Q ss_pred CeEEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 362 PSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~L~~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
+.+|+|||||++|+|..++... ...+++.+++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++..
T Consensus 84 ~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 84 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 163 (285)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhc
Confidence 5689999999999999998653 356999999999999999999999999999999999999999999999999999753
Q ss_pred e--------eeeCCCceeecceeccccccCccceeee
Q 011158 441 I--------LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 441 ~--------~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
. ...++..|++||+.....+...+|+|++
T Consensus 164 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~ 200 (285)
T d1fmka3 164 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 200 (285)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred cCCCceeeccccccccccChHHHhCCCCCcHHhhhcc
Confidence 1 2456778999999988888888898884
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-36 Score=295.70 Aligned_cols=189 Identities=19% Similarity=0.276 Sum_probs=163.9
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCh----HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS----DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 365 (492)
++|+++++||+|+||.||+|++. |+.||||+++...... ...+.+.+|+.+|++++|||||++++++.+.+.+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 46899999999999999999984 7899999997653322 23578999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCC----CeEEEEEeeccee-
Q 011158 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE----VSLLLSLCLFTVS- 440 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~----~~kl~DFGla~~~- 440 (492)
||||||++|+|.++|.+ .+.+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+|++|||++...
T Consensus 90 iv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 90 LILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEEEcCCCccccchhcc-ccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 99999999999999977 35799999999999999999999999999999999999999876 4999999998653
Q ss_pred -----eeeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 441 -----ILFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 441 -----~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
....++..|++||.+....++...|+|++ +....+|.++|.
T Consensus 169 ~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~ 217 (293)
T d1jksa_ 169 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 217 (293)
T ss_dssp TSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCC
Confidence 23567788999999988888888999994 334556666654
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-35 Score=295.61 Aligned_cols=188 Identities=15% Similarity=0.223 Sum_probs=163.2
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
++|++++.||+|+||.||+|.+ +++.||||+++... .....+.+|+.+|++++|||||++++++.+.+.+|||||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 5689999999999999999998 47889999997642 334568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccC--CCeEEEEEeeccee------e
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN--EVSLLLSLCLFTVS------I 441 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~--~~~kl~DFGla~~~------~ 441 (492)
||+||+|.++|......+++.+++.++.||+.||.|||++||+||||||+|||++.+ ..+|++|||+++.. .
T Consensus 82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~ 161 (321)
T d1tkia_ 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR 161 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEE
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCccc
Confidence 999999999998766689999999999999999999999999999999999999854 48999999998654 2
Q ss_pred eeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 442 LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 442 ~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
...++..|++||......+....|+|++ +....+|.++|..
T Consensus 162 ~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~ 205 (321)
T d1tkia_ 162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA 205 (321)
T ss_dssp EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCC
Confidence 4567888899998888888888899994 3345567766643
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-35 Score=302.00 Aligned_cols=190 Identities=19% Similarity=0.298 Sum_probs=166.3
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 368 (492)
++|+++++||+|+||.||+|++ +|+.||||+++.... .....+.+.+|+.+|++++|||||++++++.....+++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 4789999999999999999998 478999999975321 1233567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee----eee
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI----LFC 444 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~----~~~ 444 (492)
||+.+|+|.+++.+ .+.+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++... ...
T Consensus 121 e~~~~g~l~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~~~~ 199 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC 199 (350)
T ss_dssp ECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBCCCE
T ss_pred ccccccchhhhHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccccccccc
Confidence 99999999999977 4579999999999999999999999999999999999999999999999999997642 456
Q ss_pred CCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 445 GKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 445 g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
|+..|++||.+....+....|+|++ +....+|.++|..
T Consensus 200 Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~ 240 (350)
T d1rdqe_ 200 GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240 (350)
T ss_dssp ECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCC
Confidence 8889999999988888888999994 3345567777654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-36 Score=291.45 Aligned_cols=179 Identities=31% Similarity=0.494 Sum_probs=154.2
Q ss_pred eeeCCCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEec-CCeEE
Q 011158 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK-PPSLC 365 (492)
Q Consensus 287 ~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~~~ 365 (492)
|+|+.++|+++++||+|+||.||+|.++|+.||||+++.+. ..+.|.+|+.++++++||||++++|+|.. .+.+|
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 77 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 77 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEE
Confidence 89999999999999999999999999999999999997542 34678999999999999999999999865 45689
Q ss_pred EEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee---
Q 011158 366 IVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI--- 441 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~--- 441 (492)
|||||+++|+|.++|.+.. ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.+|++|||+++...
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~ 157 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 157 (262)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCCC
Confidence 9999999999999997643 358999999999999999999999999999999999999999999999999998643
Q ss_pred -eeeCCCceeecceeccccccCccceeee
Q 011158 442 -LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 442 -~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
...++..|++||+.....++..+|+|++
T Consensus 158 ~~~~~~~~y~aPE~l~~~~~t~~sDIwSf 186 (262)
T d1byga_ 158 DTGKLPVKWTAPEALREKKFSTKSDVWSF 186 (262)
T ss_dssp ----CCTTTSCHHHHHHCCCCHHHHHHHH
T ss_pred ccccccccCCChHHHhCCCCChHHHHHhH
Confidence 3456678999999888788888898884
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.1e-34 Score=285.93 Aligned_cols=192 Identities=20% Similarity=0.244 Sum_probs=161.9
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCh-------HHHHHHHHHHHHHHhcC-CCceeeEEEEEec
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS-------DMQKEFAQEVFIMRKVR-HKNVVQFIGACTK 360 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~-------~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~ 360 (492)
.++|++.+.||+|+||+||+|++ +++.||||+++...... ...+.+.+|+.+|++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 36799999999999999999998 56899999997654321 23456889999999997 9999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 361 ~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
++.+|||||||++|+|.++|+. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CcceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence 9999999999999999999976 467999999999999999999999999999999999999999999999999999653
Q ss_pred ------eeeeCCCceeecceeccc------cccCccceeee---ecccccCCCCCCCc
Q 011158 441 ------ILFCGKGRELISLFLGND------VLLQFGTYWII---FRRSSCDKKNSDAP 483 (492)
Q Consensus 441 ------~~~~g~~~~~ape~~~~e------~~~~~~d~W~l---~~~~~~gt~~Y~aP 483 (492)
....|+..|++||+..+. .++...|+|++ +....+|..+|.+.
T Consensus 161 ~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~ 218 (277)
T d1phka_ 161 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 218 (277)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCC
Confidence 235677888889877543 24556789984 33444576666543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6.3e-35 Score=286.93 Aligned_cols=190 Identities=19% Similarity=0.292 Sum_probs=160.4
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC----eE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP----SL 364 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~----~~ 364 (492)
++|++.+.||+|+||.||+|++ +++.||||+++.... +......|.+|+.+|++++||||+++++++...+ .+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 5689999999999999999998 478999999987644 3455678999999999999999999999987654 38
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee----
Q 011158 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS---- 440 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~---- 440 (492)
|||||||+||+|.+++.. .+.+++.+++.++.||+.||.|||++|||||||||+|||++.++..+++|||.+...
T Consensus 87 ~lvmE~~~g~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp EEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EEEEECCCCCEehhhhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence 999999999999999976 467999999999999999999999999999999999999999999999999987643
Q ss_pred ------eeeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 441 ------ILFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 441 ------~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
....|+..|++||......+....|+|++ +....+|.++|..
T Consensus 166 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 216 (277)
T d1o6ya_ 166 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 216 (277)
T ss_dssp -------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCC
Confidence 13467889999999888888888999994 4455667777653
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.1e-34 Score=296.79 Aligned_cols=191 Identities=18% Similarity=0.232 Sum_probs=158.8
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC----hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN----SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 364 (492)
.++|++.++||+|+||.||+|++ +|+.||||++...... ........+|+.+++.++|||||++++++...+.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 46799999999999999999998 4789999999643221 11122233456777788899999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee----
Q 011158 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS---- 440 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~---- 440 (492)
|||||||+||+|.++|.+ ...+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++..
T Consensus 83 ~ivmE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~ 161 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 161 (364)
T ss_dssp EEEECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC
T ss_pred EEEEEecCCCcHHHHHHh-cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCc
Confidence 999999999999999987 467899999999999999999999999999999999999999999999999998753
Q ss_pred -eeeeCCCceeecceec-cccccCccceeee---ecccccCCCCCCC
Q 011158 441 -ILFCGKGRELISLFLG-NDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 441 -~~~~g~~~~~ape~~~-~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
....|+..|++||++. ...+....|+|++ +....+|.++|..
T Consensus 162 ~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~ 208 (364)
T d1omwa3 162 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 208 (364)
T ss_dssp CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCC
Confidence 2357889999999875 4567888899994 3344557766653
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-35 Score=292.06 Aligned_cols=190 Identities=19% Similarity=0.317 Sum_probs=162.5
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-ChHHHHHHHHHHHHHH-hcCCCceeeEEEEEecCCeEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMR-KVRHKNVVQFIGACTKPPSLCIV 367 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~-~l~HpnIv~l~g~~~~~~~~~lV 367 (492)
++|.++++||+|+||+||+|++ +++.||||+++.... .....+.+..|+.++. .++|||||++++++.+.+.+|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5789999999999999999998 578899999975321 1223456677777665 68999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee------
Q 011158 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------ 441 (492)
Q Consensus 368 ~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------ 441 (492)
||||++|+|.+++.. ...+++..++.++.||+.||.|||+++||||||||+|||++.++.+|++|||+++...
T Consensus 82 mEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~ 160 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT 160 (320)
T ss_dssp EECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred EeecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccccc
Confidence 999999999999976 4678999999999999999999999999999999999999999999999999997542
Q ss_pred -eeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 442 -LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 442 -~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
...|+..|++||+.....+...+|+|++ +....+|..+|..
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~ 205 (320)
T d1xjda_ 161 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 205 (320)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCC
Confidence 3568888999999998889988999994 3344567777754
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-34 Score=288.96 Aligned_cols=183 Identities=23% Similarity=0.391 Sum_probs=160.3
Q ss_pred ceeeCCCCceeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEE
Q 011158 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 358 (492)
Q Consensus 286 ~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g-------~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~ 358 (492)
.||++.++|+++++||+|+||.||+|++.+ +.||||+++.. ......++|.+|+.+|++++||||++++++|
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 378888999999999999999999998753 57999999754 3455677899999999999999999999999
Q ss_pred ecCCeEEEEEeccCCCCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecC
Q 011158 359 TKPPSLCIVTEFMSGGSVYDYLHKLK-----------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415 (492)
Q Consensus 359 ~~~~~~~lV~Ey~~ggsL~~~L~~~~-----------------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrD 415 (492)
...+..++||||+++|+|.++|.... ..+++..++.|+.||+.||.|||+++|||||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD 165 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 165 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence 99999999999999999999997532 2488999999999999999999999999999
Q ss_pred CCCCCEEEccCCCeEEEEEeeccee---------eeeeCCCceeecceeccccccCccceeee
Q 011158 416 LKAANLLMDENEVSLLLSLCLFTVS---------ILFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 416 LKp~NILld~~~~~kl~DFGla~~~---------~~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
|||+|||++.++.+||+|||+++.. ....++..|++||+.....++..+|.|++
T Consensus 166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~ 228 (301)
T d1lufa_ 166 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAY 228 (301)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred EcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccc
Confidence 9999999999999999999998643 12456677999998888888888888883
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-35 Score=289.43 Aligned_cols=189 Identities=17% Similarity=0.273 Sum_probs=155.0
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
++|+++++||+|+||.||+|++. ++.||||+++...........+.+|+.+|++++|||||++++++.+++.+|||||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 57999999999999999999984 7899999998665444456789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------
Q 011158 370 FMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------- 441 (492)
Q Consensus 370 y~~ggsL~~~L~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------- 441 (492)
||. |++.+++. .....+++..+..++.||+.||.|||++|||||||||+|||++.++.+|++|||.++...
T Consensus 82 ~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~ 160 (298)
T d1gz8a_ 82 FLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT 160 (298)
T ss_dssp CCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTT
T ss_pred ecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcccce
Confidence 995 45555554 435679999999999999999999999999999999999999999999999999996542
Q ss_pred eeeCCCceeecceeccccc-cCccceeee---ecccccCCCCCC
Q 011158 442 LFCGKGRELISLFLGNDVL-LQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 ~~~g~~~~~ape~~~~e~~-~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||......+ ....|+|++ +....+|.++|.
T Consensus 161 ~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~ 204 (298)
T d1gz8a_ 161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP 204 (298)
T ss_dssp CCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred eecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCC
Confidence 2467788888886655444 566789984 444556777764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-34 Score=289.33 Aligned_cols=192 Identities=23% Similarity=0.385 Sum_probs=159.9
Q ss_pred eCCCCceeeeeeeecCceEEEEEEEC--Cc----eEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Q 011158 289 IDPKHLKFGSKVASGSYGDLYRGTYC--SQ----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (492)
Q Consensus 289 i~~~~~~~~~~LG~G~fG~Vy~~~~~--g~----~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 362 (492)
+...+|+++++||+|+||+||+|.+. |+ +||+|.++... +....++|.+|+.+|++++|||||+++++|.++
T Consensus 6 ~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~- 83 (317)
T d1xkka_ 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 83 (317)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred CCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 44567999999999999999999884 33 58999887532 334467899999999999999999999999875
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee--
Q 011158 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS-- 440 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~-- 440 (492)
..++++||+.+|+|.+++......+++..++.++.||+.||.|||+++||||||||+|||++.++.+||+|||+++..
T Consensus 84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 578889999999999999887788999999999999999999999999999999999999999999999999998753
Q ss_pred -------eeeeCCCceeecceeccccccCccceeee----ecccccCCCCCCC
Q 011158 441 -------ILFCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSDA 482 (492)
Q Consensus 441 -------~~~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~a 482 (492)
....++..|++||.+....++..+|+|++ +...++|.++|..
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~ 216 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 216 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCC
Confidence 12346788999998888888888899984 3334457777753
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-34 Score=289.92 Aligned_cols=183 Identities=23% Similarity=0.416 Sum_probs=158.0
Q ss_pred CceeeCCCCceeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEE
Q 011158 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 357 (492)
Q Consensus 285 ~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~-------g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~ 357 (492)
+.|+|+.++|++.++||+|+||.||+|.+. ++.||||+++.. ........|.+|+.++++++||||++++++
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 91 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGV 91 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-cChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence 469999999999999999999999999874 357999999754 345556779999999999999999999999
Q ss_pred EecCCeEEEEEeccCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCC
Q 011158 358 CTKPPSLCIVTEFMSGGSVYDYLHKLK---------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428 (492)
Q Consensus 358 ~~~~~~~~lV~Ey~~ggsL~~~L~~~~---------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~ 428 (492)
|...+..++|||||++|+|.+++.... ..+++..+..++.|+++||.|||+++|+||||||+|||++.++.
T Consensus 92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce
Confidence 999999999999999999999996432 34789999999999999999999999999999999999999999
Q ss_pred eEEEEEeecceee---------eeeCCCceeecceeccccccCccceee
Q 011158 429 SLLLSLCLFTVSI---------LFCGKGRELISLFLGNDVLLQFGTYWI 468 (492)
Q Consensus 429 ~kl~DFGla~~~~---------~~~g~~~~~ape~~~~e~~~~~~d~W~ 468 (492)
+||+|||+++... ...++..|++||......+....|.|+
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S 220 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWS 220 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHH
T ss_pred EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCccccccc
Confidence 9999999997542 124556677777766666776778777
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-35 Score=286.16 Aligned_cols=193 Identities=27% Similarity=0.417 Sum_probs=155.1
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEECC-----ceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~~g-----~~vAvK~l~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 361 (492)
-|+.++|++.+.||+|+||.||+|++.+ ..||||+++.... +....++|.+|+.+|++++||||++++|++.+
T Consensus 4 ~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~- 82 (273)
T d1u46a_ 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT- 82 (273)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred EEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-
Confidence 4667889999999999999999998732 3689999876543 34556789999999999999999999999976
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee
Q 011158 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI 441 (492)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~ 441 (492)
+.+++|||||++|+|.+++....+.+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 83 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 83 PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 46899999999999999998777789999999999999999999999999999999999999999999999999987531
Q ss_pred ----------eeeCCCceeecceeccccccCccceeee----ecccccCCCCCC
Q 011158 442 ----------LFCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSD 481 (492)
Q Consensus 442 ----------~~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~ 481 (492)
...++..|++||....+.++..+|+|++ +.....|.++|.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~ 216 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI 216 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCC
Confidence 2345567899999988888888899884 223334666664
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-34 Score=286.69 Aligned_cols=185 Identities=27% Similarity=0.445 Sum_probs=150.8
Q ss_pred CCceeeCCCCceeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeEE
Q 011158 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFI 355 (492)
Q Consensus 284 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~-------g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~ 355 (492)
.+.|+|+.++|+++++||+|+||.||+|++. ++.||||+++... .....+.+.+|+.++.++ +|+||+.++
T Consensus 5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 3569999999999999999999999999873 2579999997543 344567788888888887 589999999
Q ss_pred EEEecC-CeEEEEEeccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q 011158 356 GACTKP-PSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419 (492)
Q Consensus 356 g~~~~~-~~~~lV~Ey~~ggsL~~~L~~~~---------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~ 419 (492)
+++... ..+++|||||++|+|.++|+... ..+++..++.++.||+.||.|||+++||||||||+
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~ 163 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 163 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcc
Confidence 998764 46899999999999999997532 35889999999999999999999999999999999
Q ss_pred CEEEccCCCeEEEEEeecceee---------eeeCCCceeecceeccccccCccceeee
Q 011158 420 NLLMDENEVSLLLSLCLFTVSI---------LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 420 NILld~~~~~kl~DFGla~~~~---------~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
|||++.++.+||+|||+++... ...|+..|++||......++..+|+|++
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~ 222 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 222 (299)
T ss_dssp GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeeh
Confidence 9999999999999999997532 2357778999998888888888898884
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-34 Score=285.80 Aligned_cols=195 Identities=24% Similarity=0.408 Sum_probs=162.1
Q ss_pred ceeeCCCCceeeeeeeecCceEEEEEEECC---------ceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeEE
Q 011158 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS---------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFI 355 (492)
Q Consensus 286 ~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~g---------~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~ 355 (492)
.|+|+.++|+++++||+|+||.||+|++.+ ..||||+++.+. ......++.+|+.++.++ +|||||+++
T Consensus 7 ~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~ 85 (299)
T d1fgka_ 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLL 85 (299)
T ss_dssp TTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence 499999999999999999999999998632 369999998643 445567899999999888 799999999
Q ss_pred EEEecCCeEEEEEeccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCC
Q 011158 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 420 (492)
Q Consensus 356 g~~~~~~~~~lV~Ey~~ggsL~~~L~~~~---------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~N 420 (492)
++|.+++.+++|||||++|+|.++|.... ..+++.+++.++.||+.||.|||+++||||||||+|
T Consensus 86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~N 165 (299)
T d1fgka_ 86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 165 (299)
T ss_dssp EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccc
Confidence 99999999999999999999999997542 358999999999999999999999999999999999
Q ss_pred EEEccCCCeEEEEEeecceee---------eeeCCCceeecceeccccccCccceeee----ecccccCCCCCC
Q 011158 421 LLMDENEVSLLLSLCLFTVSI---------LFCGKGRELISLFLGNDVLLQFGTYWII----FRRSSCDKKNSD 481 (492)
Q Consensus 421 ILld~~~~~kl~DFGla~~~~---------~~~g~~~~~ape~~~~e~~~~~~d~W~l----~~~~~~gt~~Y~ 481 (492)
||++.++.+||+|||+++... ...++..|++||++....++...|.|++ +.....|.++|.
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~ 239 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 239 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCC
Confidence 999999999999999987542 2456678999998888888888898884 223345666664
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-34 Score=285.47 Aligned_cols=183 Identities=26% Similarity=0.427 Sum_probs=159.1
Q ss_pred ceeeCCCCceeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeEEEE
Q 011158 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGA 357 (492)
Q Consensus 286 ~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~-------g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~ 357 (492)
.|+|+.++|+++++||+|+||.||+|++. ++.||||+++... .......|.+|+.+++++ +|||||+++++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~ 95 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 59999999999999999999999999863 2579999998653 345567899999999999 69999999999
Q ss_pred EecCCeEEEEEeccCCCCHHHHHHhcC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCC
Q 011158 358 CTKPPSLCIVTEFMSGGSVYDYLHKLK-----------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 420 (492)
Q Consensus 358 ~~~~~~~~lV~Ey~~ggsL~~~L~~~~-----------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~N 420 (492)
|...+.+|||||||++|+|.+++++.. ..+++..++.++.||+.||.|||+++||||||||+|
T Consensus 96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~N 175 (311)
T d1t46a_ 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (311)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccc
Confidence 999999999999999999999997632 258999999999999999999999999999999999
Q ss_pred EEEccCCCeEEEEEeecceee---------eeeCCCceeecceeccccccCccceeee
Q 011158 421 LLMDENEVSLLLSLCLFTVSI---------LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 421 ILld~~~~~kl~DFGla~~~~---------~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
||++.++.+|++|||.++... ...++..|++||+.....++...|+|++
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~ 233 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSY 233 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccch
Confidence 999999999999999997542 2345667777877776667777788884
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-34 Score=287.96 Aligned_cols=184 Identities=20% Similarity=0.283 Sum_probs=155.5
Q ss_pred CCceeee-eeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeEEEEEec----CCe
Q 011158 292 KHLKFGS-KVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTK----PPS 363 (492)
Q Consensus 292 ~~~~~~~-~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~----~~~ 363 (492)
++|++.+ .||+|+||.||+|++ +++.||||+++.. ..+.+|+.++.++ +|||||++++++.+ ...
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 4677765 599999999999998 4688999999743 4677899987655 89999999999865 456
Q ss_pred EEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcc---CCCeEEEEEeecce
Q 011158 364 LCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVSLLLSLCLFTV 439 (492)
Q Consensus 364 ~~lV~Ey~~ggsL~~~L~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~---~~~~kl~DFGla~~ 439 (492)
+|||||||+||+|.++|.+.. ..+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~ 163 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 163 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeee
Confidence 899999999999999998643 46999999999999999999999999999999999999985 45799999999875
Q ss_pred e------eeeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 440 S------ILFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 440 ~------~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
. ....|+..|++||......+....|+|++ +....+|.++|..
T Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~ 215 (335)
T d2ozaa1 164 TTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 215 (335)
T ss_dssp CCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEE
T ss_pred ccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCC
Confidence 4 23568899999999998889989999994 4445567766643
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-34 Score=284.77 Aligned_cols=181 Identities=29% Similarity=0.450 Sum_probs=154.1
Q ss_pred eeCCCCceeeeeeeecCceEEEEEEEC--Cc--eEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCC
Q 011158 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQ--DVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPP 362 (492)
Q Consensus 288 ei~~~~~~~~~~LG~G~fG~Vy~~~~~--g~--~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~ 362 (492)
.|+.++|++.++||+|+||.||+|++. +. .||||.++... .....+.|.+|+.+|+++ +|||||+++++|...+
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 467789999999999999999999874 43 47788876432 334457899999999999 7999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCC
Q 011158 363 SLCIVTEFMSGGSVYDYLHKL---------------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 427 (492)
Q Consensus 363 ~~~lV~Ey~~ggsL~~~L~~~---------------~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~ 427 (492)
.+|||||||++|+|.++|++. ...+++..++.++.||+.||.|||+++||||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 999999999999999999753 25799999999999999999999999999999999999999999
Q ss_pred CeEEEEEeecceee------eeeCCCceeecceeccccccCccceeee
Q 011158 428 VSLLLSLCLFTVSI------LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 428 ~~kl~DFGla~~~~------~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
.+||+|||+++... ...++..|++||......++..+|+|++
T Consensus 165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSf 212 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSY 212 (309)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHH
T ss_pred ceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehh
Confidence 99999999986542 3457788999999988888888899883
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-34 Score=284.65 Aligned_cols=185 Identities=21% Similarity=0.219 Sum_probs=148.8
Q ss_pred eeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCh---HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEec
Q 011158 296 FGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS---DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (492)
Q Consensus 296 ~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 370 (492)
.+++||+|+||+||+|++ +|+.||||+++...... ...+.+.+|+.+|++++|||||++++++...+.+||||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 357899999999999987 47889999997653322 2235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------ee
Q 011158 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-------LF 443 (492)
Q Consensus 371 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-------~~ 443 (492)
|.++++..++ .....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||.++... ..
T Consensus 82 ~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~ 160 (299)
T d1ua2a_ 82 METDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ 160 (299)
T ss_dssp CSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCS
T ss_pred hcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccce
Confidence 9777665554 445679999999999999999999999999999999999999999999999999986432 24
Q ss_pred eCCCceeecceec-cccccCccceeee---ecccccCCCCCC
Q 011158 444 CGKGRELISLFLG-NDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 444 ~g~~~~~ape~~~-~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
.++..|++||.+. ...++...|+|++ +....+|.++|.
T Consensus 161 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~ 202 (299)
T d1ua2a_ 161 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLP 202 (299)
T ss_dssp CCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCC
Confidence 5778889999764 3456777899984 334445666654
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.1e-33 Score=278.83 Aligned_cols=190 Identities=17% Similarity=0.214 Sum_probs=158.6
Q ss_pred CCceeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEec
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~Ey 370 (492)
++|+++++||+|+||.||+|++. ++.||||+++....+....+.+.+|+.+|++++||||+++++++...+..|++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 58999999999999999999984 68899999987655455567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------ee
Q 011158 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-------LF 443 (492)
Q Consensus 371 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-------~~ 443 (492)
+.++.+..+. ...+.+++..+..++.||+.||+|||+++||||||||+|||++.++.+|++|||.+.... ..
T Consensus 82 ~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 160 (286)
T d1ob3a_ 82 LDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE 160 (286)
T ss_dssp CSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred ehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcccccee
Confidence 9665555554 446789999999999999999999999999999999999999999999999999986532 23
Q ss_pred eCCCceeecceeccc-cccCccceeee---ecccccCCCCCCC
Q 011158 444 CGKGRELISLFLGND-VLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 444 ~g~~~~~ape~~~~e-~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
.++..|++||..... .++...|+|++ +....+|.++|..
T Consensus 161 ~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~ 203 (286)
T d1ob3a_ 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG 203 (286)
T ss_dssp -CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCC
Confidence 566778888877544 45677789984 3344567777753
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=2.9e-33 Score=283.46 Aligned_cols=196 Identities=22% Similarity=0.284 Sum_probs=160.6
Q ss_pred CCceeeCCCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 011158 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (492)
Q Consensus 284 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 361 (492)
...|++ .++|+++++||+|+||.||+|++. ++.||||+++....+....+.+.+|+.+|++++|||||+++++|...
T Consensus 11 ~~~~~~-~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~ 89 (346)
T d1cm8a_ 11 KTAWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPD 89 (346)
T ss_dssp SSEECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSC
T ss_pred Cceeec-CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccC
Confidence 345777 578999999999999999999984 78899999987666667778899999999999999999999999765
Q ss_pred C------eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEe
Q 011158 362 P------SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLC 435 (492)
Q Consensus 362 ~------~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFG 435 (492)
+ .+||||||| +++|..+++. ..+++..++.++.||+.||.|||++|||||||||+|||++.++.+|++|||
T Consensus 90 ~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg 166 (346)
T d1cm8a_ 90 ETLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFG 166 (346)
T ss_dssp SSTTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred ccccccceEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccccccccccc
Confidence 4 479999999 7788888765 579999999999999999999999999999999999999999999999999
Q ss_pred ecceee----eeeCCCceeecceecc-ccccCccceeee---ecccccCCCCCCCc
Q 011158 436 LFTVSI----LFCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSDAP 483 (492)
Q Consensus 436 la~~~~----~~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~aP 483 (492)
.++... ...++..|++||.... ..+....|+|++ +....+|.++|...
T Consensus 167 ~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~ 222 (346)
T d1cm8a_ 167 LARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 222 (346)
T ss_dssp TCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ceeccCCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCC
Confidence 997653 3567778888887644 455677899994 33455777777543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=8.2e-34 Score=278.69 Aligned_cols=191 Identities=19% Similarity=0.322 Sum_probs=158.0
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCh----HHHHHHHHHHHHHHhcC--CCceeeEEEEEecCCe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS----DMQKEFAQEVFIMRKVR--HKNVVQFIGACTKPPS 363 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~----~~~~~~~~Ei~il~~l~--HpnIv~l~g~~~~~~~ 363 (492)
++|++.++||+|+||.||+|++ +++.||||+++...... ....++.+|+.+|++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 4689999999999999999998 47899999997643321 11244678999999997 8999999999999999
Q ss_pred EEEEEeccCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccC-CCeEEEEEeecceee
Q 011158 364 LCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-EVSLLLSLCLFTVSI 441 (492)
Q Consensus 364 ~~lV~Ey~~g-gsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~-~~~kl~DFGla~~~~ 441 (492)
.|+||||+.+ +++.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence 9999999976 688888876 4679999999999999999999999999999999999999854 789999999987542
Q ss_pred -----eeeCCCceeecceeccccc-cCccceeee---ecccccCCCCCCCc
Q 011158 442 -----LFCGKGRELISLFLGNDVL-LQFGTYWII---FRRSSCDKKNSDAP 483 (492)
Q Consensus 442 -----~~~g~~~~~ape~~~~e~~-~~~~d~W~l---~~~~~~gt~~Y~aP 483 (492)
...|+..|++||++....+ ....|+|++ +....+|.++|...
T Consensus 163 ~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (273)
T d1xwsa_ 163 DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213 (273)
T ss_dssp SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc
Confidence 3568888999998876655 455789984 33445677666543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=9.2e-33 Score=275.35 Aligned_cols=172 Identities=24% Similarity=0.465 Sum_probs=138.1
Q ss_pred CCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC----eEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP----SLCIV 367 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~----~~~lV 367 (492)
++|.+.++||+|+||.||+|+++|+.||||+++.. ......+..|+..+++++||||+++++++...+ .+|||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 46788899999999999999999999999999643 222222334555566789999999999998654 58999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--------CCceecCCCCCCEEEccCCCeEEEEEeecce
Q 011158 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ--------NNIIHRDLKAANLLMDENEVSLLLSLCLFTV 439 (492)
Q Consensus 368 ~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~--------~~IiHrDLKp~NILld~~~~~kl~DFGla~~ 439 (492)
||||++|+|.++|++ ..+++..++.++.|++.||.|||+ +|||||||||+||||+.++.+||+|||+++.
T Consensus 80 ~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 999999999999987 468999999999999999999996 5999999999999999999999999999875
Q ss_pred ee-----------eeeCCCceeecceecccc------ccCccceee
Q 011158 440 SI-----------LFCGKGRELISLFLGNDV------LLQFGTYWI 468 (492)
Q Consensus 440 ~~-----------~~~g~~~~~ape~~~~e~------~~~~~d~W~ 468 (492)
.. ...|+..|++||+..+.. ++..+|+|+
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S 203 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYA 203 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHH
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhh
Confidence 42 134556666666554432 333456666
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=3e-33 Score=277.89 Aligned_cols=191 Identities=18% Similarity=0.260 Sum_probs=158.7
Q ss_pred CCceeeeeeeecCceEEEEEEEC---CceEEEEEecCCCCChHHHHHHHHHHHHHHhc---CCCceeeEEEEEec-----
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC---SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV---RHKNVVQFIGACTK----- 360 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~---g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~g~~~~----- 360 (492)
++|+++++||+|+||.||+|++. ++.||||+++...........+.+|+.+|+.+ +||||++++++|..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 57999999999999999999983 45699999976544333334566788877766 79999999999853
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 361 ~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
...+|++||||.++++..........+++..++.++.||+.||+|||+++||||||||+|||++.++.+||+|||.++..
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~ 166 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 166 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhh
Confidence 34689999999887776666655678999999999999999999999999999999999999999999999999998764
Q ss_pred ------eeeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 441 ------ILFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 441 ------~~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
....||..|++||......+....|+|++ +....+|.++|..
T Consensus 167 ~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~ 217 (305)
T d1blxa_ 167 SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG 217 (305)
T ss_dssp CGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCC
Confidence 24678899999999988889999999994 4445567776653
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.3e-32 Score=275.44 Aligned_cols=174 Identities=22% Similarity=0.355 Sum_probs=151.3
Q ss_pred eeeeeeeecCceEEEEEEECC-----ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEec-CCeEEEEE
Q 011158 295 KFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK-PPSLCIVT 368 (492)
Q Consensus 295 ~~~~~LG~G~fG~Vy~~~~~g-----~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~~~lV~ 368 (492)
.+.++||+|+||+||+|++.. ..||||+++.. .+....++|.+|+.+|++++||||++++|++.. ++.+++||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 446899999999999999842 25899999743 345667889999999999999999999999875 56899999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI------- 441 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~------- 441 (492)
|||++|+|.+++......+++..++.++.|++.||.|||+++|+||||||+|||+++++.+||+|||+++...
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 9999999999998777788899999999999999999999999999999999999999999999999997531
Q ss_pred ----eeeCCCceeecceeccccccCccceeee
Q 011158 442 ----LFCGKGRELISLFLGNDVLLQFGTYWII 469 (492)
Q Consensus 442 ----~~~g~~~~~ape~~~~e~~~~~~d~W~l 469 (492)
...++..|++||......+...+|+|++
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~Sf 220 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 220 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhh
Confidence 1345677899998888888888898884
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.6e-32 Score=278.22 Aligned_cols=193 Identities=19% Similarity=0.311 Sum_probs=154.7
Q ss_pred ceeeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC-
Q 011158 286 VWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP- 362 (492)
Q Consensus 286 ~~ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~- 362 (492)
.|+|.. +|+++++||+|+||+||+|++ +++.||||+++... .....+.+.+|+.+|++++||||+++++++....
T Consensus 3 ~~~i~~-rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~ 80 (345)
T d1pmea_ 3 VFDVGP-RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 80 (345)
T ss_dssp CCCCCT-TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred ccCcCC-CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc
Confidence 355654 499999999999999999998 47899999997543 3555678999999999999999999999997543
Q ss_pred ----eEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecc
Q 011158 363 ----SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFT 438 (492)
Q Consensus 363 ----~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~ 438 (492)
.+|++ +|+.+|+|.+++.. ..+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||++.
T Consensus 81 ~~~~~~~l~-~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 81 EQMKDVYLV-THLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR 157 (345)
T ss_dssp TTCCCEEEE-EECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred cccceEEEE-EeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCcee
Confidence 34555 55569999999976 469999999999999999999999999999999999999999999999999986
Q ss_pred eee----------eeeCCCceeecceeccc-cccCccceeee---ecccccCCCCCCCc
Q 011158 439 VSI----------LFCGKGRELISLFLGND-VLLQFGTYWII---FRRSSCDKKNSDAP 483 (492)
Q Consensus 439 ~~~----------~~~g~~~~~ape~~~~e-~~~~~~d~W~l---~~~~~~gt~~Y~aP 483 (492)
... ...++..|++||.+... .+....|+|++ +....+|.++|...
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~ 216 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK 216 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCC
Confidence 542 23467788888876443 44566689994 44556777777643
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5.6e-32 Score=266.41 Aligned_cols=177 Identities=19% Similarity=0.251 Sum_probs=153.7
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCeEEEEEe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 369 (492)
++|+++++||+|+||+||+|++ +++.||||+++..........++.+|+.+|++++||||+++++++......++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5799999999999999999998 46789999998776666677899999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee-------e
Q 011158 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-------L 442 (492)
Q Consensus 370 y~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-------~ 442 (492)
++.+++|..++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+|++|||.++... .
T Consensus 82 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~ 160 (292)
T d1unla_ 82 FCDQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160 (292)
T ss_dssp CCSEEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCS
T ss_pred ecccccccccccc-ccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcccee
Confidence 9999888887765 5678999999999999999999999999999999999999999999999999997542 2
Q ss_pred eeCCCceeecceecccc-ccCccceeee
Q 011158 443 FCGKGRELISLFLGNDV-LLQFGTYWII 469 (492)
Q Consensus 443 ~~g~~~~~ape~~~~e~-~~~~~d~W~l 469 (492)
..++..+++||...... +....|+|++
T Consensus 161 ~~~~~~~~~pe~~~~~~~~~~~~DiwSl 188 (292)
T d1unla_ 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSA 188 (292)
T ss_dssp CCSCGGGCCHHHHTTCSCCCTHHHHHHH
T ss_pred eccccchhhhhHhccCCCCCchhhcccc
Confidence 23445566677665544 4566788984
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2e-32 Score=276.86 Aligned_cols=196 Identities=19% Similarity=0.252 Sum_probs=159.9
Q ss_pred CCceeeCCCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Q 011158 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (492)
Q Consensus 284 ~~~~ei~~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 361 (492)
.+.|++. ++|+++++||+|+||+||+|++ +|+.||||+++....+....+++.+|+.+|++++|||||++++++...
T Consensus 11 ~~~~~~~-~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~ 89 (348)
T d2gfsa1 11 KTIWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 89 (348)
T ss_dssp SSEEEEE-TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred CccccCC-CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeec
Confidence 4568884 7799999999999999999987 478999999987666666677899999999999999999999998643
Q ss_pred -----CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEee
Q 011158 362 -----PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCL 436 (492)
Q Consensus 362 -----~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGl 436 (492)
...+++|+|+.+|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||.
T Consensus 90 ~~~~~~~~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~ 167 (348)
T d2gfsa1 90 RSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL 167 (348)
T ss_dssp SSTTTCCCCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC--
T ss_pred cccccCceEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccch
Confidence 234666777789999999965 5799999999999999999999999999999999999999999999999999
Q ss_pred cceee----eeeCCCceeecceeccc-cccCccceeee---ecccccCCCCCCC
Q 011158 437 FTVSI----LFCGKGRELISLFLGND-VLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 437 a~~~~----~~~g~~~~~ape~~~~e-~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
+.... ...++..|++||..... .+....|+|++ +....+|.++|..
T Consensus 168 a~~~~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~ 221 (348)
T d2gfsa1 168 ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221 (348)
T ss_dssp --CCTGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred hcccCcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCC
Confidence 86543 34566778888865444 45667799985 3345667777654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.97 E-value=1.2e-31 Score=269.24 Aligned_cols=183 Identities=16% Similarity=0.256 Sum_probs=149.6
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCceeeEEEEEec--CCeEE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTK--PPSLC 365 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~--~~~~~ 365 (492)
.++|+++++||+|+||+||+|++ +++.||||+++... .+++.+|+.+|++++ ||||+++++++.. ...+|
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 35799999999999999999998 47889999997532 367889999999996 9999999999974 35699
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCC-CeEEEEEeecceee---
Q 011158 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-VSLLLSLCLFTVSI--- 441 (492)
Q Consensus 366 lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~-~~kl~DFGla~~~~--- 441 (492)
+|||||.+++|.++. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+|++|||++....
T Consensus 109 ~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp EEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred EEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 999999999987653 4699999999999999999999999999999999999998655 68999999997542
Q ss_pred ---eeeCCCceeecceecc-ccccCccceeee---ecccccCCCCCCC
Q 011158 442 ---LFCGKGRELISLFLGN-DVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 442 ---~~~g~~~~~ape~~~~-e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
...++..|++||.... ..+....|+|++ +....+|..+|..
T Consensus 185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~ 232 (328)
T d3bqca1 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 232 (328)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCC
Confidence 3456677888887554 345666788984 3334455555543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=8e-32 Score=273.52 Aligned_cols=184 Identities=18% Similarity=0.190 Sum_probs=147.5
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEecC------CeE
Q 011158 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP------PSL 364 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------~~~ 364 (492)
+|+..++||+|+||+||+|++ +++.||||+++.+.. .+.+|+.+|++++||||++++++|... ..+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 588889999999999999998 478899999976532 234799999999999999999998543 358
Q ss_pred EEEEeccCCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCC-CeEEEEEeecceee
Q 011158 365 CIVTEFMSGGSVYDYLH--KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-VSLLLSLCLFTVSI 441 (492)
Q Consensus 365 ~lV~Ey~~ggsL~~~L~--~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~-~~kl~DFGla~~~~ 441 (492)
|||||||+++.+..+.. .....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 99999996654333332 2345799999999999999999999999999999999999999775 89999999987542
Q ss_pred ------eeeCCCceeecceec-cccccCccceeee---ecccccCCCCCCC
Q 011158 442 ------LFCGKGRELISLFLG-NDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 442 ------~~~g~~~~~ape~~~-~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
...++..|++||... ...+....|+|++ +....+|.++|..
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~ 225 (350)
T d1q5ka_ 175 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 225 (350)
T ss_dssp TTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred CCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCC
Confidence 356778888888654 4567777899984 4445567666643
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.6e-31 Score=267.02 Aligned_cols=189 Identities=22% Similarity=0.272 Sum_probs=151.1
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEec--------C
Q 011158 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--------P 361 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--------~ 361 (492)
.+|+++++||+|+||+||+|++ +|+.||||++...........++.+|+.+|++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 6899999999999999999998 47899999997665555556788999999999999999999999855 3
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee
Q 011158 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI 441 (492)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~ 441 (492)
..+|+|||||.++.+. .+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+++...
T Consensus 90 ~~~~iv~e~~~~~~~~-~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~ 168 (318)
T d3blha1 90 GSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 168 (318)
T ss_dssp -CEEEEEECCCEEHHH-HHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred ceEEEEEeccCCCccc-hhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence 4689999999766554 444445679999999999999999999999999999999999999999999999999985431
Q ss_pred -----------eeeCCCceeecceeccc-cccCccceeee---ecccccCCCCCC
Q 011158 442 -----------LFCGKGRELISLFLGND-VLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 -----------~~~g~~~~~ape~~~~e-~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...++..|++||.+... .+....|+|++ +....+|.++|.
T Consensus 169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~ 223 (318)
T d3blha1 169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 223 (318)
T ss_dssp C-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCC
Confidence 23467778888876543 46677789984 333445655554
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.2e-31 Score=268.64 Aligned_cols=188 Identities=19% Similarity=0.213 Sum_probs=153.6
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCceeeEEEEEec------CCe
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK------PPS 363 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~------~~~ 363 (492)
++|+++++||+|+||+||+|.+. |+.||||+++....+.....++.+|+.+|++++||||++++++|.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 56999999999999999999984 7899999998776667777789999999999999999999999964 367
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee--
Q 011158 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI-- 441 (492)
Q Consensus 364 ~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~-- 441 (492)
+|+|||||.+ ++.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+++...
T Consensus 97 ~~iv~Ey~~~-~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 97 VYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp EEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eEEEEeccch-HHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc
Confidence 8999999955 5555553 468999999999999999999999999999999999999999999999999987653
Q ss_pred ----eeeCCCceeecceeccccccCccceeee---ecccccCCCCCCCc
Q 011158 442 ----LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDAP 483 (492)
Q Consensus 442 ----~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~aP 483 (492)
...++..|++||.+....+....|+|++ +.....|.++|..+
T Consensus 173 ~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~ 221 (355)
T d2b1pa1 173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_dssp --------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCC
Confidence 3567888999999888888888999994 33455677666543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.97 E-value=6.2e-31 Score=260.61 Aligned_cols=186 Identities=16% Similarity=0.190 Sum_probs=158.1
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCC-CceeeEEEEEecCCeEEEE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH-KNVVQFIGACTKPPSLCIV 367 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~g~~~~~~~~~lV 367 (492)
.++|+++++||+|+||.||+|++ +++.||||++...... ..+.+|+.+++.++| +||+.+++++......|+|
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 46799999999999999999998 4788999998654322 346789999999976 8999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcc-----CCCeEEEEEeecceee-
Q 011158 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-----NEVSLLLSLCLFTVSI- 441 (492)
Q Consensus 368 ~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~-----~~~~kl~DFGla~~~~- 441 (492)
|||+ +++|.+++......++...+..++.|++.||.|||++|||||||||+|||++. ++.+|++|||+++...
T Consensus 80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred EEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 9999 89999999887778999999999999999999999999999999999999974 5689999999997532
Q ss_pred -------------eeeCCCceeecceeccccccCccceeee---ecccccCCCCCC
Q 011158 442 -------------LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSD 481 (492)
Q Consensus 442 -------------~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~ 481 (492)
...||..|++||......++..+|+|++ +.....|..+|.
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~ 214 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ 214 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCC
Confidence 2457889999998888778888898884 323445666664
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.1e-31 Score=269.95 Aligned_cols=193 Identities=18% Similarity=0.276 Sum_probs=157.9
Q ss_pred CCCCceeeeeeeecCceEEEEEEE-----CCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCC-CceeeEEEEEecC
Q 011158 290 DPKHLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRH-KNVVQFIGACTKP 361 (492)
Q Consensus 290 ~~~~~~~~~~LG~G~fG~Vy~~~~-----~g~~vAvK~l~~~~~--~~~~~~~~~~Ei~il~~l~H-pnIv~l~g~~~~~ 361 (492)
..++|+++++||+|+||.||+|.. +|+.||||+++.... +....+.+.+|+.+|++++| |||+++++++.+.
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~ 101 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence 346799999999999999999986 357899999975432 12234668899999999977 8999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeecceee
Q 011158 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLFTVSI 441 (492)
Q Consensus 362 ~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla~~~~ 441 (492)
..+++|||||.+|+|.+++... +.+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred CceeeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 9999999999999999999874 567899999999999999999999999999999999999999999999999986531
Q ss_pred --------eeeCCCceeecceeccc--cccCccceeee---ecccccCCCCCCCc
Q 011158 442 --------LFCGKGRELISLFLGND--VLLQFGTYWII---FRRSSCDKKNSDAP 483 (492)
Q Consensus 442 --------~~~g~~~~~ape~~~~e--~~~~~~d~W~l---~~~~~~gt~~Y~aP 483 (492)
...++..|++||..... .+....|+|++ +.....|.++|...
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~ 235 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 235 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 24567778888766432 34556789984 33445577666543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=1.6e-30 Score=257.63 Aligned_cols=186 Identities=21% Similarity=0.250 Sum_probs=153.3
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCc-eeeEEEEEecCCeEEEEE
Q 011158 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN-VVQFIGACTKPPSLCIVT 368 (492)
Q Consensus 292 ~~~~~~~~LG~G~fG~Vy~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~g~~~~~~~~~lV~ 368 (492)
++|++.++||+|+||.||+|++. ++.||||++...... .++.+|+.++++++|+| |+.+.+++...+..++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 46999999999999999999984 789999998765322 35788999999998766 555566667788899999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc---cCCCeEEEEEeecceee----
Q 011158 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD---ENEVSLLLSLCLFTVSI---- 441 (492)
Q Consensus 369 Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld---~~~~~kl~DFGla~~~~---- 441 (492)
||+ +++|.+.+......+++..+..++.|++.||+|||++|||||||||+|||++ .+..+|++|||+++...
T Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 83 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred EEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 999 7788888877677899999999999999999999999999999999999986 35579999999997532
Q ss_pred ----------eeeCCCceeecceeccccccCccceeee---ecccccCCCCCCC
Q 011158 442 ----------LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDA 482 (492)
Q Consensus 442 ----------~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~a 482 (492)
...|+..|++||......++..+|+|++ +....+|.++|..
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~ 215 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQG 215 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccc
Confidence 2357888999998888888888898884 3344566666643
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.92 E-value=3.5e-26 Score=231.40 Aligned_cols=191 Identities=14% Similarity=0.150 Sum_probs=147.9
Q ss_pred CCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-----------CCceeeEEEE
Q 011158 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-----------HKNVVQFIGA 357 (492)
Q Consensus 291 ~~~~~~~~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~-----------HpnIv~l~g~ 357 (492)
..+|+++++||+|+||+||+|++ +|+.||||+++.+ ....+.+.+|+.++++++ |+||++++++
T Consensus 12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 35699999999999999999998 4789999999754 334467788999998875 4789999988
Q ss_pred Eec--CCeEEEEEeccCCCCH-HHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEccCCC----
Q 011158 358 CTK--PPSLCIVTEFMSGGSV-YDYLH-KLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEV---- 428 (492)
Q Consensus 358 ~~~--~~~~~lV~Ey~~ggsL-~~~L~-~~~~~l~~~~~~~i~~qI~~gL~yLH~-~~IiHrDLKp~NILld~~~~---- 428 (492)
+.. ....+++|+++..+.. ..... .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence 754 4556777777655433 33332 234578999999999999999999998 89999999999999987653
Q ss_pred --eEEEEEeecceee----eeeCCCceeecceeccccccCccceeee---ecccccCCCCCCCcc
Q 011158 429 --SLLLSLCLFTVSI----LFCGKGRELISLFLGNDVLLQFGTYWII---FRRSSCDKKNSDAPF 484 (492)
Q Consensus 429 --~kl~DFGla~~~~----~~~g~~~~~ape~~~~e~~~~~~d~W~l---~~~~~~gt~~Y~aPE 484 (492)
++++|||.+.... ...++..|++||......+....|.|++ +.....|+.+|.+.+
T Consensus 169 ~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp EEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred ceeeEeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence 8999999986542 3457788999998888888888899985 344556787777654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=3.1e-23 Score=191.74 Aligned_cols=132 Identities=13% Similarity=0.147 Sum_probs=104.8
Q ss_pred eeeeeeeecCceEEEEEEE-CCceEEEEEecCCCCC----------------hHHHHHHHHHHHHHHhcCCCceeeEEEE
Q 011158 295 KFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERIN----------------SDMQKEFAQEVFIMRKVRHKNVVQFIGA 357 (492)
Q Consensus 295 ~~~~~LG~G~fG~Vy~~~~-~g~~vAvK~l~~~~~~----------------~~~~~~~~~Ei~il~~l~HpnIv~l~g~ 357 (492)
.++++||+|+||.||+|++ +|+.||||+++..... ......+..|..++.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 5679999999999999987 5789999998643211 0112345678899999999999998876
Q ss_pred EecCCeEEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEccCCCeEEEEEeec
Q 011158 358 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVSLLLSLCLF 437 (492)
Q Consensus 358 ~~~~~~~~lV~Ey~~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLKp~NILld~~~~~kl~DFGla 437 (492)
.. .+++|||+++..+.+ ++......++.|++.+|.|||++||+||||||+|||+++++ ++++|||.+
T Consensus 83 ~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG~a 149 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQS 149 (191)
T ss_dssp ET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCTTC
T ss_pred cC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECCCc
Confidence 42 379999998765422 44555678999999999999999999999999999999765 789999988
Q ss_pred ce
Q 011158 438 TV 439 (492)
Q Consensus 438 ~~ 439 (492)
..
T Consensus 150 ~~ 151 (191)
T d1zara2 150 VE 151 (191)
T ss_dssp EE
T ss_pred cc
Confidence 54
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.43 E-value=3.2e-07 Score=85.97 Aligned_cols=140 Identities=11% Similarity=0.059 Sum_probs=93.4
Q ss_pred CceeeeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCeEEEEEecc
Q 011158 293 HLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFM 371 (492)
Q Consensus 293 ~~~~~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~Ey~ 371 (492)
.++..+..+-++.+.||+....++.+++|+....... ....+.+|..++..+. +--+.+++.+...++..++||+++
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l 92 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA 92 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEec
Confidence 3444444444445789998877888999988643211 1234677888888774 434677888888888899999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 011158 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ------------------------------------------- 408 (492)
Q Consensus 372 ~ggsL~~~L~~~~~~l~~~~~~~i~~qI~~gL~yLH~------------------------------------------- 408 (492)
+|.++.+.... ... ...++.+++..|..||+
T Consensus 93 ~G~~~~~~~~~---~~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T d1j7la_ 93 DGVLCSEEYED---EQS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp SSEEHHHHTTT---CSC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSS
T ss_pred ccccccccccc---ccc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchH
Confidence 98877654321 011 11223333333333331
Q ss_pred ----------C------CceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 409 ----------N------NIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 409 ----------~------~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
. .++|+|+.|.|||+++++..-++||+.++..
T Consensus 167 ~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T d1j7la_ 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp HHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccC
Confidence 1 2789999999999998776679999998775
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.72 E-value=2.5e-05 Score=72.23 Aligned_cols=137 Identities=12% Similarity=0.146 Sum_probs=84.5
Q ss_pred eeeecCc-eEEEEEEECC-ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCC--CceeeEEEEEecCCeEEEEEeccCCC
Q 011158 299 KVASGSY-GDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH--KNVVQFIGACTKPPSLCIVTEFMSGG 374 (492)
Q Consensus 299 ~LG~G~f-G~Vy~~~~~g-~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~g~~~~~~~~~lV~Ey~~gg 374 (492)
.+..|.. ..||+....+ ..+++|....... ..+..|...++.+.. -.+.+++.+...++..++||+|++|.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 4455554 5799988754 5688898765432 346678888877743 33677888888888899999999876
Q ss_pred CHHH--------------HHHhcC------CCC--CHHHHHHHH--------------------HHHHHHHHHHHHC---
Q 011158 375 SVYD--------------YLHKLK------GVF--KLPSLLKVA--------------------IDVSKGMNYLHQN--- 409 (492)
Q Consensus 375 sL~~--------------~L~~~~------~~l--~~~~~~~i~--------------------~qI~~gL~yLH~~--- 409 (492)
++.+ .+.+-. ..+ .......-. ......+..+..+
T Consensus 92 ~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 171 (255)
T d1nd4a_ 92 DLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPD 171 (255)
T ss_dssp ETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCS
T ss_pred ccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCc
Confidence 5421 111100 000 111000000 0112223344332
Q ss_pred ----CceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 410 ----NIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 410 ----~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
.++|+|+.|.|||++.++..-|+||+.++..
T Consensus 172 ~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~g 206 (255)
T d1nd4a_ 172 GEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 206 (255)
T ss_dssp SCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred cCCceEEeCCCCCcceEEeCCceEEEEEchhcccC
Confidence 3799999999999998777779999988764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.15 E-value=0.00033 Score=69.57 Aligned_cols=76 Identities=13% Similarity=0.042 Sum_probs=48.1
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCC-CC----ChHHHHHHHHHHHHHHhcC-C--CceeeEEEEEecCCeEEEE
Q 011158 298 SKVASGSYGDLYRGTY--CSQDVAIKVLKPE-RI----NSDMQKEFAQEVFIMRKVR-H--KNVVQFIGACTKPPSLCIV 367 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~--~g~~vAvK~l~~~-~~----~~~~~~~~~~Ei~il~~l~-H--pnIv~l~g~~~~~~~~~lV 367 (492)
+.||.|..-.||+.+. .++.++||.-.+. +. .+....+...|..+|+.+. + ..+.+++.+. +...++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEEE
Confidence 5689999999999975 3568999965431 10 0111234556888887663 2 3566776654 3445789
Q ss_pred EeccCCCC
Q 011158 368 TEFMSGGS 375 (492)
Q Consensus 368 ~Ey~~ggs 375 (492)
||++.+..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.73 E-value=0.0011 Score=63.73 Aligned_cols=129 Identities=13% Similarity=0.115 Sum_probs=74.7
Q ss_pred EEEEEEE-CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCce--eeEE-----EEEecCCeEEEEEeccCCCCH--
Q 011158 307 DLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV--VQFI-----GACTKPPSLCIVTEFMSGGSV-- 376 (492)
Q Consensus 307 ~Vy~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~HpnI--v~l~-----g~~~~~~~~~lV~Ey~~ggsL-- 376 (492)
.||+++. .|+.|++|+.++...+. +++..|...|..|....| +..+ ..+...+..+.++++++|..+
T Consensus 37 ~vy~v~~~dg~~~VlK~~rp~~~s~---~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 37 RVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp EEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred eeEEEEcCCCCEEEEEEeCCCCCCH---HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 7999976 56789999998764433 567778888877743222 1111 122345668899999976321
Q ss_pred ---HHHH---------Hhc--------CCCCCHH-------------------HHHHHHHHHHHHHHHHHH-------CC
Q 011158 377 ---YDYL---------HKL--------KGVFKLP-------------------SLLKVAIDVSKGMNYLHQ-------NN 410 (492)
Q Consensus 377 ---~~~L---------~~~--------~~~l~~~-------------------~~~~i~~qI~~gL~yLH~-------~~ 410 (492)
.++- +.. +..++.. ....+...+...++.+.. .+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 1111 110 0111111 111122222223333332 26
Q ss_pred ceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 411 IIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 411 IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
+||+|+.+.|||++.+ ..++||++++..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~g 221 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARNG 221 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCEE
T ss_pred eecCCCCcccEEEeCC--ceEEechhcccC
Confidence 8999999999999743 458999999875
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.43 E-value=0.01 Score=55.99 Aligned_cols=140 Identities=13% Similarity=0.102 Sum_probs=73.2
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCC-----ceeeEE-E--EEecCCeEEEEE
Q 011158 297 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK-----NVVQFI-G--ACTKPPSLCIVT 368 (492)
Q Consensus 297 ~~~LG~G~fG~Vy~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~Hp-----nIv~l~-g--~~~~~~~~~lV~ 368 (492)
.+.|..|---+.|+.+..+..+++|+..... +. .++..|+.+|..+... ..+... | +.........++
T Consensus 23 ~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~-~~---~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~ 98 (316)
T d2ppqa1 23 YKGIAEGVENSNFLLHTTKDPLILTLYEKRV-EK---NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI 98 (316)
T ss_dssp EEEECC---EEEEEEEESSCCEEEEEECC----C---CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred eecCCCCcccCeEEEEECCCcEEEEEcCCCC-CH---HHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceee
Confidence 3556677667889998877789999986532 11 3444566666666422 221110 0 112234456667
Q ss_pred eccCCCCHH-----H------HH---HhcC--------CCCCHH------------------HHHHHHHHHHHHHHHHHH
Q 011158 369 EFMSGGSVY-----D------YL---HKLK--------GVFKLP------------------SLLKVAIDVSKGMNYLHQ 408 (492)
Q Consensus 369 Ey~~ggsL~-----~------~L---~~~~--------~~l~~~------------------~~~~i~~qI~~gL~yLH~ 408 (492)
.++.+.... . .+ +... ...... .....+..+...+.-.+.
T Consensus 99 ~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 178 (316)
T d2ppqa1 99 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP 178 (316)
T ss_dssp ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred eecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCc
Confidence 766553221 1 11 1000 000100 011112222222222221
Q ss_pred ----CCceecCCCCCCEEEccCCCeEEEEEeeccee
Q 011158 409 ----NNIIHRDLKAANLLMDENEVSLLLSLCLFTVS 440 (492)
Q Consensus 409 ----~~IiHrDLKp~NILld~~~~~kl~DFGla~~~ 440 (492)
.|+||+|+.+.||+++.+...-++||+++...
T Consensus 179 ~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~~ 214 (316)
T d2ppqa1 179 KDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACND 214 (316)
T ss_dssp CSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred cccccccccCCcchhhhhcccccceeEecccccccc
Confidence 37999999999999998887789999998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.01 E-value=0.033 Score=54.35 Aligned_cols=71 Identities=13% Similarity=0.230 Sum_probs=46.6
Q ss_pred eeeeecCceEEEEEEECC---------ceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCeEEEE
Q 011158 298 SKVASGSYGDLYRGTYCS---------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIV 367 (492)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~g---------~~vAvK~l~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV 367 (492)
+.|+-|-.=.+|++.... +.|.+++.- .. .. .....+|..+++.+. +.-..++++++.. .+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~--~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I 119 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 119 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-ch--hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence 567777777899987632 347777764 22 11 234567899988885 3334577777753 689
Q ss_pred EeccCCCCH
Q 011158 368 TEFMSGGSV 376 (492)
Q Consensus 368 ~Ey~~ggsL 376 (492)
+||++|.+|
T Consensus 120 ~efi~g~~l 128 (395)
T d1nw1a_ 120 EEYIPSRPL 128 (395)
T ss_dssp ECCCCEEEC
T ss_pred EEEeccccC
Confidence 999987433
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=90.68 E-value=0.01 Score=55.81 Aligned_cols=23 Identities=26% Similarity=0.247 Sum_probs=11.4
Q ss_pred CCCCCCCcchhhhhccccCCCCC
Q 011158 141 PPAFGSSPNLEALAIEANNSHNL 163 (492)
Q Consensus 141 pp~~g~~~~l~~L~l~~n~~~g~ 163 (492)
+|+++.+++|+.|+|++|+++|.
T Consensus 237 ~~~~~~~~~L~~L~Ls~N~l~g~ 259 (313)
T d1ogqa_ 237 LGKVGLSKNLNGLDLRNNRIYGT 259 (313)
T ss_dssp GGGCCCCTTCCEEECCSSCCEEC
T ss_pred ccccccccccccccCccCeeccc
Confidence 34445555555555555555444
|